"","Gene Symbol","logFC","AveExpr","t","P.Value","adj.P.Val","B","Direction","Checked","Protein FDR Confidence: Combined","Master","Accession","Description","Exp. q_value: Combined","Sum PEP Score","Coverage [%]","No Peptides","No Isoforms","No PSMs","No Unique Peptides","No AAs","MW [kDa]","calc. pI","Score Sequest HT: Sequest HT","No Peptides (by Search Engine): Sequest HT","Biological Process","Cellular Component","Molecular Function","Pfam IDs","Entrez Gene ID","Gene ID","Ensembl Gene ID","Reactome Pathways","WikiPathways","No Protein Pathway Groups","No Razor Peptides","Abundances (Grouped): 2G11_Control_DMSO_1","Abundances (Grouped): 2G11_Control_DMSO_2","Abundances (Grouped): 2G11_Control_DMSO_3","Abundances (Grouped): SI8_AD_Abeta42_1","Abundances (Grouped): SI8_AD_Abeta42_2","Abundances (Grouped): SI8_AD_Abeta42_3","Abundances (Grouped): SI8_AD_Abeta42_Losma_1","Abundances (Grouped): SI8_AD_Abeta42_Losma_2","Abundances (Grouped): SI8_AD_Abeta42_Losma_3","Found in Sample: [S1] F1: 126, Sample, 2G11_Control_DMSO_1","Found in Sample: [S2] F1: 127N, Sample, 2G11_Control_DMSO_2","Found in Sample: [S3] F1: 127C, Sample, 2G11_Control_DMSO_3","Found in Sample: [S10] F1: 131, Sample, 2G11_Losma","Found in Sample: [S4] F1: 128N, Sample, SI8_AD_Abeta42_1","Found in Sample: [S5] F1: 128C, Sample, SI8_AD_Abeta42_2","Found in Sample: [S6] F1: 129N, Sample, SI8_AD_Abeta42_3","Found in Sample: [S7] F1: 129C, Sample, SI8_AD_Abeta42_Losma_1","Found in Sample: [S8] F1: 130N, Sample, SI8_AD_Abeta42_Losma_2","Found in Sample: [S9] F1: 130C, Sample, SI8_AD_Abeta42_Losma_3","No Protein Groups","Modifications","missing","ENSEMBL"
"1","CRACDL",1.49835050283556,6.50865189797275,16.9817366652022,1.7787821807592e-08,2.90297251899901e-05,10.0419270829309,"UP",FALSE,"High","Master Protein","Q6NV74","CRACD-like protein [OS=Homo sapiens]",0,16.847,3,2,2,3,2,962,102.1,7.96,10.01,2,NA,NA,NA,"Pf15262","343990","Q6NV74","ENSG00000196872",NA,NA,0,0,65.4,73.7,67.6,57.7,51.9,59.9,148.3,172.4,219.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); S690(100)]",0,"ENSG00000196872"
"2","SYT6",1.51121016365614,6.53540845302235,13.2719619809486,1.72978665019563e-07,0.000125631082179995,7.95586994694281,"UP",FALSE,"High","Master Protein","Q5T7P8","Synaptotagmin-6 [OS=Homo sapiens]",0,5.739,2,1,1,1,1,510,57.3,8.19,3.23,1,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi","other molecular function","Pf00168","148281","B1AMB8; B3KPK1; hsa:148281; Q5T7P8","ENSG00000134207",NA,NA,0,0,92.9,100.8,95.5,59.1,34.4,49,157.5,140.1,150.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100)]",0,"ENSG00000134207"
"3","SLC43A2",2.57173861437798,6.05961169722947,12.8581286767598,2.30939489301461e-07,0.000125631082179995,7.68019842637717,"UP",FALSE,"High","Master Protein","Q8N370","Large neutral amino acids transporter small subunit 4 [OS=Homo sapiens]",0,21.372,4,2,2,5,2,569,62.7,7.94,16.42,2,"transport;other biological processes","plasma membrane;other membranes","transporter activity",NA,"124935","B7Z6X9; C9JNU8; D3DTH9; hsa:124935; Q5CD75; Q6IPM1; Q8N370; Q8NBX1; Q8NC21; Q8WZ00","ENSG00000167703; ENSG00000278550","Amino acid transport across the plasma membrane",NA,1,0,64.8,72.8,61.7,25.2,14.4,28.2,175.3,161.7,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S274(100); S297(100)]",0,"ENSG00000167703"
"4","BET1",1.82467266839401,6.4080951992605,12.3725527714456,3.27703868534765e-07,0.000133703178362184,7.34363670063811,"UP",FALSE,"High","Master Protein","O15155","BET1 homolog [OS=Homo sapiens]",0,7.956,9,1,1,2,1,118,13.3,9.06,6.84,1,"cell organization and biogenesis;transport","other membranes;ER/Golgi","other molecular function",NA,"10282","hsa:10282; O15155; Q96EA0","ENSG00000105829","COPI-mediated anterograde transport; COPII-mediated vesicle transport",NA,2,0,49.2,58.8,58.2,41.9,50.9,58.7,203,165,224.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000105829"
"5","MAPK8IP3",0.842060008865094,6.63902424725407,11.7622671520564,5.178808438526e-07,0.000169036307433489,6.89928244571635,"UP",FALSE,"High","Master Protein","Q9UPT6","C-Jun-amino-terminal kinase-interacting protein 3 [OS=Homo sapiens]",0,60.769,4,3,7,14,3,1336,147.4,5.4,42.78,3,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf09744, Pf16471, Pf19056","23162","A2A2B3; A7E2B3; hsa:23162; Q96RY4; Q9H4I4; Q9H7P1; Q9NUG0; Q9UPT6","ENSG00000138834",NA,"MAPK signaling pathway",1,0,75.3,79.1,82.8,85.4,73.5,81.9,139.3,137.5,161.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S273(98.9); T275(98.8); S365(100)]",0,"ENSG00000138834"
"6","CBY1",-0.886901490508166,6.60530564841272,-11.3319872785721,7.24277740128919e-07,0.000169212998788043,6.57074619944622,"DOWN",FALSE,"High","Master Protein","Q9Y3M2","Protein chibby homolog 1 [OS=Homo sapiens]",0,10.338,10,1,1,1,1,126,14.5,9.13,4.11,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus","other molecular function","Pf14645","25776","B2R4S2; hsa:25776; Q66GT6; Q9UIK9; Q9Y3M2","ENSG00000100211","Deactivation of the beta-catenin transactivating complex","Genes related to primary cilium development (based on CRISPR)",2,0,92.1,84.4,92.8,127.1,136.9,143.7,82.2,77.7,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(100)]",0,"ENSG00000100211"
"7","RTN1",-1.34357263424806,6.54616112304086,-11.2369236091113,7.81163707578586e-07,0.000169212998788043,6.49637628269776,"DOWN",FALSE,"High","Master Protein","Q16799","Reticulon-1 [OS=Homo sapiens]",0,20.124,2,1,1,5,1,776,83.6,4.69,18.76,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;ER/Golgi;other cell component",NA,"Pf02453","6252","hsa:6252; Q16799; Q16800; Q16801; Q5BKZ4; Q9BQ59","ENSG00000139970",NA,NA,0,0,81,87.8,96.1,135.4,143.2,179.5,69.6,71.7,61.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S352(100)]",0,"ENSG00000139970"
"8","FUBP3",1.07333695918929,6.58595979189964,11.1619705274081,8.29475484255114e-07,0.000169212998788043,6.43727179122289,"UP",FALSE,"High","Master Protein","Q96I24","Far upstream element-binding protein 3 [OS=Homo sapiens]",0,26.071,6,2,2,4,2,572,61.6,8.38,12.73,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","translational apparatus;nucleus;other cell component","nucleic acid binding activity","Pf00013","8939","A3KFK8; A3KFL0; hsa:8939; Q92946; Q96I24; Q9BVB6","ENSG00000107164",NA,NA,0,0,108,102.8,108.8,62.2,50.3,59.8,116.8,124.1,158.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T76(100); S569(100)]",0,"ENSG00000107164"
"9","EPB41L3",-1.19677184465737,6.47654669115608,-10.9639613896454,9.7362347227197e-07,0.000172269411519833,6.27911631474452,"DOWN",FALSE,"High","Master Protein","Q9Y2J2-4","Isoform 4 of Band 4.1-like protein 3 [OS=Homo sapiens]",0,210.29,13,10,14,55,9,883,98.4,5.34,203.7,10,NA,NA,NA,NA,NA,"Q9Y2J2-4",NA,NA,NA,0,0,46.7,49.7,50.5,176.9,199.1,184.7,85.7,92.6,74.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T401(100); S448(100); S478(100); T487(100); T510(100); S591(99.4); S793(100)]",0,"ENSG00000082397"
"10","NEDD1",0.887550082149845,6.58923807267236,10.8652536922123,1.05557237450878e-06,0.000172269411519833,6.19916596876168,"UP",FALSE,"High","Master Protein","Q8NHV4","Protein NEDD1 [OS=Homo sapiens]",0,10.595,3,2,2,3,2,660,71.9,7.97,8.15,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00400","121441","B0AZN0; B4E145; G3V3F1; hsa:121441; Q8NA30; Q8NHV4","ENSG00000139350","Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2",NA,7,0,60.4,56.4,58.6,97.1,76.6,92.1,145.6,186.3,167.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S397(100); S493(100)]",0,"ENSG00000139350"
"11","NUF2",1.30284865370949,6.20755859607081,10.417737591862,1.53509553607139e-06,0.000219644566850121,5.82711810865489,"UP",FALSE,"High","Master Protein","Q9BZD4","Kinetochore protein Nuf2 [OS=Homo sapiens]",0,4.066,2,1,1,1,1,464,54.3,8.27,2.58,1,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","cytosol;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf03800","83540","hsa:83540; Q8WU69; Q96HJ4; Q96Q78; Q9BZD4","ENSG00000143228","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal",NA,6,0,163.9,148.5,158,23,21,31.1,74.3,95.6,87.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100)]",0,"ENSG00000143228"
"12","RHBDF1",0.944505824892103,6.61765127276924,10.3583103017844,1.6150335797803e-06,0.000219644566850121,5.77650045991506,"UP",FALSE,"High","Master Protein","Q96CC6","Inactive rhomboid protein 1 [OS=Homo sapiens]",0,6.07,2,3,3,5,3,855,97.3,8.44,12.46,3,"cell cycle OR cell proliferation;transport;other biological processes","other membranes;ER/Golgi","other molecular function","Pf01694, Pf12595","64285","hsa:64285; Q04842; Q1W6H2; Q4TT59; Q96CC6; Q96S34; Q9H6E1","ENSG00000007384",NA,NA,0,0,73.1,77.8,70.1,81.8,63.1,91.5,150.1,147.4,163.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100); S390(100)]",0,"ENSG00000007384"
"13","DYNC1I2",0.727841957663792,6.65249886126778,10.1304709415031,1.96658515788719e-06,0.00024688207520553,5.57971527551286,"UP",FALSE,"High","Master Protein","Q13409-2","Isoform 2B of Cytoplasmic dynein 1 intermediate chain 2 [OS=Homo sapiens]",0,138.364,8,2,9,86,2,632,70.6,5.24,266.86,2,NA,NA,NA,NA,NA,"Q13409-2",NA,NA,NA,0,0,78.4,76.1,86.3,84.4,79.9,91.2,134.4,138.2,153.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(99.4); S95(99.3)]",0,"ENSG00000077380"
"14","PPP3CB",1.44216956611534,6.5153411820583,9.66733434202417,2.96955877463445e-06,0.000346165708585958,5.16593648744172,"UP",FALSE,"High","Master Protein","P16298","Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform [OS=Homo sapiens]",0,2.98,2,1,1,1,1,524,59,5.91,3.02,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00149","5532","hsa:5532; P16298; P16299; Q5F2F9; Q8N1F0; Q8N3W4","ENSG00000107758","FCERI mediated Ca+2 mobilization; Ca2+ pathway; CLEC7A (Dectin-1) induces NFAT activation; Calcineurin activates NFAT; DARPP-32 events; ROBO receptors bind AKAP5","Physiological and pathological hypertrophy of the heart; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; Amyotrophic lateral sclerosis (ALS); Initiation of transcription and translation elongation at the HIV-1 LTR; MAPK signaling pathway; Wnt signaling; Alzheimer's disease; Calcium mediated T-cell apoptosis involved in inclusion body myositis",16,0,58.6,66.3,74,53,73.6,59.1,167.6,166.8,214.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S478(100)]",0,"ENSG00000107758"
"15","NDRG2",-0.78625272938371,6.61115989530946,-9.50011255546877,3.45998539076987e-06,0.000376446410515762,5.01182088453489,"DOWN",FALSE,"High","Master Protein","Q9UN36","Protein NDRG2 [OS=Homo sapiens]",0,168.096,13,5,19,95,5,371,40.8,5.21,376.28,5,"cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf03096","57447","B3KUE3; B4DE86; B7WP11; B7WPD5; D3DS07; D3DS10; hsa:57447; Q567T1; Q68DW2; Q86U08; Q86U46; Q96FD3; Q96FT0; Q96JU0; Q96PN0; Q9BQH5; Q9ULH2; Q9UN36","ENSG00000165795",NA,NA,0,0,82.6,88.3,88.9,125.2,162.4,127.8,78.4,83.1,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(100); S338(100); S350(99.6); S352(98.5)]",0,"ENSG00000165795"
"16","FSCN1",0.701821003993111,6.59711760205612,9.04145672316622,5.32366580948082e-06,0.000533131793832802,4.57561559825057,"UP",FALSE,"High","Master Protein","Q16658","Fascin [OS=Homo sapiens]",0,13.023,4,3,3,3,3,493,54.5,7.24,6.15,3,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf06268","6624","A6NI89; B2RE97; hsa:6624; Q16658; Q96IC5; Q96IH1; Q9BRF1","ENSG00000075618","Interleukin-4 and Interleukin-13 signaling","VEGFA-VEGFR2 signaling; Urotensin-II-mediated signaling pathway",3,0,115.8,102.5,106.5,71.6,58.5,72.1,109.8,113.5,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000075618"
"17","RNFT2",0.749237379243282,6.62204385942006,8.92787381737482,5.93942303257438e-06,0.000533131793832802,4.46443087154991,"UP",FALSE,"High","Master Protein","Q96EX2","E3 ubiquitin-protein ligase RNFT2 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,444,48.9,7.84,9.18,1,"other biological processes","other membranes","other molecular function","Pf13639","84900","E9PAM7; hsa:84900; Q96EX2; Q96SU5","ENSG00000135119",NA,NA,0,0,68,64.8,72.2,96.5,73.6,94.9,133.4,163.9,160.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(99.4)]",0,"ENSG00000135119"
"18","GAB1",-0.920809488366646,6.59151200039026,-8.91377954403419,6.0211098329111e-06,0.000533131793832802,4.45054427203839,"DOWN",FALSE,"High","Master Protein","Q13480-2","Isoform 2 of GRB2-associated-binding protein 1 [OS=Homo sapiens]",0,198.627,27,13,17,32,13,724,80,6.38,112.45,13,NA,NA,NA,NA,NA,"Q13480-2",NA,NA,NA,0,0,78.7,79.6,83.9,138.3,177.1,127.3,79.1,91,75.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S266(100); S274(100); S383(99.4); S402(100); S454(100); T503(99.4); S531(100); S547(100); S713(100)]",0,"ENSG00000109458"
"19","TRA2A",-0.796671760973086,6.40324924270511,-8.88250261894664,6.20680397231816e-06,0.000533131793832802,4.41965677835099,"DOWN",FALSE,"High","Master Protein","Q13595","Transformer-2 protein homolog alpha [OS=Homo sapiens]",0,21.595,13,6,8,27,6,282,32.7,11.27,60.44,6,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf00076","29896","B4DQI6; B4DUA9; E9PD75; hsa:29896; Q13595","ENSG00000164548",NA,"Orexin receptor pathway",1,0,149.7,130.9,128.1,93.4,69.8,96.5,58.7,62.6,61.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.6); T88(100); S260(99.7); S262(100); S278(100)]",0,"ENSG00000164548"
"20","DDB2",0.90387540146152,6.60196538776446,8.7296654088896,7.20891841306916e-06,0.000588247742506444,4.26729330513419,"UP",FALSE,"High","Master Protein","Q92466","DNA damage-binding protein 2 [OS=Homo sapiens]",0,19.569,3,1,2,4,1,427,47.8,9.47,14.67,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","1643","B2R875; hsa:1643; Q76E54; Q76E55; Q76E56; Q76E57; Q92466","ENSG00000134574","TP53 Regulates Transcription of DNA Repair Genes; Ub-specific processing proteases; Neddylation; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER","miRNA regulation of DNA damage response; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Small cell lung cancer; Hepatitis B infection; Melanoma; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum ; DNA damage response",21,0,75.7,74.9,67.9,85.8,70.7,79.1,160.5,133.4,156,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.7)]",0,"ENSG00000134574"
"21","SDC2",-0.706169455447318,6.52559685902118,-8.60642361553469,8.14609721068472e-06,0.000633068126087498,4.14268076554494,"DOWN",FALSE,"High","Master Protein","P34741","Syndecan-2 [OS=Homo sapiens]",0,7.564,4,1,1,2,1,201,22.1,4.86,7.52,1,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01034","6383","B3KQA3; hsa:6383; P34741; Q6PIS6; Q9H6V1","ENSG00000169439","Cell surface interactions at the vascular wall; RSV-host interactions; Respiratory syncytial virus (RSV) attachment and entry; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; EPHB-mediated forward signaling; A tetrasaccharide linker sequence is required for GAG synthesis; HS-GAG biosynthesis; HS-GAG degradation; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS; Defective B3GALT6 causes EDSP2 and SEMDJL1; Attachment and Entry; Retinoid metabolism and transport; Syndecan interactions","miRNA targets in ECM and membrane receptors",18,0,39.1,43.2,42.3,153.4,197.3,170.5,111.1,106.3,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100)]",0,"ENSG00000169439"
"22","MAP2K6",1.76325843295537,6.37985471380844,8.50858737166629,8.98499068374852e-06,0.000659364593055759,4.04262286351816,"UP",FALSE,"High","Master Protein","P52564","Dual specificity mitogen-activated protein kinase kinase 6 [OS=Homo sapiens]",0,14.907,5,1,2,3,1,334,37.5,7.39,7.86,1,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5608","hsa:5608; P52564","ENSG00000108984","PKR-mediated signaling; Interleukin-1 signaling; Oxidative Stress Induced Senescence; Myogenesis; NOD1/2 Signaling Pathway; activated TAK1 mediates p38 MAPK activation; PI5P Regulates TP53 Acetylation","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Photodynamic therapy-induced AP-1 survival signaling; TGF-beta signaling pathway; MAPK signaling pathway; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; p38 MAPK signaling pathway; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; 16p11.2 proximal deletion syndrome; Angiotensin II receptor type 1 pathway; Pleural mesothelioma; GNAQ pathways in port-wine stain; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Toll-like receptor signaling pathway",41,0,60,39.1,65.6,55.5,32.4,65.8,165.1,181.2,264.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000108984"
"23","PTPN21",-0.740657330910838,6.61823108368945,-8.44583882454969,9.57244206112999e-06,0.000659364593055759,3.9779144758798,"DOWN",FALSE,"High","Master Protein","Q16825","Tyrosine-protein phosphatase non-receptor type 21 [OS=Homo sapiens]",0,37.252,2,2,2,3,2,1174,133.2,7.9,10.91,2,"protein metabolism;other metabolic processes","cytoskeleton;other cell component","other molecular function","Pf00102, Pf00373, Pf09379, Pf09380","11099","hsa:11099; Q16825","ENSG00000070778",NA,NA,0,0,96.2,90,88.2,123.3,124.4,139.8,81.7,81.1,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S590(99.5); S673(100)]",0,"ENSG00000070778"
"24","TMEM230",1.28443761295838,6.55761211349922,8.43312171012966,9.69653813317293e-06,0.000659364593055759,3.96474881025227,"UP",FALSE,"High","Master Protein","Q96A57","Transmembrane protein 230 [OS=Homo sapiens]",0,35.98,22,3,4,9,3,120,13.2,9.31,31.81,3,"transport","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf05915","29058","B2RDM8; D3DVZ9; hsa:29058; Q0VGC8; Q5TDS5; Q96A57; Q96ES2; Q9P0A7","ENSG00000089063",NA,NA,0,0,73.2,77.7,73.7,53.5,75.1,61.8,173.9,136,178.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(99.7); S24(99.7)]",0,"ENSG00000089063"
"25","SLC35C2",1.06860894730667,6.62574470058461,8.34292349048376,1.06287852645835e-05,0.00069384710207201,3.87086867251997,"UP",FALSE,"High","Master Protein","Q9NQQ7","Solute carrier family 35 member C2 [OS=Homo sapiens]",0,14.897,4,1,1,2,1,365,40.4,8.18,7.68,1,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus","transporter activity","Pf03151","51006","B7Z6V6; E1P5T0; hsa:51006; Q53GK3; Q5JW05; Q96CJ8; Q9NQQ7; Q9Y304","ENSG00000080189",NA,NA,0,0,93.4,79.4,91.6,57.1,67.8,76.2,145.4,128.9,171.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000080189"
"26","PHKB",0.715120347819452,6.6360461935612,8.27141238114876,1.14374935153871e-05,0.000717922669888916,3.79580999559191,"UP",FALSE,"High","Master Protein","Q93100","Phosphorylase b kinase regulatory subunit beta [OS=Homo sapiens]",0,22.336,3,2,2,6,2,1093,124.8,6.95,20.39,2,"other metabolic processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00723, Pf19292","5257","hsa:5257; Q8N4T5; Q93100","ENSG00000102893","Glycogen breakdown (glycogenolysis)","Glycogen synthesis and degradation",2,0,97.6,108.5,96.2,69.6,64.9,85.1,117.2,129.9,129.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S701(98.8)]",0,"ENSG00000102893"
"27","CD276",0.710332812233631,6.64384790432523,8.22662594860681,1.19780339130413e-05,0.000720199786506586,3.74851603806467,"UP",FALSE,"High","Master Protein","Q5ZPR3","CD276 antigen [OS=Homo sapiens]",0,8.236,2,1,1,6,1,534,57.2,4.91,14.91,1,"signal transduction;other biological processes","plasma membrane;other membranes","signal transduction activity or receptor binding","Pf07686, Pf13927","80381","hsa:80381; Q5ZPR3; Q6P5Y4; Q6UXI2; Q8NBI8; Q8NC34; Q8NCB6; Q9BXR1","ENSG00000103855",NA,NA,0,0,80.7,93,88.7,82.9,77.7,80.2,134.5,122.8,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S525(100)]",0,"ENSG00000103855"
"28","CDK17",0.735963696509305,6.6382221717937,8.19657173501261,1.23563688861424e-05,0.000720199786506586,3.71665492250649,"UP",FALSE,"High","Master Protein","Q00537","Cyclin-dependent kinase 17 [OS=Homo sapiens]",0,8.861,3,2,2,2,1,523,59.5,9.03,5.45,2,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","5128","A8K1U6; B2RCQ2; hsa:5128; Q00537; Q8NEB8","ENSG00000059758",NA,NA,0,1,87.4,80.1,85.7,74.7,80,88.1,124.6,132.6,157.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(100); S146(100)]",0,"ENSG00000059758"
"29","ALKBH5",1.18443988573265,6.57972458851926,8.10912428112593,1.35333588750169e-05,0.000761601437380262,3.62337839681239,"UP",FALSE,"High","Master Protein","Q6P6C2","RNA demethylase ALKBH5 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,394,44.2,9.09,5.81,1,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;ER/Golgi;nucleus","other molecular function","Pf13532","54890","B4DVJ4; D3DXC6; hsa:54890; Q6P6C2; Q9NXD6","ENSG00000091542","Reversal of alkylation damage by DNA dioxygenases","Smith-Magenis and Potocki-Lupski syndrome copy number variation",2,0,62.2,67.3,75.5,61,87.7,67.1,154.6,153.2,217.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000091542"
"30","MACF1",0.518896757129422,6.66526077221085,8.01318853082253,1.49670014110453e-05,0.00079073382850618,3.52005960818937,"UP",FALSE,"High","Master Protein","Q9UPN3","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 [OS=Homo sapiens]",0,107.817,2,7,8,14,4,7388,837.8,5.39,59.11,7,"cell-cell signaling;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00435, Pf00681, Pf02187, Pf13499, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097","23499","B1ALC5; E9PJT0; hsa:23499; O75053; Q5VW20; Q8WXY1; Q8WXY2; Q96PK2; Q9H540; Q9UKP0; Q9ULG9; Q9UPN3","ENSG00000127603",NA,"Mesodermal commitment pathway; Mesodermal commitment pathway",2,2,97.6,100.8,101,84.3,74.8,88.9,119.8,116.8,125.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100); S280(100); S3927(100); S4167(100); S5592(98.8); S6967(100); S7330(100)]",0,"ENSG00000127603"
"31","CSRP1",-1.00011535876782,6.48518987089963,-8.00983233532937,1.50200665953993e-05,0.00079073382850618,3.51642625118969,"DOWN",FALSE,"High","Master Protein","P21291","Cysteine and glycine-rich protein 1 [OS=Homo sapiens]",0,45.601,19,2,2,5,2,193,20.6,8.57,19.52,2,"cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00412","1465","A8K268; hsa:1465; P21291; Q5U0J2","ENSG00000159176","MTF1 activates gene expression","MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling",3,0,42.8,45.3,41.9,160.4,203.8,185.8,82.2,108.2,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S192(100)]",0,"ENSG00000159176"
"32","PSMA5",0.649482148342142,6.65464725144736,7.90441189830267,1.67959242800841e-05,0.000856592138284288,3.40164449820954,"UP",FALSE,"High","Master Protein","P28066","Proteasome subunit alpha type-5 [OS=Homo sapiens]",0,37.796,5,1,3,9,1,241,26.4,4.79,29.19,1,"protein metabolism;other metabolic processes","non-structural extracellular;cytosol;nucleus;other cell component",NA,"Pf00227, Pf10584","5686","B2R8F6; B4E2V4; hsa:5686; P28066; Q3T1C1; Q6IBF7","ENSG00000143106","Downstream TCR signaling; Separation of Sister Chromatids; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease",63,0,90.7,83.7,86.9,90.4,73,86.4,136.5,132.3,127.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S56(100)]",0,"ENSG00000143106"
"33","ZSCAN18",-0.554865971554189,6.64327843604435,-7.72009554148309,2.04761455272638e-05,0.000970381913598646,3.19786822564408,"DOWN",FALSE,"High","Master Protein","Q8TBC5","Zinc finger and SCAN domain-containing protein 18 [OS=Homo sapiens]",0,28.922,7,3,3,4,3,510,54.8,4.82,16.92,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf02023","65982","B4DG23; E9PBI0; hsa:65982; Q8TBC5; Q9BRK7; Q9H9A0","ENSG00000121413",NA,NA,0,0,78.4,75.3,81,129.1,138.7,137.5,96.8,91.7,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(99.4); S14(99.6)]",0,"ENSG00000121413"
"34","FRMD8",0.811824052377937,6.5719811708189,7.70970187333575,2.0708379517426e-05,0.000970381913598646,3.18625844539089,"UP",FALSE,"High","Master Protein","Q9BZ67","FERM domain-containing protein 8 [OS=Homo sapiens]",0,19.272,6,2,2,7,2,464,51.2,6.23,23.03,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus",NA,"Pf00373","83786","B4E2P1; hsa:83786; Q86V56; Q8NCB5; Q9BZ67","ENSG00000126391",NA,NA,0,0,61.3,47.4,50.4,95.1,93.7,99.1,153.7,165,184.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S439(100); S446(100)]",0,"ENSG00000126391"
"35","PSMD1",0.620476203252998,6.61557991979233,7.68297293228812,2.13188895754851e-05,0.000970381913598646,3.15634328660686,"UP",FALSE,"High","Master Protein","Q99460","26S proteasome non-ATPase regulatory subunit 1 [OS=Homo sapiens]",0,56.743,5,4,4,9,4,953,105.8,5.39,36.02,4,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf01851, Pf13646, Pf18004, Pf21505","5707","B8ZZH9; hsa:5707; Q24JU0; Q53TI2; Q6GMU5; Q6P2P4; Q6PJM7; Q6PKG9; Q86VU1; Q8IV79; Q99460","ENSG00000173692","Neutrophil degranulation; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cross-presentation of soluble exogenous antigens (endosomes); Regulation of ornithine decarboxylase (ODC); Somitogenesis","Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",64,0,111.7,109.7,109.5,78.7,57.6,75.8,118.1,114.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T273(100); T311(100); S315(100)]",0,"ENSG00000173692"
"36","CCDC177",-0.699592864125708,6.56685281141405,-7.67924936899339,2.14054833882054e-05,0.000970381913598646,3.15216912574193,"DOWN",FALSE,"High","Master Protein","Q9NQR7","Coiled-coil domain-containing protein 177 [OS=Homo sapiens]",0,2.764,2,2,3,3,2,707,79.7,10.74,4.2,2,NA,NA,NA,"Pf15558","56936","B2R5G1; hsa:56936; Q2M359; Q9NQR7","ENSG00000267909",NA,NA,0,0,99.3,105,98.4,109.3,136.3,112.6,82.6,73.4,76.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100)]",0,"ENSG00000267909"
"37","SUGT1",0.892021394631988,6.61733209490828,7.62079343162864,2.28163500515682e-05,0.000984704647730313,3.08642269324406,"UP",FALSE,"High","Master Protein","Q9Y2Z0","Protein SGT1 homolog [OS=Homo sapiens]",0,8.827,3,1,1,1,1,365,41,5.16,3.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04969, Pf05002","10910","A2A303; hsa:10910; Q5JAK5; Q5TAM6; Q6VXY6; Q9Y2Z0","ENSG00000165416","The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection","Nucleotide-binding oligomerization domain (NOD) pathway",3,0,94.3,83.7,71.7,83.1,59.6,82.6,128.1,143,158.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T265(100)]",0,"ENSG00000165416"
"38","BIN1",-0.723903200955561,6.58853848432059,-7.61632978813101,2.29281719447009e-05,0.000984704647730313,3.08138556941896,"DOWN",FALSE,"High","Master Protein","O00499","Myc box-dependent-interacting protein 1 [OS=Homo sapiens]",0,52.068,7,3,4,9,3,593,64.7,5.06,34.16,3,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf03114, Pf14604","274","hsa:274; O00297; O00499; O00545; O43867; O60552; O60553; O60554; O60555; O75514; O75515; O75516; O75517; O75518; Q659B7; Q92944; Q99688","ENSG00000136717","Clathrin-mediated endocytosis","VEGFA-VEGFR2 signaling; IL-18 signaling pathway",3,0,63.7,60,64.6,145.5,189.9,131,92.4,95.4,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S331(99.2)]",0,"ENSG00000136717"
"39","SRSF10",-0.828769983053164,6.55986209277031,-7.56279899204381,2.43167271919274e-05,0.00100843761683576,3.02079076744516,"DOWN",FALSE,"High","Master Protein","O75494","Serine/arginine-rich splicing factor 10 [OS=Homo sapiens]",0,13.606,12,3,3,7,3,262,31.3,11.27,6.86,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","10772","A6NFM6; A6NI42; A6NIU7; B4DJP9; hsa:10772; O60572; O75494; Q5JRH9; Q5JRI0; Q5JRI2; Q5JRI3; Q5JRI4; Q96G09; Q96P17","ENSG00000188529","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,99.7,93.8,103.1,124.6,108.5,126.9,68.3,84.8,72.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.4); S133(100); S160(100)]",0,"ENSG00000188529"
"40","NEDD4L",-0.729503781262698,6.64669226924092,-7.54799875411571,2.47166082557784e-05,0.00100843761683576,3.00397653139952,"DOWN",FALSE,"High","Master Protein","Q96PU5","E3 ubiquitin-protein ligase NEDD4-like [OS=Homo sapiens]",0,54.193,5,3,3,6,3,975,111.9,5.82,23.04,3,"protein metabolism;other metabolic processes;transport;other biological processes","cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf00397, Pf00632","23327","hsa:23327; O43165; Q3LSM7; Q7Z5F1; Q7Z5F2; Q7Z5N3; Q8N5A7; Q8WUU9; Q96PU5; Q9BW58; Q9H2W4; Q9NT88","ENSG00000049759","Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Budding and maturation of HIV virion; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity","TGF-beta signaling pathway",6,0,76,74,73.2,149.9,147.2,137.6,94.7,97.9,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(99.6); S448(99.5); S479(100); S487(100)]",0,"ENSG00000049759"
"41","MTFR1",0.537950468540331,6.64963461935281,7.41066568747173,2.87880945411816e-05,0.0011459065924685,2.84668530755325,"UP",FALSE,"High","Master Protein","Q15390","Mitochondrial fission regulator 1 [OS=Homo sapiens]",0,12.967,8,2,2,2,2,333,37,9.01,6.44,2,"cell organization and biogenesis;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion",NA,"Pf05308","9650","E7EP84; hsa:9650; Q15390; Q6IB94; Q7Z669; Q86XH5; Q8IVD7","ENSG00000066855",NA,NA,0,0,79.8,75.9,75.5,91.5,93.7,96.4,131.3,129.7,146.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S290(100)]",0,"ENSG00000066855"
"42","SORBS2",-0.609425903536809,6.63651113914943,-7.35030044795794,3.08039655823187e-05,0.00117568085036837,2.77681535195453,"DOWN",FALSE,"High","Master Protein","O94875-10","Isoform 10 of Sorbin and SH3 domain-containing protein 2 [OS=Homo sapiens]",0,30.799,6,4,4,6,4,824,91.2,9.17,15.74,4,NA,NA,NA,NA,NA,"O94875-10",NA,NA,NA,0,0,79,77.2,81.1,133.1,146.1,127.6,87.5,100.9,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S136(100); S510(100); S529(99.5); S553(98.8)]",0,"ENSG00000154556"
"43","DCLK1",-0.786554745686655,6.59906111020914,-7.3453238094415,3.09768851506371e-05,0.00117568085036837,2.77103500672524,"DOWN",FALSE,"High","Master Protein","O15075","Serine/threonine-protein kinase DCLK1 [OS=Homo sapiens]",0,342.64,31,23,55,98,3,740,82.2,8.66,273.34,23,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","kinase activity;other molecular function","Pf00069, Pf03607","9201","B7Z3E9; hsa:9201; O15075; Q5VZY8; Q5VZZ0; Q5VZZ1","ENSG00000133083",NA,"Orexin receptor pathway",1,26,65.5,67.3,70.8,149.8,186.7,126.9,90.4,88.2,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100); S36(100); T46(100); S77(100); S172(100); S212(99.5); S298(100); S307(100); S313(99.3); S332(99.3); T336(99.2); S337(100); S352(100); S353(100); S355(98.5); S364(99.5); S735(100); S738(100)]",0,"ENSG00000133083"
"44","PLEKHA7",-0.697720980783776,6.63732992991297,-7.27283672954744,3.36189650905506e-05,0.00124695797790406,2.68649217024531,"DOWN",FALSE,"High","Master Protein","Q6IQ23","Pleckstrin homology domain-containing family A member 7 [OS=Homo sapiens]",0,69.163,6,5,9,11,5,1121,127.1,9.35,37.45,5,"cell adhesion;cell organization and biogenesis","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00169","144100","B4DK33; B4DWC3; hsa:144100; Q6IQ23; Q86VZ7","ENSG00000166689",NA,NA,0,0,90.9,89,94.5,132.2,138.9,121.8,93.4,85.2,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S536(100); S612(100); S903(99.5); S907(99.5); S986(100)]",0,"ENSG00000166689"
"45","UCHL3",-0.659083150120879,6.60241411647376,-6.92080314204998,5.04568854893502e-05,0.00173758572616062,2.26644539397059,"DOWN",FALSE,"High","Master Protein","P15374","Ubiquitin carboxyl-terminal hydrolase isozyme L3 [OS=Homo sapiens]",0,11.031,6,1,1,1,1,230,26.2,4.92,3.41,1,"protein metabolism;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf01088","7347","B2R970; hsa:7347; P15374; Q5TBK8; Q6IBE9","ENSG00000118939","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; UCH proteinases; Neddylation","Proteasome degradation",4,0,82,82.2,78.7,129.6,156.3,120,85.6,84.3,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]",0,"ENSG00000118939"
"46","RPS3",0.647224050038435,6.53297065992761,6.9018576789443,5.15927118069514e-05,0.00173758572616062,2.24338657644939,"UP",FALSE,"High","Master Protein","P23396","Small ribosomal subunit protein uS3 [OS=Homo sapiens]",0,36.532,12,3,4,10,3,243,26.7,9.66,31.23,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00189, Pf07650","6188","B2R7N5; hsa:6188; J3KN86; P23396; Q498B5; Q8NI95","ENSG00000149273","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,130.4,118.2,121,65.2,41,68.5,101.6,106.6,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T221(100)]",0,"ENSG00000149273"
"47","SPTBN1",-0.473972075165039,6.63237649868225,-6.88740232169996,5.24780169753932e-05,0.00173758572616062,2.22576114172756,"NONE",FALSE,"High","Master Protein","Q01082","Spectrin beta chain, non-erythrocytic 1 [OS=Homo sapiens]",0,262.899,6,15,27,76,15,2364,274.4,5.57,219.28,15,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00307, Pf00435","6711","B2RP63; hsa:6711; O60837; Q01082; Q16057; Q53R99; Q59ER3; Q8IX99","ENSG00000115306","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins; Signaling by FLT3 fusion proteins","TGF-beta signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",12,0,90.1,90.3,86.9,122.6,126.5,119.7,90.6,94.7,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2102(100); S2138(100); S2161(99.3); T2187(100); T2195(100); S2316(99.5); T2328(100); S2358(100)]",0,"ENSG00000115306"
"48","ARHGEF6",0.796198041900778,6.55807626972395,6.87937478492839,5.29767692521493e-05,0.00173758572616062,2.21596132729382,"UP",FALSE,"High","Master Protein","Q15052","Rho guanine nucleotide exchange factor 6 [OS=Homo sapiens]",0,66.098,5,4,5,38,3,776,87.4,6.05,102.24,4,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00169, Pf00307, Pf00621, Pf07653, Pf16523, Pf16614, Pf16615","9459","A6NMW9; A8K6S7; B1AL37; hsa:9459; Q15052; Q15396; Q5JQ66; Q7Z3W1; Q86XH0","ENSG00000129675","CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOU GTPase cycle; G beta:gamma signalling through CDC42; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Pancreatic adenocarcinoma pathway; Regulation of actin cytoskeleton",9,2,120.9,130.6,117,56.2,52.7,62.5,117.2,94,123.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100); S488(100); S640(100); S684(100)]",0,"ENSG00000129675"
"49","GOLGA4",0.645402822682991,6.63738640607905,6.87919627462064,5.29879184637785e-05,0.00173758572616062,2.21574331032027,"UP",FALSE,"High","Master Protein","Q13439","Golgin subfamily A member 4 [OS=Homo sapiens]",0,25.662,2,4,4,6,4,2230,261,5.39,15.33,4,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01465","2803","F8W8Q7; hsa:2803; Q13270; Q13439; Q13654; Q14436; Q59EW8","ENSG00000144674","Retrograde transport at the Trans-Golgi-Network; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB",NA,2,0,103.9,95.3,100.5,75.7,70.7,80.8,130.5,110.2,126.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(99.7); S71(100); S89(100); S266(100)]",0,"ENSG00000144674"
"50","JUN",0.922343050812009,6.61318726109952,6.87525295984052,5.32348568063915e-05,0.00173758572616062,2.21092622170951,"UP",FALSE,"High","Master Protein","P05412","Transcription factor Jun [OS=Homo sapiens]",0,7.778,4,1,2,2,1,331,35.7,8.76,5.31,1,"stress response;signal transduction;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00170, Pf03957","3725","hsa:3725; P05412; Q6FHM7; Q96G93","ENSG00000177606","FCERI mediated MAPK activation; MAPK6/MAPK4 signaling; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; TP53 Regulates Transcription of DNA Repair Genes; Signaling by ALK fusions and activated point mutants; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); WNT5:FZD7-mediated leishmania damping; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Activation of the AP-1 family of transcription factors","IL-5 signaling pathway; Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Quercetin and Nf-kB / AP-1 induced apoptosis; ATM signaling pathway; Apoptosis; Polycystic kidney disease pathway; Selenium metabolism and selenoproteins; IL-3 signaling pathway; Aryl hydrocarbon receptor pathway; Glucocorticoid receptor pathway; Estrogen receptor pathway; Nuclear receptors meta-pathway; Myometrial relaxation and contraction pathways; Focal adhesion; Hepatocyte growth factor receptor signaling; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; MFAP5-mediated ovarian cancer cell motility and invasiveness; Photodynamic therapy-induced AP-1 survival signaling; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Signal transduction through IL1R; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Neural crest cell migration during development; Neural crest cell migration in cancer; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Insulin signaling; TGF-beta receptor signaling in skeletal dysplasias; Host-pathogen interaction of human coronaviruses - MAPK signaling; Host-pathogen interaction of human coronaviruses - interferon induction; IL-2 signaling pathway; 3q29 copy number variation syndrome; Neuroinflammation; MAPK pathway in congenital thyroid cancer; Pleural mesothelioma; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q37 copy number variation syndrome; TROP2 regulatory signaling; IL-26 signaling pathways; Macrophage-stimulating protein (MSP) signaling network map; Osteoarthritic chondrocyte hypertrophy; 5q35 copy number variation; TGF-beta receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response (only ATM dependent); Estrogen signaling pathway; Toll-like receptor signaling pathway",98,0,81.3,82.5,77.1,70.2,85.2,69.8,138.1,124.3,180.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(99.4)]",0,"ENSG00000177606"
"51","EDC4",-0.698196324129946,6.62503014997971,-6.78170341502759,5.94753092535897e-05,0.00185792432116571,2.0960468702364,"DOWN",FALSE,"High","Master Protein","Q6P2E9","Enhancer of mRNA-decapping protein 4 [OS=Homo sapiens]",0,81.999,7,4,6,15,4,1401,151.6,5.86,80.67,4,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component",NA,"Pf16529, Pf21289","23644","A6NGM1; A8K4T4; hsa:23644; Q13025; Q13826; Q6P2E9; Q6ZR12; Q7Z6H7","ENSG00000038358","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,84.4,94.6,106.6,119.2,119.7,138.1,78.8,82.4,89.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S723(99.3); S729(99.4); S844(100); S879(100)]",0,"ENSG00000038358"
"52","DHCR7",0.943309024416291,6.58670254155973,6.75573651605589,6.13451844345098e-05,0.00185792432116571,2.06395400608771,"UP",FALSE,"High","Master Protein","Q9UBM7","7-dehydrocholesterol reductase [OS=Homo sapiens]",0,14.413,2,2,2,5,2,475,54.5,8.7,11.14,2,"other metabolic processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf01222","1717","B2R6Z2; hsa:1717; O60492; O60717; Q9UBM7","ENSG00000172893","Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis via desmosterol; Cholesterol biosynthesis via lathosterol","Vitamin D metabolism; Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism",10,0,69.9,80.6,80.9,65.7,85.8,70.5,140.9,124.7,176.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000172893"
"53","ARHGEF7",0.774515478281007,6.64836110426358,6.74132843998844,6.24101523980077e-05,0.00185792432116571,2.0461081713729,"UP",FALSE,"High","Master Protein","Q14155-1","Isoform 1 of Rho guanine nucleotide exchange factor 7 [OS=Homo sapiens]",0,35.104,6,4,6,33,3,646,73.1,7.21,77.24,4,NA,NA,NA,NA,NA,"Q14155-1",NA,NA,NA,0,0,91.2,84.4,89.8,80,86.6,69.9,125.8,127.9,163.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100); S340(100); S498(99.5); S516(100)]",0,"ENSG00000102606"
"54","GPSM1",0.654705262746726,6.62306837350459,6.73861046082154,6.2613291049261e-05,0.00185792432116571,2.042738583495,"UP",FALSE,"High","Master Protein","Q86YR5","G-protein-signaling modulator 1 [OS=Homo sapiens]",0,36.39,8,3,4,8,3,675,74.5,6.54,19.29,3,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf02188, Pf13424","26086","A9Z1X4; B1B0W3; hsa:26086; Q86SR5; Q86YR5; Q969T1; Q9UFS8","ENSG00000160360","G alpha (i) signalling events",NA,1,0,100,92.9,104.7,71.8,77.6,73.5,109.8,123.1,136.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S471(100); S492(99.8); S545(98.6)]",0,"ENSG00000160360"
"55","ZYX",0.76359473329575,6.61879389575667,6.73860271325777,6.2613871117717e-05,0.00185792432116571,2.04272897712172,"UP",FALSE,"High","Master Protein","Q15942","Zyxin [OS=Homo sapiens]",0,59.321,12,5,6,17,5,572,61.2,6.67,48.77,5,"cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00412","7791","A4D2G6; B4DQX7; hsa:7791; Q15942; Q6I9S4","ENSG00000159840; ENSG00000285443",NA,"Integrin-mediated cell adhesion; Focal adhesion",2,0,66.6,72.9,68.8,83.2,105.5,82,145.1,137,163.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S259(99.5); S267(100); S281(100); S344(100)]",0,"ENSG00000159840"
"56","PGRMC2",0.925364326926502,6.59122485708416,6.71672740127128,6.42751884363075e-05,0.00187316263442953,2.01557336755453,"UP",FALSE,"High","Master Protein","O15173","Membrane-associated progesterone receptor component 2 [OS=Homo sapiens]",0,32.159,12,2,2,5,2,223,23.8,4.88,23.86,2,"transport;signal transduction;other biological processes","ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00173","10424","hsa:10424; O15173; Q569H1","ENSG00000164040","RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Heme signaling","Ciliary landscape",7,0,100.7,97.2,84.3,64.9,65.3,66.1,152,114.8,128.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S104(100)]",0,"ENSG00000164040"
"57","USP10",0.512170383558337,6.6461925893896,6.65739487036431,6.90267944861225e-05,0.00194362253758767,1.94159669493343,"UP",FALSE,"High","Master Protein","Q14694","Ubiquitin carboxyl-terminal hydrolase 10 [OS=Homo sapiens]",0,33.398,9,3,4,6,3,798,87.1,5.31,21.59,3,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;translational apparatus;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00443, Pf07145","9100","B2RDJ8; B4DS84; hsa:9100; Q14694; Q9BWG7; Q9NSL7","ENSG00000103194","Ub-specific processing proteases; Termination of translesion DNA synthesis","VEGFA-VEGFR2 signaling",3,0,93.2,91.5,94.8,84.2,72.3,95.3,115.7,129.5,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(99.3); S211(99.3); S365(100)]",0,"ENSG00000103194"
"58","LIMA1",0.590949693533855,6.62894191592417,6.65681802644358,6.90748205760322e-05,0.00194362253758767,1.94087515857823,"UP",FALSE,"High","Master Protein","Q9UHB6","LIM domain and actin-binding protein 1 [OS=Homo sapiens]",0,123.889,17,11,13,38,11,759,85.2,6.84,109.95,11,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412","51474","B2RB09; hsa:51474; Q2TAN7; Q59FE8; Q9BVF2; Q9H8J1; Q9HBN5; Q9NX96; Q9NXC3; Q9NXU6; Q9P0H8; Q9UHB5; Q9UHB6","ENSG00000050405",NA,NA,0,0,71.2,74.3,74.7,90.6,102.7,87.3,131.7,130.5,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S132(100); S225(99.2); S362(100); S369(99.7); S490(100); S609(100); S617(100); S698(100); S726(100)]",0,"ENSG00000050405"
"59","CHMP2B",-0.53807062114843,6.62873131123347,-6.58192415977031,7.56290751861646e-05,0.00209197713057323,1.84681423871824,"DOWN",FALSE,"High","Master Protein","Q9UQN3-2","Isoform 2 of Charged multivesicular body protein 2b [OS=Homo sapiens]",0,11.604,9,2,2,3,2,172,19.1,6.24,9.88,2,NA,NA,NA,NA,NA,"Q9UQN3-2",NA,NA,NA,0,0,100,92.6,103.4,109.3,136.8,117.9,87.2,86.2,85.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100)]; Met-loss [N-Term]",0,"ENSG00000083937"
"60","CHCHD3",1.02085859736361,6.26133388119218,6.53709641801308,7.98725804914777e-05,0.00217253418936819,1.79015070651745,"UP",FALSE,"High","Master Protein","Q9NX63","MICOS complex subunit MIC19 [OS=Homo sapiens]",0,30.401,7,1,1,4,1,227,26.1,8.28,17.74,1,"cell organization and biogenesis","other membranes;mitochondrion;nucleus","other molecular function","Pf05300","54927","hsa:54927; Q9NX63","ENSG00000106554","Cristae formation; Mitochondrial protein import",NA,2,0,149.5,152.7,135.1,27,27.4,36.4,104.5,68.2,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000106554"
"61","RAB11FIP2",0.635178788443087,6.64909741781564,6.50803889183701,8.27607020642252e-05,0.00218056434133171,1.75327508120402,"UP",FALSE,"High","Master Protein","Q7L804","Rab11 family-interacting protein 2 [OS=Homo sapiens]",0,4.701,3,2,2,3,2,512,58.2,9.32,6.42,2,"cell-cell signaling;transport;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf09457","22841","A6NEI4; hsa:22841; Q3I768; Q7L804; Q9Y2F0","ENSG00000107560","Vasopressin regulates renal water homeostasis via Aquaporins",NA,1,0,101.4,97.4,100.5,73.3,83,76.1,128.9,115,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S277(100); T317(100)]",0,"ENSG00000107560"
"62","CCND2",0.813653815273907,6.60622985921183,6.50725598708562,8.28400668888271e-05,0.00218056434133171,1.75227993758454,"UP",FALSE,"High","Master Protein","P30279","G1/S-specific cyclin-D2 [OS=Homo sapiens]",0,4.551,7,1,1,1,1,289,33,5.19,2.69,1,"cell cycle OR cell proliferation;other biological processes","other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00134, Pf02984","894","A8K531; hsa:894; P30279; Q13955; Q5U035","ENSG00000118971","Cyclin D associated events in G1; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Drug-mediated inhibition of CDK4/CDK6 activity; Regulation of RUNX1 Expression and Activity","miRNA regulation of DNA damage response; Cell cycle; SRF and miRs in smooth muscle differentiation and proliferation; Glioblastoma signaling pathways; Focal adhesion; Ovarian infertility; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; G1 to S cell cycle control; Measles virus infection; IL-2 signaling pathway; Pleural mesothelioma; Hippocampal synaptogenesis and neurogenesis; JAK-STAT signaling in the regulation of beta cells; DNA damage response; DNA damage response (only ATM dependent)",24,0,70.3,75.6,63,85.6,97.7,77,152.9,140.1,156,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(99.4)]",0,"ENSG00000118971"
"63","RHPN1",-0.672538965838084,6.58819818573054,-6.46155848079246,8.76185470109714e-05,0.00226382021835694,1.69404896239462,"DOWN",FALSE,"High","Master Protein","Q8TCX5","Rhophilin-1 [OS=Homo sapiens]",0,3.106,5,2,2,2,1,670,73.5,7.53,5.24,2,"protein metabolism;signal transduction;other biological processes","cytosol",NA,"Pf00595, Pf02185, Pf03097","114822","hsa:114822; Q8TAV1; Q8TCX5; Q96PV9","ENSG00000158106","RHOA GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins","Ectoderm differentiation",3,0,105.9,139.9,120.8,112.2,108.8,103.2,76.1,76.5,69.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S102(97); T106(100)]",0,"ENSG00000158106"
"64","RGMA",-1.13625571831621,6.5718588000513,-6.4476315025511,8.91336115355774e-05,0.00226382021835694,1.67624532545473,"DOWN",FALSE,"High","Master Protein","Q96B86","Repulsive guidance molecule A [OS=Homo sapiens]",0,7.423,2,1,1,1,1,450,49.3,7.42,3.43,1,"cell organization and biogenesis;protein metabolism;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf06534, Pf06535","56963","B2RTW1; B7Z5S8; F5GXQ7; F5GZU6; G3V518; hsa:56963; Q0JV97; Q8NC80; Q96B86; Q9H0E6; Q9NPM3","ENSG00000182175","Netrin-1 signaling","Spinal cord injury; Ectoderm differentiation; Netrin-UNC5B signaling pathway",4,0,83.6,80.1,83.8,162,150.9,125.8,91.4,66,66.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000182175"
"65","CARMIL1",0.512953349154333,6.65796034646622,6.43830188803719,9.01644082066184e-05,0.00226382021835694,1.66430385470993,"UP",FALSE,"High","Master Protein","Q5VZK9","F-actin-uncapping protein LRRC16A [OS=Homo sapiens]",0,85.663,8,8,8,14,8,1371,151.5,7.85,41.64,8,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13516, Pf16000, Pf17888","55604","B8X1J0; hsa:55604; Q5VZK9; Q6ZUH5; Q6ZW07; Q9NXU7","ENSG00000079691","Factors involved in megakaryocyte development and platelet production",NA,1,0,79.8,88.3,80.3,96.8,79.9,95.7,127,136.1,126.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S880(100); T916(100); S960(100); S1094(100); S1360(100)]",0,"ENSG00000079691"
"66","TCF12",0.627018354351332,6.56901297097618,6.40968010538451,9.34081362162293e-05,0.00230100205388943,1.62759458409941,"UP",FALSE,"High","Master Protein","Q99081","Transcription factor 12 [OS=Homo sapiens]",0,5.164,2,1,1,2,1,682,72.9,7.02,3.18,1,"other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","6938","B4E1W1; hsa:6938; Q7Z3D9; Q86TC1; Q86VM2; Q99081","ENSG00000140262","RUNX1 regulates transcription of genes involved in differentiation of HSCs; NGF-stimulated transcription; Myogenesis",NA,3,0,134.5,134,113.6,60,65.8,61,104,102.9,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S559(99.3)]",0,"ENSG00000140262"
"67","ZNRF2",-0.554072700647636,6.63607188787201,-6.40058523109019,9.44651578496274e-05,0.00230100205388943,1.61590619139955,"DOWN",FALSE,"High","Master Protein","Q8NHG8","E3 ubiquitin-protein ligase ZNRF2 [OS=Homo sapiens]",0,28.804,11,2,2,4,2,242,24.1,7.09,8.38,2,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13639","223082","Q8NHG8","ENSG00000180233","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,76.4,71.4,79,129.1,161,128.8,99.8,100.2,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S135(100)]",0,"ENSG00000180233"
"68","TACC2",0.43124657327568,6.65058075135114,6.38359618276443,9.64745202942203e-05,0.00230795962020982,1.5940419172456,"NONE",FALSE,"High","Master Protein","O95359-3","Isoform 3 of Transforming acidic coiled-coil-containing protein 2 [OS=Homo sapiens]",0,76.878,4,5,10,13,5,2871,300.9,4.78,41.02,5,NA,NA,NA,NA,NA,"O95359-3",NA,NA,NA,0,0,100.2,106.7,109.8,86.2,72.8,84.3,111.4,115.3,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2088(100); S2226(100); S2317(99); S2321(100); S2569(100); T2625(100)]",0,"ENSG00000138162"
"69","EPB41L1",-0.696505813486373,6.65265410823524,-6.37441886055143,9.75791751191651e-05,0.00230795962020982,1.58221445274853,"DOWN",FALSE,"High","Master Protein","Q9H4G0","Band 4.1-like protein 1 [OS=Homo sapiens]",0,185.922,21,19,29,48,19,881,98.4,5.62,128.15,19,"cell organization and biogenesis","plasma membrane;other membranes;cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf00373, Pf04382, Pf05902, Pf08736, Pf09379, Pf09380","2036","hsa:2036; O15046; Q4VXM6; Q4VXM7; Q4VXM8; Q4VXN4; Q6ZT61; Q8IUU7; Q96CV5; Q96L65; Q9H4G0","ENSG00000088367","Trafficking of AMPA receptors; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Neurexins and neuroligins","Splicing factor NOVA regulated synaptic proteins",5,0,74.8,78.7,79.5,145.4,139.8,137.9,92,103.8,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T78(99.1); S86(100); S378(100); T475(100); T489(99.6); S510(100); S546(99.5); S667(100); T686(99.5); S759(100); S784(100); S870(100)]",0,"ENSG00000088367"
"70","RTN3",0.641351368772585,6.63170251758236,6.36106137087194,9.92115364960506e-05,0.00231304610802221,1.56497888757556,"UP",FALSE,"High","Master Protein","O95197","Reticulon-3 [OS=Homo sapiens]",0,36.798,6,4,6,11,4,1032,112.5,4.96,41.5,4,"cell organization and biogenesis;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component",NA,"Pf02453","10313","B3KQS2; B7Z308; B7Z4M0; F5H774; hsa:10313; O95197; Q147U9; Q496K2; Q53GN3; Q59EP0; Q5UEP2; Q6T930; Q7RTM7; Q7RTM8; Q7RTN3","ENSG00000133318","Synaptic adhesion-like molecules","Alzheimer's disease and miRNA effects; Alzheimer's disease",3,0,83.2,89.1,100.2,87.7,72,77.7,112.9,126.4,151.1,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss+Acetyl [N-Term]; Phospho [S30(99)]",0,"ENSG00000133318"
"71","SRSF7",-0.460680375672847,6.44671036270554,-6.33256673771745,0.000102793423652572,0.00236280094930983,1.52812878837462,"NONE",FALSE,"High","Master Protein","Q16629","Serine/arginine-rich splicing factor 7 [OS=Homo sapiens]",0,16.464,18,8,14,32,8,238,27.4,11.82,34.67,8,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","6432","B4DLU6; G5E9M3; hsa:6432; Q16629; Q564D3","ENSG00000115875","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,147.2,132.3,133.5,81.4,75.4,82.4,65.9,70.3,65.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100); S171(100); S181(100); S183(100); S196(100); S215(100); S233(100)]",0,"ENSG00000115875"
"72","DOCK6",0.570113478864704,6.6454382431347,6.31480429755461,0.000105096910286603,0.002382196633163,1.50510084478229,"UP",FALSE,"High","Master Protein","Q96HP0","Dedicator of cytokinesis protein 6 [OS=Homo sapiens]",0,18.55,2,3,3,3,3,2047,229.4,6.74,10.65,3,"signal transduction","cytosol;other cell component","enzyme regulator activity","Pf06920, Pf11878, Pf14429, Pf20421, Pf20422","57572","A6H8X5; hsa:57572; Q7Z7P4; Q96HP0; Q9P2F2","ENSG00000130158","CDC42 GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production","Genetic causes of porto-sinusoidal vascular disease",4,0,87.6,82.6,75.5,91.7,80.8,92.6,125.3,144.6,127.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S880(100); S1308(100); S1343(100)]",0,"ENSG00000130158"
"73","KIF26B",-0.624529147875545,6.62211807185034,-6.28834204171157,0.000108632878579006,0.00242861449097175,1.47071269755395,"DOWN",FALSE,"High","Master Protein","Q2KJY2","Kinesin-like protein KIF26B [OS=Homo sapiens]",0,64.183,3,5,8,13,5,2108,223.7,8.44,38,5,"developmental processes;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225","55083","hsa:55083; Q2KJY2; Q6ZQR9; Q6ZUZ0; Q8IUN3; Q8IVR1; Q9NWB4","ENSG00000162849","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,90.1,87.2,88.2,127.8,143.5,117.5,95.8,85.2,81.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1006(100); S1021(100); S1742(100); S1773(100); S1958(99.2)]",0,"ENSG00000162849"
"74","SH3BP4",0.564127482706265,6.62109066427064,6.23290526806076,0.000116465090193166,0.00256852739453036,1.39835489928432,"UP",FALSE,"High","Master Protein","Q9P0V3","SH3 domain-binding protein 4 [OS=Homo sapiens]",0,25.509,3,2,4,6,2,963,107.4,7.71,18.23,2,"transport;other biological processes","other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00791, Pf07653","23677","hsa:23677; O95082; Q309A3; Q53QD0; Q53TD1; Q9P0V3","ENSG00000130147","Amino acids regulate mTORC1","2q37 copy number variation syndrome",2,0,108,109.3,106.1,79.1,73.6,67.1,114,106.9,123.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S246(100); S279(100)]",0,"ENSG00000130147"
"75","WFS1",0.508977838800846,6.60825001301339,6.22191234532231,0.000118089622741419,0.00256963019085327,1.38395550647702,"UP",FALSE,"High","Master Protein","O76024","Wolframin [OS=Homo sapiens]",0,12.385,2,2,2,6,2,890,100.2,8.05,18.44,2,"protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf19913, Pf19914, Pf20023, Pf20053","7466","B2R797; D3DVT1; hsa:7466; O76024; Q8N6I3; Q9UNW6","ENSG00000109501","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; XBP1(S) activates chaperone genes","CAMKK2 pathway",4,0,62.7,55.7,56.4,104.6,98.7,113.1,142,140.9,158.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100); S235(100)]",0,"ENSG00000109501"
"76","EPS15L1",-0.433792218722266,6.64619393827084,-6.17765538885522,0.000124882310067371,0.00264260904095352,1.32581266812928,"NONE",FALSE,"High","Master Protein","Q9UBC2","Epidermal growth factor receptor substrate 15-like 1 [OS=Homo sapiens]",0,113.758,13,6,6,15,6,864,94.2,5.11,51.31,6,"transport","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf12763","58513","A2RRF3; A5PL29; B4DKA3; hsa:58513; Q9UBC2","ENSG00000127527","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation","EGF/EGFR signaling pathway",4,0,80.4,86.2,85.7,120.6,126.3,129.1,97.8,98,92.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(100); S255(100); T366(100)]",0,"ENSG00000127527"
"77","PRAG1",0.548413480140616,6.66078231990434,6.1726656283528,0.000125674274083259,0.00264260904095352,1.31924006651271,"UP",FALSE,"High","Master Protein","Q86YV5","Inactive tyrosine-protein kinase PRAG1 [OS=Homo sapiens]",0,50.01,4,4,4,7,4,1406,149.5,7.2,20.84,4,"other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf07714","157285","Q86YV5; Q8N3N5","ENSG00000275342","RND2 GTPase cycle",NA,1,0,97.7,95.8,92.5,78.5,74.6,96.3,117.3,133.6,122.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(100); S740(100)]",0,"ENSG00000275342"
"78","VANGL2",-0.728057677053236,6.62141102318628,-6.16848238361323,0.000126342416044838,0.00264260904095352,1.31372712036177,"DOWN",FALSE,"High","Master Protein","Q9ULK5","Vang-like protein 2 [OS=Homo sapiens]",0,12.079,6,2,5,7,2,521,59.7,9.22,16.5,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf06638","57216","D3DVE9; hsa:57216; Q5T212; Q9ULK5","ENSG00000162738","Asymmetric localization of PCP proteins; RND2 GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle","Wnt signaling; Development of ureteric collection system",7,0,87.7,92.6,85.4,131.8,109.1,145,81.2,91.5,82.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(99.4); S517(100)]",0,"ENSG00000162738"
"79","CCDC9B",-0.59261863330646,6.61448445010688,-6.15242755191052,0.000128942559908463,0.00264260904095352,1.29254615107073,"DOWN",FALSE,"High","Master Protein","Q6ZUT6","Coiled-coil domain-containing protein 9B [OS=Homo sapiens]",0,17.565,3,2,2,2,2,534,57.3,9.13,6.51,2,NA,NA,NA,"Pf15266","388115","B9EIQ8; hsa:388115; Q68DG9; Q6ZTM3; Q6ZU22; Q6ZUT6","ENSG00000188549",NA,NA,0,0,90,90.6,83.6,117.3,131.7,129.8,80.6,98.3,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S201(100)]",0,"ENSG00000188549"
"80","UCKL1",-0.691183581916661,6.44767269942476,-6.14879013466499,0.000129539658870271,0.00264260904095352,1.28774229559929,"DOWN",FALSE,"High","Master Protein","Q9NWZ5","Uridine-cytidine kinase-like 1 [OS=Homo sapiens]",0,7.134,3,1,1,2,1,548,61.1,7.36,2.31,1,"other metabolic processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00485, Pf14681","54963","B7Z8N2; hsa:54963; Q5JWV0; Q70AQ5; Q8N524; Q9H3Z2; Q9NWZ5","ENSG00000198276","Pyrimidine salvage","Pyrimidine metabolism",2,0,128,108.9,125.9,84.6,112.4,91.8,66.8,63.6,68,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(99.4)]",0,"ENSG00000198276"
"81","CAPZB",0.522973655328773,6.65284678182274,6.09413902732969,0.000138880172358507,0.00279817828751956,1.21534079600176,"UP",FALSE,"High","Master Protein","P47756-1","Isoform 2 of F-actin-capping protein subunit beta [OS=Homo sapiens]",0,5.947,3,1,1,5,1,277,31.3,5.59,13.36,1,NA,NA,NA,NA,NA,"P47756-1",NA,NA,NA,0,0,68.8,68.7,72.2,90.9,113,101,134.1,144,149.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000077549"
"82","ITPRID2",0.517494043561135,6.64022533864309,6.08401494672714,0.000140689119449642,0.00280005662124165,1.20188206366375,"UP",FALSE,"High","Master Protein","P28290","Protein ITPRID2 [OS=Homo sapiens]",0,146.527,13,13,16,35,13,1259,138.3,5.19,99.03,13,NA,"plasma membrane;other membranes;cytosol;nucleus","signal transduction activity or receptor binding;cytoskeletal activity","Pf14722, Pf14723","6744","A8K6T0; hsa:6744; P28290; Q68DA6; Q7Z7L2; Q8N1L3; Q8N263; Q8N7H2; Q8NEN5; Q96E36; Q96PW1","ENSG00000138434",NA,NA,0,0,80.6,89.1,78,89.5,93.3,88.4,127.9,129.2,127.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100); S270(100); S300(100); S330(100); S593(100); S641(100); S668(100); S737(100); S739(100); S746(100); S1134(99.5); S1165(99.5)]",0,"ENSG00000138434"
"83","RALBP1",-0.455598893990373,6.6466067695317,-6.05874140600159,0.00014531704003924,0.00285731818486795,1.16822051968057,"NONE",FALSE,"High","Master Protein","Q15311","RalA-binding protein 1 [OS=Homo sapiens]",0,14.935,4,4,4,8,4,655,76,5.88,12.49,4,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus","transporter activity;enzyme regulator activity;other molecular function","Pf00620, Pf20924","10928","D3DUI0; hsa:10928; Q15311","ENSG00000017797","CDC42 GTPase cycle; RAC1 GTPase cycle","RalA downstream regulated genes; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway",6,0,86.8,85,92.8,123.1,121.6,125.2,95.6,97.2,88.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S29(99.7); S645(100)]",0,"ENSG00000017797"
"84","REEP4",0.496185048125575,6.65753931139786,6.03474506208795,0.000149863656715433,0.00288001327215895,1.13617608391633,"NONE",FALSE,"High","Master Protein","Q9H6H4","Receptor expression-enhancing protein 4 [OS=Homo sapiens]",0.007,1.717,3,1,1,1,1,257,29.4,9.73,1.95,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;ER/Golgi","cytoskeletal activity","Pf03134","80346","D3DSQ9; hsa:80346; Q86VL1; Q9H6H4; Q9H6I5; Q9HBP4","ENSG00000168476",NA,NA,0,0,107.3,92.4,108.7,83.5,80.2,81.7,118.6,118,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100)]",0,"ENSG00000168476"
"85","DLG5",-0.655736901834049,6.61852933122156,-6.03403407731579,0.000150000691258278,0.00288001327215895,1.13522539396383,"DOWN",FALSE,"High","Master Protein","Q8TDM6","Disks large homolog 5 [OS=Homo sapiens]",0,48.202,3,5,5,9,5,1919,213.7,7.42,27.15,5,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00595, Pf00625, Pf04822, Pf16610","9231","A6H8Y3; hsa:9231; Q149N1; Q5T1H7; Q5T1H8; Q6DKG3; Q86WC0; Q8TDM6; Q8TDM7; Q9UE73; Q9Y4E3","ENSG00000151208; ENSG00000274429","RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle",NA,5,0,98.2,91.5,94.6,131.8,127.5,115.1,91.5,85.1,76.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1011(100); S1209(99.5); S1263(100); S1666(100); S1795(100)]",0,"ENSG00000151208"
"86","DENND5A",0.424497731255594,6.66018578209468,5.98467965646176,0.000159852284860396,0.00303347591735077,1.06905532905463,"NONE",FALSE,"High","Master Protein","Q6IQ26","DENN domain-containing protein 5A [OS=Homo sapiens]",0,17.672,2,2,2,5,2,1287,147,6.65,13.73,2,"transport;other biological processes","other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01477, Pf02141, Pf02759, Pf03455, Pf03456","23258","B4DJ15; E9PS91; Q6IQ26; Q96GN3; Q9H6U7; Q9UFV0; Q9UPR1","ENSG00000184014","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,95.4,95.9,93.3,85.7,80.3,96.5,115.3,116.5,127.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100); S1085(99.7)]",0,"ENSG00000184014"
"87","SPAG1",-0.739778839157592,6.57181740453987,-5.95137933272017,0.000166893060925161,0.00309876240543051,1.02421271889031,"DOWN",FALSE,"High","Master Protein","Q07617","Sperm-associated antigen 1 [OS=Homo sapiens]",0,5.488,2,1,1,4,1,926,103.6,6.86,7.19,1,"cell organization and biogenesis;other biological processes","cytosol;other cell component","other molecular function","Pf00515, Pf13877","6674","A6NP70; B3KQ58; G3XAM3; hsa:6674; Q07617; Q7Z5G1","ENSG00000104450",NA,"Ciliopathies",1,0,60.9,64.7,65.9,149.6,189.3,124.2,99.5,85.6,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S418(100)]",0,"ENSG00000104450"
"88","CDK16",0.815266568822727,6.53382697196122,5.95030379837782,0.000167125976451243,0.00309876240543051,1.02276174752971,"UP",FALSE,"High","Master Protein","Q00536","Cyclin-dependent kinase 16 [OS=Homo sapiens]",0,16.562,4,2,2,3,1,496,55.7,7.62,10.35,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5127","A8K280; B7Z7C8; hsa:5127; J3KN74; J3KQP7; Q00536","ENSG00000102225",NA,NA,0,0,56.3,46,50.2,101.5,66.6,110.3,138,177.4,188.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S153(100)]",0,"ENSG00000102225"
"89","OSBPL6",0.443249946781,6.63856786149731,5.93969340274717,0.000169442647069111,0.00309876240543051,1.00843870254004,"NONE",FALSE,"High","Master Protein","Q9BZF3","Oxysterol-binding protein-related protein 6 [OS=Homo sapiens]",0,16.892,3,3,3,5,3,934,106.2,6.93,8.42,3,"other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf01237, Pf15409","114880","B4DTW1; C4AMC0; C4AME4; D3DPF6; D3DPF7; hsa:114880; Q4ZG68; Q53T68; Q59H61; Q7Z4Q1; Q86V84; Q8N9T0; Q96SR1; Q9BZF3","ENSG00000079156","Synthesis of bile acids and bile salts",NA,1,0,106.7,102.5,99.2,83,76.5,84.6,105.7,114.8,123.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100); S44(100); S190(100)]",0,"ENSG00000079156"
"90","AJM1",-0.861533516599496,6.62884834908533,-5.92968374130644,0.00017165996618656,0.00309876240543051,0.994911810365434,"DOWN",FALSE,"High","Master Protein","C9J069","Apical junction component 1 homolog [OS=Homo sapiens]",0,33.187,3,2,2,3,2,976,106.6,9.03,11.62,2,"cell organization and biogenesis","plasma membrane;other membranes;other cell component",NA,NA,"389813","C9J069","ENSG00000232434",NA,NA,0,0,77.6,86.4,82.1,143.2,117.3,165.9,81.8,96.9,77.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(100)]",0,"ENSG00000232434"
"91","CLCN6",-0.44563732130967,6.57551796907244,-5.91910375279939,0.000174037726081043,0.00309876240543051,0.980598575510138,"NONE",FALSE,"High","Master Protein","P51797","H(+)/Cl(-) exchange transporter 6 [OS=Homo sapiens]",0,5.03,3,2,2,2,2,869,97.2,6.81,4.46,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00571, Pf00654","1185","A8K1T4; B4DGT7; F8W9R3; hsa:1185; O60818; O60819; O60820; O60821; P51797; P78520; P78521; Q17R81; Q5SNW2; Q5SNW3; Q5SNX1; Q5SNX2; Q5SNX3; Q99427; Q99428; Q99429","ENSG00000011021","Signaling by BRAF and RAF1 fusions; Stimuli-sensing channels",NA,2,0,120.5,119.1,120.9,94.8,105.6,99.6,75.4,81.3,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T25(100); S683(99.6)]",0,"ENSG00000011021"
"92","CTNNA2",-0.570594534261738,6.63640727835498,-5.91625008293393,0.000174685135600249,0.00309876240543051,0.976735213177612,"DOWN",FALSE,"High","Master Protein","P26232","Catenin alpha-2 [OS=Homo sapiens]",0,145.347,11,8,11,18,8,953,105.2,5.71,84.05,8,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01044","1496","B3KXE5; B7Z2W7; B7Z352; B7Z898; hsa:1496; P26232; Q4ZFW1; Q53R26; Q53R33; Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0","ENSG00000066032","Myogenesis","Arrhythmogenic right ventricular cardiomyopathy; Ectoderm differentiation; Ectoderm differentiation; Endometrial cancer; Pleural mesothelioma",6,0,89.8,87.3,89,124.8,110.8,139.3,89.6,94.2,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100); T535(100); T657(100); S901(100); S939(100)]",0,"ENSG00000066032"
"93","HDAC1",-0.629772545615165,6.32744365241305,-5.88964891539158,0.000180846744862983,0.00317356868404718,0.940665725841005,"DOWN",FALSE,"High","Master Protein","Q13547","Histone deacetylase 1 [OS=Homo sapiens]",0,13.136,4,1,1,2,1,482,55.1,5.48,3.3,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00850","3065","hsa:3065; Q13547; Q92534","ENSG00000116478","Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Formation of the beta-catenin:TCF transactivating complex; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Transcription of E2F targets under negative control by DREAM complex; Nuclear events stimulated by ALK signaling in cancer; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1; MECP2 regulates neuronal receptors and channels; Repression of WNT target genes; Loss of MECP2 binding ability to 5mC-DNA","Androgen receptor signaling pathway; Energy metabolism; Cell cycle; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Neural crest differentiation; Retinoblastoma gene in cancer; Notch signaling; Apoptosis-related network due to altered Notch3 in ovarian cancer; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; IL6 signaling pathway; TGF-beta signaling pathway; Valproic acid pathway; VEGFA-VEGFR2 signaling; Ethanol effects on histone modifications; Rett syndrome; Effect of progerin on genes involved in progeria; Ciliary landscape; Transcription co-factors SKI and SKIL protein partners; Overlap between signal transduction pathways contributing to LMNA laminopathies; Opioid receptor pathways; 15q11q13 copy number variation; Notch signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",56,0,154.8,148.1,119.2,69.4,75.5,74,57.9,61.7,59.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S423(99.4)]",0,"ENSG00000116478"
"94","PIK3C2A",0.469286032875303,6.61317983957868,5.87089638680962,0.000185331195862976,0.00321766501753592,0.91517739703682,"NONE",FALSE,"High","Master Protein","O00443","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [OS=Homo sapiens]",0,20.785,2,2,2,2,2,1686,190.6,8.02,7.08,2,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00168, Pf00454, Pf00613, Pf00787, Pf00792, Pf00794","5286","B0LPH2; B4E2G4; hsa:5286; O00443; Q14CQ9","ENSG00000011405","Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane","Glioblastoma signaling pathways; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Microglia pathogen phagocytosis pathway; Osteoblast differentiation and related diseases; Insulin signaling; Regulation of actin cytoskeleton; DNA damage response (only ATM dependent)",14,0,113.3,109.9,110.8,77.5,66.6,79,101.4,106.2,122.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S259(100); S1553(99.2)]",0,"ENSG00000011405"
"95","RAP1GAP",-0.716572758811067,6.64548505656778,-5.84216427997062,0.000192436602600126,0.00330585826782532,0.876026730509318,"DOWN",FALSE,"High","Master Protein","P47736-4","Isoform 4 of Rap1 GTPase-activating protein 1 [OS=Homo sapiens]",0,50.775,7,4,4,9,4,727,80.6,6.18,33.41,4,NA,NA,NA,NA,NA,"P47736-4",NA,NA,NA,0,0,71.8,66.1,77.2,152.6,132.5,152,92,104.5,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T9(100); S548(100); S579(100)]",0,"ENSG00000076864"
"96","C2CD2L",-0.663949779337861,6.59199313508555,-5.78612468213414,0.000207155366728813,0.00350243865735337,0.799324154511766,"DOWN",FALSE,"High","Master Protein","O14523","Phospholipid transfer protein C2CD2L [OS=Homo sapiens]",0,15.2,3,1,1,1,1,706,76.1,7.69,5.43,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity;other molecular function","Pf00168, Pf18696","9854","hsa:9854; O14523; Q86UT7; Q86V04; Q8N522; Q8TBN4; Q96G10","ENSG00000172375",NA,NA,0,0,86,88.1,91.5,110.6,131.6,137.6,75.6,96,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S662(100)]",0,"ENSG00000172375"
"97","BICD1",0.412316646853908,6.64223121010888,5.78137021238352,0.000208458878066796,0.00350243865735337,0.792795742361259,"NONE",FALSE,"High","Master Protein","Q96G01","Protein bicaudal D homolog 1 [OS=Homo sapiens]",0,18.071,4,3,4,5,2,975,110.7,5.81,13.2,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf09730","636","A8K2C3; F8W113; hsa:636; O43892; O43893; Q96G01","ENSG00000151746","COPI-independent Golgi-to-ER retrograde traffic",NA,1,1,71.1,68.9,72.1,98.6,109,101.5,130.7,134.3,135.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S548(100); S560(100); S610(100)]",0,"ENSG00000151746"
"98","AKAP1",0.491473117960267,6.68452222410523,5.77464435406264,0.00021031800761068,0.00350243865735337,0.783554814291564,"NONE",FALSE,"High","Master Protein","Q92667","A-kinase anchor protein 1, mitochondrial [OS=Homo sapiens]",0,61.298,10,5,6,9,5,903,97.3,4.94,28.7,5,"stress response;other biological processes","other membranes;cytosol;mitochondrion","other molecular function","Pf00013, Pf00567","8165","A8K8Q1; D3DTZ0; hsa:8165; Q13320; Q92667; Q9BW14","ENSG00000121057","Factors involved in megakaryocyte development and platelet production; Mitochondrial calcium ion transport","G protein signaling pathways",3,0,77.6,80.2,80.6,104.4,81.1,101.9,138,129.6,137.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T70(99.5); S151(99.5); S429(100); S445(99.7); T533(100)]",0,"ENSG00000121057"
"99","BAG3",-0.51474752161073,6.64226110719865,-5.73713203470633,0.000221020396883404,0.00363883443791938,0.731895068609707,"DOWN",FALSE,"High","Master Protein","O95817","BAG family molecular chaperone regulator 3 [OS=Homo sapiens]",0,92.916,14,5,10,26,5,575,61.6,6.95,82.38,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00397, Pf02179","9531","A8K5L8; hsa:9531; O95817; Q3B763; Q9NT20; Q9P120","ENSG00000151929","Regulation of HSF1-mediated heat shock response","Cell interactions of the pancreatic cancer microenvironment",2,0,85,89.9,91.6,121,138.1,121.5,97.3,95.2,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S264(100); S279(100); T285(99.3); S289(100); S377(100); S386(100)]",0,"ENSG00000151929"
"100","KBTBD11",-0.401405258813782,6.64756659704195,-5.71841079586417,0.00022658002395876,0.00363883443791938,0.706037045871251,"NONE",FALSE,"High","Master Protein","O94819","Kelch repeat and BTB domain-containing protein 11 [OS=Homo sapiens]",0,35.769,5,2,3,7,2,623,65.7,6.07,18.66,2,NA,NA,NA,"Pf00651, Pf01344","9920","hsa:9920; O94819; Q3L1I0","ENSG00000176595; ENSG00000273645",NA,NA,0,0,97.2,99.1,96.9,113.8,113.5,120.9,91.2,87.9,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S107(100); S310(100); S314(100)]",0,"ENSG00000176595"
"101","FRYL",0.593061014422608,6.63536112876654,5.71603374863368,0.000227296650418836,0.00363883443791938,0.702750201497477,"UP",FALSE,"High","Master Protein","O94915","Protein furry homolog-like [OS=Homo sapiens]",0,29.92,2,4,4,4,4,3013,339.4,5.58,12.2,4,"cell organization and biogenesis;developmental processes;other biological processes","other cell component",NA,"Pf14222, Pf14225, Pf14228, Pf19421","285527","hsa:285527; O94915; O95640; Q8WTZ5; Q9NT40","ENSG00000075539",NA,NA,0,0,68,78.8,80.1,86.5,76.8,109.5,136.2,138.4,135,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S844(100); T1959(100); S1978(100); S2272(100)]",0,"ENSG00000075539"
"102","FEZ1",1.17671859809568,6.50033429381654,5.71453252315683,0.000227750494785286,0.00363883443791938,0.700673970967939,"UP",FALSE,"High","Master Protein","Q99689","Fasciculation and elongation protein zeta-1 [OS=Homo sapiens]",0,8.513,3,1,1,1,1,392,45.1,4.3,3.51,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf07763","9638","hsa:9638; O00679; O00728; Q6IBI7; Q99689","ENSG00000149557",NA,"Prader-Willi and Angelman syndrome",1,0,106.9,134,169,52.4,34.4,41.8,131.8,104.8,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(100)]",0,"ENSG00000149557"
"103","ADGRB1",0.586634790657199,6.60857686907037,5.70826177834339,0.000229656830334373,0.00363883443791938,0.691997847364709,"UP",FALSE,"High","Master Protein","O14514","Adhesion G protein-coupled receptor B1 [OS=Homo sapiens]",0,35.014,2,2,2,4,2,1584,173.4,7.88,15.71,2,"cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf00090, Pf01825, Pf02793, Pf16489, Pf19188","575","hsa:575; O14514","ENSG00000181790",NA,"p53 transcriptional gene network",1,0,103.9,115.7,104.5,70.9,72.1,71.3,123.7,103.8,112.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1278(100); S1469(100)]",0,"ENSG00000181790"
"104","MTDH",0.42749298461566,6.62775000909768,5.68455106713433,0.000237021965349842,0.00368033079770275,0.659140427662635,"NONE",FALSE,"High","Master Protein","Q86UE4","Protein LYRIC [OS=Homo sapiens]",0,58.702,11,5,5,10,5,582,63.8,9.32,34.21,5,"signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15686","92140","hsa:92140; Q05DH2; Q52QU9; Q6PK07; Q86UE4; Q8TCX3","ENSG00000147649",NA,"Gastric cancer network 2; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; CCL18 signaling pathway",3,0,109.1,117.9,112.5,83.7,68.2,76.3,103.9,114.4,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S308(100); S426(100); S494(99.3); S568(100)]",0,"ENSG00000147649"
"105","SEPTIN10",-0.655313096136056,6.62221905721216,-5.67810955287247,0.000239066550504313,0.00368033079770275,0.650199917921235,"DOWN",FALSE,"High","Master Protein","Q9P0V9","Septin-10 [OS=Homo sapiens]",0,9.719,4,1,2,2,1,454,52.6,6.8,2.81,1,"cell cycle OR cell proliferation","cytoskeleton;other cell component","other molecular function","Pf00735","151011","B3KRQ9; hsa:151011; Q86VP5; Q9HAH6; Q9P0V9","ENSG00000186522",NA,NA,0,0,83.4,104.5,112.4,123.4,136,112.2,82.6,78.2,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(96); S28(100)]",0,"ENSG00000186522"
"106","EI24",0.453304878708763,6.65106830651419,5.67288183137213,0.00024073984095737,0.00368033079770275,0.642939663138963,"NONE",FALSE,"High","Master Protein","O14681","Etoposide-induced protein 2.4 homolog [OS=Homo sapiens]",0,23.861,8,2,3,4,2,340,38.9,9.72,12.73,2,"other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus","other molecular function","Pf07264","9538","A8K7D6; B4DKL6; hsa:9538; O14681; Q9BUQ1","ENSG00000149547",NA,"miRNA regulation of p53 pathway in prostate cancer",1,0,90.2,97.1,94.8,87.1,79.3,92,125.4,119.4,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S326(100); S330(100)]",0,"ENSG00000149547"
"107","PAK2",0.595681094693465,6.6906031280133,5.66521393831773,0.000243217055125633,0.00368033079770275,0.632283316818891,"UP",FALSE,"High","Master Protein","Q13177","Serine/threonine-protein kinase PAK 2 [OS=Homo sapiens]",0,20.098,4,3,3,8,3,524,58,5.96,24.52,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00786","5062","hsa:5062; Q13154; Q13177; Q6ISC3","ENSG00000180370","Regulation of activated PAK-2p34 by proteasome mediated degradation; MAPK6/MAPK4 signaling; FCERI mediated MAPK activation; Generation of second messenger molecules; Regulation of PAK-2p34 activity by PS-GAP/RHG10; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; RHOU GTPase cycle; Ephrin signaling; Sema3A PAK dependent Axon repulsion; Smooth Muscle Contraction; RHO GTPases activate PAKs; VEGFR2 mediated vascular permeability; Activation of RAC1; RHOH GTPase cycle; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Nef and signal transduction; Stimulation of the cell death response by PAK-2p34","Integrin-mediated cell adhesion; Apoptosis-related network due to altered Notch3 in ovarian cancer; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; MET in type 1 papillary renal cell carcinoma; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 3q29 copy number variation syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; ErbB signaling pathway",45,0,89.1,98.3,92.7,91.8,65.1,100,128.5,136.9,124.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000180370"
"108","METTL16",-0.603447877825055,6.29610093976376,-5.66418576587806,0.000243551302789153,0.00368033079770275,0.630853778993656,"DOWN",FALSE,"High","Master Protein","Q86W50","RNA N6-adenosine-methyltransferase METTL16 [OS=Homo sapiens]",0,4.72,2,1,1,2,1,562,63.6,7.85,4.54,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05971","79066","D3DTI8; hsa:79066; Q86TE5; Q86W50; Q96T16; Q9BVG7","ENSG00000127804",NA,NA,0,0,156.4,159.6,153.2,65.1,51.5,75.5,52.9,59.2,55.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000127804"
"109","PPFIBP2",0.389323868035565,6.67774768179747,5.64510993260728,0.000249843271932529,0.00374077265865952,0.604303479540572,"NONE",FALSE,"High","Master Protein","Q8ND30","Liprin-beta-2 [OS=Homo sapiens]",0,11.482,3,2,2,3,2,876,98.5,6.27,9.42,2,"cell organization and biogenesis","cytosol;other cell component","other molecular function","Pf00536, Pf07647","8495","B7Z433; E9PK77; hsa:8495; O75337; Q8ND30; Q8WW26","ENSG00000166387","Receptor-type tyrosine-protein phosphatases","Ectoderm differentiation",2,0,80.7,82,85,104.1,89.3,98.8,125,125.3,134.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000166387"
"110","MARK2",-0.444356284058721,6.62352943318349,-5.59969470752391,0.000265538901252468,0.00393963169858207,0.540880183678663,"NONE",FALSE,"High","Master Protein","Q7KZI7","Serine/threonine-protein kinase MARK2 [OS=Homo sapiens]",0,40.931,5,3,3,11,2,788,87.9,9.72,25.87,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","2011","hsa:2011; Q15449; Q15524; Q5XGA3; Q68A18; Q7KZI7; Q96HB3; Q96RG0","ENSG00000072518",NA,"Microtubule cytoskeleton regulation; Complement system in neuronal development and plasticity; Neurogenesis regulation in the olfactory epithelium",3,0,90.7,91.5,86.2,118.8,128.1,116.2,87.4,90.1,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T208(100); S456(100); S486(100)]",0,"ENSG00000072518"
"111","PPME1",0.397390206270573,6.65486474122675,5.55103901766397,0.000283540397947861,0.0041525845180508,0.472598118964077,"NONE",FALSE,"High","Master Protein","Q9Y570","Protein phosphatase methylesterase 1 [OS=Homo sapiens]",0,15.15,3,1,2,2,1,386,42.3,5.97,5.7,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes","nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf12697","51400","B3KMU6; B5MEE7; hsa:51400; J3QT22; Q8WYG8; Q9NVT5; Q9UI18; Q9Y570","ENSG00000214517","Cyclin A/B1/B2 associated events during G2/M transition",NA,1,0,113.2,102.4,102.8,84.7,82.7,82.9,109.6,113.6,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S243(99.6)]",0,"ENSG00000214517"
"112","RFTN1",-0.395312632972766,6.63628364128207,-5.54071040638046,0.000287528283428779,0.0041525845180508,0.458058805486923,"NONE",FALSE,"High","Master Protein","Q14699","Raftlin [OS=Homo sapiens]",0,56.292,12,4,4,7,4,578,63.1,5.67,22.6,4,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","nucleic acid binding activity","Pf15250","23180","hsa:23180; Q0D2G0; Q14699; Q496Y2; Q4QQI7; Q5JB48; Q7Z7P2","ENSG00000131378",NA,NA,0,0,71.9,66.6,70.2,132.1,139.3,131,104.3,101.8,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100); S220(100); S238(99.4); S555(100)]",0,"ENSG00000131378"
"113","SVIL",0.533914383377834,6.63997333928443,5.53592674003003,0.000289395679975131,0.0041525845180508,0.451319690267985,"UP",FALSE,"High","Master Protein","O95425-3","Isoform SV3 of Supervillin [OS=Homo sapiens]",0,146.348,7,12,18,39,12,2187,244.5,7.01,103.1,12,NA,NA,NA,NA,NA,"O95425-3",NA,NA,NA,0,0,82.7,82.6,78,92.5,95.3,83.8,135.4,120.5,134,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S221(100); S245(100); S263(99.3); S270(100); S646(99.4); S680(100); S742(100); S878(100); S887(100); S941(100)]",0,"ENSG00000197321"
"114","PITPNC1",-0.727659704812837,6.63733394153548,-5.53420689354366,0.000290070242069725,0.0041525845180508,0.448895995334584,"DOWN",FALSE,"High","Master Protein","Q9UKF7","Cytoplasmic phosphatidylinositol transfer protein 1 [OS=Homo sapiens]",0,34.158,11,3,4,9,3,332,38.4,6.4,26.24,3,"cell organization and biogenesis;transport;signal transduction","cytosol;nucleus;other cell component","transporter activity;other molecular function","Pf02121","26207","A8K473; hsa:26207; J3QR20; Q96I07; Q9UKF7","ENSG00000154217",NA,NA,0,0,64.8,71.6,67.4,153.2,135.5,163.3,89.6,110.3,90.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100); S299(100)]",0,"ENSG00000154217"
"115","CBARP",0.762631135601563,6.60366020484858,5.52532892102414,0.000293579401834075,0.00416627464168009,0.436377839647047,"UP",FALSE,"High","Master Protein","Q8N350","Voltage-dependent calcium channel beta subunit-associated regulatory protein [OS=Homo sapiens]",0,117.135,18,8,9,14,5,705,73.9,6.4,48.4,8,"other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","other molecular function",NA,"255057","hsa:255057; K7EJP2; O43385; Q8N350","ENSG00000099625",NA,NA,0,3,101.6,106.4,108,61.1,72,66.7,127.6,99.8,139.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S299(100); S322(100); S328(99.4); S341(100); S399(100); S507(100); S528(100); S541(100); S699(98.5)]",0,"ENSG00000099625"
"116","PPP1R9B",1.03326033449708,6.54347317272988,5.49383464336524,0.000306401257883555,0.00431074873160312,0.391877325569079,"UP",FALSE,"High","Master Protein","Q96SB3","Neurabin-2 [OS=Homo sapiens]",0,24.504,2,1,1,3,1,817,89.3,4.97,12.26,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00595, Pf17817","84687","D3DTX6; hsa:84687; Q8TCR9; Q96SB3","ENSG00000108819",NA,NA,0,0,51.8,57.7,69.8,69.9,108.9,66.2,169.4,138.1,191,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(99.7)]",0,"ENSG00000108819"
"117","LIMCH1",0.339910033627288,6.66561529198656,5.41922332461155,0.000339244883529395,0.00473037749848567,0.28587530190978,"NONE",FALSE,"High","Master Protein","Q9UPQ0","LIM and calponin homology domains-containing protein 1 [OS=Homo sapiens]",0,180.04,14,14,17,42,14,1083,121.8,6.47,126.38,14,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00412, Pf15949","22998","A8MXC3; E9PHM7; hsa:22998; Q503B5; Q5CZB1; Q5CZB6; Q5H9S8; Q68E07; Q6PJ44; Q7Z3G5; Q8N3S9; Q8N6M2; Q9UPQ0","ENSG00000064042",NA,NA,0,0,77.1,81,80.1,101,98.9,103.4,122.2,129.4,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S192(100); S201(100); S217(100); S231(100); S377(100); S471(99.6); S493(100); S670(100); S718(100); S875(100); S973(100)]",0,"ENSG00000064042"
"118","DTNA",-0.466758839627371,6.64331374316986,-5.41326817876624,0.000342024843640508,0.00473037749848567,0.277379617227361,"NONE",FALSE,"High","Master Protein","Q9Y4J8","Dystrobrevin alpha [OS=Homo sapiens]",0,62.835,9,4,5,13,3,743,83.8,6.89,31.05,4,"cell-cell signaling;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00569, Pf09068, Pf09069","1837","A8K541; A8MSZ0; A8MUY4; B4DGS6; B4DIR0; B4DIU8; hsa:1837; M0QYX6; M0R397; O15332; O15333; O75697; Q13197; Q13198; Q13199; Q13498; Q13499; Q13500; Q59GK7; Q9BS59; Q9Y4J8","ENSG00000134769",NA,"13q12.12 copy number variation",1,0,80.1,81,91.5,123.3,144.5,119.3,96.3,98.1,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S564(99); S623(98.8); S641(100); S662(100)]",0,"ENSG00000134769"
"119","MAVS",0.370986155649663,6.65212698819022,5.35571465494992,0.000370189605818425,0.00507688602265269,0.195005745303645,"NONE",FALSE,"High","Master Protein","Q7Z434","Mitochondrial antiviral-signaling protein [OS=Homo sapiens]",0,65.544,14,3,5,16,3,540,56.5,5.52,45.35,3,"stress response;signal transduction;other biological processes","other membranes;mitochondrion;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf16739","57506","A8K6X0; B2BD33; B2BD34; F5H6C8; hsa:57506; M1P2Z0; Q2HWT5; Q3I0Y2; Q5T7I6; Q7Z434; Q86VY7; Q9H1H3; Q9H4Y1; Q9H8D3; Q9ULE9","ENSG00000088888","SARS-CoV-2 activates/modulates innate and adaptive immune responses; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; PKR-mediated signaling; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Ovarian tumor domain proteases","Novel intracellular components of RIG-I-like receptor pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Lung pathology of COVID-19; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",24,0,73.1,76.2,76.3,97.9,106.4,102.2,127.8,126.4,135.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100); S222(100)]",0,"ENSG00000088888"
"120","FSBP",-0.48720602048301,6.61516192534109,-5.34781447422517,0.000374246292543687,0.00508974957859415,0.183660738370533,"NONE",FALSE,"High","Master Protein","O95073","Fibrinogen silencer-binding protein [OS=Homo sapiens]",0,4.244,4,1,1,1,1,299,34.7,7.12,2.42,1,NA,"nucleus","other molecular function","Pf13873","100861412; 25788","hsa:100861412; O95073; Q8N4S5","ENSG00000265817",NA,NA,0,0,100.2,108,115.6,108.4,125.3,102.4,84.6,80.2,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000265817"
"121","HCN4",-0.709807245297903,6.61463283236431,-5.28691500618628,0.000407168154714601,0.00546449099418053,0.0958999895086956,"DOWN",FALSE,"High","Master Protein","Q9Y3Q4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 [OS=Homo sapiens]",0,22.324,3,2,2,3,2,1203,129,8.91,11.79,2,"cell-cell signaling;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00027, Pf00520, Pf08412","10021","hsa:10021; Q9UMQ7; Q9Y3Q4","ENSG00000138622","HCN channels","Genes targeted by miRNAs in adipocytes",2,0,85.9,76.3,100.4,127.8,122.2,139.5,76.7,98.4,82.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S917(100); T1071(100)]",0,"ENSG00000138622"
"122","EIF4G1",0.733638141793834,6.5998639546345,5.28456825486073,0.000408497488535555,0.00546449099418053,0.092507289110392,"UP",FALSE,"High","Master Protein","Q04637","Eukaryotic translation initiation factor 4 gamma 1 [OS=Homo sapiens]",0,74.462,4,7,9,22,7,1599,175.4,5.33,55.11,7,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02020, Pf02847, Pf02854","1981","D3DNT2; D3DNT4; D3DNT5; E9PFM1; G5E9S1; hsa:1981; O43177; O95066; Q04637; Q5HYG0; Q6ZN21; Q8N102","ENSG00000114867","ISG15 antiviral mechanism; AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; VEGFA-VEGFR2 signaling; Acute viral myocarditis; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Pleural mesothelioma",20,0,60.6,61.3,63.3,91.3,119.7,78.5,139.8,142.2,184.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1077(100); S1147(100); S1187(100); S1209(100); S1231(100); S1238(100)]",0,"ENSG00000114867"
"123","YTHDC1",-0.465243315469992,6.45773653457145,-5.25948061832424,0.000423003374222526,0.00557647169541534,0.0561877536519173,"NONE",FALSE,"High","Master Protein","Q96MU7","YTH domain-containing protein 1 [OS=Homo sapiens]",0,11.468,5,3,4,8,3,727,84.6,6.23,17,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;nucleus","nucleic acid binding activity;other molecular function","Pf04146","91746","hsa:91746; Q4W5Q3; Q7Z622; Q8TF35; Q96MU7","ENSG00000083896; ENSG00000275272",NA,NA,0,0,143.5,136.5,126,76.1,74.5,94.7,67.4,64.2,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(99.4); S294(100); S308(100)]",0,"ENSG00000083896"
"124","MICALL1",-0.522626448361597,6.62040673213133,-5.25829491364866,0.000423702506269303,0.00557647169541534,0.0544689240127232,"DOWN",FALSE,"High","Master Protein","Q8N3F8","MICAL-like protein 1 [OS=Homo sapiens]",0,9.351,2,1,1,1,1,863,93.4,7.25,3.4,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;other cytoplasmic organelle","other molecular function","Pf00307, Pf00412, Pf12130","85377","hsa:85377; Q5TI16; Q7RTP5; Q8N3F8; Q8N3N8; Q9BVL9; Q9BY92; Q9UH43; Q9UH44; Q9UH45","ENSG00000100139",NA,NA,0,0,101,103.6,93.8,115.2,112.2,121.8,77.2,96.6,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S578(100)]",0,"ENSG00000100139"
"125","PCDHGC3",0.762907418920803,6.63504052937765,5.24651968379039,0.000430713301783933,0.00559791388456528,0.0373880773448176,"UP",FALSE,"High","Master Protein","Q9UN70","Protocadherin gamma-C3 [OS=Homo sapiens]",0,4.429,2,2,4,4,2,934,101,5.21,9.37,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes","other molecular function","Pf00028, Pf08266, Pf15974, Pf16492","5098","hsa:5098; O60622; Q08192; Q9UN70; Q9Y5C4","ENSG00000240184",NA,NA,0,0,77.1,77.9,77.9,85,63.9,101.8,165.3,119.3,150.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S733(99.6); S769(100)]",0,"ENSG00000240184"
"126","MFF",0.620807739765283,6.62031304957262,5.24406255914934,0.000432191880793643,0.00559791388456528,0.0338212796469461,"UP",FALSE,"High","Master Protein","Q9GZY8-5","Isoform 5 of Mitochondrial fission factor [OS=Homo sapiens]",0,10.805,8,2,3,5,1,238,27.1,6.62,12.09,2,NA,NA,NA,NA,NA,"Q9GZY8-5",NA,NA,NA,0,1,107.8,108.5,102.5,69.9,84.9,64.9,121.8,112.4,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100); S146(100)]",0,"ENSG00000168958"
"127","HDAC2",-0.897590237474323,6.42365568033188,-5.23090829808316,0.000440200687029126,0.00561247843667084,0.0147113587591914,"DOWN",FALSE,"High","Master Protein","Q92769","Histone deacetylase 2 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,488,55.3,5.91,4.15,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00850","3066","B3KRS5; B4DL58; E1P561; hsa:3066; Q5SRI8; Q5SZ86; Q8NEH4; Q92769","ENSG00000196591","Regulation of TP53 Activity through Acetylation; Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Factors involved in megakaryocyte development and platelet production; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; EGR2 and SOX10-mediated initiation of Schwann cell myelination; MECP2 regulates neuronal receptors and channels","Cell cycle; Neural crest differentiation; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications; Effect of progerin on genes involved in progeria; Ciliary landscape; 7q11.23 copy number variation syndrome; SARS-CoV-2 innate immunity evasion and cell-specific immune response; TAR syndrome; Notch signaling pathway",30,0,124.5,118.5,125.4,95.1,131.8,79.1,56.5,60.4,69.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S424(100)]",0,"ENSG00000196591"
"128","GFAP",-0.634269380733075,6.64210473819421,-5.22679758366098,0.000442735994747656,0.00561247843667084,0.00873431194362784,"DOWN",FALSE,"High","Master Protein","P14136","Glial fibrillary acidic protein [OS=Homo sapiens]",0,761.054,77,44,78,298,42,432,49.9,5.52,761.77,44,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00038, Pf04732","2670","A7REI1; B2RD44; D3DX59; E9PAX3; hsa:2670; P14136; Q53H98; Q5D055; Q6ZQS3; Q7Z5J6; Q7Z5J7; Q96KS4; Q96P18; Q9UFD0","ENSG00000131095","Nuclear signaling by ERBB4; Chaperone Mediated Autophagy","Neural crest differentiation; Spinal cord injury; Neuroinflammation and glutamatergic signaling; Cell lineage map for neuronal differentiation",6,3,67.7,69.6,72.2,142.3,126.3,168,100.8,103,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S8(99.6); S13(100); S16(99.7); S38(100); S82(100); S291(100); S305(100); S323(100); S337(100); S385(100); S398(100); S400(100); S424(100)]",0,"ENSG00000131095"
"129","NMT1",0.410739854536295,6.66480930813653,5.22534858368469,0.000443633405839791,0.00561247843667084,0.00662685349295966,"NONE",FALSE,"High","Master Protein","P30419","Glycylpeptide N-tetradecanoyltransferase 1 [OS=Homo sapiens]",0,15.852,2,1,1,2,1,496,56.8,7.8,6.7,1,"protein metabolism;other metabolic processes;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;other cell component","other molecular function","Pf01233, Pf02799","4836","A8K7C1; hsa:4836; P30419; Q9UE09","ENSG00000136448","Inactivation, recovery and regulation of the phototransduction cascade; Late Phase of HIV Life Cycle; Activation, myristolyation of BID and translocation to mitochondria",NA,3,0,68.7,71.1,72,106,100.1,108.2,121.4,151.4,149.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000136448"
"130","TPI1",0.42517113368659,6.65253468161276,5.21621294933616,0.00044933653314895,0.00564090170845451,-0.00666728354413149,"NONE",FALSE,"High","Master Protein","P60174","Triosephosphate isomerase [OS=Homo sapiens]",0,62.072,27,5,5,9,5,249,26.7,6.9,32.16,5,"other metabolic processes","cytosol","other molecular function","Pf00121","7167","B7Z5D8; D3DUS9; hsa:7167; P00938; P60174; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5","ENSG00000111669","Glycolysis; Gluconeogenesis","Fatty acid beta-oxidation; Cori cycle; HIF1A and PPARG regulation of glycolysis; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",10,0,77,75.5,82,98.9,102.7,92.8,126.1,122.4,143.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S212(100)]",0,"ENSG00000111669"
"131","MZT2B",-0.458319123214157,6.6370321266276,-5.20776778334863,0.000454678638060566,0.00565843494903367,-0.0189674973684584,"NONE",FALSE,"High","Master Protein","Q6NZ67","Mitotic-spindle organizing protein 2B [OS=Homo sapiens]",0,3.074,6,1,1,2,1,158,16.2,10.15,2.05,1,NA,"cytosol;cytoskeleton;nucleus",NA,"Pf12926","80097","hsa:80097; Q6NZ67; Q96CG4","ENSG00000152082; ENSG00000292119","Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes",NA,2,0,80.9,83.7,80.4,118.5,159.1,119.5,97.1,95.5,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100)]",0,"ENSG00000152082"
"132","ITPKB",-0.413425252974037,6.63969086961802,-5.20308905506881,0.00045766753264243,0.00565843494903367,-0.0257864544062194,"NONE",FALSE,"High","Master Protein","P27987","Inositol-trisphosphate 3-kinase B [OS=Homo sapiens]",0,250.122,18,14,23,49,14,946,102.3,8.43,167.63,14,"cell cycle OR cell proliferation;other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf03770","3707","hsa:3707; P27987; Q5VWL9; Q5VWM0; Q96BZ2; Q96JS1; Q9UH47","ENSG00000143772","Synthesis of IP3 and IP4 in the cytosol","CCL18 signaling pathway",2,0,90.4,83.7,87.3,122.2,132.9,115.5,97.7,92.4,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T33(100); S43(100); S65(100); S120(100); S174(100); S176(100); S204(100); S269(100); S562(100); S588(100)]",0,"ENSG00000143772"
"133","RABEP1",-0.478371658107831,6.64776261713414,-5.18270586547769,0.000470937007968364,0.00577871576695015,-0.0555309842711473,"NONE",FALSE,"High","Master Protein","Q15276","Rab GTPase-binding effector protein 1 [OS=Homo sapiens]",0,48.558,4,3,6,10,3,862,99.2,5.01,38.43,3,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf03528, Pf09311","9135","B2RAG7; hsa:9135; O95369; Q15276; Q8IVX3","ENSG00000029725","TBC/RABGAPs","GDNF signaling",2,0,76.1,82.5,84,130.3,147.3,118.2,92.1,102,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S407(99.7)]",0,"ENSG00000029725"
"134","PDS5B",-0.396551965438398,6.57580290322952,-5.17300900073972,0.00047739401635551,0.00580906504338726,-0.0697025921593415,"NONE",FALSE,"High","Master Protein","Q9NTI5","Sister chromatid cohesion protein PDS5 homolog B [OS=Homo sapiens]",0,49.897,4,3,3,6,3,1447,164.6,8.47,24.79,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf20168","23047","hsa:23047; Q5R3S3; Q5W0K8; Q6NSC3; Q8IXT6; Q9H5N8; Q9NTI5; Q9Y2I5; Q9Y451","ENSG00000083642","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cohesin complex - Cornelia de Lange syndrome; 10q22q23 copy number variation",6,0,111.1,115.5,108.4,100.7,88,111.9,80.9,85.2,80.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1166(99.2); S1182(100); S1358(100)]",0,"ENSG00000083642"
"135","BCAN",-0.436094468347387,6.61581961607907,-5.16642380163731,0.000481833112255938,0.00580906504338726,-0.0793344383068089,"NONE",FALSE,"High","Master Protein","Q96GW7","Brevican core protein [OS=Homo sapiens]",0,32.935,3,1,3,8,1,911,99.1,4.64,19.2,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00008, Pf00059, Pf00084, Pf00193, Pf07686","63827","D3DVC2; hsa:63827; Q5SZ10; Q5T3I5; Q8TBB9; Q96GW7; Q9HBK1; Q9HBK4","ENSG00000132692","ECM proteoglycans; Degradation of the extracellular matrix; A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective B3GALT6 causes EDSP2 and SEMDJL1; Chondroitin sulfate biosynthesis; Dermatan sulfate biosynthesis; CS/DS degradation; Defective CHST3 causes SEDCJD; Defective CHST14 causes EDS, musculocontractural type; Defective CHSY1 causes TPBS","Spinal cord injury",13,0,89.3,84.6,98.1,119.7,126.2,110.9,87.5,94.1,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S419(98.7)]",0,"ENSG00000132692"
"136","RRAGC",0.405179053489793,6.67049447699129,5.16187647356988,0.000484924304218035,0.00580906504338726,-0.0859892832876428,"NONE",FALSE,"High","Master Protein","Q9HB90","Ras-related GTP-binding protein C [OS=Homo sapiens]",0,25.581,4,1,2,7,1,399,44.2,5.1,24.24,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf04670","64121","hsa:64121; Q9H202; Q9H8Q8; Q9HB90","ENSG00000116954","Regulation of PTEN gene transcription; Macroautophagy; Amino acids regulate mTORC1; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Energy dependent regulation of mTOR by LKB1-AMPK","Target of rapamycin signaling; Orexin receptor pathway; 2q37 copy number variation syndrome",10,0,109.8,103,96.3,90.7,75,91.2,119,111.3,116.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(99.6)]",0,"ENSG00000116954"
"137","CAAP1",0.562965974360547,6.64494447635129,5.15789510852913,0.000487648229745132,0.00580906504338726,-0.0918183387667186,"UP",FALSE,"High","Master Protein","Q9H8G2","Caspase activity and apoptosis inhibitor 1 [OS=Homo sapiens]",0,23.177,5,1,2,2,1,361,38.3,4.72,6.78,1,"other biological processes",NA,NA,"Pf15335","79886","B4DWT4; D3DRK4; hsa:79886; Q5VY32; Q6IPE6; Q96C59; Q9H8G2","ENSG00000120159",NA,"Acute viral myocarditis",1,0,84.8,81.7,81.6,95.5,97.9,74.8,130.2,124.9,136.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S312(99.6)]",0,"ENSG00000120159"
"138","SALL2",-0.369081211732141,6.54678950017703,-5.14557076354912,0.00049618468035818,0.00586792317640978,-0.109876874917716,"NONE",FALSE,"High","Master Protein","Q9Y467","Sal-like protein 2 [OS=Homo sapiens]",0,49.876,5,2,3,8,2,1007,105.3,6.34,29.31,2,"developmental processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf13912","6297","B2RMX6; B9EGK8; hsa:6297; Q8N656; Q9Y467; Q9Y4G1","ENSG00000165821",NA,NA,0,0,128.1,114.8,123.6,92.1,83.8,98.9,79.1,80.1,75.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S806(100); S873(96.7)]",0,"ENSG00000165821"
"139","TFAP4",0.623060884408186,6.52777916707888,5.12609892886431,0.000510000070922256,0.00598791450176347,-0.138453560302766,"UP",FALSE,"High","Master Protein","Q01664","Transcription factor AP-4 [OS=Homo sapiens]",0,18.064,3,1,1,4,1,338,38.7,5.87,9.07,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","7023","hsa:7023; O60409; Q01664","ENSG00000090447",NA,"DYRK1A involvement regarding cell proliferation in brain development",1,0,136.1,134.5,120.6,55,62.7,59.5,108.2,88.4,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S124(100)]",0,"ENSG00000090447"
"140","PXN",-0.487798255049988,6.64177742300883,-5.07875735764292,0.000545338956256575,0.00632620523494371,-0.20816190185186,"NONE",FALSE,"High","Master Protein","P49023","Paxillin [OS=Homo sapiens]",0,70.586,12,4,5,9,4,591,64.5,6.19,27.01,4,"cell adhesion;cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00412, Pf03535","5829","B2RAI3; B7ZMB4; hsa:5829; O14970; O14971; O60360; P49023; Q5HYA4","ENSG00000089159","VEGFA-VEGFR2 Pathway; GAB1 signalosome; Smooth Muscle Contraction; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Integrin-mediated cell adhesion; Prolactin signaling pathway; Androgen receptor network in prostate cancer; Oncostatin M signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; 3q29 copy number variation syndrome; Regulation of actin cytoskeleton; GDNF signaling; HDAC6 interactions in the central nervous system",21,0,85,86.1,86.6,126.4,144,114.6,99.7,93.1,87.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(99.4); S303(99.6)]",0,"ENSG00000089159"
"141","DCX",-0.497834388081436,6.59619849330168,-5.07717374316704,0.000546565525813151,0.00632620523494371,-0.210499338574233,"NONE",FALSE,"High","Master Protein","O43602","Neuronal migration protein doublecortin [OS=Homo sapiens]",0,53.355,11,5,7,13,3,365,40.5,9.28,35.27,5,"cell organization and biogenesis;developmental processes;signal transduction","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf03607","1641","A6NFY6; A9Z1V8; D3DUY8; D3DUY9; D3DUZ0; hsa:1641; O43602; O43911; Q5JYZ5","ENSG00000077279","Neurofascin interactions","PAFAH1B1 copy number variation; Cell lineage map for neuronal differentiation",3,0,54.7,53.4,62.1,144.3,187.9,127.6,106.2,109,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S206(100); S332(100); S339(99.3)]",0,"ENSG00000077279"
"142","CASK",0.400887216094106,6.66073504972982,5.0702932979941,0.000551929115816523,0.00634329800713074,-0.220659202343212,"NONE",FALSE,"High","Master Protein","O14936-4","Isoform 4 of Peripheral plasma membrane protein CASK [OS=Homo sapiens]",0,26.944,2,1,1,4,1,898,102.1,6.4,11.53,1,NA,NA,NA,NA,NA,"O14936-4",NA,NA,NA,0,0,82.2,90.1,92.9,92.2,81.1,101.4,125.3,117.4,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S577(99.7)]",0,"ENSG00000147044"
"143","NSMF",-0.97726655899657,6.58710319745078,-5.06012130820543,0.000559962164137163,0.00639061714595699,-0.235692057424744,"DOWN",FALSE,"High","Master Protein","Q6X4W1","NMDA receptor synaptonuclear signaling and neuronal migration factor [OS=Homo sapiens]",0,14.394,4,1,1,1,1,530,60.1,9.07,4.14,1,"other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function",NA,"26012","hsa:26012; Q2TB96; Q6X4V7; Q6X4V8; Q6X4V9; Q6X4W1; Q8N2M2; Q96SY1; Q9NPM4; Q9NPP3; Q9NPS3","ENSG00000165802",NA,"IL-18 signaling pathway; Neuroinflammation and glutamatergic signaling",2,0,72,66.3,69.3,174.3,206.6,117.6,100.3,77.5,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000165802"
"144","NOS1AP",-0.396825856114534,6.62805975466408,-5.03913778929577,0.000576931723250113,0.00653521190970587,-0.266750385818455,"NONE",FALSE,"High","Master Protein","O75052","Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein [OS=Homo sapiens]",0,57.52,7,2,8,14,2,506,56.1,6.3,41.18,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","other molecular function","Pf00640","9722","B7ZLF5; hsa:9722; O43564; O75052; Q3T551; Q5VU95","ENSG00000198929",NA,"Sudden infant death syndrome (SIDS) susceptibility pathways",1,0,85.4,88,88.7,119.1,132.8,112,93.3,97.9,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(99.5); S371(100); S374(100)]",0,"ENSG00000198929"
"145","SNCAIP",-0.447009727891575,6.67267447620409,-5.03043500400272,0.000584130598257065,0.00653521190970587,-0.279650379792445,"NONE",FALSE,"High","Master Protein","Q9Y6H5","Synphilin-1 [OS=Homo sapiens]",0,32.504,7,5,7,9,5,919,100.3,6.34,24.77,5,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf12796, Pf16700","9627","D3DSZ1; hsa:9627; Q05BS1; Q1PSC2; Q49AC6; Q504U9; Q6L984; Q6L985; Q6L986; Q9HC59; Q9Y6H5","ENSG00000064692","Amyloid fiber formation","Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway; HDAC6 interactions in the central nervous system",4,0,85.6,91.8,90.6,121.6,136.6,123.6,95.6,104.9,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S566(99.6); S676(99.5); S801(100)]",0,"ENSG00000064692"
"146","PLEKHA5",-0.409048917212854,6.66555602323031,-5.02612696738857,0.000587729713350348,0.00653521190970587,-0.28604017473532,"NONE",FALSE,"High","Master Protein","Q9HAU0","Pleckstrin homology domain-containing family A member 5 [OS=Homo sapiens]",0,61.556,8,6,6,10,6,1116,127.4,7.53,36.05,6,"developmental processes","cytosol;nucleus;other cell component","other molecular function","Pf00169, Pf00397","54477","A0JP03; B4DGS1; E9PHQ3; F5H0I0; hsa:54477; Q6NSF8; Q86ST7; Q8N3K6; Q96DY9; Q9BVR4; Q9C0H7; Q9H924; Q9HAU0; Q9NVK8","ENSG00000052126","Synthesis of PIPs at the plasma membrane",NA,1,0,90.4,87.1,91.5,122.1,115.9,128,102.1,92.6,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100); T438(100); T460(100); S809(100); S855(100); S933(100)]",0,"ENSG00000052126"
"147","MTSS2",0.788385240828747,6.59589702675824,5.02503041942313,0.000588649602161007,0.00653521190970587,-0.287667033522157,"UP",FALSE,"High","Master Protein","Q765P7","Protein MTSS 2 [OS=Homo sapiens]",0,22.086,4,2,2,6,2,747,79.9,7.47,22.25,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf08397","92154","A6NJI7; hsa:92154; Q765P7; Q9BUA8","ENSG00000132613",NA,NA,0,0,59.6,63.2,64.6,78.2,123.7,82.3,139.7,140.8,194.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S456(100); S612(100)]",0,"ENSG00000132613"
"148","FMN2",-0.473437191637211,6.61292226036092,-5.01649493264968,0.000595862905591553,0.00657059636436091,-0.300336396621816,"NONE",FALSE,"High","Master Protein","Q9NZ56","Formin-2 [OS=Homo sapiens]",0,267.533,18,13,17,43,13,1722,180,5.47,163.48,13,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity","Pf02181","56776","B0QZA7; B4DP05; hsa:56776; Q59GF6; Q5VU37; Q9NZ55; Q9NZ56","ENSG00000155816",NA,NA,0,0,94.7,92.6,102.3,111.9,132.6,108.3,94.1,84.7,83.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100); S93(100); S295(100); S317(100); T345(100); S361(100); S396(100); S400(100); S482(100); S499(100); S511(99.4); S516(100); S747(98)]",0,"ENSG00000155816"
"149","ADD1",-0.396872916875472,6.64435830483276,-4.98227837563324,0.000625743497019272,0.00685378112171444,-0.351230498178212,"NONE",FALSE,"High","Master Protein","P35611","Alpha-adducin [OS=Homo sapiens]",0,182.37,14,9,11,36,9,737,80.9,5.83,113.72,9,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00596","118","A2A3N8; A2A3P0; B4DI79; D3DVR3; D3DVR4; D3DVR5; hsa:118; P35611; Q13734; Q14729; Q16156; Q86XM2; Q9UJB6","ENSG00000087274","XBP1(S) activates chaperone genes; Caspase-mediated cleavage of cytoskeletal proteins; Miscellaneous transport and binding events",NA,3,0,92.8,94.2,91.1,118.4,124,115.4,99.6,90.4,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T11(99.7); S355(100); S431(100); S465(100); S481(99.4); S586(100)]",0,"ENSG00000087274"
"150","NAGK",-0.359967569931054,6.65146815629618,-4.95938029263155,0.00064663322401684,0.0070137005424584,-0.385383915985808,"NONE",FALSE,"High","Master Protein","Q9UJ70","N-acetyl-D-glucosamine kinase [OS=Homo sapiens]",0,30.401,5,1,1,7,1,344,37.4,6.24,30.7,1,"other metabolic processes;stress response;other biological processes","cytosol","kinase activity;other molecular function","Pf01869","55577","B4DLZ5; hsa:55577; Q53HD5; Q6IA84; Q9BS29; Q9BVP0; Q9NV37; Q9UJ70","ENSG00000124357","Synthesis of UDP-N-acetyl-glucosamine",NA,1,0,92.5,89.3,100.5,111.5,116.7,123.4,91.2,96.8,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100)]",0,"ENSG00000124357"
"151","GIT1",0.416182182016104,6.66350433298444,4.95690125258182,0.000648939204602462,0.0070137005424584,-0.389086046231348,"NONE",FALSE,"High","Master Protein","Q9Y2X7","ARF GTPase-activating protein GIT1 [OS=Homo sapiens]",0,59.845,8,4,5,10,4,761,84.3,6.8,30.4,4,"transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;mitochondrion;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf01412, Pf08518, Pf12205, Pf12796, Pf16559","28964","B4DGU9; B4DSV3; hsa:28964; Q86SS0; Q9BRJ4; Q9Y2X7","ENSG00000108262","RHOJ GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Ephrin signaling; Activation of RAC1 downstream of NMDARs","CAMKK2 pathway; Regulation of actin cytoskeleton",12,0,72.1,80.9,82.1,91.2,101,105.6,120.7,130,144.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(99.6); S410(100); S592(100)]",0,"ENSG00000108262"
"152","EEF2",0.500835415121161,6.65480286386554,4.94825767111784,0.00065704845464021,0.0070546255129791,-0.402001067761082,"UP",FALSE,"High","Master Protein","P13639","Elongation factor 2 [OS=Homo sapiens]",0,42.458,8,8,8,15,8,858,95.3,6.83,32.78,8,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00009, Pf00679, Pf03144, Pf03764, Pf14492","1938","A0A384N6H1; B2RMP5; D6W618; hsa:1938; P13639; Q58J86","ENSG00000167658","Neutrophil degranulation; Protein methylation; Uptake and function of diphtheria toxin; Peptide chain elongation; Synthesis of diphthamide-EEF2","Translation factors; AMP-activated protein kinase signaling; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-18 signaling pathway",9,0,94.9,87.1,99.8,84.9,83.8,87.1,112.4,114.1,149.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T57(100); S502(99.5)]",0,"ENSG00000167658"
"153","TRAF4",1.05872464618297,6.34545840014979,4.92458648828278,0.000679816363286774,0.00722848918901392,-0.437425078074533,"UP",FALSE,"High","Master Protein","Q9BUZ4","TNF receptor-associated factor 4 [OS=Homo sapiens]",0,10.917,3,1,1,2,1,470,53.5,8.15,6.75,1,"protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00097, Pf02176, Pf21355","9618","hsa:9618; O75615; Q14848; Q2KJU4; Q2PJN8; Q9BUZ4","ENSG00000076604",NA,"Small cell lung cancer; p53 transcriptional gene network",2,0,131.4,131.5,128.1,35.8,35.7,40.3,95.5,70.8,138.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S426(100)]",0,"ENSG00000076604"
"154","PLEKHG2",0.698598569577688,6.63957179006528,4.92225909815388,0.000682100082786853,0.00722848918901392,-0.44091238241766,"UP",FALSE,"High","Master Protein","Q9H7P9","Pleckstrin homology domain-containing family G member 2 [OS=Homo sapiens]",0,11.031,2,2,3,5,2,1386,147.9,5.86,11.11,2,"cell organization and biogenesis","cytosol","enzyme regulator activity;other molecular function","Pf00169, Pf00621","64857","B8ZZK6; C9J0Y4; hsa:64857; Q6DHV6; Q96BU2; Q96D18; Q9H699; Q9H7P9","ENSG00000090924","G alpha (12/13) signalling events; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK",NA,4,0,105.3,116.6,106,62.4,87.9,65,120.6,108.4,135.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1257(100); S1261(100); S1318(99.3)]",0,"ENSG00000090924"
"155","EFR3B",0.713267453684459,6.64890381196667,4.91196492741257,0.000692299950518858,0.00728924851126953,-0.456346261153157,"UP",FALSE,"High","Master Protein","Q9Y2G0","Protein EFR3 homolog B [OS=Homo sapiens]",0,3.87,2,1,1,1,1,817,92.4,6.7,2.77,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton",NA,"Pf21052","22979","B7WPL8; hsa:22979; Q86XU6; Q9Y2G0","ENSG00000084710",NA,NA,0,0,67.9,98.6,104.1,84.2,66.3,90.6,134.4,130.7,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S689(100)]",0,"ENSG00000084710"
"156","BCAS3",-0.595721059396344,6.59656841028893,-4.8788791357447,0.000726202238204906,0.00759719264583594,-0.506054336793103,"DOWN",FALSE,"High","Master Protein","Q9H6U6","BCAS3 microtubule associated cell migration factor [OS=Homo sapiens]",0,15.2,2,1,1,1,1,928,101.2,6.7,4.8,1,"cell-cell signaling;other metabolic processes;stress response;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf12490, Pf21034","54828","hsa:54828; Q17RM0; Q6KF21; Q8IXI6; Q8NDR8; Q8TDL9; Q8TDM1; Q8WY55; Q9BVF0; Q9H6U6; Q9H957; Q9H9Y9; Q9NXP4","ENSG00000141376",NA,"Ectoderm differentiation",1,0,75.3,75.7,104.5,115.3,145.4,125.2,86.6,88.4,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S869(100)]",0,"ENSG00000141376"
"157","GOLM2",-0.411370247128902,6.64887108531267,-4.8708684669053,0.000734674679044363,0.00760197978196343,-0.518113173015982,"NONE",FALSE,"High","Master Protein","Q6P4E1","Protein GOLM2 [OS=Homo sapiens]",0.004,2.116,3,1,1,1,1,436,49.5,5.29,1.7,1,NA,"other membranes;ER/Golgi",NA,NA,"113201","B4DPZ6; G5E934; Q6P4E1; Q6UY45; Q96EM1","ENSG00000166734",NA,NA,0,0,99.8,97.9,97,119.2,117.9,111.6,97.7,87.8,88.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(99.4)]",0,"ENSG00000166734"
"158","RIN1",0.472631404789411,6.62936538952764,4.86964683967336,0.000735975983793028,0.00760197978196343,-0.519952953736603,"NONE",FALSE,"High","Master Protein","Q13671","Ras and Rab interactor 1 [OS=Homo sapiens]",0,23.49,3,2,3,5,2,783,84,8.02,13.07,2,"transport;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00788, Pf02204","9610","hsa:9610; O15010; Q00427; Q13671; Q96CC8","ENSG00000174791","RAB GEFs exchange GTP for GDP on RABs","Ras signaling; EGF/EGFR signaling pathway",3,0,71.7,72.9,66.3,93.2,93.9,110.5,119.4,139.7,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.4); S351(100)]",0,"ENSG00000174791"
"159","CAP2",0.307249606604155,6.66346294075982,4.86230453336189,0.000743849252463081,0.00763498100641351,-0.531015029252429,"NONE",FALSE,"High","Master Protein","P40123","Adenylyl cyclase-associated protein 2 [OS=Homo sapiens]",0,37.313,4,2,4,10,2,477,52.8,6.37,25.58,2,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf01213, Pf08603","10486","B2R5Y3; B7Z1C4; B7Z214; hsa:10486; P40123; Q6IAY2","ENSG00000112186","Role of ABL in ROBO-SLIT signaling","Ectoderm differentiation; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway",4,0,98.5,100.5,102.1,92.6,82.8,92.1,112.5,112.2,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100); T307(100); S309(100)]",0,"ENSG00000112186"
"160","SLC4A4",0.390870024627833,6.60372857996595,4.83084181429333,0.000778620845869935,0.00794193262787334,-0.578504721070026,"NONE",FALSE,"High","Master Protein","Q9Y6R1","Electrogenic sodium bicarbonate cotransporter 1 [OS=Homo sapiens]",0,89.122,5,6,11,23,6,1079,121.4,6.8,68.79,6,"transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00955, Pf07565","8671","C4B714; hsa:8671; O15153; Q8NEJ2; Q9H262; Q9NRZ1; Q9UIC0; Q9UIC1; Q9UP50; Q9Y6R1","ENSG00000080493","Bicarbonate transporters; Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)","Proximal tubule transport",3,0,111.1,112.6,102.6,82.2,73.6,75.1,101.6,103.3,114.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S245(100); T254(99.8); S1069(100)]",0,"ENSG00000080493"
"161","AKAP10",0.43826191210151,6.60407818612287,4.82332026206048,0.000787188029805601,0.00797944636424062,-0.589878649457344,"NONE",FALSE,"High","Master Protein","O43572","A-kinase anchor protein 10, mitochondrial [OS=Homo sapiens]",0,7.975,2,1,1,1,1,662,73.8,6.39,3.36,1,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;other cell component","other molecular function","Pf00615","11216","B2R650; hsa:11216; O43572; Q96AJ7","ENSG00000108599","Factors involved in megakaryocyte development and platelet production","G protein signaling pathways; TAR syndrome",3,0,100.7,111.3,112.8,82,63.5,82.3,113.8,99.3,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100)]",0,"ENSG00000108599"
"162","MAP4K4",-0.444830834042309,6.60775398096687,-4.81477194635101,0.000797047124056634,0.00802951176827424,-0.602815016113611,"NONE",FALSE,"High","Master Protein","O95819-3","Isoform 3 of Mitogen-activated protein kinase kinase kinase kinase 4 [OS=Homo sapiens]",0,73.456,8,8,9,18,2,1320,150.9,7.42,42.27,8,NA,NA,NA,NA,NA,"O95819-3",NA,NA,NA,0,4,102.6,102.3,102.1,108.4,127.9,101.8,86,91.3,80.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S643(100); S708(100); S716(100); S788(99.5); S923(100); S981(100)]",0,"ENSG00000071054"
"163","MRTFB",0.838247341283993,6.60619333918876,4.802638019039,0.000811268742279976,0.00812264164049645,-0.621195436954638,"UP",FALSE,"High","Master Protein","Q9ULH7","Myocardin-related transcription factor B [OS=Homo sapiens]",0,8.254,3,1,1,1,1,1088,118.1,6.28,3.41,1,"other biological processes","nucleus","other molecular function","Pf02037, Pf02755","57496","A6ND53; B4DGT8; hsa:57496; Q68CT1; Q6UB16; Q86WW2; Q8N226; Q9ULH7","ENSG00000186260",NA,NA,0,0,75.6,73.1,68.1,83,107,65.2,130,131.6,208,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(99.3)]",0,"ENSG00000186260"
"164","ADGRB2",0.442405585501206,6.62108143535743,4.79340781872902,0.000822268434345924,0.0081825736881253,-0.635191325777249,"NONE",FALSE,"High","Master Protein","O60241","Adhesion G protein-coupled receptor B2 [OS=Homo sapiens]",0,11.9,2,1,1,1,1,1585,172.5,7.42,3.22,1,"developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes","other molecular function","Pf00002, Pf00090, Pf01825, Pf16489, Pf19188","576","B9EGK9; hsa:576; O60241; Q5T6K0; Q8NGW8; Q96GZ9","ENSG00000121753",NA,NA,0,0,101.5,86.9,89.3,79.1,77.7,95.9,112.3,113.9,128.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1275(100)]",0,"ENSG00000121753"
"165","GNAS",0.339295323423951,6.62854921507482,4.77707498920555,0.000842124470115371,0.00832937657714112,-0.659986678863077,"NONE",FALSE,"High","Master Protein","Q5JWF2","Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas [OS=Homo sapiens]",0,14.713,2,2,2,3,1,1037,111,5.03,8.18,2,"cell adhesion;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00503","2778","A2A2S3; E1P5G3; O75684; O75685; Q5JW67; Q5JWF1; Q5JWF2; Q9NY42","ENSG00000087460","Vasopressin regulates renal water homeostasis via Aquaporins; G alpha (i) signalling events; G alpha (z) signalling events; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Prostacyclin signalling through prostacyclin receptor; Glucagon-type ligand receptors; PKA activation in glucagon signalling; Hedgehog 'off' state","Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; G protein signaling pathways; Thermogenesis; Hippo signaling regulation pathways; Purinergic signaling; GPR143 in melanocytes and retinal pigment epithelium cells; Vasopressin-regulated water reabsorption; Prostaglandin and leukotriene metabolism in senescence ; Primary ovarian insufficiency; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; Estrogen signaling pathway; Serotonin receptor 4/6/7 and NR3C signaling",29,0,103.3,97.1,101.9,82.4,83,89.5,111.3,109.3,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S995(100)]",0,"ENSG00000087460"
"166","GTF3C2",0.330618062586308,6.5769969157275,4.75020955268179,0.000875906887218433,0.00861132554181013,-0.700854115521231,"NONE",FALSE,"High","Master Protein","Q8WUA4","General transcription factor 3C polypeptide 2 [OS=Homo sapiens]",0,5.003,2,2,2,2,2,911,100.6,7.31,2.7,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf00400","2976","D6W557; hsa:2976; Q16632; Q8WUA4; Q9BWI7","ENSG00000115207","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,118.7,122.1,119.5,75.9,62.4,79.3,94.3,101.9,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100); S220(99.7)]",0,"ENSG00000115207"
"167","RAVER1",0.45161520233969,6.62670275160851,4.73709044663697,0.000892926689330992,0.0087260859699891,-0.720847844882324,"NONE",FALSE,"High","Master Protein","Q8IY67-2","Isoform 2 of Ribonucleoprotein PTB-binding 1 [OS=Homo sapiens]",0,44.152,6,3,3,10,3,739,77.8,8.84,40.2,3,NA,NA,NA,NA,NA,"Q8IY67-2",NA,NA,NA,0,0,113.1,100.8,105.8,84.5,82.3,69.6,111,108.9,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); T463(100); S567(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000161847"
"168","PEAK1",-0.353068269188502,6.63039171398927,-4.73140296769842,0.0009004145603756,0.00874688430079154,-0.729523199256201,"NONE",FALSE,"High","Master Protein","Q9H792","Inactive tyrosine-protein kinase PEAK1 [OS=Homo sapiens]",0,49.689,4,5,5,7,5,1746,193,6.89,25.33,5,"cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;other cell component","kinase activity;other molecular function","Pf00069","79834","hsa:79834; Q6ZS78; Q8NAZ4; Q8NCM3; Q8TEG7; Q9H792","ENSG00000173517","RHOV GTPase cycle; RHOU GTPase cycle",NA,2,0,99.3,97.6,93,113.4,113.1,113.3,87.1,91.6,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S281(100); S792(100); T1151(100); T1165(100)]",0,"ENSG00000173517"
"169","EML1",-0.625783525680337,6.67687826704329,-4.67491174744665,0.000978531812571438,0.00944949063974312,-0.815938561140399,"DOWN",FALSE,"High","Master Protein","O00423","Echinoderm microtubule-associated protein-like 1 [OS=Homo sapiens]",0,13.517,2,1,1,1,1,815,89.8,7.06,4.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","2009","hsa:2009; O00423; Q86U15; Q8N536; Q8N5C4; Q8WWL6","ENSG00000066629",NA,NA,0,0,86.8,82.1,90.6,134.7,112.2,153.2,84.2,103.4,90.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(100)]",0,"ENSG00000066629"
"170","NF1",0.35000697304806,6.66043838175043,4.66675274254595,0.000990398670228631,0.00950782723419485,-0.828456446700457,"NONE",FALSE,"High","Master Protein","P21359","Neurofibromin [OS=Homo sapiens]",0,105.304,3,7,9,20,7,2839,319.2,7.39,62.72,7,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00616, Pf13716","4763","hsa:4763; O00662; P21359; Q14284; Q14930; Q14931; Q9UMK3","ENSG00000196712","Regulation of RAS by GAPs; RAS signaling downstream of NF1 loss-of-function variants","Pilocytic astrocytoma; Glioblastoma signaling pathways; Aryl hydrocarbon receptor pathway; MECP2 and associated Rett syndrome; MAPK signaling pathway; Ras signaling; Transcription co-factors SKI and SKIL protein partners; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Melanoma; EGFR tyrosine kinase inhibitor resistance; NF1 copy number variation syndrome",14,0,94.5,91.9,92,89.6,86,98.7,114.7,111.7,129.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S864(99.7); S2515(100); S2543(100); T2565(99.5); S2597(100); S2817(100)]",0,"ENSG00000196712"
"171","NUP35",0.411785614262487,6.52847913495084,4.6529086960021,0.00101088648510839,0.00960972448107974,-0.849717811564484,"NONE",FALSE,"High","Master Protein","Q8NFH5","Nucleoporin NUP35 [OS=Homo sapiens]",0,26.566,9,2,4,6,2,326,34.8,9.09,14.23,2,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf05172","129401","B4DP57; B4DYB4; hsa:129401; Q4ZFZ9; Q53S95; Q8NFH5; Q8TDJ1","ENSG00000163002","HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation",NA,29,0,126.1,121.2,116.9,60,65.8,70.3,97,91.3,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T265(100); T273(100)]",0,"ENSG00000163002"
"172","DNTTIP2",-0.577728585714267,6.61548050226136,-4.65163793540683,0.00101278958991772,0.00960972448107974,-0.851670754482055,"DOWN",FALSE,"High","Master Protein","Q5QJE6","Deoxynucleotidyltransferase terminal-interacting protein 2 [OS=Homo sapiens]",0,13.772,3,1,1,1,1,756,84.4,6.16,3.1,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf08698","30836","hsa:30836; Q12987; Q53H59; Q5QJE6; Q5TFJ4; Q6TLI0; Q76MJ8; Q86WX9","ENSG00000067334",NA,NA,0,0,91.5,101.3,89.9,107.3,137,125.6,74.6,90.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000067334"
"173","SCFD1",0.352981199154464,6.63360893178335,4.63695449672685,0.00103505871725967,0.0097642533327617,-0.874252998994817,"NONE",FALSE,"High","Master Protein","Q8WVM8","Sec1 family domain-containing protein 1 [OS=Homo sapiens]",0,30.401,3,1,1,3,1,642,72.3,6.27,16.59,1,"stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi","other molecular function","Pf00995","23256","A8K2Z5; B7Z4U7; B7Z594; hsa:23256; O60754; O94990; Q7Z529; Q8WVM8; Q9BZI3; Q9UNL3; Q9Y6A8","ENSG00000092108","COPII-mediated vesicle transport; RHOA GTPase cycle",NA,2,0,99.3,117.6,113.7,84.7,72.4,83.8,105.6,106.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(100)]",0,"ENSG00000092108"
"174","PDLIM5",-0.518833421212699,6.63003701925835,-4.62941383367982,0.00104669724320737,0.00981729828111736,-0.885861727421171,"DOWN",FALSE,"High","Master Protein","Q96HC4","PDZ and LIM domain protein 5 [OS=Homo sapiens]",0,14.622,3,1,1,2,1,596,63.9,8.21,3.66,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf00595","10611","A8K6F9; D6RB78; E9PBF5; hsa:10611; O60705; Q56VN4; Q5UW38; Q8WVK0; Q96HC4","ENSG00000163110","Neurexins and neuroligins","Extracellular vesicles in the crosstalk of cardiac cells",2,0,65.5,69,81.4,138.2,161.6,122.5,96.2,106.8,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S111(99.6)]",0,"ENSG00000163110"
"175","MID1",-1.01461285240535,6.49942269754999,-4.61550732418474,0.00106852825455987,0.0099647892082383,-0.907291251508033,"DOWN",FALSE,"High","Master Protein","O15344","E3 ubiquitin-protein ligase Midline-1 [OS=Homo sapiens]",0,18.865,2,2,2,2,2,667,75.2,6.8,6.21,2,"cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00041, Pf00622, Pf00643, Pf13445, Pf18568","4281","B2RCG2; hsa:4281; O15344; O75361; Q9BZX5","ENSG00000101871","Interferon gamma signaling",NA,1,0,51.7,47.6,67.1,201,112.2,199.1,94,89.5,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S96(99.6)]",0,"ENSG00000101871"
"176","KIAA0930",0.690292902457492,6.65354054472493,4.58015066038507,0.00112624601266796,0.0104433721174666,-0.961895189919134,"NONE",FALSE,"High","Master Protein","Q6ICG6","Uncharacterized protein KIAA0930 [OS=Homo sapiens]",0,4.816,2,1,1,2,1,404,45.8,7.94,5.07,1,NA,NA,NA,"Pf09741","23313","B0QY17; B0QY19; B3KT48; hsa:23313; Q6ICG6; Q6ZVE5; Q7Z6K9; Q8IZ76; Q9Y2E2","ENSG00000100364",NA,NA,0,0,77.1,77.3,72.3,98.4,58.2,114,133.5,155.1,150.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100)]",0,"ENSG00000100364"
"177","NPM1",0.47881031997193,6.55989997213962,4.56639554152673,0.00114958950126801,0.0105996048930474,-0.983184746400788,"NONE",FALSE,"High","Master Protein","P06748","Nucleophosmin [OS=Homo sapiens]",0,99.947,33,8,8,18,8,294,32.6,4.78,83.27,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;translational apparatus;nucleus;other cell component","enzyme regulator activity;translation activity;nucleic acid binding activity;other molecular function","Pf03066, Pf16276","4869","A8K3N7; B5BU00; D3DQL6; hsa:4869; P06748; P08693; Q12826; Q13440; Q13441; Q14115; Q5EU94; Q5EU95; Q5EU96; Q5EU97; Q5EU98; Q5EU99; Q6V962; Q8WTW5; Q96AT6; Q96DC4; Q96EA5; Q9BYG9; Q9UDJ7","ENSG00000181163","TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; PKR-mediated signaling; Nuclear import of Rev protein; Deposition of new CENPA-containing nucleosomes at the centromere; SUMOylation of transcription cofactors; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation; Nuclear events stimulated by ALK signaling in cancer; SARS-CoV-1-host interactions",NA,10,0,128.4,139.2,132.8,61.5,59.3,65.7,84.1,102.4,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100); S125(100); S137(100); S227(100); S243(100)]",0,"ENSG00000181163"
"178","ZBTB20",-0.492421494243072,6.61067376450025,-4.54591804417619,0.00118530024617179,0.0108141347239204,-1.01492693501745,"NONE",FALSE,"High","Master Protein","Q9HC78","Zinc finger and BTB domain-containing protein 20 [OS=Homo sapiens]",0,75.025,12,4,5,11,4,741,81,6.49,41.39,4,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","26137","Q63HP6; Q8N6R5; Q9HC78; Q9Y410","ENSG00000181722",NA,NA,0,0,103.4,106.3,104.5,99.7,101.7,131.8,83.7,88.1,80.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T211(100); T305(99.6); S353(100); S432(99.2)]",0,"ENSG00000181722"
"179","PALLD",-0.663834716841877,6.62585313057865,-4.54177280636646,0.00119267175842071,0.0108141347239204,-1.02135944850015,"NONE",FALSE,"High","Master Protein","Q8WX93","Palladin [OS=Homo sapiens]",0,23.9,2,2,2,6,2,1383,150.5,7.09,20.33,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf07679","23022","B3KTG2; B5MD56; B7ZMM5; hsa:23022; Q7L3E0; Q7Z3W0; Q86WE8; Q8N1M2; Q8WX93; Q9UGA0; Q9UQF5; Q9Y2J6; Q9Y3E9","ENSG00000129116",NA,NA,0,0,68.1,75.9,68.3,152.5,123.7,147,83.2,96.8,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S893(100); S1121(100)]",0,"ENSG00000129116"
"180","VCP",0.490694105016884,6.67100840090145,4.54173711084681,0.00119273544749122,0.0108141347239204,-1.02141485041803,"NONE",FALSE,"High","Master Protein","P55072","Transitional endoplasmic reticulum ATPase [OS=Homo sapiens]",0,48.672,6,4,4,7,4,806,89.3,5.26,20.49,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00004, Pf02359, Pf02933, Pf17862","7415","B2R5T8; P55072; Q0V924; Q2TAI5; Q969G7; Q9UCD5; V9HW80","ENSG00000165280","Aggrephagy; Neutrophil degranulation; HSF1 activation; E3 ubiquitin ligases ubiquitinate target proteins; ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; Neddylation; KEAP1-NFE2L2 pathway; Attachment and Entry; Attachment and Entry; Ovarian tumor domain proteases; Josephin domain DUBs; Protein methylation; RHOH GTPase cycle; Translesion Synthesis by POLH; N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Alstrom syndrome; Clock-controlled autophagy in bone metabolism; HDAC6 interactions in the central nervous system",21,0,98,99.3,96.9,85.5,67.5,101.1,120.1,109.3,139.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S770(100)]",0,"ENSG00000165280"
"181","PLEKHA6",-0.499154928869594,6.63037881043805,-4.52727572789094,0.0012188380034988,0.0109897437663538,-1.04387420505651,"NONE",FALSE,"High","Master Protein","Q9Y2H5","Pleckstrin homology domain-containing family A member 6 [OS=Homo sapiens]",0,30.401,3,2,2,2,2,1048,117.1,9.1,9.56,2,NA,NA,NA,"Pf00169","22874","A7MD51; hsa:22874; Q5VTI6; Q9Y2H5","ENSG00000143850","Synthesis of PIPs at the plasma membrane",NA,1,0,91.9,82.9,77.5,131.4,130.1,119.1,101.6,88.4,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S777(100); S867(100)]",0,"ENSG00000143850"
"182","PPP1R10",0.509383898072754,6.63707100457372,4.52272690386767,0.00122717366143142,0.0110041066783301,-1.05094467403924,"NONE",FALSE,"High","Master Protein","Q96QC0","Serine/threonine-protein phosphatase 1 regulatory subunit 10 [OS=Homo sapiens]",0,16.117,5,2,2,2,2,940,99,9.17,6.12,2,"transport;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00642, Pf08711","5514","hsa:5514; O00405; Q96QC0","ENSG00000204569; ENSG00000206489; ENSG00000227804; ENSG00000230995; ENSG00000231737; ENSG00000235291; ENSG00000238104",NA,NA,0,0,78.4,84.1,82.9,78.8,102.8,93.6,120.8,118.3,152.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(99.5)]",0,"ENSG00000204569"
"183","CAST",0.821474780662928,6.58221790589546,4.50966750125147,0.00125144352706644,0.011153904180455,-1.07125918324964,"NONE",FALSE,"High","Master Protein","P20810","Calpastatin [OS=Homo sapiens]",0,17.045,7,2,2,2,2,708,76.5,5.07,4.61,2,"cell organization and biogenesis;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity","Pf00748","831","B7Z468; G5E946; G5E9D3; hsa:831; O95360; P20810; Q05DE8; Q7Z4K0; Q96D08; Q9H1Z5","ENSG00000153113","Degradation of the extracellular matrix; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",NA,2,0,59.5,67.4,63.7,80.9,129.1,67.4,142,175,152.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.3); S243(100)]",0,"ENSG00000153113"
"184","LAMTOR1",0.65547943956852,6.63515683902123,4.50642510790592,0.00125754802034541,0.011153904180455,-1.07630646082218,"NONE",FALSE,"High","Master Protein","Q6IAA8","Ragulator complex protein LAMTOR1 [OS=Homo sapiens]",0,20.327,15,2,2,4,2,161,17.7,5.15,11.86,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf15454","55004","hsa:55004; Q6IAA8; Q8WZ09; Q9NWT0","ENSG00000149357","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; Amino acids regulate mTORC1; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; Neutrophil degranulation; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; RHOH GTPase cycle","Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins",17,0,107.5,97,105.7,81.5,69.1,70.3,144.6,105.7,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S56(100)]",0,"ENSG00000149357"
"185","CTR9",-0.415847042076329,6.59938569514906,-4.49851009740134,0.00127258308933548,0.0112262464961919,-1.08863335328014,"NONE",FALSE,"High","Master Protein","Q6PD62","RNA polymerase-associated protein CTR9 homolog [OS=Homo sapiens]",0,15.666,3,3,5,7,3,1173,133.4,6.77,6.15,3,"cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf13181, Pf13374","9646","D3DQV8; hsa:9646; Q15015; Q6PD62","ENSG00000198730","E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events","Endoderm differentiation",5,0,101.8,113,106,109.3,106.1,102.9,81.7,94.1,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S970(100)]",0,"ENSG00000198730"
"186","CHD4",-0.340342149744587,6.50332449876945,-4.48042196510733,0.00130766478678349,0.0114193693422418,-1.11683569926457,"NONE",FALSE,"High","Master Protein","Q14839","Chromodomain-helicase-DNA-binding protein 4 [OS=Homo sapiens]",0,41.94,4,3,5,12,3,1912,217.9,5.86,21.38,3,"cell organization and biogenesis;DNA metabolism;stress response;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf00385, Pf00628, Pf06461, Pf06465, Pf08073, Pf08074","1108","Q14839; Q8IXZ5","ENSG00000111642","Potential therapeutics for SARS; NGF-stimulated transcription; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation","Rett syndrome; Effect of progerin on genes involved in progeria",9,0,134.4,129.1,132.6,83.2,80.4,85.8,70.4,78.2,73,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1535(100)]",0,"ENSG00000111642"
"187","KLHL9",0.48787060948674,6.61589529862441,4.48001317888997,0.00130846940379854,0.0114193693422418,-1.11747357318633,"NONE",FALSE,"High","Master Protein","Q9P2J3","Kelch-like protein 9 [OS=Homo sapiens]",0,10.005,3,1,1,1,1,617,69.4,6.35,3.8,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00651, Pf01344, Pf07707","55958","hsa:55958; Q8TCQ2; Q9P2J3","ENSG00000198642","Neddylation; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,65.7,80.3,71.3,96.5,96.4,94.4,123.6,156.4,124,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S603(100)]",0,"ENSG00000198642"
"188","SRSF8",-0.412446250542534,6.37910231790833,-4.47146284639737,0.00132542026332916,0.0115057759029425,-1.13082074561445,"NONE",FALSE,"High","Master Protein","Q9BRL6","Serine/arginine-rich splicing factor 8 [OS=Homo sapiens]",0,6.713,7,1,1,6,1,282,32.3,11.72,7.76,1,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf00076","10929","B2R6B8; hsa:10929; Q6PF01; Q96TA3; Q9BRL6","ENSG00000263465","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,154.9,148,140,66.7,66.4,71.5,59.3,66.7,63,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100); S173(100); S327(100)]",0,"ENSG00000263465"
"189","PSMD11",0.451334326349861,6.65211278421429,4.46431224440739,0.00133977539178412,0.0115560069221927,-1.14199046286881,"NONE",FALSE,"High","Master Protein","O00231","26S proteasome non-ATPase regulatory subunit 11 [OS=Homo sapiens]",0,2.799,2,1,1,1,1,422,47.4,6.48,2.37,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","other molecular function","Pf01399, Pf18055, Pf18503","5717","A8K3I7; E1P663; hsa:5717; O00231; O00495; Q53FT5","ENSG00000108671","Separation of Sister Chromatids; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling",63,0,85.2,68.5,85.4,91.3,89.4,104,119,132,141,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000108671"
"190","SLC1A3",0.410689876955125,6.58269211486967,4.46154823400378,0.00134536845295135,0.0115560069221927,-1.14630986946671,"NONE",FALSE,"High","Master Protein","P43003","Excitatory amino acid transporter 1 [OS=Homo sapiens]",0,63.48,3,1,4,33,1,542,59.5,8.41,123.08,1,"cell-cell signaling;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00375","6507","B2R5T3; hsa:6507; P43003; Q4JCQ8","ENSG00000079215","Glutamate Neurotransmitter Release Cycle; Transport of inorganic cations/anions and amino acids/oligopeptides; Astrocytic Glutamate-Glutamine Uptake And Metabolism; Defective SLC1A3 causes episodic ataxia 6 (EA6)","Synaptic vesicle pathway; Neuroinflammation and glutamatergic signaling; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",8,0,108.2,107.1,97.7,81.5,59.6,89.6,105.8,110,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S512(100)]",0,"ENSG00000079215"
"191","FAM234A",0.68103415665336,6.64723870069089,4.45607677404771,0.00135651342246885,0.0115907324893673,-1.15486331166041,"NONE",FALSE,"High","Master Protein","Q9H0X4","Protein FAM234A [OS=Homo sapiens]",0,21.137,3,2,2,3,2,552,59.6,6.28,12.46,2,NA,"other membranes;other cell component",NA,NA,"83986","D3DU45; hsa:83986; Q7L416; Q96FR1; Q96MC7; Q96S30; Q9H0X4","ENSG00000167930",NA,NA,0,0,76.8,89.1,80.5,96.4,62.7,95.4,149.7,145.4,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000167930"
"192","SLC12A6",-0.502214386411908,6.63892641158797,-4.45159721066314,0.00136571100143225,0.0116085435121741,-1.16186912140991,"NONE",FALSE,"High","Master Protein","Q9UHW9","Solute carrier family 12 member 6 [OS=Homo sapiens]",0,11.351,2,1,1,1,1,1150,127.5,7.08,3.88,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","9990","A0AV76; hsa:9990; Q2VI00; Q7Z2E7; Q7Z4G5; Q8TDD4; Q9UFR2; Q9UHW9; Q9Y642; Q9Y665","ENSG00000140199","Cation-coupled Chloride cotransporters; Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",NA,2,0,126.9,98.4,101.7,114.5,117.6,111.5,84.8,76.8,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1032(100)]",0,"ENSG00000140199"
"193","PREX1",-0.358591632967124,6.59939737162676,-4.43719420070023,0.00139573541428017,0.0118022808088355,-1.18441286080063,"NONE",FALSE,"High","Master Protein","Q8TCU6","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein [OS=Homo sapiens]",0,28.622,3,2,2,4,2,1659,186.1,6.44,10.63,2,"cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00610, Pf00621","57580","E1P5X9; hsa:57580; Q5JS95; Q5JS96; Q69YL2; Q7Z2L9; Q8TCU6; Q9BQH0; Q9BX55; Q9H4Q6; Q9P2D2; Q9UGQ4","ENSG00000124126","RAC1 GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle","Chemokine signaling pathway",13,0,88,97.4,99.3,107.7,114.4,110.8,83.5,91.9,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1200(100)]",0,"ENSG00000124126"
"194","DMWD",-0.385054686954825,6.63148663069586,-4.42343919780691,0.00142506417617025,0.0119881687397415,-1.20596812846734,"NONE",FALSE,"High","Master Protein","Q09019","Dystrophia myotonica WD repeat-containing protein [OS=Homo sapiens]",0,27.412,9,3,4,5,3,674,70.4,7.24,16.84,3,NA,"nucleus;other cell component","enzyme regulator activity","Pf00400","1762","hsa:1762; Q09019","ENSG00000185800",NA,NA,0,0,83,78.3,89.1,115.6,138.6,119.6,93.4,103.8,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(99.6); S545(100)]",0,"ENSG00000185800"
"195","ARHGAP39",-0.353094271507942,6.59478708050836,-4.41949635353845,0.00143359138903054,0.0119980571635787,-1.21215153786596,"NONE",FALSE,"High","Master Protein","Q9C0H5","Rho GTPase-activating protein 39 [OS=Homo sapiens]",0,27.459,3,2,2,2,2,1083,121.2,7.5,8.04,2,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity","Pf00620, Pf00784","80728","B4E1I1; hsa:80728; Q9C0H5","ENSG00000147799","RHOA GTPase cycle; CDC42 GTPase cycle; RHOC GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; Inactivation of CDC42 and RAC1",NA,11,0,119.8,103.3,108.8,101.2,91.6,111.7,81.3,87.4,86.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(99.7); S604(100)]",0,"ENSG00000147799"
"196","ARHGEF2",0.38437831340027,6.64138396409806,4.41071695196246,0.00145277390123178,0.0120965663612769,-1.22592733361453,"NONE",FALSE,"High","Master Protein","Q92974","Rho guanine nucleotide exchange factor 2 [OS=Homo sapiens]",0,11.504,2,3,3,4,3,986,111.5,7.27,10.47,3,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00621, Pf17838","9181","D3DVA6; hsa:9181; O75142; Q15079; Q5VY92; Q8TDA3; Q8WUG4; Q92974; Q9H023","ENSG00000116584","RHOA GTPase cycle; RHOB GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events","Pathogenic Escherichia coli infection",5,0,100.8,87.7,87.7,87,90.3,91.3,109.4,117.5,128.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S932(100)]",0,"ENSG00000116584"
"197","SH3BP2",-0.362610694160711,6.5913075817775,-4.40503529815529,0.00146533312233991,0.0121392063739022,-1.234847876154,"NONE",FALSE,"High","Master Protein","P78314","SH3 domain-binding protein 2 [OS=Homo sapiens]",0,4.573,3,2,2,2,2,561,62.2,7.78,4.98,2,"signal transduction",NA,"other molecular function","Pf00017, Pf00169","6452","A6NNC2; B2R5R6; B4DT04; D3DVR0; D6R919; hsa:6452; O00500; O15373; P78314; P78315","ENSG00000087266",NA,"B cell receptor signaling pathway",1,0,55.4,48.5,53.4,134.4,160.4,147.4,115.8,121.8,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100); S427(100)]",0,"ENSG00000087266"
"198","DPY19L3",0.569855288645623,6.58594935936643,4.3997183083734,0.00147719070049917,0.012175632440478,-1.2431997360692,"NONE",FALSE,"High","Master Protein","Q6ZPD9","Probable C-mannosyltransferase DPY19L3 [OS=Homo sapiens]",0,11.53,2,1,1,1,1,716,83.1,8.72,4.38,1,NA,"other membranes;ER/Golgi;nucleus","other molecular function","Pf10034","147991","hsa:147991; Q68DC7; Q6ZPD9; Q6ZTB7; Q6ZTS2","ENSG00000178904",NA,NA,0,0,112.5,123.9,93.9,79.9,54.3,76.1,99,125.6,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000178904"
"199","RMDN3",0.37090214650981,6.60172767246615,4.39502385249676,0.00148774462741956,0.0122010011655714,-1.25057682709914,"NONE",FALSE,"High","Master Protein","Q96TC7","Regulator of microtubule dynamics protein 3 [OS=Homo sapiens]",0,46.289,13,2,2,8,2,470,52.1,5.1,28.22,2,"other biological processes","other membranes;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity","Pf21033","55177","A9UMZ9; B3KRR3; hsa:55177; Q6ZWE9; Q96H23; Q96SD6; Q96TC7; Q9H6G1; Q9NVQ6","ENSG00000137824",NA,NA,0,0,113.6,105.7,100.2,74.2,75.7,86,104.4,102,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S212(100)]",0,"ENSG00000137824"
"200","SSBP4",-0.564433754476928,6.54373274274513,-4.38136875690859,0.00151890109589993,0.0123942329425435,-1.27205158165926,"NONE",FALSE,"High","Master Protein","Q9BWG4","Single-stranded DNA-binding protein 4 [OS=Homo sapiens]",0,3.891,4,1,1,1,1,385,39.4,6.8,1.95,1,"other biological processes","nucleus","nucleic acid binding activity","Pf04503","170463","hsa:170463; Q9BWG4; Q9BWW5","ENSG00000130511",NA,NA,0,0,83.3,73.6,88,101.8,150.2,122.7,77.6,91.6,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S342(99.4)]",0,"ENSG00000130511"
"201","SF3A3",0.676149232055554,6.34193408810322,4.37132928724842,0.00154224923879364,0.0124743699017953,-1.28785581646611,"NONE",FALSE,"High","Master Protein","Q12874","Splicing factor 3A subunit 3 [OS=Homo sapiens]",0,7.898,2,1,1,2,1,501,58.8,5.38,4.34,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf11931, Pf12108, Pf13297, Pf16837","10946","D3DPT5; hsa:10946; Q12874; Q15460; Q5VT87","ENSG00000183431","mRNA Splicing - Major Pathway","Exercise-induced circadian regulation; mRNA processing",3,0,159.6,170.7,144.5,36.7,36,41.2,76.5,65.5,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000183431"
"202","GPM6A",-0.496627035087817,6.6231712454214,-4.36502385693201,0.00155710783620354,0.0124743699017953,-1.29778863362972,"NONE",FALSE,"High","Master Protein","P51674","Neuronal membrane glycoprotein M6-a [OS=Homo sapiens]",0,35.437,9,3,3,4,3,278,31.2,5.27,14.01,3,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf01275","2823","B7Z642; E9PHI5; hsa:2823; P51674; Q92602","ENSG00000150625",NA,NA,0,0,82.7,97.3,95.4,106.1,121.9,133.9,83.6,86.4,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(99.7)]",0,"ENSG00000150625"
"203","FCHO2",-0.352923994940208,6.65863773835172,-4.36397404634307,0.00155959640316804,0.0124743699017953,-1.29944288356969,"NONE",FALSE,"High","Master Protein","Q0JRZ9","F-BAR domain only protein 2 [OS=Homo sapiens]",0,82.478,6,3,5,9,3,810,88.9,6.86,33.61,3,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00611, Pf10291","115548","A8K6W7; B2RNQ9; B4DHK0; E9PG79; hsa:115548; Q0JRZ9; Q0JTJ3; Q96CF5","ENSG00000157107","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,96.4,100.2,101.4,116.7,106.2,118.8,95,97.6,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S403(100); S488(100); S496(100)]",0,"ENSG00000157107"
"204","PLCD3",-0.381078507582579,6.65803399398573,-4.35961820655967,0.00156996704667934,0.0124743699017953,-1.30630818001676,"NONE",FALSE,"High","Master Protein","Q8N3E9","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 [OS=Homo sapiens]",0,79.647,11,4,4,9,4,789,89.2,6.98,52.08,4,"other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00168, Pf00387, Pf00388, Pf14788","113026","hsa:113026; Q8N3E9; Q8TEC1; Q8TF37; Q96FL6","ENSG00000161714","Synthesis of IP3 and IP4 in the cytosol","GPR40 pathway; Resistin as a regulator of inflammation",3,0,98,96.4,89.4,122.6,108.3,121.1,98.5,93,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T37(100); S489(100); S496(100); S557(99.3)]",0,"ENSG00000161714"
"205","IRX1",-0.503438062755586,6.61207807880438,-4.3565185124154,0.0015773915225626,0.0124743699017953,-1.31119515571785,"NONE",FALSE,"High","Master Protein","P78414","Iroquois-class homeodomain protein IRX-1 [OS=Homo sapiens]",0,25.479,8,2,2,2,2,480,49.6,6.2,8.42,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920","79192","hsa:79192; P78414; Q7Z2F8; Q8N312","ENSG00000170549","Nephron development",NA,1,0,96.5,93.2,97,122.4,123.3,107.3,92.7,94.4,75.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(100); S447(100)]",0,"ENSG00000170549"
"206","EBAG9",0.378865675314143,6.65265758815851,4.35520952888798,0.00158053801434167,0.0124743699017953,-1.31325927424761,"NONE",FALSE,"High","Master Protein","O00559","Receptor-binding cancer antigen expressed on SiSo cells [OS=Homo sapiens]",0,40.885,9,1,1,5,1,213,24.4,6.29,24.22,1,"other biological processes","other membranes;ER/Golgi;other cell component","enzyme regulator activity",NA,"9166","A8K3N6; hsa:9166; O00559; Q5Y8C7; Q6IB20; Q9BS76","ENSG00000147654","Estrogen-dependent gene expression",NA,1,0,90.9,88.6,99.3,90.6,92,88.7,119.5,108.9,127.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000147654"
"207","SORT1",-0.538813697862504,6.64543719905153,-4.35450800057564,0.00158222706474977,0.0124743699017953,-1.31436559665912,"NONE",FALSE,"High","Master Protein","Q99523","Sortilin [OS=Homo sapiens]",0,6.453,2,2,2,7,1,831,92,5.74,12.64,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf15901, Pf15902","6272","B4DWI3; C0JYZ0; hsa:6272; Q8IZ49; Q99523","ENSG00000134243","Golgi Associated Vesicle Biogenesis","Brain-derived neurotrophic factor (BDNF) signaling pathway; Neural crest cell migration in cancer; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes",5,1,78.8,80.2,96.7,124.3,112.6,145.4,84.7,97.8,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S825(100)]",0,"ENSG00000134243"
"208","SRSF9",0.516357626066778,6.66165305722593,4.34127517302424,0.00161444863305926,0.0126672123516957,-1.33524598611258,"NONE",FALSE,"High","Master Protein","Q13242","Serine/arginine-rich splicing factor 9 [OS=Homo sapiens]",0.003,2.188,4,1,1,3,1,221,25.5,8.65,6.82,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00076","8683","hsa:8683; Q13242; Q52LD1","ENSG00000111786","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing",6,0,81.7,100,99.1,83.6,83.6,90.7,137.7,110.9,122.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000111786"
"209","RAD23B",0.766079958820137,6.60355756980031,4.33104744866339,0.00163982941400344,0.012804792361979,-1.35140011615588,"NONE",FALSE,"High","Master Protein","P54727","UV excision repair protein RAD23 homolog B [OS=Homo sapiens]",0,15.2,7,1,2,3,1,409,43.1,4.84,20.4,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00240, Pf00627, Pf09280","5887","B3KWK8; G5E9P0; hsa:5887; P54727; Q7Z5K8; Q8WUB0","ENSG00000119318","Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; HDAC6 interactions in the central nervous system",8,0,55.6,70.6,69,80.4,127.1,75.7,147.7,134.9,172.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T159(99.2); S160(99.2)]",0,"ENSG00000119318"
"210","DENND2A",0.387856865071766,6.6267725794128,4.31988030740622,0.00166802528944473,0.0129629393922562,-1.36905344564632,"NONE",FALSE,"High","Master Protein","Q9ULE3","DENN domain-containing protein 2A [OS=Homo sapiens]",0,40.521,7,4,5,7,3,1009,113.8,8.95,20.86,4,"transport","cytosol;cytoskeleton","enzyme regulator activity","Pf02141, Pf03455, Pf03456","27147","C9JUI3; hsa:27147; Q1RMD5; Q86XY0; Q9ULE3","ENSG00000146966","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,78.6,77.1,81.8,103.5,81.9,95.5,110.7,129.9,136.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100); S404(98.8); S776(100)]",0,"ENSG00000146966"
"211","TRAFD1",-0.286022127992689,6.65696122727149,-4.30300619756071,0.0017116098970665,0.0132386130427134,-1.39575897056354,"NONE",FALSE,"High","Master Protein","O14545","TRAF-type zinc finger domain-containing protein 1 [OS=Homo sapiens]",0,48.399,8,3,5,12,3,582,64.8,5.29,33.65,3,"other biological processes","mitochondrion","other molecular function","Pf21366","10906","A8K5L6; B4DI89; hsa:10906; O14545","ENSG00000135148",NA,NA,0,0,91.9,98.5,99.7,109.7,114.6,116.4,93.1,98.2,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100); S327(99.5); S415(99.5)]",0,"ENSG00000135148"
"212","DDX21",0.368566100196191,6.65690424743676,4.28644399607336,0.00175556417443866,0.0134921144250413,-1.42200633708901,"NONE",FALSE,"High","Master Protein","Q9NR30","Nucleolar RNA helicase 2 [OS=Homo sapiens]",0,29.553,2,1,1,2,1,783,87.3,9.28,9.38,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;mitochondrion;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00270, Pf00271, Pf08152","9188","B2RDL0; hsa:9188; Q13436; Q5VX41; Q68D35; Q9NR30","ENSG00000165732","B-WICH complex positively regulates rRNA expression; Major pathway of rRNA processing in the nucleolus and cytosol","10q11.21q11.23 copy number variation syndrome; Rubinstein-Taybi syndrome 1",4,0,85.8,83.2,77.5,100,102.9,91.6,121.3,128.5,125.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S121(100)]",0,"ENSG00000165732"
"213","ZDHHC14",-0.711120100754679,6.56073861247681,-4.28445622227266,0.00176091934591532,0.0134921144250413,-1.42515886486291,"NONE",FALSE,"High","Master Protein","Q8IZN3","Palmitoyltransferase ZDHHC14 [OS=Homo sapiens]",0,13.312,2,1,1,1,1,488,53.4,8.24,3.84,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi","other molecular function","Pf01529","79683","A6NDB7; hsa:79683; Q5JS07; Q5JS08; Q6PHS4; Q8IZN2; Q8IZN3; Q9H7F1","ENSG00000175048",NA,NA,0,0,113.5,125.3,81,106.7,131.9,114.1,68.1,87.6,75.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S455(100)]",0,"ENSG00000175048"
"214","ARHGAP12",-0.327036970390357,6.65987690038653,-4.27200941571923,0.00179484760257263,0.0136294085886956,-1.44491041552881,"NONE",FALSE,"High","Master Protein","Q8IWW6","Rho GTPase-activating protein 12 [OS=Homo sapiens]",0,137.194,15,8,13,35,8,846,96.2,7.61,107.48,8,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other cell component","enzyme regulator activity","Pf00018, Pf00169, Pf00397, Pf00620, Pf16618","94134","B1ANY0; B1ANY1; B1ANY2; hsa:94134; Q504X1; Q86UB3; Q8IWW6; Q8IWW7; Q8N3L1; Q9NT76","ENSG00000165322","RAC1 GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; RHOV GTPase cycle",NA,4,0,78.7,82.3,85.6,127.2,127.7,119.8,97.2,106.4,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S103(100); S165(100); S176(100); S201(100); S215(100); T231(99); S240(100); S303(100); S592(100)]",0,"ENSG00000165322"
"215","C1orf226",-0.359008578099248,6.5833566870217,-4.26995654207061,0.00180050965148582,0.0136294085886956,-1.44816996283337,"NONE",FALSE,"High","Master Protein","A1L170","Uncharacterized protein C1orf226 [OS=Homo sapiens]",0,53.061,24,5,7,11,5,272,29,5.27,31.57,5,NA,NA,NA,"Pf15429","400793","A1L170; B4DF31; hsa:400793","ENSG00000239887",NA,NA,0,0,108.4,117.5,113.7,90,101.9,109.9,80.5,84.1,84.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(99.6); S223(99.7); S249(100); S258(99.4)]",0,"ENSG00000239887"
"216","OSBP",0.358105984547083,6.65607862579329,4.26873335978898,0.00180389231320971,0.0136294085886956,-1.45011238229492,"NONE",FALSE,"High","Master Protein","P22059","Oxysterol-binding protein 1 [OS=Homo sapiens]",0,81.657,8,6,9,13,6,807,89.4,7.3,42.32,6,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00169, Pf01237","5007","hsa:5007; P22059; Q6P524","ENSG00000110048","Sphingolipid de novo biosynthesis; Synthesis of bile acids and bile salts",NA,2,0,100.6,102.3,103.9,91.9,69.6,94.6,104.3,115.7,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100); S240(100); S379(100)]",0,"ENSG00000110048"
"217","ITSN1",-0.334409958789505,6.66465659986136,-4.25262037845298,0.00184908586290176,0.0139064890703026,-1.47571753444812,"NONE",FALSE,"High","Master Protein","Q15811","Intersectin-1 [OS=Homo sapiens]",0,64.282,5,5,6,11,5,1721,195.3,7.77,36.48,5,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00168, Pf00621, Pf07653, Pf12763, Pf14604, Pf16617, Pf16652","6453","A7Y322; A8CTX8; A8CTY3; A8CTY7; A8D7D0; A8DCP3; B4DTM2; E7ERJ1; E9PE44; E9PG01; E9PHV2; hsa:6453; O95216; Q0PW94; Q0PW95; Q0PW97; Q14BD3; Q15811; Q1ED40; Q20BK3; Q9UET5; Q9UK60; Q9UNK1; Q9UNK2; Q9UQ92","ENSG00000205726","Cargo recognition for clathrin-mediated endocytosis; CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOQ GTPase cycle; RHOG GTPase cycle; EPHB-mediated forward signaling",NA,8,0,85.8,85,87.3,119.9,115,128.4,104,99.9,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S559(100); S904(100); S986(100); S1137(100)]",0,"ENSG00000205726"
"218","APBA2",0.300849882050544,6.65345092557715,4.23404070086554,0.00190269048812815,0.0142439948469044,-1.50528309027911,"NONE",FALSE,"High","Master Protein","Q99767","Amyloid-beta A4 precursor protein-binding family A member 2 [OS=Homo sapiens]",0,30.401,2,2,2,3,2,749,82.5,4.86,15.79,2,"cell-cell signaling;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00595, Pf00640","321","E9PGI4; hsa:321; O60571; Q5XKC0; Q99767","ENSG00000034053; ENSG00000276495","Neurexins and neuroligins","IL-18 signaling pathway; 15q11q13 copy number variation",3,0,86.8,81.5,84.1,99,89.8,103.1,117,116.2,130.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S480(100)]",0,"ENSG00000034053"
"219","LRATD2",0.381954111994793,6.67765026904851,4.22150397089185,0.0019397882294956,0.014438686450562,-1.52525701139525,"NONE",FALSE,"High","Master Protein","Q96KN1","Protein LRATD2 [OS=Homo sapiens]",0,8.476,10,2,3,7,2,310,34.5,5.54,10.03,2,NA,"plasma membrane;other membranes;other cell component",NA,"Pf04970","157638","hsa:157638; Q96KN1","ENSG00000168672",NA,NA,0,0,87.3,85.5,84.5,102,85.9,98.6,118.6,139.8,117,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100); T289(99.1)]",0,"ENSG00000168672"
"220","MAPT",-0.42317773566769,6.6551496544705,-4.2192990776198,0.00194639155583556,0.014438686450562,-1.52877194411438,"NONE",FALSE,"High","Master Protein","P10636","Microtubule-associated protein tau [OS=Homo sapiens]",0,262.68,23,17,29,81,2,758,78.9,6.71,262.14,17,"cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00418","4137","hsa:4137; P10636; P18518; Q14799; Q15549; Q15550; Q15551; Q1RMF6; Q53YB1; Q5CZI7; Q5XWF0; Q6QT54; Q9UDJ3; Q9UMH0; Q9UQ96","ENSG00000186868; ENSG00000276155; ENSG00000277956","Caspase-mediated cleavage of cytoskeletal proteins","IL-5 signaling pathway; Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; Copper homeostasis; MAPK signaling pathway; IL-2 signaling pathway; Inclusion body myositis; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; HDAC6 interactions in the central nervous system",14,17,66.5,75.6,76.5,133.1,161.1,123.2,109.3,103,98.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S411(100); S438(100); T498(100); S516(99.2); S519(100); T529(99.6); T534(100); T548(100); S552(99.6); S579(99.8); S673(100); S713(100); S717(100); S733(99.5)]",0,"ENSG00000186868"
"221","ALG3",0.568109059430453,6.61186223943443,4.21194051056809,0.00196860206735506,0.0144798517445008,-1.54050698478931,"NONE",FALSE,"High","Master Protein","Q92685","Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase [OS=Homo sapiens]",0,23.3,3,1,1,2,1,438,50.1,9.44,8.13,1,"protein metabolism;other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf05208","10195","A8JZZ6; hsa:10195; Q92685; Q9BT71","ENSG00000214160","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG3 causes CDG-1d","N-glycan biosynthesis",3,0,65.7,67.6,62,93.7,76.8,121,125,139.7,176.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000214160"
"222","CIR1",-0.347441621662576,6.3174743531746,-4.21158373774038,0.00196968571524459,0.0144798517445008,-1.54107611747023,"NONE",FALSE,"High","Master Protein","Q86X95","Corepressor interacting with RBPJ 1 [OS=Homo sapiens]",0,3.701,2,1,1,2,1,450,52.3,9.86,5.12,1,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf10197","9541","A6NFI6; A8K8M4; hsa:9541; O95367; Q12804; Q4G1B9; Q6PJI4; Q86X95; Q8IWI2","ENSG00000138433",NA,"Notch signaling pathway",1,0,172.5,155.6,147.3,56.3,58.3,61.5,62.6,58.2,58.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S394(100)]",0,"ENSG00000138433"
"223","SLC3A2",0.708265650472141,6.58449142328173,4.20799566346756,0.00198061914894407,0.0144949347581916,-1.5468007780598,"NONE",FALSE,"High","Master Protein","P08195","Amino acid transporter heavy chain SLC3A2 [OS=Homo sapiens]",0,2.928,2,1,1,2,1,630,68,5.01,2.2,1,"other metabolic processes;transport;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","transporter activity;nucleic acid binding activity;other molecular function","Pf00128, Pf16028","6520","hsa:6520; J3KPF3; P08195; Q13543","ENSG00000168003","Tryptophan catabolism; Basigin interactions; Amino acid transport across the plasma membrane; Defective SLC7A7 causes lysinuric protein intolerance (LPI)","mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; Proximal tubule transport; Pleural mesothelioma",8,0,114.8,104.9,122.8,76.4,63.5,57.6,128.4,91.8,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100)]",0,"ENSG00000168003"
"224","YRDC",0.320319368745338,6.67173187866193,4.19878451851461,0.00200898200093152,0.0146078651354451,-1.56150416773721,"NONE",FALSE,"High","Master Protein","Q86U90","Threonylcarbamoyl-AMP synthase [OS=Homo sapiens]",0,10.839,5,1,1,2,1,279,29.3,8.57,6.66,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;mitochondrion;other cell component","nucleic acid binding activity;other molecular function","Pf01300","79693","hsa:79693; Q4W4X8; Q6NVW3; Q7L4E4; Q7Z2I4; Q86U90; Q9H5F8","ENSG00000196449",NA,NA,0,0,94.2,82.6,95.1,99.1,88.9,96.6,116.9,116.7,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000196449"
"225","EPHB2",0.658752156209695,6.6415704343247,4.1971846310017,0.00201395199477644,0.0146078651354451,-1.56405907373219,"NONE",FALSE,"High","Master Protein","P29323","Ephrin type-B receptor 2 [OS=Homo sapiens]",0,16.868,2,2,2,6,2,1055,117.4,6.55,16.59,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00041, Pf00536, Pf01404, Pf07699, Pf07714, Pf14575","2048","hsa:2048; O43477; P29323; Q5T0U6; Q5T0U7; Q5T0U8","ENSG00000133216","EPHB-mediated forward signaling; Ephrin signaling; L1CAM interactions; EPH-ephrin mediated repulsion of cells","Microtubule cytoskeleton regulation; Nod-like receptor (NLR) signaling pathway; Transcriptional activation by NRF2 in response to phytochemicals; VEGFA-VEGFR2 signaling; Neovascularization processes; NRF2-ARE regulation; Neural crest cell migration during development; Neural crest cell migration in cancer; Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution",14,0,82.9,85,80.7,103.2,54.6,95.3,129.8,155.6,121.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S575(100)]",0,"ENSG00000133216"
"226","ACTL6A",0.321848520171151,6.40926345394252,4.19111157007659,0.00203293644206035,0.0146803197939933,-1.57376018950058,"NONE",FALSE,"High","Master Protein","O96019","Actin-like protein 6A [OS=Homo sapiens]",0.006,1.808,2,1,1,2,1,429,47.4,5.6,4.55,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00022","86","B3KMN1; D3DNR9; hsa:86; O96019; Q8TAE5; Q9BVS8; Q9H0W6","ENSG00000136518","UCH proteinases; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines; HATs acetylate histones; DNA Damage Recognition in GG-NER","Androgen receptor network in prostate cancer; Gastric cancer network 1; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",10,0,165.2,154.2,139.4,52.4,46,57.9,79.8,77.8,74.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000136518"
"227","SEC22B",0.376649161718828,6.65118350181483,4.1740153226922,0.00208740280696735,0.015007230753175,-1.60109408715577,"NONE",FALSE,"High","Master Protein","O75396","Vesicle-trafficking protein SEC22b [OS=Homo sapiens]",0,27.309,7,1,1,3,1,215,24.7,8.51,12.99,1,"cell organization and biogenesis;transport;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf00957, Pf13774","9554","A8K1G0; hsa:9554; O75396","ENSG00000265808","COPI-dependent Golgi-to-ER retrograde traffic; ER-Phagosome pathway; COPII-mediated vesicle transport; Cargo concentration in the ER",NA,4,0,71.2,86.4,73.2,97.6,95.2,107.3,124.1,123.8,140.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(100)]",0,"ENSG00000265808"
"228","WRAP53",-0.372163017143835,6.66442855733695,-4.16801057172497,0.0021068975014994,0.015029334902178,-1.6107031156825,"NONE",FALSE,"High","Master Protein","Q9BUR4","Telomerase Cajal body protein 1 [OS=Homo sapiens]",0,42.376,12,3,5,13,3,548,59.3,4.58,37.54,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","55135","B3KPR9; D3DTQ4; hsa:55135; Q08ET9; Q9BUR4; Q9NW09","ENSG00000141499","Association of TriC/CCT with target proteins during biosynthesis; Telomere Extension By Telomerase",NA,2,0,80.6,84.5,81.2,122.2,115.5,138.3,102.8,102.8,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S85(99.5); S90(100); S491(100)]",0,"ENSG00000141499"
"229","CSTF2",-0.47199809457928,6.62268444706715,-4.1673984255582,0.00210889564497474,0.015029334902178,-1.61168294200484,"NONE",FALSE,"High","Master Protein","P33240","Cleavage stimulation factor subunit 2 [OS=Homo sapiens]",0,30.401,7,1,1,3,1,577,60.9,6.83,8.87,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf14304, Pf14327","1478","hsa:1478; P33240; Q5H951; Q6LA74; Q8N502","ENSG00000101811","tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",6,0,88.4,76.4,77.4,123.4,109.4,143.2,94.3,98.1,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S524(98.3)]",0,"ENSG00000101811"
"230","ELAVL1",-0.598711766042126,6.59898829664883,-4.15860321262522,0.00213782684562429,0.0151198595977441,-1.62576595568893,"NONE",FALSE,"High","Master Protein","Q15717","ELAV-like protein 1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,326,36.1,9.17,4.69,1,"cell organization and biogenesis;transport;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","1994","B4DVB8; hsa:1994; Q15717; Q53XN6; Q9BTT1","ENSG00000066044","HuR (ELAVL1) binds and stabilizes mRNA","AMP-activated protein kinase signaling; Endoderm differentiation; Pre-implantation embryo; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Gastrin signaling pathway; IL-18 signaling pathway; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; 1p36 copy number variation syndrome",10,0,70,94.8,81.3,110,162.6,130.3,99.7,87.3,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000066044"
"231","GRIA1",0.585939227836761,6.59939481045088,4.157909306062,0.0021401271857101,0.0151198595977441,-1.62687744830902,"NONE",FALSE,"High","Master Protein","P42261","Glutamate receptor 1 [OS=Homo sapiens]",0,20.128,2,1,1,4,1,906,101.4,7.71,12.01,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf00060, Pf00497, Pf01094, Pf10613","2890","B7Z2S0; B7Z2W8; B7Z3F6; B7Z9G9; D3DQI4; E7ESV8; hsa:2890; P42261; Q2NKM6","ENSG00000155511","COPII-mediated vesicle transport; Cargo concentration in the ER; Unblocking of NMDA receptors, glutamate binding and activation; Synaptic adhesion-like molecules; Long-term potentiation; Trafficking of GluR2-containing AMPA receptors; Activation of AMPA receptors","Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Common pathways underlying drug addiction; MECP2 and associated Rett syndrome; Phosphodiesterases in neuronal function; Fragile X syndrome; PKC-gamma calcium signaling pathway in ataxia; 3q29 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; NRXN1 deletion syndrome; HDAC6 interactions in the central nervous system",20,0,80.8,62.2,76.4,80.7,75.5,111.9,118.6,148,144.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S849(100)]",0,"ENSG00000155511"
"232","DNMT3A",-0.372451776514837,6.53081387927848,-4.13149275024527,0.00222967409390707,0.0156846039709325,-1.66923451316893,"NONE",FALSE,"High","Master Protein","Q9Y6K1","DNA (cytosine-5)-methyltransferase 3A [OS=Homo sapiens]",0,49.687,5,3,4,6,3,912,101.8,6.57,22.72,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00145, Pf00855, Pf17980, Pf21255","1788","E9PEB8; hsa:1788; Q86TE8; Q86XF5; Q8IZV0; Q8WXU9; Q9Y6K1","ENSG00000119772","RMTs methylate histone arginines; PRC2 methylates histones and DNA; Defective pyroptosis; DNA methylation; SUMOylation of DNA methylation proteins","One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; One-carbon metabolism and related pathways; MTHFR deficiency; Opioid receptor pathways; Spina bifida",12,0,127.1,119.9,125.2,86,102,86.5,75.4,79.1,75.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100); S243(100)]",0,"ENSG00000119772"
"233","ILDR2",0.736030623018014,6.58834981406133,4.11838006426138,0.00227558575760661,0.015914790793507,-1.6902909172154,"NONE",FALSE,"High","Master Protein","Q71H61","Immunoglobulin-like domain-containing receptor 2 [OS=Homo sapiens]",0,6.725,5,3,3,4,3,639,71.2,8.12,5.31,3,"cell-cell signaling;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cell component",NA,"Pf05624","387597","hsa:387597; Q71H61","ENSG00000143195",NA,NA,0,0,103.4,102.9,95,64.2,84.3,61.3,114.5,100.3,159.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100); S547(100)]",0,"ENSG00000143195"
"234","SPG21",0.421283628414561,6.61625722788623,4.1165985170151,0.00228190015053961,0.015914790793507,-1.69315331758625,"NONE",FALSE,"High","Master Protein","Q9NZD8","Maspardin [OS=Homo sapiens]",0,4.28,3,1,1,2,1,308,34.9,6.28,4.49,1,"signal transduction","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding","Pf00561","51324","B4DW44; Q6ZMB6; Q9NZD8","ENSG00000090487",NA,NA,0,0,114.9,114.8,103.5,79.6,73.9,75.3,103.5,98.2,125.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100)]",0,"ENSG00000090487"
"235","KLF13",-0.396023273077442,6.58662359869226,-4.10583255711369,0.00232045414780522,0.0161100525428158,-1.7104589507478,"NONE",FALSE,"High","Master Protein","Q9Y2Y9","Krueppel-like factor 13 [OS=Homo sapiens]",0.006,1.918,3,1,1,1,1,288,31.2,9.54,2.12,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","51621","hsa:51621; Q9Y2Y9; Q9Y356","ENSG00000169926; ENSG00000275746",NA,"15q13.3 copy number variation syndrome; 15q11q13 copy number variation",2,0,105.1,113,103.3,105.1,88.6,114.9,86.8,89.3,76.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100)]",0,"ENSG00000169926"
"236","CTNND2",-0.37070245421912,6.66884275054623,-4.10329533944964,0.00232963995104445,0.0161100525428158,-1.71453937863211,"NONE",FALSE,"High","Master Protein","Q9UQB3","Catenin delta-2 [OS=Homo sapiens]",0,213.461,17,16,29,60,15,1225,132.6,7.74,186.45,16,"cell adhesion;cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00514","1501","B0FTZ7; hsa:1501; O00379; O15390; O43206; O43840; Q13589; Q9UM66; Q9UPM3; Q9UQB3","ENSG00000169862",NA,"Ectoderm differentiation; Ectoderm differentiation",2,0,83.9,83.5,85.7,124.4,115,132,94.9,109.4,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S201(100); S267(100); S276(99.6); S285(100); S299(99.2); S305(99.2); S327(100); S415(100); S438(100); S461(99.4); S474(99.6); S534(100); S537(100); S1060(99.2); S1065(100); S1082(100)]",0,"ENSG00000169862"
"237","TPPP",-0.478588577857867,6.61624583654846,-4.09781519129837,0.00234961167646053,0.0161785883748035,-1.7233553133697,"NONE",FALSE,"High","Master Protein","O94811","Tubulin polymerization-promoting protein [OS=Homo sapiens]",0,57.18,24,5,6,14,5,219,23.7,9.44,26.83,5,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf05517","11076","hsa:11076; O94811","ENSG00000171368",NA,"Microtubule cytoskeleton regulation; Glial cell differentiation; HDAC6 interactions in the central nervous system; Sudden infant death syndrome (SIDS) susceptibility pathways",4,0,60.1,57.2,60.7,153.6,167.5,125.1,101.6,110.6,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T14(100); S18(100); S32(100); S160(99.6)]",0,"ENSG00000171368"
"238","LHFPL3",1.39702690804636,6.44381437173689,4.0951533783454,0.00235937747132551,0.0161785883748035,-1.72763866195993,"NONE",FALSE,"High","Master Protein","Q86UP9","LHFPL tetraspan subfamily member 3 protein [OS=Homo sapiens]",0,4.824,4,1,1,6,1,236,25.8,5.95,11.65,1,"other biological processes","plasma membrane;other membranes",NA,"Pf10242","375612","A1L383; A4D0Q5; hsa:375612; Q86UP9","ENSG00000187416",NA,NA,0,0,111.7,117,90,40.1,68.3,30.6,170.7,86.6,146.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S234(100)]",0,"ENSG00000187416"
"239","FXR2",-0.497121399330586,6.63796525858345,-4.08018818701294,0.00241508599812167,0.0164328937721797,-1.7517359428514,"NONE",FALSE,"High","Master Protein","P51116","RNA-binding protein FXR2 [OS=Homo sapiens]",0,15.2,3,1,2,4,1,673,74.2,6.23,16.64,1,"developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf05641, Pf12235, Pf16096, Pf17904, Pf18336","9513","B2R9M2; D3DTQ1; hsa:9513; P51116; Q86V09; Q8WUM2","ENSG00000129245",NA,"VEGFA-VEGFR2 signaling",1,0,69,65.5,67.7,135.6,135.2,149.3,101.1,120.4,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S603(100)]",0,"ENSG00000129245"
"240","PNPO",0.463665329465542,6.66880978576586,4.0797860397425,0.00241660202532054,0.0164328937721797,-1.75238385188391,"NONE",FALSE,"High","Master Protein","Q9NVS9","Pyridoxine-5'-phosphate oxidase [OS=Homo sapiens]",0,15.2,6,1,1,2,1,261,30,7.06,8.88,1,"other metabolic processes","cytosol","other molecular function","Pf01243, Pf10590","55163","B4E0V0; B4E152; B4E1D7; D3DTT9; hsa:55163; Q9NVS9","ENSG00000108439","Vitamin B6 activation to pyridoxal phosphate","Selenium micronutrient network; Vitamin B6-dependent and responsive disorders",3,0,103.9,88.8,87.5,83.8,89.2,94.1,106.5,128,144.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(100)]",0,"ENSG00000108439"
"241","PAICS",0.392821204938373,6.63195394867079,4.07136647247804,0.00244857406211009,0.0165812152255754,-1.76595315838987,"NONE",FALSE,"High","Master Protein","P22234","Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase [OS=Homo sapiens]",0,12.241,4,2,2,3,2,425,47,7.23,8.38,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00731, Pf01259","10606","E9PDH9; hsa:10606; P22234; Q68CQ5","ENSG00000128050","Purine ribonucleoside monophosphate biosynthesis","Metabolic reprogramming in colon cancer",2,0,115.3,110.5,110.1,83.7,60.3,92.9,105.2,114.8,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S107(100)]",0,"ENSG00000128050"
"242","RGL2",0.384102818219427,6.63577119240239,4.06310004721316,0.00248039905640788,0.0167273192564366,-1.77928369460428,"NONE",FALSE,"High","Master Protein","O15211","Ral guanine nucleotide dissociation stimulator-like 2 [OS=Homo sapiens]",0,33.692,8,3,3,7,3,777,83.5,6.18,17.38,3,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00617, Pf00618, Pf00788","5863","B4DG72; hsa:5863; O15211; Q5STK0; Q9Y3F3","ENSG00000206282; ENSG00000224841; ENSG00000228736; ENSG00000237441; ENSG00000237825","RAF/MAP kinase cascade","Ras signaling",2,0,79.6,83.8,92.8,93.2,90,93,107.8,119.5,142.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S409(100); S619(100)]",0,"ENSG00000237441"
"243","GRAMD2B",0.570880634020271,6.67913237925309,4.05180420256989,0.00252459432651814,0.0169553001682206,-1.79751232730175,"NONE",FALSE,"High","Master Protein","Q96HH9","GRAM domain-containing protein 2B [OS=Homo sapiens]",0,54.599,15,4,4,5,4,432,47.8,7.9,18.22,4,NA,"cytoskeleton","other molecular function","Pf02893","65983","B7Z1F2; B7Z3R1; B7Z6D8; B7Z8T2; D3DSZ3; hsa:65983; Q96HH9; Q9H753","ENSG00000155324",NA,NA,0,0,96.2,94.6,94.2,75.8,66.4,113.9,134.8,120.1,124.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S72(99.4); T220(99.7)]",0,"ENSG00000155324"
"244","MTFR1L",0.717999310670643,6.61899463474861,4.03942903291325,0.00257396737419917,0.0171774535947406,-1.81749961712683,"NONE",FALSE,"High","Master Protein","Q9H019","Mitochondrial fission regulator 1-like [OS=Homo sapiens]",0,39.157,14,4,8,30,4,292,31.9,6.1,47.54,4,"cell organization and biogenesis;other metabolic processes","mitochondrion",NA,"Pf05308","56181","A6NCB4; B7WNV5; D3DPJ4; hsa:56181; Q63HP1; Q7Z2S7; Q9H019; Q9NUI7","ENSG00000117640",NA,NA,0,0,101.7,108.4,113.6,65.1,78.7,63.3,139.3,94.4,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S103(100); S238(99.7)]",0,"ENSG00000117640"
"245","PPP1R12A",0.33488365095139,6.65994067267063,4.0371666327061,0.00258310320241396,0.0171774535947406,-1.82115554961482,"NONE",FALSE,"High","Master Protein","O14974","Protein phosphatase 1 regulatory subunit 12A [OS=Homo sapiens]",0,49.685,3,3,4,5,3,1030,115.2,5.4,22.26,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf15898","4659","B4DZ09; F8VWB4; hsa:4659; O14974; Q2NKL4; Q569H0; Q86WU3; Q8NFR6; Q9BYH0","ENSG00000058272","Regulation of PLK1 Activity at G2/M Transition; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs","Focal adhesion; Hippo-Merlin signaling dysregulation; Regulation of actin cytoskeleton",8,0,73.7,77.5,72.5,99.6,117,100.4,122.7,132.8,133.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S445(100)]",0,"ENSG00000058272"
"246","CERT1",-1.04976655545949,6.57878410275548,-4.03564954499463,0.00258924851979545,0.0171774535947406,-1.8236074204683,"NONE",FALSE,"High","Master Protein","Q9Y5P4","Ceramide transfer protein [OS=Homo sapiens]",0,8.702,2,1,1,1,1,624,70.8,5.48,2.84,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus","transporter activity;kinase activity;other molecular function","Pf00169, Pf01852","10087","A8K7S2; B3KUB7; hsa:10087; Q53YV1; Q53YV2; Q96Q85; Q96Q88; Q9H2S7; Q9H2S8; Q9Y5P4","ENSG00000113163",NA,"Sphingolipid pathway",1,0,92.5,98.7,68.9,156.7,115.4,140.9,72.4,105.1,60.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S123(100)]",0,"ENSG00000113163"
"247","DPYSL3",-0.476150802176486,6.61015798927443,-4.02685657220017,0.00262517139600483,0.0173155990283972,-1.83782353461764,"NONE",FALSE,"High","Master Protein","Q14195-2","Isoform LCRMP-4 of Dihydropyrimidinase-related protein 3 [OS=Homo sapiens]",0,243.83,18,11,22,112,9,684,73.9,6.35,269.98,11,NA,NA,NA,NA,NA,"Q14195-2",NA,NA,NA,0,0,52,51.9,53.3,155.6,141.1,159.5,102.6,127,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(99.4); S102(100); T621(97.9); T623(100); T628(100); S636(100); S653(99.4)]",0,"ENSG00000113657"
"248","NUFIP2",0.334906884902805,6.64531356237706,4.0253710620251,0.00263129200921722,0.0173155990283972,-1.84022611650259,"NONE",FALSE,"High","Master Protein","Q7Z417","FMR1-interacting protein NUFIP2 [OS=Homo sapiens]",0,61.475,7,3,4,7,3,695,76.1,8.7,27.98,3,NA,"cytosol;nucleus;other cell component","nucleic acid binding activity","Pf15293","57532","A1L3A6; A1L3A7; hsa:57532; Q7Z417; Q9P2M5","ENSG00000108256",NA,NA,0,0,77.8,82.5,87.4,96.9,105.2,92.1,114.9,122,130.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S212(100); S629(100)]",0,"ENSG00000108256"
"249","IL1RAP",0.268087334257528,6.64679476417265,4.02184972467232,0.00264586082630002,0.0173415456567134,-1.84592233524431,"NONE",FALSE,"High","Master Protein","Q9NPH3","Interleukin-1 receptor accessory protein [OS=Homo sapiens]",0,58.263,3,3,5,12,3,570,65.4,8.12,41.88,3,"cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf01582, Pf18452","3556","B1NLD0; D3DNW0; hsa:3556; O14915; Q86WJ7; Q9NPH3","ENSG00000196083",NA,"IL-1 signaling pathway; Interleukin-1 (IL-1) structural pathway; Signal transduction through IL1R; 2q13 copy number variation syndrome",4,0,96.5,94.4,96,95.3,83.6,94.1,113.4,108.5,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(99.8)]",0,"ENSG00000196083"
"250","AGFG1",-0.382524110992614,6.66020596689113,-4.00607181413368,0.00271219036567055,0.0177051787070973,-1.87146239884197,"NONE",FALSE,"High","Master Protein","P52594","Arf-GAP domain and FG repeat-containing protein 1 [OS=Homo sapiens]",0,26.633,4,2,2,5,2,562,58.2,8.63,18.86,2,"cell organization and biogenesis;other metabolic processes;transport","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf01412","3267","B3KUL1; E9PHX7; hsa:3267; P52594; Q15277; Q4VAS0; Q4VAS1; Q4VAS3; Q53QT8; Q53R11","ENSG00000173744","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,79.3,85.1,89.1,118.5,112.8,139.4,98.5,95.4,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T177(100); S181(100)]",0,"ENSG00000173744"
"251","CHTF18",-0.78355944523379,5.84920837074355,-4.0023857599826,0.00272793741570987,0.0177307774954705,-1.87743314622221,"NONE",FALSE,"High","Master Protein","Q8WVB6","Chromosome transmission fidelity protein 18 homolog [OS=Homo sapiens]",0,14.861,2,1,1,2,1,975,107.3,7.21,7.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00004","63922","B7ZBA2; D3DU68; hsa:63922; Q7Z6Y4; Q7Z6Y6; Q8WVB6; Q9BR83; Q9BRG5; Q9H7K3","ENSG00000127586","Polymerase switching on the C-strand of the telomere","Gastric cancer network 2; 7q11.23 copy number variation syndrome",3,0,193.3,191,191.2,43.4,28,29.9,38.8,42.9,37.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S871(100)]",0,"ENSG00000127586"
"252","GORASP2",0.294663988949218,6.6637727229062,4.00007908707727,0.00273784064268294,0.0177307774954705,-1.88117031973055,"NONE",FALSE,"High","Master Protein","Q9H8Y8","Golgi reassembly-stacking protein 2 [OS=Homo sapiens]",0,59.312,13,3,5,6,3,452,47.1,4.82,27.47,3,"cell organization and biogenesis;stress response;other biological processes","other membranes;ER/Golgi",NA,"Pf04495","26003","B4DKT0; hsa:26003; Q53TE3; Q96I74; Q96K84; Q9H8Y8; Q9H946; Q9UFW4","ENSG00000115806","Golgi Cisternae Pericentriolar Stack Reorganization",NA,1,0,79.9,89.4,90.8,101.5,95,96.4,118.5,122.4,117.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T222(100); T415(100); T433(99)]",0,"ENSG00000115806"
"253","SCD5",-0.606230665236892,6.57235649484014,-3.98976955853179,0.00278256766781942,0.0178614588388138,-1.89788066499126,"NONE",FALSE,"High","Master Protein","Q86SK9","Stearoyl-CoA desaturase 5 [OS=Homo sapiens]",0,9.072,5,1,1,1,1,330,37.6,9.61,2.92,1,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf00487","79966","B2RPG0; hsa:79966; Q4W5Q5; Q86SK9; Q8NDS0; Q9H7D1","ENSG00000145284","Fatty acyl-CoA biosynthesis; EGR2 and SOX10-mediated initiation of Schwann cell myelination",NA,2,0,103.6,103.7,106.6,104.9,103.1,125,64,91.5,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(99.2)]",0,"ENSG00000145284"
"254","TJP2",-0.285547433432742,6.61755950288094,-3.98909083017368,0.00278553915106395,0.0178614588388138,-1.89898120809754,"NONE",FALSE,"High","Master Protein","Q9UDY2","Tight junction protein ZO-2 [OS=Homo sapiens]",0,45.118,6,7,7,14,7,1190,133.9,7.4,35.61,7,"cell adhesion;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00595, Pf00625, Pf07653","9414","A2A3H9; B7Z2R8; B7Z7T6; F5H301; F5H886; hsa:9414; Q15883; Q5VXL0; Q5VXL1; Q8N756; Q8NI14; Q99839; Q9UDY0; Q9UDY1; Q9UDY2","ENSG00000119139","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Signaling by Hippo; Apoptotic cleavage of cell adhesion  proteins","1q21.1 copy number variation syndrome; 15q11q13 copy number variation",7,0,118.8,107.5,113.2,101,90,109.9,86.2,89.5,86,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S244(100); S266(100); S415(100); S702(100)]",0,"ENSG00000119139"
"255","ATAT1",-0.463722404098188,6.65187292540973,-3.98787898472585,0.00279085294356466,0.0178614588388138,-1.90094631652792,"NONE",FALSE,"High","Master Protein","Q5SQI0-4","Isoform 4 of Alpha-tubulin N-acetyltransferase 1 [OS=Homo sapiens]",0,37.601,11,3,4,9,3,333,37.5,10.05,27.35,3,NA,NA,NA,NA,NA,"Q5SQI0-4",NA,NA,NA,0,0,76.7,77,77.5,142.1,139.5,119.4,104.8,90,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S315(100); S324(99.4)]",0,"ENSG00000137343"
"256","OSTM1",0.433598816248374,6.63368466019546,3.97260724643145,0.00285874021943596,0.0182244688989042,-1.92572469579791,"NONE",FALSE,"High","Master Protein","Q86WC4","Osteopetrosis-associated transmembrane protein 1 [OS=Homo sapiens]",0,3.903,4,1,1,3,1,334,37.2,6.01,7.49,1,"transport;other biological processes","other membranes;cytosol;other cytoplasmic organelle",NA,"Pf09777","28962","E1P5E3; hsa:28962; Q5R391; Q6PCA7; Q7RTW6; Q86WC4; Q8NC29; Q8TC82; Q9Y2S9","ENSG00000081087","Stimuli-sensing channels","Autosomal recessive osteopetrosis pathways",2,0,100.8,102.7,100.2,81.7,91.3,75.2,122.1,105.6,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(99.5)]",0,"ENSG00000081087"
"257","PCDH8",-0.461350304183738,6.51090495388118,-3.96764972620113,0.00288114991877851,0.0182958625192472,-1.93377381381109,"NONE",FALSE,"High","Master Protein","O95206","Protocadherin-8 [OS=Homo sapiens]",0,9.267,2,1,2,2,1,1070,112.9,5.54,4.9,1,"cell adhesion;cell-cell signaling;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00028, Pf08266","5100","B4DMV7; hsa:5100; O95206; Q5TAN1; Q5TAN2; Q8IYE9; Q96SF1","ENSG00000136099",NA,NA,0,0,145,120.4,122.8,94,76.7,94.6,83.9,64.2,68.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S800(100)]",0,"ENSG00000136099"
"258","AMOTL1",0.574095272927018,6.66264525359651,3.95753114858147,0.0029274653001084,0.018517920037895,-1.95021090197599,"NONE",FALSE,"High","Master Protein","Q8IY63","Angiomotin-like protein 1 [OS=Homo sapiens]",0,14.978,2,2,2,3,2,956,106.5,7.11,9.92,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf12240","154810","hsa:154810; Q63HK7; Q8IY63; Q8NDN0; Q8TEN8; Q8WXD1; Q96CM5","ENSG00000166025","Signaling by Hippo",NA,1,0,73.1,72.2,90.3,78.6,81.1,119.3,138.2,127.7,148,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S793(100); S828(100)]",0,"ENSG00000166025"
"259","RNF180",0.465653361592567,6.64824900778607,3.90631563385894,0.00317421421565068,0.020001226254602,-2.03357805897375,"NONE",FALSE,"High","Master Protein","Q86T96","E3 ubiquitin-protein ligase RNF180 [OS=Homo sapiens]",0,10.169,2,1,1,1,1,592,68.2,8.56,3.97,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf00097, Pf19332","285671","hsa:285671; Q0JSU3; Q495A8; Q86T96; Q8NBD1","ENSG00000164197",NA,NA,0,0,93.7,102.3,109.4,75.7,70.1,99.6,126.8,109,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(100)]",0,"ENSG00000164197"
"260","CA14",0.30577058824752,6.65728906903101,3.90123876512328,0.0031998384031749,0.0200322859831211,-2.04185731230154,"NONE",FALSE,"High","Master Protein","Q9ULX7","Carbonic anhydrase 14 [OS=Homo sapiens]",0,21.129,4,2,2,6,2,337,37.6,6.37,17.86,2,"other metabolic processes","plasma membrane;other membranes","other molecular function","Pf00194","23632","hsa:23632; Q5TB24; Q8NCF4; Q9ULX7","ENSG00000118298","Reversible hydration of carbon dioxide",NA,1,0,93.2,87.1,96.2,97.1,77.7,101.6,110.2,119.1,119.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100)]",0,"ENSG00000118298"
"261","CTTN",0.310366598044975,6.66351002871802,3.90047880185402,0.00320369279509474,0.0200322859831211,-2.04309687879815,"NONE",FALSE,"High","Master Protein","Q14247","Src substrate cortactin [OS=Homo sapiens]",0,103.104,7,5,8,24,5,550,61.5,5.4,77.5,5,"cell adhesion;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf02218, Pf14604","2017","hsa:2017; Q14247; Q8N707; Q96H99","ENSG00000085733; ENSG00000288401","Clathrin-mediated endocytosis; RHO GTPases activate PAKs","Pathogenic Escherichia coli infection; Hepatitis C and hepatocellular carcinoma; ADHD and autism (ASD) linked metabolic pathways and SNP; HDAC6 interactions in the central nervous system",6,0,83,97.1,94.5,95,96.9,92.3,112.4,116.3,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); T401(99.5); S405(100); S418(100)]",0,"ENSG00000085733"
"262","BAG6",-0.284452643594671,6.57834743622208,-3.8934583716996,0.0032395307499009,0.0201790617703751,-2.05455068664488,"NONE",FALSE,"High","Master Protein","P46379","Large proline-rich protein BAG6 [OS=Homo sapiens]",0,47.48,5,3,5,7,3,1132,119.3,5.6,19.73,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;translation activity;other molecular function","Pf00240, Pf12057, Pf20960","7917","A2ADJ7; A3KQ42; A3KQ44; A6NGY6; A6PWF7; B0UX84; B4DZ12; B4E3V4; E7EMZ4; F8VXY4; hsa:7917; O95874; P46379; Q5HYL9; Q5SQ35; Q5SQ36; Q5SQ37; Q5SQ41; Q5SRP8; Q5SRP9; Q5STC1; Q5STX1; Q5STX3; Q96SA6; Q9BCN4","ENSG00000096155; ENSG00000204463; ENSG00000227761; ENSG00000228760; ENSG00000229524; ENSG00000233348; ENSG00000234651","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",NA,1,0,101.8,110.2,113.3,94.1,94.1,105.9,85.2,88,83.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(98.3); S964(100); S973(100)]",0,"ENSG00000204463"
"263","CKB",-0.309621810485328,6.66336026074922,-3.8781163900868,0.00331932310428177,0.0205974726471021,-2.07959902412419,"NONE",FALSE,"High","Master Protein","P12277","Creatine kinase B-type [OS=Homo sapiens]",0,265.996,46,16,22,47,16,381,42.6,5.59,150.03,16,"other metabolic processes","non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion","kinase activity;other molecular function","Pf00217, Pf02807","1152","A8K236; B2R5R4; hsa:1152; P12277; Q2LE07; Q6FG40; Q9UC66","ENSG00000166165","RND3 GTPase cycle; Creatine metabolism",NA,2,0,85,84.2,89.6,121.9,110.1,126.9,95.9,104.6,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T35(100); S164(99.5); T322(100)]; Met-loss [N-Term]",0,"ENSG00000166165"
"264","RPS6",-0.736150536201406,6.53424666855584,-3.86331254290327,0.00339827607345035,0.0209346154745802,-2.10379190567285,"NONE",FALSE,"High","Master Protein","P62753","Small ribosomal subunit protein eS6 [OS=Homo sapiens]",0,23.26,13,6,8,12,6,249,28.7,10.84,23.04,6,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01092","6194","hsa:6194; P08227; P10660; P62753; Q4VBY7; Q8N6Z7","ENSG00000137154","Regulation of expression of SLITs and ROBOs; Protein hydroxylation; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Nuclear events stimulated by ALK signaling in cancer; SARS-CoV-1 modulates host translation machinery","IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Hereditary leiomyomatosis and renal cell carcinoma pathway; Thermogenesis; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; IL-2 signaling pathway; Pleural mesothelioma; 2q37 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways",49,0,111.1,109.1,102.9,110.2,168.6,81.8,69.4,68,81.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S236(99.5); S240(100); S244(99.7)]",0,"ENSG00000137154"
"265","ELF2",-0.768078837857563,6.44569584436535,-3.86071161911342,0.0034123500374058,0.0209346154745802,-2.10804474000323,"NONE",FALSE,"High","Master Protein","Q15723-1","Isoform 1 of ETS-related transcription factor Elf-2 [OS=Homo sapiens]",0,7.915,5,1,2,5,1,581,62.7,6.7,2.7,1,NA,NA,NA,NA,NA,"Q15723-1",NA,NA,NA,0,0,121.2,137.9,112.3,86.6,129.2,83.7,55.4,66,76.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S400(95.8)]",0,"ENSG00000109381"
"266","PEX14",0.425763830495935,6.64448968387657,3.85884766732032,0.00342247378939981,0.0209346154745802,-2.11109295933642,"NONE",FALSE,"High","Master Protein","O75381","Peroxisomal membrane protein PEX14 [OS=Homo sapiens]",0,5.096,3,1,1,2,1,377,41.2,4.94,4.66,1,"cell organization and biogenesis;stress response;transport;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf04695","5195","B2R7N1; B3KML6; B7Z1N2; hsa:5195; O75381; Q8WX51","ENSG00000142655","E3 ubiquitin ligases ubiquitinate target proteins; Peroxisomal protein import; Class I peroxisomal membrane protein import",NA,3,0,90.7,93.6,103.1,87.6,80.5,88.6,131.4,104.8,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(100)]",0,"ENSG00000142655"
"267","SNAP23",-0.392514534461219,6.65635022936439,-3.85838994329906,0.00342496466403977,0.0209346154745802,-2.11184155406099,"NONE",FALSE,"High","Master Protein","O00161","Synaptosomal-associated protein 23 [OS=Homo sapiens]",0,20.752,8,1,1,3,1,211,23.3,5.01,11.55,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport","plasma membrane;other membranes;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00835","8773","hsa:8773; O00161; O00162; Q13602; Q6IAE3","ENSG00000092531","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; ER-Phagosome pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; trans-Golgi Network Vesicle Budding","Insulin signaling",13,0,76,79.2,86.9,127.2,127.5,128.1,111.3,96.4,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S110(100)]",0,"ENSG00000092531"
"268","CNP",0.377172058980684,6.65364263033197,3.84519614213957,0.00349758803582989,0.0212987450540089,-2.13342881600711,"NONE",FALSE,"High","Master Protein","P09543","2',3'-cyclic-nucleotide 3'-phosphodiesterase [OS=Homo sapiens]",0,20.683,7,3,4,5,3,421,47.5,9.07,9.58,3,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;other membranes;cytoskeleton;mitochondrion;other cell component","nucleic acid binding activity;other molecular function","Pf05881, Pf13671","1267","hsa:1267; P09543","ENSG00000173786",NA,"Glial cell differentiation; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Cell lineage map for neuronal differentiation",5,0,90.1,96.3,88.5,97.6,69.9,101.5,122.5,115.7,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S170(100)]",0,"ENSG00000173786"
"269","G3BP1",-0.353743481244286,6.66537426390115,-3.83801500174129,0.00353779337821823,0.0214634899377403,-2.14518577234137,"NONE",FALSE,"High","Master Protein","Q13283","Ras GTPase-activating protein-binding protein 1 [OS=Homo sapiens]",0,28.716,4,1,1,4,1,466,52.1,5.52,18.19,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00076, Pf02136","10146","hsa:10146; Q13283; Q5HYE9","ENSG00000145907","SARS-CoV-2 activates/modulates innate and adaptive immune responses","7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system",3,0,83.1,90.2,102,121.9,114.6,120.9,98.1,101.2,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(99.5)]",0,"ENSG00000145907"
"270","CRACD",0.363639262008462,6.62591732559354,3.83262457890799,0.00356829156051214,0.0215093407575518,-2.15401437729634,"NONE",FALSE,"High","Master Protein","Q6ZU35","Capping protein-inhibiting regulator of actin dynamics [OS=Homo sapiens]",0,51.809,7,7,7,14,7,1233,136.7,5.6,37.98,7,"cell organization and biogenesis;other biological processes","cytosol",NA,"Pf15262","57482","hsa:57482; Q6ZU35; Q9NTE2; Q9NTP8; Q9ULK9","ENSG00000109265",NA,NA,0,0,103.9,95.5,99.6,78.7,87.1,88.1,114.7,101.4,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S132(99.2); S420(100); S556(100); S874(99.1); S1017(100); S1072(100); S1143(100)]",0,"ENSG00000109265"
"271","AGAP1",0.617703841761542,6.6489660043352,3.83103406695374,0.00357734306116683,0.0215093407575518,-2.15661992466271,"NONE",FALSE,"High","Master Protein","Q9UPQ3","Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 [OS=Homo sapiens]",0,13.656,3,2,2,2,2,857,94.4,7.94,5.68,2,"transport","other cell component","enzyme regulator activity;other molecular function","Pf00071, Pf01412, Pf12796","116987","B2RTX7; hsa:116987; Q541S5; Q6P9D7; Q9NV93; Q9UPQ3","ENSG00000157985",NA,"2q37 copy number variation syndrome",1,0,114.3,102.6,87.5,84.1,52.3,99.6,134.7,112.5,119.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100); T836(100)]",0,"ENSG00000157985"
"272","USP42",-0.342074279665762,6.6560522325016,-3.82971113704836,0.00358489012625863,0.0215093407575518,-2.15878731683582,"NONE",FALSE,"High","Master Protein","Q9H9J4","Ubiquitin carboxyl-terminal hydrolase 42 [OS=Homo sapiens]",0,23.567,3,2,2,2,2,1324,145.3,8.63,6.73,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf00443","84132","A2RUE3; B5MDA5; hsa:84132; Q0VIN8; Q3C166; Q6P9B4; Q9H9J4","ENSG00000106346","Ub-specific processing proteases",NA,1,0,86.6,85.3,94.3,120.1,110.1,125.3,99.1,102.9,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S754(99.2); S856(100)]",0,"ENSG00000106346"
"273","KIF21A",0.31403904329121,6.66011562704429,3.81752771160791,0.00365518482667183,0.0218507752275766,-2.17875595288471,"NONE",FALSE,"High","Master Protein","Q7Z4S6","Kinesin-like protein KIF21A [OS=Homo sapiens]",0,75.88,4,5,7,22,5,1674,187.1,6.42,71.37,5,"other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225, Pf00400","55605","A8MX28; B0I1R9; B9EGE4; F5H0C3; F5H219; hsa:55605; Q2UVF1; Q6UKL9; Q7Z4S6; Q7Z668; Q86WZ5; Q8IVZ8; Q9C0F5; Q9NXU4; Q9Y590","ENSG00000139116","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,77.6,75,79.8,103.4,104.3,101.1,116.1,123.3,147.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S853(100); S1212(100); S1229(100); S1239(100); S1662(100)]",0,"ENSG00000139116"
"274","FAM171A1",-0.410658908329663,6.62386484381187,-3.80293542120286,0.00374128574258956,0.022283862525205,-2.20269203543875,"NONE",FALSE,"High","Master Protein","Q5VUB5","Protein FAM171A1 [OS=Homo sapiens]",0,34.461,5,3,3,3,3,890,97.8,6.58,11.02,3,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes",NA,"Pf10577, Pf20771","221061","D3DRT9; hsa:221061; Q32M49; Q5VUB5; Q8N4I0","ENSG00000148468",NA,NA,0,0,99.1,102.6,106.4,113.7,95.8,120.1,97.7,86.6,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T448(100); S494(99.4); S849(100)]",0,"ENSG00000148468"
"275","NKTR",0.358138681879863,6.51136451687721,3.79687868523789,0.00377764545188586,0.0223558905875131,-2.2126331712128,"NONE",FALSE,"High","Master Protein","P30414","NK-tumor recognition protein [OS=Homo sapiens]",0,39.273,5,5,5,8,5,1462,165.6,9.99,17.3,5,"protein metabolism;other metabolic processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00160","4820","hsa:4820; P30414","ENSG00000114857",NA,NA,0,0,139,138.5,129.7,63.1,46.7,74.4,95,86.4,87.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(100); S463(100); S613(99); T1155(100); S1462(100)]",0,"ENSG00000114857"
"276","IFI16",-0.420399104781324,6.60078470119821,-3.79636012912133,0.00378077561406471,0.0223558905875131,-2.21348446182595,"NONE",FALSE,"High","Master Protein","Q16666","Gamma-interferon-inducible protein 16 [OS=Homo sapiens]",0,60.801,3,1,6,34,1,785,88.2,9.28,136.18,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02758, Pf02760","3428","A0A346JEQ3; B4DJT8; H3BLV7; hsa:3428; Q16666; Q59GX0; Q5T3W7; Q5T3W8; Q5T3X0; Q5T3X1; Q5T3X2; Q8N9E5; Q8NEQ7; Q96AJ5; Q9UH78","ENSG00000163565","IRF3-mediated induction of type I IFN",NA,2,0,96.9,92.5,97.8,107.3,141.8,99.4,90.5,85.5,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100)]",0,"ENSG00000163565"
"277","DCLK2",-0.326394674341263,6.66759823125369,-3.78353785288533,0.00385904604419192,0.0226757844146075,-2.23454250927639,"NONE",FALSE,"High","Master Protein","Q8N568","Serine/threonine-protein kinase DCLK2 [OS=Homo sapiens]",0,216.21,27,16,27,64,14,766,83.6,8.34,190.19,16,"cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf03607","166614","C9J5Q9; hsa:166614; Q59GC8; Q8N399; Q8N568","ENSG00000170390",NA,NA,0,0,77.3,79.1,77.5,130,128.2,125.7,97.5,114.3,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S34(99.5); T61(100); S166(100); S182(99.6); S223(100); S308(100); S317(99.5); S347(100); S355(100); S360(100); S362(100); S375(100); S682(99.5)]",0,"ENSG00000170390"
"278","PTGR2",0.619660178831176,6.61379936271867,3.78295172701491,0.00386266425690006,0.0226757844146075,-2.23550548393072,"NONE",FALSE,"High","Master Protein","Q8N8N7","Prostaglandin reductase 2 [OS=Homo sapiens]",0,15.2,5,1,1,3,1,351,38.5,5.41,10.66,1,"other metabolic processes","other cell component","other molecular function","Pf00107, Pf16884","145482","hsa:145482; Q3L8A4; Q6MZH8; Q8N8N7","ENSG00000140043","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-6-fatty acids in senescence",4,0,78.2,63.9,101.4,93.4,63.3,98,131,121.4,145.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000140043"
"279","CCDC86",0.324962627604563,6.67467944277693,3.77367235422308,0.00392042295430627,0.0229323665284152,-2.25075540249803,"NONE",FALSE,"High","Master Protein","Q9H6F5","Coiled-coil domain-containing protein 86 [OS=Homo sapiens]",0,58.666,23,4,4,11,4,360,40.2,10.33,44.74,4,NA,"nucleus;other cell component",NA,"Pf03879","79080","B4DY99; hsa:79080; Q9H6F5","ENSG00000110104",NA,NA,0,0,80.4,89,78,95.5,104.4,103.9,119.2,119.1,140.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); S47(99.3); S91(100); S102(100); S113(99.3)]",0,"ENSG00000110104"
"280","ZNF282",0.471425581096019,6.61198705775767,3.77128615344725,0.00393542149549166,0.0229378852880085,-2.2546782645321,"NONE",FALSE,"High","Master Protein","Q9UDV7","Zinc finger protein 282 [OS=Homo sapiens]",0,6.077,3,1,1,1,1,671,74.2,5.9,2.83,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","8427","B4DRI5; hsa:8427; O43691; Q6DKK0; Q9UDV7","ENSG00000170265","Generic Transcription Pathway",NA,1,0,135.2,109.6,108.3,68.4,78.9,71.3,113.6,95.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(99.2)]",0,"ENSG00000170265"
"281","ARFGAP3",0.298319242290399,6.65745768287493,3.76676486539992,0.00396400533984851,0.0230222658883728,-2.26211264724748,"NONE",FALSE,"High","Master Protein","Q9NP61","ADP-ribosylation factor GTPase-activating protein 3 [OS=Homo sapiens]",0,22.285,3,1,2,3,1,516,56.9,7.36,6.75,1,"cell organization and biogenesis;transport","other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01412","26286","E9PB03; hsa:26286; Q9BSC6; Q9H9J0; Q9NP61; Q9NT10; Q9NUP5; Q9Y4V3; Q9Y4V4","ENSG00000242247","CDC42 GTPase cycle; RHOG GTPase cycle; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport","Ciliary landscape",5,0,84.6,79.8,78.4,104,99,98.7,117.3,131.1,121.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(98.9)]",0,"ENSG00000242247"
"282","ATL1",0.370564352053503,6.67644480907249,3.76082207450743,0.00400190728293955,0.023130483180891,-2.2718873591042,"NONE",FALSE,"High","Master Protein","Q8WXF7","Atlastin-1 [OS=Homo sapiens]",0,10.311,3,1,1,1,1,558,63.5,6.18,3.64,1,"cell organization and biogenesis;developmental processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf02263","51062","A6NND5; A8K2C0; G5E9T1; hsa:51062; O95890; Q69YH7; Q8WXF7; Q96FK0","ENSG00000198513",NA,NA,0,0,74.7,86.4,77.6,106.4,82.9,110.1,133.2,124.8,128.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.6)]",0,"ENSG00000198513"
"283","WRNIP1",0.483153629861495,6.64123784513486,3.75782361166192,0.00402117481915135,0.023130483180891,-2.27682049911559,"NONE",FALSE,"High","Master Protein","Q96S55","ATPase WRNIP1 [OS=Homo sapiens]",0,35.225,5,3,5,7,3,665,72.1,6.1,15.51,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00004, Pf12002, Pf16193, Pf18279","56897","B2RDB0; hsa:56897; Q53EP6; Q59ET8; Q5W0E2; Q5W0E4; Q8WV26; Q96S55; Q9H681; Q9NRJ6","ENSG00000124535",NA,NA,0,0,87.5,91.6,83.9,88.2,75.8,97.6,100.7,137.4,145.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T116(100); S153(99.6)]",0,"ENSG00000124535"
"284","DOCK1",0.337523202345751,6.66758074846417,3.75720567664963,0.00402515761236094,0.023130483180891,-2.27783724501861,"NONE",FALSE,"High","Master Protein","Q14185","Dedicator of cytokinesis protein 1 [OS=Homo sapiens]",0,16.814,2,2,2,3,2,1865,215.2,7.56,8.55,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf06920, Pf14429, Pf16172, Pf20421, Pf20422","1793","A9Z1Z5; hsa:1793; Q14185","ENSG00000150760","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; DCC mediated attractive signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","Integrin-mediated cell adhesion; Androgen receptor network in prostate cancer; Focal adhesion; Hepatocyte growth factor receptor signaling; Regulation of actin cytoskeleton",14,0,90.4,92.1,109.1,90.8,83.7,95.9,120.6,109.7,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1681(100); T1767(100)]",0,"ENSG00000150760"
"285","TMEM201",0.470660513573006,6.62131546495944,3.75372052705828,0.00404769805278227,0.023178397270669,-2.28357235603716,"NONE",FALSE,"High","Master Protein","Q5SNT2","Transmembrane protein 201 [OS=Homo sapiens]",0,8.027,2,1,1,2,1,666,72.2,9.22,5.24,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf09779, Pf10476","199953","B9EH90; hsa:199953; Q5SNT2; Q5SNT3","ENSG00000188807",NA,NA,0,0,81.9,84.6,83.9,85.3,90.3,91.7,101.6,145.3,134.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(100)]",0,"ENSG00000188807"
"286","PHACTR4",-0.42283875506198,6.67858405525618,-3.74847313085701,0.00408188566746442,0.0232924384940627,-2.29220953655481,"NONE",FALSE,"High","Master Protein","Q8IZ21","Phosphatase and actin regulator 4 [OS=Homo sapiens]",0,10.987,4,2,2,2,2,702,78.2,6.62,3.52,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf02755","65979","A2APK6; B9ZVW0; D3DPM3; hsa:65979; Q68DD4; Q6NUN6; Q8IZ21; Q8N384; Q9H395; Q9H6X0; Q9H8W6","ENSG00000204138",NA,NA,0,0,71.8,81.7,97,113.5,148.2,137.2,98.4,100.1,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S118(100); S176(98.9)]",0,"ENSG00000204138"
"287","HEPACAM",-0.38329685839401,6.56582074858455,-3.7434164315977,0.00411511708652768,0.0234002476836696,-2.30053525660613,"NONE",FALSE,"High","Master Protein","Q14CZ8","Hepatic and glial cell adhesion molecule [OS=Homo sapiens]",0,139.98,24,8,14,48,7,416,46,9.11,127.55,8,"cell adhesion;cell cycle OR cell proliferation;other biological processes","other membranes;other cell component",NA,"Pf07686, Pf13927","220296","hsa:220296; Q14CZ8; Q67IP8; Q6ZWL4; Q8N7I3; Q8ND35","ENSG00000165478",NA,NA,0,2,118,124.3,109,95.8,111,89.8,82.1,75,84.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100); T295(100); S299(100); S318(100); S350(100); S364(99.3); S376(99.4); S383(99.4)]",0,"ENSG00000165478"
"288","FGFR3",-0.481992205752129,6.62544698172,-3.73925377146093,0.00414268567483075,0.0234752188240409,-2.30739074342475,"NONE",FALSE,"High","Master Protein","P22607","Fibroblast growth factor receptor 3 [OS=Homo sapiens]",0,21.334,4,2,3,4,2,806,87.7,5.9,9.61,2,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component","kinase activity;other molecular function","Pf07679, Pf07714, Pf13927, Pf21165","2261","D3DVP9; D3DVQ0; hsa:2261; P22607; Q14308; Q16294; Q16608; Q59FL9","ENSG00000068078","Signaling by activated point mutants of FGFR3; t(4;14) translocations of FGFR3; Signaling by FGFR3 fusions in cancer","Neural crest differentiation; Bladder cancer; NOTCH1 regulation of endothelial cell calcification; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; Ras signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Head and neck squamous cell carcinoma; Endochondral ossification; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; FGF23 signaling in hypophosphatemic rickets and related disorders; EGFR tyrosine kinase inhibitor resistance; Endochondral ossification with skeletal dysplasias; Pleural mesothelioma; Regulation of actin cytoskeleton; 4p16.3 copy number variation",25,0,100.2,110.8,117.3,115.1,88.7,122.2,94.8,75.1,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S408(100); S445(99.2)]",0,"ENSG00000068078"
"289","GNG12",0.390553545266989,6.62815955497026,3.72920104990494,0.00421006356564332,0.0237744766059858,-2.32395315573238,"NONE",FALSE,"High","Master Protein","Q9UBI6","Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [OS=Homo sapiens]",0,26.83,32,2,3,4,2,72,8,8.97,10.81,2,"signal transduction","plasma membrane;other membranes","other molecular function","Pf00631","55970","hsa:55970; Q69YP5; Q9BRV5; Q9UBI6","ENSG00000172380","G alpha (z) signalling events; G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Myometrial relaxation and contraction pathways; G protein signaling pathways; MAPK signaling pathway; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Regulation of actin cytoskeleton; Calcium regulation in cardiac cells",37,0,105.5,98,120.4,74.3,78.8,86.3,113.9,99.5,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100); S49(100)]",0,"ENSG00000172380"
"290","PRRT3",0.924315010587447,6.52337011314736,3.72591435519342,0.00423234054317385,0.0238178612636542,-2.32937017373215,"NONE",FALSE,"High","Master Protein","Q5FWE3","Proline-rich transmembrane protein 3 [OS=Homo sapiens]",0,7.936,2,2,2,2,2,981,102.1,7.78,5.06,2,NA,"other membranes",NA,NA,"285368","hsa:285368; Q49AD0; Q5FWE3; Q6UXY6; Q8NBC9","ENSG00000163704",NA,NA,0,0,126.7,163.7,93,45.2,62,49.9,127.5,84.8,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S815(100); S976(99.6)]",0,"ENSG00000163704"
"291","TBC1D15",0.316419562169409,6.64803048726675,3.71666803026894,0.00429567572969911,0.0240912123397558,-2.34461491745336,"NONE",FALSE,"High","Master Protein","Q8TC07-3","Isoform 3 of TBC1 domain family member 15 [OS=Homo sapiens]",0,29.223,5,2,2,6,2,682,78.5,5.35,19.95,2,NA,NA,NA,NA,NA,"Q8TC07-3",NA,NA,NA,0,0,103,83.7,95.6,90,85.2,97.4,115.1,114.2,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); S666(100)]",0,"ENSG00000121749"
"292","HNRNPA3",-0.500110563232406,6.61274609927978,-3.71395010318213,0.0043144809465731,0.0241138113178332,-2.34909753053911,"NONE",FALSE,"High","Master Protein","P51991","Heterogeneous nuclear ribonucleoprotein A3 [OS=Homo sapiens]",0,23.18,6,1,1,3,1,378,39.6,9.01,8,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076","220988","D3DPF4; hsa:220988; P51991; Q53RW7; Q6URK5","ENSG00000170144","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,90.6,86.3,84.2,106,168.8,116.1,89.4,83,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S358(100)]",0,"ENSG00000170144"
"293","NUP88",0.248977054836741,6.46509724857962,3.7095420357116,0.00434516354073316,0.024117206877777,-2.35636906478868,"NONE",FALSE,"High","Master Protein","Q99567","Nuclear pore complex protein Nup88 [OS=Homo sapiens]",0,41.262,5,2,4,7,2,741,83.5,5.69,32.5,2,"other metabolic processes;transport","cytosol;nucleus","other molecular function","Pf10168","4927","D3DTM2; hsa:4927; Q99567; Q9BWE5","ENSG00000108559","Viral Messenger RNA Synthesis; HCMV Early Events; SUMOylation of DNA damage response and repair proteins; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses","Ciliary landscape",29,0,145.5,136.1,138,65.1,51.5,62.7,82.5,81.5,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(99.4); S517(100)]",0,"ENSG00000108559"
"294","GTF2I",-0.305186054818991,6.25555617754193,-3.70770267556586,0.00435803393697445,0.024117206877777,-2.35940378263865,"NONE",FALSE,"High","Master Protein","P78347","General transcription factor II-I [OS=Homo sapiens]",0,49.377,8,7,10,25,7,998,112.3,6.39,30.19,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02946","2969","hsa:2969; O14743; O15359; O43546; O43588; O43589; P78347; Q75M85; Q75M86; Q75M87; Q75M88; Q86U51; Q9BSZ4","ENSG00000263001",NA,"B cell receptor signaling pathway; 7q11.23 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease",3,0,175.8,167,171.5,51.1,42.6,55,55.1,55.6,55.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100); S674(100); S823(100); S831(99.6)]",0,"ENSG00000263001"
"295","KIF1A",0.286265390015075,6.52790814418591,3.70750470050803,0.00435942158636288,0.024117206877777,-2.3597304351581,"NONE",FALSE,"High","Master Protein","Q12756","Kinesin-like protein KIF1A [OS=Homo sapiens]",0,31.514,3,4,4,7,4,1690,190.9,6.21,24.36,4,"transport;other biological processes","other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00225, Pf00498, Pf12423, Pf12473, Pf16183","547","B0I1S5; F5H045; hsa:547; O95068; Q12756; Q13355; Q14752; Q2NKJ6; Q4LE42; Q53T78; Q59GH1; Q63Z40; Q6P1R9; Q7KZ57","ENSG00000130294","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins","2q37 copy number variation syndrome",3,0,132.2,126.4,131,64.4,58.7,75.7,91.2,86.6,93.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1310(100); S1337(100); S1370(100); S1548(100)]",0,"ENSG00000130294"
"296","NES",0.412412265015849,6.57503363570151,3.68146409359416,0.00454603597203619,0.0250646307647401,-2.40272686790905,"NONE",FALSE,"High","Master Protein","P48681","Nestin [OS=Homo sapiens]",0,1080.398,46,58,86,285,57,1621,177.3,4.36,1120.31,58,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00038","10763","hsa:10763; O00552; P48681; Q3LIF5; Q5SYZ6","ENSG00000132688",NA,"Cell lineage map for neuronal differentiation",1,1,114.3,125.2,120.2,61.8,69.6,77.4,108.5,90.9,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T315(100); S325(100); T338(100); S398(100); S459(100); S471(100); S548(100); S564(100); S578(100); S588(100); S680(100); S702(100); S746(100); S768(100); S814(100); S828(100); S842(100); T851(100); S905(100); S913(100); S931(100); S934(100); S965(100); S1016(100); S1030(100); S1175(100); S1347(100); S1418(100); S1442(100); S1498(99.3); S1502(100); S1521(100); S1577(100); S1617(99.1); S1618(99.5)]",0,"ENSG00000132688"
"297","PRKD1",0.248910909069668,6.67112293941079,3.67279742451565,0.00460998110306811,0.0253316133340308,-2.41704982487254,"NONE",FALSE,"High","Master Protein","Q15139","Serine/threonine-protein kinase D1 [OS=Homo sapiens]",0,60.266,7,4,4,8,2,912,101.6,6.62,33.09,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00130, Pf00169","5587","A6NL64; B2RAF6; Q15139","ENSG00000184304","Sphingolipid de novo biosynthesis","Apoptosis modulation and signaling; Cardiac hypertrophic response; Myometrial relaxation and contraction pathways; G protein signaling pathways; VEGFA-VEGFR2 signaling; Wnt signaling pathway and pluripotency; Gastrin signaling pathway; Osteoblast differentiation and related diseases; Calcium regulation in cardiac cells",10,2,90.3,94.2,89.9,93.7,94.5,103.9,113.1,116.3,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S205(100); S219(99.5); S397(100); S742(100)]",0,"ENSG00000184304"
"298","RPL24",0.744974465459495,6.57318281791762,3.66990145924674,0.00463155735584439,0.0253647704856981,-2.42183728202532,"NONE",FALSE,"High","Master Protein","P83731","Large ribosomal subunit protein eL24 [OS=Homo sapiens]",0,9.909,8,1,2,3,1,157,17.8,11.25,9.33,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes","cytosol;ER/Golgi;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf01246","6152","B2R4Y3; hsa:6152; P38663; P83731; Q6IBS3","ENSG00000114391","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,72.7,68.7,68.2,91.1,66.8,90.5,98.4,202.1,165.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T83(100)]",0,"ENSG00000114391"
"299","PRKRA",0.396604657679254,6.68160401794707,3.66615925834577,0.00465959487428565,0.0254329726917531,-2.42802475699858,"NONE",FALSE,"High","Master Protein","O75569","Interferon-inducible double-stranded RNA-dependent protein kinase activator A [OS=Homo sapiens]",0,36.71,6,2,2,11,2,313,34.4,8.41,32.79,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00035","8575","A8K3I6; hsa:8575; O75569; Q53G24; Q6X7T5; Q8NDK4","ENSG00000180228","PKR-mediated signaling; MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis","VEGFA-VEGFR2 signaling; Ebola virus infection in host",5,0,76.5,76,80.5,113.2,80.9,106.2,120.1,152.8,131.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100)]",0,"ENSG00000180228"
"300","GYG2",-0.421179878165582,6.69263443359497,-3.65503064924781,0.00474402609565301,0.0257263306225179,-2.44643220791945,"NONE",FALSE,"High","Master Protein","O15488","Glycogenin-2 [OS=Homo sapiens]",0,5.593,2,2,2,2,2,501,55.1,5.1,5.07,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf01501","8908","B7WNN6; hsa:8908; O15485; O15486; O15487; O15488; O15489; O15490","ENSG00000056998","Glycogen synthesis; Glycogen storage disease type 0 (liver GYS2); Glycogen storage disease type IV (GBE1); Glycogen breakdown (glycogenolysis)","Glycogen synthesis and degradation; Disorders of galactose metabolism",6,0,80.6,87.7,82.9,131,118.7,138.1,88.2,102.4,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(100)]",0,"ENSG00000056998"
"301","SH3PXD2B",0.312379226424139,6.66605870666149,3.65492065015241,0.00474486857682468,0.0257263306225179,-2.44661420602891,"NONE",FALSE,"High","Master Protein","A1X283","SH3 and PX domain-containing protein 2B [OS=Homo sapiens]",0,48.694,10,5,5,7,5,911,101.5,8.69,20.1,5,"cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00787, Pf07653","285590","A1X283; B6F0V2; hsa:285590; Q9P2Q1","ENSG00000174705",NA,NA,0,0,89.1,89.3,91.5,96.2,84.2,103.1,106.1,128.6,125.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S291(98.9); S675(100)]",0,"ENSG00000174705"
"302","NFIB",-0.280710993013756,6.62629368973554,-3.64253539787889,0.0048407337566958,0.0261014782829997,-2.46711262103582,"NONE",FALSE,"High","Master Protein","O00712","Nuclear factor 1 B-type [OS=Homo sapiens]",0,49.271,13,3,5,7,3,420,47.4,8.87,25.18,3,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4781","G3V1P1; H7BYE8; hsa:4781; O00166; O00712; Q12858; Q5VW29; Q63HM5; Q6ZNF9; Q96J45","ENSG00000147862","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination","Pathways affected in adenoid cystic carcinoma",3,0,102.6,94.5,107.1,102.6,106.7,112.7,89.7,89,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S265(100); S295(100); S328(100)]",0,"ENSG00000147862"
"303","SRGAP1",-0.456676011400623,6.65444227544284,-3.64185652899181,0.00484604651945399,0.0261014782829997,-2.46823656449612,"NONE",FALSE,"High","Master Protein","Q7Z6B7","SLIT-ROBO Rho GTPase-activating protein 1 [OS=Homo sapiens]",0,12.06,2,2,2,4,2,1085,124.2,6.83,7.38,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00611, Pf00620","57522","hsa:57522; Q7Z6B7; Q9H8A3; Q9P2P2","ENSG00000196935","RAC1 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; Inactivation of CDC42 and RAC1",NA,4,0,84.9,87.1,89.7,132.7,99.4,133.8,92.5,103,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S906(100); S932(100)]",0,"ENSG00000196935"
"304","TNS1",-0.252301499869809,6.64740921823543,-3.63659911260794,0.00488739730688014,0.02622520105355,-2.47694209985218,"NONE",FALSE,"High","Master Protein","Q9HBL0","Tensin-1 [OS=Homo sapiens]",0,73.254,5,6,6,8,6,1839,196.9,8.16,36.64,6,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00017, Pf00130, Pf08416, Pf10409","7145","A0A804HI61; hsa:7145; Q4ZG71; Q6IPI5; Q9HBL0","ENSG00000079308",NA,"Integrin-mediated cell adhesion",1,0,81.8,76.7,78.2,119.8,124.4,123.1,106.2,102.5,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T985(99.3); S1032(100); S1281(100); S1373(99.5); S1418(100); S1485(100)]",0,"ENSG00000079308"
"305","METTL2B",-0.359419926268553,6.42313650453078,-3.63486012085878,0.00490115583414997,0.02622520105355,-2.47982212619722,"NONE",FALSE,"High","Master Protein","Q6P1Q9","tRNA N(3)-methylcytidine methyltransferase METTL2B [OS=Homo sapiens]",0,10.132,3,1,1,1,1,378,43.4,5.86,4.29,1,"RNA metabolism OR transcription;other metabolic processes","other cell component","other molecular function","Pf08242","55798","B4DZ68; hsa:55798; Q0IJ54; Q3B7J1; Q6P1Q9","ENSG00000165055",NA,NA,0,0,144.1,138,133,76.1,69.5,75.3,61,68.2,74.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T154(100)]",0,"ENSG00000165055"
"306","CLIP2",-0.285214098846539,6.67162854289502,-3.62536451572094,0.00497699965505704,0.0264085876761455,-2.49555262543454,"NONE",FALSE,"High","Master Protein","Q9UDT6","CAP-Gly domain-containing linker protein 2 [OS=Homo sapiens]",0,105.094,13,8,12,20,8,1046,115.8,6.73,62.68,8,"cell organization and biogenesis","cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf01302","7461","hsa:7461; O14527; O43611; Q9UDT6","ENSG00000106665",NA,"7q11.23 copy number variation syndrome",1,0,71.4,72.3,76.8,133.1,125.7,129.2,105.3,111.2,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100); S48(99.5); T177(98); S195(99.7); S202(100); S923(100)]",0,"ENSG00000106665"
"307","HSP90AB1",0.375762501753293,6.65876254873765,3.62493475102743,0.00498046114386755,0.0264085876761455,-2.49626475149845,"NONE",FALSE,"High","Master Protein","P08238","Heat shock protein HSP 90-beta [OS=Homo sapiens]",0,257.293,19,15,15,59,7,724,83.2,5.03,237.08,15,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","3326","B2R5P0; hsa:3326; P08238; Q5T9W7; Q9NQW0; Q9NTK6","ENSG00000096384","Potential therapeutics for SARS; Regulation of actin dynamics for phagocytic cup formation; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Aryl hydrocarbon receptor signalling; Neutrophil degranulation; Estrogen-dependent gene expression; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; Uptake and function of diphtheria toxin; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication","Nuclear receptors meta-pathway; NRF2 pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway",25,1,101.3,104.7,106.2,99.8,69.4,83.6,107.5,124.4,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S255(100)]",0,"ENSG00000096384"
"308","SMAD5",-0.440896299225304,6.61923173836033,-3.62449897027433,0.00498397365456667,0.0264085876761455,-2.49698686159972,"NONE",FALSE,"High","Master Protein","Q99717","Mothers against decapentaplegic homolog 5 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,465,52.2,7.71,9.9,1,"developmental processes;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03165, Pf03166","4090","hsa:4090; O14688; Q15798; Q99717; Q9UQA1","ENSG00000113658","Signaling by BMP","Differentiation of white and brown adipocyte; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Neovascularization processes; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Network map of SARS-CoV-2 signaling pathway; Clock-controlled autophagy in bone metabolism; Markers of kidney cell lineage; 10q11.21q11.23 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; TGF-beta receptor signaling",14,0,78.7,77.9,89.4,128.2,137.5,112.2,88.5,109.5,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000113658"
"309","STX4",0.320266165433605,6.62694488490566,3.62191070413582,0.0050048891380946,0.0264335892342084,-2.50127606357943,"NONE",FALSE,"High","Master Protein","Q12846","Syntaxin-4 [OS=Homo sapiens]",0,16.072,11,2,2,3,2,297,34.2,6.28,3.78,2,"cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00804, Pf05739","6810","A8MXY0; hsa:6810; Q12846; Q15525; Q6FHE8","ENSG00000103496","Translocation of SLC2A4 (GLUT4) to the plasma membrane; ER-Phagosome pathway; trans-Golgi Network Vesicle Budding; Disinhibition of SNARE formation; Other interleukin signaling","Insulin signaling; Vasopressin-regulated water reabsorption",7,0,91,103.8,100,90.3,80.1,88.3,102.8,107.4,125.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(100)]",0,"ENSG00000103496"
"310","RBM8A",0.397992408610585,6.65972129381986,3.6173108019286,0.00504228682862498,0.0265452003365031,-2.50890023113138,"NONE",FALSE,"High","Master Protein","Q9Y5S9","RNA-binding protein 8A [OS=Homo sapiens]",0,4.48,5,1,1,1,1,174,19.9,5.72,2.4,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076","9939","B3KQI9; hsa:9939; Q6FHD1; Q6IQ40; Q9GZX8; Q9NZI4; Q9Y5S9","ENSG00000265241","Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway",NA,6,0,83.2,85.3,81.8,91.8,108.1,91.5,132.4,111,132.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000265241"
"311","NPDC1",-0.364308012241571,6.64956824360358,-3.61142679425529,0.00509055002605575,0.0266712151064501,-2.51865523977529,"NONE",FALSE,"High","Master Protein","Q9NQX5","Neural proliferation differentiation and control protein 1 [OS=Homo sapiens]",0,6.875,10,2,2,2,2,325,34.5,7.01,2.13,2,NA,"plasma membrane;other membranes",NA,"Pf06809","56654","hsa:56654; Q5SPY8; Q9BTD6; Q9BXT3; Q9NQS2; Q9NQX5; Q9Y434","ENSG00000107281","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",NA,1,0,94.6,84.4,82.4,116.3,129.4,122,102.9,102.2,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(100); S312(100)]",0,"ENSG00000107281"
"312","BCKDHA",-1.51943342989657,6.31079209359052,-3.61041365460378,0.00509890877035075,0.0266712151064501,-2.52033518888767,"NONE",FALSE,"High","Master Protein","P12694","2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial [OS=Homo sapiens]",0,15.2,3,1,1,4,1,445,50.4,8.27,13.12,1,"other metabolic processes","mitochondrion","other molecular function","Pf00676","593","B4DP47; E7EW46; hsa:593; P12694; Q16034; Q16472","ENSG00000248098","Glyoxylate metabolism and glycine degradation; Branched-chain amino acid catabolism","Lipid metabolism pathway",3,0,44.2,60.8,102.3,99.3,169.7,244.8,45.5,62.6,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.6)]",0,"ENSG00000248098"
"313","CARHSP1",-0.394769398948881,6.62545295018551,-3.60770612710982,0.00512131713931749,0.026702842081042,-2.52482510855946,"NONE",FALSE,"High","Master Protein","Q9Y2V2","Calcium-regulated heat-stable protein 1 [OS=Homo sapiens]",0,42.399,18,5,6,25,5,147,15.9,8.21,52.29,5,"signal transduction;other biological processes","cytosol;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00313","23589","B2R4C3; D3DUF5; hsa:23589; Q2YDX5; Q9BQ53; Q9Y2V2","ENSG00000153048",NA,NA,0,0,76.4,77.2,81.9,111.8,171,118.5,97.5,96.4,102.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S32(100); S41(100); S52(100)]",0,"ENSG00000153048"
"314","CLU",-0.367578100089816,6.48946301727028,-3.59537141698947,0.00522471102931672,0.0271505969611331,-2.5452872322135,"NONE",FALSE,"High","Master Protein","P10909","Clusterin [OS=Homo sapiens]",0,176.695,23,9,12,23,9,449,52.5,6.27,78.28,9,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf01093","1191","B2R9Q1; B3KSE6; hsa:1191; P10909; P11380; P11381; Q2TU75; Q5HYC1; Q7Z5B9","ENSG00000120885","Regulation of Complement cascade; Platelet degranulation ; Antimicrobial peptides; Terminal pathway of complement","Dengue-2 interactions with complement and coagulation cascades; Male infertility; Complement system in neuronal development and plasticity; Complement and coagulation cascades",8,0,134.8,135.7,143.5,79.9,77.7,83.2,79.2,67.1,64.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S396(99.4)]",0,"ENSG00000120885"
"315","CDH6",-0.557241917872523,6.56691473109288,-3.59250647022002,0.00524903616514658,0.0271505969611331,-2.55004162116771,"NONE",FALSE,"High","Master Protein","P55285","Cadherin-6 [OS=Homo sapiens]",0,16.453,3,2,2,3,2,790,88.3,4.93,7.19,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00028, Pf01049","1004","A8K5H5; hsa:1004; P55285; Q9BWS0","ENSG00000113361","Adherens junctions interactions","Neural crest differentiation; Ectoderm differentiation; Ectoderm differentiation; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Pleural mesothelioma",8,0,128.8,121.9,97.5,108.8,75.6,123.9,77,86.1,68.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S648(100); S786(100)]",0,"ENSG00000113361"
"316","LEMD2",0.436021979178951,6.52586490777736,3.5915596858324,0.00525710088218018,0.0271505969611331,-2.55161295393608,"NONE",FALSE,"High","Master Protein","Q8NC56","LEM domain-containing protein 2 [OS=Homo sapiens]",0,8.484,6,3,3,8,3,503,56.9,9,6.76,3,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytoskeleton;nucleus;other cell component",NA,"Pf03020, Pf09402","221496","B4DVH5; E7EVT2; Q5T972; Q5T974; Q8NC56","ENSG00000161904","Sealing of the nuclear envelope (NE) by ESCRT-III; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina",NA,4,0,129.5,126.7,120.3,55.9,70,64.9,96,86.7,106,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S499(99.6)]",0,"ENSG00000161904"
"317","ZNF362",-0.335091244730319,6.58538048103703,-3.58758352366444,0.00529111121303264,0.0271855489135935,-2.55821276135376,"NONE",FALSE,"High","Master Protein","Q5T0B9","Zinc finger protein 362 [OS=Homo sapiens]",0,3.625,2,1,1,1,1,420,45.8,9.64,2.67,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096","149076","hsa:149076; Q5T0B9; Q8WYU4","ENSG00000160094",NA,NA,0,0,101,101.1,99.3,101.9,111.2,103.2,96.5,86.6,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100)]",0,"ENSG00000160094"
"318","TLE3",-0.335872482223643,6.62393059417646,-3.58687633765463,0.0052971841633105,0.0271855489135935,-2.55938670801189,"NONE",FALSE,"High","Master Protein","Q04726","Transducin-like enhancer protein 3 [OS=Homo sapiens]",0,30.401,4,2,2,4,2,772,83.4,7.2,16.96,2,"cell-cell signaling;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00400, Pf03920","7090","B4DPT0; E9PD64; F8W964; hsa:7090; Q04726; Q6PI57; Q8IVV6; Q8WVR2; Q9HCM5","ENSG00000140332","Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; Estrogen-dependent gene expression; Repression of WNT target genes","White fat cell differentiation",5,0,71,80.1,81.9,122,142.7,114.6,103.6,96.3,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S286(99.3)]",0,"ENSG00000140332"
"319","KCNN3",-0.482497696764185,6.62636301379967,-3.58438027240797,0.00531867725505862,0.0272102861450021,-2.56353054855793,"NONE",FALSE,"High","Master Protein","Q9UGI6","Small conductance calcium-activated potassium channel protein 3 [OS=Homo sapiens]",0,17.758,3,2,2,2,2,731,81.3,8.95,8.23,2,"transport","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf02888, Pf03530, Pf07885","3782","B1ANX0; hsa:3782; O43517; Q86VF9; Q8WXG7; Q9UGI6","ENSG00000143603","Ca2+ activated K+ channels","Estradiol regulation in porto-sinusoidal vascular disease; Genetic causes of porto-sinusoidal vascular disease",3,0,67.8,64.7,66.2,140.3,136.4,139.9,118.6,106.9,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100); S167(100)]",0,"ENSG00000143603"
"320","ZC3H14",0.412982393199835,6.65357183639706,3.57637416989998,0.00538823176175047,0.0274799819849274,-2.57682510661029,"NONE",FALSE,"High","Master Protein","Q6PJT7","Zinc finger CCCH domain-containing protein 14 [OS=Homo sapiens]",0,9.227,2,1,1,3,1,736,82.8,7.31,5.88,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf14608","79882","A8MY46; B4DXU8; B4DZW7; B4E2H4; G3V5R4; hsa:79882; Q6MZU4; Q6PJ32; Q6PJT7; Q6PUI6; Q6PUI8; Q86TQ5; Q86TW0; Q86TW1; Q8NCT6; Q8NCZ3; Q8TDE2; Q9HAC9; Q9Y5A0","ENSG00000100722",NA,NA,0,0,94.4,96.7,91.1,93.3,92.1,80.3,131.6,108.8,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(100)]",0,"ENSG00000100722"
"321","C11orf96",0.371452564568192,6.68316837395014,3.56106028546049,0.00552392816230884,0.0280842702831403,-2.60226819438061,"NONE",FALSE,"High","Master Protein","Q7Z7L8","Uncharacterized protein C11orf96 [OS=Homo sapiens]",0,33.742,13,4,4,6,4,435,46.1,9.99,17.3,4,NA,NA,NA,"Pf15766","387763","Q7Z7L8",NA,NA,NA,0,0,79.4,98.8,93.5,88.6,97.2,100.5,110,124.3,138.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S385(100); S399(100); S406(100); S425(100)]",0,"ENSG00000187479"
"322","ATXN2",-0.255880073517727,6.65865919302021,-3.54987724965714,0.00562526770287078,0.0284807938439507,-2.62085920245522,"NONE",FALSE,"High","Master Protein","Q99700","Ataxin-2 [OS=Homo sapiens]",0,54.917,5,5,6,8,5,1313,140.2,9.57,25.54,5,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity","Pf06741, Pf07145, Pf14438","6311","A6NLD4; hsa:6311; Q24JQ7; Q6ZQZ7; Q99493; Q99700","ENSG00000204842",NA,"Parkinson's disease pathway; EGF/EGFR signaling pathway",2,0,89.9,88.1,93.5,116.9,114.3,116.6,97.5,105.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S667(99.5); T741(100); S772(99.4); S784(100); S889(99.7)]",0,"ENSG00000204842"
"323","SLC16A2",0.374039743785626,6.66280785128311,3.54861536253047,0.00563682378161525,0.0284807938439507,-2.6229575796945,"NONE",FALSE,"High","Master Protein","P36021","Monocarboxylate transporter 8 [OS=Homo sapiens]",0,22.529,2,1,1,3,1,539,59.5,5.59,10.35,1,"cell-cell signaling;other metabolic processes;transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function",NA,"6567","hsa:6567; P36021; Q7Z797","ENSG00000147100","Transport of organic anions","Angiopoietin-like protein 8 regulatory pathway",2,0,77,72.6,81.6,116.9,89.5,92.9,124.6,130.3,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T80(100)]",0,"ENSG00000147100"
"324","PTPN14",-0.284263824326764,6.6098469089864,-3.53512819263468,0.00576189189319994,0.0290228628694516,-2.64539247312813,"NONE",FALSE,"High","Master Protein","Q15678","Tyrosine-protein phosphatase non-receptor type 14 [OS=Homo sapiens]",0,25.245,2,2,3,4,2,1187,135.2,8.31,12.27,2,"protein metabolism;other metabolic processes;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00102, Pf00373, Pf09379, Pf09380","5784","hsa:5784; Q15678; Q5VSI0","ENSG00000152104","Interleukin-37 signaling","VEGFA-VEGFR2 signaling",2,0,99.3,106.3,109.3,105.6,90.1,110.9,86,94.5,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S314(100); S594(100)]",0,"ENSG00000152104"
"325","BSG",0.329012058134505,6.65312676552119,3.52709361656598,0.00583776765948134,0.0293145748316109,-2.65876360415033,"NONE",FALSE,"High","Master Protein","P35613","Basigin [OS=Homo sapiens]",0,30.401,5,2,2,3,2,385,42.2,5.66,12.16,2,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf13927","682","A6NJW1; D3YLG5; hsa:682; P35613; Q7Z796; Q8IZL7","ENSG00000172270","Degradation of the extracellular matrix; Integrin cell surface interactions; Pyruvate metabolism; Aspirin ADME; Basigin interactions; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)","Matrix metalloproteinases; VEGFA-VEGFR2 signaling; IL-18 signaling pathway",10,0,101.5,106.1,102.9,84.3,90.3,86.4,119.1,102.6,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100)]",0,"ENSG00000172270"
"326","RAB11FIP5",0.382088351937309,6.64838163882919,3.50688089425902,0.00603328432001499,0.0301405894692612,-2.69242166876279,"NONE",FALSE,"High","Master Protein","Q9BXF6","Rab11 family-interacting protein 5 [OS=Homo sapiens]",0,9.24,5,3,3,3,3,653,70.4,9.23,6.98,3,"cell-cell signaling;transport;other biological processes","other membranes;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00168, Pf09457","26056","hsa:26056; O94939; Q9BXF6; Q9P0M1","ENSG00000135631",NA,NA,0,0,102.9,103.6,92.9,80.3,101.4,81.9,116.4,109.2,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(99.4); S307(100); S482(100)]",0,"ENSG00000135631"
"327","RPL12",0.335862793970356,6.24546821199367,3.50628009883342,0.00603919899292182,0.0301405894692612,-2.69342254136547,"NONE",FALSE,"High","Master Protein","P30050","Large ribosomal subunit protein uL11 [OS=Homo sapiens]",0,7.136,10,2,2,3,2,165,17.8,9.42,7.09,2,"protein metabolism;other metabolic processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00298, Pf03946","6136","hsa:6136; P30050; Q5VVV2; Q6PB27","ENSG00000197958","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,171.7,169.8,138,40.8,33.5,44.3,69.5,64.6,63.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S38(100); S126(100)]",0,"ENSG00000197958"
"328","SAFB",0.325399108522934,6.6723759400666,3.49836361724444,0.00611770047703813,0.0304392901784336,-2.70661300330345,"NONE",FALSE,"High","Master Protein","Q15424","Scaffold attachment factor B1 [OS=Homo sapiens]",0,88.639,13,7,8,24,4,915,102.6,5.47,64.92,7,"cell organization and biogenesis;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf02037","6294","A0AV56; B7Z5B6; B7ZLP6; F5H0H3; hsa:6294; O60406; Q15424; Q59HH8","ENSG00000160633","SUMOylation of transcription cofactors","Interleukin-1 (IL-1) structural pathway",2,2,87.9,93.4,93.6,102.1,72.6,104,119.2,116.3,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100); S589(100); S604(100)]",0,"ENSG00000160633"
"329","SMAP1",-0.601229352750887,6.68129047112016,-3.49015693700627,0.00620020074480517,0.0307560109894287,-2.72029145810931,"NONE",FALSE,"High","Master Protein","Q8IYB5","Stromal membrane-associated protein 1 [OS=Homo sapiens]",0,28.522,6,1,2,5,1,467,50.4,8.75,11.36,1,"other biological processes","plasma membrane;other membranes;other cell component","enzyme regulator activity;other molecular function","Pf01412","60682","hsa:60682; Q53H70; Q5SYQ2; Q6PK24; Q8IYB5; Q8NDH4; Q96L38; Q96L39; Q9H8X4","ENSG00000112305",NA,NA,0,0,101.2,82.1,96.8,140,92.5,148.6,86.8,99.5,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(99.5)]",0,"ENSG00000112305"
"330","POU3F2",0.279034941556037,6.44204951056651,3.48450027140713,0.00625773902889199,0.0309473639247022,-2.72972229671962,"NONE",FALSE,"High","Master Protein","P20265","POU domain, class 3, transcription factor 2 [OS=Homo sapiens]",0,33.283,11,2,3,5,2,443,46.9,7.87,20.37,2,"cell cycle OR cell proliferation;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf00157","5454","hsa:5454; P20265; Q14960; Q86V54; Q9UJL0","ENSG00000184486","EGR2 and SOX10-mediated initiation of Schwann cell myelination","MECP2 and associated Rett syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways",3,0,151.1,146,138.3,59.8,51.3,59.2,83.2,73.8,84.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S341(99.6)]",0,"ENSG00000184486"
"331","EGLN1",-0.338512357784904,6.64796078535514,-3.48189904522724,0.00628438415909976,0.0309852415336882,-2.73405979037233,"NONE",FALSE,"High","Master Protein","Q9GZT9","Egl nine homolog 1 [OS=Homo sapiens]",0,12.052,4,1,1,2,1,426,46,8.53,8.23,1,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf01753, Pf13640","54583","hsa:54583; Q8N3M8; Q9BZS8; Q9BZT0; Q9GZT9","ENSG00000135766","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Photodynamic therapy-induced HIF-1 survival signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Type 2 papillary renal cell carcinoma; Markers of kidney cell lineage",5,0,87.1,83.4,76,122.5,140.3,115.2,104.3,100.9,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(100)]",0,"ENSG00000135766"
"332","NFIX",-0.354293749639714,6.65983638089999,-3.47629856571196,0.00634215259747823,0.0310471464836082,-2.74339998215826,"NONE",FALSE,"High","Master Protein","Q14938","Nuclear factor 1 X-type [OS=Homo sapiens]",0,38.595,10,3,3,7,3,502,55.1,8.68,14.26,3,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4784","B4DM25; hsa:4784; O60413; Q0VG09; Q12859; Q13050; Q13052; Q14938; Q5U094; Q9UPH1; Q9Y6R8","ENSG00000008441","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination","Oxidative stress response",3,0,93.8,93.9,96.5,114.2,103.7,130.6,96.9,101.8,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(99.6); S301(100)]",0,"ENSG00000008441"
"333","PRKAR1A",-0.271085575686808,6.63163412495967,-3.47555582147189,0.00634985528733608,0.0310471464836082,-2.74463884603057,"NONE",FALSE,"High","Master Protein","P10644","cAMP-dependent protein kinase type I-alpha regulatory subunit [OS=Homo sapiens]",0,24.327,5,2,2,3,2,381,43,5.35,12.33,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5573","hsa:5573; K7ER48; P10644; Q567S7","ENSG00000108946","FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase","Mesodermal commitment pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways",27,0,102.5,113.1,117.1,106.6,98,101.4,91.2,91.2,85.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100)]",0,"ENSG00000108946"
"334","PYGO2",-0.285096433911844,6.62905516633744,-3.47515543154637,0.00635401159652276,0.0310471464836082,-2.74530669317941,"NONE",FALSE,"High","Master Protein","Q9BRQ0","Pygopus homolog 2 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,406,41.2,7.28,9.25,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","nucleus","enzyme regulator activity;other molecular function","Pf00628","90780","hsa:90780; Q8WYZ4; Q96CY2; Q9BRQ0","ENSG00000163348","Deactivation of the beta-catenin transactivating complex; Formation of the beta-catenin:TCF transactivating complex","1q21.1 copy number variation syndrome",3,0,99,84.9,92.8,106,121.4,114.7,97.7,93.7,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T302(100)]",0,"ENSG00000163348"
"335","NELFE",0.466131963625095,6.64089568328065,3.46849135197062,0.00642360577438139,0.0312424003588697,-2.75642384110867,"NONE",FALSE,"High","Master Protein","P18615","Negative elongation factor E [OS=Homo sapiens]",0,27.593,12,5,5,8,5,380,43.2,9.33,24,5,"other biological processes","plasma membrane;other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","7936","A2BE08; B4DUN1; B4DYX9; hsa:7936; P18615; Q5JP74; Q5JP75; Q96F56; Q9NPK2","ENSG00000204356; ENSG00000206268; ENSG00000206357; ENSG00000229363; ENSG00000231044; ENSG00000233801","Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes","Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation",16,0,82.3,76,71.1,91.7,117,86.4,113.7,134.9,153.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); T91(100); S115(100); S251(100)]",0,"ENSG00000204356"
"336","PPFIA1",-0.346570349733748,6.62555091049904,-3.46481441078628,0.00646234335745216,0.0312424003588697,-2.76255900349957,"NONE",FALSE,"High","Master Protein","Q13136","Liprin-alpha-1 [OS=Homo sapiens]",0,36.286,3,2,4,7,2,1202,135.7,6.29,24.52,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","cytosol;other cell component",NA,"Pf00536, Pf07647","8500","A6NLE3; hsa:8500; Q13135; Q13136; Q14567; Q8N4I2","ENSG00000131626; ENSG00000288198","Glutamate Neurotransmitter Release Cycle; Serotonin Neurotransmitter Release Cycle; Norepinephrine Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle; Acetylcholine Neurotransmitter Release Cycle; Receptor-type tyrosine-protein phosphatases","Cell lineage map for neuronal differentiation",7,0,86.5,91.8,101.8,101.3,110.5,129,90.7,95.4,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S693(97.5)]",0,"ENSG00000131626"
"337","KCNIP3",-0.454973407817181,6.63175652977725,-3.46350654900733,0.00647618049165337,0.0312424003588697,-2.76474144420077,"NONE",FALSE,"High","Master Protein","Q9Y2W7","Calsenilin [OS=Homo sapiens]",0,10.16,7,1,1,2,1,256,29.2,5.4,6.89,1,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus","transporter activity;nucleic acid binding activity;other molecular function","Pf13499, Pf13833","30818","H7BY46; hsa:30818; Q3YAC3; Q3YAC4; Q53TJ5; Q96T40; Q9UJ84; Q9UJ85; Q9Y2W7","ENSG00000115041","Regulation of NPAS4 gene transcription; Phase 1 - inactivation of fast Na+ channels","Thyroid stimulating hormone (TSH) signaling pathway",3,0,71,78.4,76.3,120.4,177.9,122,111.8,98.2,87.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000115041"
"338","BMP2K",-0.310496081528033,6.64763644499644,-3.46294896159393,0.00648208910362459,0.0312424003588697,-2.76567192826088,"NONE",FALSE,"High","Master Protein","Q9NSY1","BMP-2-inducible protein kinase [OS=Homo sapiens]",0,40.701,7,4,5,10,4,1161,129.1,6.51,18.72,4,"other metabolic processes;other biological processes","nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf15282","55589","hsa:55589; O94791; Q4W5H2; Q8IYF2; Q8N2G7; Q8NHG9; Q9NSY1; Q9NTG8","ENSG00000138756",NA,NA,0,0,94,95.7,88.9,120.8,111.6,112.1,102.1,95.3,90.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S949(100); T1014(100); S1029(100)]",0,"ENSG00000138756"
"339","MCOLN1",-0.25199445255233,6.53654453653442,-3.4622324723909,0.00648968978042698,0.0312424003588697,-2.76686761140585,"NONE",FALSE,"High","Master Protein","Q9GZU1","Mucolipin-1 [OS=Homo sapiens]",0,11.767,3,1,1,1,1,580,65,7.24,4.1,1,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf08016, Pf21381","57192","D6W647; hsa:57192; Q7Z4F7; Q9GZU1; Q9H292; Q9H4B3; Q9H4B5","ENSG00000090674","Transferrin endocytosis and recycling; TRP channels","Iron metabolism in placenta",3,0,117.9,129,114.8,85.7,81.9,94.7,81.4,78.4,81.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(100)]",0,"ENSG00000090674"
"340","SYNPO",-0.292713281865214,6.61241067175809,-3.45762531185586,0.00653878525200355,0.0313777797479241,-2.77455685159622,"NONE",FALSE,"High","Master Protein","Q8N3V7-2","Isoform 2 of Synaptopodin [OS=Homo sapiens]",0,125.655,20,10,11,23,10,903,96.3,9.77,76.28,10,NA,NA,NA,NA,NA,"Q8N3V7-2",NA,NA,NA,0,0,62,65.7,65.4,127.9,148.3,125.7,115.5,111,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); S281(100); S441(100); S510(100); S589(100); S610(100); S646(98.8); S738(99.3); S784(100); S854(99.3)]",0,"ENSG00000171992"
"341","NADK",0.528891895930217,6.59900866550804,3.45599375698199,0.00655626402821208,0.0313777797479241,-2.77728019654351,"NONE",FALSE,"High","Master Protein","O95544","NAD kinase [OS=Homo sapiens]",0,10.552,3,1,1,1,1,446,49.2,6.47,3.67,1,"other metabolic processes;other biological processes","cytosol","kinase activity;other molecular function","Pf01513, Pf20143","65220","A6NNN3; A8K296; B7Z434; F5GXR5; hsa:65220; O95544; Q5QPS4; Q9H2P2; Q9H931","ENSG00000008130","Nicotinate metabolism","NAD+ metabolism; 1p36 copy number variation syndrome",3,0,56.3,60.5,60.7,85.8,95.1,130.4,122,167.3,162.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100)]",0,"ENSG00000008130"
"342","FLCN",-0.357485279167115,6.61741943142917,-3.4529319041981,0.00658919663656883,0.0314431839499425,-2.78239140178373,"NONE",FALSE,"High","Master Protein","Q8NFG4","Folliculin [OS=Homo sapiens]",0,30.401,3,1,1,3,1,579,64.4,6.23,17.66,1,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf11704, Pf16692","201163","A6NJJ8; hsa:201163; Q6ZRX1; Q8NFG4; Q96BD2; Q96BE4","ENSG00000154803","Amino acids regulate mTORC1","Ciliopathies; Bardet-Biedl syndrome; Smith-Magenis and Potocki-Lupski syndrome copy number variation",4,0,94.4,102.8,114.9,107.3,120.8,98.6,82.4,90.2,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100)]",0,"ENSG00000154803"
"343","IRF3",0.910998935511248,6.58441363891334,3.44303208908866,0.0066968575027692,0.0318637651443712,-2.79892129838976,"NONE",FALSE,"High","Master Protein","Q14653","Interferon regulatory factor 3 [OS=Homo sapiens]",0,4.247,5,1,1,1,1,427,47.2,5.34,2.52,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00605, Pf10401","3661","A8K7L2; B2RAZ3; hsa:3661; Q14653; Q5FBY1; Q5FBY2; Q5FBY4; Q7Z5G6","ENSG00000126456","ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; Interferon gamma signaling; Interferon alpha/beta signaling; Negative regulators of DDX58/IFIH1 signaling; TICAM1-dependent activation of IRF3/IRF7; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; IRF3 mediated activation of type 1 IFN","Apoptosis; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; Novel intracellular components of RIG-I-like receptor pathway; Fibrin complement receptor 3 signaling pathway; White fat cell differentiation; Ebola virus infection in host; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; STING pathway in Kawasaki-like disease and COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Lung pathology of COVID-19; Urotensin-II-mediated signaling pathway; Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ; Toll-like receptor signaling pathway",38,0,92.8,51.9,66.3,76.6,45.2,124.6,137.4,170.3,155,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(99)]",0,"ENSG00000126456"
"344","TWF1",-0.433046725796577,6.67149382792631,-3.43479569990059,0.00678781989069234,0.0321814086853405,-2.81267828678847,"NONE",FALSE,"High","Master Protein","Q12792","Twinfilin-1 [OS=Homo sapiens]",0,22.984,5,1,2,3,1,350,40.3,6.96,6.9,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00241","5756","A8K5A8; B3KXS6; B4DLX9; hsa:5756; Q12792; Q59G07; Q5U0B1; Q6FHJ1; Q6FHL6; Q6NUK9; Q86XL6; Q8TCD3","ENSG00000151239","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHOBTB2 GTPase cycle",NA,3,0,92.5,77.3,89,136.1,121.9,120.7,101.3,87,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S143(99.4)]",0,"ENSG00000151239"
"345","PALM2AKAP2",0.283753275702491,6.65217626567299,3.43342739947294,0.00680305514487897,0.0321814086853405,-2.81496411143893,"NONE",FALSE,"High","Master Protein","Q9Y2D5","PALM2-AKAP2 fusion protein [OS=Homo sapiens]",0,53.463,5,3,3,7,3,1103,122,5.06,30.34,3,NA,"plasma membrane;other membranes",NA,"Pf03285, Pf15304","445815","A9Z1X9; B1ALX9; B2RTU4; B3KQ00; B4DTZ2; B7ZW07; B9EJB5; hsa:445815; Q8IXS6; Q8N9D5; Q96DU1; Q9UG26; Q9Y2D5","ENSG00000157654",NA,NA,0,0,79.7,81.9,86.9,93.3,109.2,99.3,118.1,115.3,129.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S696(100); S951(100)]",0,"ENSG00000157654"
"346","DAB2IP",-0.225995693654846,6.60609989049171,-3.42574745252151,0.00688922815309677,0.0324948564909073,-2.82779596514123,"NONE",FALSE,"High","Master Protein","Q5VWQ8","Disabled homolog 2-interacting protein [OS=Homo sapiens]",0,14.885,2,3,3,4,3,1189,131.5,8.72,8.67,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00168, Pf00616, Pf12004","153090","A6H8V2; A6NHI9; B0QZB1; G3XA90; hsa:153090; Q5VWQ8; Q8TDL2; Q96SE1; Q9C0C0","ENSG00000136848","Regulation of RAS by GAPs","Ebola virus infection in host",2,0,111.2,117.5,109.7,97.8,92.2,101,87.9,89.8,85.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S702(99.6); S747(100); S978(100)]",0,"ENSG00000136848"
"347","ATP2B1",-0.393201380094089,6.6304754016106,-3.42145506346399,0.00693788369707404,0.0326300466675067,-2.83496930864877,"NONE",FALSE,"High","Master Protein","P20020","Plasma membrane calcium-transporting ATPase 1 [OS=Homo sapiens]",0,79.67,8,5,8,12,2,1220,134.6,5.91,38.05,5,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","490","hsa:490; P20020; Q12992; Q12993; Q13819; Q13820; Q13821; Q16504; Q93082","ENSG00000070961","Sensory processing of sound by inner hair cells of the cochlea; Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D receptor pathway; Splicing factor NOVA regulated synaptic proteins; Vitamin D-sensitive calcium signaling in depression; Calcium regulation in cardiac cells",8,3,74.8,76.1,84.9,112.9,117.2,147.9,94.4,98.5,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1127(99.7); S1155(100); S1178(99); S1182(100); S1211(98.9)]",0,"ENSG00000070961"
"348","EDC3",-0.417447781555575,6.62123616552676,-3.41724012147323,0.0069860083661533,0.0327411370442154,-2.84201426497514,"NONE",FALSE,"High","Master Protein","Q96F86","Enhancer of mRNA-decapping protein 3 [OS=Homo sapiens]",0,14.937,3,1,1,2,1,508,56,7.11,9.49,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf03853, Pf09532, Pf12701, Pf16598","80153","B3KPH0; D3DW61; hsa:80153; Q96F86; Q9H797","ENSG00000179151","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,88.8,91.8,100.8,107.1,141.4,109.9,98.3,80,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(100)]",0,"ENSG00000179151"
"349","SPTAN1",-0.356956038596747,6.65950286070266,-3.41587857017117,0.00700162795859752,0.0327411370442154,-2.84429021360409,"NONE",FALSE,"High","Master Protein","Q13813","Spectrin alpha chain, non-erythrocytic 1 [OS=Homo sapiens]",0,166.924,7,13,17,27,13,2472,284.4,5.35,83.27,13,"cell organization and biogenesis","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00018, Pf00435, Pf08726, Pf13499","6709","hsa:6709; Q13186; Q13813; Q15324; Q16606; Q59EF1; Q5VXV5; Q5VXV6; Q7Z6M5; Q9P0V0","ENSG00000197694","Neutrophil degranulation; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Interaction between L1 and Ankyrins; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Caspase-mediated cleavage of cytoskeletal proteins","Fas ligand pathway and stress induction of heat shock proteins",12,0,81.3,82.5,85.2,120.8,113.5,136.9,109,99.6,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1031(100); S1186(99.3); S1190(100); S1217(100); S1323(100)]",0,"ENSG00000197694"
"350","CRTC3",-0.346955719171789,6.63641065697608,-3.41392339973269,0.0070241208840045,0.0327524722362724,-2.84755863280932,"NONE",FALSE,"High","Master Protein","Q6UUV7","CREB-regulated transcription coactivator 3 [OS=Homo sapiens]",0,65.523,16,5,6,9,5,619,66.9,6.84,32.3,5,"cell organization and biogenesis;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf12884, Pf12885, Pf12886","64784","hsa:64784; Q6DK61; Q6DK62; Q6UUV7; Q8NF38; Q9H6U2","ENSG00000140577","Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis",NA,3,0,95.1,111.7,105,101.8,101.2,124.4,82.7,94.6,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S329(100); S370(99.5); T412(98.8)]",0,"ENSG00000140577"
"351","ERBIN",-0.273380875054917,6.66068708986004,-3.40843393007033,0.00708767506341324,0.0329087684399185,-2.85673643218007,"NONE",FALSE,"High","Master Protein","Q96RT1","Erbin [OS=Homo sapiens]",0,112.694,9,9,12,22,9,1412,158.2,5.5,54.4,9,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","extracellular matrix;plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity","Pf00595, Pf13855","55914","A0AVR1; B4E3F1; B7ZLV9; E7EQW9; E9PCR8; hsa:55914; Q1RMD0; Q86W38; Q96RT1; Q9NR18; Q9NW48; Q9ULJ5","ENSG00000112851","Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants; RHOG GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle","Nucleotide-binding oligomerization domain (NOD) pathway; Nod-like receptor (NLR) signaling pathway; Pathways affected in adenoid cystic carcinoma",26,0,76.7,75,74.2,128.9,129.1,125.1,106.7,113.6,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S852(99); S872(100); S1015(100); S1079(99.3); S1179(100)]",0,"ENSG00000112851"
"352","SYNM",-0.401301053013567,6.6343641684786,-3.40637989385,0.00711160867704476,0.0329087684399185,-2.86017099630747,"NONE",FALSE,"High","Master Protein","O15061","Synemin [OS=Homo sapiens]",0,242.4,13,14,21,62,14,1565,172.8,5.15,221.07,14,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00038","23336","A7E2Y2; hsa:23336; O15061; Q2TBJ4; Q5NJJ9; Q8TE61; Q8TE62","ENSG00000182253",NA,NA,0,0,74.5,72.7,72.4,131.1,142.4,123.6,117.7,98.3,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S566(100); S592(100); T598(100); S653(100); S777(100); S1049(100); T1094(100); S1163(99.3); S1432(100); S1540(100)]",0,"ENSG00000182253"
"353","AMPD2",0.420931360505052,6.63008257511647,3.40582108966585,0.00711813435005591,0.0329087684399185,-2.86110541654656,"NONE",FALSE,"High","Master Protein","Q01433","AMP deaminase 2 [OS=Homo sapiens]",0,41.668,5,4,4,10,4,825,94.8,6.55,33.92,4,"other metabolic processes;other biological processes","cytosol","other molecular function","Pf19326","271","A0A5F9UK94; B4DK50; B4DZI5; E9PNG0; hsa:271; Q01433; Q14856; Q14857; Q16686; Q16687; Q16688; Q16729; Q5T693; Q5T695; Q96IA1; Q9UDX8; Q9UDX9; Q9UMU4","ENSG00000116337","Purine salvage",NA,1,0,69.2,68.2,64.9,103.3,120.3,92.1,119.4,131.5,166.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S46(100); S114(100)]",0,"ENSG00000116337"
"354","HNRNPM",0.506879814995985,6.63691018323932,3.38307381436589,0.00738911477354666,0.0340650714983846,-2.89915751043879,"NONE",FALSE,"High","Master Protein","P52272","Heterogeneous nuclear ribonucleoprotein M [OS=Homo sapiens]",0,30.974,4,2,3,4,2,730,77.5,8.7,8.92,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf11532","4670","hsa:4670; P52272; Q15584; Q8WZ44; Q96H56; Q9BWL9; Q9Y492","ENSG00000099783","mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",4,0,89.8,94.6,92,78.4,100.8,78.4,99.1,140.6,133.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S618(100)]",0,"ENSG00000099783"
"355","TNKS1BP1",0.283205859623383,6.64912451449148,3.37367482446839,0.00750418274435454,0.034498102081089,-2.91488842719318,"NONE",FALSE,"High","Master Protein","Q9C0C2","182 kDa tankyrase-1-binding protein [OS=Homo sapiens]",0,229.802,15,18,22,40,18,1729,181.7,4.86,127.28,18,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf15327","85456","A7E2F8; hsa:85456; Q6PJ35; Q6ZV74; Q9C0C2","ENSG00000149115","Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors","Ciliary landscape",4,0,74.6,78.5,80.6,99.9,115.7,96.3,119.1,123.9,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S221(100); T239(100); S429(100); S494(100); S601(100); S672(100); S691(100); S872(100); S893(100); S1138(100); S1158(100); S1473(100); S1620(99.5); S1652(100); S1666(100)]",0,"ENSG00000149115"
"356","IRF2BP2",0.294692077031771,6.64402461848659,3.36300102667604,0.00763711151157888,0.0350105786148785,-2.93275850610089,"NONE",FALSE,"High","Master Protein","Q7Z5L9","Interferon regulatory factor 2-binding protein 2 [OS=Homo sapiens]",0,44.289,12,4,4,6,4,587,61,8.69,22.36,4,"other biological processes","nucleus;other cell component","other molecular function","Pf11261","359948","B1AM35; B1AM36; hsa:359948; Q6P083; Q7Z5L8; Q7Z5L9; Q8N351; Q8WUH8","ENSG00000168264",NA,NA,0,0,83.1,85.5,88.4,95.5,107.1,90.1,120.5,114.3,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(100); S240(100); S360(100)]",0,"ENSG00000168264"
"357","PRIMPOL",0.523919678535472,6.63170722900861,3.35751175066273,0.00770642073628331,0.0352015739788093,-2.94195089830873,"NONE",FALSE,"High","Master Protein","Q96LW4","DNA-directed primase/polymerase protein [OS=Homo sapiens]",0,6.029,3,1,1,2,1,560,64.4,5.3,5.77,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","mitochondrion;nucleus;other cell component","other molecular function","Pf01896, Pf03121","201973","A0A0A0MTC0; D3DP55; D6RDM1; hsa:201973; Q5HYJ9; Q96LW4","ENSG00000164306",NA,NA,0,0,82.5,84.8,79.1,101.8,55.4,109.5,127.8,119,137.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S255(100)]",0,"ENSG00000164306"
"358","TOMM70",-0.275933121292337,6.63166381631113,-3.35477408959799,0.00774123032663365,0.0352015739788093,-2.94653597045892,"NONE",FALSE,"High","Master Protein","O94826","Mitochondrial import receptor subunit TOM70 [OS=Homo sapiens]",0,36.564,4,1,2,6,1,608,67.4,7.12,23.77,1,"cell organization and biogenesis;transport;other biological processes","other membranes;mitochondrion","transporter activity;other molecular function","Pf00515, Pf13181","9868","D3DN48; hsa:9868; O94826","ENSG00000154174","Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Mitochondrial protein import; DDX58/IFIH1-mediated induction of interferon-alpha/beta; SARS-CoV-1 activates/modulates innate immune responses; PINK1-PRKN Mediated Mitophagy","Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",9,0,87.5,85.2,93.7,108.9,113,122,92.9,94.4,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S91(100)]",0,"ENSG00000154174"
"359","SCARF2",0.266137512442578,6.65778763952902,3.35459732488202,0.0077434834916621,0.0352015739788093,-2.94683203112342,"NONE",FALSE,"High","Master Protein","Q96GP6","Scavenger receptor class F member 2 [OS=Homo sapiens]",0,109.837,7,7,7,13,7,871,92.3,8.32,50.24,7,"cell adhesion;transport","other membranes","other molecular function",NA,"91179","E5RFB8; hsa:91179; Q58A83; Q8IXF3; Q96GP6; Q9BW74","ENSG00000244486",NA,"22q11.2 copy number variation syndrome",1,0,86.5,86.4,87.7,92.8,92,108.4,108.3,122.1,124.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S483(100); S653(100); S687(100); S698(99.4); S742(100)]",0,"ENSG00000244486"
"360","PHGDH",-0.264415840495492,6.63335589805086,-3.35119567189022,0.0077869757959229,0.0352162574054012,-2.95252970888902,"NONE",FALSE,"High","Master Protein","O43175","D-3-phosphoglycerate dehydrogenase [OS=Homo sapiens]",0,103.423,18,7,7,8,7,533,56.6,6.71,27.44,7,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","cytosol","other molecular function","Pf00389, Pf02826, Pf19304","26227","B2RD08; hsa:26227; O43175; Q5SZU3; Q9BQ01","ENSG00000092621","Serine biosynthesis","Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",5,0,103.6,93.9,99.1,102.9,106.2,117.5,88.4,94.3,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000092621"
"361","VDAC1",0.320549600595816,6.4143655626607,3.35096995481811,0.00778987066381729,0.0352162574054012,-2.95290779894669,"NONE",FALSE,"High","Master Protein","P21796","Voltage-dependent anion-selective channel protein 1 [OS=Homo sapiens]",0,118.315,31,8,10,21,7,283,30.8,8.54,71.68,8,"cell-cell signaling;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;mitochondrion;other cell component","transporter activity;other molecular function","Pf01459","7416","B3KVK4; D3DQ93; P21796; Q5FVE7; Q9UIQ5; Q9UPL0","ENSG00000213585","Ub-specific processing proteases; Pyruvate metabolism; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy; Mitochondrial calcium ion transport","Alzheimer's disease and miRNA effects; Alzheimer's disease; Arsenic metabolism and reactive oxygen species generation; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes",10,1,160.8,141.2,141.7,56.9,39.4,59.7,85.9,71.8,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S104(100)]",0,"ENSG00000213585"
"362","SNTA1",-0.541844184884022,6.60916450887673,-3.34350778619385,0.00788620430168421,0.0355141899875015,-2.9654087796842,"NONE",FALSE,"High","Master Protein","Q13424","Alpha-1-syntrophin [OS=Homo sapiens]",0,15.148,4,1,1,2,1,505,53.9,6.8,8.49,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6640","A8K7H9; B4DX40; E1P5N1; hsa:6640; Q13424; Q16438","ENSG00000101400",NA,"13q12.12 copy number variation; Sudden infant death syndrome (SIDS) susceptibility pathways",2,0,91.3,86.9,98.5,96,114.6,156.6,84.2,83,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000101400"
"363","SRSF6",-0.2333531707576,6.35616979316684,-3.34250097315668,0.00789929593472,0.0355141899875015,-2.96709564529554,"NONE",FALSE,"High","Master Protein","Q13247","Serine/arginine-rich splicing factor 6 [OS=Homo sapiens]",0,51.706,8,6,9,46,5,344,39.6,11.43,114.78,6,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","6431","B7Z6J3; E1P5W6; hsa:6431; Q13244; Q13245; Q13247; Q96J06; Q9UJB8; Q9Y3N7","ENSG00000124193","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,165.1,153.4,152.6,61.9,54.8,61.2,61.4,62.8,64.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100); S303(100); S314(100); S316(100)]",0,"ENSG00000124193"
"364","HMGA1",0.27627447686804,6.64680854739539,3.32480362942495,0.00813312290045234,0.0364649905866434,-2.99675440608634,"NONE",FALSE,"High","Master Protein","P17096","High mobility group protein HMG-I/HMG-Y [OS=Homo sapiens]",0,12.326,26,2,2,3,2,107,11.7,10.32,4.89,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function",NA,"3159","hsa:3159; P10910; P17096; Q5T6U9; Q9UKB0","ENSG00000137309","Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Adipogenesis; Pre-implantation embryo; Male infertility; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Orexin receptor pathway",13,0,102.4,90.6,88.9,97.1,91.3,89.7,114,113.6,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T53(100)]",0,"ENSG00000137309"
"365","DHX57",-0.293895898151432,6.65017743020559,-3.32162170482411,0.00817591780875416,0.0365564325037994,-3.00208847259103,"NONE",FALSE,"High","Master Protein","Q6P158","Putative ATP-dependent RNA helicase DHX57 [OS=Homo sapiens]",0,31.689,2,2,2,4,2,1386,155.5,7.71,12.45,2,NA,NA,"other molecular function","Pf00270, Pf00271, Pf04408, Pf05773, Pf07717, Pf18044, Pf21010","90957","A2RRC7; hsa:90957; Q53SI4; Q6P158; Q6P9G1; Q7Z6H3; Q8NG17; Q96M33","ENSG00000163214",NA,NA,0,0,77.7,72.9,78.5,129.1,126.9,122.5,95.6,111.7,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(100); S132(100)]",0,"ENSG00000163214"
"366","ARFGAP1",-0.351693928805138,6.641051342801,-3.3184671043719,0.00821857511294862,0.036639093263792,-3.00737717932533,"NONE",FALSE,"High","Master Protein","Q8N6T3","ADP-ribosylation factor GTPase-activating protein 1 [OS=Homo sapiens]",0,11.333,3,1,1,2,1,406,44.6,5.66,7.72,1,"transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf01412","55738","B7Z3U0; B7Z8H8; B7ZBI3; E1P5I9; E7EV62; hsa:55738; Q6PK71; Q8N6T3; Q96KC4; Q96T02; Q9NSU3; Q9NVF6; Q9UIL0","ENSG00000101199","COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic; Clathrin-mediated endocytosis; XBP1(S) activates chaperone genes","IL-18 signaling pathway",5,0,95.6,103.7,98.9,112.3,91.3,127.4,93.4,95.9,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T189(100)]",0,"ENSG00000101199"
"367","MSANTD2",-0.300578846770251,6.63249039568095,-3.31694012511446,0.00823930589939441,0.036639093263792,-3.00993732726374,"NONE",FALSE,"High","Master Protein","Q6P1R3","Myb/SANT-like DNA-binding domain-containing protein 2 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,559,61.3,6.19,11.22,1,NA,NA,NA,"Pf13837","79684","B3KRY6; hsa:79684; Q6P1R3; Q9H042; Q9H5K8","ENSG00000120458",NA,NA,0,0,86,90.9,94.5,105,135.6,111.8,94.5,93,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100)]",0,"ENSG00000120458"
"368","FKBP15",-0.564340775796163,6.62017926274698,-3.3152198571897,0.00826272561175681,0.0366433918434432,-3.01282166741781,"NONE",FALSE,"High","Master Protein","Q5T1M5","FK506-binding protein 15 [OS=Homo sapiens]",0,85.256,8,5,6,11,5,1219,133.5,5.2,44.68,5,"transport","other membranes;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00254","23307","hsa:23307; Q05DK8; Q5T1M2; Q5T1M5; Q6DD85; Q9Y4D0","ENSG00000119321",NA,"TYROBP causal network in microglia",1,0,76.9,69.5,81.3,142.2,170,107,96,108.9,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S311(100); S956(100); S1114(100); S1164(100)]",0,"ENSG00000119321"
"369","RPRD2",-0.269811014344499,6.64239354722932,-3.30013459201854,0.00847106714007709,0.0374655327170889,-3.03812029428543,"NONE",FALSE,"High","Master Protein","Q5VT52","Regulation of nuclear pre-mRNA domain-containing protein 2 [OS=Homo sapiens]",0,63.658,7,5,5,7,5,1461,155.9,7.42,25.27,5,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf04818","23248","A8K6N8; B3KPT1; B4E2Q6; hsa:23248; O75048; Q5VT51; Q5VT52; Q5VT53; Q6MZL4; Q86XD2; Q9P0D7","ENSG00000163125","RNA polymerase II transcribes snRNA genes",NA,1,0,87.8,88.5,91.4,103.6,118.5,125.2,99.9,94.6,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S593(100); S614(100); T723(100); T732(100); S769(97.2)]",0,"ENSG00000163125"
"370","PSMD2",0.248494498487824,6.63501999996044,3.29492823845499,0.00854422552525679,0.0375937250797845,-3.04685378548101,"NONE",FALSE,"High","Master Protein","Q13200","26S proteasome non-ATPase regulatory subunit 2 [OS=Homo sapiens]",0,60.801,3,2,2,5,2,908,100.1,5.2,24.68,2,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","enzyme regulator activity","Pf01851, Pf17781, Pf18051","5708","B4DX07; B4DXY1; E7EW34; E9PCS3; hsa:5708; Q12932; Q13200; Q15321; Q53XQ4; Q96I12","ENSG00000175166","Neutrophil degranulation; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",65,0,100.8,105.1,100.5,91.9,84.4,86.6,104.6,102.6,115.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000175166"
"371","SH3GL1",0.55111386838511,6.61424215314029,3.29479384894625,0.00854612255183827,0.0375937250797845,-3.04707923427662,"NONE",FALSE,"High","Master Protein","Q99961","Endophilin-A2 [OS=Homo sapiens]",0.003,2.39,2,1,2,3,1,368,41.5,5.43,6.76,1,"cell organization and biogenesis;transport;developmental processes;signal transduction","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf03114","6455","B4DRA1; E7EVZ4; hsa:6455; M0QZV5; Q99668; Q99961","ENSG00000141985","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell","Fragile X syndrome",6,0,65.2,72.5,61.4,84.6,120.4,99.1,111.8,164.6,171.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(99.3)]",0,"ENSG00000141985"
"372","SYMPK",-0.267074323948085,6.62348668554914,-3.29160597960133,0.00859124994373128,0.037690644914434,-3.05242734643519,"NONE",FALSE,"High","Master Protein","Q92797","Symplekin [OS=Homo sapiens]",0,40.615,5,3,3,4,3,1274,141.1,6.13,14.63,3,"cell adhesion;RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf11935, Pf12295","8189","hsa:8189; O00521; O00689; O00733; Q59GT5; Q8N2U5; Q92797","ENSG00000125755","Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs",NA,5,0,103.2,105,103.1,105,103.2,105.5,93.4,97,83,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S501(100); S1243(100); S1259(100)]",0,"ENSG00000125755"
"373","ATRX",-0.497281839855675,6.60568920520345,-3.28739690149356,0.00865121087015984,0.0378519467563026,-3.05948930968109,"NONE",FALSE,"High","Master Protein","P46100","Transcriptional regulator ATRX [OS=Homo sapiens]",0,89.36,5,8,10,12,8,2492,282.4,6.55,35.18,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf17981","546","D3DTE2; P46100; P51068; Q15886; Q59FB5; Q59H31; Q5H9A2; Q5JWI4; Q7Z2J1; Q9H0Z1; Q9NTS3","ENSG00000085224","Inhibition of DNA recombination at telomere; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations","Pathways affected in adenoid cystic carcinoma",4,0,102.4,95.6,102.4,123.5,79.5,127.6,83.1,95.8,77.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S598(100); S677(100); S1076(99.7); S1352(100)]",0,"ENSG00000085224"
"374","MAPK4",-0.342346089279968,6.61216528335739,-3.28180047375425,0.00873160550579531,0.0381015512980159,-3.06888004409595,"NONE",FALSE,"High","Master Protein","P31152","Mitogen-activated protein kinase 4 [OS=Homo sapiens]",0,4.09,2,1,1,1,1,587,65.9,5.45,2.71,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;signal transduction","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5596","A1A4C4; hsa:5596; P31152; Q0VG04","ENSG00000141639","MAPK6/MAPK4 signaling","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; B cell receptor signaling pathway; S1P receptor signal transduction; TGF-beta signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Splicing factor NOVA regulated synaptic proteins; EGF/EGFR signaling pathway; Osteoblast differentiation and related diseases; Insulin signaling; Regulation of actin cytoskeleton",13,0,117.2,116.4,130.7,92.4,103.7,101.6,90.1,85.3,74.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S434(100)]",0,"ENSG00000141639"
"375","ANKS1A",-0.282657688637518,6.66733088796979,-3.27537014448834,0.00882493258707437,0.0384061066189477,-3.07967155307064,"NONE",FALSE,"High","Master Protein","Q92625","Ankyrin repeat and SAM domain-containing protein 1A [OS=Homo sapiens]",0,31.494,4,3,3,6,3,1134,123,6.38,19.82,3,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding","Pf00023, Pf00536, Pf00640","23294","A2RUC1; B4DQW8; hsa:23294; Q5JYI9; Q5SYR2; Q86WQ7; Q92625","ENSG00000064999",NA,NA,0,0,79.8,80.6,89.2,124,130.9,117.2,104.8,108,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S626(99.3); S647(100)]",0,"ENSG00000064999"
"376","SAMD4B",-0.248144411164049,6.64642955217933,-3.27273844450278,0.00886342438563696,0.0384710335036157,-3.08408857878308,"NONE",FALSE,"High","Master Protein","Q5PRF9","Protein Smaug homolog 2 [OS=Homo sapiens]",0,31.646,8,2,2,5,2,694,75.4,6.83,24.79,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00536","55095","A5Z0M6; hsa:55095; Q5PRF9; Q6P194","ENSG00000179134",NA,NA,0,0,96,95,90.1,103.6,122.6,115.4,97.1,96.5,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100)]",0,"ENSG00000179134"
"377","MEIS1",0.315219040741729,6.65919940656264,3.26582761546181,0.00896533084982203,0.0387306120910234,-3.09568889055155,"NONE",FALSE,"High","Master Protein","O00470","Homeobox protein Meis1 [OS=Homo sapiens]",0,8.551,3,1,3,6,1,390,43,6.33,5.4,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920, Pf16493","4211","A8MV50; hsa:4211; O00470","ENSG00000143995","Activation of anterior HOX genes in hindbrain development during early embryogenesis","Mesodermal commitment pathway; Nephrogenesis",3,0,92.9,103.8,103.7,89.5,97,83.6,113,118.8,105.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100)]",0,"ENSG00000143995"
"378","SLC39A10",0.480851891977912,6.64104641090933,3.26483504102824,0.00898006626305444,0.0387306120910234,-3.09735514039633,"NONE",FALSE,"High","Master Protein","Q9ULF5","Zinc transporter ZIP10 [OS=Homo sapiens]",0,17.391,5,3,3,5,3,831,94.1,6.76,10.44,3,"transport;other biological processes","plasma membrane;other membranes","transporter activity","Pf02535","57181","A8K5C6; B4DGU0; hsa:57181; Q3MJA4; Q68CR5; Q6DKH6; Q9ULF5; Q9Y3Z1","ENSG00000196950","Zinc influx into cells by the SLC39 gene family","Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis",4,0,93.7,96.4,93.8,99.5,60.2,92.2,129.1,128,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T536(100); S546(100); S591(100)]",0,"ENSG00000196950"
"379","EDF1",0.567711770541181,6.52102896601649,3.26386943918987,0.00899442523437369,0.0387306120910234,-3.09897614521432,"NONE",FALSE,"High","Master Protein","O60869","Endothelial differentiation-related factor 1 [OS=Homo sapiens]",0.004,2.055,4,1,1,2,1,148,16.4,9.95,4.82,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01381, Pf08523","8721","hsa:8721; O60869; Q5T5T2; Q9UIM1","ENSG00000107223",NA,NA,0,0,45,49.3,49,93.6,125.7,102.7,114.9,209,166.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100)]",0,"ENSG00000107223"
"380","LRRC4C",-0.584798037535494,6.54972720947547,-3.24951926560743,0.00921063343882517,0.0395572467688491,-3.12307040427664,"NONE",FALSE,"High","Master Protein","Q9HCJ2","Leucine-rich repeat-containing protein 4C [OS=Homo sapiens]",0,3.857,2,1,1,1,1,640,71.9,7.15,2.53,1,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00560, Pf07679, Pf13855","57689","A8K0T1; hsa:57689; Q7L0N3; Q9HCJ2","ENSG00000148948",NA,NA,0,0,95.6,66.5,79.1,110.7,178.9,110.2,77.1,98.6,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S631(100)]",0,"ENSG00000148948"
"381","KRI1",0.257043653684651,6.66206969646436,3.24694425606708,0.00924999385013891,0.0396220209013824,-3.12739465475955,"NONE",FALSE,"High","Master Protein","Q8N9T8","Protein KRI1 homolog [OS=Homo sapiens]",0,30.401,7,2,2,7,2,703,82.5,5.14,32.85,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component",NA,"Pf05178, Pf12936","65095","hsa:65095; Q2M1R5; Q2M1R7; Q7L5J7; Q8N9T8; Q96G92; Q9BU50; Q9H6I1; Q9H978","ENSG00000129347",NA,NA,0,0,87,90.9,99.9,93.5,88.1,103,117.9,109.3,117.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); S628(99.3)]",0,"ENSG00000129347"
"382","TCOF1",0.218340503601792,6.64276101387624,3.23711976195943,0.00940176680309822,0.0401667105305139,-3.14389508885158,"NONE",FALSE,"High","Master Protein","Q13428","Treacle protein [OS=Homo sapiens]",0,102.622,8,9,10,13,9,1488,152,9.04,38.92,9,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf03546","6949","A0JLU0; B4E111; hsa:6949; Q13428; Q6SC72; Q7Z5W9; Q96A52; Q99408; Q99860","ENSG00000070814",NA,NA,0,0,93.3,98.2,94.7,93.5,93,93.6,109.3,107.8,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100); S381(100); S446(100); S906(100); S1111(99.5); S1228(99.6); S1350(100); S1378(100); S1471(100)]",0,"ENSG00000070814"
"383","H1-4",0.338241011582602,6.6181490923281,3.23427301945675,0.00944622250570163,0.040251266656149,-3.14867683378525,"NONE",FALSE,"High","Master Protein","P10412","Histone H1.4 [OS=Homo sapiens]",0,135.492,41,12,13,21,4,219,21.9,11.03,58.08,12,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3008","hsa:3008; P10412; Q4VB25","ENSG00000168298","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Pathways affected in adenoid cystic carcinoma",3,9,105.5,102.9,103.7,82.4,68.1,95.2,96,107.9,124.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S104(100); S113(100)]",0,"ENSG00000168298"
"384","NAV1",-0.235805429753159,6.66461408539942,-3.22669653092208,0.00956559828163533,0.0405694169465011,-3.16140448929546,"NONE",FALSE,"High","Master Protein","Q8NEY1","Neuron navigator 1 [OS=Homo sapiens]",0,207.258,13,16,18,31,16,1877,202.3,8.07,102.18,16,"cell organization and biogenesis;developmental processes","cytoskeleton;other cell component","other molecular function",NA,"89796","A8MS88; hsa:89796; Q5SVH1; Q5SVH2; Q5SVH3; Q5SVH7; Q5VUY9; Q8IVL2; Q8NEY1; Q96II1; Q9H7V9; Q9H9S9; Q9H9T5; Q9UGI1; Q9ULK7; Q9ULR9","ENSG00000134369",NA,NA,0,0,100.2,100.5,105.4,103.1,115.4,111.7,90.7,98.9,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S199(100); S377(100); S391(100); S507(100); S541(99.4); S672(100); S760(100); S808(100); S954(100); S1000(100); S1181(98.6); S1253(100)]",0,"ENSG00000134369"
"385","NOPCHAP1",0.347468239739396,6.64048921663233,3.22578069584949,0.00958013320604191,0.0405694169465011,-3.16294310961005,"NONE",FALSE,"High","Master Protein","Q8N5I9","NOP protein chaperone 1 [OS=Homo sapiens]",0,12.556,6,1,1,1,1,185,20.1,5.22,4.01,1,"cell organization and biogenesis","nucleus","other molecular function","Pf15370","121053","Q8N5I9","ENSG00000151131",NA,NA,0,0,72.2,70.5,67.3,97,129.5,98.5,130,129,135.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100)]",0,"ENSG00000151131"
"386","SRSF5",-0.333665640019394,6.19222229015463,-3.22481635268067,0.00959546258661116,0.0405694169465011,-3.16456325187331,"NONE",FALSE,"High","Master Protein","Q13243","Serine/arginine-rich splicing factor 5 [OS=Homo sapiens]",0,9.704,4,1,1,3,1,272,31.2,11.59,7.92,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf00076","6430","hsa:6430; O14797; Q13243; Q16662; Q49AD6; Q6FGE0","ENSG00000100650","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway","mRNA processing",6,0,179.1,167.6,160.8,49.1,45.7,47.5,59.1,49,53.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000100650"
"387","KCNH7",-0.589544361274497,6.60970990465837,-3.2192976421696,0.00968367653331731,0.0408365894118188,-3.17383548154555,"NONE",FALSE,"High","Master Protein","Q9NS40","Potassium voltage-gated channel subfamily H member 7 [OS=Homo sapiens]",0,7.363,3,2,3,4,2,1196,134.9,7.65,2.12,2,"transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf00027, Pf00520, Pf13426","90134","hsa:90134; Q53QU4; Q53TB7; Q53TP9; Q8IV15; Q9NS40","ENSG00000184611","Voltage gated Potassium channels",NA,1,0,95.4,87.3,111.4,119.7,94.4,135.4,67.7,91.6,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1104(98.5)]",0,"ENSG00000184611"
"388","RALGPS1",-0.356603613334887,6.63905044464662,-3.21752141640031,0.00971224603925102,0.0408515091135507,-3.17681998771858,"NONE",FALSE,"High","Master Protein","Q5JS13","Ras-specific guanine nucleotide-releasing factor RalGPS1 [OS=Homo sapiens]",0,10.459,3,1,1,1,1,557,62.1,9.11,3.5,1,"signal transduction;other biological processes","plasma membrane;other membranes;other cell component","enzyme regulator activity","Pf00169, Pf00617","9649","B4DR86; E9PBQ5; hsa:9649; O15059; Q5JS13; Q5JT60; Q5JT65; Q5JUG5; Q8N4S6; Q8N5H4; Q8WUV7; Q9NZ16","ENSG00000136828",NA,NA,0,0,101.5,98.6,85.1,115.1,130,105,92.4,87.1,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000136828"
"389","CEP170",0.25910106432199,6.69400549947551,3.20328933099114,0.00994431823050085,0.0417201217279624,-3.20073669518101,"NONE",FALSE,"High","Master Protein","Q5SW79","Centrosomal protein of 170 kDa [OS=Homo sapiens]",0,101.734,9,10,12,21,10,1584,175.2,7.11,61.19,10,NA,"cytosol;cytoskeleton;other cell component",NA,"Pf00498, Pf15308","9859","hsa:9859; O75058; Q5SW77; Q5SW78; Q5SW79; Q7LGA9; Q86W31; Q9UQ08; Q9UQ09","ENSG00000143702; ENSG00000276725",NA,"Ciliary landscape",1,0,82.8,86.5,81.5,108.2,96.4,105.7,119.4,132.6,117.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S359(100); S446(100); S667(100); S838(99); S881(100); S1112(100); S1165(100)]",0,"ENSG00000143702"
"390","GTF3C1",-0.305542633613665,6.4839518097892,-3.19853277689938,0.0100231467329673,0.0419430140210326,-3.20873120806234,"NONE",FALSE,"High","Master Protein","Q12789","General transcription factor 3C polypeptide 1 [OS=Homo sapiens]",0,48.618,4,5,5,8,5,2109,238.7,7.3,28.37,5,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04182","2975","B2RP21; hsa:2975; Q12789; Q12838; Q6DKN9; Q9Y4W9","ENSG00000077235","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,132.6,124.7,122.8,77.9,93.9,77.2,74.8,74.5,74,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S667(100); S739(100); S1068(100); S1856(98.9)]",0,"ENSG00000077235"
"391","GLIPR2",-0.405567887750617,6.64083294761141,-3.19297561720519,0.010116058647316,0.0422235491366232,-3.21807206946097,"NONE",FALSE,"High","Master Protein","Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 [OS=Homo sapiens]",0,3.195,6,1,1,2,1,154,17.2,9.41,4.46,1,"other biological processes","non-structural extracellular;other membranes;ER/Golgi","other molecular function","Pf00188","152007","hsa:152007; Q5VZR1; Q8N2S6; Q8WWC9; Q8WX36; Q9H4G4","ENSG00000122694",NA,NA,0,0,75.1,77.8,94.4,114.6,121.1,139.5,95.5,89,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(100)]",0,"ENSG00000122694"
"392","MCM6",-0.317632180774075,6.14713940397995,-3.18773700965175,0.010204456264757,0.0424838587349068,-3.22687819434759,"NONE",FALSE,"High","Master Protein","Q14566","DNA replication licensing factor MCM6 [OS=Homo sapiens]",0,11.186,2,1,1,2,1,821,92.8,5.41,7.11,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00493, Pf14551, Pf17207, Pf17855, Pf18263","4175","B2R6H2; hsa:4175; Q13504; Q14566; Q99859","ENSG00000076003","Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA","Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication",11,0,178.7,175.2,167.2,44.6,36.4,46.8,51.4,55.6,49.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S762(100)]",0,"ENSG00000076003"
"393","DNAJC5",-0.92143175029324,6.50508046273747,-3.1787795329734,0.0103574528392862,0.0429755922790046,-3.24193728053032,"NONE",FALSE,"High","Master Protein","Q9H3Z4","DnaJ homolog subfamily C member 5 [OS=Homo sapiens]",0,40.478,9,1,5,21,1,198,22.1,5.07,52.38,1,"cell-cell signaling;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00226","80331","A8K0M0; B3KY68; E1P5G8; hsa:80331; Q9H3Z4; Q9H3Z5; Q9H7H2","ENSG00000101152","Sensory processing of sound by inner hair cells of the cochlea; Neutrophil degranulation; GABA synthesis, release, reuptake and degradation",NA,3,0,52.8,67.1,109.1,115.7,115.8,218.9,65,84.4,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(99.5)]",0,"ENSG00000101152"
"394","SGPP1",0.28694425850126,6.65358660252178,3.17626732262051,0.0104007844686961,0.0429755922790046,-3.24616107810498,"NONE",FALSE,"High","Master Protein","Q9BX95","Sphingosine-1-phosphate phosphatase 1 [OS=Homo sapiens]",0,23.038,3,1,1,3,1,441,49.1,8.82,12.28,1,"other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf01569","81537","B2RAH0; hsa:81537; Q9BX95; Q9H189","ENSG00000126821; ENSG00000285281","Sphingolipid catabolism","Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Biosynthesis and turnover of 1-deoxy-sphingoid bases",4,0,91.6,108.1,100.3,88.4,84.5,94.8,116.5,102.2,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(100)]",0,"ENSG00000126821"
"395","FARP1",-0.307077251244659,6.64642365254352,-3.17520262832055,0.0104192049624558,0.0429755922790046,-3.24795119899574,"NONE",FALSE,"High","Master Protein","Q9Y4F1","FERM, ARHGEF and pleckstrin domain-containing protein 1 [OS=Homo sapiens]",0,187.075,12,7,11,38,7,1045,118.6,8.15,167.53,7,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00169, Pf00373, Pf00621, Pf08736, Pf09379, Pf09380","10160","hsa:10160; Q5JVI9; Q6IQ29; Q9Y4F1","ENSG00000152767","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOF GTPase cycle",NA,4,0,85,86.5,91.8,114.1,104.9,131.4,91.6,105.2,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.6); S403(100); S427(100); S510(100); S872(99.6); S889(100)]",0,"ENSG00000152767"
"396","CDK13",-0.288501149901757,6.59693025010501,-3.17470067074205,0.0104279010676997,0.0429755922790046,-3.24879517272665,"NONE",FALSE,"High","Master Protein","Q14004","Cyclin-dependent kinase 13 [OS=Homo sapiens]",0,52.607,6,7,7,9,6,1512,164.8,9.69,22.9,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00069","8621","hsa:8621; Q14004; Q53G78; Q6DKQ9; Q75MH4; Q75MH5; Q96JN4; Q9H4A0; Q9H4A1; Q9UDR4","ENSG00000065883","Neutrophil degranulation; TP53 Regulates Transcription of DNA Repair Genes",NA,2,1,110,103.8,104.3,101.3,86.5,114.7,89.2,93.6,81.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); S360(100); S400(100); S525(100); T871(100); T1246(100)]",0,"ENSG00000065883"
"397","CXCR4",-0.30421354398755,6.64259703500007,-3.17167019269672,0.0104805610251133,0.0430838176145715,-3.25389062860807,"NONE",FALSE,"High","Master Protein","P61073","C-X-C chemokine receptor type 4 [OS=Homo sapiens]",0,22.003,9,2,4,6,2,352,39.7,8.21,11.79,2,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00001, Pf12109","7852","B2R5N0; hsa:7852; O60835; P30991; P56438; P61073; Q53S69; Q9BXA0; Q9UKN2","ENSG00000121966","G alpha (i) signalling events; Chemokine receptors bind chemokines; Signaling by ROBO receptors; Formation of definitive endoderm; Specification of primordial germ cells; Binding and entry of HIV virion","Peptide GPCRs; Cardiac progenitor differentiation; Hematopoietic stem cell differentiation; Amplification and expansion of oncogenic pathways as metastatic traits; Chemokine signaling pathway; Acute viral myocarditis; Neovascularization processes; Selective expression of chemokine receptors during T-cell polarization; GPCRs, class A rhodopsin-like; Genes controlling nephrogenesis; CCL18 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; 2q37 copy number variation syndrome; Cell interactions of the pancreatic cancer microenvironment; TAR syndrome; 5q35 copy number variation; IL-19 signaling pathway",23,0,84.3,87.9,92.7,106.4,109.3,133.8,93.9,99.5,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T318(99.7)]",0,"ENSG00000121966"
"398","IRS2",0.27188206852782,6.659031176795,3.15966157362953,0.0106919351270779,0.0438423068527415,-3.27408386053891,"NONE",FALSE,"High","Master Protein","Q9Y4H2","Insulin receptor substrate 2 [OS=Homo sapiens]",0,122.605,11,12,13,28,12,1338,137.2,8.65,75.89,12,"cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00169, Pf02174","8660","hsa:8660; Q96RR2; Q9BZG0; Q9Y4H2; Q9Y6I5","ENSG00000185950","Growth hormone receptor signaling; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; Erythropoietin activates Phosphoinositide-3-kinase (PI3K); RAF/MAP kinase cascade; PI3K Cascade; Interleukin-7 signaling; PI3K/AKT activation; Signaling by Leptin; Erythropoietin activates Phospholipase C gamma (PLCG); Erythropoietin activates STAT5; Erythropoietin activates RAS; SOS-mediated signalling; IRS activation; Signal attenuation","Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Adipogenesis; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Farnesoid X receptor pathway; Nuclear receptors meta-pathway; Transcription factor regulation in adipogenesis; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; IL-4 signaling pathway; Nonalcoholic fatty liver disease; Insulin signaling; FOXA2 pathway; Alzheimer's disease; EPO receptor signaling; Interferon type I signaling pathways",38,0,93.6,88.5,95.8,97.2,99.1,89.8,120,109.6,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T350(100); T520(99.6); S560(100); S577(100); S608(100); S620(99.6); S805(99.6); S915(100); S1100(100); S1203(99.3)]",0,"ENSG00000185950"
"399","MAP4",-0.300233866644469,6.68575587494744,-3.15331200423469,0.0108054654850675,0.0441967911569677,-3.284762209191,"NONE",FALSE,"High","Master Protein","P27816","Microtubule-associated protein 4 [OS=Homo sapiens]",0,279.764,21,21,33,142,21,1152,120.9,5.43,402.78,21,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00418","4134","P27816; Q13082; Q59FT2; Q68D74; Q6ZUW9; Q86V26; Q96A76; Q96NS9","ENSG00000047849",NA,"Splicing factor NOVA regulated synaptic proteins; 2q37 copy number variation syndrome",2,0,71.4,78.5,78.5,136.6,129.5,124.7,105.4,115.8,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100); S358(100); S384(100); T451(100); S507(100); T521(100); S696(100); S740(100); S787(98.9); S801(99.4); S825(100); S868(99.6); S941(99.7); S1073(100)]",0,"ENSG00000047849"
"400","SUN2",0.410885978091502,6.61893103020986,3.15002987985198,0.0108646348123803,0.0443277100345117,-3.29028219601435,"NONE",FALSE,"High","Master Protein","Q9UH99","SUN domain-containing protein 2 [OS=Homo sapiens]",0,11.745,4,1,1,1,1,717,80.3,6.73,3.89,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf07738, Pf18580","25777","B0QY62; hsa:25777; O75156; Q2NKN8; Q2T9F7; Q504T5; Q6B4H1; Q7Z3E3; Q9UH99","ENSG00000100242","Meiotic synapsis",NA,1,0,100.6,125.9,93.4,88.7,60.2,89.6,103.1,121,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100)]",0,"ENSG00000100242"
"401","KANK1",0.221040392277722,6.66861321222378,3.14409359600858,0.01097249959091,0.0446561579360727,-3.30026652329401,"NONE",FALSE,"High","Master Protein","Q14678","KN motif and ankyrin repeat domain-containing protein 1 [OS=Homo sapiens]",0,29.108,2,2,2,4,2,1352,147.2,5.3,16.47,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00023, Pf12075","23189","A2A2W8; D3DRH3; hsa:23189; Q14678; Q5W0W0; Q8IY65; Q8WX74","ENSG00000107104","Estrogen-dependent gene expression; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB","VEGFA-VEGFR2 signaling",3,0,93.2,87.7,93.6,94.3,99.1,101.9,109.5,114.5,121.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); S881(99.4)]",0,"ENSG00000107104"
"402","ADGRG1",-0.269361602345534,6.65437637464516,-3.14121948237286,0.0110251180610259,0.0447586882477468,-3.30510075558578,"NONE",FALSE,"High","Master Protein","Q9Y653","Adhesion G-protein coupled receptor G1 [OS=Homo sapiens]",0,59.309,3,4,8,16,4,693,77.7,8.48,45.54,4,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf01825, Pf18587, Pf18619","9289","A6NIT7; A6NJV9; B0M0K4; B4DR54; hsa:9289; O95966; Q6ZMP1; Q8NGB3; Q96HB4; Q9Y653","ENSG00000205336",NA,"GPCRs, other",1,0,71.4,71.3,68.6,128.2,120.8,139.1,105.7,115.4,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S678(100)]",0,"ENSG00000205336"
"403","ARL3",-0.881805956878765,6.20071613947052,-3.13702698061788,0.0111023383535924,0.0449603379480467,-3.31215274649026,"NONE",FALSE,"High","Master Protein","P36405","ADP-ribosylation factor-like protein 3 [OS=Homo sapiens]",0,5.344,4,1,1,3,1,182,20.4,7.24,7.49,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00025","403","B2R6C7; hsa:403; P36405; Q53X83; Q5JSM2","ENSG00000138175","Trafficking of myristoylated proteins to the cilium","Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome",5,0,7.3,13.6,10.7,206.6,183.3,222.2,76.5,184.7,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S5(100)]",0,"ENSG00000138175"
"404","TFE3",-0.273069425954527,6.66700679998515,-3.13010532176122,0.011231043553924,0.0453689680198116,-3.32379590972429,"NONE",FALSE,"High","Master Protein","P19532","Transcription factor E3 [OS=Homo sapiens]",0,25.406,3,1,2,4,1,575,61.5,5.58,16.25,1,"cell organization and biogenesis;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00010, Pf11851, Pf15951","7030","A8MZL6; hsa:7030; P19532; Q5JU74; Q92757; Q92758; Q99964","ENSG00000068323; ENSG00000292217",NA,"MET in type 1 papillary renal cell carcinoma; Type 2 papillary renal cell carcinoma; TGF-beta receptor signaling in skeletal dysplasias; Autophagy in pancreatic ductal adenocarcinoma; TGF-beta receptor signaling",5,0,76.3,77.1,83.8,128.2,136,116.9,106.3,109.9,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S556(100)]",0,"ENSG00000068323"
"405","ARHGAP5",-0.257933244163655,6.67018080224737,-3.11777690909666,0.0114640915234614,0.0461960428797261,-3.34453564673616,"NONE",FALSE,"High","Master Protein","Q13017","Rho GTPase-activating protein 5 [OS=Homo sapiens]",0,51.302,3,3,5,6,3,1502,172.4,6.62,24.06,3,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf01846, Pf16512, Pf19518","394","A1L375; A1L376; A8KAA1; D3DS89; D3DS90; hsa:394; Q05BE8; Q05BU8; Q13017; Q59ER0; Q6DHZ3","ENSG00000100852","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOC GTPase cycle; RND2 GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle","Focal adhesion",15,0,90.4,97.5,91.4,118.9,108.4,117.9,93.7,106.3,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1176(100); S1202(100); S1218(99.5)]",0,"ENSG00000100852"
"406","ESF1",0.280710435748539,6.57208705164908,3.11408995072389,0.0115347468725309,0.0462856628701899,-3.35073849177347,"NONE",FALSE,"High","Master Protein","Q9H501","ESF1 homolog [OS=Homo sapiens]",0,15.073,2,1,1,1,1,851,98.7,5.11,4.33,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf08159","51575","hsa:51575; Q86X92; Q9H501; Q9H9Q5; Q9HA35; Q9NX93; Q9P1S6","ENSG00000089048",NA,NA,0,0,126.7,115.4,126.5,78.5,68.5,69.5,96,89.1,103.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(100)]",0,"ENSG00000089048"
"407","DPYSL2",-0.449261917685655,6.59374182879845,-3.11247687353125,0.0115657995558042,0.0462856628701899,-3.35345234249075,"NONE",FALSE,"High","Master Protein","Q16555","Dihydropyrimidinase-related protein 2 [OS=Homo sapiens]",0,279.019,36,18,30,71,15,572,62.3,6.38,225.7,18,"cell organization and biogenesis;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton","other molecular function","Pf01979","1808","A8K5H2; B4DR31; D3DSS7; hsa:1808; O00424; Q16555","ENSG00000092964","Recycling pathway of L1; CRMPs in Sema3A signaling","Microtubule cytoskeleton regulation; Brain-derived neurotrophic factor (BDNF) signaling pathway",4,3,62.2,64.7,64.4,138.4,195.1,108.4,100.3,105.9,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T509(100); T514(99.8); S518(99.2); S522(100); S542(100); T569(100)]",0,"ENSG00000092964"
"408","MFHAS1",-0.396372275217634,6.65810858043898,-3.11015610900143,0.0116106261494553,0.0462856628701899,-3.35735686267801,"NONE",FALSE,"High","Master Protein","Q9Y4C4","Malignant fibrous histiocytoma-amplified sequence 1 [OS=Homo sapiens]",0,27.034,2,1,1,2,1,1052,116.9,7.88,8.05,1,"stress response;signal transduction;other biological processes","other cell component","other molecular function","Pf13855","9258","hsa:9258; Q96CI0; Q9Y4C4","ENSG00000147324",NA,"8p23.1 copy number variation syndrome",1,0,85.5,82.4,95.2,123.3,113.3,128.7,101.4,108.8,81.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1038(100)]",0,"ENSG00000147324"
"409","ARHGAP17",-0.334054608796881,6.56542688194634,-3.10934809284577,0.0116262751313905,0.0462856628701899,-3.35871630608289,"NONE",FALSE,"High","Master Protein","Q68EM7","Rho GTPase-activating protein 17 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,881,95.4,7.62,9.95,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf03114","55114","A8K6M6; hsa:55114; Q68EM7; Q6ZUS4; Q7Z2F2; Q8NDG2; Q96KS2; Q96KS3; Q96SS8; Q9BVF6; Q9H8U5; Q9NW54","ENSG00000140750; ENSG00000288353","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle",NA,6,0,103.4,117.5,115.9,89.5,98.9,103.9,78.4,93.8,76.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S676(99.3)]",0,"ENSG00000140750"
"410","AHNAK2",-0.661130393024938,6.52744162320602,-3.10925196247286,0.0116281383436139,0.0462856628701899,-3.35887804070249,"NONE",FALSE,"High","Master Protein","Q8IVF2","Protein AHNAK2 [OS=Homo sapiens]",0,30.408,4,3,4,8,3,5795,616.2,5.36,20.86,3,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,NA,"113146","hsa:113146; Q5BKX7; Q7Z343; Q7Z358; Q7Z394; Q7Z3G0; Q86WQ6; Q8IVF2; Q8IYY1; Q8N3G4; Q96EX9","ENSG00000185567",NA,NA,0,0,50.5,41.3,55.6,142.4,162.8,180.6,127.3,112.3,74.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S294(100); S842(100); S1007(100); S1337(100); S1502(100); S1667(100); S1832(100); S1997(100); S2162(100); S2492(100); S2822(100); S2987(100); S3152(100); S3482(100); S3812(100); S3977(100); S4142(100); S4307(100)]",0,"ENSG00000185567"
"411","RBM15B",-0.477588347812855,6.59813464833212,-3.10578972847132,0.0116954483886665,0.0464403206090117,-3.36470314475342,"NONE",FALSE,"High","Master Protein","Q8NDT2","Putative RNA-binding protein 15B [OS=Homo sapiens]",0,25.909,4,4,4,12,4,890,97.1,9.85,10.57,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf07744","29890","A4QPG7; hsa:29890; Q6QE19; Q8NDT2; Q9BV96","ENSG00000259956",NA,NA,0,0,109.6,101.8,99.4,107.5,82.5,134.9,87,93.9,72.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(99.5); S609(99.7)]",0,"ENSG00000259956"
"412","URI1",0.604628866710412,6.43398482450922,3.07521130662857,0.012307553299783,0.048752249964189,-3.41615492285562,"NONE",FALSE,"High","Master Protein","O94763","Unconventional prefoldin RPB5 interactor 1 [OS=Homo sapiens]",0,26.88,5,2,2,3,2,535,59.8,5.05,13.06,2,"other biological processes","cytosol;mitochondrion;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf02996","8725","A8K805; H7BY42; hsa:8725; O94763; Q8TC23; Q9UNU3","ENSG00000105176",NA,NA,0,0,33.2,32.5,52.5,95.4,143,99.9,144.2,163.5,183.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(99.3)]",0,"ENSG00000105176"
"413","SH3BP5L",-0.352753523969637,6.65996209697835,-3.06247325890147,0.0125721320506025,0.0496797082483857,-3.43758979752182,"NONE",FALSE,"High","Master Protein","Q7L8J4","SH3 domain-binding protein 5-like [OS=Homo sapiens]",0,25.172,18,4,4,4,4,393,43.5,5.77,9.55,4,"signal transduction","other cell component","enzyme regulator activity","Pf05276","80851","B4DQ94; hsa:80851; Q7L8J4; Q96FI5; Q9BQH8; Q9C0E3","ENSG00000175137",NA,NA,0,0,65.8,89.8,85.2,123,133.5,127.4,94.4,103.9,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S350(100); S362(100)]",0,"ENSG00000175137"
"414","SCAF11",0.348405980656805,6.64201111806384,3.05588411173813,0.0127112715298568,0.0500528109468991,-3.44867782641677,"NONE",FALSE,"High","Master Protein","Q99590","Protein SCAF11 [OS=Homo sapiens]",0,20.389,2,2,2,2,2,1463,164.6,8.41,7.99,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf13639","9169","A6NEU9; A6NLW5; hsa:9169; Q8IW59; Q99590","ENSG00000139218",NA,"Apoptosis",1,0,97.4,94.8,113.1,88.6,93.7,76,118.8,104.8,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S608(100); S902(100)]",0,"ENSG00000139218"
"415","ADGRB3",0.825817098377549,6.58105997033022,3.05404247667193,0.0127504414362117,0.0500528109468991,-3.45177688927351,"NONE",FALSE,"High","Master Protein","O60242","Adhesion G protein-coupled receptor B3 [OS=Homo sapiens]",0,10.927,2,1,1,1,1,1522,171.4,7.06,4.21,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","enzyme regulator activity;other molecular function","Pf00002, Pf00090, Pf01825, Pf02793, Pf16489, Pf19188","577","B7Z1K0; hsa:577; O60242; O60297; Q2NKN6; Q5VY37; Q9BX54","ENSG00000135298",NA,NA,0,0,150,165.5,89.8,45.7,63,62.3,140.8,86.6,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1220(100)]",0,"ENSG00000135298"
"416","PHACTR2",-0.388843936624662,6.67296134768356,-3.05310854838131,0.0127703524220407,0.0500528109468991,-3.45334848443255,"NONE",FALSE,"High","Master Protein","O75167","Phosphatase and actin regulator 2 [OS=Homo sapiens]",0,15.033,5,2,2,2,2,634,69.7,8.16,3.67,2,"cell organization and biogenesis","plasma membrane;other membranes","enzyme regulator activity;cytoskeletal activity","Pf02755","9749","A6NKP5; A7MCZ5; A8MZC0; B2RWP7; B4DN76; B4DPB5; B4DTH7; hsa:9749; O75167; Q5TFA0; Q68DM2","ENSG00000112419","Platelet degranulation",NA,1,0,74.3,84.9,83.1,140.7,108.2,130.7,108.7,97.7,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T25(99.5); S237(99.1)]",0,"ENSG00000112419"
"417","ARHGEF11",-0.241377713767647,6.64918181705846,-3.05222450151083,0.0127892292676819,0.0500528109468991,-3.45483614075731,"NONE",FALSE,"High","Master Protein","O15085","Rho guanine nucleotide exchange factor 11 [OS=Homo sapiens]",0,18.524,2,2,2,2,2,1522,167.6,5.5,5.66,2,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity","Pf00595, Pf00621, Pf09128, Pf17838","9826","D3DVD0; hsa:9826; O15085; Q5VY40; Q6PFW2","ENSG00000132694","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle; Sema4D induced cell migration and growth-cone collapse",NA,8,0,94.7,90.6,85.2,117,115.1,111.4,95,102.6,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T668(100); S1480(99.3)]",0,"ENSG00000132694"
"418","ABI2",-0.205651642394007,6.65400220347838,-3.0487123736278,0.0128645053642003,0.0502269683119017,-3.46074628211586,"NONE",FALSE,"High","Master Protein","Q9NYB9","Abl interactor 2 [OS=Homo sapiens]",0,58.658,14,5,8,39,5,513,55.6,6.16,52.68,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00018, Pf07815","10152","B4DSN1; hsa:10152; Q13147; Q13249; Q13801; Q9BV70; Q9NYB9","ENSG00000138443","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway","Regulation of actin cytoskeleton",8,0,86.1,88.8,90.8,109.1,122.7,115.5,101.8,98.8,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S196(100); S216(100); S227(100); T361(100)]",0,"ENSG00000138443"
"419","GFPT1",0.411428030327769,6.69909159286246,3.04580656000835,0.012927128796975,0.0503510124025376,-3.46563612895251,"NONE",FALSE,"High","Master Protein","Q06210","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 [OS=Homo sapiens]",0,21.463,2,1,1,5,1,699,78.8,7.11,18.57,1,"protein metabolism;other metabolic processes;other biological processes","cytosol","other molecular function","Pf01380, Pf13522","2673","hsa:2673; Q06210; Q53QE6; Q9BXF8","ENSG00000198380","XBP1(S) activates chaperone genes; Synthesis of UDP-N-acetyl-glucosamine; Defective GFPT1 causes CMSTA1","UDP-derived sugars synthesis in fibroblasts",4,0,82.6,80.1,78.3,114,70.4,115.4,118.8,144.4,142.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S261(100)]",0,"ENSG00000198380"
"420","SH3KBP1",0.561312075490686,6.57498909178288,3.03542747737014,0.0131533664966746,0.0511102241013641,-3.48310177194171,"NONE",FALSE,"High","Master Protein","Q96B97","SH3 domain-containing kinase-binding protein 1 [OS=Homo sapiens]",0,9.927,4,2,2,2,2,665,73.1,6.62,4.51,2,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf14604","30011","B7Z1D5; hsa:30011; Q5JPT4; Q5JPT5; Q8IWX6; Q8IX98; Q96B97; Q96RN4; Q9NYR0","ENSG00000147010","Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Reelin signalling pathway","EGF/EGFR signaling pathway",9,0,102.2,119.3,112.6,65.9,78.9,61.7,105.2,87.4,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(99.5); S230(100)]",0,"ENSG00000147010"
"421","PBXIP1",0.288514354161429,6.62930826290699,3.03063574278237,0.0132591762759808,0.0513989921197164,-3.49116509357603,"NONE",FALSE,"High","Master Protein","Q96AQ6","Pre-B-cell leukemia transcription factor-interacting protein 1 [OS=Homo sapiens]",0,28.122,3,3,4,4,3,731,80.6,5.33,12.79,3,"cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"57326","hsa:57326; Q5T174; Q5T176; Q96AQ6; Q9H8X6; Q9HA02; Q9HD85","ENSG00000163346",NA,"VEGFA-VEGFR2 signaling",1,0,75.7,90.7,93.4,95.1,88.9,98,109.9,110.4,131.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(100); S551(99.4)]",0,"ENSG00000163346"
"422","SRRM2",-0.19101787367625,6.58066971009979,-3.01706588400138,0.013563567707198,0.0524543661093533,-3.51399935418384,"NONE",FALSE,"High","Master Protein","Q9UQ35","Serine/arginine repetitive matrix protein 2 [OS=Homo sapiens]",0,1249.598,37,112,196,571,112,2752,299.4,12.06,1330.17,112,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf08312","23524","A6NKB9; D3DU97; hsa:23524; O15038; O94803; Q6NSL3; Q6PIM3; Q6PK40; Q8IW17; Q96GY7; Q9P0G1; Q9UHA8; Q9UQ35; Q9UQ36; Q9UQ37; Q9UQ38; Q9UQ40","ENSG00000167978","mRNA Splicing - Major Pathway",NA,1,0,119.1,112.5,113.7,93.3,89.4,93.7,85.6,86.4,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(100); S222(100); T252(100); S295(100); S297(100); S323(99.3); S333(100); S351(100); S353(100); S377(100); S398(99.2); S404(100); S440(98.2); S456(99.7); S486(100); S510(100); S746(99.7); S774(100); S780(100); S783(100); S790(100); T792(100); S819(99.3); S820(99.7); T848(100); T866(100); S876(99.7); T903(99.1); S908(100); S914(100); S954(100); S972(99); S974(98.6); T983(100); S994(100); T1003(100); S1014(100); T1043(99.5); S1083(100); S1103(99.6); S1110(99.5); S1112(98.8); S1124(100); S1132(100); S1179(100); T1208(100); S1219(99.7); S1320(100); S1329(100); S1401(98.4); S1404(99.4); T1413(99.4); S1421(99.4); T1434(100); S1443(99.5); T1472(100); S1482(99.6); T1492(100); S1499(100); T1511(100); S1519(100); T1531(100); S1542(99.3); S1552(100); S1601(99.7); S1616(99.7); S1620(99.2); S1672(99.6); S1675(99.7); S1691(99.2); S1694(100); S1727(99.6); S1731(100); S1762(100); S1764(100); S1854(99.8); S1857(99.7); T1880(100); S1925(100); T1927(100); S1948(100); T1950(100); S1960(100); T1962(100); S1975(100); S2020(100); T2022(100); S2032(100); T2034(100); S2044(100); S2046(100); S2067(100); S2071(100); S2102(99); T2104(100); S2132(100); S2272(100); S2310(100); S2382(99.4); T2409(99.7); S2426(100); S2449(100); S2581(100); S2688(100); S2694(100); S2702(100)]",0,"ENSG00000167978"
"423","POLDIP2",0.365737592419122,6.26766258068973,3.01543436210281,0.0136006428314358,0.0524734021297947,-3.51674468121331,"NONE",FALSE,"High","Master Protein","Q9Y2S7","Polymerase delta-interacting protein 2 [OS=Homo sapiens]",0,9.85,3,1,1,2,1,368,42,8.63,6.65,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytoskeleton;mitochondrion;nucleus;other cell component","nucleic acid binding activity","Pf04379, Pf08755","26073","B2R846; hsa:26073; Q96JE4; Q9Y2S7","ENSG00000004142",NA,NA,0,0,184,150.8,138.6,41.8,29.3,49.6,72.4,62.6,71.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T292(100)]",0,"ENSG00000004142"
"424","DCTN4",0.607777895017352,6.61337632135996,3.00529758677075,0.0138333246618913,0.0531672751668065,-3.53380120192402,"NONE",FALSE,"High","Master Protein","Q9UJW0","Dynactin subunit 4 [OS=Homo sapiens]",0,4.623,3,1,1,1,1,460,52.3,7.34,2.26,1,NA,"cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf05502","51164","B3KWW0; D3DQH0; E5RGT5; hsa:51164; Q8TAN8; Q9UJW0","ENSG00000132912","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; MHC class II antigen presentation; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic","Vasopressin-regulated water reabsorption",5,0,91,106.9,64.2,86.9,59.4,102.2,111,140.8,135.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100)]",0,"ENSG00000132912"
"425","SLC12A7",0.319909028367005,6.45665713714136,3.00476573448795,0.0138456445746892,0.0531672751668065,-3.5346960946803,"NONE",FALSE,"High","Master Protein","Q9Y666","Solute carrier family 12 member 7 [OS=Homo sapiens]",0,11.812,2,1,1,1,1,1083,119,6.71,3.3,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","10723","A6NDS8; hsa:10723; Q4G0F3; Q96I81; Q9H7I3; Q9H7I7; Q9UFW2; Q9Y666","ENSG00000113504","Cation-coupled Chloride cotransporters",NA,1,0,146.7,144.2,138.7,68.1,46,58.3,91.2,75.7,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T30(100)]",0,"ENSG00000113504"
"426","ZCRB1",-0.349148590061119,6.54068157645302,-3.00096449522357,0.013934023882314,0.0533810492392873,-3.54109197484852,"NONE",FALSE,"High","Master Protein","Q8TBF4","Zinc finger CCHC-type and RNA-binding motif-containing protein 1 [OS=Homo sapiens]",0,5.06,6,1,1,1,1,217,24.6,8.53,2.13,1,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","other molecular function","Pf00076, Pf00098","85437","hsa:85437; Q6PJX0; Q8TBF4; Q96TA6","ENSG00000139168","mRNA Splicing - Minor Pathway; Replication of the SARS-CoV-1 genome; Replication of the SARS-CoV-2 genome",NA,3,0,95.2,92.3,91,94,97,122.3,77.4,87.4,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100)]",0,"ENSG00000139168"
"427","MYRIP",-0.423924266457022,6.62756725065563,-2.99352990793841,0.0141085473825827,0.053815807398063,-3.55360085066477,"NONE",FALSE,"High","Master Protein","Q8NFW9","Rab effector MyRIP [OS=Homo sapiens]",0,9.832,2,1,1,1,1,859,95.6,5.6,3.44,1,"transport;other biological processes","cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf02318, Pf04698","25924","B3KWM3; B3KWW4; B7Z2H1; B7Z9V3; G3XAI8; hsa:25924; Q32M41; Q32M42; Q569F7; Q8IUF5; Q8NFW9; Q9Y3V4","ENSG00000170011","Insulin processing","Deregulation of Rab and Rab effector genes in bladder cancer",2,0,67.5,66.1,52.3,144.2,139.6,142.6,103.8,121.6,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000170011"
"428","TMEM192",0.572340820959508,6.3259464817936,2.99332202426249,0.0141134592931195,0.053815807398063,-3.55395061196277,"NONE",FALSE,"High","Master Protein","Q8IY95","Transmembrane protein 192 [OS=Homo sapiens]",0,11.727,4,1,1,2,1,271,30.9,7.99,5.9,1,NA,"other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf14802","201931","hsa:201931; Q7Z3A1; Q8IY95; Q8N928","ENSG00000170088",NA,NA,0,0,149.7,143.4,141.7,30.9,39.2,56.7,89.6,61.5,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(99.7)]",0,"ENSG00000170088"
"429","ICE1",-0.381769568696201,6.58481346329392,-2.98758742466652,0.0142496476220533,0.0542084496950839,-3.56359880481508,"NONE",FALSE,"High","Master Protein","Q9Y2F5","Little elongation complex subunit 1 [OS=Homo sapiens]",0,24.716,2,2,2,3,2,2266,247.7,5.48,7.03,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function",NA,"23379","hsa:23379; Q68DE1; Q6ZT40; Q7L587; Q7Z3A9; Q9NTH9; Q9Y2F5","ENSG00000164151","RNA polymerase II transcribes snRNA genes",NA,1,0,122.8,101.4,113.8,99.9,108.6,97.5,76.2,98.6,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S960(100); S1692(100)]",0,"ENSG00000164151"
"430","CLIP3",-0.33075154544154,6.6324802939572,-2.98175616401826,0.0143895067092626,0.0544920574911217,-3.57340922598056,"NONE",FALSE,"High","Master Protein","Q96DZ5","CAP-Gly domain-containing linker protein 3 [OS=Homo sapiens]",0,6.905,2,1,1,1,1,547,59.5,7.8,2.56,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf12796","25999","A8K0E4; hsa:25999; Q8WWL1; Q96C99; Q96DZ5; Q9UFT7","ENSG00000105270","Regulation of TNFR1 signaling",NA,1,0,114.1,91,104.7,105.6,98.7,121.2,98.5,90.8,82.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S402(100)]",0,"ENSG00000105270"
"431","SLC1A2",0.341676775718942,6.61580657115491,2.98169511069003,0.0143909784183048,0.0544920574911217,-3.57351193887128,"NONE",FALSE,"High","Master Protein","P43004","Excitatory amino acid transporter 2 [OS=Homo sapiens]",0,16.108,5,2,3,5,2,574,62.1,6.54,11.55,2,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00375","6506","B4DQE9; hsa:6506; P43004; Q14417; Q541G6; U3KQQ4","ENSG00000110436","Glutamate Neurotransmitter Release Cycle; Transport of inorganic cations/anions and amino acids/oligopeptides; Astrocytic Glutamate-Glutamine Uptake And Metabolism","Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Cell lineage map for neuronal differentiation",6,0,126.1,130.9,111.4,73.3,71.1,80.8,91.8,118.4,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100); S534(100)]",0,"ENSG00000110436"
"432","BRD8",0.211648703409806,6.62837716302498,2.97273221633944,0.0146087057756834,0.0551599019186586,-3.58859008857981,"NONE",FALSE,"High","Master Protein","Q9H0E9-2","Isoform 2 of Bromodomain-containing protein 8 [OS=Homo sapiens]",0,33.778,4,3,5,8,3,951,102.8,4.69,19.26,3,NA,NA,NA,NA,NA,"Q9H0E9-2",NA,NA,NA,0,0,110.5,112.4,117.3,81.1,77.5,91.8,100.9,99,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T264(100); S268(100); S460(100)]",0,"ENSG00000112983"
"433","UFL1",-0.567006871337996,6.57859380513772,-2.97166108691866,0.0146349494673892,0.0551599019186586,-3.59039195770785,"NONE",FALSE,"High","Master Protein","O94874","E3 UFM1-protein ligase 1 [OS=Homo sapiens]",0,30.289,2,1,2,16,1,794,89.5,6.79,27.72,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","other molecular function","Pf09743","23376","A0PJ53; B4DJ57; C0H5X5; hsa:23376; O94874; Q8N765; Q9NTQ0","ENSG00000014123","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,81.7,95.4,120.6,103.1,86.6,147.1,75.3,81.1,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S458(100)]",0,"ENSG00000014123"
"434","NECTIN2",-0.815862647636029,6.59109557575164,-2.96993023502789,0.0146774586164449,0.0551926554424841,-3.59330358484898,"NONE",FALSE,"High","Master Protein","Q92692","Nectin-2 [OS=Homo sapiens]",0,33.757,9,2,2,3,2,538,57.7,4.82,11.3,2,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf07686, Pf08205","5819","A8K5L5; hsa:5819; O75455; Q6IBI6; Q92692; Q96J29","ENSG00000130202","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Nectin/Necl  trans heterodimerization","Monoamine transport",4,0,54.7,87.2,81.1,157.2,85.5,196.2,98.3,88.3,77.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T410(100); S433(100)]",0,"ENSG00000130202"
"435","AGAP2",0.328692754649113,6.62050784007869,2.95400937715691,0.0150744213292932,0.0565550703664516,-3.62008325078371,"NONE",FALSE,"High","Master Protein","Q99490","Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 [OS=Homo sapiens]",0,21.973,3,2,2,2,2,1192,124.6,9.89,7.44,2,"cell organization and biogenesis;transport;other biological processes","cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf00071, Pf01412","116986","A8K9F7; hsa:116986; O00578; Q548E0; Q8IWU3; Q99490","ENSG00000135439","Netrin-1 signaling","Prolactin signaling pathway; Fragile X syndrome; Netrin-UNC5B signaling pathway; 15q25 copy number variation",5,0,67.3,64.4,80.8,97.2,105,109.9,110.5,137.2,144.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S638(100)]",0,"ENSG00000135439"
"436","ERC1",-0.280569324695373,6.64852877139849,-2.93641977167103,0.0155257261945702,0.0581146448383914,-3.64966432230692,"NONE",FALSE,"High","Master Protein","Q8IUD2","ELKS/Rab6-interacting/CAST family member 1 [OS=Homo sapiens]",0,28.653,3,3,4,15,3,1116,128,5.97,15.28,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf09457, Pf10174","23085","A2RU77; A7E295; D3DUP7; D3DUP8; hsa:23085; Q6NVK2; Q8IUD2; Q8IUD3; Q8IUD4; Q8IUD5; Q8NAS1; Q9NXN5; Q9UIK7; Q9UPS1","ENSG00000082805",NA,"Cell lineage map for neuronal differentiation",1,0,82.6,83.1,86.6,116.9,141.4,109.9,93.9,107,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S37(99.4)]",0,"ENSG00000082805"
"437","ANK2",-0.199346142880032,6.66308060178826,-2.93067990348568,0.0156759543545456,0.0585426945231542,-3.65931583341393,"NONE",FALSE,"High","Master Protein","Q01484","Ankyrin-2 [OS=Homo sapiens]",0,340.352,5,15,34,90,15,3957,433.4,5.14,342.48,15,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00023, Pf00531, Pf00791, Pf17809","287","hsa:287; Q01484; Q01485; Q08AC7; Q08AC8; Q7Z3L5","ENSG00000145362","Interaction between L1 and Ankyrins; COPI-mediated anterograde transport",NA,2,0,89,89.7,94.1,115.2,108.7,117.2,100.5,104.2,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100); S901(100); S1461(100); S1755(99.5); S3793(100); S3795(99.6); T3803(100); T3814(100); S3818(99.5); S3823(100); S3845(99.7); S3909(98.4); S3947(99.5)]",0,"ENSG00000145362"
"438","ZNF148",0.252778327309284,6.65777441717374,2.92169811973527,0.0159140064258801,0.0592323721148056,-3.67441702074237,"NONE",FALSE,"High","Master Protein","Q9UQR1","Zinc finger protein 148 [OS=Homo sapiens]",0,30.401,5,2,3,4,2,794,88.9,6.48,18.39,2,"stress response;other biological processes","ER/Golgi;nucleus","nucleic acid binding activity;other molecular function","Pf00096","7707","D3DN27; O00389; O43591; Q58EY5; Q6PJ98; Q9UQR1","ENSG00000163848",NA,NA,0,0,103.1,100.5,103.1,98,70.5,98.8,107.7,113.1,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S306(100); S412(100)]",0,"ENSG00000163848"
"439","MIA3",-0.582897776563658,6.61679880704448,-2.92097923995227,0.0159332177441175,0.0592323721148056,-3.67562559638395,"NONE",FALSE,"High","Master Protein","Q5JRA6","Transport and Golgi organization protein 1 homolog [OS=Homo sapiens]",0,28.846,3,2,2,4,2,1907,213.6,4.84,17.03,2,"cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf07653","375056","A8K2S0; A8MT05; A8MT13; B7Z430; hsa:375056; Q14083; Q3S4X3; Q5JRA5; Q5JRA6; Q5JRB0; Q5JRB1; Q5JRB2; Q6UVY8; Q86Y60; Q8N8M5; Q92580","ENSG00000154305","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo concentration in the ER","Type I collagen synthesis in the context of osteogenesis imperfecta",4,0,69.9,61.2,75,149.9,163.7,118.6,123.1,79.6,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100); S1906(100)]",0,"ENSG00000154305"
"440","RRM2",-0.7444031612841,6.58590569517412,-2.915085106334,0.0160916244910447,0.0596132046085859,-3.68553426997583,"NONE",FALSE,"High","Master Protein","P31350","Ribonucleoside-diphosphate reductase subunit M2 [OS=Homo sapiens]",0,7.902,5,1,1,1,1,389,44.8,5.38,2.96,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf00268","6241","B2R9B5; hsa:6241; J3KP43; P31350; Q5WRU7","ENSG00000171848","Transcriptional Regulation by E2F6; Interconversion of nucleotide di- and triphosphates; G1/S-Specific Transcription","Fluoropyrimidine activity; Retinoblastoma gene in cancer; Hepatitis C and hepatocellular carcinoma; Pyrimidine metabolism; Orexin receptor pathway",8,0,59.5,43.7,71.2,145,257.9,112.5,85.1,116.9,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(100)]",0,"ENSG00000171848"
"441","CD99",-0.520018434562502,6.56746996119232,-2.91210533455719,0.0161723153021759,0.0596132046085859,-3.69054323757623,"NONE",FALSE,"High","Master Protein","P14209","CD99 antigen [OS=Homo sapiens]",0,35.437,16,2,3,4,2,185,18.8,4.75,13.93,2,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf12301","4267","A6NIW1; hsa:4267; O00518; P14209; Q6ICV7","ENSG00000002586; ENSG00000292348","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Cell surface interactions at the vascular wall",NA,2,0,61.8,57.4,65.8,132.3,214.3,105.4,98.3,108.3,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S168(100); T181(100)]",0,"ENSG00000002586"
"442","TMEM132A",-0.525742538328397,6.56137077329372,-2.91195049773193,0.0161765194357883,0.0596132046085859,-3.69080351021074,"NONE",FALSE,"High","Master Protein","Q24JP5","Transmembrane protein 132A [OS=Homo sapiens]",0,28.839,3,3,3,3,2,1023,110,5.62,10.7,3,"other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf15705, Pf15706, Pf16070","54972","hsa:54972; Q24JP5; Q69YU7; Q86VZ8; Q86W97; Q9H8K3; Q9HCI9; Q9NWY0","ENSG00000006118","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,93,73.4,60.8,109.7,180.1,120.1,86,97.8,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S485(100); S529(100)]",0,"ENSG00000006118"
"443","PPP1R7",0.289955173441522,6.65738035986228,2.91175715606643,0.0161817706137277,0.0596132046085859,-3.69112850655539,"NONE",FALSE,"High","Master Protein","Q15435","Protein phosphatase 1 regulatory subunit 7 [OS=Homo sapiens]",0,13.179,4,1,2,3,1,360,41.5,4.91,4.29,1,"other biological processes","other cell component","enzyme regulator activity","Pf12799, Pf14580","5510","B4DFD4; B5MCY6; hsa:5510; Q15435; Q9UQE5; Q9UQE6; Q9Y6K4","ENSG00000115685",NA,"2q37 copy number variation syndrome",1,0,82.3,77.8,81.7,114.6,91.7,94,115.8,120.1,136.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100)]",0,"ENSG00000115685"
"444","NOC2L",0.373723812447571,6.50173435951993,2.90935193529234,0.0162472416894192,0.0597195910746219,-3.69517145988988,"NONE",FALSE,"High","Master Protein","Q9Y3T9","Nucleolar complex protein 2 homolog [OS=Homo sapiens]",0,19.727,2,2,2,5,2,749,84.9,5.62,11.91,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf03715","26155","hsa:26155; Q5SVA3; Q9BTN6; Q9Y3T9","ENSG00000188976","Regulation of TP53 Activity through Phosphorylation","1p36 copy number variation syndrome",2,0,141,123.3,112,64.8,70.8,58.6,92.6,85.3,100.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S56(100)]",0,"ENSG00000188976"
"445","KTN1",-0.189560847019743,6.63688962309368,-2.90185495878313,0.0164530450788908,0.060249988005187,-3.7077721348889,"NONE",FALSE,"High","Master Protein","Q86UP2","Kinectin [OS=Homo sapiens]",0,65.342,4,3,3,8,3,1357,156.2,5.64,35.11,3,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi","cytoskeletal activity","Pf05104","3895","B4DZ88; hsa:3895; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86UP2; Q86W57","ENSG00000126777","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOG GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; RHO GTPases activate KTN1","Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",11,0,97.9,97.6,102.9,103.7,103.4,110,95.1,98.3,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T153(100); S1313(100)]",0,"ENSG00000126777"
"446","PPP2R5A",-0.362002329640667,6.63769078920876,-2.90140877784176,0.0164653766239665,0.060249988005187,-3.70852201000685,"NONE",FALSE,"High","Master Protein","Q15172","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform [OS=Homo sapiens]",0,3.696,2,1,2,4,1,486,56.2,6.71,2.26,1,"protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01603","5525","B2R6D2; B7Z7L2; D3DT99; hsa:5525; Q15172; Q2NL72; Q5VVB2; Q8TBI9","ENSG00000066027","PKR-mediated signaling; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome",27,0,94.5,90.5,80.7,114.5,138.3,112.4,89.5,88.9,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(99.6)]",0,"ENSG00000066027"
"447","VASP",0.366082997075592,6.67372506052539,2.89392756662226,0.0166735466568182,0.060875230747041,-3.72109443467294,"NONE",FALSE,"High","Master Protein","P50552","Vasodilator-stimulated phosphoprotein [OS=Homo sapiens]",0,11.674,7,1,1,1,1,380,39.8,8.94,3.62,1,"cell organization and biogenesis;developmental processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00568, Pf08776","7408","B2RBT9; hsa:7408; P50552; Q6PIZ1; Q93035","ENSG00000125753","Generation of second messenger molecules; Signaling by ROBO receptors; Cell-extracellular matrix interactions","Integrin-mediated cell adhesion; Focal adhesion",5,0,87.2,97.9,116.8,96.5,65.1,102.8,115.3,115.3,115.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(99.4)]",0,"ENSG00000125753"
"448","PDLIM4",0.329799048633816,6.65099776861979,2.88389844486024,0.0169568147997604,0.0617712539134129,-3.7379459542585,"NONE",FALSE,"High","Master Protein","P50479","PDZ and LIM domain protein 4 [OS=Homo sapiens]",0,28.128,5,1,1,6,1,330,35.4,7.91,23.5,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf00595, Pf15936","8572","B2R8U1; hsa:8572; P50479; Q53Y39; Q96AT8; Q9BTW8; Q9Y292","ENSG00000131435",NA,NA,0,0,72.4,75.1,70.1,107.4,120.8,91.7,136.4,120.6,131.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(99.7)]",0,"ENSG00000131435"
"449","SORBS3",-0.279005756320065,6.64941628219645,-2.85876020484957,0.0176884924895226,0.0642034943617975,-3.78016947447191,"NONE",FALSE,"High","Master Protein","O60504","Vinexin [OS=Homo sapiens]",0,28.582,3,2,3,7,2,671,75.3,9.45,21.99,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00018, Pf02208, Pf14604","10174","hsa:10174; O60504; Q5BJE4; Q6NX54; Q96FY4; Q9UQE4","ENSG00000120896","Smooth Muscle Contraction",NA,1,0,72.2,67.6,78.4,123.9,118.9,138.6,98.8,108.2,116.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S530(99.6); S545(100)]",0,"ENSG00000120896"
"450","ANP32A",-0.269456982197867,6.64379288176702,-2.85774211747201,0.017718790857825,0.0642034943617975,-3.78187901405532,"NONE",FALSE,"High","Master Protein","P39687","Acidic leucine-rich nuclear phosphoprotein 32 family member A [OS=Homo sapiens]",0,5.92,8,2,2,3,2,249,28.6,4.09,2.57,2,"transport;signal transduction;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf14580","8125","B2R6T4; hsa:8125; P39687; Q53FK4; Q5J8L8; Q7M4N6","ENSG00000140350","HuR (ELAVL1) binds and stabilizes mRNA","IL-18 signaling pathway",2,0,76.4,81.5,75.4,119.7,147.9,112.3,100.7,105,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T15(100)]",0,"ENSG00000140350"
"451","DNM1L",0.307265701942899,6.69998647549437,2.85694634399763,0.0177425097776781,0.0642034943617975,-3.78321522307393,"NONE",FALSE,"High","Master Protein","O00429","Dynamin-1-like protein [OS=Homo sapiens]",0,25.263,2,1,1,3,1,736,81.8,6.81,13.92,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00350, Pf01031, Pf02212","10059","A8K4X9; B4DGC9; B4DSU8; G8JLD5; hsa:10059; J3KPI2; O00429; O14541; O60709; Q59GN9; Q7L6B3; Q8TBT7; Q9BWM1; Q9Y5J2","ENSG00000087470","Apoptotic execution phase","Synaptic vesicle pathway; CAMKK2 pathway",3,0,83,93.1,84.1,110.4,80.3,107.3,124.6,131.6,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S616(100)]",0,"ENSG00000087470"
"452","VPS13D",0.232568479971669,6.65348901777641,2.8531559007088,0.0178559307522325,0.0644709712116007,-3.78957953584509,"NONE",FALSE,"High","Master Protein","Q5THJ4","Intermembrane lipid transfer protein VPS13D [OS=Homo sapiens]",0,31.41,2,4,4,4,4,4388,491.6,6.58,13.77,4,"cell organization and biogenesis;transport;other biological processes","other membranes",NA,"Pf00627, Pf06650, Pf12624, Pf16908, Pf16909, Pf16910","55187","hsa:55187; J3KP14; Q58F10; Q5THJ4; Q6MZK9; Q6ZV12; Q709C4; Q709C5; Q86UB4; Q9NSJ3; Q9UIM0","ENSG00000048707",NA,NA,0,0,75.6,71,77.6,101.9,107.6,114.1,119.2,116.7,142.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1038(100); S1042(100); S1709(99.4); S2093(100)]",0,"ENSG00000048707"
"453","ADAR",0.359587556478224,6.58689678153725,2.8480217652196,0.018010731730177,0.0648733082656701,-3.79819904245181,"NONE",FALSE,"High","Master Protein","P55265","Double-stranded RNA-specific adenosine deaminase [OS=Homo sapiens]",0,25.324,3,3,3,3,3,1226,136,8.65,9.52,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00035, Pf02137, Pf02295","103","B1AQQ9; B1AQR0; D3DV76; hsa:103; O15223; O43859; O43860; P55265; Q9BYM3; Q9BYM4","ENSG00000160710","PKR-mediated signaling; Interferon alpha/beta signaling; C6 deamination of adenosine; Formation of editosomes by ADAR proteins","Measles virus infection; Cytosolic DNA-sensing pathway",6,0,115.5,105.8,125.5,74.7,70.7,75.2,109,85.6,111.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T601(99.4); S825(100)]",0,"ENSG00000160710"
"454","IRF2BP1",0.229697305718773,6.59422646410376,2.84682984039286,0.0180468639415528,0.0648733082656701,-3.80019996563071,"NONE",FALSE,"High","Master Protein","Q8IU81","Interferon regulatory factor 2-binding protein 1 [OS=Homo sapiens]",0,47.419,10,5,5,10,5,584,61.6,8.18,31.84,5,"protein metabolism;other metabolic processes;other biological processes","nucleus","other molecular function","Pf11261","26145","Q53EL7; Q6DC95; Q8IU81; Q9BRZ9; Q9Y4P4","ENSG00000170604",NA,NA,0,0,112,111.4,110.5,79.4,79.3,82.9,93.6,98.2,109.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S125(100); S384(100); S453(100)]",0,"ENSG00000170604"
"455","ARVCF",-0.505018295469776,6.61123113224582,-2.8427374520255,0.0181714812291352,0.0651777084965904,-3.80706954025198,"NONE",FALSE,"High","Master Protein","O00192","Splicing regulator ARVCF [OS=Homo sapiens]",0,62.034,6,5,6,14,5,962,104.6,6.81,41.36,5,"cell adhesion;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00514","421","B7WNV2; hsa:421; O00192","ENSG00000099889",NA,"22q11.2 copy number variation syndrome",1,0,117.9,111.5,108.3,119.5,73.3,124.9,94.3,85.1,68.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S606(100); T642(100); T872(100)]",0,"ENSG00000099889"
"456","PPP2R5E",-0.227966947772734,6.6372570004142,-2.83994802917,0.0182569212036464,0.0653281194274403,-3.81175152119289,"NONE",FALSE,"High","Master Protein","Q16537","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform [OS=Homo sapiens]",0,2.942,2,1,2,2,1,467,54.7,6.95,4.18,1,"signal transduction","cytosol;nucleus;other cell component","enzyme regulator activity","Pf01603","5529","A4FU37; B7ZAW5; B7ZKK8; B7ZKK9; hsa:5529; J3KQN6; Q16537; Q52LW4","ENSG00000154001","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome; DNA damage response (only ATM dependent)",28,0,98.5,99.2,98.9,107,96.2,117.4,88.4,98,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100)]",0,"ENSG00000154001"
"457","CLCC1",0.238397992724737,6.65420073126524,2.83875867882791,0.018293474619081,0.0653281194274403,-3.81374771621136,"NONE",FALSE,"High","Master Protein","Q96S66","Chloride channel CLIC-like protein 1 [OS=Homo sapiens]",0.006,1.794,2,1,1,1,1,551,62,5.55,2.6,1,"transport","other membranes;ER/Golgi;nucleus;other cell component","transporter activity","Pf05934","23155","hsa:23155; O94861; Q8WYP8; Q8WYP9; Q96S66; Q9BU25","ENSG00000121940",NA,NA,0,0,78.2,93.2,89.3,93.9,99.2,103.9,114.4,111.9,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(99.3)]",0,"ENSG00000121940"
"458","MSL3",-0.274553454641314,6.61825131175744,-2.83624523130522,0.0183709667862603,0.0654616109064995,-3.8179660618901,"NONE",FALSE,"High","Master Protein","Q8N5Y2","Male-specific lethal 3 homolog [OS=Homo sapiens]",0,10.091,2,1,1,2,1,521,59.8,8.21,5.14,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05712, Pf11717","10943","A6NCU2; A6NHW8; A8K165; B4DUV8; B7Z227; hsa:10943; Q8N5Y2; Q9UG70; Q9Y5Z8","ENSG00000005302","HATs acetylate histones",NA,1,0,100.7,96.2,107.1,105.6,89,118.9,93.1,96.8,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S400(99.6)]",0,"ENSG00000005302"
"459","TRPT1",0.374527603215934,6.66697925297804,2.83292124943967,0.0184739593415023,0.0655556147710257,-3.82354430914451,"NONE",FALSE,"High","Master Protein","Q86TN4","tRNA 2'-phosphotransferase 1 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,253,27.7,9.98,3.23,1,"RNA metabolism OR transcription;other metabolic processes",NA,"other molecular function","Pf01885","83707","A8MU17; A8MYC9; F5H2B2; hsa:83707; Q86TN4; Q9BSB9","ENSG00000149743",NA,NA,0,0,82.8,88,89,100.6,65.2,118,121,119,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(99.4)]",0,"ENSG00000149743"
"460","SNX24",0.248484805385768,6.5938212061408,2.83280134223641,0.0184776855359509,0.0655556147710257,-3.82374552610383,"NONE",FALSE,"High","Master Protein","Q9Y343","Sorting nexin-24 [OS=Homo sapiens]",0,9.584,10,1,1,1,1,169,19.8,7.24,3.53,1,"transport","other membranes","other molecular function","Pf00787","28966","hsa:28966; Q6UY33; Q9Y343","ENSG00000064652",NA,NA,0,0,120.8,115.7,127.6,87.9,63.9,75.6,101.1,94.5,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100)]",0,"ENSG00000064652"
"461","ANKRD6",-0.327235820220436,6.64823038983184,-2.8286649929866,0.0186066922400944,0.0658076384844494,-3.83068636098905,"NONE",FALSE,"High","Master Protein","Q9Y2G4","Ankyrin repeat domain-containing protein 6 [OS=Homo sapiens]",0,22.202,6,2,2,3,2,727,79.9,9.32,6.85,2,"other biological processes","nucleus;other cell component",NA,"Pf12796","22881","B3KUC3; hsa:22881; Q5JUJ4; Q5JUJ5; Q8IUQ8; Q9NU24; Q9UFQ9; Q9Y2G4","ENSG00000135299",NA,NA,0,0,70.9,83.5,85.5,129.8,104.7,131.8,106.2,100,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(99.7)]",0,"ENSG00000135299"
"462","GPRC5B",-0.387716077330609,6.61940440457223,-2.82794093204483,0.018629368247436,0.0658076384844494,-3.83190126251394,"NONE",FALSE,"High","Master Protein","Q9NZH0","G-protein coupled receptor family C group 5 member B [OS=Homo sapiens]",0,7.351,5,2,3,5,2,403,44.8,8.24,7.65,2,"signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00003","51704","D2DFB0; hsa:51704; O75205; Q8NBZ8; Q9NZH0","ENSG00000167191",NA,"GPCRs, class C metabotropic glutamate, pheromone",1,0,60.6,66,72,124.4,125.3,160.3,105.9,119.8,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S354(100); S360(100); S362(100)]",0,"ENSG00000167191"
"463","ARHGAP23",-0.245072177765019,6.61660875230559,-2.82491187856737,0.0187245352860022,0.0660009537510919,-3.83698344849376,"NONE",FALSE,"High","Master Protein","Q9P227","Rho GTPase-activating protein 23 [OS=Homo sapiens]",0,27.737,5,5,5,5,5,1491,162.1,9.19,11.61,5,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00620, Pf15410, Pf17820","57636","hsa:57636; Q9P227","ENSG00000273780; ENSG00000275832","RHOA GTPase cycle; RAC1 GTPase cycle","17q12 copy number variation syndrome",3,0,98.5,95.8,107.4,101.5,105.4,109.4,83.6,95.2,99.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S372(100); S598(100); S1393(100)]",0,"ENSG00000275832"
"464","PCDH1",-0.202637105972658,6.63889922332884,-2.8138460617001,0.0190764032198669,0.0670393663882307,-3.85554614665702,"NONE",FALSE,"High","Master Protein","Q08174-2","Isoform 2 of Protocadherin-1 [OS=Homo sapiens]",0,80.393,4,4,5,16,4,1237,133.6,5.06,65.17,4,NA,NA,NA,NA,NA,"Q08174-2",NA,NA,NA,0,0,90,94.3,91,106.7,120.3,108.8,95.9,101,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S962(100); S984(100); S1173(100)]",0,"ENSG00000156453"
"465","SLC26A6",-0.374107329087346,6.57421990596466,-2.81208930826182,0.0191328761398139,0.0670393663882307,-3.85849252270392,"NONE",FALSE,"High","Master Protein","Q9BXS9","Solute carrier family 26 member 6 [OS=Homo sapiens]",0,9.816,2,1,1,1,1,759,82.9,8.37,3,1,"stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","transporter activity;other molecular function","Pf00916, Pf01740","65010","B4DMZ1; hsa:65010; Q548A7; Q96Q90; Q9BXS9; Q9NQU1","ENSG00000225697","Multifunctional anion exchangers","Thyroxine (thyroid hormone) production; Proximal tubule transport",3,0,109.5,121.9,109,101,84.3,109.1,97.2,78.8,70.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S616(99.1)]",0,"ENSG00000225697"
"466","UBXN7",0.457952383666183,6.60568594903925,2.81179454836153,0.0191423680986002,0.0670393663882307,-3.85898687055768,"NONE",FALSE,"High","Master Protein","O94888","UBX domain-containing protein 7 [OS=Homo sapiens]",0,8.433,4,1,2,2,1,489,54.8,5.16,5.11,1,"protein metabolism;other metabolic processes","other membranes;cytosol;ER/Golgi;nucleus","other molecular function","Pf00789, Pf13899, Pf14555","26043","D3DXB3; hsa:26043; O94888; Q6ZP77; Q86X20; Q8N327","ENSG00000163960","Neddylation; KEAP1-NFE2L2 pathway","3q29 copy number variation syndrome",3,0,55.9,82.5,82.5,98,94.1,93.5,116.7,118.5,166.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100)]",0,"ENSG00000163960"
"467","ZC3HAV1",-0.253643345440697,6.65195345392266,-2.80870592612207,0.0192421158331173,0.0672443962305084,-3.86416660206537,"NONE",FALSE,"High","Master Protein","Q7Z2W4","Zinc finger CCCH-type antiviral protein 1 [OS=Homo sapiens]",0,15.174,3,2,2,2,2,902,101.4,8.4,6.52,2,"stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00644, Pf02825, Pf18606, Pf18633","56829","A4D1R2; A4D1S4; hsa:56829; Q7Z2W4; Q8IW57; Q8TAJ3; Q96N79; Q9H8R9; Q9P0Y7","ENSG00000105939","Signaling by BRAF and RAF1 fusions",NA,1,0,90.4,86.6,78.1,117.4,121.3,118.2,99.6,95.7,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S378(99.6)]",0,"ENSG00000105939"
"468","TP53BP2",-0.215249090738757,6.6709596494629,-2.78546194933296,0.0200098386999192,0.0697778990561286,-3.90313173263276,"NONE",FALSE,"High","Master Protein","Q13625","Apoptosis-stimulating of p53 protein 2 [OS=Homo sapiens]",0,20.969,4,3,3,7,3,1128,125.5,6.07,19.62,3,"cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00018, Pf00023, Pf21801","7159","B4DG66; hsa:7159; Q12892; Q13625; Q86X75; Q96KQ3","ENSG00000143514","TP53 Regulates Transcription of Death Receptors and Ligands; Activation of PUMA and translocation to mitochondria; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain; Regulation of TP53 Activity through Association with Co-factors",NA,5,0,89.6,88.7,90.3,117.6,111.4,118.7,99.5,110.1,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S480(100); S556(99.3); S698(100)]",0,"ENSG00000143514"
"469","TFIP11",0.258735673310049,6.62757608754741,2.78309397528859,0.0200897671681646,0.0699072495062786,-3.90709965531033,"NONE",FALSE,"High","Master Protein","Q9UBB9","Tuftelin-interacting protein 11 [OS=Homo sapiens]",0,20.658,3,1,2,2,1,837,96.8,5.67,6.18,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","extracellular matrix;nucleus;other cell component","nucleic acid binding activity","Pf01585, Pf07842, Pf12457","24144","hsa:24144; O95908; Q20WL0; Q5H8V8; Q9UBB9; Q9UGV7; Q9Y2Q8","ENSG00000100109","mRNA Splicing - Major Pathway",NA,1,0,109.3,100.2,122.1,88.9,66.5,92.8,101.2,104.9,106.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100)]",0,"ENSG00000100109"
"470","PCYT1A",-0.215027234065212,6.61825310529822,-2.77969162309975,0.0202051747510841,0.0701592450931262,-3.91280029223488,"NONE",FALSE,"High","Master Protein","P49585","Choline-phosphate cytidylyltransferase A [OS=Homo sapiens]",0,42.729,11,5,8,17,5,367,41.7,7.25,41.75,5,"other metabolic processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01467","5130","A9LYK9; D3DXB1; hsa:5130; P49585; Q86Y88","ENSG00000161217","Synthesis of PC","Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; One-carbon metabolism and related pathways; Glycerolipids and glycerophospholipids; 3q29 copy number variation syndrome; Acetylcholine synthesis",7,0,111.8,102.2,106.9,104.5,87.6,107.1,86.5,95.1,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100); S329(100); S331(100); S343(99.6); S347(100); S362(100)]",0,"ENSG00000161217"
"471","LMNB1",0.186915089317695,6.4311052035533,2.77468746876269,0.0203761327606644,0.0706026510942768,-3.92118354318941,"NONE",FALSE,"High","Master Protein","P20700","Lamin-B1 [OS=Homo sapiens]",0,78.278,19,8,11,11,6,586,66.4,5.16,32.3,8,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00038, Pf00932","4001","B2R6J6; hsa:4001; P20700; Q3SYN7; Q96EI6","ENSG00000113368","RHOD GTPase cycle; RHOF GTPase cycle; Meiotic synapsis; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina; Breakdown of the nuclear lamina; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Fas ligand pathway and stress induction of heat shock proteins; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome",14,2,148.4,141.1,138.9,56.7,51.3,65.1,76.9,78.1,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100); S302(100); S375(100); S393(100)]",0,"ENSG00000113368"
"472","SALL1",-0.375502344039631,6.51677597736375,-2.77329384621562,0.0204240028164804,0.0706185860095255,-3.92351796233258,"NONE",FALSE,"High","Master Protein","Q9NSC2","Sal-like protein 1 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1324,140.3,7.02,4.05,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf12874","6299","hsa:6299; Q99881; Q9NSC2; Q9NSC3; Q9P1R0","ENSG00000103449","Formation of the ureteric bud; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation","GDNF/RET signaling axis; Development of ureteric collection system; Markers of kidney cell lineage",5,0,128.2,136.4,116.4,108.1,62.5,91.8,73.7,80.7,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S586(99.3)]",0,"ENSG00000103449"
"473","BCL7C",-0.425201862810145,6.62247050791736,-2.76749856931176,0.0206242873381593,0.0711603317883214,-3.93322424427023,"NONE",FALSE,"High","Master Protein","Q8WUZ0","B-cell CLL/lymphoma 7 protein family member C [OS=Homo sapiens]",0,15.2,15,1,1,1,1,217,23.5,5.2,5.13,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component",NA,"Pf04714","9274","hsa:9274; O43770; Q6PD89; Q8WUZ0","ENSG00000099385",NA,NA,0,0,73.1,88.7,85.2,102,117.4,157.7,90.5,93,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(98.4); S126(98.5)]",0,"ENSG00000099385"
"474","DCP1B",-0.288207971007052,6.66548801839131,-2.75770299632907,0.0209673379162969,0.0721913406738325,-3.94962585789686,"NONE",FALSE,"High","Master Protein","Q8IZD4","mRNA-decapping enzyme 1B [OS=Homo sapiens]",0,20.604,8,3,3,4,3,617,67.7,8.56,12.6,3,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf06058, Pf16741","196513","B4DRD1; hsa:196513; Q86XH9; Q8IZD4; Q96BP8; Q96MZ8","ENSG00000151065; ENSG00000284850","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,70.3,79.3,92.8,124.7,135.2,119.4,108.5,99.1,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S448(100); S511(100)]",0,"ENSG00000151065"
"475","NOL4L",0.212236171851751,6.65503426512192,2.75498862112111,0.021063412308659,0.0723383163464741,-3.95416973230266,"NONE",FALSE,"High","Master Protein","Q96MY1","Nucleolar protein 4-like [OS=Homo sapiens]",0,21.478,8,2,2,2,2,436,47.2,5.08,7.05,2,NA,"cytosol;nucleus",NA,NA,"140688","hsa:140688; Q5JYB7; Q6P0Y4; Q96MY1; Q9BR34; Q9NQF6","ENSG00000197183",NA,NA,0,0,88.4,86.8,100.2,98.7,99,94.2,109.8,111.8,117.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]",0,"ENSG00000197183"
"476","GTF3C3",0.232701675744677,6.59647380631619,2.75399546340451,0.0210986756010549,0.0723383163464741,-3.95583216627917,"NONE",FALSE,"High","Master Protein","Q9Y5Q9","General transcription factor 3C polypeptide 3 [OS=Homo sapiens]",0,22.671,6,2,2,4,2,886,101.2,5.07,10.86,2,"RNA metabolism OR transcription;other metabolic processes","other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf13181","9330","hsa:9330; Q4ZG48; Q86XJ8; Q8WX84; Q96B44; Q9H5I8; Q9NT97; Q9Y5Q9","ENSG00000119041","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,117.3,112.7,105.7,87.6,79.8,74.1,98.1,98.5,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(100)]",0,"ENSG00000119041"
"477","ZNF316",0.345822470315534,6.60495501385788,2.74858944332509,0.0212916693511234,0.0727768476441285,-3.96488013314662,"NONE",FALSE,"High","Master Protein","A6NFI3","Zinc finger protein 316 [OS=Homo sapiens]",0,10.962,3,2,2,2,2,1004,108.4,5.31,5.97,2,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","100131017","A6NFI3","ENSG00000205903",NA,NA,0,0,114.6,114.5,110,85,84.4,64.5,110.9,95.2,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(100); S112(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000205903"
"478","DBN1",-0.291715221874703,6.63782601614298,-2.74791788197134,0.0213157678761602,0.0727768476441285,-3.96600398327734,"NONE",FALSE,"High","Master Protein","Q16643","Drebrin [OS=Homo sapiens]",0,172.705,15,5,15,69,5,649,71.4,4.45,268.54,5,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00241","1627","A8MV58; B2RBG0; hsa:1627; Q16643; Q9UFZ5","ENSG00000113758","RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; RHOD GTPase cycle; RHOH GTPase cycle","5q35 copy number variation",5,0,80.6,86,93.3,110.6,140.6,110.2,104.8,91.7,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100); S337(100); T346(100); S381(100); S601(100)]",0,"ENSG00000113758"
"479","MTMR3",0.238517289143807,6.62148109840345,2.7444527335118,0.0214405499283236,0.0730500573758331,-3.97180240313712,"NONE",FALSE,"High","Master Protein","Q13615","Myotubularin-related protein 3 [OS=Homo sapiens]",0,50.31,5,3,3,5,3,1198,133.5,5.8,24.77,3,"protein metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;other cell component","other molecular function","Pf01363, Pf06602","8897","A5PL26; A7MD32; hsa:8897; Q13615; Q9NYN5; Q9NYN6; Q9UDX6; Q9UEG3","ENSG00000100330","Synthesis of PIPs at the plasma membrane; Macroautophagy",NA,2,0,107.4,112.6,111.8,82.4,86.3,82.3,107.6,96.4,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S613(100); S633(100); S647(100)]",0,"ENSG00000100330"
"480","PPP2R5D",-0.360994417684654,6.56590506959343,-2.73682034721924,0.0217179989480006,0.0738411964232021,-3.98457129325762,"NONE",FALSE,"High","Master Protein","Q14738","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform [OS=Homo sapiens]",0,6.71,2,1,2,2,1,602,69.9,8.13,2.07,1,"protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01603","5528","A8K3I9; B5BUA6; hsa:5528; O00494; O00696; Q14738; Q15171; Q5TC39","ENSG00000112640","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling; DARPP-32 events; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome",33,0,123.9,111.6,83.9,109.3,98.4,96.8,81.5,82.8,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S598(99.4)]",0,"ENSG00000112640"
"481","ZEB1",-0.261049550999806,6.62710616713152,-2.73118950104892,0.0219250046384258,0.0743900365278812,-3.9939891163179,"NONE",FALSE,"High","Master Protein","P37275","Zinc finger E-box-binding homeobox 1 [OS=Homo sapiens]",0,30.044,4,2,3,4,2,1124,124,4.94,13.35,2,"cell cycle OR cell proliferation;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf05605","6935","B4DJV0; B4DUW9; E9PCM7; F5H4I8; hsa:6935; P37275; Q12924; Q13800; Q2KJ05; Q5T968; Q5VZ84; Q8NB68","ENSG00000148516","Interleukin-4 and Interleukin-13 signaling","Hypoxia-mediated EMT and stemness; TGF-beta signaling pathway; Clear cell renal cell carcinoma pathways; Epithelial to mesenchymal transition in colorectal cancer; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; CCL18 signaling pathway; Hypertrophy model",8,0,83.1,80.5,85.8,117,130.6,108.4,106.7,93,100.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100); S887(99.3)]",0,"ENSG00000148516"
"482","PEX11G",0.35037726059389,6.52206229394178,2.72928335047991,0.0219955292843333,0.0744744891950869,-3.99717673923975,"NONE",FALSE,"High","Master Protein","Q96HA9","Peroxisomal membrane protein 11C [OS=Homo sapiens]",0,3.568,5,1,1,1,1,241,26.6,9.13,2.18,1,"cell organization and biogenesis","other membranes;other cytoplasmic organelle;other cell component",NA,"Pf05648","92960","hsa:92960; Q8NDM0; Q96HA9","ENSG00000104883",NA,NA,0,0,111.1,118.8,121.3,73.1,49.8,83.6,84.3,95.9,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000104883"
"483","SMARCC2",-0.21264351347487,6.63611937828302,-2.71900643120904,0.0223797129131703,0.0756184088494698,-4.01435826851564,"NONE",FALSE,"High","Master Protein","Q8TAQ2","SWI/SNF complex subunit SMARCC2 [OS=Homo sapiens]",0,74.832,4,5,7,30,5,1214,132.8,5.69,92.28,5,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf04433, Pf16495, Pf16496, Pf16498","6601","F8VTJ5; hsa:6601; Q59GV3; Q8TAQ2; Q92923; Q96E12; Q96GY4","ENSG00000139613","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome; 10q11.21q11.23 copy number variation syndrome",7,0,89.6,91.4,92.8,114.4,105.3,112.9,96.7,105.9,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(99.7); S304(100); S347(100)]",0,"ENSG00000139613"
"484","SP4",-0.41643105876232,6.59701492409552,-2.71115580530043,0.022677737422254,0.0764670815560301,-4.02747827959339,"NONE",FALSE,"High","Master Protein","Q02446","Transcription factor Sp4 [OS=Homo sapiens]",0,51.795,9,3,5,16,3,784,81.9,7.05,14.57,3,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6671","hsa:6671; O60402; Q02446; Q32M52","ENSG00000105866",NA,NA,0,0,122.7,149.4,96,98.2,112,94.6,88.5,78.9,75.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S757(100)]",0,"ENSG00000105866"
"485","LARP4",0.299542423292232,6.64076179374095,2.70613912131819,0.0228702673262781,0.0768213984854641,-4.03585981238287,"NONE",FALSE,"High","Master Protein","Q71RC2","La-related protein 4 [OS=Homo sapiens]",0,19.975,5,2,2,5,2,724,80.5,6.61,13.97,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity","Pf05383","113251","A8K6T1; E9PDG5; G3XAA8; G5E976; hsa:113251; Q5CZ97; Q6ZV14; Q71RC2; Q96NF9","ENSG00000161813",NA,NA,0,0,96.8,103.1,105.6,89.6,101.3,74.7,105.6,108,115.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S597(100); S722(100)]",0,"ENSG00000161813"
"486","FOXK2",-0.21425803668936,6.51744358042866,-2.70596548234321,0.0228769605783919,0.0768213984854641,-4.03614988281661,"NONE",FALSE,"High","Master Protein","Q01167","Forkhead box protein K2 [OS=Homo sapiens]",0,17.187,4,2,2,2,2,660,69,9.54,6.35,2,"other metabolic processes;stress response;other biological processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf00498","3607","A6NEP5; hsa:3607; Q01167; Q13622; Q13623; Q13624","ENSG00000141568","UCH proteinases",NA,1,0,133,130.2,130.3,84.7,69.8,85.8,72.5,78.9,82,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100); S398(100)]",0,"ENSG00000141568"
"487","AGPS",-0.234696515429847,6.6670952964869,-2.70302687600307,0.0229905340377185,0.0770442536951882,-4.04105859002219,"NONE",FALSE,"High","Master Protein","O00116","Alkyldihydroxyacetonephosphate synthase, peroxisomal [OS=Homo sapiens]",0,14.77,3,1,1,1,1,658,72.9,7.34,4.37,1,"other metabolic processes","cytosol;other cytoplasmic organelle","other molecular function","Pf01565, Pf02913","8540","A5D8U9; hsa:8540; O00116; Q2TU35","ENSG00000018510","Plasmalogen biosynthesis; TYSND1 cleaves peroxisomal proteins","Triacylglyceride synthesis",4,0,97.8,106.3,102.7,105.3,105.8,117.2,90,106,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100)]",0,"ENSG00000018510"
"488","SLC35F6",-0.229673482538643,6.64085598591883,-2.69572846229036,0.0232750665401741,0.0778379274458282,-4.05324715475452,"NONE",FALSE,"High","Master Protein","Q8N357","Solute carrier family 35 member F6 [OS=Homo sapiens]",0.006,2.017,4,1,1,2,1,371,40.2,6.93,1.64,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","transporter activity","Pf06027","54978","D6W543; hsa:54978; Q53GK2; Q8N357; Q8NBX6; Q9NWX0","ENSG00000213699",NA,NA,0,0,91.3,96.4,108,114.2,97.4,110.4,94.6,93.3,99.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T365(100)]",0,"ENSG00000213699"
"489","HP1BP3",-0.254224489038123,6.56288964857118,-2.68775781087343,0.0235898505665367,0.0787059331378929,-4.06655363517751,"NONE",FALSE,"High","Master Protein","Q5SSJ5","Heterochromatin protein 1-binding protein 3 [OS=Homo sapiens]",0,47.587,10,7,7,12,7,553,61.2,9.67,28.53,7,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","50809","A6NI71; A8K5D7; B3KMZ8; B4E210; hsa:50809; Q05BI0; Q5SSJ5; Q5SSJ6; Q5SWC6; Q6PIM9; Q8NDF0; Q9UHY0","ENSG00000127483",NA,NA,0,0,117.2,116.3,109.2,93.2,104.3,85.8,88.2,81.3,81.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T51(100); S249(99.6)]",0,"ENSG00000127483"
"490","PTPN12",0.267911639561289,6.66722746835715,2.68672199685526,0.0236310706112546,0.0787059331378929,-4.06828248891174,"NONE",FALSE,"High","Master Protein","Q05209","Tyrosine-protein phosphatase non-receptor type 12 [OS=Homo sapiens]",0,8.693,3,2,2,5,2,780,88.1,5.62,10.35,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00102","5782","A4D1C5; B4DKY2; E9PBR5; E9PEH9; hsa:5782; Q05209; Q16130; Q59FD6; Q75MN8; Q86XU4","ENSG00000127947","Signaling by PDGF; SHC1 events in ERBB2 signaling; Downregulation of ERBB2 signaling; EGFR downregulation; Interleukin-37 signaling; Constitutive Signaling by Overexpressed ERBB2","EGF/EGFR signaling pathway",7,0,82.4,91,91,88.4,114.3,98.2,120.2,113.6,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); T509(100)]",0,"ENSG00000127947"
"491","SORBS1",-0.318679039901967,6.65945084410341,-2.68473055057906,0.0237105232119172,0.0788097227736231,-4.07160612492209,"NONE",FALSE,"High","Master Protein","Q9BX66-12","Isoform 12 of Sorbin and SH3 domain-containing protein 1 [OS=Homo sapiens]",0,126.445,10,12,14,28,12,1294,143.7,8.6,65.08,12,NA,NA,NA,NA,NA,"Q9BX66-12",NA,NA,NA,0,0,66.1,66.6,68.5,146.3,128.9,127.3,119,110.3,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S204(100); T286(100); S345(100); S1205(99.3)]",0,"ENSG00000095637"
"492","TMX1",0.177196700938376,6.54558099819067,2.68012287789756,0.02389538505549,0.0792438970157757,-4.07929489736574,"NONE",FALSE,"High","Master Protein","Q9H3N1","Thioredoxin-related transmembrane protein 1 [OS=Homo sapiens]",0,83.578,11,3,3,19,3,280,31.8,4.98,99.62,3,"stress response;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf00085","81542","B2R7A4; hsa:81542; Q8N487; Q8NBN5; Q9H3N1; Q9Y4T6","ENSG00000139921",NA,NA,0,0,128.5,123.6,119.3,78.3,62.8,78,89.6,91.2,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100); S270(100)]",0,"ENSG00000139921"
"493","LNPK",0.436424418134894,6.63750036266468,2.67905932121037,0.0239382605568489,0.0792438970157757,-4.08106939664818,"NONE",FALSE,"High","Master Protein","Q9C0E8","Endoplasmic reticulum junction formation protein lunapark [OS=Homo sapiens]",0,17.549,8,2,2,2,2,428,47.7,5.11,6.74,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf10058","80856","B7ZLA8; hsa:80856; Q2M2V8; Q2YD99; Q658W8; Q8N5V9; Q96MS5; Q9C0E8","ENSG00000144320",NA,NA,0,0,78.5,98.3,123.9,71.6,87.4,92.2,116.8,102.7,129.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S177(100); S384(100)]",0,"ENSG00000144320"
"494","LLGL1",-0.281787474920964,6.67540871582345,-2.67563237069601,0.0240769383003018,0.0795416261256933,-4.08678648474262,"NONE",FALSE,"High","Master Protein","Q15334","Lethal(2) giant larvae protein homolog 1 [OS=Homo sapiens]",0,43.438,8,6,7,14,6,1064,115.3,6.29,31.47,6,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf08366","3996","A7MBM7; hsa:3996; O00188; Q15334; Q58F11; Q86UK6","ENSG00000131899",NA,"Smith-Magenis and Potocki-Lupski syndrome copy number variation",1,0,81.3,77.4,76.1,132.7,122.8,123,96.3,117.7,107,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S420(100); S655(100); S659(100); S663(100); S682(99.5); S961(100); S967(100)]",0,"ENSG00000131899"
"495","NUP155",0.290345737011867,6.50246622493808,2.67026216077652,0.0242958770260995,0.0800572777412532,-4.09574349393317,"NONE",FALSE,"High","Master Protein","O75694","Nuclear pore complex protein Nup155 [OS=Homo sapiens]",0,21.931,3,2,2,3,2,1391,155.1,6.16,11.12,2,"cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus","other molecular function","Pf08801","9631","hsa:9631; O75694; Q9UBE9; Q9UFL5","ENSG00000113569","HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation",NA,29,0,148.2,129.4,117.2,63.9,65.6,63.4,82,86.5,100,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S992(100)]; Met-loss [N-Term]",0,"ENSG00000113569"
"496","MAP1S",-0.212107162999268,6.64093910565521,-2.66940192025349,0.0243311334311652,0.0800572777412532,-4.09717806963201,"NONE",FALSE,"High","Master Protein","Q66K74","Microtubule-associated protein 1S [OS=Homo sapiens]",0,132.747,12,8,16,36,8,1059,112.1,7.3,129.04,8,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function",NA,"55201","B4DH53; hsa:55201; Q27QB1; Q66K74; Q6NXF1; Q8N3L8; Q8N3W5; Q8NI88; Q96H94; Q96IT4; Q96SP8; Q9BRC6; Q9H928; Q9NVK7","ENSG00000130479",NA,NA,0,0,94.1,95.7,89.6,112.5,118.2,102.8,97.2,99.9,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S475(99.6); S547(100); S592(100); S595(97.8); S600(96.2); S640(99.2); S646(100); S657(100); S731(100); S741(100); S759(100)]",0,"ENSG00000130479"
"497","DUS3L",-0.391246664730547,6.62135556240133,-2.65939192946884,0.0247451789352166,0.0811951283016157,-4.11386652937765,"NONE",FALSE,"High","Master Protein","Q96G46","tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like [OS=Homo sapiens]",0,29.984,4,1,3,4,1,650,72.5,8.05,15.51,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes",NA,"other molecular function","Pf01207","56931","hsa:56931; Q96G46; Q96HM5; Q9BSU4; Q9H877; Q9NPR1","ENSG00000141994",NA,NA,0,0,97.4,100.1,100,93.8,102.6,139.2,79.2,93.4,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T273(99.1); S276(99.1)]",0,"ENSG00000141994"
"498","SHARPIN",0.210428213852439,6.66152814977622,2.65790302220135,0.024807365697385,0.0811951283016157,-4.11634806534907,"NONE",FALSE,"High","Master Protein","Q9H0F6","Sharpin [OS=Homo sapiens]",0,37.315,11,2,2,3,2,387,39.9,5.8,12.05,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;other cell component","other molecular function","Pf16764","81858","A6NEG3; C0L3L2; D3DWL3; hsa:81858; Q8IXF5; Q8IXF6; Q8N2E7; Q8TB25; Q9BUE4; Q9H0F6","ENSG00000179526","Neurexins and neuroligins; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TNFR1-induced proapoptotic signaling",NA,4,0,85.4,80.9,87.6,105.4,100,99.8,112.7,127.6,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(99.4); S165(100)]",0,"ENSG00000179526"
"499","TBC1D10B",-0.194566955403157,6.65138053599282,-2.65745266437325,0.0248262065088886,0.0811951283016157,-4.11709863069063,"NONE",FALSE,"High","Master Protein","Q4KMP7","TBC1 domain family member 10B [OS=Homo sapiens]",0,125.229,9,8,11,22,8,808,87.1,9.19,62.42,8,"transport;other biological processes","plasma membrane;other membranes;cytosol","enzyme regulator activity","Pf00566","26000","B9A6L0; hsa:26000; Q4KMP7; Q6IN54; Q6P530; Q71RG7; Q86VC5; Q9H8Z2; Q9NUN6; Q9UFP2","ENSG00000169221","TBC/RABGAPs",NA,1,0,92.9,94.6,91.1,116.1,108.9,107.6,96.9,101,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S132(100); T148(99.3); T152(99.2); S661(100); S678(100)]",0,"ENSG00000169221"
"500","TPD52L2",0.652907551175626,6.59527038065719,2.65449538988286,0.0249502815501699,0.0814377189797547,-4.12202677410837,"NONE",FALSE,"High","Master Protein","O43399","Tumor protein D54 [OS=Homo sapiens]",0,13.056,5,1,1,4,1,206,22.2,5.36,10.8,1,"other metabolic processes;other biological processes","other cell component","other molecular function","Pf04201","7165","B4DPJ6; E1P5G7; hsa:7165; O43398; O43399; Q5JWU5; Q5JWU6; Q5JWU8; Q5U0E0; Q9H3Z6","ENSG00000101150",NA,NA,0,0,57.3,68.1,64.7,77,175.3,72.1,159.7,133.3,149.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000101150"
"501","PCDH7",-0.215597356242612,6.64558054949202,-2.65066676039053,0.0251118387213525,0.0818014387090765,-4.12840583318055,"NONE",FALSE,"High","Master Protein","O60245","Protocadherin-7 [OS=Homo sapiens]",0,41.302,4,3,4,7,3,1069,116,5.19,24.77,3,"cell adhesion","plasma membrane;other membranes","other molecular function","Pf00028, Pf08266, Pf08374","5099","hsa:5099; O60245; O60246; O60247; Q4W5C4","ENSG00000169851","RHOA GTPase cycle; RHOB GTPase cycle; Platelet degranulation",NA,3,0,94.9,102.8,100.5,108.5,106.6,108,103.1,91.6,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S974(100); S989(100); S999(98.4); S1011(99.5)]",0,"ENSG00000169851"
"502","SLC6A11",0.260522053879085,6.46948954299457,2.6446326505481,0.0253685914429542,0.0824731897109585,-4.13845687399387,"NONE",FALSE,"High","Master Protein","P48066","Sodium- and chloride-dependent GABA transporter 3 [OS=Homo sapiens]",0,20.311,7,3,4,5,3,632,70.6,6.89,15.05,3,"transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00209","6538","B2R6U6; hsa:6538; P48066; Q8IYC9","ENSG00000132164","Na+/Cl- dependent neurotransmitter transporters; Creatine metabolism; Reuptake of GABA","Nuclear receptors meta-pathway; NRF2 pathway; GABA receptor signaling",6,0,153.3,144.2,129.5,59.5,53.1,64.4,73.7,86.9,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S603(100); S618(100)]",0,"ENSG00000132164"
"503","FRMD4A",0.213103776533565,6.64765757162212,2.64234678277216,0.025466541011119,0.0826270276941277,-4.14226358876424,"NONE",FALSE,"High","Master Protein","Q9P2Q2","FERM domain-containing protein 4A [OS=Homo sapiens]",0,87.861,9,6,11,16,6,1039,115.4,8.87,50.56,6,"other biological processes","cytoskeleton;other cell component","other molecular function","Pf00373, Pf09379, Pf09380, Pf11819","55691","A7E2Y3; hsa:55691; Q5T377; Q9P2Q2","ENSG00000151474",NA,NA,0,0,101.8,94.3,102.5,88.2,97.1,92.6,110.1,103.2,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100); S365(98.6); S694(100); S711(100); S727(99.6); S800(100)]",0,"ENSG00000151474"
"504","TRIM47",0.19247225178131,6.63775679657113,2.63351443157698,0.0258485798368786,0.0837001632813212,-4.15696779393595,"NONE",FALSE,"High","Master Protein","Q96LD4","E3 ubiquitin-protein ligase TRIM47 [OS=Homo sapiens]",0,23.27,2,2,2,3,2,638,69.5,6.44,10.56,2,"protein metabolism;other metabolic processes","cytosol;nucleus","other molecular function","Pf00643, Pf13445","91107","hsa:91107; Q96AD0; Q96GU5; Q96LD4; Q9BRN7","ENSG00000132481",NA,NA,0,0,107.9,104.5,99.3,86.6,83.1,98.2,106.7,104.9,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S588(100)]",0,"ENSG00000132481"
"505","ADD3",-0.39787750026725,6.64890081585479,-2.63106247551579,0.0259556518339791,0.083880443154562,-4.16104854466253,"NONE",FALSE,"High","Master Protein","Q9UEY8","Gamma-adducin [OS=Homo sapiens]",0,252.277,9,7,18,58,7,706,79.1,6.32,208.77,7,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00596","120","D3DRA8; hsa:120; O43243; Q5VU09; Q92773; Q9UEY7; Q9UEY8","ENSG00000148700","RHOD GTPase cycle; RHOF GTPase cycle; Miscellaneous transport and binding events",NA,3,0,97,100.7,99.6,128.9,89,120,103.3,94.3,78,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S423(100); S650(100); S677(100); S681(99.6); S683(99.5)]",0,"ENSG00000148700"
"506","SON",-0.399116646199546,6.59669465319957,-2.62974320537228,0.0260134452752741,0.0839010725083939,-4.1632439488254,"NONE",FALSE,"High","Master Protein","P18583","Protein SON [OS=Homo sapiens]",0,72.935,3,8,13,22,8,2426,263.7,5.64,63.75,8,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf01585, Pf14709, Pf17069","6651","D3DSF5; D3DSF6; E7ETE8; E7EU67; E7EVW3; E9PFQ2; hsa:6651; O14487; O95981; P18583; Q14120; Q6PKE0; Q9H7B1; Q9P070; Q9P072; Q9UKP9; Q9UPY0","ENSG00000159140",NA,NA,0,0,114.9,103.4,102.8,113.1,72.9,124.6,85.4,94.7,75.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(99.6); S1556(99.6); S1697(100); S1887(100); S1950(100); S1952(99.2); S2009(100); S2013(100); S2031(100)]",0,"ENSG00000159140"
"507","KCNQ2",0.219270633182854,6.63720650447102,2.62634741164631,0.0261627983018344,0.0842163448295734,-4.16889414258602,"NONE",FALSE,"High","Master Protein","O43526","Potassium voltage-gated channel subfamily KQT member 2 [OS=Homo sapiens]",0,28.019,4,3,3,3,3,872,95.8,9.23,11.76,3,"cell-cell signaling;transport;developmental processes","plasma membrane;other membranes;other cell component","transporter activity;cytoskeletal activity;other molecular function","Pf00520, Pf03520, Pf11956, Pf16642","3785","hsa:3785; O43526; O43796; O75580; O95845; Q4VXP4; Q4VXR6; Q5VYT8; Q96J59; Q99454","ENSG00000075043","Interaction between L1 and Ankyrins; Voltage gated Potassium channels","Splicing factor NOVA regulated synaptic proteins; Vitamin D-sensitive calcium signaling in depression; KCNQ2-related epilepsies; Acetaminophen in analgesia and antipyresis",6,0,87.2,87.8,86.9,88.4,100.7,104.7,116.4,108.6,116.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(99.6); S507(100)]",0,"ENSG00000075043"
"508","MAP1A",0.220818938053956,6.67543212168231,2.62092991229186,0.0264028477179504,0.0848217469993998,-4.17790591247879,"NONE",FALSE,"High","Master Protein","P78559","Microtubule-associated protein 1A [OS=Homo sapiens]",0,665.628,18,34,48,139,34,2803,305.3,4.92,495.19,34,"cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function",NA,"4130","hsa:4130; O95643; P78559; Q12973; Q15882; Q9UJT4","ENSG00000166963",NA,NA,0,0,79.1,81.5,81.1,110.3,106.1,101.2,127.8,119,116.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100); T504(100); S605(100); S612(100); T616(100); S644(100); S667(100); S844(99.4); S896(100); S909(100); S986(100); S1069(100); S1144(99.3); S1146(100); S1172(100); S1218(100); S1311(99.4); S1326(100); S1654(99.7); S1675(99.7); S1776(100); S1791(100); S1797(100); S1801(100); S1818(100); S2022(100); S2106(100); S2449(100); S2617(100); S2629(100); S2664(100)]",0,"ENSG00000166963"
"509","PEA15",-0.420003979114631,6.58357078349761,-2.61439684120376,0.0266952600724348,0.0855926609788087,-4.18876957164259,"NONE",FALSE,"High","Master Protein","Q15121","Astrocytic phosphoprotein PEA-15 [OS=Homo sapiens]",0,36.172,10,2,2,14,2,130,15,5.02,41.72,2,"transport;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf01335","8682","B1AKZ3; hsa:8682; O00511; Q15121","ENSG00000162734","RAF/MAP kinase cascade; RAF-independent MAPK1/3 activation","Apoptosis modulation and signaling",3,0,50.6,53.9,55.5,139.2,216.3,117.1,113.9,102.4,119.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100)]",0,"ENSG00000162734"
"510","PDE4B",0.21527914356665,6.6194984550017,2.61289481663869,0.0267629454120654,0.0856414253186093,-4.19126664871971,"NONE",FALSE,"High","Master Protein","Q07343-3","Isoform PDE4B3 of 3',5'-cyclic-AMP phosphodiesterase 4B [OS=Homo sapiens]",0,20.958,8,4,4,4,4,721,82,5.58,9.81,4,NA,NA,NA,NA,NA,"Q07343-3",NA,NA,NA,0,0,118.8,108,109,87.2,79.9,82.7,94.7,109.9,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S182(100); S275(100); S717(99.6)]",0,"ENSG00000184588"
"511","RECQL5",0.284468297979929,6.66613591338508,2.60736604929974,0.027013568044005,0.0862742525397575,-4.20045613452452,"NONE",FALSE,"High","Master Protein","O94762","ATP-dependent DNA helicase Q5 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,991,108.8,8.56,8.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00270, Pf00271, Pf06959, Pf16124","9400","hsa:9400; O94762; Q6P4G0; Q9H0B1; Q9P1W7; Q9UNC8","ENSG00000108469",NA,NA,0,0,89.3,80.1,101.9,101.5,94.6,93.2,125.4,108.4,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S815(100)]",0,"ENSG00000108469"
"512","ARAF",-0.322508186800011,6.59669352176152,-2.60022979496917,0.0273405296181709,0.0870181103485591,-4.21231287358277,"NONE",FALSE,"High","Master Protein","P10398","Serine/threonine-protein kinase A-Raf [OS=Homo sapiens]",0,16.676,3,2,2,4,1,606,67.5,9.01,10.7,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;mitochondrion","kinase activity;other molecular function","Pf00130, Pf02196, Pf07714","369","hsa:369; P07557; P10398; Q5H9B2; Q5H9B3","ENSG00000078061","Signaling by BRAF and RAF1 fusions; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; Common pathways underlying drug addiction; Bladder cancer; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Endometrial cancer; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Fragile X syndrome; Hepatitis B infection; Melanoma; EGFR tyrosine kinase inhibitor resistance; Alzheimer's disease; Acute myeloid leukemia; ErbB signaling pathway",33,1,110.4,93.7,106.4,92.4,96.7,124.5,81.8,85.8,98.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S257(100); S582(100)]",0,"ENSG00000078061"
"513","AFDN",0.197832916083967,6.6588050623044,2.59891091712151,0.0274013880458511,0.0870181103485591,-4.21450358883386,"NONE",FALSE,"High","Master Protein","P55196","Afadin [OS=Homo sapiens]",0,62.133,5,8,8,13,8,1824,206.7,6.47,35.8,8,"cell adhesion;cell-cell signaling;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00498, Pf00595, Pf00788, Pf01843","4301","O75087; O75088; O75089; P55196; Q59FP0; Q5TIG6; Q5TIG7; Q9NSN7; Q9NU92","ENSG00000130396",NA,"VEGFA-VEGFR2 signaling; Ras signaling; 1q21.1 copy number variation syndrome",3,0,93.6,99.9,93.1,98.6,99.1,91.6,107.7,110.4,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S1083(100); S1182(100); S1275(100); T1330(100); S1774(100); S1799(100)]",0,"ENSG00000130396"
"514","KLC1",0.18922513608813,6.62629005363114,2.59856270796081,0.0274174784090058,0.0870181103485591,-4.21508194979979,"NONE",FALSE,"High","Master Protein","Q07866-6","Isoform N of Kinesin light chain 1 [OS=Homo sapiens]",0,84.952,12,8,10,19,7,628,71,6.67,58.62,8,NA,NA,NA,NA,NA,"Q07866-6",NA,NA,NA,0,1,62.4,59.9,63.3,113.8,129.8,113.7,128.1,131.5,134.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S460(100); S521(100); S524(100); S546(99.5); S552(100); S559(100); S591(100); S622(100)]",0,"ENSG00000126214"
"515","SRSF4",-0.228212683164609,6.58471650260374,-2.59706437906826,0.0274868222780626,0.0870181103485591,-4.21757046821018,"NONE",FALSE,"High","Master Protein","Q08170","Serine/arginine-rich splicing factor 4 [OS=Homo sapiens]",0,14.257,5,3,5,7,2,494,56.6,11.52,10.41,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","6429","hsa:6429; Q08170; Q5VXP1; Q9BUA4; Q9UEB5","ENSG00000116350","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing",6,0,117.2,113.2,112,99,98.6,88.6,89.5,89.2,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S269(100); S456(100)]",0,"ENSG00000116350"
"516","TMCC2",0.562761964327676,6.60873639849979,2.59649802902605,0.027513079007265,0.0870181103485591,-4.21851103694491,"NONE",FALSE,"High","Master Protein","O75069","Transmembrane and coiled-coil domains protein 2 [OS=Homo sapiens]",0,7.086,2,1,1,2,1,709,77.4,6.81,6.94,1,"protein metabolism;other metabolic processes","other membranes;ER/Golgi;other cell component",NA,"Pf10267","9911","A2RRH3; B2RAX5; B3KTM7; B7Z1P7; hsa:9911; O75069; Q6ZN09; Q7Z6C6","ENSG00000133069",NA,NA,0,0,117.6,119.2,106.2,80.7,40.9,92.9,117.7,134.4,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(100)]",0,"ENSG00000133069"
"517","ANO8",0.321208762282765,6.672967345161,2.59359983357669,0.027647835689777,0.0872751795855243,-4.2233237049365,"NONE",FALSE,"High","Master Protein","Q9HCE9","Anoctamin-8 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1232,135.9,5.82,4.79,1,"transport","plasma membrane;other membranes;ER/Golgi","transporter activity","Pf04547","57719","A6NIJ0; hsa:57719; Q9HCE9","ENSG00000074855","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Stimuli-sensing channels; Induction of Cell-Cell Fusion",NA,4,0,85.7,84.4,74.7,103.8,104.2,96.2,138.6,123.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S641(100)]",0,"ENSG00000074855"
"518","CDC5L",0.884751240841323,6.42874439131385,2.59241063657542,0.027703319996628,0.0872815023831988,-4.2252981993766,"NONE",FALSE,"High","Master Protein","Q99459","Cell division cycle 5-like protein [OS=Homo sapiens]",0,9.832,2,1,1,1,1,802,92.2,8.18,3.15,1,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11831, Pf13921","988","hsa:988; Q76N46; Q99459; Q99974","ENSG00000096401","mRNA Splicing - Major Pathway",NA,1,0,35.1,58.9,47.6,93.8,39.1,126.7,107,246.8,167.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(100)]",0,"ENSG00000096401"
"519","ZDHHC8",-0.279315745935006,6.62832165304534,-2.58815444227856,0.0279028134995105,0.08764468499825,-4.23236378596615,"NONE",FALSE,"High","Master Protein","Q9ULC8","Palmitoyltransferase ZDHHC8 [OS=Homo sapiens]",0,22.983,7,4,4,5,4,765,81.4,9.17,7.78,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi","other molecular function","Pf01529","29801","hsa:29801; Q2TGE9; Q6ICL1; Q6ZNF5; Q7Z6L9; Q9ULC8","ENSG00000099904","HDL assembly; Maturation of spike protein","22q11.2 copy number variation syndrome",3,0,92,86.4,100.3,99,107.1,129.8,95.5,91.8,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S526(100); S725(100); S743(99.1)]",0,"ENSG00000099904"
"520","DST",-0.229195020633319,6.65540325452009,-2.58766167522772,0.0279260025729718,0.08764468499825,-4.23318169006872,"NONE",FALSE,"High","Master Protein","Q03001-11","Isoform 6 of Dystonin [OS=Homo sapiens]",0,20.163,16,2,3,3,2,224,25.4,10.67,10.8,2,NA,NA,NA,NA,NA,"Q03001-11",NA,NA,NA,0,0,75.8,81,85.3,116.7,123.5,124.4,113.1,103.8,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S157(100); S170(100)]",0,"ENSG00000151914"
"521","PPAN",0.275409951217222,6.59918108804785,2.585925411318,0.0280078626249315,0.0877328825410523,-4.23606336694206,"NONE",FALSE,"High","Master Protein","Q9NQ55","Suppressor of SWI4 1 homolog [OS=Homo sapiens]",0,23.311,3,1,1,4,1,473,53.2,10.13,14.15,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf04427","56342; 692312","C9J3F9; hsa:56342; hsa:692312; Q9BW97; Q9H170; Q9NQ55","ENSG00000130810",NA,NA,0,0,121.9,113.8,106.1,73.4,82.9,80.8,100.6,92.1,111.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S359(100)]",0,"ENSG00000130810"
"522","PLXDC2",0.24108091612089,6.60441959250048,2.57856353006255,0.0283576233791301,0.0886583167715331,-4.24827826882666,"NONE",FALSE,"High","Master Protein","Q6UX71","Plexin domain-containing protein 2 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,529,59.5,6.46,4.14,1,NA,"other membranes",NA,"Pf01437","84898","hsa:84898; Q6UX71; Q96E59; Q96PD9; Q96SU9","ENSG00000120594",NA,NA,0,0,61.9,57.5,56.3,114.5,114.7,117.5,118.7,150.8,141.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(100)]",0,"ENSG00000120594"
"523","WASHC2A",-0.173643894249311,6.66286508975847,-2.57148664417723,0.02869795041881,0.0894000421309745,-4.26001471738651,"NONE",FALSE,"High","Master Protein","Q641Q2","WASH complex subunit 2A [OS=Homo sapiens]",0,93.519,8,6,7,18,1,1341,147.1,4.81,56.96,6,"transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf15255","387680","A2A3S2; A2A3U6; hsa:387680; Q5SNT6; Q641Q2; Q6DHY0","ENSG00000099290",NA,NA,0,4,88.7,91.6,96.1,112.3,115.7,110.1,101.6,102,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.7); S498(100); S539(100); S728(100)]",0,"ENSG00000099290"
"524","MYO9B",0.257738814743454,6.64234577956751,2.57027136573828,0.0287568014771884,0.0894000421309745,-4.26202960100373,"NONE",FALSE,"High","Master Protein","Q13459","Unconventional myosin-IXb [OS=Homo sapiens]",0,101.376,4,7,8,12,7,2157,243.2,8.75,48.33,7,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00063, Pf00612, Pf00620, Pf00788","4650","hsa:4650; O75314; Q13459; Q9NUJ2; Q9UHN0","ENSG00000099331","RHOA GTPase cycle; RAC1 GTPase cycle; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHOB GTPase cycle; RHOC GTPase cycle; CDC42 GTPase cycle; RHOF GTPase cycle; SLIT2:ROBO1 increases RHOA activity","Vitamin D receptor pathway",10,0,84.3,79.9,86.5,101.5,106.9,91.4,106,118.5,134.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1281(100); S1290(100); S1331(100); T1346(100); S1992(100)]",0,"ENSG00000099331"
"525","DOCK7",-0.209586076832629,6.63841159241089,-2.57022179111835,0.0287592047296333,0.0894000421309745,-4.26211179026508,"NONE",FALSE,"High","Master Protein","Q96N67","Dedicator of cytokinesis protein 7 [OS=Homo sapiens]",0,71.84,3,4,5,11,4,2140,242.4,6.8,36.47,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","other cell component","enzyme regulator activity;other molecular function","Pf06920, Pf11878, Pf14429, Pf20421, Pf20422","85440","hsa:85440; Q00M63; Q2PPY7; Q45RE8; Q45RE9; Q5T1B9; Q5T1C0; Q6ZV32; Q8TB82; Q96N67; Q96NG6; Q96NI0; Q9C092","ENSG00000116641","CDC42 GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production; MET activates RAP1 and RAC1",NA,4,0,94.7,86.7,95.3,109.8,104.8,116.7,90.9,104.3,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S900(100); S929(99.7); S1432(100)]",0,"ENSG00000116641"
"526","RASAL2",-0.208254872265695,6.65268041861704,-2.56899441368403,0.0288187687753845,0.0894003469928075,-4.26414655926595,"NONE",FALSE,"High","Master Protein","Q9UJF2-2","Isoform 2 of Ras GTPase-activating protein nGAP [OS=Homo sapiens]",0,15.397,4,3,3,3,3,1280,143.8,7.55,5.72,3,NA,NA,NA,NA,NA,"Q9UJF2-2",NA,NA,NA,0,0,96,96.9,88.2,111.2,100.2,120.6,97.2,97.8,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S134(100); S877(99.5); S1069(99.1)]",0,"ENSG00000075391"
"527","FNBP1",-0.253560279726347,6.65865524098665,-2.56796414716025,0.0288688620497608,0.0894003469928075,-4.2658544238336,"NONE",FALSE,"High","Master Protein","Q96RU3","Formin-binding protein 1 [OS=Homo sapiens]",0,9.056,2,1,1,1,1,617,71.3,5.72,3.75,1,"transport;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf00611","23048","B7ZL12; E9PGQ4; hsa:23048; O60301; Q3MIN8; Q5TC87; Q5TC88; Q6P658; Q7LGG2; Q96RU3; Q9H8H8; Q9NWD1","ENSG00000187239","RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle; Clathrin-mediated endocytosis",NA,5,0,76.9,84.3,98.3,118.8,113.2,121.9,102.5,94.8,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S296(100)]",0,"ENSG00000187239"
"528","PI4KB",0.182607514915857,6.66000036802088,2.55753267430047,0.0293809705729596,0.0908139090436933,-4.28313982189144,"NONE",FALSE,"High","Master Protein","Q9UBF8","Phosphatidylinositol 4-kinase beta [OS=Homo sapiens]",0,57.255,6,4,4,5,4,816,91.3,6.25,24.3,4,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00454, Pf21245","5298","B4DGI2; hsa:5298; O15096; P78405; Q5VWB9; Q5VWC0; Q5VWC1; Q9BWR6; Q9UBF8","ENSG00000143393","Synthesis of PIPs at the Golgi membrane",NA,1,0,88.5,89.7,93,104.3,96.8,95.7,113.6,110.6,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(99.5); S277(100); S428(100)]",0,"ENSG00000143393"
"529","TUBB4B",-0.329844680868352,6.58096424706591,-2.55589752087038,0.0294620610304756,0.0908837807447853,-4.28584821159817,"NONE",FALSE,"High","Master Protein","P68371","Tubulin beta-4B chain [OS=Homo sapiens]",0,180.606,40,13,17,48,2,445,49.8,4.89,113.24,13,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response","non-structural extracellular;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00091, Pf03953","10383","A2BFA2; hsa:10383; P05217; P68371","ENSG00000188229","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Intraflagellar transport; Recycling pathway of L1; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",42,0,125.2,109.3,96.7,107.7,80,107.9,75.4,86.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S172(100); T312(100)]",0,"ENSG00000188229"
"530","EZR",-0.28123819214307,6.6446251673755,-2.55351075967146,0.0295808254906244,0.0908837807447853,-4.28980097212879,"NONE",FALSE,"High","Master Protein","P15311","Ezrin [OS=Homo sapiens]",0,48.587,11,6,7,11,4,586,69.4,6.27,29.64,6,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00373, Pf00769, Pf09379, Pf09380, Pf20492","7430","E1P5A8; hsa:7430; P15311; P23714; Q4VX75; Q96CU8; Q9NSJ4","ENSG00000092820","Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Netrin-1 signaling","Pathogenic Escherichia coli infection; AGE/RAGE pathway; VEGFA-VEGFR2 signaling; 16p11.2 proximal deletion syndrome; CCL18 signaling pathway; Regulation of actin cytoskeleton; GDNF signaling",11,0,95.8,85.1,96.8,107.9,99.2,131.2,94.9,103.5,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S535(99.6)]",0,"ENSG00000092820"
"531","ACBD5",0.302985309266083,6.58244885580303,2.55145438394977,0.029683532329931,0.0908837807447853,-4.29320604291172,"NONE",FALSE,"High","Master Protein","Q5T8D3","Acyl-CoA-binding domain-containing protein 5 [OS=Homo sapiens]",0,5.123,2,1,1,3,1,534,60.1,5.33,4.94,1,"other metabolic processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00887","91452","B3KQ56; D3DRW0; hsa:91452; Q5T8D3; Q5T8D4; Q5T8E1; Q5T8E2; Q86UV1; Q8N6E3; Q9UFB5","ENSG00000107897","RHOA GTPase cycle; RHOC GTPase cycle; Peroxisomal lipid metabolism; Class I peroxisomal membrane protein import",NA,4,0,107.7,123.2,106,87.9,64.8,76.3,112.3,100.4,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100)]",0,"ENSG00000107897"
"532","API5",0.194734849376196,6.58171074233033,2.55111513611737,0.0297005103414999,0.0908837807447853,-4.29376774239145,"NONE",FALSE,"High","Master Protein","Q9BZZ5","Apoptosis inhibitor 5 [OS=Homo sapiens]",0,27.084,4,3,3,7,3,524,59,7.34,15.62,3,"other biological processes","nucleus;other cell component","other molecular function","Pf05918","8539","B4DGR0; B4DRJ2; B4E283; D3DR21; G3V1C3; hsa:8539; O15441; Q9BZZ5; Q9Y4J7","ENSG00000166181",NA,NA,0,0,120.7,120.9,120,78.1,73.1,78.1,87.5,100.3,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S464(100); S470(100)]",0,"ENSG00000166181"
"533","UGP2",0.296714626608146,6.60874459419883,2.55071654418382,0.0297204706445006,0.0908837807447853,-4.29442768186269,"NONE",FALSE,"High","Master Protein","Q16851","UTP--glucose-1-phosphate uridylyltransferase [OS=Homo sapiens]",0.003,2.473,3,1,1,1,1,508,56.9,8.15,1.74,1,"other metabolic processes;developmental processes","cytosol;other cell component","other molecular function","Pf01704","7360","hsa:7360; Q07131; Q0P6K2; Q16851; Q86Y81; Q9BU15","ENSG00000169764","Glycogen synthesis; Formation of the active cofactor, UDP-glucuronate","Exercise-induced circadian regulation; Glycogen synthesis and degradation; Glucuronidation",5,0,65.6,70,56.7,106.6,117,105.5,127,147.7,122.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000169764"
"534","PUM1",0.305118889304876,6.65917124702101,2.55037254841154,0.0297377076701687,0.0908837807447853,-4.29499721274661,"NONE",FALSE,"High","Master Protein","Q14671","Pumilio homolog 1 [OS=Homo sapiens]",0,26.059,3,2,2,3,2,1186,126.4,6.84,10.63,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00806","9698","A8K6W4; B4DG92; D3DPN3; E9PCJ0; hsa:9698; Q14671; Q53HH5; Q5VXY7; Q9HAN1","ENSG00000134644","Golgi Associated Vesicle Biogenesis",NA,1,0,84.7,98.6,95.8,92.1,76.5,108.2,100.4,130,122,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(98.5); S709(100)]",0,"ENSG00000134644"
"535","RCC1",-0.187328155727755,6.57469829901305,-2.54666281157897,0.0299242296631347,0.0912828837574502,-4.30113829165021,"NONE",FALSE,"High","Master Protein","P18754","Regulator of chromosome condensation [OS=Homo sapiens]",0,28.103,3,2,2,10,2,421,44.9,7.52,29.81,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00415","1104","hsa:1104; P18754; Q16269; Q6NT97","ENSG00000180198","Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation","22q11.2 copy number variation syndrome",4,0,114,116.8,125.2,88,88.2,93.6,84.5,82.6,87.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000180198"
"536","ARHGAP32",-0.22461210762237,6.63160126277323,-2.54427518515286,0.0300448926855565,0.0914799717590079,-4.30508989442615,"NONE",FALSE,"High","Master Protein","A7KAX9","Rho GTPase-activating protein 32 [OS=Homo sapiens]",0,18.946,2,4,4,5,4,2087,230.4,6.74,10.72,4,"signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf14604","9743","A7KAX9; hsa:9743; I7H0B0; O94820; Q86YL6; Q8IUG4; Q9BWG3","ENSG00000134909","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle","Fragile X syndrome",13,0,94.8,86.4,95.4,102.2,126.1,110,91.9,98.7,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S871(100); S892(100); S904(100); S952(100)]",0,"ENSG00000134909"
"537","NOVA1",0.253794078470076,6.64401697644672,2.54262598080257,0.0301285208344701,0.0915637728153727,-4.30781898715049,"NONE",FALSE,"High","Master Protein","P51513","RNA-binding protein Nova-1 [OS=Homo sapiens]",0,14.266,2,1,2,3,1,507,51.7,8.72,8.58,1,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00013","4857","A8K0S4; A8K4Q7; D3DS81; D3DS82; hsa:4857; P51513; Q6B004","ENSG00000139910",NA,NA,0,0,102.1,95.2,96.9,92.3,103.1,81.5,112.1,106,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(99.3)]",0,"ENSG00000139910"
"538","GGA3",0.264843628292626,6.67754464453798,2.53743017949001,0.0303935077092032,0.0921974062851667,-4.31641483189551,"NONE",FALSE,"High","Master Protein","Q9NZ52","ADP-ribosylation factor-binding protein GGA3 [OS=Homo sapiens]",0,7.161,2,1,1,1,1,723,78.3,5.58,3.51,1,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00790, Pf02883, Pf03127, Pf18308","23163","B7Z7E2; B7Z7M9; hsa:23163; J3KRN0; Q15017; Q6IS16; Q9NZ52; Q9UJY3","ENSG00000125447","Amyloid fiber formation; TBC/RABGAPs; MET receptor recycling",NA,3,0,69.4,80,84.8,103.9,113.2,104.3,135.4,115.9,126.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100)]",0,"ENSG00000125447"
"539","AQP4",-0.224912182692418,6.59561279857569,-2.53343942812706,0.0305986098759285,0.092647367936021,-4.32301484385941,"NONE",FALSE,"High","Master Protein","P55087","Aquaporin-4 [OS=Homo sapiens]",0,49.961,9,5,8,17,5,323,34.8,7.66,40.12,5,"cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00230","361","hsa:361; P55087; P78564","ENSG00000171885","Passive transport by Aquaporins; Vasopressin regulates renal water homeostasis via Aquaporins","Spinal cord injury; Vasopressin-regulated water reabsorption; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",6,0,121.3,125.2,122.6,83.1,102.3,95.3,84.3,83.7,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S316(100); S321(99.6)]",0,"ENSG00000171885"
"540","RPS27",0.629725156331509,6.57075037248573,2.5268870573338,0.0309383540451076,0.0934251551994691,-4.33384709712611,"NONE",FALSE,"High","Master Protein","P42677","Small ribosomal subunit protein eS27 [OS=Homo sapiens]",0,11.816,24,3,3,5,3,84,9.5,9.45,11.04,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01667","6232","hsa:6232; P42677; Q5T4L6","ENSG00000177954","Separation of Sister Chromatids; Regulation of expression of SLITs and ROBOs; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",25,0,110.6,104.8,106.1,70.8,59.7,71.5,73.3,145.3,146.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100); S78(100)]",0,"ENSG00000177954"
"541","EMD",0.22166505156594,6.64765648839946,2.52628073789098,0.030969980982177,0.0934251551994691,-4.33484918438485,"NONE",FALSE,"High","Master Protein","P50402","Emerin [OS=Homo sapiens]",0,37.404,13,3,3,5,3,254,29,5.5,23.35,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity","Pf03020","2010","hsa:2010; P50402; Q6FI02","ENSG00000102119","RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina","Arrhythmogenic right ventricular cardiomyopathy; Envelope proteins and their potential roles in EDMD physiopathology; Influence of laminopathies on Wnt signaling",12,0,98.7,98.1,104.9,90.7,73.2,106,106.9,109.6,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S87(100)]",0,"ENSG00000102119"
"542","CDK12",0.17304637873879,6.61561433497962,2.52290414697733,0.0311466999572601,0.0934430250012241,-4.34042896644587,"NONE",FALSE,"High","Master Protein","Q9NYV4","Cyclin-dependent kinase 12 [OS=Homo sapiens]",0,30.762,4,6,6,12,5,1490,164.1,9.44,30.61,6,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","51755","A7E2B2; B4DYX4; B9EIQ6; hsa:51755; O94978; Q9NYV4","ENSG00000167258","TP53 Regulates Transcription of DNA Repair Genes","17q12 copy number variation syndrome",2,0,106.8,109.7,106.3,88.4,74.3,93.8,101.9,102.9,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S293(100); S423(100); T692(100); T893(100); S1083(99.7)]",0,"ENSG00000167258"
"543","STK11IP",-0.395871126934284,6.53895646542381,-2.52282612359162,0.0311507952525016,0.0934430250012241,-4.34055788243681,"NONE",FALSE,"High","Master Protein","Q8N1F8","Serine/threonine-protein kinase 11-interacting protein [OS=Homo sapiens]",0,27.312,3,4,4,9,4,1088,120.2,5.36,18.55,4,"other biological processes","non-structural extracellular;other cytoplasmic organelle;other cell component","other molecular function","Pf15904","114790","C9JQV3; hsa:114790; Q8N1F8; Q8NAW9; Q8WXE4; Q96CN3; Q96PY9","ENSG00000144589","Neutrophil degranulation",NA,1,0,112.6,114.3,114.5,88.4,122.8,86.4,68.7,77.6,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S482(100); S761(100)]",0,"ENSG00000144589"
"544","SLU7",0.192101433824201,6.54250135908666,2.52196650298037,0.0311959504988552,0.0934430250012241,-4.34197816041167,"NONE",FALSE,"High","Master Protein","O95391","Pre-mRNA-splicing factor SLU7 [OS=Homo sapiens]",0,17.82,5,2,2,4,2,586,68.3,7.14,12.36,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11708","10569","D3DQK2; hsa:10569; O95391; Q3LUJ0; Q3LUJ1; Q6RXQ5; Q96FM9","ENSG00000164609","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,4,0,126.9,123.2,119.9,82.4,59.2,76.4,88.5,92.1,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100); S466(100)]",0,"ENSG00000164609"
"545","RPS20",0.178787485707254,6.50277390318545,2.52179567417656,0.0312049317559235,0.0934430250012241,-4.34226039524844,"NONE",FALSE,"High","Master Protein","P60866","Small ribosomal subunit protein uS10 [OS=Homo sapiens]",0,26.467,33,4,5,5,4,119,13.4,9.94,9.86,4,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00338","6224","B2R4F4; B4DW28; hsa:6224; P17075; P60866; Q5M8S9","ENSG00000008988","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,140.6,129.5,125.2,69.5,56.7,74.9,83.9,85,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S93(100)]",0,"ENSG00000008988"
"546","CEP68",0.335222412112008,6.66642073264677,2.51985566659073,0.0313071073275554,0.0935772878362097,-4.34546532129217,"NONE",FALSE,"High","Master Protein","Q76N32","Centrosomal protein of 68 kDa [OS=Homo sapiens]",0,12.242,2,1,1,1,1,757,81.1,5.16,3.71,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"23177","B4DRQ1; D6W5F1; D6W5F2; hsa:23177; O60326; Q76N32; Q9BQ18; Q9UDM9","ENSG00000011523",NA,NA,0,0,82.6,88.9,93.6,89.6,114.6,89.5,135.3,110.8,113.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S478(100)]",0,"ENSG00000011523"
"547","SSR3",0.247752010278603,6.63850421805388,2.51513087241185,0.0315573435307898,0.0941528055616983,-4.35326876977301,"NONE",FALSE,"High","Master Protein","Q9UNL2","Translocon-associated protein subunit gamma [OS=Homo sapiens]",0,18.218,8,1,1,2,1,185,21.1,9.61,6.67,1,"other biological processes","other membranes;ER/Golgi",NA,"Pf07074","6747","B2R7D0; B4E2P2; D3DNK5; hsa:6747; Q549M4; Q9UNL2","ENSG00000114850","SRP-dependent cotranslational protein targeting to membrane","VEGFA-VEGFR2 signaling",2,0,111.3,103.6,113,74,85.3,97.5,107.5,105.6,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000114850"
"548","EPS8",-0.307900355159889,6.61856935311822,-2.50967494962882,0.0318487742442729,0.0948489043187105,-4.36227619800911,"NONE",FALSE,"High","Master Protein","Q12929","Epidermal growth factor receptor kinase substrate 8 [OS=Homo sapiens]",0,13.164,4,2,2,3,2,822,91.8,7.5,5.02,2,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf00018, Pf08416, Pf18016","2059","A6NMC3; A8K6W2; A8KA66; B4DX66; hsa:2059; Q12929; Q8N6J0","ENSG00000151491","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea","EGF/EGFR signaling pathway; IL-18 signaling pathway",4,0,80.3,81.5,63.3,126.9,131.3,120.7,105.5,99,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S659(100)]",0,"ENSG00000151491"
"549","JUND",0.349424541289744,6.65510548083214,2.50775266733499,0.0319520891929543,0.0949832596774161,-4.36544886560202,"NONE",FALSE,"High","Master Protein","P17535","Transcription factor JunD [OS=Homo sapiens]",0,7.345,7,1,1,1,1,347,35.2,7.37,2.62,1,"other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170, Pf03957","3727","hsa:3727; P17535; Q53EK9","ENSG00000130522","NGF-stimulated transcription; Estrogen-dependent gene expression","Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; Angiotensin II receptor type 1 pathway; Hypertrophy model; 10q11.21q11.23 copy number variation syndrome; Osteoarthritic chondrocyte hypertrophy",14,0,102.9,88.1,81.2,100.9,95.8,83.4,103.4,116.4,147,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100)]",0,"ENSG00000130522"
"550","GCFC2",-0.326973187521113,6.63717201030186,-2.50499484639258,0.0321008922614227,0.0952521021284397,-4.36999972507288,"NONE",FALSE,"High","Master Protein","P16383","Intron Large complex component GCFC2 [OS=Homo sapiens]",0,8.128,2,1,1,1,1,781,89.3,5.99,2.88,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf07842","6936","A4UHQ8; A4UHQ9; hsa:6936; O95032; P16383; Q53TY0; Q6P2F2","ENSG00000005436","mRNA Splicing - Major Pathway",NA,1,0,96.7,79.8,114.9,109.7,110.8,118.6,87,89.8,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S180(100)]",0,"ENSG00000005436"
"551","WAC",-0.33694363625191,6.5932622727212,-2.50351831057498,0.0321808438356426,0.0953160383661865,-4.37243584446418,"NONE",FALSE,"High","Master Protein","Q9BTA9","WW domain-containing adapter protein with coiled-coil [OS=Homo sapiens]",0,27.683,7,4,4,7,4,647,70.7,9.45,13.31,4,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes","nucleus","other molecular function","Pf00397","51322","A8K2A9; C9JBT9; D3DRW5; D3DRW6; D3DRW7; hsa:51322; Q53EN9; Q5JU75; Q5JU77; Q5VXK0; Q5VXK2; Q8TCK1; Q96DP3; Q96FW6; Q96JI3; Q9BTA9","ENSG00000095787","E3 ubiquitin ligases ubiquitinate target proteins",NA,1,0,84.3,91.4,81.3,104.2,151.7,101.9,90.1,89.4,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100); S64(99.6); S511(100)]",0,"ENSG00000095787"
"552","RRP12",0.22824614664503,6.62441082944316,2.49642312016085,0.0325677992372237,0.0961888391683751,-4.3841381113817,"NONE",FALSE,"High","Master Protein","Q5JTH9","RRP12-like protein [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1297,143.6,8.75,7.49,1,"RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;cytosol;nucleus;other cell component",NA,"Pf08161","23223","B4DK00; E9PCK7; hsa:23223; Q5JTH8; Q5JTH9; Q69YK4; Q96E87; Q9BUH3; Q9Y4C7","ENSG00000052749",NA,NA,0,0,104.9,92.2,92.1,84.8,83.1,103,111.3,107.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1080(100)]",0,"ENSG00000052749"
"553","PNN",0.250400409327105,6.63553299557075,2.49595666829031,0.0325933995466369,0.0961888391683751,-4.3849072076769,"NONE",FALSE,"High","Master Protein","Q9H307","Pinin [OS=Homo sapiens]",0,44.862,8,6,6,7,6,717,81.6,7.14,20.95,6,"cell adhesion;RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04696, Pf04697","5411","B4DZX8; hsa:5411; O60899; Q53EM7; Q6P5X4; Q7KYL1; Q99738; Q9H307; Q9UHZ9; Q9UQR9","ENSG00000100941","mRNA Splicing - Major Pathway",NA,1,0,98,102.1,95.8,94.9,94,82.2,100,108.1,122.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S100(100); S381(100)]",0,"ENSG00000100941"
"554","USP39",-0.231373765855622,6.62449727390057,-2.4919469428118,0.0328142903569566,0.0966659239396266,-4.39151733220658,"NONE",FALSE,"High","Master Protein","Q53GS9","Ubiquitin carboxyl-terminal hydrolase 39 [OS=Homo sapiens]",0,58.419,5,5,5,15,5,565,65.3,8.91,40.24,5,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00443, Pf02148","10713","A8K086; B3KM40; B4DHT4; D6W5L4; G5E9H0; hsa:10713; Q53GS9; Q6NX47; Q96RK9; Q9BV89; Q9H381; Q9P050; Q9Y310","ENSG00000168883","mRNA Splicing - Major Pathway",NA,1,0,90.5,90.2,95.4,104.4,129.8,102.6,95.2,93.3,102.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(99.1); S82(100)]",0,"ENSG00000168883"
"555","MRPL1",0.392476219594894,6.2775487499136,2.48775532480757,0.0330467883787589,0.0970552877959312,-4.39842499606475,"NONE",FALSE,"High","Master Protein","Q9BYD6","Large ribosomal subunit protein uL1m [OS=Homo sapiens]",0,4.52,4,1,1,1,1,325,36.9,8.78,2.57,1,"protein metabolism;other metabolic processes","other membranes;mitochondrion;translational apparatus","other molecular function","Pf00687","65008","A6NG03; hsa:65008; Q4W5B8; Q6IAG4; Q96BW3; Q9BYD6; Q9H793; Q9NRL5","ENSG00000169288","Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination",NA,3,0,185.2,177.2,153.4,42.3,35.7,33.2,72.9,55.6,73.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000169288"
"556","JMY",-0.328372980379974,6.67514299349782,-2.48742096845784,0.0330654044206726,0.0970552877959312,-4.39897590300505,"NONE",FALSE,"High","Master Protein","Q8N9B5","Junction-mediating and -regulatory protein [OS=Homo sapiens]",0,33.19,4,3,3,6,3,988,111.4,6.18,15.28,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf15871, Pf15920","133746","A1L4P5; B5MDS2; B5MDT0; hsa:133746; Q8N9B5","ENSG00000152409","Regulation of TP53 Activity through Methylation",NA,1,0,79.8,81.6,96.1,123.6,103.8,138.2,88.4,108.7,108.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100); S142(100); S713(100)]",0,"ENSG00000152409"
"557","NUCB1",-0.338980516216083,6.61528378039636,-2.4855410536232,0.0331702665934821,0.0971882856024466,-4.40207308769764,"NONE",FALSE,"High","Master Protein","Q02818","Nucleobindin-1 [OS=Homo sapiens]",0,5.691,3,1,1,1,1,461,53.8,5.25,2.86,1,"signal transduction","ER/Golgi","enzyme regulator activity;nucleic acid binding activity;other molecular function",NA,"4924","B2RD64; hsa:4924; Q02818; Q15838; Q7Z4J7; Q9BUR1","ENSG00000104805","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,97.4,96.8,93,113,133.8,94.6,103.4,82,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S369(100)]",0,"ENSG00000104805"
"558","GRB10",-0.201934434552455,6.63858811259001,-2.4841318762456,0.0332490869726395,0.0972446414683649,-4.40439440975172,"NONE",FALSE,"High","Master Protein","Q13322","Growth factor receptor-bound protein 10 [OS=Homo sapiens]",0,10.467,3,1,1,1,1,594,67.2,7.87,3.78,1,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00017, Pf00169, Pf00788, Pf08947","2887","A4D258; A7VJ95; A8K0E6; D3DVM9; hsa:2887; O00427; O00701; O75222; Q13322; Q92606; Q92907; Q92948","ENSG00000106070","RET signaling; Signaling by SCF-KIT; FLT3 Signaling; Response of EIF2AK1 (HRI) to heme deficiency; IRS activation; Signal attenuation","Kit receptor signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; EGF/EGFR signaling pathway; Insulin signaling",13,0,106.2,88.3,94.2,107.5,109.5,109.3,99.6,96.9,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000106070"
"559","DNMBP",0.447473073916589,6.62384965454436,2.48015772167277,0.0334723769814687,0.0977225746578837,-4.41093952150282,"NONE",FALSE,"High","Master Protein","Q6XZF7","Dynamin-binding protein [OS=Homo sapiens]",0,17.211,3,3,3,3,3,1577,177.2,5.39,8.08,3,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity","Pf00018, Pf00621, Pf03114, Pf07653, Pf14604","23268","hsa:23268; Q6XZF7; Q8IVY3; Q9Y2L3","ENSG00000107554","CDC42 GTPase cycle","15q11q13 copy number variation",2,0,77.2,57.3,102.8,104.6,71.2,100.5,117.6,130.1,138.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S659(100); S684(100); S1379(100)]",0,"ENSG00000107554"
"560","FAM171A2",-0.351536702377226,6.62702331182156,-2.47676750266018,0.0336640320570647,0.0981066077091601,-4.4165212138069,"NONE",FALSE,"High","Master Protein","A8MVW0","Protein FAM171A2 [OS=Homo sapiens]",0,37.936,8,3,3,5,3,826,87.4,8.05,15.39,3,NA,"other membranes",NA,"Pf10577, Pf20771","284069","A8MQB4; A8MVW0; hsa:284069","ENSG00000161682",NA,NA,0,0,95.8,93.5,92,103.1,92,141,85.5,100.4,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S446(100); S789(100)]",0,"ENSG00000161682"
"561","PRICKLE2",0.224171156720237,6.65893770308822,2.47405787086974,0.0338179935362494,0.098260387626318,-4.4209812298925,"NONE",FALSE,"High","Master Protein","Q7Z3G6","Prickle-like protein 2 [OS=Homo sapiens]",0,15.131,3,2,3,5,2,844,95.6,7.36,6.38,2,"cell-cell signaling;signal transduction","other membranes;nucleus;other cell component","other molecular function","Pf00412, Pf06297","166336","hsa:166336; Q0VF44; Q7Z3G6","ENSG00000163637",NA,"Wnt signaling",1,0,81.8,95.2,84.1,104.1,92.5,99.8,107.7,114,131,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S753(100); S806(99.7)]",0,"ENSG00000163637"
"562","RBBP6",0.167357227906263,6.63203827869737,2.47372041063473,0.0338372168173963,0.098260387626318,-4.42153661282978,"NONE",FALSE,"High","Master Protein","Q7Z6E9","E3 ubiquitin-protein ligase RBBP6 [OS=Homo sapiens]",0,89.919,4,9,9,18,9,1792,201.4,9.64,55.65,9,"protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf04564, Pf08783, Pf13696","5930","Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q7Z6E9; Q8N0V2; Q96PH3; Q9H3I8; Q9H5M5; Q9NPX4","ENSG00000122257","RHOBTB1 GTPase cycle; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,106.6,107.6,107.5,91.9,80.1,91.5,105.6,102.3,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S730(100); S772(100); S861(100); S1179(100); S1277(100); T1468(100)]",0,"ENSG00000122257"
"563","NIBAN2",-0.24757798470364,6.60993692034396,-2.47125806346879,0.0339778112938727,0.0984934068056841,-4.42558859329618,"NONE",FALSE,"High","Master Protein","Q96TA1","Protein Niban 2 [OS=Homo sapiens]",0,35.76,3,1,3,8,1,746,84.1,6.19,24.94,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function",NA,"64855","hsa:64855; Q4LE55; Q5VVW6; Q5VVW7; Q96TA1; Q9BUS2; Q9NT35","ENSG00000136830",NA,NA,0,0,55.6,53,63.9,124.6,142.1,146.8,103.6,118.2,131.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S691(99); S692(100)]",0,"ENSG00000136830"
"564","C2CD5",0.184247449544474,6.65873445660227,2.45435726708688,0.0349585359434567,0.101156614644896,-4.45337684196598,"NONE",FALSE,"High","Master Protein","Q86YS7-3","Isoform 3 of C2 domain-containing protein 5 [OS=Homo sapiens]",0,97.313,12,8,11,18,8,1051,116,5.87,56.55,8,NA,NA,NA,NA,NA,"Q86YS7-3",NA,NA,NA,0,0,98.4,94.6,91.7,99.3,82.5,104.3,106.6,113.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S260(100); S281(98.1); S295(100); S307(99.5); T339(100); S643(100); S659(99.8); S864(100)]",0,"ENSG00000111731"
"565","SEPTIN7",-0.23228831062771,6.65398875692802,-2.45149026762845,0.0351276587174549,0.10146608677325,-4.45808665501449,"NONE",FALSE,"High","Master Protein","Q16181","Septin-7 [OS=Homo sapiens]",0,71.021,15,8,8,19,8,437,50.6,8.63,53.8,8,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00735","989","hsa:989; Q16181; Q52M76; Q6NX50","ENSG00000122545","MAPK6/MAPK4 signaling",NA,1,0,97.9,101,95.5,118.4,98.2,110.3,91.4,105.4,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T228(100); S334(100); T426(100)]",0,"ENSG00000122545"
"566","CLASP2",0.201154999574562,6.67221965316323,2.44854558189151,0.0353022062139443,0.101790106963175,-4.46292283024034,"NONE",FALSE,"High","Master Protein","O75122","CLIP-associating protein 2 [OS=Homo sapiens]",0,83.747,6,4,6,13,4,1294,141,8.4,49.02,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf12348, Pf21040","23122","B2RTR1; F5H604; hsa:23122; O75122; Q7L8F6; Q8N6R6; Q9BQT3; Q9BQT4; Q9H7A3; Q9NSZ2","ENSG00000163539","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Role of ABL in ROBO-SLIT signaling","7q11.23 copy number variation syndrome",8,0,81.5,85.1,83.2,100.7,115.8,100.4,116.7,114.3,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S370(99.8); S404(98.8); S525(100); S529(99.3); S596(100)]",0,"ENSG00000163539"
"567","ABCF1",0.196179987610574,6.65966750357213,2.44333317894285,0.0356132777579671,0.102389457931113,-4.47148021764047,"NONE",FALSE,"High","Master Protein","Q8NE71","ATP-binding cassette sub-family F member 1 [OS=Homo sapiens]",0,105.238,6,5,7,16,5,845,95.9,6.8,69.1,5,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00005","23","A2BF75; hsa:23; O14897; Q69YP6; Q8NE71","ENSG00000204574; ENSG00000206490; ENSG00000225989; ENSG00000231129; ENSG00000232169; ENSG00000236149; ENSG00000236342","ABC-family proteins mediated transport","IL-18 signaling pathway",2,0,70.4,69.9,73.2,107.7,128.6,105.7,121.7,124.1,135.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(100); S166(100); S228(100)]",0,"ENSG00000204574"
"568","ZFP36L1",-0.284577438594758,6.66489786796051,-2.44296176282807,0.0356355466328874,0.102389457931113,-4.47208983009612,"NONE",FALSE,"High","Master Protein","Q07352","mRNA decay activator protein ZFP36L1 [OS=Homo sapiens]",0,6.607,6,2,2,2,2,338,36.3,7.96,3.06,2,"cell adhesion;cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00642, Pf04553","677","hsa:677; Q07352; Q13851","ENSG00000185650","Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","Modulators of TCR signaling and T cell activation",2,0,88.5,84.1,74.4,117.3,107.4,139.9,98.1,104.8,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S90(100)]",0,"ENSG00000185650"
"569","SUB1",0.344722435448745,6.47625555775718,2.43916881663338,0.0358637480990769,0.102759982900172,-4.47831408092297,"NONE",FALSE,"High","Master Protein","P53999","Activated RNA polymerase II transcriptional coactivator p15 [OS=Homo sapiens]",0,44.446,40,4,8,9,4,127,14.4,9.6,24.63,4,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02229","10923","hsa:10923; P53999; Q96L29","ENSG00000113387",NA,NA,0,0,117.9,113,111.5,62.4,70.4,62.6,78.7,91,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100); S56(99.1); S118(100)]",0,"ENSG00000113387"
"570","RSL1D1",0.201532392967957,6.57226733586151,2.43872680707487,0.0358904352041041,0.102759982900172,-4.47903928074939,"NONE",FALSE,"High","Master Protein","O76021","Ribosomal L1 domain-containing protein 1 [OS=Homo sapiens]",0,37.719,6,2,3,12,2,490,54.9,10.13,40.94,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity","Pf00687","26156","B4DJ58; D3DUG7; hsa:26156; O76021; Q2M1T7; Q6PL22; Q8IWS7; Q8WUZ1; Q9HDA9; Q9Y3Z9","ENSG00000171490",NA,NA,0,0,113.2,107.2,110,75.3,82.6,82.4,92.3,100,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100); S427(100)]",0,"ENSG00000171490"
"571","CSPG5",-0.257791889505357,6.60059448713202,-2.43606572577033,0.0360515176519873,0.102973680723919,-4.48340466064664,"NONE",FALSE,"High","Master Protein","O95196","Chondroitin sulfate proteoglycan 5 [OS=Homo sapiens]",0,23.215,5,3,3,4,3,566,60,4.5,10.71,3,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding","Pf06566, Pf06567","10675","hsa:10675; O95196; Q71M39; Q71M40","ENSG00000114646","A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective B3GALT6 causes EDSP2 and SEMDJL1; Chondroitin sulfate biosynthesis; Dermatan sulfate biosynthesis; CS/DS degradation; Defective CHST3 causes SEDCJD; Defective CHST14 causes EDS, musculocontractural type; Defective CHSY1 causes TPBS",NA,10,0,123.8,111.3,109.9,104.6,101.3,87.1,94.1,82.5,83,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T493(100); S543(100)]",0,"ENSG00000114646"
"572","PDLIM3",-0.217648461267776,6.62056319863357,-2.43541089691847,0.0360912655478442,0.102973680723919,-4.48447871221279,"NONE",FALSE,"High","Master Protein","Q53GG5-2","Isoform 2 of PDZ and LIM domain protein 3 [OS=Homo sapiens]",0,15.2,7,1,2,6,1,316,34.3,7.71,15.71,1,NA,NA,NA,NA,NA,"Q53GG5-2",NA,NA,NA,0,0,86.8,89.8,90.5,115.3,120.6,99.1,95,100.4,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(99.4)]",0,"ENSG00000154553"
"573","BNIP3L",-0.233636813461928,6.65672263547982,-2.43391404047238,0.0361822868249761,0.103053214831346,-4.48693361404193,"NONE",FALSE,"High","Master Protein","O60238","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like [OS=Homo sapiens]",0,2.831,4,2,3,3,2,219,23.9,5.85,4.2,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;mitochondrion;ER/Golgi;nucleus","other molecular function","Pf06553","665","B0AZS9; hsa:665; O60238; Q5JW63; Q8NF87","ENSG00000104765","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","Apoptosis; Photodynamic therapy-induced HIF-1 survival signaling",3,0,70.3,67.1,79.7,117.1,143.4,128.4,100.4,119.2,111.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S168(100)]",0,"ENSG00000104765"
"574","RFC1",0.234291124288263,6.5002872869549,2.43139335181325,0.0363360780404526,0.103310939655085,-4.49106686688094,"NONE",FALSE,"High","Master Protein","P35251","Replication factor C subunit 1 [OS=Homo sapiens]",0,21.463,4,4,4,4,4,1148,128.2,9.36,10.69,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00004, Pf00533, Pf08519","5981","A8K6E7; hsa:5981; P35251; Q5XKF5; Q6PKU0; Q86V41; Q86V46","ENSG00000035928","Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER","miRNA regulation of DNA damage response; DNA replication; Male infertility; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",22,0,146.3,137.3,134,65.8,54.6,66.9,75.1,92.3,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100); S190(100); S368(100)]",0,"ENSG00000035928"
"575","SNN",-0.232095118821999,6.65822663943383,-2.42933229526295,0.0364623057434711,0.103489535605817,-4.49444572261541,"NONE",FALSE,"High","Master Protein","O75324","Stannin [OS=Homo sapiens]",0,18.973,32,2,2,2,2,88,9.5,5.31,6.41,2,"other biological processes","other membranes;mitochondrion;other cell component","other molecular function","Pf09049, Pf09050, Pf09051","8303","D3DUG4; hsa:8303; O75324; Q6FGI0","ENSG00000184602",NA,NA,0,0,90.2,85.5,86.1,120.2,105.2,121.6,108.7,101.8,93.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S66(100)]",0,"ENSG00000184602"
"576","PPP1CB",-0.270517704623566,6.60578660102946,-2.42771010789067,0.0365619595563087,0.103592218742875,-4.4971046448937,"NONE",FALSE,"High","Master Protein","P62140","Serine/threonine-protein phosphatase PP1-beta catalytic subunit [OS=Homo sapiens]",0,7.871,5,1,1,2,1,327,37.2,6.19,5.84,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00149, Pf16891","5500","B2R5V4; D6W565; hsa:5500; P37140; P62140; Q5U087; Q6FG45","ENSG00000213639","Circadian Clock; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; Triglyceride catabolism; Regulation of PLK1 Activity at G2/M Transition; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PAKs; Downregulation of TGF-beta receptor signaling; Maturation of hRSV A proteins","Common pathways underlying drug addiction; Focal adhesion; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Airway smooth muscle cell contraction; Neuroinflammation and glutamatergic signaling; G13 signaling pathway",19,0,106.4,105.4,107.5,94.9,82.9,124.6,91.1,86.1,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T316(100)]",0,"ENSG00000213639"
"577","F2R",-0.262321118830377,6.67096124626582,-2.42396903653922,0.0367928059175632,0.104065613964407,-4.50323507098735,"NONE",FALSE,"High","Master Protein","P25116","Proteinase-activated receptor 1 [OS=Homo sapiens]",0,14.069,4,1,1,1,1,425,47.4,8.27,3.93,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00001","2149","hsa:2149; P25116; Q53XV0; Q96RF7; Q9BUN4","ENSG00000181104","G alpha (q) signalling events; Peptide ligand-binding receptors; Thrombin signalling through proteinase activated receptors (PARs); Common Pathway of Fibrin Clot Formation","GPCRs, other; Apoptosis-related network due to altered Notch3 in ovarian cancer; IL1 and megakaryocytes in obesity; Dengue-2 interactions with complement and coagulation cascades; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; GPCRs, class A rhodopsin-like; Regulation of actin cytoskeleton; Complement and coagulation cascades",13,0,67.9,70.4,72.2,133.8,153.1,117.9,107.8,123.5,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S418(100)]",0,"ENSG00000181104"
"578","NOP56",0.189394309358869,6.64526187209735,2.40766203076517,0.0378159490279741,0.10677444431428,-4.52993139814886,"NONE",FALSE,"High","Master Protein","O00567","Nucleolar protein 56 [OS=Homo sapiens]",0,130.673,11,5,10,29,5,594,66,9.19,85.34,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01798, Pf08156","10528","hsa:10528; O00567; Q2M3T6; Q9NQ05","ENSG00000101361","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; Association of TriC/CCT with target proteins during biosynthesis",NA,3,0,102.1,105.1,102.3,85.9,94,94,100.3,105.8,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T468(98.4); S519(99.6)]",0,"ENSG00000101361"
"579","HCFC1",0.248621595465154,6.64547445637944,2.40545154349621,0.0379567816852849,0.106850860666508,-4.53354694181944,"NONE",FALSE,"High","Master Protein","P51610","Host cell factor 1 [OS=Homo sapiens]",0,45.601,3,2,2,5,2,2035,208.6,7.46,27.6,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus;other cell component","other molecular function","Pf01344, Pf13415, Pf13854","3054","hsa:3054; P51610; Q6P4G5","ENSG00000172534","UCH proteinases; Formation of WDR5-containing histone-modifying complexes; Transcriptional activation of mitochondrial biogenesis; HATs acetylate histones","Mitochondrial gene expression; Pleural mesothelioma",6,0,97,85.7,92.3,87.8,80,115.2,109.7,112.5,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1507(100)]",0,"ENSG00000172534"
"580","LBR",0.181440887603948,6.59663750476031,2.40518250238308,0.0379739578349109,0.106850860666508,-4.53398694022987,"NONE",FALSE,"High","Master Protein","Q14739","Delta(14)-sterol reductase LBR [OS=Homo sapiens]",0,20.417,4,4,4,11,4,615,70.7,9.36,15.81,4,"other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01222, Pf09465","3930","B2R5P3; hsa:3930; Q14739; Q14740; Q53GU7; Q59FE6","ENSG00000143815","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Regulation of MECP2 expression and activity; Initiation of Nuclear Envelope (NE) Reformation; Cholesterol biosynthesis","Gastric cancer network 2; Envelope proteins and their potential roles in EDMD physiopathology; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism",18,0,112.4,106,111.8,84.4,75.9,88.2,105.1,96.6,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(99.7); S99(100); S516(100)]",0,"ENSG00000143815"
"581","FBXL7",0.213005007743493,6.63583056491015,2.40227874834883,0.0381598275587451,0.107095391988337,-4.5387350859108,"NONE",FALSE,"High","Master Protein","Q9UJT9","F-box/LRR-repeat protein 7 [OS=Homo sapiens]",0,9.382,5,1,1,1,1,491,54.5,8.27,3.66,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;other cell component",NA,"Pf00646, Pf13516","23194","B9EGF1; D6RDY7; hsa:23194; O94926; Q9UJT9","ENSG00000183580","Antigen processing: Ubiquitination & Proteasome degradation; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Neddylation",NA,3,0,85.4,92.2,91.6,99.4,98.2,91.6,107.6,105.7,126,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100)]",0,"ENSG00000183580"
"582","KAZN",-0.332613637407666,6.62513345682813,-2.40177588686179,0.0381921067017231,0.107095391988337,-4.53955721330028,"NONE",FALSE,"High","Master Protein","Q674X7","Kazrin [OS=Homo sapiens]",0,7.571,4,2,2,2,2,775,86.3,7.03,4.2,2,"other biological processes","plasma membrane;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf00536, Pf07647","23254","B0QYQ0; B1AJZ1; B1AK78; hsa:23254; Q5TGF1; Q674X4; Q674X6; Q674X7; Q6ZUD1; Q8IYN7; Q8N409; Q9UIL2; Q9UPX4","ENSG00000189337","Formation of the cornified envelope",NA,1,0,109.6,92.9,99.6,102.5,100.2,124.6,76.1,95.6,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S769(100)]",0,"ENSG00000189337"
"583","YAP1",-0.590627989060689,6.57289756928632,-2.39867325219219,0.0383918633129566,0.1073782400345,-4.54462879326459,"NONE",FALSE,"High","Master Protein","P46937","Transcriptional coactivator YAP1 [OS=Homo sapiens]",0,19.879,13,3,3,4,3,504,54.4,5.17,6.44,3,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00397","10413","B4DTY1; B7ZA01; E3WEB5; E3WEB6; E9PRV2; F5H202; hsa:10413; K0KQ18; K0KYZ8; K0L195; K0L1G3; P46937; Q7Z574; Q8IUY9","ENSG00000137693","Nuclear signaling by ERBB4; RUNX2 regulates osteoblast differentiation; Zygotic genome activation (ZGA); RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of axial mesoderm; Signaling by Hippo; YAP1- and WWTR1 (TAZ)-stimulated gene expression; EGR2 and SOX10-mediated initiation of Schwann cell myelination; RUNX3 regulates YAP1-mediated transcription","Mesodermal commitment pathway; Mesodermal commitment pathway; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; miR-509-3p alteration of YAP1/ECM axis; Ciliary landscape; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-YAP signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Leukocyte-intrinsic Hippo pathway functions; Netrin-UNC5B signaling pathway; Galanin receptor pathway; Pleural mesothelioma; GNAQ pathways in port-wine stain",24,0,91.7,102.8,94.8,94.9,119.4,136.2,64,73.7,121.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(99.4); S367(99.3)]",0,"ENSG00000137693"
"584","CBL",-0.189791193209651,6.64578480997628,-2.39816682192009,0.0384245662868552,0.1073782400345,-4.54545645692048,"NONE",FALSE,"High","Master Protein","P22681","E3 ubiquitin-protein ligase CBL [OS=Homo sapiens]",0,23.182,2,1,2,8,1,906,99.6,6.54,25.74,1,"protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00097, Pf00627, Pf02262, Pf02761, Pf02762","867","A3KMP8; P22681","ENSG00000110395","Spry regulation of FGF signaling; Regulation of signaling by CBL; Regulation of KIT signaling; Negative regulation of FLT3; Cargo recognition for clathrin-mediated endocytosis; Interleukin-6 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Signaling by CSF1 (M-CSF) in myeloid cells; TGF-beta receptor signaling activates SMADs; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; FLT3 signaling by CBL mutants","RANKL/RANK signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Physico-chemical features and toxicity-associated pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; IL-4 signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; Insulin signaling; IL-2 signaling pathway; 4p16.3 copy number variation; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway",39,0,87.7,93.8,98.6,106.7,104,119,95.3,105.6,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S483(100)]",0,"ENSG00000110395"
"585","NAV2",0.167194459079485,6.65946038197844,2.39457620638938,0.0386572198593778,0.107728884397506,-4.55132342440111,"NONE",FALSE,"High","Master Protein","Q8IVL1","Neuron navigator 2 [OS=Homo sapiens]",0,32.148,2,5,6,8,5,2488,268,9.03,19.57,5,"cell organization and biogenesis;developmental processes;other biological processes","extracellular matrix;nucleus","other molecular function","Pf00307","89797","A6NEC1; hsa:89797; Q8IVK3; Q8IVK4; Q8IVK5; Q8IVK6; Q8IVK7; Q8IVK8; Q8IVL1; Q8NHC9; Q8NHD0; Q8TDE9; Q8TDF0; Q8TEB3; Q96B30; Q9NUZ6; Q9NVM7; Q9P2C8","ENSG00000166833",NA,NA,0,0,79.5,80.1,83.2,101.6,108.8,109.6,113.4,114.8,128.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S311(100); S458(100); S1104(100); S1319(99.7); S1977(99.6)]",0,"ENSG00000166833"
"586","TJAP1",0.185055477403113,6.66330543352976,2.39419405749321,0.0386820626574377,0.107728884397506,-4.55194772014571,"NONE",FALSE,"High","Master Protein","Q5JTD0","Tight junction-associated protein 1 [OS=Homo sapiens]",0,46.731,8,3,3,7,3,557,61.8,5.97,27.8,3,"cell organization and biogenesis","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf15453","93643","hsa:93643; Q05BH9; Q5JTD0; Q5JTD1; Q5JWW1; Q68DB2; Q6P2P3; Q9H7V7","ENSG00000137221",NA,NA,0,0,89.4,92.2,93.4,95.6,108.4,96,111.6,110.2,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S300(100); T422(100); S545(100)]",0,"ENSG00000137221"
"587","ENGASE",-0.346839396965771,6.58996778075673,-2.39237991632502,0.0388002111718929,0.107873840941276,-4.55491105378455,"NONE",FALSE,"High","Master Protein","Q8NFI3","Cytosolic endo-beta-N-acetylglucosaminidase [OS=Homo sapiens]",0,7.923,2,1,1,1,1,743,83.9,6.79,2.63,1,"protein metabolism;other metabolic processes","cytosol","other molecular function","Pf03644","64772","hsa:64772; Q659F0; Q8NFI3; Q8TB86; Q9H6U4","ENSG00000167280","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",NA,1,0,107.5,91.5,101.3,105.1,87.4,121.6,99.6,92.9,73.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(99.6)]",0,"ENSG00000167280"
"588","S1PR1",0.229676309518211,6.6574974339489,2.39046575096215,0.0389252589709566,0.10803745347041,-4.55803718147134,"NONE",FALSE,"High","Master Protein","P21453","Sphingosine 1-phosphate receptor 1 [OS=Homo sapiens]",0,11.678,3,1,1,2,1,382,42.8,9.5,6.91,1,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00001","1901","D3DT66; hsa:1901; P21453; Q9BYY4; Q9NYN8","ENSG00000170989","Potential therapeutics for SARS; Interleukin-4 and Interleukin-13 signaling; Lysosphingolipid and LPA receptors","GPCRs, other; Small ligand GPCRs; S1P receptor signal transduction; VEGFA-VEGFR2 signaling; Sphingolipid metabolism in senescence; GDNF signaling; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Primary ovarian insufficiency",11,0,97.1,94.5,98.1,84.5,86.4,111.3,112.6,113.8,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000170989"
"589","RBM15",0.183738750874212,6.64615270829024,2.38133766883641,0.0395270492955885,0.109521467657726,-4.57293632020938,"NONE",FALSE,"High","Master Protein","Q96T37","RNA-binding protein 15 [OS=Homo sapiens]",0,75.389,7,8,10,22,8,977,107.1,10.08,54.93,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf07744","64783","A1A693; hsa:64783; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4; Q96SC5; Q96SC6; Q96SC9; Q96SD0; Q96T37; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0","ENSG00000162775",NA,NA,0,0,101.5,104,98.2,91.8,77.5,103.5,106,106.3,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); S128(100); S294(100); T568(100); S670(100); S674(100); S700(100); S708(100)]",0,"ENSG00000162775"
"590","EFR3A",0.296864816920784,6.62367353604332,2.36695744690365,0.0404937035395738,0.112009701994211,-4.59637942474033,"NONE",FALSE,"High","Master Protein","Q14156","Protein EFR3 homolog A [OS=Homo sapiens]",0,4.393,2,1,1,1,1,821,92.9,6.7,2.32,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol",NA,"Pf21052","23167","A7MD19; hsa:23167; Q14156; Q2VPK2; Q63HL7; Q68DX1; Q6IQ18","ENSG00000132294",NA,NA,0,0,98.1,91.1,79,96.2,99.4,83.4,123.8,113.3,104.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S694(100)]",0,"ENSG00000132294"
"591","STX17",0.265494132733239,6.66400618100133,2.36342945407013,0.0407343847080454,0.112484798381608,-4.60212540823492,"NONE",FALSE,"High","Master Protein","P56962","Syntaxin-17 [OS=Homo sapiens]",0,17.27,5,1,2,2,1,302,33.4,6.57,6.7,1,"cell organization and biogenesis;other metabolic processes;transport","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function",NA,"55014","hsa:55014; P56962; Q4VXC2","ENSG00000136874","COPII-mediated vesicle transport",NA,1,0,96.4,86.7,80.1,99.1,102.7,95.5,129.7,112.7,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S289(99.6)]",0,"ENSG00000136874"
"592","RPRD1A",-0.2944829114817,6.61812888244863,-2.35518463406846,0.0413023394209498,0.113860503268564,-4.61554507402793,"NONE",FALSE,"High","Master Protein","Q96P16","Regulation of nuclear pre-mRNA domain-containing protein 1A [OS=Homo sapiens]",0,15.2,8,1,1,1,1,312,35.7,7.55,4.42,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf04818, Pf16566","55197","A8KA42; B2RBA3; hsa:55197; Q7Z5G8; Q96FY9; Q96P16; Q9NVL4","ENSG00000141425","RNA polymerase II transcribes snRNA genes",NA,1,0,99.1,81.6,92.9,95.1,116.5,128.5,93.4,102.2,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S156(99.7)]",0,"ENSG00000141425"
"593","SLC23A2",-0.196619868831848,6.60192316940014,-2.35070339359205,0.0416142875225971,0.114527010517502,-4.62283389007485,"NONE",FALSE,"High","Master Protein","Q9UGH3","Solute carrier family 23 member 2 [OS=Homo sapiens]",0,14.406,3,1,2,3,1,650,70.3,7.68,7.65,1,"cell adhesion;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00860","9962","B4DJZ1; hsa:9962; Q8WWR4; Q92512; Q96D54; Q9UGH3; Q9UNU1; Q9UP85","ENSG00000089057","Vitamin C (ascorbate) metabolism",NA,1,0,107.1,114.8,102.5,99.9,98.7,95.8,82.9,93.4,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(100)]",0,"ENSG00000089057"
"594","RBSN",0.736471311601375,6.60303761287623,2.34888798022421,0.041741318831234,0.114683219415108,-4.6257856668593,"NONE",FALSE,"High","Master Protein","Q9H1K0","Rabenosyn-5 [OS=Homo sapiens]",0,7.609,3,2,2,2,2,784,88.8,5.5,4.33,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf01363, Pf11464, Pf16601","64145","B4DWY8; C9J4P5; hsa:64145; Q3KP30; Q59EY8; Q8NAQ1; Q9H1K0","ENSG00000131381","Factors involved in megakaryocyte development and platelet production; Toll Like Receptor 9 (TLR9) Cascade",NA,2,0,95.2,104.6,68,50.2,148.8,64.3,131,116.7,144.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(99.2); S548(100)]",0,"ENSG00000131381"
"595","PABPN1",0.20455910641802,6.60493860437655,2.34743006946678,0.0418436096064076,0.114771043491861,-4.62815573129845,"NONE",FALSE,"High","Master Protein","Q86U42","Polyadenylate-binding protein 2 [OS=Homo sapiens]",0,31.836,22,2,2,5,2,306,32.7,5.06,18.21,2,"RNA metabolism OR transcription;other metabolic processes;transport;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","8106","D3DS49; hsa:8106; O43484; Q86U42","ENSG00000100836","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs; Inhibition of Host mRNA Processing and RNA Silencing; Z-decay: degradation of maternal mRNAs by zygotically expressed factors","mRNA processing",7,0,120.5,126.7,132,72.2,80.1,78,93.6,94.4,98.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S150(100)]",0,"ENSG00000100836"
"596","SUGP2",-0.19915315361387,6.50502196268878,-2.34132425726597,0.0422746858137107,0.115758871221436,-4.63807750974295,"NONE",FALSE,"High","Master Protein","Q8IX01","SURP and G-patch domain-containing protein 2 [OS=Homo sapiens]",0,18.549,2,1,1,3,1,1082,120.1,7.28,10.35,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf01585, Pf01805","10147","C9JI71; hsa:10147; O15071; O60369; Q5JPH7; Q8IX01; Q8WUF7","ENSG00000064607",NA,"mRNA processing",1,0,136.2,137,141.3,79.9,61.1,89.1,76.3,73.2,76.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S277(99.3)]",0,"ENSG00000064607"
"597","MCM2",0.355952200605551,6.6397824389944,2.33723138968357,0.0425660799301376,0.116361545135653,-4.64472449847522,"NONE",FALSE,"High","Master Protein","P49736","DNA replication licensing factor MCM2 [OS=Homo sapiens]",0,12.237,2,2,2,2,2,904,101.8,5.52,4.58,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00493, Pf12619, Pf14551, Pf17207, Pf17855","4171","hsa:4171; P49736; Q14577; Q15023; Q8N2V1; Q969W7; Q96AE1; Q9BRM7","ENSG00000073111","Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA","Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication; 1p36 copy number variation syndrome",11,0,84.6,104.6,94.4,86.8,93.2,87.7,92.3,136.5,125.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(99.2)]",0,"ENSG00000073111"
"598","KLF3",-0.444086981474048,6.61350313676632,-2.33230053606025,0.0429197492540117,0.11690883047245,-4.65272831303508,"NONE",FALSE,"High","Master Protein","P57682","Krueppel-like factor 3 [OS=Homo sapiens]",0,15.212,8,2,2,3,2,345,38.8,9.38,6.11,2,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","51274","hsa:51274; P57682; Q6PIR1; Q86TN0; Q9P2X6","ENSG00000109787",NA,NA,0,0,95.6,100.2,94.1,97.3,84.1,166.5,84.5,89.5,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.4); S250(100)]",0,"ENSG00000109787"
"599","CSNK1E",-0.168095015877454,6.63841261337704,-2.33202268600559,0.0429397637021675,0.11690883047245,-4.65317918815447,"NONE",FALSE,"High","Master Protein","P49674","Casein kinase I isoform epsilon [OS=Homo sapiens]",0,16.914,6,2,3,4,2,416,47.3,9.66,11.41,2,"cell-cell signaling;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","102800317; 1454","hsa:102800317; hsa:1454; P49674","ENSG00000213923","Major pathway of rRNA processing in the nucleolus and cytosol; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Circadian Clock; WNT mediated activation of DVL","Alzheimer's disease and miRNA effects; Melatonin metabolism and effects; Wnt signaling pathway; Wnt signaling pathway and pluripotency; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Pleural mesothelioma; Alzheimer's disease",20,0,81.2,86.2,79.4,114.8,118.8,114.5,99.1,106.4,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(99.5); S389(100)]",0,"ENSG00000213923"
"600","ADAM17",0.551785990714428,6.59390488424466,2.33144802148187,0.042981187673695,0.11690883047245,-4.65411166693747,"NONE",FALSE,"High","Master Protein","P78536","Disintegrin and metalloproteinase domain-containing protein 17 [OS=Homo sapiens]",0,11.362,3,2,2,3,2,824,93,5.76,6.98,2,"cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00200, Pf13574, Pf16698","6868","hsa:6868; O60226; P78536","ENSG00000151694","Collagen degradation; Release of Hh-Np from the secreting cell; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant; Growth hormone receptor signaling; Nuclear signaling by ERBB4; Signaling by EGFR; TNF signaling; CD163 mediating an anti-inflammatory response; Regulated proteolysis of p75NTR","Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Notch signaling; Copper homeostasis; Ebola virus infection in host; Soluble ACE2-mediated cell entry of SARS-CoV-2; Interactions of natural killer cells in pancreatic cancer; Alzheimer's disease; TROP2 regulatory signaling; Notch signaling pathway",23,0,81.7,85.1,91.5,65.3,124.6,69.8,142.4,94.5,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S791(100); S819(100)]",0,"ENSG00000151694"
"601","USP8",-0.16609615048306,6.66309335786834,-2.3279042975301,0.043237498606227,0.117410312355012,-4.6598605264237,"NONE",FALSE,"High","Master Protein","P40818","Ubiquitin carboxyl-terminal hydrolase 8 [OS=Homo sapiens]",0,76.617,4,5,7,11,5,1118,127.4,8.51,49.73,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00443, Pf00581, Pf08969, Pf20625","9101","B4DKA8; hsa:9101; P40818; Q2TB31; Q7Z3U2; Q86VA0; Q8IWI7","ENSG00000138592","Negative regulation of MET activity; Ub-specific processing proteases; Downregulation of ERBB2:ERBB3 signaling; Regulation of FZD by ubiquitination","EGF/EGFR signaling pathway; Male infertility",6,0,88.6,90.3,93,110.4,120.1,110.5,97,105.4,105.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S392(100); T577(100)]",0,"ENSG00000138592"
"602","ZKSCAN8",-0.254947505518314,6.40864807252328,-2.32563734006127,0.0434022476060324,0.117661907131304,-4.6635368996071,"NONE",FALSE,"High","Master Protein","Q15776","Zinc finger protein with KRAB and SCAN domains 8 [OS=Homo sapiens]",0,20.392,3,1,1,2,1,578,65.8,7.39,8.19,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352, Pf02023","7745","A1L3D4; B4DYF1; hsa:7745; Q15776; Q4VAR1; Q4VAR2; Q4VAR3; Q9H4T1","ENSG00000198315","Generic Transcription Pathway",NA,1,0,152.4,137.6,164.9,70,52,73.4,63.3,67.5,66.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100)]",0,"ENSG00000198315"
"603","EXOC1",-0.385293374982597,6.68623369657204,-2.32132049206485,0.0437176711925329,0.118320463327054,-4.67053494792501,"NONE",FALSE,"High","Master Protein","Q9NV70-2","Isoform 2 of Exocyst complex component 1 [OS=Homo sapiens]",0,31.987,6,4,7,12,4,879,100.2,6.6,36.6,4,NA,NA,NA,NA,NA,"Q9NV70-2",NA,NA,NA,0,0,87.5,89.9,90.4,129.4,86.8,148.3,94,111.1,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S448(100); S455(100); S458(99.7); S467(99.5); S486(100)]",0,"ENSG00000090989"
"604","RAB12",-0.203805592532968,6.58029795313086,-2.3187895989107,0.0439036404550026,0.118627055004245,-4.67463614159425,"NONE",FALSE,"High","Master Protein","Q6IQ22","Ras-related protein Rab-12 [OS=Homo sapiens]",0,15.2,8,1,1,2,1,244,27.2,8.41,10.71,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle","other molecular function","Pf00071","201475","A6NEF5; hsa:201475; Q4KMQ3; Q6IQ22",NA,"RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation",NA,2,0,109.4,120.5,105.8,95.7,89.5,96,85.5,81,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000206418"
"605","MAP2K2",-0.340660372489328,6.66468967398243,-2.31156596680173,0.0444386970921206,0.119874303560894,-4.68633497116812,"NONE",FALSE,"High","Master Protein","P36507","Dual specificity mitogen-activated protein kinase kinase 2 [OS=Homo sapiens]",0,29.522,11,2,2,6,2,400,44.4,6.55,12.98,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069","5605","hsa:5605; P36507","ENSG00000126934","Signaling by BRAF and RAF1 fusions; Uptake and function of anthrax toxins; Signal transduction by L1; RAF activation; MAPK1 (ERK2) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Negative feedback regulation of MAPK pathway; Signaling by MAP2K mutants","IL-5 signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; IL6 signaling pathway; Pathways affected in adenoid cystic carcinoma; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ethanol metabolism production of ROS by CYP2E1; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Kallmann syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; Acute myeloid leukemia; Macrophage-stimulating protein (MSP) signaling network map; GNAQ pathways in port-wine stain; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling; Toll-like receptor signaling pathway",88,0,102.4,86.1,87.5,116.9,104.1,132,81.8,113.4,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T394(100)]",0,"ENSG00000126934"
"606","MAP7D1",0.182723780273081,6.66152162910971,2.30996217265846,0.0445583527420617,0.119998732137037,-4.6889309898371,"NONE",FALSE,"High","Master Protein","Q3KQU3","MAP7 domain-containing protein 1 [OS=Homo sapiens]",0,106.307,14,8,9,12,8,841,92.8,10.11,47.35,8,"cell organization and biogenesis","cytoskeleton;other cell component",NA,"Pf05672","55700","D3DPS4; hsa:55700; Q3KQU3; Q7L8J5; Q8N905; Q8TAK0; Q9HBQ2; Q9NW29; Q9ULN3","ENSG00000116871",NA,NA,0,0,93.4,93.3,103.2,93.1,84.6,107.7,109.3,107.8,113.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(99); S116(99.5); S254(100); S273(100); S460(100); S544(100); S834(100)]",0,"ENSG00000116871"
"607","APC",-0.207813853720837,6.6541014489685,-2.3073519374159,0.0447537705230417,0.120326447271176,-4.69315504322382,"NONE",FALSE,"High","Master Protein","P25054","Adenomatous polyposis coli protein [OS=Homo sapiens]",0,67.844,4,9,9,17,9,2843,311.5,7.8,37.77,9,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00514, Pf05923, Pf05924, Pf05937, Pf05956, Pf05972, Pf11414, Pf16629, Pf16630, Pf16633, Pf16634, Pf16635, Pf16636, Pf16689, Pf18797","324","B7Z2B6; D3DT03; hsa:324; P25054; Q15162; Q15163; Q93042","ENSG00000134982","Deactivation of the beta-catenin transactivating complex; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Ovarian tumor domain proteases; Apoptotic cleavage of cellular proteins; APC truncation mutants are not K63 polyubiquitinated","Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Gastric cancer network 1; Brain-derived neurotrophic factor (BDNF) signaling pathway; Endoderm differentiation; Extracellular vesicle-mediated signaling in recipient cells; Copper homeostasis; Wnt signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Regulation of sister chromatid separation at the metaphase-anaphase transition; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Ciliary landscape; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Regulation of actin cytoskeleton; Cohesin complex - Cornelia de Lange syndrome; Alzheimer's disease; 2q21.1 copy number variation syndrome; HDAC6 interactions in the central nervous system; DNA damage response (only ATM dependent)",45,0,85.8,97.7,91.4,107,129.6,108.2,94.2,103.3,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S780(100); S1042(100); S1360(100); S1392(98.7); S2129(99.8); S2449(100); S2724(100)]",0,"ENSG00000134982"
"608","SMC3",-0.333896989543041,6.48429329082718,-2.30390093420093,0.0450134193436609,0.120825494027721,-4.69873764869167,"NONE",FALSE,"High","Master Protein","Q9UQE7","Structural maintenance of chromosomes protein 3 [OS=Homo sapiens]",0,15.2,2,1,3,4,1,1217,141.5,7.18,15.41,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf02463, Pf06470","9126","A8K156; hsa:9126; O60464; Q5T482; Q9UQE7","ENSG00000108055","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Meiotic synapsis; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cell cycle; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; 10q22q23 copy number variation",15,0,124.9,134.8,144.3,80,65.3,93.8,61.2,79.2,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1067(100)]",0,"ENSG00000108055"
"609","CHMP5",0.368784925652418,6.63758175993803,2.30250329441521,0.0451189941168563,0.120905977838687,-4.70099791543169,"NONE",FALSE,"High","Master Protein","Q9NZZ3","Charged multivesicular body protein 5 [OS=Homo sapiens]",0,15.2,10,1,1,1,1,219,24.6,4.83,4.46,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component",NA,"Pf03357","51510","B2RD95; B4DIR6; hsa:51510; Q5VXW2; Q96AV2; Q9HB68; Q9NYS4; Q9NZZ3; Q9Y323","ENSG00000086065","Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT)","Ferroptosis",3,0,57.3,85.5,85,109.3,94.2,95,121.9,115.5,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(100)]",0,"ENSG00000086065"
"610","FAS",0.266134518517239,6.67234492926665,2.3015443242066,0.0451915725990192,0.120905977838687,-4.7025485431335,"NONE",FALSE,"High","Master Protein","P25445","Tumor necrosis factor receptor superfamily member 6 [OS=Homo sapiens]",0,6.057,8,1,1,1,1,335,37.7,7.94,3.09,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00020, Pf00531","355","A9UJX4; B6VNV4; hsa:355; P25445; Q14292; Q14293; Q14294; Q14295; Q16652; Q5T9P1; Q5T9P2; Q5T9P3; Q6SSE9","ENSG00000026103","Regulation by c-FLIP; RIPK1-mediated regulated necrosis; CASP8 activity is inhibited; TP53 Regulates Transcription of Death Receptors and Ligands; Dimerization of procaspase-8; FasL/ CD95L signaling","miRNA regulation of DNA damage response; Alzheimer's disease and miRNA effects; Allograft rejection; Adipogenesis; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Photodynamic therapy-induced AP-1 survival signaling; MAPK signaling pathway; Apoptosis modulation by HSP70; VEGFA-VEGFR2 signaling; Nonalcoholic fatty liver disease; Control of immune tolerance by vasoactive intestinal peptide; Measles virus infection; Hepatitis B infection; Male infertility; IL-18 signaling pathway; 7q11.23 copy number variation syndrome; p53 transcriptional gene network; Complement system in neuronal development and plasticity; Familial hyperlipidemia type 4; Alzheimer's disease; Cell interactions of the pancreatic cancer microenvironment; T-cell receptor signaling pathway; DNA damage response",32,0,67.4,89,81.8,106.2,108.8,101.3,131.7,123.7,116.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S212(100)]",0,"ENSG00000026103"
"611","SF1",0.202197214127701,6.64415121867015,2.29480438791012,0.0457049031227066,0.122079217506149,-4.71344171760825,"NONE",FALSE,"High","Master Protein","Q15637","Splicing factor 1 [OS=Homo sapiens]",0,27.083,4,1,1,21,1,639,68.3,8.98,76.51,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","translational apparatus;nucleus","nucleic acid binding activity;other molecular function","Pf00013, Pf00098, Pf16275","7536","B7Z1Q1; C9JJE2; hsa:7536; Q14818; Q14819; Q15637; Q15913; Q8IY00; Q92744; Q92745; Q969H7; Q9BW01; Q9UEI0","ENSG00000168066","mRNA Splicing - Major Pathway",NA,1,0,92.8,99.6,96,95.6,93.5,92.2,118.3,102.5,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S82(100)]",0,"ENSG00000168066"
"612","RAD23A",0.288722110691836,6.65978311742382,2.29198148293003,0.0459215902436415,0.122457573983044,-4.718001458272,"NONE",FALSE,"High","Master Protein","P54725","UV excision repair protein RAD23 homolog A [OS=Homo sapiens]",0,30.401,8,1,1,4,1,363,39.6,4.58,22.42,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00240, Pf00627, Pf09280","5886","hsa:5886; K7ESE3; P54725; Q59EU8; Q5M7Z1","ENSG00000179262","Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER","Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",6,0,70,71.1,67.7,125.9,100.2,100.4,126.4,153.1,121.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S123(100)]",0,"ENSG00000179262"
"613","RSRC2",-0.160424860506388,6.54861527303704,-2.28853781312473,0.0461872853828908,0.122613383824797,-4.72356174348793,"NONE",FALSE,"High","Master Protein","Q7L4I2","Arginine/serine-rich coiled-coil protein 2 [OS=Homo sapiens]",0,38.469,10,6,8,14,6,434,50.5,11.33,37.36,6,NA,NA,NA,"Pf15477","65117","hsa:65117; Q6N040; Q6NW16; Q7L4I2; Q9H864","ENSG00000111011",NA,NA,0,0,124.2,124,115.6,91.5,80.6,83.5,82.6,84.8,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S4(99.1); S17(99.4); S30(99.6); T220(100); S222(100)]; Met-loss [N-Term]",0,"ENSG00000111011"
"614","SZT2",-0.189395986666299,6.60443251136381,-2.28811198537272,0.0462202440059063,0.122613383824797,-4.72424913657181,"NONE",FALSE,"High","Master Protein","Q5T011","KICSTOR complex protein SZT2 [OS=Homo sapiens]",0,22.434,2,2,2,3,2,3432,377.8,6.27,6.77,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","other membranes;other cytoplasmic organelle;other cell component",NA,NA,"23334","A0PJK5; A7E2X4; hsa:23334; O75055; Q5JUY7; Q5T011; Q5T012; Q5XKC7; Q6ZNI8; Q6ZT24; Q7Z636; Q8NAY9; Q9H5H7; Q9UFQ8","ENSG00000198198","Amino acids regulate mTORC1",NA,1,0,101.5,97.7,109.6,104.3,90.3,102.1,87.7,99,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1388(98.5); S1819(92.8)]",0,"ENSG00000198198"
"615","SIPA1L3",0.194318040106165,6.6305468886338,2.28796183835354,0.046231870699377,0.122613383824797,-4.72449150292997,"NONE",FALSE,"High","Master Protein","O60292","Signal-induced proliferation-associated 1-like protein 3 [OS=Homo sapiens]",0,39.253,3,4,6,6,3,1781,194.5,8.32,15.28,4,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","23094","hsa:23094; O60292; Q2TV87","ENSG00000105738",NA,NA,0,0,111.5,100.3,101,86.4,93.1,89,108.2,106.1,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S172(99.6); S1364(100); S1495(100); T1703(99.3)]",0,"ENSG00000105738"
"616","HDAC4",-0.181242620969373,6.65478573006001,-2.28733369809515,0.0462805419338694,0.122613383824797,-4.72550539375098,"NONE",FALSE,"High","Master Protein","P56524","Histone deacetylase 4 [OS=Homo sapiens]",0,34.96,8,4,4,6,4,1084,119,6.96,18.47,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00850, Pf12203","9759","E9PGB9; F5GX36; hsa:9759; P56524; Q86YH7; Q9UND6","ENSG00000068024","SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SUMOylation of intracellular receptors; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; RUNX3 regulates p14-ARF; RUNX2 regulates chondrocyte maturation","MicroRNAs in cardiomyocyte hypertrophy; Genes targeted by miRNAs in adipocytes; Neural crest differentiation; Cardiac hypertrophic response; Initiation of transcription and translation elongation at the HIV-1 LTR; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; Ethanol effects on histone modifications; Endochondral ossification; Endochondral ossification with skeletal dysplasias; CAMKK2 pathway; 2q37 copy number variation syndrome",20,0,87.3,103.5,95.4,108,111.3,111.3,97.4,96.2,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100); T355; S565(100); S632(99.5)]",0,"ENSG00000068024"
"617","CCDC120",-0.282797538046696,6.61050601811791,-2.28634002023174,0.0463576388312499,0.122618584396434,-4.72710914217887,"NONE",FALSE,"High","Master Protein","Q96HB5","Coiled-coil domain-containing protein 120 [OS=Homo sapiens]",0,7.951,2,1,1,1,1,630,67.5,9.38,3.13,1,"cell organization and biogenesis;other biological processes","cytoskeleton;other cytoplasmic organelle;other cell component",NA,"Pf11819","90060","A8K5Q5; B4DF24; B4DFC1; B4DTU2; F5GZU4; hsa:90060; Q96HB5","ENSG00000147144; ENSG00000292279",NA,NA,0,0,100,95.9,74.2,108,121.6,111.2,87.6,96.9,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S360(100)]",0,"ENSG00000147144"
"618","CLDN12",-0.443279058490634,6.55241397430578,-2.2838424356646,0.0465519735720122,0.122933367102789,-4.73113924395774,"NONE",FALSE,"High","Master Protein","P56749","Claudin-12 [OS=Homo sapiens]",0,9.571,7,1,2,2,1,244,27.1,8.46,7.03,1,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component","other molecular function",NA,"9069","D6W5Q4; hsa:9069; P56749; Q7LDZ0","ENSG00000157224","Tight junction interactions","Epithelial to mesenchymal transition in colorectal cancer; IL-18 signaling pathway",3,0,51.8,63,63.8,112,210.9,125.9,84.8,110.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(99.5)]",0,"ENSG00000157224"
"619","GPR37L1",0.837463322320676,6.55719899073722,2.27245751957398,0.0474479330857555,0.125096973822218,-4.74949385390595,"NONE",FALSE,"High","Master Protein","O60883","G-protein coupled receptor 37-like 1 [OS=Homo sapiens]",0,9.835,2,1,2,4,1,481,52.7,7.36,10.97,1,"stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00001","9283","B2R7M9; hsa:9283; O60883; Q5SXP7; Q86VP7","ENSG00000170075","G alpha (i) signalling events; Peptide ligand-binding receptors","GPCRs, class A rhodopsin-like",3,0,69,55.9,16.6,103,50.3,141.1,189.3,185.4,149.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S471(100)]",0,"ENSG00000170075"
"620","STOML2",0.215351896367705,6.58144484434609,2.27123765339236,0.0475449239755761,0.125150509561517,-4.75145892717679,"NONE",FALSE,"High","Master Protein","Q9UJZ1","Stomatin-like protein 2, mitochondrial [OS=Homo sapiens]",0,25.765,4,1,1,3,1,356,38.5,7.39,10.21,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion","signal transduction activity or receptor binding;other molecular function","Pf01145, Pf16200","30968","B4E1K7; D3DRN3; hsa:30968; O60376; Q53G29; Q96FY2; Q9P042; Q9UJZ1","ENSG00000165283","Processing of SMDT1; Cellular response to mitochondrial stress",NA,2,0,126.4,119.9,111.6,83.7,64.2,83.3,104.5,94.8,88.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T327(100)]",0,"ENSG00000165283"
"621","ACAP2",0.26131154715584,6.64565004353702,2.26877862861593,0.0477410271360341,0.125181634935407,-4.75541921486301,"NONE",FALSE,"High","Master Protein","Q15057","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 [OS=Homo sapiens]",0,38.793,4,4,5,8,4,778,88,6.8,23.58,4,"transport;other biological processes","other membranes;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf01412, Pf12796, Pf16746","23527","A8K2V4; hsa:23527; Q15057; Q8N5Z8; Q9UQR3","ENSG00000114331",NA,NA,0,0,98.7,98.8,101.3,99.8,63.5,104.1,105.7,113,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(99.6); S521(100); S540(100)]",0,"ENSG00000114331"
"622","DNAJB11",0.261967889527775,6.57119174604374,2.26829733600111,0.0477795015132489,0.125181634935407,-4.75619419525343,"NONE",FALSE,"High","Master Protein","Q9UBS4","DnaJ homolog subfamily B member 11 [OS=Homo sapiens]",0,50.622,4,1,2,9,1,358,40.5,6.18,36.5,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00226, Pf01556","51726","hsa:51726; Q542Y5; Q542Y9; Q6IAQ8; Q96JC6; Q9UBS4","ENSG00000090520","XBP1(S) activates chaperone genes","Photodynamic therapy-induced unfolded protein response",2,0,113.4,124,115,77.5,68.4,78,109.3,83.8,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T188(100)]",0,"ENSG00000090520"
"623","TOMM20",0.214263873419497,6.62733165685277,2.26764460801006,0.0478317286326639,0.125181634935407,-4.75724514496793,"NONE",FALSE,"High","Master Protein","Q15388","Mitochondrial import receptor subunit TOM20 homolog [OS=Homo sapiens]",0,8.352,9,1,2,6,1,145,16.3,8.6,14.49,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;mitochondrion;other cell component","transporter activity;other molecular function","Pf02064","9804","A8K195; hsa:9804; Q15388; Q498B3; Q6IBT4","ENSG00000173726","Ub-specific processing proteases; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy",NA,3,0,96.4,96.7,96.9,93.4,93.2,87.6,118.2,104.8,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000173726"
"624","SNTB1",-0.309243848242931,6.65796327433828,-2.267247045302,0.0478635662988321,0.125181634935407,-4.75788521256925,"NONE",FALSE,"High","Master Protein","Q13884","Beta-1-syntrophin [OS=Homo sapiens]",0,106.402,12,5,6,16,5,538,58,8.63,77.01,5,"other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6641","A8K9E0; hsa:6641; O14912; Q13884; Q4KMG8","ENSG00000172164",NA,"IL-18 signaling pathway; 13q12.12 copy number variation",2,0,82.2,91,92.4,113.6,95.9,142,95.7,108.9,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S219(100); S389(100)]",0,"ENSG00000172164"
"625","CBS",0.23591655592727,6.59219709902639,2.26626160660301,0.0479425713248579,0.125187642243469,-4.75947160610564,"NONE",FALSE,"High","Master Protein","P35520","Cystathionine beta-synthase [OS=Homo sapiens]",0.003,2.422,2,1,1,1,1,551,60.5,6.65,2.05,1,"DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00291, Pf00571","102724560; 875","B2R993; D3DSK4; hsa:102724560; hsa:875; P35520; Q99425; Q9BWC5","ENSG00000160200","Metabolism of ingested SeMet, Sec, MeSec into H2Se; Cysteine formation from homocysteine","Selenium micronutrient network; Vitamin B12 metabolism; Folate-alcohol and cancer pathway hypotheses; Folate metabolism; Trans-sulfuration pathway; Trans-sulfuration, one-carbon metabolism and related pathways; Vitamin D receptor pathway; Amino acid metabolism; Methionine metabolism leading to sulfur amino acids and related disorders; Ferroptosis; Ciliary landscape",13,0,116.8,129.1,129.7,75.8,74.3,74.4,94.1,106.9,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100)]",0,"ENSG00000160200"
"626","MYH9",-0.262850648822256,6.63802744100839,-2.2586109826806,0.0485602747968099,0.126598032697115,-4.77178092500814,"NONE",FALSE,"High","Master Protein","P35579","Myosin-9 [OS=Homo sapiens]",0,61.891,2,4,4,17,4,1960,226.4,5.6,58.8,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00063, Pf01576, Pf02736","4627","A8K6E4; hsa:4627; O60805; P35579; Q60FE2; Q86T83","ENSG00000100345","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Signaling by ALK fusions and activated point mutants; RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs; CD163 mediating an anti-inflammatory response","Primary focal segmental glomerulosclerosis (FSGS); VEGFA-VEGFR2 signaling; Nephrotic syndrome; HDAC6 interactions in the central nervous system",17,0,67.1,66.4,66.9,140.3,135.3,120.1,113.2,121.3,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1943(100)]",0,"ENSG00000100345"
"627","INTS3",-0.208116157810457,6.44561028810238,-2.25615584641049,0.0487601365849182,0.126916336374141,-4.77572845193569,"NONE",FALSE,"High","Master Protein","Q68E01","Integrator complex subunit 3 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1043,118,5.8,8.97,1,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component",NA,"Pf10189","65123","A8K1W0; B4DQC8; B4E3U9; D3DV57; hsa:65123; Q4G0E5; Q5VUQ5; Q5VUQ6; Q5VUR0; Q5VUR1; Q68DJ1; Q68E01; Q69YR5; Q6AI57; Q6DKG7; Q6MZQ4; Q6MZZ9; Q8NC46; Q8TB23; Q9H6S9","ENSG00000143624; ENSG00000262826","RNA polymerase II transcribes snRNA genes",NA,1,0,147.5,133.1,143.7,69.2,58.7,83.9,74.5,71.1,67.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S502(100)]",0,"ENSG00000143624"
"628","ZDHHC5",0.15877598883145,6.66737993371191,2.24429973299084,0.0497366057282478,0.12916891266357,-4.79477336835313,"NONE",FALSE,"High","Master Protein","Q9C0B5","Palmitoyltransferase ZDHHC5 [OS=Homo sapiens]",0,30.48,7,3,3,6,3,715,77.5,9.01,12.28,3,"protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf01529","25921","hsa:25921; Q2TGF0; Q6ZMF0; Q8TAK8; Q9C0B5; Q9H923; Q9UFI7","ENSG00000156599","Maturation of spike protein",NA,1,0,86.3,83.8,83.7,106.9,95.4,109.7,117.3,112.6,119.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S380(100); S590(98.8)]",0,"ENSG00000156599"
"629","LRIG1",-0.256497211342815,6.65833787323874,-2.24373183553327,0.0497838517557511,0.12916891266357,-4.79568484385325,"NONE",FALSE,"High","Master Protein","Q96JA1","Leucine-rich repeats and immunoglobulin-like domains protein 1 [OS=Homo sapiens]",0,45.224,4,2,2,6,2,1093,119,7.09,21.46,2,"developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes",NA,"Pf01463, Pf07679, Pf12799, Pf13855, Pf13927","26018","hsa:26018; Q6IQ51; Q96CF9; Q96JA1; Q9BYB8; Q9UFI4","ENSG00000144749","Signaling by EGFR; Negative regulation of MET activity","GDNF signaling",3,0,103.5,94,90.4,112.6,96.6,125.2,103.5,101,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1069(100)]",0,"ENSG00000144749"
"630","SURF6",0.236042640461512,6.63323069701675,2.24058012462614,0.0500468509126696,0.129645175697582,-4.80074206769257,"NONE",FALSE,"High","Master Protein","O75683","Surfeit locus protein 6 [OS=Homo sapiens]",0,3.129,2,1,1,1,1,361,41.4,10.64,2.78,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf04935","6838","hsa:6838; O75683; Q5T8U1; Q9BRK9; Q9BTZ5; Q9UK24","ENSG00000148296; ENSG00000281309",NA,NA,0,0,112.2,118.4,118.4,77,76.9,92.5,88.9,106.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000148296"
"631","TEX2",0.368456642611521,6.60611045555812,2.23704791842313,0.0503432051975981,0.130206197912013,-4.80640725970127,"NONE",FALSE,"High","Master Protein","Q8IWB9","Testis-expressed protein 2 [OS=Homo sapiens]",0,12.73,2,2,2,4,2,1127,125.2,6.01,11.36,2,"other metabolic processes;transport;signal transduction","other membranes;ER/Golgi;nucleus","other molecular function",NA,"55852","hsa:55852; Q6AHZ5; Q8IWB9; Q8N3L0; Q9C0C5","ENSG00000136478","RHOA GTPase cycle",NA,1,0,60.6,63.2,63.7,102.3,153,85.7,141.7,126.4,139.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100); S266(99.5)]",0,"ENSG00000136478"
"632","SNW1",-0.222305318127982,6.58246860504864,-2.22626704511124,0.0512583027076562,0.132363212055213,-4.82368137492431,"NONE",FALSE,"High","Master Protein","Q13573","SNW domain-containing protein 1 [OS=Homo sapiens]",0,24.852,3,2,3,5,2,536,61.5,9.52,15.87,2,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus","signal transduction activity or receptor binding;other molecular function","Pf02731","22938","A8K8A9; hsa:22938; Q13483; Q13573; Q32N03; Q5D0D6","ENSG00000100603","mRNA Splicing - Major Pathway; Formation of paraxial mesoderm; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Pre-NOTCH Transcription and Translation; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling","TGF-beta signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Splicing factor NOVA regulated synaptic proteins; Notch signaling pathway",16,0,109.8,104,117.8,91.9,105.8,92.8,82.6,83.7,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S224(100); S232(100)]",0,"ENSG00000100603"
"633","STIP1",0.294330538254473,6.66756697745102,2.22273379141464,0.0515617077272742,0.132936345988802,-4.82933706141067,"NONE",FALSE,"High","Master Protein","P31948","Stress-induced-phosphoprotein 1 [OS=Homo sapiens]",0,27.307,5,2,3,5,2,543,62.6,6.8,13.82,2,"other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00515, Pf13181, Pf17830","10963","B4DM70; F5H0T1; G3XAD8; hsa:10963; P31948; Q3ZCU9; Q5TZU9","ENSG00000168439","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RND1 GTPase cycle","VEGFA-VEGFR2 signaling",3,0,80.8,57.4,76,100.5,102.3,124.2,137.2,127.8,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S481(100)]",0,"ENSG00000168439"
"634","RPL4",-0.286478866659308,6.0498832334411,-2.22122872624896,0.0516914780002557,0.133060713085832,-4.83174537236003,"NONE",FALSE,"High","Master Protein","P36578","Large ribosomal subunit protein uL4 [OS=Homo sapiens]",0,19.875,7,3,3,4,3,427,47.7,11.06,7.65,3,"protein metabolism;other metabolic processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf00573, Pf14374","6124","A8K502; hsa:6124; P36578; P39029; Q4VBR0; Q969Z9","ENSG00000174444","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,188.6,177.4,163,42.8,23.8,47.3,49.5,49.1,46,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000174444"
"635","RFX4",-0.252422302278715,6.41614456860457,-2.2165807868888,0.0520942366523426,0.133886290104918,-4.83917949112757,"NONE",FALSE,"High","Master Protein","Q33E94","Transcription factor RFX4 [OS=Homo sapiens]",0,43.754,3,1,3,7,1,735,83.3,6.86,31.83,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02257","5992","A8K5Y0; B2RDW4; hsa:5992; Q33DW6; Q33DW7; Q33E94; Q33E95; Q6YM53; Q8MHQ1; Q8NC78; Q8NDF9; Q8SNA1; Q96S80; Q9BXI0","ENSG00000111783",NA,NA,0,0,153.7,152.2,132.7,77.2,57.3,69.4,76,66.4,61,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(100)]",0,"ENSG00000111783"
"636","PRKDC",-0.175868796055227,6.49239772621758,-2.20194000184912,0.0533828825458106,0.136842092549239,-4.86256442675904,"NONE",FALSE,"High","Master Protein","P78527","DNA-dependent protein kinase catalytic subunit [OS=Homo sapiens]",0,139.061,4,9,13,22,9,4128,468.8,7.12,76.58,9,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00454, Pf02259, Pf02260, Pf08163, Pf19704, Pf20502","5591","hsa:5591; P78527; P78528; Q13327; Q13337; Q14175; Q59H99; Q7Z611; Q96SE6; Q9UME3","ENSG00000253729","E3 ubiquitin ligases ubiquitinate target proteins; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); IRF3-mediated induction of type I IFN","miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Fas ligand pathway and stress induction of heat shock proteins; Pathways affected in adenoid cystic carcinoma; Non-homologous end joining; Osteoblast differentiation and related diseases; DNA repair pathways, full network; DNA damage response",13,0,129.8,124.8,118.1,76.5,77.7,83.4,75.7,76.2,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S511(100); S2612(100); S3205(100); S3731(100)]",0,"ENSG00000253729"
"637","SLC4A10",0.383734661695185,6.61532727559822,2.20161295796288,0.0534120177413388,0.136842092549239,-4.86308623259587,"NONE",FALSE,"High","Master Protein","Q6U841","Sodium-driven chloride bicarbonate exchanger [OS=Homo sapiens]",0,14.989,2,1,1,1,1,1118,125.9,6.49,3.63,1,"transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00955, Pf07565","57282","B7Z1R0; B7Z2J0; B7ZLC5; B9EG69; F8W675; hsa:57282; Q4ZFX6; Q6U841; Q8TCP2; Q9HCQ6","ENSG00000144290","Bicarbonate transporters",NA,1,0,69.6,51.4,65.7,112.4,96.9,111.1,174,119,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100)]",0,"ENSG00000144290"
"638","EML3",0.205655173236416,6.63102491976127,2.18994176962155,0.0544618948860102,0.139313185664528,-4.88169151856714,"NONE",FALSE,"High","Master Protein","Q32P44","Echinoderm microtubule-associated protein-like 3 [OS=Homo sapiens]",0,19.723,4,4,4,8,4,896,95.1,7.12,17.58,4,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","256364","hsa:256364; Q32P44; Q6ZQW7; Q8NA55","ENSG00000149499",NA,NA,0,0,64.4,56.6,61.5,121.3,114.3,117,117.6,139.6,152.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(100); S889(100)]",0,"ENSG00000149499"
"639","TBC1D22A",-0.245541616130653,6.64764722728675,-2.1880296025692,0.0546357951732914,0.139422352105404,-4.88473668798022,"NONE",FALSE,"High","Master Protein","Q8WUA7","TBC1 domain family member 22A [OS=Homo sapiens]",0,29.63,6,1,1,2,1,517,59.1,5.97,8.57,1,NA,NA,"enzyme regulator activity;other molecular function","Pf00566","25771","B0QYI2; B0QYI3; B9A6M3; hsa:25771; Q5TE47; Q6ZUH2; Q8WUA7; Q92680; Q9BVD6; Q9UGG0; Q9UGT2; Q9UGU6; Q9UH25; Q9Y4W5","ENSG00000054611",NA,NA,0,0,79.9,79.4,85.1,125.7,123.3,112.9,94.3,97.9,122.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100)]",0,"ENSG00000054611"
"640","KDM5C",-0.313410878353739,6.51181595932627,-2.18759458652926,0.0546754321981977,0.139422352105404,-4.88542933986112,"NONE",FALSE,"High","Master Protein","P41229","Lysine-specific demethylase 5C [OS=Homo sapiens]",0,19.099,2,2,3,5,2,1560,175.6,5.58,3.96,2,"cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00628, Pf01388, Pf02373, Pf02375, Pf02928, Pf08429, Pf21323","8242","B0QZ44; B4E3I2; F5H3T1; hsa:8242; P41229; Q5JUX3; Q5JUX4; Q5JUX5; Q7Z5S5","ENSG00000126012","HDMs demethylate histones","Clear cell renal cell carcinoma pathways",2,0,129,105.3,116.2,81.8,102,88.3,67.4,90.7,80.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100)]",0,"ENSG00000126012"
"641","ATP2B2",0.171999627514378,6.62550017207071,2.18214990286363,0.0551738881546664,0.140307774401723,-4.8940947970377,"NONE",FALSE,"High","Master Protein","Q01814","Plasma membrane calcium-transporting ATPase 2 [OS=Homo sapiens]",0,36.112,4,3,5,7,1,1243,136.8,5.91,19.65,3,"transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","491","hsa:491; O00766; Q01814; Q12994; Q16818","ENSG00000157087","Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D-sensitive calcium signaling in depression; PKC-gamma calcium signaling pathway in ataxia; Calcium regulation in cardiac cells",6,0,86.4,87.8,88.9,94.6,98.7,100.3,112.3,102.3,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(99.6); S1150(99.7); S1234(98.9)]",0,"ENSG00000157087"
"642","NCOR1",-0.185963942396469,6.5985713572978,-2.18192466882047,0.0551946024300895,0.140307774401723,-4.89445311459085,"NONE",FALSE,"High","Master Protein","O75376","Nuclear receptor corepressor 1 [OS=Homo sapiens]",0,44.076,4,6,8,10,6,2440,270,7.11,22.92,6,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf15784","9611","B3DLF8; E9PGV6; hsa:9611; O75376; Q86YY0; Q9UPV5; Q9UQ18","ENSG00000141027","PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; Transcriptional activation of mitochondrial biogenesis; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Nuclear signaling by ERBB4; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NR1D1 (REV-ERBA) represses gene expression; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis","Androgen receptor signaling pathway; Adipogenesis; Ovarian infertility; MECP2 and associated Rett syndrome; Pathways affected in adenoid cystic carcinoma; Rett syndrome; 22q11.2 copy number variation syndrome; Notch signaling pathway",30,0,117.8,109.7,112.4,90.4,103.7,94.3,91.9,90.6,83.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1322(100); S1472(100); S1977(99.4); S1980(98.4); S1981(98.4); S2120(100); S2184(100)]",0,"ENSG00000141027"
"643","MAST1",0.342940297361866,6.67608086126311,2.17814713941801,0.0555431350723024,0.140886309342895,-4.90046084955259,"NONE",FALSE,"High","Master Protein","Q9Y2H9","Microtubule-associated serine/threonine-protein kinase 1 [OS=Homo sapiens]",0,21.107,2,2,2,3,1,1570,170.6,8.44,9.89,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","22983","hsa:22983; O00114; Q8N6X0; Q9Y2H9","ENSG00000105613",NA,NA,0,0,96.9,105.9,98.3,94.3,75,97.3,141.4,108.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S789(100); S1258(100)]",0,"ENSG00000105613"
"644","ACSS2",-0.241025456774898,6.50481608330877,-2.17758866414873,0.0555948426573677,0.140886309342895,-4.90134875029241,"NONE",FALSE,"High","Master Protein","Q9NR19","Acetyl-coenzyme A synthetase, cytoplasmic [OS=Homo sapiens]",0,19.206,4,2,2,6,2,701,78.5,6.46,10.99,2,"other metabolic processes","cytosol;mitochondrion;other cell component","other molecular function","Pf00501, Pf13193, Pf16177","55902","A6NE90; hsa:55902; Q5QPH2; Q5QPH3; Q8N238; Q96EL0; Q9NQP7; Q9NR19; Q9UJ15","ENSG00000131069","Transcriptional activation of mitochondrial biogenesis; Ethanol oxidation","Fatty acid beta-oxidation; Fatty acid biosynthesis; Lipid metabolism pathway; Ethanol effects on histone modifications; Fluoroacetic acid toxicity; Amino acid conjugation of benzoic acid",8,0,132.2,125.3,136.4,81.4,85.4,74.6,71.6,72.6,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S267(100)]",0,"ENSG00000131069"
"645","ABR",-0.171323054730816,6.66278457549087,-2.17408317317541,0.0559204689254358,0.141491791141568,-4.9069202900366,"NONE",FALSE,"High","Master Protein","Q12979","Active breakpoint cluster region-related protein [OS=Homo sapiens]",0,29.682,6,2,2,3,2,859,97.5,6.55,12.82,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00168, Pf00620, Pf00621","29","B3KW89; B7Z6H7; D3DTH3; D3DTH4; F5H3S2; F5H8B3; hsa:29; Q12979; Q13693; Q13694","ENSG00000159842; ENSG00000276016; ENSG00000278741","RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle",NA,9,0,92.3,92.7,86.6,111.6,109.9,117.8,96.3,110.2,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100); S72(100)]",0,"ENSG00000159842"
"646","PTDSS1",-0.18024221245786,6.25348155560688,-2.1713595518946,0.0561747373221345,0.141915125866445,-4.91124708943348,"NONE",FALSE,"High","Master Protein","P48651","Phosphatidylserine synthase 1 [OS=Homo sapiens]",0.004,2.094,2,1,1,2,1,473,55.5,8.43,4.09,1,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf03034","9791","B4DE85; E5RFC5; hsa:9791; P48651; Q9BUQ5","ENSG00000156471","Synthesis of PS","Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",3,0,169.3,155.7,150.4,55.5,39.6,56.8,63.3,59.6,54.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(100)]",0,"ENSG00000156471"
"647","EFCC1",0.201847605561826,6.64210833852291,2.1695444453497,0.0563448089756058,0.142124773181126,-4.91412960147461,"NONE",FALSE,"High","Master Protein","Q9HA90","EF-hand and coiled-coil domain-containing protein 1 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,598,65.7,5.6,4.36,1,NA,NA,"other molecular function","Pf15799","79825","A8MYE2; hsa:79825; Q9HA90","ENSG00000114654",NA,NA,0,0,93.7,85.8,84.2,99.6,109,90,110.8,115,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S394(100)]",0,"ENSG00000114654"
"648","WASHC2C",-0.165380510981429,6.6848154361358,-2.16818990508187,0.056472050174904,0.142225904144203,-4.91628017898058,"NONE",FALSE,"High","Master Protein","Q9Y4E1-1","Isoform 5 of WASH complex subunit 2C [OS=Homo sapiens]",0,86.9,8,6,7,17,1,1318,144.6,4.79,57.18,6,NA,NA,NA,NA,NA,"Q9Y4E1-1",NA,NA,NA,0,0,80.6,94.5,91.9,112.1,115.4,121.7,105,102.6,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.7); S498(100); S539(100); S726(100)]",0,"ENSG00000172661"
"649","PGD",0.191898723103566,6.69267195527645,2.16672715295349,0.056609767785505,0.142353067836586,-4.91860205810193,"NONE",FALSE,"High","Master Protein","P52209","6-phosphogluconate dehydrogenase, decarboxylating [OS=Homo sapiens]",0,39.807,6,3,3,3,3,483,53.1,7.23,11.07,3,"other metabolic processes","cytosol","other molecular function","Pf00393, Pf03446","5226","A8K2Y9; B4DQJ8; hsa:5226; P52209; Q9BWD8","ENSG00000142657","NFE2L2 regulates pentose phosphate pathway genes; Pentose phosphate pathway","Pentose phosphate metabolism; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling; Metabolic reprogramming in colon cancer",7,0,76.4,84,79.1,115,97.6,113.4,122.6,130.7,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000142657"
"650","GDAP1",0.201837367029158,6.58218253018369,2.16522157747459,0.0567518555328382,0.142490812660911,-4.92099136418894,"NONE",FALSE,"High","Master Protein","Q8TB36","Ganglioside-induced differentiation-associated protein 1 [OS=Homo sapiens]",0,43.814,4,3,3,14,3,358,41.3,8.34,40.25,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;mitochondrion;other cytoplasmic organelle",NA,"Pf13410, Pf13417","54332","A8K957; E7FJF3; E7FJF4; hsa:54332; Q8TB36","ENSG00000104381","Class I peroxisomal membrane protein import","Intracellular trafficking proteins involved in CMT neuropathy",2,0,122.8,118.5,114.2,79.5,69.2,83.3,98.5,85.5,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000104381"
"651","LRRC4B",-0.306443561118144,6.65124145607878,-2.1641989042075,0.0568485658054998,0.142514376950193,-4.92261400025548,"NONE",FALSE,"High","Master Protein","Q9NT99","Leucine-rich repeat-containing protein 4B [OS=Homo sapiens]",0,18.766,4,2,2,7,2,713,76.4,7.23,16.01,2,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding","Pf07679, Pf13855","94030","Q3ZCQ4; Q58F20; Q9NT99","ENSG00000131409","Receptor-type tyrosine-protein phosphatases",NA,1,0,98.3,100.2,82.8,119.1,134.5,98.8,103.6,100.6,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S693(100); S704(100)]",0,"ENSG00000131409"
"652","VPS26B",0.16809977652014,6.6697353328706,2.1572672043726,0.0575082713672527,0.143947084158522,-4.93360545100634,"NONE",FALSE,"High","Master Protein","Q4G0F5","Vacuolar protein sorting-associated protein 26B [OS=Homo sapiens]",0,7.681,7,2,3,5,2,336,39.1,7.36,4.57,2,"stress response;transport;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component",NA,"Pf03643","112936","hsa:112936; Q4G0F5; Q96A55","ENSG00000151502",NA,NA,0,0,94.6,95,106,97.1,83.3,105.4,105,112.8,110.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100)]",0,"ENSG00000151502"
"653","MECP2",-0.185764567926423,6.6250056162707,-2.15515390026026,0.0577108629126756,0.144232968259551,-4.93695410022417,"NONE",FALSE,"High","Master Protein","P51608","Methyl-CpG-binding protein 2 [OS=Homo sapiens]",0,46.151,8,3,3,7,3,486,52.4,9.95,30.4,3,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01429","4204","hsa:4204; O15233; P51608; Q6QHH9; Q7Z384","ENSG00000169057",NA,"Ectoderm differentiation; MECP2 and associated Rett syndrome; Lung fibrosis; Rett syndrome; Transcription co-factors SKI and SKIL protein partners; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Neurogenesis regulation in the olfactory epithelium; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways",10,0,97,104.2,94.2,109.5,103.1,101,99.1,97.7,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S350(99.7)]",0,"ENSG00000169057"
"654","NMNAT1",-0.285186453585443,6.56569038828334,-2.15171958934121,0.05804156015093,0.144704928615554,-4.94239357898501,"NONE",FALSE,"High","Master Protein","Q9HAN9","Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 [OS=Homo sapiens]",0,14.398,7,1,1,1,1,279,31.9,8.87,3.75,1,"other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf01467","64802","B1AN63; hsa:64802; Q8TAE9; Q9H247; Q9H6B6; Q9HAN9","ENSG00000173614","Nicotinate metabolism","NAD biosynthesis II (from tryptophan); NAD+ metabolism; NAD+ biosynthetic pathways",4,0,84.3,98.7,125.2,94,100.3,106.1,78.3,90.1,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(98.9)]",0,"ENSG00000173614"
"655","ZFP91",-0.157692631560304,6.65575031789679,-2.15084651863084,0.0581259205991528,0.144704928615554,-4.94377593225057,"NONE",FALSE,"High","Master Protein","Q96JP5","E3 ubiquitin-protein ligase ZFP91 [OS=Homo sapiens]",0,22.19,5,3,3,3,3,570,63.4,7.36,9.34,3,"protein metabolism;other metabolic processes;signal transduction;other biological processes","nucleus","other molecular function","Pf00096","80829","A6NHC4; A8MSG7; Q86V47; Q96JP4; Q96JP5; Q96QA3","ENSG00000186660",NA,NA,0,0,88.8,90.6,88.5,110.7,115.9,112.1,101.5,97.4,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(99.5); S103(100)]",0,"ENSG00000186660"
"656","CCNL1",0.150949500538654,6.60458140432246,2.14918202482797,0.0582870795941705,0.144704928615554,-4.94641083322592,"NONE",FALSE,"High","Master Protein","Q9UK58","Cyclin-L1 [OS=Homo sapiens]",0,28.12,11,3,3,6,3,526,59.6,10.7,16.17,3,"other biological processes","nucleus;other cell component","enzyme regulator activity","Pf00134, Pf02984","57018","B3KMY3; C9JPL0; hsa:57018; Q6NVY9; Q6UWS7; Q8NI48; Q96QT0; Q9NZF3; Q9UK58","ENSG00000163660",NA,NA,0,0,121.3,108.2,106.8,88.1,77.2,85.6,99,97.8,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100); S338(99.2); S352(100)]",0,"ENSG00000163660"
"657","TRIM16",-0.449439953281166,6.631993439971,-2.1487440099562,0.0583295603706287,0.144704928615554,-4.94710409673907,"NONE",FALSE,"High","Master Protein","O95361","Tripartite motif-containing protein 16 [OS=Homo sapiens]",0,11.501,4,1,1,2,1,564,63.9,5.49,2.74,1,"other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00622, Pf00643, Pf13765","10626","O95361; Q6IAL8; Q7Z6I2; Q96BE8; Q96J43","ENSG00000221926",NA,NA,0,0,101,76.3,103.5,137.1,114.9,101.3,84.7,115.9,77.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(99.4)]",0,"ENSG00000221926"
"658","SHROOM2",-0.202743639685909,6.63708142538846,-2.14860507605389,0.0583430410717124,0.144704928615554,-4.9473239828342,"NONE",FALSE,"High","Master Protein","Q13796","Protein Shroom2 [OS=Homo sapiens]",0,33.178,3,4,4,5,4,1616,176.3,7.09,15.08,4,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;cytoskeletal activity;other molecular function","Pf00595, Pf08687, Pf08688","357","B9EIQ7; hsa:357; Q13796","ENSG00000146950",NA,"VEGFA-VEGFR2 signaling",1,0,100.2,98,97.1,97.7,119.4,108.5,88.8,94.8,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S974(100); S1036(100); S1297(99.6)]",0,"ENSG00000146950"
"659","HUWE1",-0.183830442352458,6.63131447934392,-2.14584966658018,0.0586110178824654,0.145148985104983,-4.95168387142354,"NONE",FALSE,"High","Master Protein","Q7Z6Z7","E3 ubiquitin-protein ligase HUWE1 [OS=Homo sapiens]",0,98.632,3,6,8,24,6,4374,481.6,5.22,63.6,6,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00627, Pf00632, Pf02825, Pf06012, Pf06025, Pf14377","10075","hsa:10075; O15029; Q4G2Z2; Q5H961; Q6P4D0; Q7Z6Z7; Q8NG67; Q9BUI0; Q9HCJ4; Q9NSL6; Q9P0A9","ENSG00000086758","Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation",NA,2,0,103.5,102.8,100.8,99.3,95,115.5,86.6,97.6,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1395(100); S1907(100); T2889(100); S2918(99.2); S3816(100)]",0,"ENSG00000086758"
"660","YWHAQ",-0.207431945551185,6.62579467060514,-2.14469802333055,0.0587233715026734,0.145206882261156,-4.95350554902254,"NONE",FALSE,"High","Master Protein","P27348","14-3-3 protein theta [OS=Homo sapiens]",0,98.507,40,7,8,11,4,245,27.7,4.78,34.19,7,"signal transduction;other biological processes","cytosol;other cell component","other molecular function","Pf00244","10971","D6W4Z5; hsa:10971; P27348; Q567U5; Q5TZU8; Q9UP48","ENSG00000134308","Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria","Cell cycle; Pathogenic Escherichia coli infection; Primary focal segmental glomerulosclerosis (FSGS); IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Leukocyte-intrinsic Hippo pathway functions; Hepatitis B infection; Opioid receptor pathways; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",19,0,96.8,95.3,98.1,108.1,106.9,104.4,106.7,90.6,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000134308"
"661","PANK2",-0.239446216428511,6.61452426067295,-2.1410472201486,0.0590809134595965,0.145869970901757,-4.95927818917197,"NONE",FALSE,"High","Master Protein","Q9BZ23","Pantothenate kinase 2, mitochondrial [OS=Homo sapiens]",0,20.437,3,1,1,2,1,570,62.6,9.28,6.77,1,"other metabolic processes;developmental processes;other biological processes","cytosol;mitochondrion;nucleus","kinase activity;other molecular function","Pf03630","80025","B1AK33; B2Z3X0; D3DVZ0; hsa:80025; Q5T7I2; Q5T7I4; Q7RTX5; Q8N7Q4; Q8TCR5; Q9BYW5; Q9BZ23; Q9HAF2","ENSG00000125779","Coenzyme A biosynthesis","Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Iron metabolism disorders",3,0,72.7,72.4,81.8,116.6,100.1,139.1,103.1,105.5,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000125779"
"662","SLC15A2",-0.414280897010129,6.55365779605148,-2.13890596950385,0.0592915907699202,0.14616899718506,-4.96266234831846,"NONE",FALSE,"High","Master Protein","Q16348","Solute carrier family 15 member 2 [OS=Homo sapiens]",0,52.18,3,2,3,19,2,729,81.7,8.16,82.11,2,"stress response;transport;other biological processes","plasma membrane;other membranes","transporter activity","Pf00854","6565","A8K1A5; B4E2A7; hsa:6565; Q16348","ENSG00000163406","Proton/oligopeptide cotransporters","Carnosine metabolism of glial cells",2,0,118.1,116.7,112.9,112.1,61,116.6,86.3,88.3,64.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100); S28(100)]",0,"ENSG00000163406"
"663","PTK2",0.212728659189046,6.63317574363874,2.13375435503833,0.0598014221115364,0.147203500582243,-4.9707994499581,"NONE",FALSE,"High","Master Protein","Q05397","Focal adhesion kinase 1 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1052,119.2,6.62,8.15,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;kinase activity;other molecular function","Pf00373, Pf03623, Pf07714, Pf18038, Pf21477","5747","B4E2N6; F5H4S4; hsa:5747; J3QT16; Q05397; Q14291; Q8IYN9; Q9UD85","ENSG00000169398","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Signal regulatory protein family interactions; EPHB-mediated forward signaling; DCC mediated attractive signaling; RAF/MAP kinase cascade; VEGFA-VEGFR2 Pathway; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; MET activates PTK2 signaling; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; Apoptotic cleavage of cellular proteins","Androgen receptor signaling pathway; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Corticotropin-releasing hormone signaling pathway; Alpha 6 beta 4 signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); Apoptosis-related network due to altered Notch3 in ovarian cancer; Focal adhesion; Hepatocyte growth factor receptor signaling; Overview of nanoparticle effects; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; Hippo-Merlin signaling dysregulation; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Small cell lung cancer; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Pleural mesothelioma; Regulation of actin cytoskeleton; 2q13 copy number variation syndrome; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map; 8q11.23 (RB1CC1) copy number variation; ErbB signaling pathway",51,0,76.4,88.1,79.2,104.9,98.7,98.7,106.8,112.1,137.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S910(100)]",0,"ENSG00000169398"
"664","CLIP1",-0.147493285045849,6.65418761351108,-2.13270275003295,0.0599060114110862,0.147238871420019,-4.97245964645173,"NONE",FALSE,"High","Master Protein","P30622","CAP-Gly domain-containing linker protein 1 [OS=Homo sapiens]",0,35.282,4,3,4,5,3,1438,162.1,5.36,16.18,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf16641","6249","A0AVD3; hsa:6249; P30622; Q17RS4; Q29RG0","ENSG00000130779","RHO GTPases Activate Formins; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases activate IQGAPs; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Microtubule cytoskeleton regulation; PAFAH1B1 copy number variation",9,0,98.3,98.2,101.2,104.6,108.2,105.9,101.5,99.2,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T146(99.6); T182(100); S204(100)]",0,"ENSG00000130779"
"665","TTYH2",-0.162100431840337,6.60269156037452,-2.1301138359467,0.0601642464701025,0.147651203367229,-4.97654561504996,"NONE",FALSE,"High","Master Protein","Q9BSA4","Protein tweety homolog 2 [OS=Homo sapiens]",0,13.606,4,2,3,15,2,534,58.7,5.83,6.06,2,"transport","plasma membrane;other membranes","transporter activity","Pf04906","94015","B3KX97; hsa:94015; Q3B7H8; Q3B7R9; Q6AWB4; Q8NBB7; Q96PK1; Q9BSA4","ENSG00000141540","Stimuli-sensing channels",NA,1,0,99.9,102.7,96.3,95.5,103.8,104.5,88.2,96.5,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S444(100); S504(100)]",0,"ENSG00000141540"
"666","GLIS2",-0.287947266463457,6.48907699078713,-2.12366298049677,0.0608123585479356,0.149017671396743,-4.98671913967286,"NONE",FALSE,"High","Master Protein","Q9BZE0","Zinc finger protein GLIS2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,524,55.7,8.84,4.32,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","84662","B3KX84; hsa:84662; Q9BZE0","ENSG00000126603; ENSG00000274636",NA,"Ciliopathies; Orexin receptor pathway",2,0,86.6,94.2,121.8,99,70.9,103.4,80.1,89.2,77,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(98.9)]",0,"ENSG00000126603"
"667","CXADR",-0.22410664993077,6.65053612170799,-2.122443724179,0.0609356075116601,0.149095819278904,-4.98864078517927,"NONE",FALSE,"High","Master Protein","P78310","Coxsackievirus and adenovirus receptor [OS=Homo sapiens]",0,4.546,3,1,1,5,1,365,40,7.56,14.78,1,"cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf07686, Pf13927","1525","B2R8V8; B7WPI3; D3YHP0; hsa:1525; O00694; P78310; Q8WWT6; Q8WWT7; Q8WWT8; Q9UKV4","ENSG00000154639","Cell surface interactions at the vascular wall; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","Acute viral myocarditis; 15q11q13 copy number variation",4,0,87.1,80,75.6,122,123.2,117.2,111,109.1,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(100)]",0,"ENSG00000154639"
"668","MAST2",-0.167795058272211,6.67045369166746,-2.11819294317574,0.0613671778319977,0.1497480497564,-4.99533730221046,"NONE",FALSE,"High","Master Protein","Q6P0Q8","Microtubule-associated serine/threonine-protein kinase 2 [OS=Homo sapiens]",0,57.708,4,5,5,8,4,1798,196.3,8.16,24.94,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","23139","hsa:23139; O94899; Q5VT07; Q5VT08; Q6P0Q8; Q7LGC4; Q8NDG1; Q96B94; Q9BYE8","ENSG00000086015",NA,NA,0,1,91.1,92.6,96.2,117.1,99.3,116.7,97.6,102.5,105.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S74(100); S148(100); S1381(100); S1399(100)]",0,"ENSG00000086015"
"669","EXOC7",-0.223195449321461,6.67205070531468,-2.1180112536988,0.0613856895141124,0.1497480497564,-4.99562342276114,"NONE",FALSE,"High","Master Protein","Q9UPT5","Exocyst complex component 7 [OS=Homo sapiens]",0,45.203,4,3,3,6,3,735,83.3,6.79,22.46,3,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf03081, Pf20669","23265","B5MC69; B8XXP2; hsa:23265; Q8ND93; Q8WV91; Q96FF0; Q9H8C3; Q9H9X3; Q9HA32; Q9UPT5","ENSG00000182473","VxPx cargo-targeting to cilium; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing","Angiopoietin-like protein 8 regulatory pathway; Ciliary landscape",5,0,87.5,83.5,87.1,127.1,105.7,120.6,111.3,104.4,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100); S283(100)]",0,"ENSG00000182473"
"670","NRCAM",-0.349591562920258,6.60354183243623,-2.11152926669321,0.0620496329569196,0.150958143750501,-5.0058253921842,"NONE",FALSE,"High","Master Protein","Q92823","Neuronal cell adhesion molecule [OS=Homo sapiens]",0,6.558,2,1,1,2,1,1304,143.8,5.66,2.41,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf00041, Pf07679, Pf13882, Pf13927","4897","A4D0S3; E9PDA4; hsa:4897; O15051; O15179; Q14BM2; Q92823; Q9UHI3; Q9UHI4","ENSG00000091129","Neurofascin interactions; Interaction between L1 and Ankyrins; NrCAM interactions",NA,3,0,82.1,73.3,116.7,101,128.7,120,95.4,100.8,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1295(99.1)]",0,"ENSG00000091129"
"671","WDR44",-0.16662244261832,6.65990345099784,-2.11136316499103,0.0620667367993789,0.150958143750501,-5.00608667217029,"NONE",FALSE,"High","Master Protein","Q5JSH3","WD repeat-containing protein 44 [OS=Homo sapiens]",0,85.395,13,7,8,18,7,913,101.3,5.45,41.63,7,"cell organization and biogenesis;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00400","54521","B4DSE9; F8W913; hsa:54521; Q0JS52; Q0JTF3; Q5JSH2; Q5JSH3; Q6ZSC1; Q7Z365; Q7Z3P6; Q8NAU8; Q8NHU5; Q9NUV4","ENSG00000131725",NA,"Ectoderm differentiation",1,0,88.8,90.8,92,118.1,109.1,109.1,103.9,104.9,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S96(99.4); S162(99.1); S344(100); S403(100); S561(100)]",0,"ENSG00000131725"
"672","GNG2",0.275187670439479,6.63714018432648,2.10884248744282,0.0623268519575287,0.151346574774784,-5.01005082455793,"NONE",FALSE,"High","Master Protein","P59768","Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [OS=Homo sapiens]",0,19.739,23,1,1,3,1,71,7.8,7.99,8.82,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","plasma membrane;other membranes","other molecular function","Pf00631","54331","hsa:54331; P59768; Q5JPE2; Q6P9A9","ENSG00000186469","G alpha (q) signalling events; G alpha (12/13) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Myometrial relaxation and contraction pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells",36,0,77.6,92.6,78,92.1,92,110.4,132.2,118.6,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T52(100)]",0,"ENSG00000186469"
"673","MARK4",-0.303433034905559,6.59946065307278,-2.10802036513165,0.0624119147202387,0.151346574774784,-5.01134337068271,"NONE",FALSE,"High","Master Protein","Q96L34","MAP/microtubule affinity-regulating kinase 4 [OS=Homo sapiens]",0,19.779,5,2,2,4,1,752,82.5,9.66,7.17,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","57787","hsa:57787; Q8NG37; Q96JG7; Q96L34; Q96SQ2; Q9BYD8","ENSG00000007047","Anchoring of the basal body to the plasma membrane",NA,1,0,83.4,116.2,107.2,106.1,121.3,92.1,93.5,79.5,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T214(100); S438(100)]",0,"ENSG00000007047"
"674","SPECC1",-0.14290192693824,6.65966031247355,-2.10676026617262,0.0625425098442373,0.151438243421061,-5.01332415501192,"NONE",FALSE,"High","Master Protein","Q5M775","Cytospin-B [OS=Homo sapiens]",0,87.326,12,8,10,16,8,1068,118.5,6.7,53.56,8,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf00307","92521","B4DHH0; B7WNS8; hsa:92521; Q5IBP1; Q5IBP2; Q5IBP3; Q5IBP4; Q5M772; Q5M773; Q5M774; Q5M775; Q86XT8; Q8N4U4; Q8WU84; Q9HCQ3","ENSG00000128487",NA,NA,0,0,77.1,79,81.6,118.7,122.5,117.6,108.8,111,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(99.4); S218(100); S315(100); S360(99.3); S810(100); S847(100); S914(100)]",0,"ENSG00000128487"
"675","ETV6",-0.309976616687498,6.57176548712251,-2.1024186805178,0.0629944756959066,0.152306643460325,-5.02014554433443,"NONE",FALSE,"High","Master Protein","P41212","Transcription factor ETV6 [OS=Homo sapiens]",0,5.083,2,1,1,3,1,452,53,7.43,2.65,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00178, Pf02198","2120","A3QVP6; A8K076; hsa:2120; P41212; Q9UMF6; Q9UMF7; Q9UMG0","ENSG00000139083","Signaling by FLT3 fusion proteins; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB","Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Exercise-induced circadian regulation",4,0,106.2,88.4,92.4,99.1,104.2,114.6,74.5,90.2,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100)]",0,"ENSG00000139083"
"676","MTX3",-0.156145642936355,6.63293681086183,-2.0925632960045,0.0640320803087442,0.15458632405898,-5.03561112575459,"NONE",FALSE,"High","Master Protein","Q5HYI7","Metaxin-3 [OS=Homo sapiens]",0,46.981,16,3,3,7,3,312,35.1,7.8,23.89,3,"cell organization and biogenesis;transport","other cell component",NA,"Pf10568, Pf17171","345778","B4DL65; E9PB57; hsa:345778; Q5HYI7; Q7Z380; Q8NB92","ENSG00000177034",NA,NA,0,0,87.9,95.7,93.6,100.9,109.1,115.7,95,101.1,101.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S249(100); S284(100); S311(100)]",0,"ENSG00000177034"
"677","PRKAB2",0.190067825713013,6.65266776247319,2.09162241002203,0.0641319910036112,0.154598832079606,-5.03708622709006,"NONE",FALSE,"High","Master Protein","O43741","5'-AMP-activated protein kinase subunit beta-2 [OS=Homo sapiens]",0,29.673,13,2,3,6,2,272,30.3,6.46,12.24,2,"other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf04739, Pf16561","5565","A8K9V5; B4DH06; hsa:5565; O43741; Q5VXY0","ENSG00000131791","Translocation of SLC2A4 (GLUT4) to the plasma membrane; Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Carnitine metabolism; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; AMPK inhibits chREBP transcriptional activation activity; Activation of PPARGC1A (PGC-1alpha) by phosphorylation; Lipophagy","AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Sterol regulatory element-binding proteins (SREBP) signaling; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Caloric restriction and aging; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; Pleural mesothelioma",25,0,86.3,82.6,85.8,101.9,106.9,97.5,123.8,114.2,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(99.6)]",0,"ENSG00000131791"
"678","FAM193A",-0.198544774336204,6.6312710967631,-2.08776889259064,0.064542747037109,0.155359532691094,-5.04312515259726,"NONE",FALSE,"High","Master Protein","P78312","Protein FAM193A [OS=Homo sapiens]",0,25.309,4,3,3,10,3,1265,139.9,6.48,19.11,3,NA,NA,NA,"Pf15914","8603","B7ZM85; B9EGR0; E9PFA1; hsa:8603; O43607; P78311; P78312; P78313; Q9UEG8","ENSG00000125386",NA,NA,0,0,101.4,100.6,92.8,109.9,114.8,95.4,95,100,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(99.5); S1144(100)]",0,"ENSG00000125386"
"679","IWS1",-0.27742257540953,6.60898208360084,-2.08125115872059,0.0652432234932327,0.156814345715693,-5.05332988772777,"NONE",FALSE,"High","Master Protein","Q96ST2","Protein IWS1 homolog [OS=Homo sapiens]",0,6.842,3,2,2,3,2,819,91.9,4.69,2.39,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus",NA,"Pf08711","55677","hsa:55677; Q2TB65; Q6P157; Q8N3E8; Q96MI7; Q96ST2; Q9NV97; Q9NWH8","ENSG00000163166","Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events",NA,3,0,91.4,93.1,107.8,111.7,84,119.6,98.4,79.2,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S440(100)]",0,"ENSG00000163166"
"680","AKAP12",-0.205247628156905,6.65953494814014,-2.0799508911686,0.0653838335232339,0.156902555247301,-5.05536428834055,"NONE",FALSE,"High","Master Protein","Q02952","A-kinase anchor protein 12 [OS=Homo sapiens]",0,131.223,10,10,13,21,10,1782,191.4,4.41,60.89,10,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf03832, Pf10522","9590","hsa:9590; O00310; O00498; Q02952; Q4LE68; Q5SZ80; Q5TGN1; Q68D82; Q99970","ENSG00000131016","RHOD GTPase cycle; RHOF GTPase cycle","G protein signaling pathways",3,0,79.8,81.2,85.3,117.7,142.6,106.1,108.7,102.7,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T21(98.8); S283(99.4); S598(99.4); S612(100); S696(100); S698(99.7); S1331(100); S1395(100)]",0,"ENSG00000131016"
"681","NUCKS1",-0.367585763888542,6.58193509216798,-2.07838907547656,0.065553110177753,0.156902555247301,-5.05780728381473,"NONE",FALSE,"High","Master Protein","Q9H1E3","Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 [OS=Homo sapiens]",0,108.788,35,8,11,25,8,243,27.3,5.08,63.8,8,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function",NA,"64710","hsa:64710; Q54AC0; Q5PXE7; Q9H1D6; Q9H1E3; Q9H723","ENSG00000069275",NA,NA,0,0,60.6,75.1,69.5,121,202.2,100.6,102.7,107.4,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S61(100); S79(100); S113(100); S214(100); T222(99.4)]",0,"ENSG00000069275"
"682","GBF1",-0.402912671585195,6.67073452526848,-2.07824868138233,0.0655683472295708,0.156902555247301,-5.05802685516409,"NONE",FALSE,"High","Master Protein","Q92538-1","Isoform 4 of Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 [OS=Homo sapiens]",0,39.342,3,3,3,3,3,1859,206.3,5.73,12.64,3,NA,NA,NA,NA,NA,"Q92538-1",NA,NA,NA,0,0,80.7,71.9,87.1,125.3,90.8,184.9,93.4,111.6,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1298(100); T1337(100); S1784(99.5)]",0,"ENSG00000107862"
"683","YWHAB",-0.204741819445339,6.66262514597999,-2.07621714540823,0.0657892102353427,0.157200572626763,-5.06120348718278,"NONE",FALSE,"High","Master Protein","P31946","14-3-3 protein beta/alpha [OS=Homo sapiens]",0,65.413,30,7,8,10,3,246,28.1,4.83,33.57,7,"signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00244","7529","A8K9K2; E1P616; hsa:7529; P31946","ENSG00000166913","Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; Negative regulation of MAPK pathway; Frs2-mediated activation; ARMS-mediated activation; Activation of BAD and translocation to mitochondria ; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","Cell cycle; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Hepatitis B infection; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",33,0,76.3,86.8,94.7,114.2,105,129.6,104.5,102.7,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000166913"
"684","SOX2",0.141377916017737,6.63978852613202,2.06532180547386,0.0669859009603647,0.15982600930894,-5.07822025732433,"NONE",FALSE,"High","Master Protein","P48431","Transcription factor SOX-2 [OS=Homo sapiens]",0,14.079,8,2,3,3,2,317,34.3,9.74,7.1,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505, Pf12336","6657","hsa:6657; P48431; Q14537","ENSG00000181449","Transcriptional Regulation by MECP2; Deactivation of the beta-catenin transactivating complex; Formation of the anterior neural plate; Formation of the posterior neural plate; Interleukin-4 and Interleukin-13 signaling; Germ layer formation at gastrulation; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation; Specification of the neural plate border; POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation","Cell differentiation - expanded index; Cardiac progenitor differentiation; Endoderm differentiation; Dopaminergic neurogenesis; Mesodermal commitment pathway; Ectoderm differentiation; let-7 inhibition of ES cell reprogramming; Pre-implantation embryo; Wnt signaling pathway and pluripotency; Neurogenesis regulation in the olfactory epithelium; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",22,0,99,105.8,101.5,91.4,86.9,97.2,106.7,104.1,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S250(98.6)]",0,"ENSG00000181449"
"685","PRKCG",-0.216421933580953,6.5963503161095,-2.06165070819701,0.0673937763479638,0.160564442335587,-5.08394632924235,"NONE",FALSE,"High","Master Protein","P05129","Protein kinase C gamma type [OS=Homo sapiens]",0,10.516,4,2,2,2,1,697,78.4,7.46,5.32,2,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5582","B7Z8Q0; hsa:5582; P05129","ENSG00000126583","G alpha (z) signalling events; Disinhibition of SNARE formation; WNT5A-dependent internalization of FZD4; Trafficking of GluR2-containing AMPA receptors; Calmodulin induced events","Glioblastoma signaling pathways; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; G protein signaling pathways; Wnt signaling pathway; MAPK signaling pathway; Wnt signaling pathway and pluripotency; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Hippo signaling regulation pathways; Hepatitis B infection; PKC-gamma calcium signaling pathway in ataxia; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Kisspeptin/kisspeptin receptor system in the ovary; Neuroinflammation and glutamatergic signaling; Opioid receptor pathways; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; ErbB signaling pathway",29,0,102.9,101.6,111.6,96.4,113.6,92.7,87.2,84.2,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T514(100); T655(100)]",0,"ENSG00000126583"
"686","SPRY2",-0.657274923816649,6.52651422016242,-2.0596965847816,0.0676118535292461,0.160849190903396,-5.08699274189075,"NONE",FALSE,"High","Master Protein","O43597","Protein sprouty homolog 2 [OS=Homo sapiens]",0,16.193,5,1,2,3,1,315,34.7,8.35,3.44,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","enzyme regulator activity;other molecular function","Pf05210","10253","B2R9J9; hsa:10253; O43597; Q5T6Z7","ENSG00000136158","EGFR downregulation; Spry regulation of FGF signaling","Glioblastoma signaling pathways; Androgen receptor network in prostate cancer; Ectoderm differentiation; EGF/EGFR signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development",8,0,93.8,37.1,68,157.3,153.6,110.2,95.1,105.7,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(99.7)]",0,"ENSG00000136158"
"687","MAPRE3",0.188983435260622,6.67296774284633,2.0553037934207,0.0681045420548003,0.161785462348521,-5.09383694771062,"NONE",FALSE,"High","Master Protein","Q9UPY8","Microtubule-associated protein RP/EB family member 3 [OS=Homo sapiens]",0.01,1.516,2,1,1,2,1,281,32,5.54,4.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf03271","22924","B7WPK5; hsa:22924; O00265; Q6FHB0; Q6FI15; Q9BZP7; Q9BZP8; Q9UPY8","ENSG00000084764",NA,NA,0,0,91.2,90.5,91.7,108,102.7,90.7,118.5,111.9,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.7)]",0,"ENSG00000084764"
"688","CREB1",0.181578077094454,6.63035633958698,2.05433759131675,0.0682133681122411,0.161808454591828,-5.09534159577192,"NONE",FALSE,"High","Master Protein","P16220","Cyclic AMP-responsive element-binding protein 1 [OS=Homo sapiens]",0,32.298,11,2,3,7,2,327,35.1,5.27,15.6,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170, Pf02173","1385","hsa:1385; P16220; P21934; Q6V963; Q9UMA7","ENSG00000118260","ADORA2B mediated anti-inflammatory cytokines production; FCGR3A-mediated IL10 synthesis; HCMV Early Events; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; MECP2 regulates transcription of neuronal ligands; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Regulation of MECP2 expression and activity; Transcriptional regulation of granulopoiesis; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK; NOTCH2 intracellular domain regulates transcription; MECP2 regulates neuronal receptors and channels; CaMK IV-mediated phosphorylation of CREB; CREB1 phosphorylation through the activation of Adenylate Cyclase; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde; PKA-mediated phosphorylation of CREB; CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling; MECP2 regulates transcription factors","Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Energy metabolism; miRNAs involved in DNA damage response; Folate-alcohol and cancer pathway hypotheses; Sterol regulatory element-binding proteins (SREBP) signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; Ovarian infertility; MECP2 and associated Rett syndrome; Transcription factor regulation in adipogenesis; BDNF-TrkB signaling; ERK pathway in Huntington's disease; VEGFA-VEGFR2 signaling; Mitochondrial gene expression; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; p38 MAPK signaling pathway; NO/cGMP/PKG mediated neuroprotection; White fat cell differentiation; PI3K-Akt signaling pathway; Phosphodiesterases in neuronal function; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; G1 to S cell cycle control; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Hepatitis B infection; Melanoma; mBDNF and proBDNF regulation of GABA neurotransmission; CAMKK2 pathway; GPR143 in melanocytes and retinal pigment epithelium cells; Galanin receptor pathway; Neuroinflammation and glutamatergic signaling; Vasopressin-regulated water reabsorption; Pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Rubinstein-Taybi syndrome 1; Smith-Magenis and Potocki-Lupski syndrome copy number variation; Interferon type I signaling pathways; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling",85,0,102.9,99.6,102.3,88.6,85.4,94.7,112.8,95.5,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S326(100)]",0,"ENSG00000118260"
"689","EGFR",0.186236613837316,6.66201475588436,2.05261648320464,0.0684076321266532,0.162031962205173,-5.0980211751256,"NONE",FALSE,"High","Master Protein","P00533","Epidermal growth factor receptor [OS=Homo sapiens]",0,87.014,7,5,7,14,5,1210,134.2,6.68,62.9,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","1956","hsa:1956; O00688; O00732; P00533; P06268; Q14225; Q68GS5; Q92795; Q9BZS2; Q9GZX1; Q9H2C9; Q9H3C9; Q9UMD7; Q9UMD8; Q9UMG5","ENSG00000146648","HCMV Early Events; NOTCH3 Activation and Transmission of Signal to the Nucleus; PIP3 activates AKT signaling; Respiratory syncytial virus (RSV) attachment and entry; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; Signaling by ERBB4; SHC1 events in ERBB2 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Cargo recognition for clathrin-mediated endocytosis; Signal transduction by L1; GRB2 events in EGFR signaling; GAB1 signalosome; SHC1 events in EGFR signaling; EGFR downregulation; EGFR interacts with phospholipase C-gamma; Inhibition of Signaling by Overexpressed EGFR; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; PLCG1 events in ERBB2 signaling; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; PTK6 promotes HIF1A stabilization; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants","Androgen receptor signaling pathway; Glioblastoma signaling pathways; AGE/RAGE pathway; Gastric cancer network 2; Spinal cord injury; Aryl hydrocarbon receptor pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; TCA cycle nutrient use and invasiveness of ovarian cancer; Extracellular vesicle-mediated signaling in recipient cells; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced AP-1 survival signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; ERK pathway in Huntington's disease; RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Endometrial cancer; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Extracellular vesicles in the crosstalk of cardiac cells; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Regulatory circuits of the STAT3 signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Gastrin signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Pleural mesothelioma; Regulation of actin cytoskeleton; 2q37 copy number variation syndrome; TROP2 regulatory signaling; TAR syndrome; NF1 copy number variation syndrome ; HDAC6 interactions in the central nervous system; ErbB signaling pathway",84,0,93.6,92.3,91.6,91.8,90.1,112.1,103.1,113.8,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T693(100); S991(100); S1042(100); S1166(100); S1204(100)]",0,"ENSG00000146648"
"690","APPL2",0.24524380831711,6.62221207301178,2.05174533774107,0.0685061604911578,0.162031962205173,-5.09937712710206,"NONE",FALSE,"High","Master Protein","Q8NEU8","DCC-interacting protein 13-beta [OS=Homo sapiens]",0,15.2,3,1,1,1,1,664,74.4,4.94,4.49,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00169, Pf00640, Pf16746","55198","B7Z411; B7Z4B0; F5GZG0; F8W1P5; hsa:55198; Q8N4R7; Q8NEU8; Q9NVL2","ENSG00000136044",NA,NA,0,0,77.7,111.6,92.3,91.2,80.3,100.8,114.2,103.8,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T399(100)]",0,"ENSG00000136044"
"691","APOE",0.330156548650255,6.50983754999656,2.04002109776555,0.0698454201993262,0.164960529327497,-5.11760454460774,"NONE",FALSE,"High","Master Protein","P02649","Apolipoprotein E [OS=Homo sapiens]",0,25.177,14,5,5,5,5,317,36.1,5.73,10.37,5,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf01442","348","B2RC15; C0JYY5; hsa:348; P02649; Q9P2S4","ENSG00000130203","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Amyloid fiber formation; Retinoid metabolism and transport; Nuclear signaling by ERBB4; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Chylomicron clearance; Scavenging by Class A Receptors; Chylomicron assembly; Chylomicron remodeling; HDL remodeling; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","Vitamin B12 metabolism; Alzheimer's disease and miRNA effects; Apoptosis-related network due to altered Notch3 in ovarian cancer; ApoE and miR-146 in inflammation and atherosclerosis; Statin inhibition of cholesterol production; Familial hyperlipidemia type 3; Alzheimer's disease; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes; HDAC6 interactions in the central nervous system",22,0,138.5,126.8,131,55.9,60.2,73.9,74.8,86.9,113.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000130203"
"692","PLCD1",-0.264091276009883,6.6252998355256,-2.03402549251631,0.0705398936025979,0.166359980288208,-5.12691014081393,"NONE",FALSE,"High","Master Protein","P51178","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 [OS=Homo sapiens]",0,37.72,6,2,2,9,2,756,85.6,6.7,19.65,2,"other metabolic processes;transport;signal transduction","plasma membrane;other membranes;other cell component","other molecular function","Pf00168, Pf00387, Pf00388, Pf09279, Pf16457","5333","B3KR14; hsa:5333; P51178; Q86VN8","ENSG00000187091","Synthesis of IP3 and IP4 in the cytosol","Myometrial relaxation and contraction pathways; GPR40 pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; Orexin receptor pathway",6,0,110.4,94.9,88.1,115.7,91.5,114.4,81.9,97.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S179(100)]",0,"ENSG00000187091"
"693","NONO",0.137669368214885,6.63682419670148,2.02877446496911,0.0711535126209223,0.167265229018116,-5.13505131482282,"NONE",FALSE,"High","Master Protein","Q15233","Non-POU domain-containing octamer-binding protein [OS=Homo sapiens]",0,34.841,14,3,4,6,3,471,54.2,8.95,22.98,3,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08075","4841","B7Z4C2; D3DVV4; F5GYZ3; hsa:4841; O00201; P30807; Q12786; Q15233; Q9BQC5","ENSG00000147140",NA,"mRNA processing",1,0,105.8,110.2,109,90.3,89.1,89.4,98.6,103.8,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T428(100); T450(100)]",0,"ENSG00000147140"
"694","TMCC1",0.367767718872989,6.64811652663052,2.0281857028689,0.0712226290877161,0.167265229018116,-5.13596361514864,"NONE",FALSE,"High","Master Protein","O94876","Transmembrane and coiled-coil domains protein 1 [OS=Homo sapiens]",0,26.248,6,3,3,6,3,653,72,6.55,19.74,3,"cell organization and biogenesis;transport","other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf10267","23023","A8K5Y3; B4DE04; hsa:23023; O94876; Q68E06; Q8IXM8","ENSG00000172765",NA,NA,0,0,101.8,112.6,101.2,95.8,54.8,101.2,125.5,118.9,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S382(100); S414(99.4)]",0,"ENSG00000172765"
"695","SBF2",0.278446702768025,6.63426594145317,2.02811264795907,0.071231209661514,0.167265229018116,-5.1360768081489,"NONE",FALSE,"High","Master Protein","Q86WG5","Myotubularin-related protein 13 [OS=Homo sapiens]",0,26.344,2,2,2,2,2,1849,208.3,7.06,8.25,2,"other metabolic processes;developmental processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf02141, Pf02893, Pf03456, Pf06602, Pf12335","81846","hsa:81846; Q3MJF0; Q68DQ3; Q6P459; Q6PJD1; Q7Z325; Q7Z621; Q86VE2; Q86WG5; Q96FE2; Q9C097","ENSG00000133812","RAB GEFs exchange GTP for GDP on RABs; Synthesis of PIPs at the plasma membrane","Intracellular trafficking proteins involved in CMT neuropathy",3,0,95.4,99.8,110.3,92.2,62.3,105.7,113,96.6,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1214(100); S1687(100)]",0,"ENSG00000133812"
"696","KDM1A",-0.343895060596576,6.61844007084258,-2.02475881723174,0.0716261892156587,0.167951064367751,-5.14127158560163,"NONE",FALSE,"High","Master Protein","O60341","Lysine-specific histone demethylase 1A [OS=Homo sapiens]",0,30.401,4,2,2,4,2,852,92.8,6.52,18.35,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01593, Pf04433","23028","A8MWP9; hsa:23028; O60341; Q5TH94; Q5TH95; Q86VT7; Q8IXK4; Q8NDP6; Q8TAZ3; Q96AW4","ENSG00000004487","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; Estrogen-dependent gene expression; Factors involved in megakaryocyte development and platelet production; HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3","Androgen receptor signaling pathway; Effect of progerin on genes involved in progeria; Thermogenesis; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Neurogenesis regulation in the olfactory epithelium",14,0,103.6,91.8,98.7,101.2,83.2,140.7,81.1,89.5,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000004487"
"697","CDC42EP4",-0.290303824407021,6.6536183908522,-2.02224472944289,0.0719236362000357,0.168304516621955,-5.14516345521293,"NONE",FALSE,"High","Master Protein","Q9H3Q1","Cdc42 effector protein 4 [OS=Homo sapiens]",0,167.019,33,12,21,74,12,356,38,5.19,243.72,12,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00786, Pf14957","23580","B3KUS7; hsa:23580; O95828; Q96FT3; Q9H3Q1","ENSG00000179604","RAC1 GTPase cycle; RAC2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle",NA,4,0,80.3,89.4,85,117.7,157.6,101.4,113.1,93.6,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S74(99.5); S105(100); S118(100); S138(99.3); S140(98); S142(99.7); S292(100); S295(100); S322(100)]",0,"ENSG00000179604"
"698","FLYWCH1",-0.169974486591022,6.58309180712476,-2.021742624022,0.0719831817414981,0.168304516621955,-5.14594049788709,"NONE",FALSE,"High","Master Protein","Q4VC44","FLYWCH-type zinc finger-containing protein 1 [OS=Homo sapiens]",0.01,1.539,2,1,1,1,1,716,80.1,8.34,2.21,1,"stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04500, Pf15423, Pf16662","84256","D3DUA1; hsa:84256; Q4VC44; Q6ZSQ1; Q8WV62; Q9BQG6; Q9BUS5; Q9HCM0","ENSG00000059122",NA,NA,0,0,117.1,100.9,99.7,98.8,82.2,104.1,86,91.8,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(99.4)]",0,"ENSG00000059122"
"699","DDX24",0.174591388604253,6.59130773639428,2.01895226157614,0.0723149495673757,0.168838337187349,-5.15025738378247,"NONE",FALSE,"High","Master Protein","Q9GZR7","ATP-dependent RNA helicase DDX24 [OS=Homo sapiens]",0,16.484,5,2,2,2,2,859,96.3,9.06,6.77,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271","57062","E7EMJ4; hsa:57062; Q4V9L5; Q9GZR7","ENSG00000089737; ENSG00000273761",NA,NA,0,0,115.8,115.8,101.9,89.4,66.5,90.5,96.3,102.4,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S287(100)]",0,"ENSG00000089737"
"700","PCGF6",-0.227913580211435,6.51819116337404,-2.01269055142268,0.0730647444518797,0.17034523277924,-5.15993606248963,"NONE",FALSE,"High","Master Protein","Q9BYE7","Polycomb group RING finger protein 6 [OS=Homo sapiens]",0,12.902,4,1,1,2,1,350,39,4.97,7.1,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf13923, Pf16207","84108","A8K3R4; hsa:84108; Q5SYD1; Q5SYD6; Q96ID9; Q96SJ1; Q9BYE7","ENSG00000156374","Transcriptional Regulation by E2F6",NA,1,0,114.3,138.5,126.7,75.2,70.9,100.9,77.3,74,82.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000156374"
"701","EPN2",-0.393264546023343,6.62923834857221,-2.01001333061578,0.0733875685529631,0.170853797258824,-5.16407056182016,"NONE",FALSE,"High","Master Protein","O95208-2","Isoform 2 of Epsin-2 [OS=Homo sapiens]",0,39.396,6,2,4,9,2,584,62.3,7.53,37.52,2,NA,NA,NA,NA,NA,"O95208-2",NA,NA,NA,0,0,68.1,73.6,85.1,108.4,137.6,144.8,76.7,109.4,127,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(99.7); S192(100)]",0,"ENSG00000072134"
"702","SYAP1",0.262305209431513,6.67941351503941,2.00670586694876,0.0737882566076584,0.171541929891308,-5.16917531625232,"NONE",FALSE,"High","Master Protein","Q96A49","Synapse-associated protein 1 [OS=Homo sapiens]",0,14.768,6,2,2,4,2,352,39.9,4.53,10.62,2,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf03909","94056","hsa:94056; Q68CP1; Q96A49; Q96C60; Q96JQ6; Q96T20","ENSG00000169895",NA,NA,0,0,72.2,73.1,75.3,106.7,97.3,122.8,142.6,133.6,109.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T248(100)]",0,"ENSG00000169895"
"703","PAWR",0.318652784128626,6.60128479350635,1.99945874746589,0.0746734830576935,0.173352950711459,-5.18034871721342,"NONE",FALSE,"High","Master Protein","Q96IZ0","PRKC apoptosis WT1 regulator protein [OS=Homo sapiens]",0,10.904,4,1,2,5,1,340,36.5,5.41,7.4,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function",NA,"5074","hsa:5074; O75796; Q6FHY9; Q8N700; Q96IZ0","ENSG00000177425",NA,NA,0,0,67,60.7,53.4,106.6,136.6,98.5,110.3,161,153.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100)]",0,"ENSG00000177425"
"704","RBM5",-0.166715197572058,6.58988694582346,-1.99644902963853,0.0750440652594052,0.173965787646803,-5.1849842078568,"NONE",FALSE,"High","Master Protein","P52756","RNA-binding protein 5 [OS=Homo sapiens]",0,20.671,3,2,2,3,2,815,92.1,6.28,7.16,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf00641, Pf01585, Pf17780","10181","B2RA45; B4DM16; B4DMF9; B4DZ63; hsa:10181; P52756; Q93021; Q9BU14; Q9HDA6; Q9UKY8; Q9UL24","ENSG00000003756","mRNA Splicing - Major Pathway","mRNA processing",2,0,100.2,115.3,122.4,97.2,81.8,98.1,87.4,89.4,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S624(100)]",0,"ENSG00000003756"
"705","RGS12",-0.161999383617011,6.63813727048662,-1.99185395007104,0.0756132113851287,0.175036540397915,-5.19205595573513,"NONE",FALSE,"High","Master Protein","O14924","Regulator of G-protein signaling 12 [OS=Homo sapiens]",0,46.059,3,3,3,6,3,1447,156.3,7.44,22.73,3,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00595, Pf00615, Pf02188, Pf02196, Pf16611, Pf16612, Pf16613","6002","B1AQ30; B1AQ31; B1AQ32; B7Z764; E7EMN9; hsa:6002; O14922; O14923; O14924; O43510; O75338; Q147X0; Q8WX95","ENSG00000159788","G alpha (i) signalling events",NA,1,0,100.9,103.7,106.8,104.9,88.2,111.1,94.9,100,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S850(100)]",0,"ENSG00000159788"
"706","EFNB1",0.203664454268259,6.6185303839273,1.98346450902327,0.0766628784628891,0.177215039166339,-5.20494996653941,"NONE",FALSE,"High","Master Protein","P98172","Ephrin-B1 [OS=Homo sapiens]",0,27.006,4,1,2,7,1,346,38,8.94,21.08,1,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding","Pf00812","1947","D3DVU0; hsa:1947; P98172","ENSG00000090776","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells",NA,4,0,102.5,90.6,98,89.4,99,86.5,96.6,116.3,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S281(100)]",0,"ENSG00000090776"
"707","ENAH",0.221768585921008,6.60542823647447,1.97481591562151,0.0777593825990836,0.179495491374405,-5.21821879540492,"NONE",FALSE,"High","Master Protein","Q8N8S7-2","Isoform 2 of Protein enabled homolog [OS=Homo sapiens]",0,39.559,11,4,6,8,4,570,63.9,6.43,28.41,4,NA,NA,NA,NA,NA,"Q8N8S7-2",NA,NA,NA,0,0,47.9,50.2,52.6,132.5,111.9,123.6,145.5,150.2,131.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(100); T464(99.1); T489(99.5); T493(100); S508(100)]",0,"ENSG00000154380"
"708","CRKL",-0.148103069311261,6.65080151375549,-1.96773778562862,0.078667782408717,0.18129325499049,-5.22906026297785,"NONE",FALSE,"High","Master Protein","P46109","Crk-like protein [OS=Homo sapiens]",0,30.371,14,2,3,5,2,303,33.8,6.74,14.93,2,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00017, Pf00018, Pf07653","1399","A8KA44; D3DX35; hsa:1399; P46109","ENSG00000099942","Downstream signal transduction; Regulation of signaling by CBL; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1; MET receptor recycling","Androgen receptor network in prostate cancer; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; Chemokine signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; 22q11.2 copy number variation syndrome; IL-2 signaling pathway; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway",22,0,81.3,83.8,92.2,107.7,125.8,113.3,103.8,102.6,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(99.1); S107(100)]",0,"ENSG00000099942"
"709","RFX3",-0.285116773290813,6.44936011835935,-1.96658044201516,0.0788172641120156,0.18129325499049,-5.23083140274116,"NONE",FALSE,"High","Master Protein","P48380","Transcription factor RFX3 [OS=Homo sapiens]",0,28.782,2,1,2,11,1,749,83.5,6,23.25,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02257, Pf04589","5991","A8K0H5; D3DRH8; D3DRH9; hsa:5991; P48380; Q5JTL7; Q5JTL8; Q6NW13; Q8WTU4; Q95HL5; Q95HL6","ENSG00000080298",NA,"Alstrom syndrome",1,0,149.6,150.2,141.1,78.8,44.1,94.2,71.7,66.7,66.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S155(100)]",0,"ENSG00000080298"
"710","SOS1",-0.134131923338659,6.62969427463201,-1.96608569820812,0.0788812466164315,0.18129325499049,-5.2315884003638,"NONE",FALSE,"High","Master Protein","Q07889","Son of sevenless homolog 1 [OS=Homo sapiens]",0,22.043,3,2,2,2,2,1333,152.4,6.84,6.88,2,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00169, Pf00617, Pf00618, Pf00621","6654","A8K2G3; B4DXG2; hsa:6654; Q07889","ENSG00000115904","Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RET signaling; Interleukin receptor SHC signaling; RAF/MAP kinase cascade; Downstream signal transduction; Tie2 Signaling; DAP12 signaling; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Regulation of KIT signaling; SHC1 events in ERBB2 signaling; SHC1 events in ERBB4 signaling; GRB2 events in ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; GRB2 events in EGFR signaling; SHC1 events in EGFR signaling; NCAM signaling for neurite out-growth; Signaling by FGFR1 in disease; Signaling by CSF1 (M-CSF) in myeloid cells; SHC-mediated cascade:FGFR1; FRS-mediated FGFR1 signaling; SHC-mediated cascade:FGFR2; FRS-mediated FGFR2 signaling; Signaling by FGFR2 in disease; SHC-mediated cascade:FGFR3; FRS-mediated FGFR3 signaling; FRS-mediated FGFR4 signaling; SHC-mediated cascade:FGFR4; Signaling by FGFR3 in disease; Activated NTRK2 signals through FRS2 and FRS3; Activation of RAC1; Erythropoietin activates RAS; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; SOS-mediated signalling; Signalling to RAS; SHC-related events triggered by IGF1R; Signaling by FGFR4 in disease; MET activates RAS signaling; Activated NTRK2 signals through RAS; Activated NTRK3 signals through RAS; Constitutive Signaling by Overexpressed ERBB2; Signaling by FLT3 fusion proteins; Signaling by FLT3 ITD and TKD mutants; Signal attenuation; GRB2:SOS provides linkage to MAPK signaling for Integrins ; Interleukin-15 signaling","IL-5 signaling pathway; Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; Pilocytic astrocytoma; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; TNF-alpha signaling pathway; Oncostatin M signaling pathway; Alpha 6 beta 4 signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; miRNA regulation of prostate cancer signaling pathways; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Pleural mesothelioma; Regulation of actin cytoskeleton; Acute myeloid leukemia; 4p16.3 copy number variation; 5q35 copy number variation; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent)",120,0,102.8,106.5,98.4,98.2,101.8,104.5,96,95.1,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1082(100); S1210(100)]",0,"ENSG00000115904"
"711","FTSJ3",0.218899437799809,6.53070177800398,1.96472239266543,0.0790578090947475,0.18129325499049,-5.23367395386436,"NONE",FALSE,"High","Master Protein","Q8IY81","pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 [OS=Homo sapiens]",0,20.237,5,2,5,8,2,847,96.5,8.4,18.44,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf01728, Pf07780, Pf11861","117246","B2RCA5; D3DU22; hsa:117246; Q8IY81; Q8N3A3; Q8WXX1; Q9BWM4; Q9NXT6","ENSG00000108592","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,139.3,123.6,122.5,67.2,69.9,68.8,93.4,78.1,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.6); S335(99.7); S584(100)]",0,"ENSG00000108592"
"712","GMPS",0.14230618854933,6.61853722791395,1.96444618764533,0.0790936259517334,0.18129325499049,-5.23409641204133,"NONE",FALSE,"High","Master Protein","P49915","GMP synthase [glutamine-hydrolyzing] [OS=Homo sapiens]",0,5.437,2,1,1,1,1,693,76.7,6.87,2.9,1,"other metabolic processes","cytosol","other molecular function","Pf00117, Pf00958, Pf02540","8833","A8K639; B4DXV7; F8W720; hsa:8833; P49915","ENSG00000163655","Purine ribonucleoside monophosphate biosynthesis; Azathioprine ADME",NA,2,0,113.4,109,106.4,83.5,88.3,91,98.2,102.1,100,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(99.1)]",0,"ENSG00000163655"
"713","PLEKHO2",-0.288546721291834,6.63438694881752,-1.95959786631693,0.0797248288812111,0.182483759795423,-5.2415078981518,"NONE",FALSE,"High","Master Protein","Q8TD55","Pleckstrin homology domain-containing family O member 2 [OS=Homo sapiens]",0,27.697,10,3,3,8,3,490,53.3,5.43,10.23,3,"other biological processes","non-structural extracellular;other cell component",NA,"Pf00169","80301","hsa:80301; Q7L4H4; Q8TD55; Q8WYS8","ENSG00000241839","Neutrophil degranulation",NA,1,0,79.4,75.8,73.6,124.8,167.7,100.8,112.6,95.9,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T311(100); S390(99.7)]",0,"ENSG00000241839"
"714","EEA1",0.473136148670422,6.567146540932,1.95597459720084,0.0801996395845093,0.18331346190745,-5.2470416394145,"NONE",FALSE,"High","Master Protein","Q15075","Early endosome antigen 1 [OS=Homo sapiens]",0,10.758,3,1,1,2,1,1411,162.4,5.68,6.2,1,"cell-cell signaling;cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf01363","8411","hsa:8411; Q14221; Q15075","ENSG00000102189","Toll Like Receptor 9 (TLR9) Cascade","VEGFA-VEGFR2 signaling",2,0,34.3,70.1,58,117.7,110.4,95.7,175.5,124.3,140.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100)]",0,"ENSG00000102189"
"715","PNPLA2",0.17199360301518,6.64973552971648,1.95399903911075,0.0804596475416808,0.183613525974581,-5.25005704126952,"NONE",FALSE,"High","Master Protein","Q96AD5","Patatin-like phospholipase domain-containing protein 2 [OS=Homo sapiens]",0,14.22,3,1,1,1,1,504,55.3,7.08,4.14,1,"cell organization and biogenesis;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01734","57104","hsa:57104; O60643; Q5EFF5; Q6XYE5; Q96AD5; Q96ET6; Q9NQ61; Q9NQ62","ENSG00000177666","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Acyl chain remodeling of DAG and TAG","Fatty acid beta-oxidation; Triacylglyceride synthesis; Lipid metabolism pathway; Thermogenesis; Glycerolipids and glycerophospholipids; Familial partial lipodystrophy; 5q35 copy number variation",10,0,120.6,95.2,116.5,90.8,78.5,94.9,101.8,102.6,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S404(100)]",0,"ENSG00000177666"
"716","FAM171B",-0.201754455674272,6.638682379063,-1.95326897233438,0.0805559341898283,0.183613525974581,-5.25117105500418,"NONE",FALSE,"High","Master Protein","Q6P995","Protein FAM171B [OS=Homo sapiens]",0,24.974,3,3,3,4,3,826,92.1,8.65,10.81,3,NA,"other membranes",NA,"Pf10577, Pf20771","165215","hsa:165215; Q53SK3; Q6P995; Q8N1Y4; Q8N3K1; Q8N970; Q8NB81; Q8TF55; Q8WYR8","ENSG00000144369",NA,NA,0,0,95.9,112,112.2,102.5,111.6,96.4,101.4,88.5,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S436(100); S794(100)]",0,"ENSG00000144369"
"717","MAP1B",-0.213519784741835,6.66931564398284,-1.94879569323489,0.0811482772518907,0.184464431469843,-5.25799299691045,"NONE",FALSE,"High","Master Protein","P46821","Microtubule-associated protein 1B [OS=Homo sapiens]",0,2115.584,38,81,202,879,80,2468,270.5,4.81,3122.64,81,"cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00414","4131","A2BDK5; hsa:4131; P46821","ENSG00000131711","RSV-host interactions","Microtubule cytoskeleton regulation; Fragile X syndrome; Neurogenesis regulation in the olfactory epithelium; HDAC6 interactions in the central nervous system",5,1,80.2,85.3,87,124.8,131.4,105.6,111.6,105.9,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(99.9); S91(100); S343(100); T527(100); S541(100); S544(100); S561(100); S614(100); T704(100); S831(100); S832(100); S891(100); S970(99.7); S995(100); S1016(100); T1067(100); S1154(100); T1206(98.9); S1208(100); S1247(100); S1256(98.6); S1260(100); S1265(100); T1282(100); S1298(100); S1312(100); S1326(100); S1339(100); S1378(100); S1389(100); S1396(100); S1400(100); S1421(100); S1427(100); S1438(100); S1443(100); S1501(100); S1620(100); S1653(100); S1772(100); S1779(100); S1782(100); S1785(100); T1788(100); S1793(99.6); S1819(99.3); S1852(99.7); S1915(99.6); S1917(100); T1932(100); T1949(100); S1965(99.6); T2034(100); S2087(99.5); S2209(100); S2211(100); S2271(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000131711"
"718","CENPB",0.268603942361259,6.64213034879826,1.94843646181168,0.0811960234590042,0.184464431469843,-5.25854055128891,"NONE",FALSE,"High","Master Protein","P07199","Major centromere autoantigen B [OS=Homo sapiens]",0,15.2,4,1,1,2,1,599,65.1,4.55,9.61,1,NA,"nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03184, Pf03221, Pf04218, Pf09026","1059","hsa:1059; P07199; Q96EI4","ENSG00000125817",NA,"IL-18 signaling pathway",1,0,93.1,94.2,85.1,92.8,100.3,91.7,94.2,135,119.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S156(100)]",0,"ENSG00000125817"
"719","PKN2",0.386436968157238,6.61236955801339,1.94789276880932,0.0812683371487848,0.184464431469843,-5.25936918722811,"NONE",FALSE,"High","Master Protein","Q16513","Serine/threonine-protein kinase N2 [OS=Homo sapiens]",0,12.484,4,2,2,4,2,984,112,6.3,3.26,2,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00433, Pf02185","5586","B4DQ21; B4DTP5; B4DVG1; D3DT24; hsa:5586; Q08AF4; Q16513; Q9H1W4","ENSG00000065243","RAC1 GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases activate PKNs","PI3K-Akt signaling pathway",6,0,98.7,103.6,92,62.2,111.5,85.8,104.2,96.6,147.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S583(100)]",0,"ENSG00000065243"
"720","DCP1A",-0.170217222710585,6.62926542008016,-1.94552518710672,0.081583943810067,0.184923605969485,-5.26297643856625,"NONE",FALSE,"High","Master Protein","Q9NPI6","mRNA-decapping enzyme 1A [OS=Homo sapiens]",0,27.577,3,2,2,2,2,582,63.2,6.25,8.81,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf06058, Pf16741","55802","B4DHN9; hsa:55802; Q9NPI6; U3KQM8","ENSG00000272886","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); mRNA decay by 5' to 3' exoribonuclease; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","TGF-beta signaling pathway",5,0,102.8,111.5,93.8,105,94.4,105.7,94.8,89.8,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S525(100)]",0,"ENSG00000272886"
"721","U2SURP",0.132454842822155,6.66136276316354,1.94324216610413,0.0818893702810169,0.185358463659667,-5.26645307561202,"NONE",FALSE,"High","Master Protein","O15042","U2 snRNP-associated SURP motif-containing protein [OS=Homo sapiens]",0,10.384,2,3,3,7,3,1029,118.2,8.47,7.27,3,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf00076, Pf01805, Pf04818, Pf08312","23350","A0PJ60; hsa:23350; O15042; Q0D2M1; Q2NKQ7; Q9BR70","ENSG00000163714","mRNA Splicing - Major Pathway",NA,1,0,92.7,91.5,90.7,103.4,99.6,98.6,106.4,112.5,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S485(99.5); T919(100)]",0,"ENSG00000163714"
"722","NASP",-0.196417519105258,6.41360290284501,-1.94057526710741,0.0822475147368756,0.18591127984845,-5.27051207401162,"NONE",FALSE,"High","Master Protein","P49321","Nuclear autoantigenic sperm protein [OS=Homo sapiens]",0,4.128,2,2,2,2,2,788,85.2,4.3,4.67,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf10516","4678","A8K6H2; B4DQP3; D3DQ07; F5H3J2; hsa:4678; P49321; Q53GW5; Q5T622; Q5T625; Q96A69; Q9BTW2","ENSG00000132780",NA,NA,0,0,130.6,149.4,155,65.4,60,69.6,65.7,73.7,66,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S421(100); S726(100)]",0,"ENSG00000132780"
"723","PALM",-0.27453687541476,6.63735230823151,-1.93831869684382,0.0825517051518765,0.186340778434111,-5.27394468390017,"NONE",FALSE,"High","Master Protein","O75781","Paralemmin-1 [OS=Homo sapiens]",0,182.159,19,9,16,34,9,387,42.1,5,99.3,9,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding","Pf03285","5064","hsa:5064; O43359; O75781; O95673; Q92559; Q9UPJ4; Q9UQS2; Q9UQS3","ENSG00000099864",NA,NA,0,0,83.4,84.5,87.7,115.3,149.8,99.2,112,92.3,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100); S124(100); T141(100); T145(100); S152(100); T154(100); S162(100); S249(99.6)]",0,"ENSG00000099864"
"724","NCOR2",-0.137640461347874,6.59268171587846,-1.9367712168857,0.0827609197665135,0.186555001462638,-5.27629765788867,"NONE",FALSE,"High","Master Protein","Q9Y618","Nuclear receptor corepressor 2 [OS=Homo sapiens]",0,45.487,2,5,5,10,5,2514,273.5,7.59,23.29,5,"transport;developmental processes;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00249, Pf15784","9612","hsa:9612; O00613; O15416; O15421; Q13354; Q56D06; Q59GM0; Q9Y5U0; Q9Y618","ENSG00000196498","Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; SUMOylation of transcription cofactors; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; HDACs deacetylate histones; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis","Androgen receptor signaling pathway; Adipogenesis; Aryl hydrocarbon receptor pathway; Notch signaling; Rett syndrome; Notch signaling pathway",23,0,104.8,95.2,93.3,98.4,99.3,102.2,92.9,94.7,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100); S152(100); S939(99.2); S1251(100); T1383(100)]",0,"ENSG00000196498"
"725","MEF2D",-0.363724323003386,6.62555901527962,-1.93471415879682,0.0830397994617378,0.186862141220858,-5.27942419991947,"NONE",FALSE,"High","Master Protein","Q14814","Myocyte-specific enhancer factor 2D [OS=Homo sapiens]",0,2.834,3,1,1,1,1,521,55.9,7.88,2.95,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00319, Pf12347","4209","D3DVC0; hsa:4209; Q14814; Q14815; Q5T9U5; Q5T9U6","ENSG00000116604; ENSG00000291761","NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Myogenesis","Energy metabolism; SRF and miRs in smooth muscle differentiation and proliferation; Cell differentiation - expanded index; Cell differentiation - index; B cell receptor signaling pathway; Adipogenesis; p38 MAPK signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; EGF/EGFR signaling pathway; Gastrin signaling pathway; Modulators of TCR signaling and T cell activation; Pleural mesothelioma; Calcium mediated T-cell apoptosis involved in inclusion body myositis",18,0,108.2,77.2,92.9,101.6,88.6,159.2,94,93.9,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100)]",0,"ENSG00000116604"
"726","RPL23A",0.281775743560262,6.61915769056304,1.9340783705772,0.0831261731166317,0.186862141220858,-5.28039024999529,"NONE",FALSE,"High","Master Protein","P62750","Large ribosomal subunit protein uL23 [OS=Homo sapiens]",0,4.345,5,1,1,2,1,156,17.7,10.45,5.64,1,"cell organization and biogenesis;protein metabolism;other metabolic processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00276, Pf03939","6147","B2R5B2; hsa:6147; P29316; P39024; P62750; Q92774","ENSG00000198242","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,88.9,89.4,90.5,82.8,108.5,91.2,108.4,97.1,144.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(99.6)]",0,"ENSG00000198242"
"727","STRIP1",-0.15099582896215,6.6279926526133,-1.93291073509449,0.0832850196716331,0.186867858077404,-5.28216405897075,"NONE",FALSE,"High","Master Protein","Q5VSL9","Striatin-interacting protein 1 [OS=Homo sapiens]",0,37.587,2,1,1,6,1,837,95.5,6.29,27.88,1,"cell organization and biogenesis;other biological processes","cytosol;nucleus","other molecular function","Pf07923, Pf11882","85369","hsa:85369; Q0V925; Q5VSL8; Q5VSL9; Q658K2; Q6ZV31; Q8N598; Q96SN2; Q9C0A2","ENSG00000143093",NA,NA,0,0,101.9,102.9,100.2,101.7,89.8,112.5,92.2,93.6,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000143093"
"728","VCPIP1",-0.340290820627184,6.66075565305482,-1.93216447281531,0.0833866914359807,0.186867858077404,-5.2832974974955,"NONE",FALSE,"High","Master Protein","Q96JH7","Deubiquitinating protein VCPIP1 [OS=Homo sapiens]",0,8.894,2,2,2,2,2,1222,134.2,7.2,5.68,2,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf02338, Pf19437, Pf21403","80124","hsa:80124; Q504T4; Q86T93; Q86W01; Q8N3A9; Q96JH7; Q9H5R8","ENSG00000175073","Ovarian tumor domain proteases","Alstrom syndrome",2,0,77.1,74.9,78.4,131.2,89.6,161.5,91.1,111.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S768(100); S998(99.6)]",0,"ENSG00000175073"
"729","LRPAP1",-0.129935671041427,6.62389861323265,-1.93153733727833,0.0834722233691343,0.186867858077404,-5.28424985719621,"NONE",FALSE,"High","Master Protein","P30533","Alpha-2-macroglobulin receptor-associated protein [OS=Homo sapiens]",0,17.088,7,2,2,4,2,357,41.4,8.78,13.39,2,"transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf06400, Pf06401","4043","D3DVR9; hsa:4043; P30533; Q2M310; Q53HQ3; Q53HS6","ENSG00000163956",NA,"Cholesterol metabolism",1,0,98.6,95.5,101.9,101.3,102.7,103.3,99.1,96,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S247(100)]",0,"ENSG00000163956"
"730","BCL10",-0.221794493540718,6.61625222815939,-1.92914968748683,0.0837986178773137,0.187341567638049,-5.28787448271153,"NONE",FALSE,"High","Master Protein","O95999","B-cell lymphoma/leukemia 10 [OS=Homo sapiens]",0,9.991,5,1,1,1,1,233,26.2,5.74,3.58,1,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00619","8915","hsa:8915; O95999; Q5VUF1","ENSG00000142867","FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling","B cell receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Modulators of TCR signaling and T cell activation; T-cell receptor signaling pathway",9,0,59.6,57.4,59.2,131.4,176.1,119.5,103.5,120.7,130.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000142867"
"731","RBM25",-0.285949158685399,6.6345901740122,-1.92252655545282,0.0847102910844843,0.189120649863035,-5.29791865662931,"NONE",FALSE,"High","Master Protein","P49756","RNA-binding protein 25 [OS=Homo sapiens]",0,48.323,4,3,3,7,3,843,100.1,6.32,24.65,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf01480","58517","A0PJL9; B2RNA8; B3KT03; hsa:58517; P49756; Q2TA72; Q5XJ17; Q6P665; Q9H6A1; Q9UEQ5; Q9UIE9","ENSG00000119707","mRNA Splicing - Major Pathway",NA,1,0,88.5,89.7,95.4,121.6,133.9,92.9,109.9,89.1,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S583(100); S677(100)]",0,"ENSG00000119707"
"732","ATP2A2",0.175590352314819,6.54361586628418,1.91347052664632,0.0859719194873368,0.191392960848866,-5.31162788644333,"NONE",FALSE,"High","Master Protein","P16615","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [OS=Homo sapiens]",0,62.164,6,4,4,8,4,1042,114.7,5.34,28.19,4,"cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","transporter activity;nucleic acid binding activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf13246","488","A6NDN7; B4DF05; hsa:488; P16614; P16615; Q86VJ2","ENSG00000174437","Ion homeostasis; Ion transport by P-type ATPases; Pre-NOTCH Processing in Golgi; Reduction of cytosolic Ca++ levels","Alzheimer's disease and miRNA effects; Arrhythmogenic right ventricular cardiomyopathy; Endothelin pathways; Myometrial relaxation and contraction pathways; Alzheimer's disease; Calcium regulation in cardiac cells",10,0,131.3,123.6,126.7,74.2,59.7,81.9,97.8,84.3,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S663(100)]",0,"ENSG00000174437"
"733","FAM110B",0.176022581097214,6.69098514718458,1.91192255242585,0.086189328299654,0.191392960848866,-5.31396839305887,"NONE",FALSE,"High","Master Protein","Q8TC76","Protein FAM110B [OS=Homo sapiens]",0,11.947,5,2,2,2,2,370,40.7,9.39,6.24,2,NA,"cytosol;cytoskeleton;mitochondrion",NA,"Pf14160, Pf14161","90362","hsa:90362; Q5BM08; Q8TC76; Q9Y4K2","ENSG00000169122",NA,NA,0,0,81.7,94.9,101.5,103.5,107.8,95.2,114,113.4,116.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(99.7); S301(100)]",0,"ENSG00000169122"
"734","R3HDM2",0.192713618722005,6.66335375070708,1.91079225339057,0.0863484010396592,0.191392960848866,-5.31567685420932,"NONE",FALSE,"High","Master Protein","Q9Y2K5","R3H domain-containing protein 2 [OS=Homo sapiens]",0,36.025,3,2,3,5,2,976,106.9,8.85,14.52,2,NA,"nucleus",NA,"Pf01424","22864","B7ZL65; hsa:22864; Q2M1T9; Q3ZCT5; Q9Y2K5","ENSG00000179912",NA,NA,0,0,83.7,90.8,73.3,95.2,111.5,110.2,113.6,117.6,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S855(100)]",0,"ENSG00000179912"
"735","SEC16A",-0.151008341724888,6.6524466711706,-1.91078222884469,0.0863498130747865,0.191392960848866,-5.31569200443698,"NONE",FALSE,"High","Master Protein","O15027","Protein transport protein Sec16A [OS=Homo sapiens]",0,72.178,4,5,7,12,5,2357,251.7,5.8,43.16,5,"cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component",NA,"Pf12931, Pf12932","9919","A1YCA4; hsa:9919; J3KNL6; O15027; Q4G0D7; Q5SXP0; Q5SXP1; Q8N347; Q96HP1","ENSG00000148396","COPII-mediated vesicle transport",NA,1,0,78,77.1,89.1,118.8,119.2,114.3,104.6,110.1,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1069(100); S1964(100); T2054(100); S2081(99.5)]",0,"ENSG00000148396"
"736","TERF2",0.231794743975533,6.6577738217553,1.91020186948361,0.0864315980840485,0.191392960848866,-5.31656904919049,"NONE",FALSE,"High","Master Protein","Q15554","Telomeric repeat-binding factor 2 [OS=Homo sapiens]",0,9.686,3,1,1,1,1,542,59.6,9.35,3.27,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf08558, Pf16772","7014","hsa:7014; Q15554","ENSG00000132604","Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand","Hematopoietic stem cell gene regulation by GABP alpha/beta complex; DNA repair pathways, full network; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",17,0,115.4,110.4,112.7,89.3,79.9,89.6,117.6,111,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000132604"
"737","VEPH1",-0.28216054260397,6.65743836340649,-1.9097431051686,0.0864962991028002,0.191392960848866,-5.31726225485852,"NONE",FALSE,"High","Master Protein","Q14D04","Ventricular zone-expressed PH domain-containing protein homolog 1 [OS=Homo sapiens]",0,19.105,5,3,3,4,3,833,94.7,6.71,8.82,3,"other biological processes","plasma membrane;other membranes","other molecular function","Pf00169","79674","D3DNL0; F5GZ91; hsa:79674; Q14D04; Q2TAA9; Q3MIX2; Q6PEL3; Q86TL5; Q8TCR3; Q96SP7; Q9C0H1; Q9H9Q7","ENSG00000197415",NA,NA,0,0,105.4,96.1,98.9,116,77,132,92.7,103.1,88.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S430(100); S478(98.1)]",0,"ENSG00000197415"
"738","MVB12A",0.307399181916412,6.56738869768637,1.90936950445181,0.0865490227368034,0.191392960848866,-5.3178267214803,"NONE",FALSE,"High","Master Protein","Q96EY5","Multivesicular body subunit 12A [OS=Homo sapiens]",0,32.328,5,1,2,5,1,273,28.8,8.91,17.7,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10240","93343","hsa:93343; Q96EY5; Q96I18","ENSG00000141971","Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; HCMV Late Events","7q11.23 copy number variation syndrome",6,0,52,58,49.6,117.2,107.4,117.2,108,176.8,157.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100)]",0,"ENSG00000141971"
"739","IQSEC1",0.156723087867472,6.64440644974665,1.90558232915754,0.0870851816599065,0.192318019579117,-5.32354593100672,"NONE",FALSE,"High","Master Protein","Q6DN90","IQ motif and SEC7 domain-containing protein 1 [OS=Homo sapiens]",0,50.432,9,6,7,12,6,963,108.2,6.93,30.71,6,"cell organization and biogenesis;developmental processes;other biological processes","ER/Golgi;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01369, Pf16453","9922","A0A087WWK8; hsa:9922; O94863; Q6DN90; Q96D85","ENSG00000144711",NA,"EGF/EGFR signaling pathway",1,0,90.3,94.3,93.6,93,97.2,101.6,99.3,115.4,114.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100); S105(100); S180(100); S198(100); S417(100)]",0,"ENSG00000144711"
"740","BRD7",-0.388552040597386,6.51071377998088,-1.90338214594131,0.0873980929650531,0.192748226647252,-5.3268662233783,"NONE",FALSE,"High","Master Protein","Q9NPI1","Bromodomain-containing protein 7 [OS=Homo sapiens]",0,10.168,2,1,1,1,1,651,74.1,6.39,3.7,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00439, Pf12024","29117","hsa:29117; Q4VC09; Q8N2L9; Q96KA4; Q9BV48; Q9NPI1; Q9UH59","ENSG00000166164","Regulation of TP53 Activity through Acetylation",NA,1,0,124.8,113.8,116.8,81.1,59.4,133.3,69.5,82.8,77.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S279(100)]",0,"ENSG00000166164"
"741","FBXO42",-0.342720349490596,6.6254948262762,-1.90234879059457,0.08754542025212,0.192812585494548,-5.32842506826132,"NONE",FALSE,"High","Master Protein","Q6P3S6","F-box only protein 42 [OS=Homo sapiens]",0,3.219,4,1,1,1,1,717,77.8,7.43,2.24,1,NA,"other cell component","other molecular function","Pf12937, Pf13415, Pf13854","54455","B3KP30; hsa:54455; Q5TEU8; Q6P3S6; Q86XI0; Q8N3N4; Q8N5F8; Q9BRM0; Q9P2L4","ENSG00000037637; ENSG00000291375",NA,NA,0,0,91.5,56.6,75.1,127.4,113.8,137.2,86.7,118,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000037637"
"742","SF3B1",-0.167746074066633,6.63244620441005,-1.90124665201141,0.087702810184094,0.19289890326205,-5.33008725839779,"NONE",FALSE,"High","Master Protein","O75533","Splicing factor 3B subunit 1 [OS=Homo sapiens]",0,55.588,7,6,7,12,6,1304,145.7,7.09,34.41,6,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf08920","23451","E9PCH3; hsa:23451; O75533","ENSG00000115524","B-WICH complex positively regulates rRNA expression; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing; 10q11.21q11.23 copy number variation syndrome",5,0,105.8,104,104.6,102.3,92.4,108.1,101.7,95,85.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100); T211(100); T235(100); T248(100); T426(100)]",0,"ENSG00000115524"
"743","ALAD",-0.280119370211064,6.67915770358619,-1.89294385019601,0.0888970193744993,0.195262362879115,-5.34259526115978,"NONE",FALSE,"High","Master Protein","P13716","Delta-aminolevulinic acid dehydratase [OS=Homo sapiens]",0.003,2.304,2,1,1,2,1,330,36.3,6.79,4.95,1,"cell organization and biogenesis;other metabolic processes;stress response;other biological processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf00490","210","A8K375; B2R6F2; hsa:210; P13716; Q16870; Q16871; Q9BVQ9","ENSG00000148218","Neutrophil degranulation; Heme biosynthesis","Hemesynthesis defects and porphyrias; Heme biosynthesis",4,0,62.8,69.8,83.4,136.4,121.2,135.3,118.2,122.2,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100)]",0,"ENSG00000148218"
"744","EPRS1",0.195061539293326,6.64983899146584,1.89114983675946,0.0891570453786481,0.195570293088648,-5.3452946745597,"NONE",FALSE,"High","Master Protein","P07814","Bifunctional glutamate/proline--tRNA ligase [OS=Homo sapiens]",0,35.568,2,2,3,10,2,1512,170.5,7.33,31.45,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf00458, Pf00587, Pf00749, Pf03129, Pf03950, Pf09180, Pf20974","2058","A0AVA9; B9EGH3; hsa:2058; P07814; Q05BP6; Q05DF8; Q5DSM1; Q5H9S5; Q6PD57; Q86X73","ENSG00000136628","tRNA modification in the nucleus and cytosol; Selenoamino acid metabolism; Cytosolic tRNA aminoacylation","Parkinson's disease pathway; VEGFA-VEGFR2 signaling; Amino acid metabolism",6,0,98.5,94.2,95.3,93.2,75.6,112.7,113,102.1,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S886(99)]",0,"ENSG00000136628"
"745","INTS12",0.329958810224506,6.61498755913557,1.88805964649812,0.089606607421336,0.196292595049155,-5.34994171006736,"NONE",FALSE,"High","Master Protein","Q96CB8","Integrator complex subunit 12 [OS=Homo sapiens]",0,5.481,2,1,1,1,1,462,48.8,9.69,3.11,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00628","57117","B2RC48; hsa:57117; Q3B6Z3; Q96CB8; Q9HD71","ENSG00000138785","RNA polymerase II transcribes snRNA genes",NA,1,0,67.6,63,79.8,97.1,131.1,92.6,101.6,148.7,151.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S378(100)]",0,"ENSG00000138785"
"746","AFAP1",0.184178187879358,6.61976976629299,1.88644130032349,0.0898428889550561,0.196546373692562,-5.35237401245315,"NONE",FALSE,"High","Master Protein","Q8N556","Actin filament-associated protein 1 [OS=Homo sapiens]",0,38.528,5,2,3,5,2,730,80.7,8.68,13.17,2,NA,"cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169","60312","A8K442; B4DMU2; E9PDT7; hsa:60312; Q59EY5; Q8N556; Q9HBY1","ENSG00000196526",NA,NA,0,0,109.2,105.3,106.8,80.1,96.8,86.7,100.8,96,110.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S265(100); S668(100)]",0,"ENSG00000196526"
"747","UFD1",0.414765549481483,6.56887026079981,1.88490501369329,0.0900677278151829,0.196774473620319,-5.35468210912886,"NONE",FALSE,"High","Master Protein","Q92890-1","Isoform Long of Ubiquitin recognition factor in ER-associated degradation protein 1 [OS=Homo sapiens]",0,21.313,3,1,1,4,1,343,38.7,6.34,14.14,1,NA,NA,NA,NA,NA,"Q92890-1",NA,NA,NA,0,0,52,49.5,56.7,99.6,108.5,122.5,99.3,209.1,158.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000070010"
"748","FOXO1",-0.576040622922087,6.60048368018753,-1.88180916816902,0.0905224081476594,0.19750343595853,-5.35933067407795,"NONE",FALSE,"High","Master Protein","Q12778","Forkhead box protein O1 [OS=Homo sapiens]",0.003,2.309,4,1,1,1,1,655,69.6,6.77,2.54,1,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf16675, Pf16676","2308","hsa:2308; O43523; Q12778; Q5VYC7; Q6NSK6","ENSG00000150907","Constitutive Signaling by AKT1 E17K in Cancer; MAPK6/MAPK4 signaling; AKT phosphorylates targets in the nucleus; Regulation of localization of FOXO transcription factors; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Interleukin-4 and Interleukin-13 signaling; FOXO-mediated transcription of cell cycle genes; FOXO-mediated transcription of cell death genes; Regulation of FOXO transcriptional activity by acetylation; AKT-mediated inactivation of FOXO1A","Androgen receptor signaling pathway; Energy metabolism; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; AGE/RAGE pathway; Adipogenesis; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Vitamin D receptor pathway; Nuclear receptors meta-pathway; Copper homeostasis; Melatonin metabolism and effects; RAC1/PAK1/p38/MMP2 pathway; Transcription factor regulation in adipogenesis; NAD metabolism, sirtuins and aging; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; White fat cell differentiation; Somatroph axis (GH) and its relationship to dietary restriction and aging; EGF/EGFR signaling pathway; Leukocyte-intrinsic Hippo pathway functions; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; Kynurenine pathway and links to cell senescence; FOXA2 pathway; Pleural mesothelioma; Interactions of natural killer cells in pancreatic cancer; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Warburg effect modulated by deubiquitinating enzymes and their substrates; Extrafollicular and follicular B cell activation by SARS-CoV-2; Primary ovarian insufficiency; Rubinstein-Taybi syndrome 1; ErbB signaling pathway",52,0,103.5,87.4,82,130.4,176.8,85.4,59.4,109.7,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000150907"
"749","ANGPT2",-0.517613721028741,6.51756549576239,-1.88020879632287,0.0907582904209897,0.197548775076317,-5.36173234934799,"NONE",FALSE,"High","Master Protein","O15123","Angiopoietin-2 [OS=Homo sapiens]",0.006,1.881,2,1,1,1,1,496,56.9,5.58,2.29,1,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00147","285","A0AV38; A8K205; B7ZLM7; hsa:285; O15123; Q9NRR7; Q9P2Y7","ENSG00000091879","Tie2 Signaling","RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Hypothesized pathways in pathogenesis of cardiovascular disease; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Pleural mesothelioma",7,0,121.5,94.3,99.4,80.1,66.8,172.8,68.1,77.4,89.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S221(100)]",0,"ENSG00000091879"
"750","WDR77",-0.160302203343393,6.6584147828521,-1.88002591170816,0.0907852826637488,0.197548775076317,-5.3620067447505,"NONE",FALSE,"High","Master Protein","Q9BQA1","Methylosome protein WDR77 [OS=Homo sapiens]",0,14.167,4,1,1,4,1,342,36.7,5.17,15.79,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","79084","B3KMW6; B4DP38; hsa:79084; Q3LID2; Q53FU2; Q6JZZ5; Q96GK4; Q9BQA1; Q9BWY3","ENSG00000116455","RMTs methylate histone arginines; snRNP Assembly",NA,2,0,92,87.9,96.5,117.7,112,102.4,98.2,105,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T5(100)]",0,"ENSG00000116455"
"751","CGN",0.219423591869146,6.62106876387272,1.87761072792763,0.0911424468272579,0.198061881787064,-5.3656292833554,"NONE",FALSE,"High","Master Protein","Q9P2M7","Cingulin [OS=Homo sapiens]",0,13.899,2,1,1,2,1,1203,137,5.52,7.46,1,"cell organization and biogenesis","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity","Pf01576","57530","A6H8L3; A7MD22; hsa:57530; Q5T386; Q9NR25; Q9P2M7","ENSG00000143375","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","15q11q13 copy number variation",2,0,82.7,86.3,83.9,105.1,69.2,112.7,116.8,109.4,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100)]",0,"ENSG00000143375"
"752","TNIK",-0.135224519073513,6.63891110958146,-1.87388705778415,0.0916956822286139,0.198999140155715,-5.37121025416596,"NONE",FALSE,"High","Master Protein","Q9UKE5","TRAF2 and NCK-interacting protein kinase [OS=Homo sapiens]",0,92.248,7,9,10,17,7,1360,154.8,7.17,52.83,9,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf00780","23043","A7E2A3; A8K4U1; D3DNQ6; hsa:23043; O60298; Q8WUY7; Q9UKD8; Q9UKD9; Q9UKE0; Q9UKE1; Q9UKE2; Q9UKE3; Q9UKE4; Q9UKE5","ENSG00000154310","Oxidative Stress Induced Senescence","Hippo-YAP signaling; Pleural mesothelioma",3,2,102.8,99.6,98.2,101.2,110.5,101.3,94.8,99.7,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S548(99.6); S570(100); S640(100); S707(100); S769(100)]",0,"ENSG00000154310"
"753","ANTXR1",0.149803862557981,6.62869139382072,1.87077159126143,0.0921609588240663,0.199743273307936,-5.37587575967022,"NONE",FALSE,"High","Master Protein","Q9H6X2","Anthrax toxin receptor 1 [OS=Homo sapiens]",0,34.392,6,2,2,13,2,564,62.7,7.61,42.28,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00092, Pf05586, Pf05587","84168","A8K7U8; hsa:84168; J7K7G4; J7KF88; Q4ZFV6; Q53QD8; Q96P02; Q9H6X2; Q9NVP3","ENSG00000169604",NA,"Primary ovarian insufficiency",1,0,107,108.9,101,92.8,76.3,96.3,107.2,102.2,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100); S563(100)]",0,"ENSG00000169604"
"754","SNIP1",-0.242942944377204,6.56362035504184,-1.86738636786033,0.09266901522426,0.200545726798514,-5.38094118905357,"NONE",FALSE,"High","Master Protein","Q8TAD8","Smad nuclear-interacting protein 1 [OS=Homo sapiens]",0,41.173,10,4,5,11,4,396,45.8,9.99,15.6,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf00498","79753","hsa:79753; Q8TAD8; Q96SP9; Q9H9T7","ENSG00000163877","mRNA Splicing - Major Pathway","TGF-beta signaling pathway",2,0,99.5,110.4,107.9,88.4,122.6,87.7,91.9,88.8,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100); S54(99.5); S76(100)]",0,"ENSG00000163877"
"755","ZNF423",-0.136958704703975,6.59117859339612,-1.86666924799703,0.0927769753265186,0.200545726798514,-5.38201369848423,"NONE",FALSE,"High","Master Protein","Q2M1K9","Zinc finger protein 423 [OS=Homo sapiens]",0,11.026,2,2,2,2,2,1284,144.5,6.89,5.46,2,"developmental processes;signal transduction;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf13912","23090","hsa:23090; O94860; Q2M1K9; Q76N04; Q9NZ13","ENSG00000102935",NA,"Differentiation of white and brown adipocyte; White fat cell differentiation; Joubert syndrome; Ciliopathies; TGF-beta receptor signaling in skeletal dysplasias; TGF-beta receptor signaling",6,0,120.4,118.4,106.6,95.7,79.9,96.8,88.6,90.2,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T383(99.6)]",0,"ENSG00000102935"
"756","H2AX",0.171485112498879,6.46406194945394,1.86487770806015,0.0930471979425382,0.200863792383892,-5.38469225750101,"NONE",FALSE,"High","Master Protein","P16104","Histone H2AX [OS=Homo sapiens]",0,29.395,29,7,7,15,4,143,15.1,10.74,29.14,7,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00125, Pf16211","3014","hsa:3014; P16104; Q4ZGJ7; Q6IAS5","ENSG00000188486","RMTs methylate histone arginines; Amyloid fiber formation; Meiotic synapsis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Replacement of protamines by nucleosomes in the male pronucleus","miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; Proteasome degradation; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; DNA repair pathways, full network; 5q35 copy number variation; DNA damage response",47,3,141.1,129.8,125.6,64.6,55.1,70.7,79.6,76.5,92.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000188486"
"757","NEXN",-0.304176510297511,6.67247493901712,-1.86127156421117,0.0935933451540779,0.201625741330669,-5.39008025291219,"NONE",FALSE,"High","Master Protein","Q0ZGT2","Nexilin [OS=Homo sapiens]",0,9.736,2,1,1,4,1,675,80.6,5.33,10.76,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf07679","91624","A0PJ84; B4DPZ7; hsa:91624; Q0D2H2; Q0ZGT2; Q14CC2; Q14CC3; Q16081; Q7Z2X0; Q96DL0; Q9Y2V1","ENSG00000162614",NA,"VEGFA-VEGFR2 signaling",1,0,68.9,97.2,90.6,131,111.9,122.4,116.1,104.4,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000162614"
"758","SEC61B",0.315233229131781,6.60836984285642,1.86058554332478,0.093697579562836,0.201625741330669,-5.39110470053112,"NONE",FALSE,"High","Master Protein","P60468","Protein transport protein Sec61 subunit beta [OS=Homo sapiens]",0,26.137,26,2,3,5,2,96,10,11.56,17.33,2,"protein metabolism;other metabolic processes;stress response;transport","other membranes;cytosol;ER/Golgi","translation activity;other molecular function","Pf03911","10952","hsa:10952; P38390; P38391; P60468; Q6IBC1","ENSG00000106803","ER-Phagosome pathway; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; SRP-dependent cotranslational protein targeting to membrane",NA,3,0,101.3,116.7,131.2,66.7,104,67.3,99,94.1,113.3,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S17(96.9)]",0,"ENSG00000106803"
"759","PML",-0.140703880968491,6.59767402904485,-1.86010409794842,0.0937707951409177,0.201625741330669,-5.39182354719337,"NONE",FALSE,"High","Master Protein","P29590","Protein PML [OS=Homo sapiens]",0,24.314,5,4,5,9,4,882,97.5,6.21,20.87,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00097, Pf00643, Pf12126","5371","E9PBR7; hsa:5371; P29590; P29591; P29592; P29593; Q00755; Q15959; Q59FP9; Q8WUA0; Q96S41; Q9BPW2; Q9BWP7; Q9BZX6; Q9BZX7; Q9BZX8; Q9BZX9; Q9BZY0; Q9BZY2; Q9BZY3","ENSG00000140464","HCMV Early Events; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Interferon gamma signaling; Regulation of TP53 Activity through Acetylation; Regulation of PTEN localization; Regulation of RUNX1 Expression and Activity","miRNA regulation of DNA damage response; Wnt/beta-catenin signaling pathway in leukemia; TGF-beta signaling pathway; p53 transcriptional gene network; Acute myeloid leukemia; DNA damage response",13,0,116.6,112.2,113.5,92.7,90.4,94.5,93.4,83.5,91.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S40(100); S403(100); S505(100); S518(100); S527(100)]",0,"ENSG00000140464"
"760","SPAG9",0.209522100411655,6.66896689929026,1.85905582676562,0.093930394643451,0.201703163234358,-5.39338842350869,"NONE",FALSE,"High","Master Protein","O60271","C-Jun-amino-terminal kinase-interacting protein 4 [OS=Homo sapiens]",0,87.874,6,5,8,17,5,1321,146.1,5.15,52.1,5,"transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf09744, Pf16471, Pf19056","9043","A6H8U5; A8MSX0; B4DHH2; hsa:9043; O60271; O60905; Q3KQU8; Q3MKM7; Q86WC7; Q86WC8; Q8IZX7; Q96II0; Q9H811","ENSG00000008294","Myogenesis",NA,1,0,95.9,97.5,95.3,107.6,73,101.7,112.4,121.4,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T217(100); T226(99.6); S730(100)]",0,"ENSG00000008294"
"761","TRIM3",-0.183294544006975,6.62844153082701,-1.85680838229432,0.0942734205087224,0.202173748055499,-5.39674206377674,"NONE",FALSE,"High","Master Protein","O75382","Tripartite motif-containing protein 3 [OS=Homo sapiens]",0,33.2,4,2,3,4,2,744,80.8,7.83,14.72,2,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00097, Pf00630, Pf00643, Pf01436","10612","B7Z5E6; F5H2Q8; hsa:10612; O75382; Q4V9L4; Q9C038; Q9C039","ENSG00000110171","Interferon gamma signaling",NA,1,0,94.4,97.5,91.8,108.9,118.4,97.2,96.6,91,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S427(100)]",0,"ENSG00000110171"
"762","OSBPL11",-0.188079160410306,6.61448613759884,-1.85416261066155,0.0946787356274312,0.202776504650876,-5.40068766806721,"NONE",FALSE,"High","Master Protein","Q9BXB4","Oxysterol-binding protein-related protein 11 [OS=Homo sapiens]",0,35.618,4,2,3,5,2,747,83.6,7.06,20.27,2,"transport;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00169, Pf01237","114885","A8K9I7; hsa:114885; Q9BXB4","ENSG00000144909","RHOH GTPase cycle",NA,1,0,106.9,102,105,96.9,90.6,113.5,85.1,88.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S286(99.5)]",0,"ENSG00000144909"
"763","EPHB1",0.202753455029419,6.65066929446513,1.84930896514184,0.0954264971644762,0.204110148587713,-5.40791901378008,"NONE",FALSE,"High","Master Protein","P54762","Ephrin type-B receptor 1 [OS=Homo sapiens]",0,26.991,5,4,4,4,4,984,109.8,6.4,11.01,4,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00041, Pf00536, Pf01404, Pf07714, Pf14575","2047","A8K593; B3KTB2; B5A969; hsa:2047; O43569; O95142; O95143; P54762; Q0VG87","ENSG00000154928","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells","Neural crest cell migration during development; Neural crest cell migration in cancer",6,0,90.4,91.5,98,87.4,80.4,118.5,113.2,107.5,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S570(100); S583(99.6); S774(99.6); S899(99.1)]",0,"ENSG00000154928"
"764","GATAD2B",-0.146064621144609,6.64184209839202,-1.84660304347921,0.0958457549080214,0.204438006959394,-5.41194665536479,"NONE",FALSE,"High","Master Protein","Q8WXI9","Transcriptional repressor p66-beta [OS=Homo sapiens]",0,71.193,11,4,7,10,4,593,65.2,9.7,35.47,4,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00320, Pf16563","57459","D3DUZ2; hsa:57459; Q5VUR2; Q7LG68; Q8WXI9; Q9ULS0","ENSG00000143614; ENSG00000261992","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation",NA,6,0,99.9,101.8,94.4,109.3,91.1,111.5,99.5,97.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T120(100); S135(99.4); S334(99.3); S486(100)]",0,"ENSG00000143614"
"765","PPP1R3D",0.189769395507076,6.63935721675116,1.84649372783435,0.0958627282626704,0.204438006959394,-5.41210930856692,"NONE",FALSE,"High","Master Protein","O95685","Protein phosphatase 1 regulatory subunit 3D [OS=Homo sapiens]",0,21.821,6,1,1,3,1,299,32.5,8.07,12.58,1,"other metabolic processes;other biological processes","other cell component","other molecular function","Pf03370","5509","hsa:5509; O95685; Q6DK02","ENSG00000132825",NA,NA,0,0,70.5,74.4,67.3,97,131.4,113.8,122.1,119.7,132.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100)]",0,"ENSG00000132825"
"766","ABI1",-0.207660601877241,6.65534236536855,-1.84589601424737,0.0959555841488333,0.204438006959394,-5.41299858003887,"NONE",FALSE,"High","Master Protein","Q8IZP0","Abl interactor 1 [OS=Homo sapiens]",0,50.659,11,4,6,24,4,508,55,7.06,51.29,4,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00018, Pf07815","10006","A9Z1Y6; B3KX62; B4DQ58; H7BXI6; hsa:10006; O15147; O76049; O95060; Q5T2R3; Q5T2R4; Q5T2R6; Q5T2R7; Q5T2R9; Q5W070; Q5W072; Q8IZP0; Q8TB63; Q96S81; Q9NXZ9; Q9NYB8","ENSG00000136754","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway","EGF/EGFR signaling pathway",8,0,82.8,88.5,88.9,117.5,140.4,98.2,103,99.4,104.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S216(99.4); S225(100); S231(100)]",0,"ENSG00000136754"
"767","SP9",-0.291056258700862,6.4796376567413,-1.83810050498605,0.0971743006348557,0.206764613606368,-5.42458422317248,"NONE",FALSE,"High","Master Protein","P0CG40","Transcription factor Sp9 [OS=Homo sapiens]",0.003,2.353,4,1,1,2,1,484,48.9,8.76,2.14,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","100131390","hsa:100131390; P0CG40","ENSG00000217236",NA,NA,0,0,140.6,101,108.4,80.6,78.2,96.3,94.5,66.4,70.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T30(99.3)]",0,"ENSG00000217236"
"768","ABLIM1",-0.143400255950831,6.65603127349651,-1.83481271017007,0.0976925927750864,0.207596759647059,-5.42946357283489,"NONE",FALSE,"High","Master Protein","O14639","Actin-binding LIM protein 1 [OS=Homo sapiens]",0,118.535,14,9,12,36,9,778,87.6,8.59,101.55,9,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf02209, Pf16182","3983","A6NI16; A6NJ06; A8MXA9; B3KVH2; hsa:3983; O14639; Q15039; Q5JVV1; Q5JVV2; Q5T6N2; Q5T6N3; Q5T6N5; Q68CQ9; Q9BUP1","ENSG00000099204","DCC mediated attractive signaling","Male infertility",2,0,77.5,78,82.5,115.7,134.6,112.2,104.3,111.5,109.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(99.6); S352(91.9); S367(98.1); S431(100); S452(100); S655(100); S706(100)]",0,"ENSG00000099204"
"769","RSF1",0.186650843456348,6.65067253409991,1.82991710573526,0.0984690924907663,0.208974719044123,-5.4367213475263,"NONE",FALSE,"High","Master Protein","Q96T23","Remodeling and spacing factor 1 [OS=Homo sapiens]",0,128.331,8,8,9,21,8,1441,163.7,5.01,69.53,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00628, Pf15612","51773","hsa:51773; Q86X86; Q96T23; Q9H3L8; Q9NVZ8; Q9NYU0","ENSG00000048649","Deposition of new CENPA-containing nucleosomes at the centromere",NA,1,0,98.8,104.7,98.6,97.7,72.5,103.8,111.1,112.2,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S473(100); S604(100); S622(100); S865(99.6); S1282(100); T1305(100); S1345(100)]",0,"ENSG00000048649"
"770","FAM76B",-0.363515480536067,6.48261349028566,-1.82886242577083,0.0986371239533012,0.209059462716607,-5.43828371002338,"NONE",FALSE,"High","Master Protein","Q5HYJ3","Protein FAM76B [OS=Homo sapiens]",0,8.078,4,1,1,2,1,339,38.7,9.25,7.66,1,NA,"nucleus",NA,"Pf16046","143684","B2R9C2; hsa:143684; Q5HYJ3; Q6PIU3; Q8TC53","ENSG00000077458",NA,NA,0,0,123.7,121.3,145.8,87.3,74.1,82.4,68.9,96.6,60.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000077458"
"771","ACTR10",0.396850103152325,6.63447989954682,1.82541946261328,0.0991875066517656,0.209953321472998,-5.44338098850001,"NONE",FALSE,"High","Master Protein","Q9NZ32","Actin-related protein 10 [OS=Homo sapiens]",0,20.012,6,2,2,3,2,417,46.3,7.37,9.98,2,"transport","non-structural extracellular;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component",NA,"Pf00022","55860","hsa:55860; Q9H9Y5; Q9NWY2; Q9NZ32","ENSG00000131966","MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Neutrophil degranulation",NA,5,0,80.5,81.5,85.1,84.5,146.4,71.9,124.4,103.3,151.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S414(100)]",0,"ENSG00000131966"
"772","SGTA",-0.154646919641896,6.63650953992002,-1.82377092887913,0.0994520422140397,0.210240586649369,-5.44582000161524,"NONE",FALSE,"High","Master Protein","O43765","Small glutamine-rich tetratricopeptide repeat-containing protein alpha [OS=Homo sapiens]",0,58.119,8,3,5,12,3,313,34,4.87,35.45,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00515, Pf13181, Pf16546","6449","D6W610; hsa:6449; O43765; Q6FIA9; Q9BTZ9","ENSG00000104969","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",NA,1,0,91,90,100.3,102,118.9,105.1,94.8,97.4,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T81(100)]",0,"ENSG00000104969"
"773","GPBP1",0.209072384981213,6.64469400289312,1.81834245927756,0.100327755324258,0.211817460141254,-5.45384396737857,"NONE",FALSE,"High","Master Protein","Q86WP2","Vasculin [OS=Homo sapiens]",0,13.193,4,1,1,2,1,473,53.3,7.05,8.24,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15337","65056","A6NKW3; hsa:65056; Q6NSH6; Q86WP2; Q9H0D4; Q9H785; Q9NSN4","ENSG00000062194",NA,NA,0,0,105.2,97.2,103.8,83.2,96.5,95,110,93.7,120.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S381(99.3)]",0,"ENSG00000062194"
"774","NUMBL",-0.41975859472613,6.54105981812422,-1.81516352734092,0.100843881907313,0.212017853935286,-5.45853748289187,"NONE",FALSE,"High","Master Protein","Q9Y6R0","Numb-like protein [OS=Homo sapiens]",0,16.815,3,2,2,4,2,609,64.9,8.85,8.89,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","other cell component",NA,"Pf00640, Pf06311","9253","hsa:9253; Q7Z4J9; Q9Y6R0","ENSG00000105245",NA,"Notch signaling; Neurogenesis regulation in the olfactory epithelium; Notch signaling pathway",3,0,58.1,52.7,58.8,128.9,219.9,100.6,90.4,97.1,137.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(100)]",0,"ENSG00000105245"
"775","PPP1R9A",0.263048518740584,6.6520830031073,1.81494795327368,0.100878970913147,0.212017853935286,-5.458855622433,"NONE",FALSE,"High","Master Protein","Q9ULJ8-3","Isoform 3 of Neurabin-1 [OS=Homo sapiens]",0,52.726,6,4,5,8,4,1374,154,5.59,23.84,4,NA,NA,NA,NA,NA,"Q9ULJ8-3",NA,NA,NA,0,0,97.9,97.9,103,85.6,64.8,121.4,107.3,114.9,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(99.4); S338(100); S1250(100)]",0,"ENSG00000158528"
"776","MAP3K7",-0.213726087820169,6.64954972873248,-1.81461879263959,0.100932570185954,0.212017853935286,-5.45934135534943,"NONE",FALSE,"High","Master Protein","O43318","Mitogen-activated protein kinase kinase kinase 7 [OS=Homo sapiens]",0,33.497,5,2,2,4,2,606,67.2,7.11,17.32,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf07714","6885","B2RE27; E1P523; hsa:6885; O43317; O43318; O43319; Q5TDN2; Q5TDN3; Q5TDT7; Q9NTR3; Q9NZ70","ENSG00000135341","FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Ca2+ pathway; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NF-kappa-B signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway","IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Ebstein-Barr virus LMP1 signaling; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; Fas ligand pathway and stress induction of heat shock proteins; Wnt signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; Angiopoietin-like protein 8 regulatory pathway; Wnt signaling pathway and pluripotency; p38 MAPK signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; miRNA role in immune response in sepsis; Signal transduction through IL1R; Measles virus infection; Hepatitis B infection; IL-18 signaling pathway; Insulin signaling; Host-pathogen interaction of human coronaviruses - interferon induction; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway",50,0,84.1,92.7,85.5,107.1,146.3,102.8,94.8,107.3,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S374(99.5); S439(100)]",0,"ENSG00000135341"
"777","TCF20",-0.218975241008253,6.59470974496766,-1.81455891145941,0.100942323840513,0.212017853935286,-5.45942971571412,"NONE",FALSE,"High","Master Protein","Q9UGU0","Transcription factor 20 [OS=Homo sapiens]",0,15.059,2,2,2,3,2,1960,211.6,9.04,9.39,2,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf13771","6942","A9JX12; hsa:6942; O14528; Q13078; Q4V353; Q9H4M0; Q9UGU0","ENSG00000100207; ENSG00000262024; ENSG00000276461",NA,"Matrix metalloproteinases",1,0,107.1,97.6,112.7,101.3,114.7,86.1,93.6,81.6,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1369(98.6); T1671(100)]",0,"ENSG00000100207"
"778","CENPA",-0.176854690807524,6.4842128758606,-1.80011928625931,0.103319884560424,0.216732714142175,-5.48069538026694,"NONE",FALSE,"High","Master Protein","P49450","Histone H3-like centromeric protein A [OS=Homo sapiens]",0,22.025,10,2,3,9,2,140,16,11.71,11.18,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00125","1058","D6W544; hsa:1058; P49450; Q53T74; Q9BVW2","ENSG00000115163","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Deposition of new CENPA-containing nucleosomes at the centromere; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2q37 copy number variation syndrome",8,0,142,133.3,134.6,77.3,77.3,69.3,74.9,68.2,81.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100)]",0,"ENSG00000115163"
"779","DECR2",0.176627350861855,6.65333942451308,1.79745273859032,0.103764558702612,0.217386084470685,-5.48461341036918,"NONE",FALSE,"High","Master Protein","Q9NUI1","Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] [OS=Homo sapiens]",0,6.345,4,1,1,1,1,292,30.8,9.22,2.92,1,"other metabolic processes","other membranes;cytosol;other cytoplasmic organelle","other molecular function","Pf13561","26063","hsa:26063; Q6ZRS7; Q96ET0; Q9NUI1","ENSG00000242612; ENSG00000274296","Peroxisomal protein import; Beta-oxidation of very long chain fatty acids",NA,2,0,112.2,105.4,101,101.2,68.7,99.3,101.9,104.5,110.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(100)]",0,"ENSG00000242612"
"780","PNISR",0.115116677464771,6.55777996030611,1.79278878703161,0.104546564568377,0.218743581250757,-5.49145942150147,"NONE",FALSE,"High","Master Protein","Q8TF01","Arginine/serine-rich protein PNISR [OS=Homo sapiens]",0,13.941,3,3,3,4,3,805,92.5,10.02,11.79,3,NA,"plasma membrane;other membranes;cytosol;nucleus;other cell component",NA,"Pf15996","25957","A8K540; E1P5D2; hsa:25957; Q5T064; Q5T065; Q6P2B4; Q6P2N4; Q6PJ93; Q6PK36; Q7Z640; Q8N2L1; Q8TF00; Q8TF01; Q96K10; Q96SI3; Q96SM5; Q9P076; Q9P0C0; Q9Y4N3","ENSG00000132424",NA,NA,0,0,132.2,129.3,125.5,77,67.1,78.2,85.1,89.7,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(100); S563(100); S726(100)]",0,"ENSG00000132424"
"781","GOLM1",-0.208034715246926,6.66344553710097,-1.78391887689476,0.106048783932435,0.221518562438967,-5.50445494587325,"NONE",FALSE,"High","Master Protein","Q8NBJ4","Golgi membrane protein 1 [OS=Homo sapiens]",0,65.961,12,2,3,9,2,401,45.3,4.97,32.59,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;ER/Golgi",NA,NA,"51280","hsa:51280; Q6IAF4; Q8NBJ4; Q9NRB9","ENSG00000135052","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,91.6,88.1,97.8,113.4,96.8,125.5,106.5,106.6,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100); S309(100)]",0,"ENSG00000135052"
"782","PRKAR2A",-0.204305200295285,6.60241749616607,-1.78335875172538,0.106144311168672,0.221518562438967,-5.50527452721721,"NONE",FALSE,"High","Master Protein","P13861","cAMP-dependent protein kinase type II-alpha regulatory subunit [OS=Homo sapiens]",0,23.216,11,2,2,5,2,404,45.5,5.07,17.31,2,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5576","hsa:5576; P13861; Q16823; Q9BUB1","ENSG00000114302","Factors involved in megakaryocyte development and platelet production; FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5","Myometrial relaxation and contraction pathways; G protein signaling pathways; TGF-beta signaling pathway; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GDNF signaling; Calcium regulation in cardiac cells; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways",22,0,123.2,103.7,102.2,96.4,112,91.1,91.1,81.9,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000114302"
"783","SPIN1",-0.177300966693355,6.6397067710058,-1.78112985667859,0.10652522559945,0.222029588988891,-5.50853460400782,"NONE",FALSE,"High","Master Protein","Q9Y657","Spindlin-1 [OS=Homo sapiens]",0,3.967,10,1,1,1,1,262,29.6,6.96,2.95,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus","other molecular function","Pf02513","10927","A8K0X6; B3KRQ4; hsa:10927; Q7KZJ8; Q9GZT2; Q9H0N7; Q9Y657","ENSG00000106723",NA,NA,0,0,107.2,81.7,91,110,115.9,104.2,99,98.4,100.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100)]",0,"ENSG00000106723"
"784","BCL2L13",0.306885684168397,6.64298884282701,1.7791651744128,0.10686202860577,0.222084672939917,-5.51140654953708,"NONE",FALSE,"High","Master Protein","Q9BXK5","Bcl-2-like protein 13 [OS=Homo sapiens]",0,57.097,6,2,3,14,2,485,52.7,4.44,44.99,2,"other biological processes","other membranes;mitochondrion;nucleus","enzyme regulator activity","Pf00452","23786","B3KPE7; hsa:23786; Q96B37; Q96IB7; Q9BXK5; Q9BY01; Q9HC05; Q9UFE0; Q9UKN3","ENSG00000099968",NA,"Regulation of apoptosis by parathyroid hormone-related protein; TAR syndrome",2,0,70.3,75,88.1,109.6,116.7,82.3,144.1,117.8,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(99.5); S426(100)]",0,"ENSG00000099968"
"785","TPR",0.170253316101861,6.64794481863228,1.77893343323198,0.106901820198051,0.222084672939917,-5.51174520149797,"NONE",FALSE,"High","Master Protein","P12270","Nucleoprotein TPR [OS=Homo sapiens]",0,30.401,2,2,2,2,2,2363,267.1,5.02,10.34,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf07926","7175","hsa:7175; P12270; Q15624; Q15655; Q5SWY0; Q99968","ENSG00000047410","Transport of Mature mRNA derived from an Intron-Containing Transcript; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants",NA,29,0,111.4,98.5,87.8,94.9,90.8,96.2,105.9,115,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(100); S2155(100)]",0,"ENSG00000047410"
"786","U2AF2",0.228890917089285,6.66273735650753,1.77802251098684,0.107058364009272,0.222084672939917,-5.51307615272215,"NONE",FALSE,"High","Master Protein","P26368","Splicing factor U2AF 65 kDa subunit [OS=Homo sapiens]",0,36.064,8,3,3,8,3,475,53.5,9.09,25.38,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076","11338","hsa:11338; P26368; Q96HC5","ENSG00000063244","mRNA Splicing - Major Pathway; Protein hydroxylation; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing; Warburg effect modulated by deubiquitinating enzymes and their substrates",7,0,101.9,97.6,101.3,97.3,63.9,115.4,107.3,114,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S79(100)]",0,"ENSG00000063244"
"787","WDR3",0.132674051224818,6.49766897485941,1.77780381375627,0.107095978923845,0.222084672939917,-5.51339564128534,"NONE",FALSE,"High","Master Protein","Q9UNX4","WD repeat-containing protein 3 [OS=Homo sapiens]",0,15.2,3,1,1,3,1,943,106,6.64,14.08,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","other membranes;nucleus;other cell component","nucleic acid binding activity","Pf00400, Pf04003, Pf12894","10885","hsa:10885; Q9UNX4","ENSG00000065183","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol",NA,2,0,150.1,124.7,136.9,68.8,61.2,68.5,84.6,83.4,80.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(99.4)]",0,"ENSG00000065183"
"788","GPATCH8",-0.181153783156823,6.57945508132202,-1.77419905667561,0.10771773325344,0.223004838012353,-5.5186588994238,"NONE",FALSE,"High","Master Protein","Q9UKJ3","G patch domain-containing protein 8 [OS=Homo sapiens]",0,33.203,4,4,4,6,4,1502,164.1,8.66,17.67,4,NA,"nucleus","other molecular function","Pf01585","23131","B9EGP9; hsa:23131; O60300; Q8TB99; Q9UKJ3","ENSG00000186566",NA,NA,0,0,108,114.6,118.3,87,104.5,90.3,82.4,84.2,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S653(100); S1035(100); S1081(100)]",0,"ENSG00000186566"
"789","ARMC10",0.324180899623856,6.63514880082309,1.77364841256872,0.107813000730237,0.223004838012353,-5.51946241717342,"NONE",FALSE,"High","Master Protein","Q8N2F6","Armadillo repeat-containing protein 10 [OS=Homo sapiens]",0,37.333,6,2,2,3,2,343,37.5,6.61,12.29,2,"other biological processes","other membranes;mitochondrion;ER/Golgi","other molecular function","Pf04826","83787","A8K703; B4DWJ8; F5GX65; hsa:83787; Q75K91; Q75MG6; Q75ML8; Q8IZC1; Q8IZC2; Q8IZC3; Q8N2F6; Q9BTM6","ENSG00000170632",NA,NA,0,0,107.3,95.3,94.9,86.2,110.6,72.2,126.1,90.2,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000170632"
"790","EIF3CL",0.125187402335771,6.68219860305934,1.76805295780242,0.108785473845185,0.224731510525748,-5.52762038989773,"NONE",FALSE,"High","Master Protein","B5ME19","Eukaryotic translation initiation factor 3 subunit C-like protein [OS=Homo sapiens]",0,49.811,2,2,2,10,2,914,105.4,5.64,36.51,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf01399, Pf05470","728689","B5ME19; hsa:728689","ENSG00000205609",NA,NA,0,0,84.9,90.4,89.3,108.2,95.2,110.3,109.2,116.4,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000205609"
"791","MPZL1",-0.186842225400921,6.65970122988087,-1.76286935371909,0.109693546161392,0.226095828710215,-5.53516632011618,"NONE",FALSE,"High","Master Protein","O95297","Myelin protein zero-like protein 1 [OS=Homo sapiens]",0,9.373,4,1,1,2,1,269,29.1,8.72,6.11,1,"cell-cell signaling;signal transduction","plasma membrane;other membranes","other molecular function","Pf07686","9019","B2REB9; B2REC0; hsa:9019; O95297; Q5R332; Q8IX11; Q9BWZ3; Q9NYK4; Q9UL20","ENSG00000197965",NA,NA,0,0,76.9,74.1,78.6,126.6,114.2,125,120.6,106.4,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100)]",0,"ENSG00000197965"
"792","HSPB1",-0.149106456673787,6.64332575534039,-1.76242438953422,0.10977181887765,0.226095828710215,-5.53581354681813,"NONE",FALSE,"High","Master Protein","P04792","Heat shock protein beta-1 [OS=Homo sapiens]",0,5.993,5,1,1,4,1,205,22.8,6.4,12.79,1,"protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00011","3315","B2R4N8; hsa:3315; P04792; Q6FI47; Q96C20; Q96EI7; Q9UC31; Q9UC34; Q9UC35; Q9UC36","ENSG00000106211","AUF1 (hnRNP D0) binds and destabilizes mRNA; MAPK6/MAPK4 signaling; Extra-nuclear estrogen signaling; VEGFA-VEGFR2 Pathway","Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; p38 MAPK signaling pathway; Extracellular vesicles in the crosstalk of cardiac cells; Ferroptosis; IL-18 signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy; GDNF signaling; Macrophage-stimulating protein (MSP) signaling network map; 7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system",18,0,59.3,62.3,66.9,127.5,150.6,124.9,110.7,116.4,133.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(99.7)]",0,"ENSG00000106211"
"793","KDM1B",0.258675459583914,6.61825873451104,1.76191484435611,0.109861514808333,0.226095828710215,-5.53655460894283,"NONE",FALSE,"High","Master Protein","Q8NB78","Lysine-specific histone demethylase 2 [OS=Homo sapiens]",0,9.33,2,1,1,1,1,822,92,7.87,3.09,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf01593, Pf04433, Pf07496","221656","A2A2C5; A2A2C6; hsa:221656; Q5TGV3; Q6AI15; Q6ZUU4; Q8N258; Q8NB78; Q96EL7","ENSG00000165097","UCH proteinases; HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","Vitamin D-sensitive calcium signaling in depression",4,0,121.1,93,100.3,92.7,76.2,84.8,108.4,87.7,128,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100)]",0,"ENSG00000165097"
"794","TRPS1",-0.180992685722972,6.58574262502459,-1.75980168550499,0.11023421473686,0.226577126512034,-5.53962674530578,"NONE",FALSE,"High","Master Protein","Q9UHF7","Zinc finger transcription factor Trps1 [OS=Homo sapiens]",0,21.864,3,2,2,3,2,1281,141.4,7.58,9.27,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00320","7227","B4E1Z5; hsa:7227; Q08AU2; Q9NWE1; Q9UHF7; Q9UHH6","ENSG00000104447",NA,NA,0,0,120.5,109.9,124.4,94.2,85.5,92.5,84.6,77.5,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S1066(100)]",0,"ENSG00000104447"
"795","RAPGEF2",-0.143043273705605,6.65170473526398,-1.75728562666405,0.110679485897961,0.227153759969066,-5.54328218571159,"NONE",FALSE,"High","Master Protein","Q9Y4G8","Rap guanine nucleotide exchange factor 2 [OS=Homo sapiens]",0,62.078,6,5,5,7,5,1499,167.3,6.67,27.86,5,"cell organization and biogenesis;protein metabolism;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00595, Pf00617, Pf00618, Pf00788","9693","D3DP27; hsa:9693; Q9Y4G8","ENSG00000109756","RAF/MAP kinase cascade","MAPK signaling pathway",2,0,92.9,98.6,97,108.8,92.1,117.7,97.5,103.2,97.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S930(100); S959(99.4); S1080(100); S1159(98.7); T1217(98.6)]",0,"ENSG00000109756"
"796","SPIRE2",-0.286880029219526,6.64042615379071,-1.75664493632392,0.110793132926088,0.227153759969066,-5.54421258468921,"NONE",FALSE,"High","Master Protein","Q8WWL2","Protein spire homolog 2 [OS=Homo sapiens]",0,9.72,2,1,1,1,1,714,79.6,7.62,3.34,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf16474","84501","A4QPB1; hsa:84501; Q2TA98; Q6P433; Q8ND47; Q8WWL2; Q96JJ5","ENSG00000204991",NA,NA,0,0,94.3,105.9,69.1,119.2,136.9,99.8,97.9,95.1,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000204991"
"797","NHSL1",0.171906340667215,6.6550599289988,1.7543280553581,0.111204999157729,0.227712118726994,-5.54757567808285,"NONE",FALSE,"High","Master Protein","Q5SYE7","NHS-like protein 1 [OS=Homo sapiens]",0,52.136,6,5,7,8,5,1610,170.6,6.96,21.07,5,"other biological processes",NA,NA,"Pf15273","57224","hsa:57224; Q3ZCS5; Q5SYE7; Q5SYE8; Q9P2J0","ENSG00000135540",NA,"Thyroid hormones production and peripheral downstream signaling effects",1,0,96.6,94.8,94.6,91,112,92.1,105.5,106.3,119.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S842(100); S851(90.7); S1181(100); S1191(98.1); S1233(100)]",0,"ENSG00000135540"
"798","RRAS2",-0.185142579371721,6.64903867981627,-1.74754823618052,0.112418298203995,0.229908098582607,-5.55740399473697,"NONE",FALSE,"High","Master Protein","P62070","Ras-related protein R-Ras2 [OS=Homo sapiens]",0,40.111,8,3,3,5,3,204,23.4,6.01,20.92,3,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf00071","22800","B2R9Z3; B7Z5Z2; B7Z6C4; B7Z7H6; hsa:22800; P17082; P62070","ENSG00000133818","RND1 GTPase cycle","MAPK signaling pathway; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Regulation of actin cytoskeleton",6,0,95.1,94.6,95.4,108.3,87.8,125.3,99,103.9,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S186(100)]",0,"ENSG00000133818"
"799","DDX17",0.242038958800998,6.65867234708045,1.74442917128055,0.112980535991469,0.230768754365553,-5.56191898609715,"NONE",FALSE,"High","Master Protein","Q92841","Probable ATP-dependent RNA helicase DDX17 [OS=Homo sapiens]",0,11.974,5,1,1,1,1,729,80.2,8.27,3.67,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00270, Pf00271","10521","B1AHM0; H3BLZ8; hsa:10521; Q69YT1; Q6ICD6; Q92841","ENSG00000100201","SUMOylation of transcription cofactors","Novel intracellular components of RIG-I-like receptor pathway",2,0,110.4,87.2,77.2,94.2,88.1,108.6,125.5,114.7,105.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100)]",0,"ENSG00000100201"
"800","TAGLN2",0.235373468500813,6.6654540306819,1.74275526339827,0.113283331242643,0.231097995734992,-5.56434033910017,"NONE",FALSE,"High","Master Protein","P37802","Transgelin-2 [OS=Homo sapiens]",0,14.607,13,2,2,2,2,199,22.4,8.25,6.29,2,"cell organization and biogenesis;other biological processes","non-structural extracellular;cytosol;cytoskeleton","cytoskeletal activity","Pf00307, Pf00402","8407","E9KL39; hsa:8407; P37802; Q5JRQ6; Q5JRQ7; Q6FGI1; Q9BUH5; Q9H4P0","ENSG00000158710","Platelet degranulation",NA,1,0,75.3,63.8,87.5,119.1,107.3,97.1,132,120.5,123.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S163(100)]",0,"ENSG00000158710"
"801","DNAJB2",0.151088573990963,6.65152439934096,1.74064719760512,0.113665717247948,0.231588577463984,-5.56738801321309,"NONE",FALSE,"High","Master Protein","P25686","DnaJ homolog subfamily B member 2 [OS=Homo sapiens]",0,6.937,2,1,1,4,1,324,35.6,5.95,4.99,1,"protein metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00226","3300","A8K9P6; hsa:3300; P25686; Q53QD7; Q8IUK1; Q8IUK2; Q96F52","ENSG00000135924",NA,NA,0,0,100,89.7,102.1,99.5,95.6,92.9,110.6,100.3,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100)]",0,"ENSG00000135924"
"802","CAMK2D",0.209701873194866,6.50216580575204,1.7398364083289,0.113813101673384,0.23159972809347,-5.5685596824695,"NONE",FALSE,"High","Master Protein","Q13557-8","Isoform Delta 6 of Calcium/calmodulin-dependent protein kinase type II subunit delta [OS=Homo sapiens]",0,91.705,12,8,12,35,1,478,54.1,7.25,89.11,8,NA,NA,NA,NA,NA,"Q13557-8",NA,NA,NA,0,0,143.1,129,135.6,67,71.5,59,87.4,78,90.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T287(100); S315(100); S319(100); T336(99.6); T337(97.6); S472(100)]",0,"ENSG00000145349"
"803","CHERP",0.203347345174843,6.66777295521596,1.73804028560789,0.11414022105388,0.231976140423328,-5.57115425239525,"NONE",FALSE,"High","Master Protein","Q8IWX8","Calcium homeostasis endoplasmic reticulum protein [OS=Homo sapiens]",0,16.014,3,2,2,4,2,916,103.6,9.04,6.44,2,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01585, Pf01805, Pf04818","10523","hsa:10523; O00302; Q4G0Y5; Q8IWX8; Q8WU30; Q99492","ENSG00000085872","mRNA Splicing - Major Pathway",NA,1,0,86,94.2,81,92.6,101.4,112.4,100.9,129.8,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S817(100); T819(100); S904(100)]",0,"ENSG00000085872"
"804","EPB41L2",0.157851612562956,6.6621687453399,1.736487259194,0.114423758583826,0.232140764846421,-5.57339654552949,"NONE",FALSE,"High","Master Protein","O43491-4","Isoform 4 of Band 4.1-like protein 2 [OS=Homo sapiens]",0,154.779,12,13,15,51,1,852,95.5,5.77,121.71,13,NA,NA,NA,NA,NA,"O43491-4",NA,NA,NA,0,12,69.2,68.4,68.6,118.3,103.9,122,114.4,138.5,132.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S499(100); T510(100); S550(100); S598(100); S613(99.6); S648(99.7)]",0,"ENSG00000079819"
"805","SCD",-0.347321638864977,6.67299777641895,-1.73603904974332,0.114505708150349,0.232140764846421,-5.57404348754631,"NONE",FALSE,"High","Master Protein","O00767","Stearoyl-CoA desaturase [OS=Homo sapiens]",0,36.216,4,2,2,5,2,359,41.5,9,19.21,2,"other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function",NA,"6319","B2R5U0; D3DR68; hsa:6319; O00767; Q16150; Q53GR9; Q5W037; Q5W038; Q6GSS4; Q96KF6; Q9BS07; Q9Y695","ENSG00000099194","Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis","Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Adipogenesis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; PPAR signaling pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis pathway in hepatocytes",13,0,92.7,83.5,86.3,138.8,73.4,144.5,99.7,105.8,93.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T199(100)]",0,"ENSG00000099194"
"806","ARID1A",0.158636093785696,6.64523663187456,1.73311567553587,0.115041527056511,0.232937682575963,-5.57826094407527,"NONE",FALSE,"High","Master Protein","O14497","AT-rich interactive domain-containing protein 1A [OS=Homo sapiens]",0,56.016,3,4,4,6,4,2285,241.9,6.7,22.01,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01388, Pf12031","8289","D3DPL1; hsa:8289; O14497; Q53FK9; Q5T0W1; Q5T0W2; Q5T0W3; Q8NFD6; Q96T89; Q9BY33; Q9HBJ5; Q9UPZ1","ENSG00000117713","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",7,0,99.3,90.6,107.3,94,79.5,104.8,109.9,108.2,102.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(100); S1184(100); S1751(100); S1755(99.4)]",0,"ENSG00000117713"
"807","RWDD2B",0.194949007356673,6.59364467286276,1.73110069256495,0.115412180271359,0.2333986099168,-5.58116575077628,"NONE",FALSE,"High","Master Protein","P57060","RWD domain-containing protein 2B [OS=Homo sapiens]",0,9.592,7,1,1,2,1,319,36.3,5.87,6.23,1,NA,NA,NA,"Pf05773, Pf06544","10069","hsa:10069; P57060","ENSG00000156253; ENSG00000291523",NA,NA,0,0,111.1,105.7,109.1,86.1,74.1,86.8,108.4,107,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(97.9)]",0,"ENSG00000156253"
"808","RGS6",-0.174173453805419,6.56687740745537,-1.71989457359161,0.117493476034207,0.237063992918874,-5.59728842919505,"NONE",FALSE,"High","Master Protein","P49758","Regulator of G-protein signaling 6 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,472,54.4,7.42,5.9,1,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00610, Pf00615, Pf00631, Pf18148","9628","C9JE95; F8W7W5; hsa:9628; O75576; O75577; P49758; Q7Z4K3; Q7Z4K4; Q7Z4K5; Q7Z4K6; Q8TE13; Q8TE14; Q8TE15; Q8TE16; Q8TE17; Q8TE18; Q8TE19; Q8TE20; Q8TE21; Q8TE22; Q9UDS8; Q9UDT0; Q9Y245; Q9Y647","ENSG00000182732","G alpha (i) signalling events; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","Myometrial relaxation and contraction pathways; Calcium regulation in cardiac cells",4,0,89.7,79.9,89.4,103.4,104.3,107.3,84,102.9,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S244(100)]",0,"ENSG00000182732"
"809","ALYREF",-0.379461623686479,6.57750809625582,-1.71977868253328,0.117515177862358,0.237063992918874,-5.59745488046241,"NONE",FALSE,"High","Master Protein","Q86V81","THO complex subunit 4 [OS=Homo sapiens]",0,12.842,7,1,1,1,1,257,26.9,11.15,4.24,1,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf13865","10189","hsa:10189; O43672; Q86V81",NA,"mRNA Splicing - Major Pathway; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,7,0,55.2,60.9,56.7,130,112.1,184.8,81.2,132.4,125.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S239(100)]",0,"ENSG00000183684"
"810","DCAF5",-0.119469720531246,6.58988610415933,-1.7163631117663,0.11815642108404,0.238063307665621,-5.60235793415213,"NONE",FALSE,"High","Master Protein","Q96JK2","DDB1- and CUL4-associated factor 5 [OS=Homo sapiens]",0,38.387,5,4,4,8,4,942,103.9,5.76,21.77,4,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf00400","8816","B2RN31; G3V4J7; hsa:8816; O60559; Q8N3V3; Q8N3V5; Q96JK2","ENSG00000139990","Neddylation",NA,1,0,104.9,108,110.6,91.2,94.7,96.3,91,94,88.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S648(100); S794(100)]",0,"ENSG00000139990"
"811","PLPP3",-0.487297551343958,6.65485688458536,-1.7142375987525,0.118557073550653,0.238400495922282,-5.6054065257596,"NONE",FALSE,"High","Master Protein","O14495","Phospholipid phosphatase 3 [OS=Homo sapiens]",0,9.318,4,1,1,1,1,311,35.1,9.14,3.65,1,"cell adhesion;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf01569","8613","B2R651; D3DQ52; hsa:8613; O14495; Q5U0F7; Q96GW0; Q99782","ENSG00000162407","Sphingolipid catabolism","Triacylglyceride synthesis; Sphingolipid metabolism: integrated pathway",3,0,115.1,94,101.2,131.9,59.2,164.6,91.5,103.9,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S297(100)]",0,"ENSG00000162407"
"812","SLTM",-0.170897540003621,6.54254011864787,-1.71392589253266,0.118615933020155,0.238400495922282,-5.6058534343449,"NONE",FALSE,"High","Master Protein","Q9NWH9","SAFB-like transcription modulator [OS=Homo sapiens]",0,73.246,4,4,4,10,4,1034,117.1,7.87,37.39,4,"other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf02037","79811","A8K5V8; B2RTX3; hsa:79811; Q2VPK7; Q52MB3; Q658J7; Q6ZNF2; Q86TK6; Q9H7C3; Q9H8U9; Q9NWH9","ENSG00000137776",NA,NA,0,0,124.3,127.1,129.8,88.8,68.5,89.7,84.4,87.3,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S289(100); S344(99.4); S553(100)]",0,"ENSG00000137776"
"813","GAB2",0.18951280767648,6.65212614862563,1.70926982701591,0.119498307592485,0.239460572102454,-5.61252396766226,"NONE",FALSE,"High","Master Protein","Q9UQC2","GRB2-associated-binding protein 2 [OS=Homo sapiens]",0,42.923,11,6,6,7,6,676,74.4,8.31,18.57,6,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00169","9846","A2RRM2; A6NEW9; A7MD36; hsa:9846; O60317; Q9UQC2","ENSG00000033327","PIP3 activates AKT signaling; Role of LAT2/NTAL/LAB on calcium mobilization; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; Interleukin receptor SHC signaling; PI3K Cascade; Signaling by SCF-KIT; Signaling by CSF3 (G-CSF); Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; Signaling by FLT3 fusion proteins; Signaling by FLT3 ITD and TKD mutants; STAT5 activation downstream of FLT3 ITD mutants; Interleukin-15 signaling; STAT5 Activation","RANKL/RANK signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Imatinib and chronic myeloid leukemia; BDNF-TrkB signaling; IL-4 signaling pathway; Ras signaling; EGF/EGFR signaling pathway; IL-2 signaling pathway; GDNF signaling; Interferon type I signaling pathways; T-cell receptor signaling pathway",32,0,87.9,89.4,93.6,93.1,114.5,92.8,114.7,101,124.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(99); S210(100); S223(100); S285(100); T391(100); S405(100)]",0,"ENSG00000033327"
"814","EFHD2",0.188870325637602,6.60810464848804,1.70915171995317,0.119520767578687,0.239460572102454,-5.6126930497857,"NONE",FALSE,"High","Master Protein","Q96C19","EF-hand domain-containing protein D2 [OS=Homo sapiens]",0,19.814,7,2,2,2,2,240,26.7,5.2,7.13,2,NA,"other membranes","other molecular function","Pf21008","79180","hsa:79180; Q5JYW9; Q96C19","ENSG00000142634","RHOD GTPase cycle",NA,1,0,107.8,97.6,92.9,87.3,96.6,85.7,105.4,93.9,115.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S74(99.4)]",0,"ENSG00000142634"
"815","HSPD1",0.140621870236585,6.46523188484022,1.70882164138824,0.119583557759497,0.239460572102454,-5.6131655576831,"NONE",FALSE,"High","Master Protein","P10809","60 kDa heat shock protein, mitochondrial [OS=Homo sapiens]",0,284.395,45,20,21,39,20,573,61,5.87,146.68,20,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00118","3329","B2R5M6; B7Z712; hsa:3329; P10809; Q38L19; Q9UCR6","ENSG00000144381","Mitochondrial protein import; Mitochondrial protein degradation; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation","Apoptosis-related network due to altered Notch3 in ovarian cancer; 8p23.1 copy number variation syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways",6,0,146.4,142.3,138.9,65,55.8,64.2,86.2,74.2,77.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100)]",0,"ENSG00000144381"
"816","ZC3HC1",0.216724073474443,6.62192809065647,1.70328802048648,0.120640681489585,0.241106334918652,-5.62107975059278,"NONE",FALSE,"High","Master Protein","Q86WB0","Zinc finger C3HC-type protein 1 [OS=Homo sapiens]",0,44.709,17,5,5,10,5,502,55.2,5.62,17.8,5,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","other membranes;nucleus","other molecular function","Pf07967, Pf08600","51530","A6NH66; hsa:51530; Q75MF3; Q75MF4; Q86WB0; Q8N330; Q96F75; Q9HA34; Q9NVX4; Q9P0R0","ENSG00000091732","Nuclear events stimulated by ALK signaling in cancer",NA,1,0,108.3,99.3,106.4,84.2,95.5,83.9,97.3,94.1,128.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S321(100); S344(100); S370(100); S395(99.5)]",0,"ENSG00000091732"
"817","FBXL20",-0.148036242419464,6.60916611623739,-1.7029741067485,0.120700904184154,0.241106334918652,-5.62152830268455,"NONE",FALSE,"High","Master Protein","Q96IG2","F-box/LRR-repeat protein 20 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,436,48.4,7.49,9.29,1,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;other cell component",NA,"Pf12937, Pf13516","84961","A8K729; hsa:84961; Q38J52; Q96IG2","ENSG00000108306","Neddylation; Antigen processing: Ubiquitination & Proteasome degradation","17q12 copy number variation syndrome",3,0,115.6,114.5,105.5,91.3,90,103.8,82.7,95.1,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T417(100)]",0,"ENSG00000108306"
"818","SNAPIN",0.20064951882681,6.65349449849354,1.70001832763276,0.121269294991839,0.241842674275446,-5.62574966866151,"NONE",FALSE,"High","Master Protein","O95295","SNARE-associated protein Snapin [OS=Homo sapiens]",0,25.467,11,1,1,3,1,136,14.9,9.31,12.03,1,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf14712","23557","D3DV56; hsa:23557; O95295; Q5SXU8","ENSG00000143553","Golgi Associated Vesicle Biogenesis","Alstrom syndrome",2,0,92.9,101,103.9,92.5,102.4,87.4,121.8,98,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000143553"
"819","TSC2",-0.258590202332621,6.65720942649097,-1.69932780433825,0.121402431004911,0.241842674275446,-5.6267352939267,"NONE",FALSE,"High","Master Protein","P49815","Tuberin [OS=Homo sapiens]",0,84.781,7,9,12,20,9,1807,200.5,7.31,41.51,9,"stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf02145, Pf03542, Pf11864","7249","A7E2E2; B4DIL8; B4DIQ7; B4DRN2; B7Z2B8; C9J378; hsa:7249; O75275; P49815; Q4LE71; Q8TAZ1","ENSG00000103197","Constitutive Signaling by AKT1 E17K in Cancer; TP53 Regulates Metabolic Genes; AKT phosphorylates targets in the cytosol; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; TBC/RABGAPs; Inhibition of TSC complex formation by PKB","AMP-activated protein kinase signaling; Target of rapamycin signaling; Follicle stimulating hormone (FSH) signaling pathway; Glioblastoma signaling pathways; Brain-derived neurotrophic factor (BDNF) signaling pathway; Nanoparticle triggered autophagic cell death; Polycystic kidney disease pathway; Wnt signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; ATM signaling in development and disease ; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; p53 transcriptional gene network; Pleural mesothelioma; DYRK1A involvement regarding cell proliferation in brain development; Primary ovarian insufficiency; Monoamine transport",35,0,101.7,99.4,101.7,117.7,77.5,125.2,87.3,111,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1097(99.1); S1387(99.1); S1411(100); S1420(100); S1452(100)]",0,"ENSG00000103197"
"820","RNF25",0.188510624803685,6.61730366841883,1.69809945183725,0.121639590861064,0.241842674275446,-5.62848806806898,"NONE",FALSE,"High","Master Protein","Q96BH1","E3 ubiquitin-protein ligase RNF25 [OS=Homo sapiens]",0,2.944,2,1,1,1,1,459,51.2,6.54,2.78,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus","other molecular function","Pf05773, Pf13639","64320","A8K0D6; hsa:64320; Q53HQ5; Q96BH1; Q9H874","ENSG00000163481","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,102.3,86.6,104.2,86.5,91.4,94.3,93.7,117.1,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S450(100)]",0,"ENSG00000163481"
"821","AHNAK",-0.134017842113719,6.64553682707024,-1.69723573905286,0.121806600846497,0.241842674275446,-5.62972012214984,"NONE",FALSE,"High","Master Protein","Q09666","Neuroblast differentiation-associated protein AHNAK [OS=Homo sapiens]",0,445.002,6,32,45,73,32,5890,628.7,6.15,248.6,32,"other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"79026","A1A586; hsa:79026; Q09666","ENSG00000124942",NA,NA,0,0,74.8,81.6,79.8,115.3,132.4,111.1,107.1,109.9,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S135(100); S210(100); S216(100); S379(100); S511(100); S559(100); S570(100); S2150(100); S3326(100); S4425(100); S4520(100); S4908(100); S4995(99.3); S5110(100); S5400(100); S5448(100); S5731(100); S5749(100); S5752(100); S5782(100); T5794(98.1); S5830(100); S5841(100); S5867(100)]",0,"ENSG00000124942"
"822","PCBP1",-0.121100922903749,6.61762125700943,-1.69721576980834,0.121810464616677,0.241842674275446,-5.62974860358039,"NONE",FALSE,"High","Master Protein","Q15365","Poly(rC)-binding protein 1 [OS=Homo sapiens]",0,114.013,17,4,10,41,2,356,37.5,7.09,120.82,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013","5093","hsa:5093; Q13157; Q14975; Q15365","ENSG00000169564","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","Ferroptosis",3,2,107.2,101.5,110.2,95.8,100.5,98.3,94.5,91.1,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S190(99.6)]",0,"ENSG00000169564"
"823","EIF4G3",0.135699030684282,6.61045560437136,1.69294603918409,0.122639155844502,0.243192104906715,-5.63583426046971,"NONE",FALSE,"High","Master Protein","O43432","Eukaryotic translation initiation factor 4 gamma 3 [OS=Homo sapiens]",0,76.459,3,4,4,7,4,1585,176.5,5.38,26.74,4,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity","Pf02020, Pf02847, Pf02854","8672","B9EGQ7; hsa:8672; O43432; Q15597; Q504Z1; Q5SWC3; Q8NEN1","ENSG00000075151","ISG15 antiviral mechanism","Translation factors; Translation inhibitors in chronically activated PDGFRA cells",3,0,117.1,121.7,117.1,84.8,69.1,92.6,92.2,102.6,94.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(100); S1156(100); S1409(100)]",0,"ENSG00000075151"
"824","MATR3",-0.282135332424934,6.30967024929068,-1.68576105221792,0.124045198396998,0.245430355539014,-5.64605649685504,"NONE",FALSE,"High","Master Protein","P43243","Matrin-3 [OS=Homo sapiens]",0,75.888,8,9,14,44,9,847,94.6,6.25,113.75,9,"stress response;developmental processes;other biological processes","other membranes;nucleus","nucleic acid binding activity;other molecular function",NA,"9782","B7ZAV5; D3DQC3; hsa:9782; P43243; Q9UHW0; Q9UQ27","ENSG00000015479",NA,NA,0,0,167.4,153.9,154.2,57.2,71.1,46.5,65.5,53.7,62.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); S598(100); S604(99.4); S615(100); S621(99.6); S705(98.9)]",0,"ENSG00000015479"
"825","SENP3",-0.215036836884992,6.59173694730973,-1.6856418191804,0.124068653994906,0.245430355539014,-5.64622593525997,"NONE",FALSE,"High","Master Protein","Q9H4L4","Sentrin-specific protease 3 [OS=Homo sapiens]",0,30.401,3,1,2,3,1,574,65,8.56,15.76,1,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf02902, Pf19722","26168","hsa:26168; Q66K15; Q86VS7; Q96PS4; Q9H4L4; Q9Y3W9","ENSG00000161956","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,102.7,101.9,98.2,100.7,112.1,93.7,106.2,85.8,81.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S181(100)]",0,"ENSG00000161956"
"826","TTLL12",0.161770866340412,6.63041432048214,1.68255329717824,0.124677630938513,0.246336433040743,-5.65061268946346,"NONE",FALSE,"High","Master Protein","Q14166","Tubulin--tyrosine ligase-like protein 12 [OS=Homo sapiens]",0,30.401,4,1,1,6,1,644,74.4,5.53,27.05,1,"protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf03133","23170","hsa:23170; Q14166; Q20WK5; Q9UGU3","ENSG00000100304","Carboxyterminal post-translational modifications of tubulin",NA,1,0,97.7,110.4,118.2,88.5,86.1,87.9,93.9,111,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(99.5)]",0,"ENSG00000100304"
"827","TTYH1",0.151869622590284,6.62639920037011,1.68151446266804,0.124883069593145,0.246443977721901,-5.65208721364064,"NONE",FALSE,"High","Master Protein","Q9H313-3","Isoform 3 of Protein tweety homolog 1 [OS=Homo sapiens]",0,61.779,10,3,4,14,2,460,49.7,6.23,45.69,3,NA,NA,NA,NA,NA,"Q9H313-3",NA,NA,NA,0,1,99,92.8,111.1,92.5,83.3,95.1,108.8,96.3,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T156(99.9); T157(99.9); T166(100); S435(100)]",0,"ENSG00000167614"
"828","TOP2B",-0.16470689546636,6.61717932601099,-1.67809678612982,0.125561108364341,0.247482764312323,-5.65693479916193,"NONE",FALSE,"High","Master Protein","Q02880","DNA topoisomerase 2-beta [OS=Homo sapiens]",0,48.733,4,4,5,6,4,1626,183.2,8,19.22,4,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00204, Pf00521, Pf01751, Pf02518, Pf08070, Pf16898","7155","hsa:7155; Q02880; Q13600; Q9UMG8; Q9UQP8","ENSG00000077097","SUMOylation of DNA replication proteins",NA,1,0,99.7,97.3,109.9,100.3,108.4,96.8,84.9,94,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1466(100); S1524(99.6); S1550(99.7)]",0,"ENSG00000077097"
"829","CASP3",-0.335180636976468,6.62292918564912,-1.67057016828814,0.127066078254045,0.250049376084892,-5.66759158978615,"NONE",FALSE,"High","Master Protein","P42574","Caspase-3 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,277,31.6,6.54,4.1,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00656","836","A8K5M2; D3DP53; hsa:836; P42574; Q96AN1; Q96KP2","ENSG00000164305","Degradation of the extracellular matrix; Caspase-mediated cleavage of cytoskeletal proteins; Other interleukin signaling; Apoptosis induced DNA fragmentation; Signaling by Hippo; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Caspase activation via Dependence Receptors in the absence of ligand; Pyroptosis; NADE modulates death signalling; Apoptotic cleavage of cell adhesion  proteins; Stimulation of the cell death response by PAK-2p34","miRNA regulation of DNA damage response; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Corticotropin-releasing hormone signaling pathway; Parkinson's disease pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; Hepatitis C and hepatocellular carcinoma; MAPK signaling pathway; Apoptosis modulation by HSP70; ERK pathway in Huntington's disease; Oxidative damage response; miRNA regulation of p53 pathway in prostate cancer; Prion disease pathway; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; MTHFR deficiency; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; Complement system in neuronal development and plasticity; Orexin receptor pathway; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; Urotensin-II-mediated signaling pathway; DYRK1A involvement regarding cell proliferation in brain development; IL-26 signaling pathways; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response",60,0,68.5,79.8,63.8,113.6,104.6,187.7,92.2,109.7,118,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000164305"
"830","IKBKG",0.177578686046034,6.6718627985677,1.67005480989527,0.127169719454939,0.250049376084892,-5.66832032284524,"NONE",FALSE,"High","Master Protein","Q9Y6K9","NF-kappa-B essential modulator [OS=Homo sapiens]",0,12.663,3,1,1,1,1,419,48.2,5.71,4.06,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf11577, Pf16516, Pf18414","8517","hsa:8517; Q7LBY6; Q7Z7F1; Q9Y6K9","ENSG00000269335","PKR-mediated signaling; NOD1/2 Signaling Pathway; activated TAK1 mediates p38 MAPK activation; FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; ER-Phagosome pathway; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Ovarian tumor domain proteases; RIP-mediated NFkB activation via ZBP1; IKBKB deficiency causes SCID; IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR); IkBA variant leads to EDA-ID; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; SUMOylation of immune response proteins","Nucleotide-binding oligomerization domain (NOD) pathway; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis; Ebstein-Barr virus LMP1 signaling; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; ATM signaling in development and disease ; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; miRNA role in immune response in sepsis; Suppression of HMGB1-mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Hepatitis B infection; Host-pathogen interaction of human coronaviruses - interferon induction; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Network map of SARS-CoV-2 signaling pathway; Acute myeloid leukemia; T-cell receptor signaling pathway; Estrogen signaling pathway; Toll-like receptor signaling pathway",76,0,96.3,110.9,101.1,96.6,107.4,83.7,105.2,104.5,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100)]",0,"ENSG00000269335"
"831","DYNC1LI2",-0.13417233356406,6.65656794113996,-1.66919261921439,0.127343281105271,0.25008933184573,-5.66953921382627,"NONE",FALSE,"High","Master Protein","O43237","Cytoplasmic dynein 1 light intermediate chain 2 [OS=Homo sapiens]",0,58.649,14,3,4,14,3,492,54.1,6.38,47.64,3,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf05783","1783","A8K6V1; B4DZP4; hsa:1783; O43237; Q8TAT3","ENSG00000135720","HCMV Early Events; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption",14,0,87.6,84.4,91.7,113.5,102.9,119.6,102.7,110.4,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(100); S407(100)]",0,"ENSG00000135720"
"832","SLC12A4",-0.239739998553263,6.67773227659112,-1.66630023344209,0.127927090594018,0.250933908472882,-5.67362571180795,"NONE",FALSE,"High","Master Protein","Q9UP95","Solute carrier family 12 member 4 [OS=Homo sapiens]",0,37.006,3,2,4,10,2,1085,120.6,6.44,32.66,2,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","6560","B4DF69; B4DR04; B4DZ82; B7ZAV0; F5H066; F5H0S9; F5H3C0; hsa:6560; O60632; O75893; Q13953; Q96LD5; Q9UP95","ENSG00000124067","Cation-coupled Chloride cotransporters","Proximal tubule transport",2,0,102.3,103,101.5,117.1,75,131.3,95.4,100.3,94,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); S967(100)]",0,"ENSG00000124067"
"833","PRKAA1",0.168694957978252,6.65179426423067,1.66433957110726,0.128324210302348,0.251410697735212,-5.67639362534308,"NONE",FALSE,"High","Master Protein","Q13131","5'-AMP-activated protein kinase catalytic subunit alpha-1 [OS=Homo sapiens]",0,29.016,6,3,3,5,3,559,64,8.12,14.37,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf16579, Pf21147","5562","A8MTQ6; B2R7E1; hsa:5562; O00286; Q13131; Q5D0E1; Q86VS1; Q9UNQ4","ENSG00000132356","Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK","AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Thyroxine (thyroid hormone) production; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; mir-124 predicted interactions with cell cycle and differentiation ; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin and adiponectin; Lipid metabolism pathway; PI3K-Akt signaling pathway; Hereditary leiomyomatosis and renal cell carcinoma pathway; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; IL-18 signaling pathway; Insulin signaling; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Pleural mesothelioma; Affected pathways in Duchenne muscular dystrophy; ADHD and autism (ASD) linked metabolic pathways and SNP",36,0,81.9,78.2,84.4,99.9,104.8,110.4,102.1,118.6,137.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S486(99.3); S496(100); S508(100)]",0,"ENSG00000132356"
"834","SRPK2",-0.154684851979667,6.63505853886964,-1.66147302711068,0.128906812333893,0.25222073494235,-5.68043718267514,"NONE",FALSE,"High","Master Protein","P78362","SRSF protein kinase 2 [OS=Homo sapiens]",0,11.135,3,2,4,7,2,688,77.5,4.97,8.31,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","6733","A8MVX2; hsa:6733; O75220; O75221; P78362; Q6NUL0; Q6V1X2; Q8IYQ3","ENSG00000135250","Maturation of nucleoprotein","mRNA processing",2,0,99,103.8,98.7,100,119.7,96.4,96.8,92.4,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S497(99.1)]",0,"ENSG00000135250"
"835","WDR20",-0.197021976923714,6.66267411284652,-1.66078618704104,0.129046760831411,0.25222073494235,-5.68140547435368,"NONE",FALSE,"High","Master Protein","Q8TBZ3","WD repeat-containing protein 20 [OS=Homo sapiens]",0,19.265,4,2,2,3,2,569,62.9,8,10.63,2,NA,"nucleus;other cell component","enzyme regulator activity","Pf00400","91833","B4DN18; E7EUY8; F8W9S4; G3V2F8; G3V5R0; H0YJJ1; hsa:91833; Q86TU2; Q8NCN7; Q8TBZ3; Q8WXX2; Q9UF86","ENSG00000140153","Ub-specific processing proteases",NA,1,0,75,90,86.4,106.9,128.6,125,92.7,119.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S434(99.6); S465(100)]",0,"ENSG00000140153"
"836","PLEKHA2",0.18497531208123,6.65272278671485,1.65519845601875,0.130190399409123,0.254151593104891,-5.68927475475993,"NONE",FALSE,"High","Master Protein","Q9HB19","Pleckstrin homology domain-containing family A member 2 [OS=Homo sapiens]",0,3.239,3,1,1,1,1,425,47.2,8.66,2.13,1,"other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00169","59339","A8K727; hsa:59339; Q9HB19","ENSG00000169499","Synthesis of PIPs at the plasma membrane",NA,1,0,81.6,79.2,84,99.6,104.1,110.1,101.3,137.4,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S184(100)]",0,"ENSG00000169499"
"837","GIT2",0.201152981560356,6.64946480521649,1.64873741173461,0.131524152873487,0.256448527466583,-5.69835569796672,"NONE",FALSE,"High","Master Protein","Q14161","ARF GTPase-activating protein GIT2 [OS=Homo sapiens]",0,16.518,3,1,1,2,1,759,84.5,7.23,7,1,"transport;developmental processes;other biological processes","nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf01412, Pf08518, Pf12205, Pf16559","9815","hsa:9815; Q14161; Q86U59; Q96CI2; Q9BV91; Q9Y5V2","ENSG00000139436","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle","Integrin-mediated cell adhesion",9,0,80.5,90.8,85.5,87.4,109.9,108.3,106.7,107.1,140.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000139436"
"838","TOPORS",-0.163299064536759,6.54148405935025,-1.64611148920582,0.132069727022368,0.25720500537053,-5.70204079165295,"NONE",FALSE,"High","Master Protein","Q9NS56","E3 ubiquitin-protein ligase Topors [OS=Homo sapiens]",0,13.09,2,2,2,2,2,1045,119.1,9.51,6.42,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00097","10210","hsa:10210; O43273; Q6P987; Q9NS55; Q9NS56; Q9UNR9","ENSG00000197579","SUMOylation of SUMOylation proteins; SUMOylation of transcription cofactors; SUMOylation of immune response proteins","Ciliopathies",4,0,134.9,114.2,127.6,81.5,72.1,94.8,74.6,83.8,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S98(100); S736(99.7)]",0,"ENSG00000197579"
"839","PRPF38B",-0.121079552000609,6.4315163435896,-1.64399371957388,0.132511206484375,0.257590843487134,-5.70501039343636,"NONE",FALSE,"High","Master Protein","Q5VTL8","Pre-mRNA-splicing factor 38B [OS=Homo sapiens]",0,11.939,4,2,2,11,2,546,64.4,10.54,13.41,2,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf03371","55119","hsa:55119; Q05DD6; Q32Q58; Q5VTL8; Q5VTL9; Q6PK39; Q7Z6E2; Q86WF3; Q8IWG9; Q9NW40","ENSG00000134186",NA,NA,0,0,148.6,139.8,145.2,72.5,60.3,64.1,72.4,70.9,70.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); S527(100); S529(100)]",0,"ENSG00000134186"
"840","TMF1",-0.127484742698547,6.64411341248077,-1.6433079530722,0.13265444844066,0.257590843487134,-5.70597154106638,"NONE",FALSE,"High","Master Protein","P82094","TATA element modulatory factor [OS=Homo sapiens]",0,39.703,4,2,3,5,2,1093,122.8,4.92,14.95,2,"cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus","nucleic acid binding activity;other molecular function","Pf12325, Pf12329","7110","B7ZLJ2; hsa:7110; P82094; Q17R87; Q59GK0","ENSG00000144747","Retrograde transport at the Trans-Golgi-Network",NA,1,0,98,98.7,109.8,109.2,94.2,101.5,97.1,95.8,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100); T401(100)]",0,"ENSG00000144747"
"841","PDAP1",0.151183085863146,6.63154430543194,1.64289219141789,0.13274135990973,0.257590843487134,-5.70655415026935,"NONE",FALSE,"High","Master Protein","Q13442","28 kDa heat- and acid-stable phosphoprotein [OS=Homo sapiens]",0,30.781,23,3,5,8,3,181,20.6,8.87,25.02,3,"signal transduction","non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component",NA,"Pf10252","11333","D6W5S5; hsa:11333; Q13442; Q92906","ENSG00000106244","Neutrophil degranulation",NA,1,0,68.5,67.4,68.5,109.1,135.1,103.1,117.8,124.8,132.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T18(99.7); S63(100); S176(100)]",0,"ENSG00000106244"
"842","SRCAP",-0.170365047325818,6.61180622231649,-1.64190074292223,0.132948820412653,0.257687024837826,-5.70794314177441,"NONE",FALSE,"High","Master Protein","Q6ZRS2","Helicase SRCAP [OS=Homo sapiens]",0,30.792,2,3,3,4,3,3230,343.3,5.96,11.95,3,"cell organization and biogenesis;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf07529","10847","B0JZA6; hsa:10847; O15026; Q6ZRS2; Q7Z744; Q9Y5L9","ENSG00000080603",NA,"Pathways affected in adenoid cystic carcinoma",1,0,106.2,103.5,97.7,99.2,114.3,93.8,84.7,94.6,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1859(100); S2790(99.5); S3016(100)]",0,"ENSG00000080603"
"843","SF3B2",-0.113407990644146,6.59406079588719,-1.64033155974135,0.133277767347532,0.25801816881515,-5.71014056913592,"NONE",FALSE,"High","Master Protein","Q13435","Splicing factor 3B subunit 2 [OS=Homo sapiens]",0,46.416,6,3,5,8,3,895,100.2,5.67,23.22,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf02037, Pf04037, Pf04046","10992","A8K485; B4DT19; hsa:10992; Q13435; Q7L4T5; Q7Z627; Q969K1; Q96CM6; Q9BWD2","ENSG00000087365","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",3,0,109.7,116.6,116.1,94.8,83.5,93.6,87.4,93.8,87,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S309(99.5); T780(99.5)]",0,"ENSG00000087365"
"844","KIAA1958",-0.255610293459548,6.66823513591075,-1.63864155518703,0.133632859558336,0.258399083885313,-5.71250588042292,"NONE",FALSE,"High","Master Protein","Q8N8K9","Uncharacterized protein KIAA1958 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,716,79.2,6.83,4.16,1,NA,NA,NA,"Pf12012","158405","B7ZKW6; hsa:158405; Q2M336; Q5T252; Q8N8K9; Q8TF43; Q96N02","ENSG00000165185",NA,NA,0,0,92.5,83.3,91,142.8,103.5,101.3,102.4,97,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S84(99.3)]",0,"ENSG00000165185"
"845","MYH14",-0.225548626397037,6.47446994804027,-1.63629664115257,0.134126964071645,0.259047580313521,-5.71578554109885,"NONE",FALSE,"High","Master Protein","Q7Z406","Myosin-14 [OS=Homo sapiens]",0,30.401,2,1,1,2,1,1995,227.7,5.6,10.4,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00063, Pf01576, Pf02736","79784","B0I1S2; C3TTN4; hsa:79784; Q5CZ75; Q6XYE4; Q76B62; Q7Z406; Q8WV23; Q96I22; Q9BT27; Q9BW35; Q9H882","ENSG00000105357","RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs",NA,6,0,148.6,138.4,121.8,73.7,59.2,95.2,64.2,78.4,80.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1969(100)]",0,"ENSG00000105357"
"846","RER1",0.221859041454852,6.57483722703446,1.63540254433446,0.134315793611982,0.259105644414604,-5.71703535804652,"NONE",FALSE,"High","Master Protein","O15258","Protein RER1 [OS=Homo sapiens]",0,9.646,9,1,1,1,1,196,22.9,9.54,3.47,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding","Pf03248","11079","hsa:11079; O15258; O95322","ENSG00000157916",NA,"1p36 copy number variation syndrome",1,0,113.5,116.7,115.3,89.2,57.8,86.9,110,96.8,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100)]",0,"ENSG00000157916"
"847","SASH1",0.16301584807901,6.66454556233825,1.63079163639356,0.135293390642223,0.260388730486918,-5.72347466001653,"NONE",FALSE,"High","Master Protein","O94885","SAM and SH3 domain-containing protein 1 [OS=Homo sapiens]",0,64.291,9,7,7,10,7,1247,136.6,6.09,28.83,7,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00536, Pf07647, Pf07653, Pf12485","23328","hsa:23328; O94885; Q5TGN5; Q8TAI0; Q9H7R7","ENSG00000111961",NA,NA,0,0,92.4,93.4,92.5,98.6,114.3,90.5,112.5,104.7,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S355(99.4); S407(100); S442(100); S721(99.3); S813(100); S837(99.6)]",0,"ENSG00000111961"
"848","PHF6",-0.186573620553243,6.41225663195765,-1.63022175524776,0.135414657959702,0.260388730486918,-5.72426981186794,"NONE",FALSE,"High","Master Protein","Q8IWS0","PHD finger protein 6 [OS=Homo sapiens]",0,19.593,9,2,2,5,2,365,41.3,8.68,7.47,2,"developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf13771","84295","A8K230; B4E0G4; D3DTG3; E9PC97; hsa:84295; Q5JRC7; Q5JRC8; Q8IWS0; Q96JK3; Q9BRU0","ENSG00000156531",NA,"Mesodermal commitment pathway",1,0,150,139.1,139.4,63.9,52.1,84.3,63.8,71.7,73.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S155(99.1); S204(99.5)]",0,"ENSG00000156531"
"849","ABL2",0.175412180619338,6.66944309328815,1.63001077252048,0.135459578543746,0.260388730486918,-5.72456415525831,"NONE",FALSE,"High","Master Protein","P42684","Tyrosine-protein kinase ABL2 [OS=Homo sapiens]",0,15.66,2,2,2,3,2,1182,128.3,8.07,9.82,2,"cell adhesion;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;cytoskeleton","cytoskeletal activity;kinase activity;other molecular function","Pf00017, Pf00018, Pf07714, Pf08919","27","A0M8X0; B7UEF2; B7UEF3; B7UEF4; B7UEF5; hsa:27; P42684; Q5T0X6; Q5W0C5; Q6NZY6; Q7Z301","ENSG00000143322","RAC3 GTPase cycle; RAC1 GTPase cycle; Negative regulation of FLT3; Role of ABL in ROBO-SLIT signaling","Ras signaling; Acute viral myocarditis; ErbB signaling pathway",7,0,78.8,85.5,78.1,118.4,83.4,111.8,114.2,126.4,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S631(100); S936(100)]",0,"ENSG00000143322"
"850","RRBP1",0.218002054197646,6.59939680021181,1.62742974802594,0.136010189880951,0.261139564571426,-5.72816322612935,"NONE",FALSE,"High","Master Protein","Q9P2E9","Ribosome-binding protein 1 [OS=Homo sapiens]",0,37.85,7,8,8,10,8,1410,152.4,8.6,12.71,8,"protein metabolism;other metabolic processes;transport","other membranes;ER/Golgi;translational apparatus","other molecular function","Pf05104","6238","A0A0A0MRV0; A2A2S6; A6NCN6; hsa:6238; O75300; O75301; Q5W165; Q96SB2; Q9BWP1; Q9H476; Q9P2E9","ENSG00000125844","Signaling by ALK fusions and activated point mutants","Ectoderm differentiation",2,0,103.9,112.4,114.1,83.8,98.8,69.1,107.4,91.5,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S135(99.6); T225(100); T245(100); T255(100); S533(100); S573(100); S583(100)]",0,"ENSG00000125844"
"851","DGCR8",-0.140039759446244,6.59883470770927,-1.62413562450646,0.136715840050914,0.262185958828544,-5.73275200234715,"NONE",FALSE,"High","Master Protein","Q8WYQ5","Microprocessor complex subunit DGCR8 [OS=Homo sapiens]",0,13.658,3,1,1,1,1,773,86,5.95,3.74,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00035","54487","B2R8G1; hsa:54487; Q6DCB2; Q6MZE9; Q6Y2L0; Q8WYQ5; Q96G39; Q96GP8; Q9H6L8; Q9H6T7; Q9NRW2","ENSG00000128191","Transcriptional Regulation by MECP2; MicroRNA (miRNA) biogenesis","miRNA biogenesis; exRNA mechanism of action and biogenesis; DDX1 as a regulatory component of the Drosha microprocessor; 22q11.2 copy number variation syndrome",6,0,118.9,117.8,125.1,82.6,85.4,102,90.5,86,85.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S377(100)]",0,"ENSG00000128191"
"852","CDC42EP1",0.144101814016287,6.6430423648381,1.62296853063021,0.13696663453159,0.262358623891497,-5.73437652814184,"NONE",FALSE,"High","Master Protein","Q00587","Cdc42 effector protein 1 [OS=Homo sapiens]",0,81.123,24,7,9,25,7,391,40.3,7.15,70.85,7,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00786, Pf14957","11135","A8K825; hsa:11135; Q00587; Q96GN1","ENSG00000128283","RHOJ GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle",NA,7,0,98.1,101,100.4,88,90.9,101.9,111.4,108.1,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S101(100); S121(100); S192(100); S195(100); T367(100)]",0,"ENSG00000128283"
"853","PLEKHO1",0.182025897058972,6.63816696674985,1.61800521818075,0.138037797327625,0.264100451628,-5.74127779105123,"NONE",FALSE,"High","Master Protein","Q53GL0","Pleckstrin homology domain-containing family O member 1 [OS=Homo sapiens]",0,18.369,5,2,2,6,2,409,46.2,8.82,13.55,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;nucleus;other cell component",NA,"Pf00169","51177","hsa:51177; Q336K5; Q53GL0; Q8IZ51; Q9NRV3; Q9UL48","ENSG00000023902",NA,NA,0,0,91.3,112.5,98.4,83.1,107.6,91.3,107.6,107.1,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100)]",0,"ENSG00000023902"
"854","TOB2",-0.165017441169027,6.61568997120167,-1.61657198907607,0.138348502879394,0.264384961006055,-5.74326840390531,"NONE",FALSE,"High","Master Protein","Q14106","Protein Tob2 [OS=Homo sapiens]",0,3.262,2,1,1,1,1,344,36.6,6.93,2.73,1,"other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf07145, Pf07742","10766","hsa:10766; Q14106; Q6FHR7; Q6PIT9; Q9BY97; Q9UBI0","ENSG00000183864",NA,"Bone morphogenic protein signaling and regulation",1,0,104.3,120.1,116,89.5,94.3,103.8,96.7,93.1,80.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S222(100)]",0,"ENSG00000183864"
"855","SRSF11",0.202280701141334,6.57595714506139,1.61403493161945,0.138900037959644,0.265128493508935,-5.74678966954269,"NONE",FALSE,"High","Master Protein","Q05519","Serine/arginine-rich splicing factor 11 [OS=Homo sapiens]",0,48.857,11,6,6,16,6,484,53.5,10.52,35.16,6,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00076","9295","hsa:9295; Q05519; Q5T758; Q8IWE6","ENSG00000116754","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,5,0,121.1,124.2,114.5,79.4,85.2,66.4,105.8,87.5,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(99.7); T325(100); S414(99.4); S449(100); S456(100)]",0,"ENSG00000116754"
"856","SNX17",-0.147176063209121,6.66141519340665,-1.61133429342918,0.139489293042002,0.265942203556715,-5.75053451879722,"NONE",FALSE,"High","Master Protein","Q15036","Sorting nexin-17 [OS=Homo sapiens]",0,47.144,8,3,3,6,3,470,52.9,7.46,19.15,3,"other metabolic processes;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00787, Pf18116, Pf21271, Pf21273","9784","B4DQM7; hsa:9784; Q15036; Q53HN7; Q6IAS3","ENSG00000115234",NA,NA,0,0,86,74.6,85.6,117,109.8,123.6,102.3,115.1,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S336(99.6); S409(100); S421(99.6)]",0,"ENSG00000115234"
"857","SERBP1",0.317934752636849,6.52823194536688,1.60925829589566,0.139943774472345,0.266222403041132,-5.75341077954764,"NONE",FALSE,"High","Master Protein","Q8NC51","SERPINE1 mRNA-binding protein 1 [OS=Homo sapiens]",0,4.857,7,2,2,3,2,408,44.9,8.65,2.32,2,"cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf04774, Pf16174","26135","hsa:26135; Q5VU19; Q5VU20; Q5VU22; Q8NC51; Q8WUH0; Q96SE2; Q9BTY3; Q9BUM4; Q9Y367; Q9Y4S3","ENSG00000142864",NA,"Apoptosis-related network due to altered Notch3 in ovarian cancer",1,0,42.9,41.8,50.9,108.8,151.4,104.4,103.1,182.7,178.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S74(100)]",0,"ENSG00000142864"
"858","MARCKSL1",-0.305839476606024,6.62977291910197,-1.60917282901541,0.139962513363536,0.266222403041132,-5.75352914720435,"NONE",FALSE,"High","Master Protein","P49006","MARCKS-related protein [OS=Homo sapiens]",0,136.133,61,7,12,51,7,195,19.5,4.67,152.14,7,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf02063","65108","D3DPQ0; hsa:65108; P49006; Q5TEE6; Q6NXS5","ENSG00000175130",NA,NA,0,0,71.1,94,85.2,114,184.4,93.6,108.2,96.9,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); T85(100); S104(100); T148(100); S165(100); S184(94.8)]",0,"ENSG00000175130"
"859","ASAP1",-0.134484687341135,6.6530061002824,-1.60729253942874,0.140375340293919,0.266696804842463,-5.75613235302445,"NONE",FALSE,"High","Master Protein","Q9ULH1","Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 [OS=Homo sapiens]",0,42.269,4,3,5,7,3,1129,125.4,7.31,23.06,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf01412, Pf12796, Pf14604, Pf16746","50807","B2RNV3; hsa:50807; Q9ULH1","ENSG00000153317","VxPx cargo-targeting to cilium","EGF/EGFR signaling pathway; CCL18 signaling pathway",3,0,88.3,95.5,88.3,110.3,121,102.6,101.6,99.2,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S843(100); S1008(100); S1041(100)]",0,"ENSG00000153317"
"860","HABP4",0.150598437974238,6.67876393968666,1.60528062351489,0.140818270048334,0.267227228742884,-5.75891586566389,"NONE",FALSE,"High","Master Protein","Q5JVS0","Intracellular hyaluronan-binding protein 4 [OS=Homo sapiens]",0,43.041,12,2,2,3,2,413,45.8,7.46,14.08,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf04774, Pf16174","22927","hsa:22927; O75804; Q5JVS0; Q8WV33; Q9NYJ2","ENSG00000130956","Platelet degranulation",NA,1,0,88.8,94.9,97,106.7,87.2,103.6,121.1,106.9,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S108(100)]",0,"ENSG00000130956"
"861","VDAC2",0.197039950844342,6.37183074811115,1.60200700796016,0.141541633118718,0.268287973576943,-5.76344069085639,"NONE",FALSE,"High","Master Protein","P45880","Voltage-dependent anion-selective channel protein 2 [OS=Homo sapiens]",0,96.669,23,7,7,17,6,294,31.5,7.56,57.11,7,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytoskeleton;mitochondrion;other cell component","transporter activity;other molecular function","Pf01459","7417","hsa:7417; P45880; Q5VWK1; Q5VWK3; Q6IB40; Q7L3J5; Q9BWK8; Q9Y5I6","ENSG00000165637","Ub-specific processing proteases; Mitochondrial calcium ion transport","Alzheimer's disease and miRNA effects; Ferroptosis; Alzheimer's disease",5,0,169.4,144.5,145.9,53.1,34.8,65.6,78.4,64.8,71.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000165637"
"862","PRPF4B",-0.118070735002932,6.58382728397784,-1.60112362517507,0.141737399157216,0.26834737288234,-5.76466080444242,"NONE",FALSE,"High","Master Protein","Q13523","Serine/threonine-protein kinase PRP4 homolog [OS=Homo sapiens]",0,74.942,12,15,16,29,15,1007,116.9,10.26,70.22,15,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","8899","A8K5C9; hsa:8899; Q13523; Q5D0F6; Q5TAY8; Q8IVC3; Q8TDP2; Q96QT7; Q9UEE6","ENSG00000112739","mRNA Splicing - Major Pathway","mRNA processing",2,0,121.1,113.8,117.2,92.3,75.1,96.8,86,92.1,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S239(100); S241(99.5); S257(100); S277(100); S294(100); S356(100); S368(100); S387(100); S431(100); S437(100); S569(100)]",0,"ENSG00000112739"
"863","RANBP2",0.158229733775602,6.61297013087513,1.59776920088894,0.14248297226057,0.269446362374565,-5.76929035869516,"NONE",FALSE,"High","Master Protein","P49792","E3 SUMO-protein ligase RanBP2 [OS=Homo sapiens]",0,24.793,2,4,4,8,4,3224,358,6.2,15.43,4,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00160, Pf00638, Pf00641, Pf12185","5903","hsa:5903; P49792; Q13074; Q15280; Q53TE2; Q59FH7","ENSG00000153201","tRNA processing in the nucleus; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Signaling by ALK fusions and activated point mutants",NA,35,0,115.8,114,114,84.3,65.1,101.5,98.1,94.8,102.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S788(99.7); S1456(100); T2293(100); S2668(100)]",0,"ENSG00000153201"
"864","STX12",-0.158394837608557,6.6334792377535,-1.59650975019366,0.142763806131976,0.269664967138178,-5.77102712732006,"NONE",FALSE,"High","Master Protein","Q86Y82","Syntaxin-12 [OS=Homo sapiens]",0,7.847,4,1,2,5,1,276,31.6,5.59,5.51,1,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf05739, Pf14523","23673","B1AJQ7; hsa:23673; O95564; Q86Y82","ENSG00000117758",NA,NA,0,0,92,93.1,96.4,99.2,123.7,104.8,90.3,98.6,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100)]",0,"ENSG00000117758"
"865","SPHK2",-0.151777663457109,6.62790962345399,-1.58925351641678,0.144391433528539,0.272168316191564,-5.78101800127672,"NONE",FALSE,"High","Master Protein","Q9NRA0","Sphingosine kinase 2 [OS=Homo sapiens]",0,28.354,7,2,2,4,2,654,69.2,6.95,17.04,2,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00781, Pf19279","56848","A0T4C8; B4DU87; hsa:56848; Q9BRN1; Q9H0Q2; Q9NRA0; Q9NWU7","ENSG00000063176","Sphingolipid de novo biosynthesis","Sphingolipid pathway; S1P receptor signal transduction; Metabolism of sphingolipids in ER and Golgi apparatus; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids",7,0,85.4,76.1,91.8,117.2,106.1,111.8,96.7,110.4,102.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(99.4); S484(100)]",0,"ENSG00000063176"
"866","AATF",-0.199159873834767,6.58040731145155,-1.58911506925339,0.14442264817518,0.272168316191564,-5.78120836894914,"NONE",FALSE,"High","Master Protein","Q9NY61","Protein AATF [OS=Homo sapiens]",0,15.2,3,1,1,1,1,560,63.1,4.94,4.55,1,"cell adhesion;stress response;developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity;other molecular function","Pf08164, Pf13339","26574","A6NCJ6; B3KQ26; hsa:26574; Q9NY61; Q9P0A4; Q9UNX5","ENSG00000275700; ENSG00000276072","NRAGE signals death through JNK","17q12 copy number variation syndrome",2,0,112.3,118.6,106.7,98.7,108,79.6,95.2,80.7,85,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000275700"
"867","PGRMC1",-0.224540320490113,6.34827505312272,-1.58384590754065,0.145615116645995,0.274099043098344,-5.78844642569053,"NONE",FALSE,"High","Master Protein","O00264","Membrane-associated progesterone receptor component 1 [OS=Homo sapiens]",0,115.061,22,5,6,41,5,195,21.7,4.7,157.87,5,"cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;mitochondrion;ER/Golgi;other cell component","other molecular function","Pf00173","10857","B7Z1L3; hsa:10857; O00264; Q9UGJ9","ENSG00000101856","Neutrophil degranulation","Primary ovarian insufficiency",2,0,160.2,151.5,155.3,58.7,67.9,50.5,71.2,60,60.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S181(100)]",0,"ENSG00000101856"
"868","ERBB4",0.212907577254992,6.61406370914072,1.58202878694651,0.146028375763411,0.274445439292938,-5.79093930047884,"NONE",FALSE,"High","Master Protein","Q15303","Receptor tyrosine-protein kinase erbB-4 [OS=Homo sapiens]",0,30.055,2,1,1,3,1,1308,146.7,6.39,13.54,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","2066","B7ZLD7; B7ZLE2; B7ZLE3; hsa:2066; Q15303; Q2M1W1; Q59EW4","ENSG00000178568",NA,"Mammary gland development pathway - Embryonic development (Stage 1 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); EV release from cardiac cells and their functional effects; Physico-chemical features and toxicity-associated pathways; Melanoma; Neurogenesis regulation in the olfactory epithelium; 10q22q23 copy number variation; ErbB signaling pathway",8,0,105.3,92.2,105.5,90.5,82.2,89.6,121.9,88.9,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T699(100)]",0,"ENSG00000178568"
"869","MYH10",-0.198118732202087,6.65141392357176,-1.58155863464499,0.146135469819585,0.274445439292938,-5.7915840228054,"NONE",FALSE,"High","Master Protein","P35580","Myosin-10 [OS=Homo sapiens]",0,69.537,3,6,10,17,6,1976,228.9,5.54,63.44,6,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00063, Pf00612, Pf01576, Pf02736","4628","B2RWP9; D3DTS1; F8VTL3; hsa:4628; P35580; Q12989; Q149N3; Q149N4; Q16087; Q4LE45; Q6PK16; Q9BWG0","ENSG00000133026","Sema4D induced cell migration and growth-cone collapse; EPHA-mediated growth cone collapse; RHO GTPases activate PAKs; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs","Regulation of actin cytoskeleton",7,0,73.6,80.7,83.4,116.1,108.1,132.4,90.3,113.8,118.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1935(100); S1956(100); S1975(100)]",0,"ENSG00000133026"
"870","SLC16A1",0.172259330114891,6.67179877707221,1.57552592730028,0.147515837994202,0.276719365064985,-5.79984678961127,"NONE",FALSE,"High","Master Protein","P53985","Monocarboxylate transporter 1 [OS=Homo sapiens]",0,92.802,9,5,7,12,5,500,53.9,8.66,41.51,5,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;other molecular function",NA,"6566","hsa:6566; P53985; Q49A45; Q5T8R6; Q9NSJ9","ENSG00000155380; ENSG00000281917","Basigin interactions; Pyruvate metabolism; Aspirin ADME; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)","Photodynamic therapy-induced HIF-1 survival signaling; Fragile X syndrome; Glucose metabolism in triple-negative breast cancer cells",8,0,83.7,83.3,79.9,111.8,88.7,113.7,126.1,123.3,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S461(100); S467(100); S498(100)]",0,"ENSG00000155380"
"871","NOP2",0.142018436961911,6.67403599540256,1.57337924104515,0.148009814249477,0.277327229454819,-5.80278257198258,"NONE",FALSE,"High","Master Protein","P46087","Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase [OS=Homo sapiens]",0,9.954,2,1,1,1,1,812,89.2,9.23,3.54,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf01189, Pf08062, Pf17125","4839","A1A4Z3; B3KPD6; hsa:4839; P46087; Q05BA7; Q0P5S5; Q3KQS4; Q58F30","ENSG00000111641","rRNA modification in the nucleus and cytosol; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation","Imatinib and chronic myeloid leukemia",3,0,92.6,93.6,89,105,109.7,92.4,110.5,117.3,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S732(100)]",0,"ENSG00000111641"
"872","MTA1",0.152540725731858,6.59919177934254,1.5690561790732,0.149009052395345,0.278879327418811,-5.80868762048309,"NONE",FALSE,"High","Master Protein","Q13330","Metastasis-associated protein MTA1 [OS=Homo sapiens]",0,24.127,4,3,4,7,3,715,80.7,9.26,16.25,3,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf00320, Pf01426, Pf01448, Pf17226","9112","A5PLK4; hsa:9112; Q13330; Q86SW2; Q8NFI8; Q96GI8","ENSG00000182979","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; SUMOylation of transcription factors","Effect of progerin on genes involved in progeria; TAR syndrome",8,0,115.9,105.9,109.3,82.6,78.5,91.3,92.3,92.9,113,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S449(100); S522(100); S639(100)]",0,"ENSG00000182979"
"873","SIPA1L1",-0.126544619312524,6.6770380382014,-1.56788437872331,0.149280931790482,0.279068133656434,-5.81028658784065,"NONE",FALSE,"High","Master Protein","O43166","Signal-induced proliferation-associated 1-like protein 1 [OS=Homo sapiens]",0,138.525,10,14,16,32,14,1804,199.9,8.19,99.77,14,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","signal transduction activity or receptor binding;enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","26037","hsa:26037; J3KP19; O43166; O95321; Q9UDU4; Q9UNU4","ENSG00000197555","Neurexins and neuroligins",NA,1,0,81.4,78.1,87.6,121.2,109.1,121.6,110,110.8,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S208(99.8); T239(100); S255(100); S310(100); S1181(100); S1270(100); S1393(100); S1433(99.5); S1528(100); S1549(100); S1585(100)]",0,"ENSG00000197555"
"874","FASN",-0.151506765050791,6.58155988050152,-1.55995017880424,0.15113339923257,0.282207903372487,-5.82109459685488,"NONE",FALSE,"High","Master Protein","P49327","Fatty acid synthase [OS=Homo sapiens]",0,67.126,3,5,6,8,5,2511,273.3,6.44,24.49,5,"other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00107, Pf00109, Pf00550, Pf00698, Pf00975, Pf02801, Pf08242, Pf08659, Pf16197, Pf21089, Pf21149","2194","hsa:2194; P49327; Q13479; Q16702; Q4LE83; Q6P4U5; Q6SS02; Q969R1; Q96C68; Q96IT0","ENSG00000169710","ChREBP activates metabolic gene expression; Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis; Vitamin B5 (pantothenate) metabolism","AMP-activated protein kinase signaling; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-9 fatty acid synthesis; FOXA2 pathway",18,0,121.1,107.4,117.7,89.6,73.5,107.3,83.2,92.7,86.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100); T2204(100)]",0,"ENSG00000169710"
"875","DEK",-0.193485709804088,6.21700282881095,-1.55693358771641,0.151843028094234,0.282987692073205,-5.82519531343628,"NONE",FALSE,"High","Master Protein","P35659","Protein DEK [OS=Homo sapiens]",0,32.194,5,3,3,4,3,375,42.6,8.56,9.28,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf08766","7913","B2R6K6; B4DN37; hsa:7913; P35659; Q5TGV4; Q5TGV5","ENSG00000124795","B-WICH complex positively regulates rRNA expression; Transcriptional regulation of granulopoiesis; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","IL-18 signaling pathway; 10q11.21q11.23 copy number variation syndrome",5,0,168.4,159.3,167.9,53.8,44.1,42.5,57.7,50.5,62.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S307(100)]",0,"ENSG00000124795"
"876","PPP1R1C",-0.36870144697981,6.55849952459823,-1.55670125154015,0.151897805303999,0.282987692073205,-5.82551095343139,"NONE",FALSE,"High","Master Protein","Q8WVI7","Protein phosphatase 1 regulatory subunit 1C [OS=Homo sapiens]",0,8.947,14,1,1,1,1,109,12.3,6.8,2.82,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","other cell component","enzyme regulator activity","Pf05395","151242","hsa:151242; Q5HYJ5; Q8TD54; Q8WVI7","ENSG00000150722",NA,NA,0,0,56.3,63.3,77.9,131.1,207.2,85.2,100,95,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100)]",0,"ENSG00000150722"
"877","NADK2",0.166903561248892,6.52347334748242,1.55052046824994,0.153361455919173,0.285388707024047,-5.83389758098611,"NONE",FALSE,"High","Master Protein","Q4G0N4","NAD kinase 2, mitochondrial [OS=Homo sapiens]",0,13.249,4,1,1,1,1,442,49.4,8.18,3.43,1,"other metabolic processes","mitochondrion","kinase activity;other molecular function","Pf01513","133686","B5MC93; hsa:133686; Q4G0N4; Q6UTX5; Q96NM0","ENSG00000152620","Mitochondrial protein degradation; Nicotinate metabolism",NA,2,0,111.5,124.4,95.6,80,68.5,79.7,100.4,93.4,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S367(100)]",0,"ENSG00000152620"
"878","PPIG",0.148107688478452,6.48279553748315,1.5475883936413,0.154060135509154,0.286362347552323,-5.83786913452424,"NONE",FALSE,"High","Master Protein","Q13427","Peptidyl-prolyl cis-trans isomerase G [OS=Homo sapiens]",0,61.559,11,12,15,33,12,754,88.6,10.29,55.55,12,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf00160","9360","D3DPC5; D3DPC6; hsa:9360; O00706; Q13427; Q53R40; Q53SN4; Q96DG9","ENSG00000138398","mRNA Splicing - Major Pathway; SARS-CoV-1 activates/modulates innate immune responses",NA,2,0,139.3,138.3,131.8,66.5,63.4,63.8,91.3,76.6,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S290(100); T358(100); S397(100); S415(100); T552(100); S687(100); S696(100); S717(100)]",0,"ENSG00000138398"
"879","EMSY",0.142163539740379,6.62983248069024,1.54428097470518,0.154851624665592,0.287048778441387,-5.84234371654214,"NONE",FALSE,"High","Master Protein","Q7Z589","BRCA2-interacting transcriptional repressor EMSY [OS=Homo sapiens]",0,15.275,2,2,2,2,2,1322,141.4,9.33,6.2,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf03735","56946","B7ZKT8; B7ZKU0; B7ZKU2; hsa:56946; Q17RM7; Q4G109; Q7Z589; Q8NBU6; Q8TE50; Q9H8I9; Q9NRH0","ENSG00000158636",NA,"Mesodermal commitment pathway",1,0,101.6,111.2,95.8,97.9,90.5,84.6,102.1,99.3,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(99.5)]",0,"ENSG00000158636"
"880","ZBTB40",-0.184048997265164,6.55504778103116,-1.54393620568134,0.154934336399471,0.287048778441387,-5.84280982280593,"NONE",FALSE,"High","Master Protein","Q9NUA8","Zinc finger and BTB domain-containing protein 40 [OS=Homo sapiens]",0,7.152,3,2,2,3,2,1239,138,6.57,2.99,2,"stress response;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651, Pf12874","9923","hsa:9923; O75066; Q5TFU5; Q8N1R1; Q9NUA8","ENSG00000184677",NA,NA,0,0,126.9,124.6,126.6,84,93.9,81.2,72.2,86.8,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S728(100)]",0,"ENSG00000184677"
"881","OGFR",-0.166067945569842,6.56790971678099,-1.54384138236799,0.15495709179342,0.287048778441387,-5.84293800711543,"NONE",FALSE,"High","Master Protein","Q9NZT2","Opioid growth factor receptor [OS=Homo sapiens]",0,30.401,3,1,1,5,1,677,73.3,4.84,19.64,1,"other biological processes","other membranes;nucleus;other cell component","other molecular function","Pf04664, Pf04680","11054","hsa:11054; O96029; Q4VXW5; Q96CM2; Q9BQW1; Q9H4H0; Q9H7J5; Q9NZT2; Q9NZT3; Q9NZT4","ENSG00000060491",NA,NA,0,0,102.2,110.9,111.9,91.6,91.2,95.3,77.1,88.1,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100)]",0,"ENSG00000060491"
"882","CBX8",-0.110948930167027,6.49847174181999,-1.5401729974162,0.155839683569586,0.288356421298826,-5.84789339565487,"NONE",FALSE,"High","Master Protein","Q9HC52","Chromobox protein homolog 8 [OS=Homo sapiens]",0,17.307,7,2,2,3,2,389,43.4,9.91,9.07,2,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00385, Pf17218","57332","hsa:57332; Q96H39; Q9HC52; Q9NR07","ENSG00000141570","SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription",NA,8,0,132.3,135,129.3,77,71.4,75.9,82.6,76.5,76.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S191(99.6); S311(100)]",0,"ENSG00000141570"
"883","NRBP2",-0.140359414611096,6.66570058983676,-1.53424758662036,0.157274656960414,0.290682038685613,-5.85588271419952,"NONE",FALSE,"High","Master Protein","Q9NSY0","Nuclear receptor-binding protein 2 [OS=Homo sapiens]",0,28.722,7,3,3,5,3,501,57.8,6.49,19.65,3,"developmental processes;other biological processes","other cell component","kinase activity;other molecular function","Pf00069","340371","B4DF59; hsa:340371; Q2HIX8; Q597G7; Q8NCX8; Q8WYS5; Q9NSY0","ENSG00000185189",NA,NA,0,0,86.1,78.6,88,118.4,101.8,124.6,102.3,112.3,106,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); T411(100)]",0,"ENSG00000185189"
"884","CRELD2",-0.421113248733442,6.56548203958055,-1.52998292164042,0.158314626061688,0.292273155806193,-5.8616213508797,"NONE",FALSE,"High","Master Protein","Q6UXH1","Protein disulfide isomerase CRELD2 [OS=Homo sapiens]",0,4.965,3,2,2,4,2,353,38.2,4.59,6.41,2,NA,"non-structural extracellular;ER/Golgi","other molecular function","Pf07645","79174","A5GZA2; A5GZA3; A5GZA4; A5GZA5; A5GZA6; hsa:79174; Q4W0V0; Q6UXH1; Q86UC0; Q9BU47","ENSG00000184164",NA,NA,0,0,68.1,61.2,70.1,107.1,220.8,105.3,132.3,79.1,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(99.6)]",0,"ENSG00000184164"
"885","RBM14",-0.138010220693673,6.46147197029671,-1.52591326767974,0.159312672448701,0.293545283242584,-5.86708858019636,"NONE",FALSE,"High","Master Protein","Q96PK6","RNA-binding protein 14 [OS=Homo sapiens]",0,16.669,4,3,3,13,3,669,69.4,9.67,31.37,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00076","100526737; 10432","B0LM41; B3KMN4; D6RGD8; hsa:100526737; hsa:10432; O75932; Q2PYN1; Q53GV1; Q68DQ9; Q96PK5; Q96PK6","ENSG00000239306","RUNX2 regulates bone development","Ciliary landscape",2,0,157.4,137.2,135,68.9,56.3,83.6,75.4,68.8,74.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T206(100); S582(100); S618(100)]",0,"ENSG00000239306"
"886","STK10",0.148717070483089,6.65936491805474,1.52556728190713,0.159397776768921,0.293545283242584,-5.86755297595007,"NONE",FALSE,"High","Master Protein","O94804","Serine/threonine-protein kinase 10 [OS=Homo sapiens]",0,21.781,3,2,2,2,2,968,112.1,6.95,6.23,2,"cell adhesion;cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","kinase activity;other molecular function","Pf00069, Pf12474","6793","A6ND35; B2R8F5; B3KMY1; hsa:6793; O94804; Q6NSK0; Q9UIW4","ENSG00000072786","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Neutrophil degranulation",NA,4,0,91.2,71.3,78.7,109.1,110,102.9,116,118.3,120.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(100); T952(100)]",0,"ENSG00000072786"
"887","LARP1",-0.123533889557867,6.66963057458239,-1.5247652139085,0.159595220118075,0.293545283242584,-5.86862929796217,"NONE",FALSE,"High","Master Protein","Q6PKG0","La-related protein 1 [OS=Homo sapiens]",0,146.662,13,10,15,30,10,1096,123.4,8.82,99.2,10,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf05383, Pf21071","23367","hsa:23367; O94836; Q6PKG0; Q8N4M2; Q8NB73; Q9UFD7","ENSG00000155506","SARS-CoV-2 activates/modulates innate and adaptive immune responses","Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway",4,0,81.8,84.8,85.4,115,130.8,108.2,104.4,105.2,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S215(100); S517(100); T526(100); S548(100); S766(100); S774(100); T785(100); T788(100); S850(98.6)]",0,"ENSG00000155506"
"888","RTKN",0.180263870215378,6.6388890900942,1.52398415520394,0.159787698021055,0.293545283242584,-5.86967709729759,"NONE",FALSE,"High","Master Protein","Q9BST9","Rhotekin [OS=Homo sapiens]",0,27.349,9,3,3,6,3,563,62.6,7.44,11.97,3,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton","enzyme regulator activity;other molecular function","Pf00169, Pf08174","6242","H7BXD4; hsa:6242; Q8WVN1; Q96PT6; Q9BST9; Q9HB05","ENSG00000114993","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins","G13 signaling pathway",5,0,101.3,105.3,106.6,84.4,91,95.1,88.5,118.2,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); S239(99.4); S520(100)]",0,"ENSG00000114993"
"889","PPIB",0.144474310980423,6.56656936482458,1.52351651427683,0.15990303725653,0.293545283242584,-5.87030428728625,"NONE",FALSE,"High","Master Protein","P23284","Peptidyl-prolyl cis-trans isomerase B [OS=Homo sapiens]",0,29.474,24,6,6,6,5,216,23.7,9.41,10.54,6,"protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00160","5479","A8K534; hsa:5479; P23284; Q6IBH5; Q9BVK5","ENSG00000166794","Collagen biosynthesis and modifying enzymes; SARS-CoV-1 activates/modulates innate immune responses","Prolactin signaling pathway; Type I collagen synthesis in the context of osteogenesis imperfecta",4,1,118.7,115.7,114.6,85.6,60.1,91.7,97.6,93.5,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000166794"
"890","PKD2",-0.162469928010701,6.63914392924686,-1.51980153292848,0.160821901503286,0.294651622829742,-5.87528258965378,"NONE",FALSE,"High","Master Protein","Q13563","Polycystin-2 [OS=Homo sapiens]",0,10.95,2,1,1,1,1,968,109.6,5.69,3.24,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf08016, Pf18109, Pf20519","5311","hsa:5311; O60441; Q13563; Q15764; Q2M1Q3; Q2M1Q5","ENSG00000118762","VxPx cargo-targeting to cilium","Polycystic kidney disease pathway; Ciliopathies; Bardet-Biedl syndrome",4,0,91.5,104.3,86.3,106.4,114.4,105,87.9,102.3,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000118762"
"891","TRIM28",-0.164523599491458,6.56559251246713,-1.51962053884186,0.160866786728738,0.294651622829742,-5.87552494417096,"NONE",FALSE,"High","Master Protein","Q13263","Transcription intermediary factor 1-beta [OS=Homo sapiens]",0,180.887,22,8,16,63,8,835,88.5,5.77,172.88,8,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00628, Pf00643, Pf14634","10155","hsa:10155; O00677; Q13263; Q7Z632; Q93040; Q96IM1","ENSG00000130726","Generic Transcription Pathway; HCMV Early Events; SUMOylation of transcription cofactors","Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; ATM signaling in development and disease",6,0,118.5,107,110.9,83.8,105.5,90.3,85.5,80.8,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(97.5); S258; S473(100); T541(100); S594(100); S598(99.4); S752(100)]",0,"ENSG00000130726"
"892","C2orf49",0.147836857251531,6.65718569912895,1.51484647463462,0.16205469333587,0.296494685565179,-5.88191116126723,"NONE",FALSE,"High","Master Protein","Q9BVC5","Ashwin [OS=Homo sapiens]",0,9.989,9,2,2,2,2,232,25.8,9.74,5.59,2,"RNA metabolism OR transcription;other metabolic processes;developmental processes","nucleus;other cell component",NA,"Pf15323","79074","B3KXN3; B4E2G9; hsa:79074; Q9BVC5","ENSG00000135974","tRNA processing in the nucleus",NA,1,0,113.7,112.2,103.4,101.6,75.8,91.8,111.3,99,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S182(100)]",0,"ENSG00000135974"
"893","MCMBP",-0.152367479683132,6.42676588679326,-1.51212120402765,0.162736249857436,0.297408241620756,-5.88555123251839,"NONE",FALSE,"High","Master Protein","Q9BTE3","Mini-chromosome maintenance complex-binding protein [OS=Homo sapiens]",0,6.274,2,1,1,1,1,642,72.9,5.87,2.79,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf09739","79892","B3KSP7; hsa:79892; Q6IA56; Q9BTE3; Q9BVT9; Q9H916","ENSG00000197771",NA,NA,0,0,145.5,131.5,140.8,74.5,51.8,76.9,77.1,68.5,66.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000197771"
"894","KHDRBS1",0.106095841402018,6.63098858439162,1.51029671615501,0.163193933449718,0.297911073143109,-5.88798591372153,"NONE",FALSE,"High","Master Protein","Q07666","KH domain-containing, RNA-binding, signal transduction-associated protein 1 [OS=Homo sapiens]",0,54.37,12,2,2,10,2,443,48.2,8.66,37.05,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf16274, Pf16568","10657","D3DPP3; hsa:10657; Q07666; Q6PJX7; Q8NB97; Q99760","ENSG00000121774","PTK6 Regulates Proteins Involved in RNA Processing","Leptin signaling pathway; Primary ovarian insufficiency",3,0,103.4,107,109.2,91.7,90.2,90.1,101,97.6,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.5); S58(100)]",0,"ENSG00000121774"
"895","SHISA6",-0.102630053169179,6.58478072332571,-1.50822975474637,0.163713804011904,0.298526176701036,-5.89074198922499,"NONE",FALSE,"High","Master Protein","Q6ZSJ9","Protein shisa-6 [OS=Homo sapiens]",0,27.053,9,3,3,3,3,500,55.7,9.35,10.38,3,"cell-cell signaling;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf13908","388336","B3KXV5; Q4PL63; Q6ZSJ9","ENSG00000188803",NA,NA,0,0,124.5,116.1,116.1,89,80,94,90.6,88.4,84.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S391(100); S425(100)]",0,"ENSG00000188803"
"896","STAT1",0.144150579615499,6.60999775345738,1.50700892925174,0.164021539475751,0.298753518330832,-5.8923687451328,"NONE",FALSE,"High","Master Protein","P42224","Signal transducer and activator of transcription 1-alpha/beta [OS=Homo sapiens]",0,32.229,3,1,2,4,1,750,87.3,6.05,14.08,1,"cell cycle OR cell proliferation;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf12162, Pf21354","6772","A8K989; B2RCA0; D2KFR8; D3DPI7; hsa:6772; P42224; Q53S88; Q53XW4; Q68D00; Q9UDL5","ENSG00000115415","Regulation of RUNX2 expression and activity; PKR-mediated signaling; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants; Signaling by SCF-KIT; Downstream signal transduction; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Interleukin-4 and Interleukin-13 signaling; Growth hormone receptor signaling; Interleukin-6 signaling; Interferon alpha/beta signaling; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; NOTCH3 Intracellular Domain Regulates Transcription; Interleukin-20 family signaling; Interleukin-35 Signalling; Interleukin-27 signaling; Interleukin-9 signaling; Interleukin-21 signaling","IL-5 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Type III interferon signaling; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; AGE/RAGE pathway; Allograft rejection; Interleukin-11 signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Endoderm differentiation; Kit receptor signaling pathway; IL6 signaling pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; p38 MAPK signaling pathway; Immune response to tuberculosis; Ebola virus infection in host; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; IL-10 anti-inflammatory signaling pathway ; Overview of interferons-mediated signaling pathway; Measles virus infection; Tryptophan metabolism; Hepatitis B infection; Endochondral ossification; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Endochondral ossification with skeletal dysplasias; TGF-beta receptor signaling in skeletal dysplasias; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; IL-2 signaling pathway; SARS coronavirus and innate immunity; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; CCL18 signaling pathway; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q13 copy number variation syndrome; TROP2 regulatory signaling; IL-26 signaling pathways; JAK-STAT signaling in the regulation of beta cells; IL-19 signaling pathway; TGF-beta receptor signaling; EPO receptor signaling; Interferon type I signaling pathways; Type II interferon signaling; Toll-like receptor signaling pathway",83,0,90.1,98.1,98.1,85.4,84.2,106.6,96.8,106.2,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100)]",0,"ENSG00000115415"
"897","SERINC3",0.248359241014614,6.60873230657444,1.50515534146114,0.164489743737483,0.299272309676223,-5.89483711495653,"NONE",FALSE,"High","Master Protein","Q13530","Serine incorporator 3 [OS=Homo sapiens]",0,9.934,6,1,1,1,1,473,52.5,7.46,3.23,1,"other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity","Pf03348","10955","B4DUE9; hsa:10955; O43717; Q13530; Q9BR33","ENSG00000132824","Serine biosynthesis",NA,1,0,78.2,116.1,110.2,99.6,60.3,97.7,99.7,101.4,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(99.3)]",0,"ENSG00000132824"
"898","RPS8",0.110427181032207,6.45395507338458,1.50404021905461,0.164771979131918,0.29945197098362,-5.89632119291416,"NONE",FALSE,"High","Master Protein","P62241","Small ribosomal subunit protein eS8 [OS=Homo sapiens]",0,59.476,17,4,6,8,4,208,24.2,10.32,27.02,4,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01201","6202","hsa:6202; P09058; P62241; Q6IRL7","ENSG00000142937","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,152.4,133.6,138.6,66.7,55.9,63.2,77.8,76.1,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T130(100); S160(99.7)]",0,"ENSG00000142937"
"899","STIM2",-0.151770625359906,6.57322500402053,-1.50197471609,0.165295872492322,0.300069926482169,-5.89906831344292,"NONE",FALSE,"High","Master Protein","Q9P246","Stromal interaction molecule 2 [OS=Homo sapiens]",0,17.584,5,2,2,5,2,746,83.9,6.76,9.28,2,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi","transporter activity;other molecular function","Pf07647, Pf16533","57620","A6H8L7; B7ZVY0; hsa:57620; Q96BF1; Q9BQH2; Q9H8R1; Q9P246","ENSG00000109689",NA,"Calcium regulation in cardiac cells",1,0,111.1,103.1,99.4,101.1,86.2,94.9,98.2,92.8,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S640(100)]",0,"ENSG00000109689"
"900","UTP6",-0.123558629070875,6.43680299394205,-1.5007637633325,0.165603694456445,0.300294699281021,-5.90067780134646,"NONE",FALSE,"High","Master Protein","Q9NYH9","U3 small nucleolar RNA-associated protein 6 homolog [OS=Homo sapiens]",0,24.708,3,2,2,2,2,597,70.1,7.28,7.44,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf08640","55813","hsa:55813; Q8IX96; Q96BL2; Q9NQ91; Q9NYH9","ENSG00000108651","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol","NF1 copy number variation syndrome",3,0,150.8,140.1,139.3,68.7,67.4,63.3,71.2,74,70.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(100)]",0,"ENSG00000108651"
"901","VASH1",-0.140313037656769,6.66488127546087,-1.49858293163847,0.166159320986312,0.300967826692188,-5.90357434659591,"NONE",FALSE,"High","Master Protein","Q7L8A9","Tubulinyl-Tyr carboxypeptidase 1 [OS=Homo sapiens]",0.002,2.684,3,1,1,1,1,365,40.9,9.48,2.38,1,"cell cycle OR cell proliferation;protein metabolism;stress response;developmental processes;other biological processes","non-structural extracellular;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf14822","22846","hsa:22846; Q7L8A9; Q96H02; Q9UBF4; Q9Y629","ENSG00000071246","Carboxyterminal post-translational modifications of tubulin",NA,1,0,89.9,89.2,82.9,117.6,117.4,107.9,95.1,109.8,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100)]",0,"ENSG00000071246"
"902","UNK",-0.12773851672643,6.61634795154081,-1.49071904226964,0.16817639761295,0.304283681712123,-5.91399741978903,"NONE",FALSE,"High","Master Protein","Q9C0B0","RING finger protein unkempt homolog [OS=Homo sapiens]",0,28.937,2,1,1,2,1,810,88,6.86,9.84,1,"developmental processes;other biological processes","other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00642, Pf18384","85451","hsa:85451; Q9C0B0","ENSG00000132478",NA,NA,0,0,86.1,90.4,98.1,104.3,112.6,101.2,102,102.3,92.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S385(100)]",0,"ENSG00000132478"
"903","NFIA",-0.235199134569638,6.6408566382227,-1.48898304189884,0.168624545402571,0.304756653485045,-5.91629379784281,"NONE",FALSE,"High","Master Protein","Q12857","Nuclear factor 1 A-type [OS=Homo sapiens]",0,39.921,9,2,2,3,2,509,55.9,8.44,11.71,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4774","B4DRJ3; B4DS53; F5H0R0; F8W8W3; hsa:4774; Q12857; Q8TA97; Q9H3X9; Q9P2A9","ENSG00000162599","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,84.4,76.8,101.5,91,118.2,139.7,97.9,98.2,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(100); S300(100)]",0,"ENSG00000162599"
"904","YBX1",-0.117773206737769,6.64330111823681,-1.48786022427932,0.168914954174479,0.304943811076051,-5.91777817433005,"NONE",FALSE,"High","Master Protein","P67809","Y-box-binding protein 1 [OS=Homo sapiens]",0,44.283,16,3,5,9,3,324,35.9,9.88,20.67,3,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00313","4904","hsa:4904; P16990; P16991; P67809; Q14972; Q15325; Q5FVF0","ENSG00000065978","mRNA Splicing - Major Pathway; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Interferon gamma signaling; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Noncanonical activation of NOTCH3","Brain-derived neurotrophic factor (BDNF) signaling pathway; MECP2 and associated Rett syndrome; mRNA processing; Sudden infant death syndrome (SIDS) susceptibility pathways",10,0,88.3,91.8,99.9,100.3,116.7,108.2,102.1,98.3,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S314(99.2)]",0,"ENSG00000065978"
"905","PDHA1",-0.228355710348639,6.5514557208144,-1.48502979087867,0.169648959633642,0.305930499582436,-5.92151694762822,"NONE",FALSE,"High","Master Protein","P08559","Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial [OS=Homo sapiens]",0,5.512,5,2,2,2,2,390,43.3,8.06,2.28,2,"other metabolic processes","mitochondrion;nucleus;other cell component","other molecular function","Pf00676","5160","A5YVE9; B2R5P7; B7Z3T7; B7Z3X5; hsa:5160; P08559; Q53H41; Q5JPT8; Q9NP12; Q9UBJ8; Q9UBU0; Q9UNG4; Q9UNG5","ENSG00000131828","Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid; Mitochondrial protein degradation","TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Lipid metabolism pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways; TCA cycle in senescence; Neuroinflammation and glutamatergic signaling; Acetylcholine synthesis; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",17,0,118.9,120.6,117.9,74.5,125.3,80.7,82.6,79.5,84.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T231(99.5)]",0,"ENSG00000131828"
"906","PHYHIPL",0.162915930060807,6.67392062486741,1.48416865755832,0.169872824311302,0.305996080878637,-5.92265355614963,"NONE",FALSE,"High","Master Protein","Q96FC7","Phytanoyl-CoA hydroxylase-interacting protein-like [OS=Homo sapiens]",0,68.406,8,2,6,14,2,376,42.5,6.42,58.07,2,NA,"other cell component",NA,"Pf00041, Pf19281","84457","B7WP61; hsa:84457; Q68DF3; Q6UXY3; Q8N3W3; Q96FC7; Q96JM9; Q96NP7","ENSG00000165443",NA,NA,0,0,88.1,90.9,96.6,99.8,83,116.2,99.6,123.1,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100); S15(100); S25(100)]",0,"ENSG00000165443"
"907","USP6NL",0.143246203600292,6.62295959408852,1.48278093822254,0.170234124054477,0.306308809765057,-5.9244843406056,"NONE",FALSE,"High","Master Protein","Q92738","USP6 N-terminal-like protein [OS=Homo sapiens]",0,22.405,4,2,2,4,2,828,94,9.07,16.42,2,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00566","9712","A8KA79; hsa:9712; Q15400; Q5VV10; Q7L0K9; Q92738","ENSG00000148429","Retrograde transport at the Trans-Golgi-Network","EGF/EGFR signaling pathway",2,0,108.3,107.6,99.8,97.8,86.2,82.8,105.6,106.6,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S585(100); S716(100)]",0,"ENSG00000148429"
"908","GIGYF1",-0.189496258995704,6.61324591508111,-1.48121629342223,0.170642289012382,0.30670508333503,-5.92654725795748,"NONE",FALSE,"High","Master Protein","O75420","GRB10-interacting GYF protein 1 [OS=Homo sapiens]",0,19.458,4,2,2,4,2,1035,114.5,5.39,13.07,2,"signal transduction","cytosol;other cell component",NA,"Pf02213",NA,"O75420; Q6Y7W7; Q8WZ38","ENSG00000146830",NA,NA,0,0,81.7,115.4,90.1,106.9,88.2,118.1,88.5,100.5,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S406(100); S538(100)]",0,"ENSG00000146830"
"909","PABIR1",0.101528072659853,6.66879799098679,1.47963189586893,0.171056473995676,0.307111293246362,-5.92863483341933,"NONE",FALSE,"High","Master Protein","Q96E09","PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 [OS=Homo sapiens]",0,15.2,9,1,1,1,1,287,30.5,6.79,4.56,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","nucleus;other cell component","enzyme regulator activity",NA,"116224","hsa:116224; Q96E09","ENSG00000187866",NA,NA,0,0,89.2,82.9,81.8,104.4,106.9,110.8,112.3,115.5,114.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000187866"
"910","CCZ1",-0.137548066293368,6.6105384355821,-1.47387989742516,0.172567485714176,0.309483666687401,-5.93620182300906,"NONE",FALSE,"High","Master Protein","P86791","Vacuolar fusion protein CCZ1 homolog [OS=Homo sapiens]",0,9.727,3,1,1,1,1,482,55.8,6.48,3.84,1,"transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity","Pf19031, Pf19032, Pf19033","221960; 51622","A2RU45; hsa:221960; hsa:51622; O95766; P86791; Q9UG65; Q9Y359","ENSG00000122674","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,111.4,105.6,111.9,95.3,82.2,107.9,82.8,98,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000122674"
"911","PROX1",-0.102534769020734,6.50494710653529,-1.46814774520145,0.174084801318258,0.311862124864322,-5.94372430693029,"NONE",FALSE,"High","Master Protein","Q92786","Prospero homeobox protein 1 [OS=Homo sapiens]",0,25.283,6,3,4,10,3,737,83.2,7.18,24.03,3,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05044","5629","A6NK29; A8K2B1; hsa:5629; Q5SW76; Q8TB91; Q92786","ENSG00000117707",NA,"PTF1A related regulatory pathway; Epithelial to mesenchymal transition in colorectal cancer",2,0,137.3,131.5,127,77.9,69.6,77.9,76.9,76.8,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100); S511(100)]",0,"ENSG00000117707"
"912","GGT7",0.191375130128056,6.65092552082942,1.4655477593516,0.174776830535359,0.312677057778572,-5.94713027004027,"NONE",FALSE,"High","Master Protein","Q9UJ14","Glutathione hydrolase 7 [OS=Homo sapiens]",0,12.065,3,1,1,2,1,662,70.4,5.1,5.24,1,"other metabolic processes;other biological processes","plasma membrane;other membranes","other molecular function","Pf01019","2686","hsa:2686; Q8N899; Q8NF66; Q9BYP5; Q9BYP6; Q9UJ14","ENSG00000131067","Glutathione synthesis and recycling; Aflatoxin activation and detoxification; Paracetamol ADME",NA,3,0,101.4,71,83.5,101.7,86.8,114.5,107.5,114.7,129.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S72(99.5)]",0,"ENSG00000131067"
"913","SUPT7L",0.141547511095443,6.58147898340431,1.46500015423637,0.174922888328331,0.312677057778572,-5.94784714380451,"NONE",FALSE,"High","Master Protein","O94864","STAGA complex 65 subunit gamma [OS=Homo sapiens]",0,39.133,6,1,2,6,1,414,46.2,5.12,14.16,1,"other biological processes","nucleus;other cell component","other molecular function","Pf07524","9913","B4E3W3; hsa:9913; O94864; Q6IB21; Q9H2T6","ENSG00000119760","HATs acetylate histones",NA,1,0,103.9,103.6,117.2,87.2,86.2,76.2,102.6,95.3,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S108(99.3)]",0,"ENSG00000119760"
"914","AAK1",-0.141615447575278,6.66305917894373,-1.4618137518259,0.1757748687355,0.313856220761855,-5.95201513113571,"NONE",FALSE,"High","Master Protein","Q2M2I8","AP2-associated protein kinase 1 [OS=Homo sapiens]",0,75.564,10,6,7,16,6,961,103.8,6.6,48.25,6,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00069","22848","hsa:22848; Q2M2I8; Q4ZFZ3; Q53RX6; Q9UPV4","ENSG00000115977","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,90,96.9,90.1,115.4,112.9,104,110.1,101.8,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T620(100); S623(99.4); S624(100); S637(100); S652(99.7); S731(100)]",0,"ENSG00000115977"
"915","FOXC1",0.223023810722085,6.61919485675557,1.45965595360711,0.176353859719742,0.314545900614885,-5.9548343910483,"NONE",FALSE,"High","Master Protein","Q12948","Forkhead box protein C1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,553,56.8,8.51,4.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250","2296","Q12948; Q86UP7; Q9BYM1; Q9NUE5; Q9UDD0; Q9UP06","ENSG00000054598","Formation of the ureteric bud; Formation of intermediate mesoderm","Heart development; Mesodermal commitment pathway; Mesodermal commitment pathway; BMP signaling in eyelid development; 22q11.2 copy number variation syndrome; Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system",10,0,90.6,103.9,93.3,76.9,109.5,92.4,124.7,97.7,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000054598"
"916","UPF1",-0.168842606180671,6.61083594402733,-1.45848803574952,0.176667929198922,0.314762074729957,-5.95635922868839,"NONE",FALSE,"High","Master Protein","Q92900","Regulator of nonsense transcripts 1 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1129,124.3,6.61,4.75,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09416, Pf13086, Pf13087, Pf18141","5976","hsa:5976; O00239; O43343; Q86Z25; Q92842; Q92900","ENSG00000005007","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Pathophysiological roles of DUX4 in FSHD1",3,0,130.1,104,102.3,90.6,96.9,103.5,81.5,101,90.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1107(100)]",0,"ENSG00000005007"
"917","KCTD15",-0.217737121240105,6.66796685755495,-1.45701625640799,0.177064400459234,0.315124429170633,-5.95827968781095,"NONE",FALSE,"High","Master Protein","Q96SI1","BTB/POZ domain-containing protein KCTD15 [OS=Homo sapiens]",0,12.388,7,1,1,2,1,283,31.9,7.44,5.87,1,"cell organization and biogenesis","nucleus","other molecular function","Pf02214, Pf20871","79047","A8K600; hsa:79047; Q96SI1; Q9BVI6","ENSG00000153885","Negative regulation of activity of TFAP2 (AP-2) family transcription factors",NA,1,0,106.3,102.9,109.5,101.1,78.6,136.2,102.5,94.2,88.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100)]",0,"ENSG00000153885"
"918","SARM1",0.101782093210928,6.635087280108,1.4553240059175,0.177521213751958,0.315266094430996,-5.96048631034087,"NONE",FALSE,"High","Master Protein","Q6SZW1","NAD(+) hydrolase SARM1 [OS=Homo sapiens]",0,35.351,4,2,2,5,2,724,79.3,6.55,21.27,2,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","other molecular function","Pf07647, Pf13676","23098","hsa:23098; O60277; Q6SZW1; Q7LGG3; Q9NXY5","ENSG00000004139",NA,NA,0,0,97.5,94.7,104,93.6,88.6,101,102.4,101.4,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S572(100)]",0,"ENSG00000004139"
"919","CCNL2",0.0958017815540666,6.64010846180177,1.4552901776785,0.177530355871376,0.315266094430996,-5.96053040433612,"NONE",FALSE,"High","Master Protein","Q96S94","Cyclin-L2 [OS=Homo sapiens]",0,18.5,6,2,2,3,2,520,58.1,10.26,11.84,2,"other biological processes","nucleus;other cell component","enzyme regulator activity","Pf00134, Pf02984","81669","A0A024R072; A0A024R077; A0A0C4DGC4; A8K8A3; B1B152; F2Z3J5; hsa:81669; Q5T2N5; Q5T2N6; Q6IQ12; Q7Z4Z8; Q8N3C9; Q8N3D5; Q8NHE3; Q8TEL0; Q96B00; Q96S94","ENSG00000221978",NA,"1p36 copy number variation syndrome",1,0,103.5,98.3,101.2,97.8,89.5,94.7,101.5,102.1,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S330(100); S348(100)]",0,"ENSG00000221978"
"920","SPARCL1",0.24024514192632,6.64215132734093,1.4532024119346,0.178095365244878,0.315925691390913,-5.96325047851241,"NONE",FALSE,"High","Master Protein","Q14515","SPARC-like protein 1 [OS=Homo sapiens]",0,9.335,3,2,2,2,2,664,75.2,4.81,5.76,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","extracellular matrix;ER/Golgi;other cell component","other molecular function","Pf07648, Pf09289, Pf10591","8404","B4E2Z0; E7ESU2; hsa:8404; Q14515; Q14800","ENSG00000152583","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,73.4,88,80.2,106.1,92.9,102.4,134,134.5,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S84(100); S92(100)]",0,"ENSG00000152583"
"921","GNL1",-0.116665482348193,6.6417672660398,-1.44864297012538,0.179334685842903,0.31777872670534,-5.96918217305966,"NONE",FALSE,"High","Master Protein","P36915","Guanine nucleotide-binding protein-like 1 [OS=Homo sapiens]",0,35.676,5,2,2,6,2,607,68.6,5.8,13,2,"stress response;signal transduction;other biological processes","non-structural extracellular","other molecular function","Pf01926","2794","B0S838; hsa:2794; P36915; Q96CT5","ENSG00000204590; ENSG00000206492; ENSG00000226882; ENSG00000228581; ENSG00000229470; ENSG00000232143; ENSG00000235986",NA,NA,0,0,92.9,85,95.4,108,105.2,111.5,103.5,95,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(100)]",0,"ENSG00000204590"
"922","EVL",0.211709132934542,6.63049326192519,1.4465464286861,0.179907050205898,0.318126424076363,-5.97190572245649,"NONE",FALSE,"High","Master Protein","Q9UI08","Ena/VASP-like protein [OS=Homo sapiens]",0,7.499,3,1,1,2,1,416,44.6,8.84,4.71,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00568, Pf08776","51466","A8K105; B7Z3I5; hsa:51466; O95884; Q7Z522; Q8TBV1; Q9UF25; Q9UI08; Q9UIC2","ENSG00000196405","Generation of second messenger molecules; RHO GTPases Activate Formins; Signaling by ROBO receptors",NA,3,0,72.4,71.4,66.7,108.2,141.5,90.3,118.2,115.5,148.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S331(100)]",0,"ENSG00000196405"
"923","MINK1",-0.120737951101667,6.66485412297158,-1.44649626064452,0.179920765577502,0.318126424076363,-5.97197086331019,"NONE",FALSE,"High","Master Protein","Q8N4C8-3","Isoform 2 of Misshapen-like kinase 1 [OS=Homo sapiens]",0,70.229,7,6,6,11,4,1303,146.6,7.46,42.22,6,NA,NA,NA,NA,NA,"Q8N4C8-3",NA,NA,NA,0,0,84.2,87.9,85.5,114,129.2,104.5,105.1,109.3,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S601(100); S641(100); S696(100); T780(100)]",0,"ENSG00000141503"
"924","NCL",0.2074954528655,6.64080375459266,1.43654440758475,0.1826593816985,0.322501838544601,-5.98486427933374,"NONE",FALSE,"High","Master Protein","P19338","Nucleolin [OS=Homo sapiens]",0,26.891,6,4,4,8,4,710,76.6,4.7,22.99,4,"developmental processes;other biological processes","plasma membrane;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","4691","hsa:4691; P19338; Q53SK1; Q8NB06; Q9UCF0; Q9UDG1","ENSG00000115053","Respiratory syncytial virus (RSV) attachment and entry; Major pathway of rRNA processing in the nucleolus and cytosol","Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling",4,0,85.6,89.4,90.8,89.3,127.7,87.1,100,129,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); S563(100)]",0,"ENSG00000115053"
"925","SEMA6A",0.192660436869388,6.64465302070978,1.43607093800438,0.182790564126076,0.322501838544601,-5.9854762741299,"NONE",FALSE,"High","Master Protein","Q9H2E6","Semaphorin-6A [OS=Homo sapiens]",0,16.304,3,2,2,2,2,1030,114.3,8.41,4.62,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding","Pf01403, Pf01437","57556","hsa:57556; Q9H2E6; Q9P2H9","ENSG00000092421","Other semaphorin interactions","Spinal cord injury",2,0,74.2,66.9,91.2,110,94.1,111.4,103.8,137.3,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S760(99.1); T761(100); S994(99.3)]",0,"ENSG00000092421"
"926","BRAF",-0.116621053990552,6.61361900996814,-1.42822531706212,0.184976149990295,0.326005482488295,-5.9955984118415,"NONE",FALSE,"High","Master Protein","P15056","Serine/threonine-protein kinase B-raf [OS=Homo sapiens]",0,32.905,7,3,4,4,3,766,84.4,7.53,16.66,3,"cell adhesion;cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component","kinase activity;other molecular function","Pf00130, Pf02196, Pf07714","673","A4D1T4; B6HY61; B6HY62; B6HY63; B6HY64; B6HY65; B6HY66; hsa:673; P15056; Q13878; Q3MIN6; Q9UDP8; Q9Y6T3","ENSG00000157764","Signaling by BRAF and RAF1 fusions; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Spry regulation of FGF signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; ARMS-mediated activation; Signalling to p38 via RIT and RIN; Negative feedback regulation of MAPK pathway","Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Alzheimer's disease and miRNA effects; Pilocytic astrocytoma; Glioblastoma signaling pathways; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Polycystic kidney disease pathway; Bladder cancer; Focal adhesion; BDNF-TrkB signaling; MAPK signaling pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Endometrial cancer; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Rett syndrome; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Fragile X syndrome; Hepatitis B infection; Melanoma; EGFR tyrosine kinase inhibitor resistance; Regucalcin in proximal tubule epithelial kidney cells; MAPK pathway in congenital thyroid cancer; TCA cycle in senescence; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; Acute myeloid leukemia; ErbB signaling pathway; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling",56,0,107.6,105.5,104.3,95.9,84.2,109.7,93,89.6,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(99.5); T401(99.2); S729(100)]",0,"ENSG00000157764"
"927","HOMEZ",-0.204908389531401,6.58814133450292,-1.42688471435593,0.185351845140909,0.326315222513445,-5.9973244303717,"NONE",FALSE,"High","Master Protein","Q8IX15","Homeobox and leucine zipper protein Homez [OS=Homo sapiens]",0,15.2,4,1,1,4,1,550,61.2,4.93,18.01,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11569","57594","A1L445; B4DZ80; F8WCA3; hsa:57594; Q6P049; Q86XB6; Q8IX15; Q9P2A5","ENSG00000290292",NA,NA,0,0,92.7,136.8,124.3,96.8,74.1,104.3,78.5,96.9,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T451(100)]",0,"ENSG00000215271"
"928","GIGYF2",0.0964599966208057,6.66533587986304,1.42335082567375,0.186345336212617,0.327710763684257,-6.00186926769644,"NONE",FALSE,"High","Master Protein","Q6Y7W6","GRB10-interacting GYF protein 2 [OS=Homo sapiens]",0,58.669,6,5,7,11,5,1299,150,5.54,40.25,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf02213","26058","A6H8W4; B9EG55; E9PBB0; hsa:26058; O75137; Q6Y7W6; Q7Z2Z8; Q7Z3I2; Q96HU4; Q9NV82","ENSG00000204120",NA,"VEGFA-VEGFR2 signaling",1,0,72.6,73.3,73.5,109.1,121.4,117.5,118.3,127.4,120.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.5); S160(100); S201(100)]",0,"ENSG00000204120"
"929","KIF5C",0.427735723924245,6.61615766472828,1.42218508125241,0.186674065832251,0.327935495627808,-6.00336689872306,"NONE",FALSE,"High","Master Protein","O60282","Kinesin heavy chain isoform 5C [OS=Homo sapiens]",0,18.768,3,1,1,2,1,957,109.4,6.19,6.69,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00225","3800","hsa:3800; O60282; O95079; Q2YDC5","ENSG00000168280","Insulin processing","Alzheimer's disease and miRNA effects; Alzheimer's disease",3,0,32.5,43.1,77.7,137.9,78.6,131.2,136.6,208.4,154,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T396(100)]",0,"ENSG00000168280"
"930","DPF3",0.164044394160117,6.67981860782971,1.41920160049864,0.187517647571403,0.329041561526724,-6.00719614883109,"NONE",FALSE,"High","Master Protein","Q92784-3","Isoform 3 of Zinc finger protein DPF3 [OS=Homo sapiens]",0,3.72,2,1,1,2,1,412,46.4,7.28,2.27,1,NA,NA,NA,NA,NA,"Q92784-3",NA,NA,NA,0,0,78.1,74.8,78.1,115.5,117.4,101.5,137.6,115.3,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S403(100)]",0,"ENSG00000205683"
"931","WNK1",-0.388064838115623,6.54167469130895,-1.4180936762632,0.187831745275584,0.329041561526724,-6.00861682235265,"NONE",FALSE,"High","Master Protein","Q9H4A3","Serine/threonine-protein kinase WNK1 [OS=Homo sapiens]",0,22.362,2,3,5,7,2,2382,250.6,6.34,13.86,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf12202","65125","A1L4B0; C5HTZ5; C5HTZ6; C5HTZ7; H6WZW3; hsa:65125; O15052; P54963; Q4VBX9; Q6IFS5; Q86WL5; Q8N673; Q96CZ6; Q9H4A3; Q9P1S9","ENSG00000060237","Stimuli-sensing channels","Ciliary landscape",2,0,71.4,71.3,74.5,103.1,206.9,96.3,89.8,71.8,139.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S185(100); S378(100); S2032(100)]",0,"ENSG00000060237"
"932","STUB1",0.134811498860492,6.63235117115125,1.41744747590121,0.188015151887369,0.329041561526724,-6.00944510179283,"NONE",FALSE,"High","Master Protein","Q9UNE7","E3 ubiquitin-protein ligase CHIP [OS=Homo sapiens]",0,46.596,6,2,3,9,2,303,34.8,5.87,37.78,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf04564, Pf12895, Pf18391","10273","A2IDB9; O60526; Q969U2; Q9HBT1; Q9UNE7","ENSG00000103266","Antigen processing: Ubiquitination & Proteasome degradation; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Regulation of necroptotic cell death; Downregulation of ERBB2 signaling; Regulation of TNFR1 signaling; Downregulation of TGF-beta receptor signaling","Androgen receptor signaling pathway; Parkin-ubiquitin proteasomal system pathway; HDAC6 interactions in the central nervous system",11,0,105.5,105.3,115.1,95.1,85.5,84.5,110,96.6,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100)]",0,"ENSG00000103266"
"933","KIAA1143",0.167409234979224,6.62138423012032,1.41711295328009,0.188110157416932,0.329041561526724,-6.00987378601653,"NONE",FALSE,"High","Master Protein","Q96AT1","Uncharacterized protein KIAA1143 [OS=Homo sapiens]",0,8.777,9,1,1,3,1,154,17.5,6.11,7.99,1,NA,NA,NA,"Pf15377","57456","A8K0I4; hsa:57456; Q96AT1; Q96HJ8; Q9ULS7","ENSG00000163807; ENSG00000281665",NA,NA,0,0,72.7,81.3,76.9,89.8,124,108.2,104.5,126.8,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100)]",0,"ENSG00000163807"
"934","SESN3",0.195042681519401,6.68078504283841,1.41374263080148,0.189069636821615,0.3303657893928,-6.01418911408921,"NONE",FALSE,"High","Master Protein","P58005","Sestrin-3 [OS=Homo sapiens]",0,16.932,4,1,1,4,1,492,57.3,6.25,9.24,1,"stress response;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf04636","143686","B7Z7P9; hsa:143686; P58005; Q96AD1","ENSG00000149212","TP53 Regulates Metabolic Genes","Angiopoietin-like protein 8 regulatory pathway; miRNA regulation of p53 pathway in prostate cancer",3,0,83.3,90.9,115.6,85.9,87.4,120.1,114.9,110.1,113.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100)]",0,"ENSG00000149212"
"935","LRWD1",-0.161793756938175,6.6374297807187,-1.41188816250995,0.189599360570662,0.330937065723338,-6.01656070125637,"NONE",FALSE,"High","Master Protein","Q9UFC0","Leucine-rich repeat and WD repeat-containing protein 1 [OS=Homo sapiens]",0,28.664,4,1,1,2,1,647,70.8,7.21,10.88,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400, Pf00560","222229","A8K4K2; B2R9G2; hsa:222229; Q8N0T9; Q8WV43; Q96GJ2; Q9UFC0","ENSG00000161036",NA,"Male infertility",1,0,91.5,100.6,101.1,100.8,91.3,122.2,85.5,100.2,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S251(100)]",0,"ENSG00000161036"
"936","TAGLN3",0.136637749565114,6.65856800233864,1.40939656755498,0.190313076854949,0.331827928875295,-6.01974387899615,"NONE",FALSE,"High","Master Protein","Q9UI15","Transgelin-3 [OS=Homo sapiens]",0,7.423,5,2,2,2,2,199,22.5,7.33,5.25,2,"cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;nucleus","cytoskeletal activity","Pf00307, Pf00402","29114","D3DN64; hsa:29114; Q96A74; Q9UI15","ENSG00000144834",NA,NA,0,0,75,67.2,72.8,103.8,136.5,110.5,116.1,128.6,129.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S163(100)]",0,"ENSG00000144834"
"937","ANAPC4",0.1567079549501,6.6383700887043,1.40772466111148,0.190793280912342,0.332310175505808,-6.02187779030704,"NONE",FALSE,"High","Master Protein","Q9UJX5","Anaphase-promoting complex subunit 4 [OS=Homo sapiens]",0,19.597,3,1,1,2,1,808,92.1,5.53,6.75,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf12894, Pf12896","29945","A8K8H1; E9PCR4; hsa:29945; Q6PCC6; Q9NSH6; Q9UJX5","ENSG00000053900","Separation of Sister Chromatids; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects","Cell cycle",19,0,95.6,100.8,108.7,105.7,73.6,91.8,96.1,115.2,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S777(100)]",0,"ENSG00000053900"
"938","CTNND1",-0.20129563898134,6.67461233731279,-1.40627370260451,0.191210863590398,0.332682440703123,-6.02372835509923,"NONE",FALSE,"High","Master Protein","O60716-3","Isoform 1AC of Catenin delta-1 [OS=Homo sapiens]",0,109.963,11,8,13,37,8,939,104.9,6.87,122.86,8,NA,NA,NA,NA,NA,"O60716-3",NA,NA,NA,0,0,89.7,85.2,87.7,114.3,91.2,139.8,104.3,114.9,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T177(100); S252(100); S268(99.8); S349(100); S352(100); S864(100); S920(100)]",0,"ENSG00000198561"
"939","ZNF687",0.139412284712307,6.60163184989195,1.4029153060848,0.192180399343056,0.334013218027548,-6.02800688584459,"NONE",FALSE,"High","Master Protein","Q8N1G0","Zinc finger protein 687 [OS=Homo sapiens]",0,41.293,3,2,2,3,2,1237,129.4,8.19,11.81,2,"other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf16622","57592","D3DV17; hsa:57592; Q68DQ8; Q8N1G0; Q9H937; Q9P2A7","ENSG00000143373",NA,NA,0,0,122.1,115.2,112.7,86.9,65.2,94.2,104,89.9,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S1191(100)]",0,"ENSG00000143373"
"940","PLEC",-0.138536716600959,6.66625874854175,-1.39900342587956,0.193315009385874,0.335627760976326,-6.03298207640909,"NONE",FALSE,"High","Master Protein","Q15149","Plectin [OS=Homo sapiens]",0,289.56,5,17,35,94,17,4684,531.5,5.96,279.59,17,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00681, Pf03501, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097","5339","hsa:5339; Q15148; Q15149; Q16640; Q6S376; Q6S377; Q6S378; Q6S379; Q6S380; Q6S381; Q6S382; Q6S383","ENSG00000178209","Assembly of collagen fibrils and other multimeric structures; Caspase-mediated cleavage of cytoskeletal proteins; Type I hemidesmosome assembly","Envelope proteins and their potential roles in EDMD physiopathology",4,0,82.4,79,82.1,117.1,108.4,125.4,95.6,116.4,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100); S720(100); S1047(100); S1435(100); S1721(100); S1732(100); T4030(100); S4386(99.7); S4389(100); S4396(100); S4613(100); S4616(100); T4623(99.6); S4675(99.4)]",0,"ENSG00000178209"
"941","LRCH4",-0.192885963050893,6.64833722693943,-1.3976084331847,0.193720996005868,0.335975202424629,-6.03475404039338,"NONE",FALSE,"High","Master Protein","O75427","Leucine-rich repeat and calponin homology domain-containing protein 4 [OS=Homo sapiens]",0,13.179,3,1,1,1,1,683,73.4,8.22,4.2,1,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;nucleus",NA,"Pf00307, Pf13855","4034","A4D2D5; hsa:4034; O75427; Q8WV85; Q96ID0","ENSG00000077454",NA,NA,0,0,91.9,81.8,92.3,113.4,148,92.8,102.8,102.5,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S513(98.6)]",0,"ENSG00000077454"
"942","KHSRP",-0.135773003142846,6.63144069914197,-1.39687370523864,0.19393511703744,0.335989502128558,-6.03568684729422,"NONE",FALSE,"High","Master Protein","Q92945","Far upstream element-binding protein 2 [OS=Homo sapiens]",0,16.187,3,2,2,3,2,711,73.1,7.3,10.7,2,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf09005","8570","hsa:8570; O00301; Q59EZ9; Q5U4P6; Q92945; Q9UNT5; Q9UQH5","ENSG00000088247","ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA","Pre-implantation embryo",3,0,98.8,99.3,98.1,102.9,117.2,94.1,91.1,96.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S480(100)]",0,"ENSG00000088247"
"943","MSH6",0.102972873099595,6.56971897969967,1.39542888065226,0.194356769356427,0.336362934877719,-6.03752024680506,"NONE",FALSE,"High","Master Protein","P52701","DNA mismatch repair protein Msh6 [OS=Homo sapiens]",0,14.508,2,2,2,2,2,1360,152.7,6.9,5.6,2,"cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00488, Pf00855, Pf01624, Pf05188, Pf05190, Pf05192","2956","B4DF41; B4E3I4; F5H2F9; hsa:2956; O43706; O43917; P52701; Q8TCX4; Q9BTB5","ENSG00000116062","Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Defective Mismatch Repair Associated With MSH2; Defective Mismatch Repair Associated With MSH6","Glioblastoma signaling pathways; Retinoblastoma gene in cancer; Chromosomal and microsatellite instability in colorectal cancer ; DNA repair pathways, full network; DNA mismatch repair",8,0,113.8,111.4,105.8,90.3,71.2,85.7,95.3,97.6,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(99.6); S227(100)]",0,"ENSG00000116062"
"944","MYO18A",-0.181722163914635,6.65805357214083,-1.39396901991136,0.19478360304665,0.336672397964188,-6.03937145585387,"NONE",FALSE,"High","Master Protein","Q92614","Unconventional myosin-XVIIIa [OS=Homo sapiens]",0,26.855,2,4,4,4,4,2054,233,6.3,12.85,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;other biological processes","other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00063, Pf00595, Pf01576","399687","hsa:399687; Q5H9U3; Q5QD01; Q5W9F9; Q5W9G1; Q8IXP8; Q92614","ENSG00000196535","Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; Signaling by FLT3 fusion proteins",NA,3,0,75.9,72.9,71.4,135,99.3,130.8,103.3,122,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100); S987(100); S1640(100); S1998(100)]",0,"ENSG00000196535"
"945","HNRNPU",-0.0989019348321936,6.40541233492189,-1.39340688881738,0.194948171615293,0.336672397964188,-6.04008393787073,"NONE",FALSE,"High","Master Protein","Q00839","Heterogeneous nuclear ribonucleoprotein U [OS=Homo sapiens]",0,83.946,13,9,9,13,9,825,90.5,6,38.89,9,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00622, Pf02037, Pf13671","3192","hsa:3192; O75507; Q00839; Q8N174; Q96HY9; Q9BQ09","ENSG00000153187","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer",4,0,159.4,148.6,139.9,62.2,52.2,69.2,67.6,69.6,70,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S192(99.4)]",0,"ENSG00000153187"
"946","FARP2",0.100777972366749,6.61131735754977,1.39141540929935,0.195532147130738,0.337323957840766,-6.04260654340347,"NONE",FALSE,"High","Master Protein","O94887","FERM, ARHGEF and pleckstrin domain-containing protein 2 [OS=Homo sapiens]",0,32.472,4,3,4,5,3,1054,119.8,8.79,13.96,3,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity","Pf00169, Pf00373, Pf00621, Pf08736, Pf09379, Pf09380","9855","B7Z6J8; F5GZ84; hsa:9855; O94887; Q53QM5; Q8WU27; Q9UFE7","ENSG00000006607","RAC1 GTPase cycle; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion","2q37 copy number variation syndrome; TAR syndrome",4,0,114.4,114.4,115.4,85.2,77.5,92.2,100,97.9,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T22(100); S439(100)]",0,"ENSG00000006607"
"947","NAP1L1",-0.196858342968671,6.68478168516874,-1.38993661369238,0.195966747741642,0.337716718388975,-6.04447818999731,"NONE",FALSE,"High","Master Protein","P55209","Nucleosome assembly protein 1-like 1 [OS=Homo sapiens]",0,27.422,4,1,2,5,1,391,45.3,4.46,17.93,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00956","4673","B3KNT8; B3KV44; hsa:4673; P55209","ENSG00000187109",NA,"VEGFA-VEGFR2 signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies",2,0,65.7,64.2,81.2,135.5,116.1,135.8,127.5,116.4,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T62(100); S69(100)]",0,"ENSG00000187109"
"948","POP1",-0.180239734769361,6.38985221095278,-1.38715621642385,0.196786099676751,0.338771007038457,-6.0479936504317,"NONE",FALSE,"High","Master Protein","Q99575","Ribonucleases P/MRP protein subunit POP1 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1024,114.6,9.22,8.18,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf06978, Pf08170","10940","A8K5W9; Q15037; Q99575","ENSG00000104356","tRNA processing in the nucleus",NA,1,0,140,158.5,130.1,59.5,71.9,62.3,67,62.7,75.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S367(100)]",0,"ENSG00000104356"
"949","PABPC1",-0.568848939743885,6.1577818741191,-1.38481895971164,0.197477115297275,0.339602373198264,-6.05094520691899,"NONE",FALSE,"High","Master Protein","P11940","Polyadenylate-binding protein 1 [OS=Homo sapiens]",0,3.265,2,1,1,1,1,636,70.6,9.5,2.58,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf00658","26986","hsa:26986; P11940; Q15097; Q93004","ENSG00000070756","AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; Endoderm differentiation; VEGFA-VEGFR2 signaling; Acute viral myocarditis",13,0,215.9,132.1,112.5,55.1,50,60.6,80.8,42.4,53.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T319(100)]",0,"ENSG00000070756"
"950","CCNK",0.128649583828379,6.62041744203388,1.38263918953369,0.198123427193419,0.340355192820694,-6.05369490796024,"NONE",FALSE,"High","Master Protein","O75909-1","Isoform 3 of Cyclin-K [OS=Homo sapiens]",0,21.272,6,2,3,7,2,357,41.3,8.15,20.28,2,NA,NA,NA,NA,NA,"O75909-1",NA,NA,NA,0,0,104.7,109.2,102.2,91.3,99.6,80.8,100,99.8,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(100); S340(100)]",0,"ENSG00000090061"
"951","NAPA",-0.269187350778616,6.60306591299706,-1.38013207493923,0.198869019177296,0.341276802626021,-6.05685398239195,"NONE",FALSE,"High","Master Protein","P54920","Alpha-soluble NSF attachment protein [OS=Homo sapiens]",0,26.022,6,1,1,2,1,295,33.2,5.36,7.5,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf14938","8775","A8K879; hsa:8775; P54920; Q96IK3; Q9BVJ3","ENSG00000105402","COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Golgi Associated Vesicle Biogenesis; Intra-Golgi traffic; COPII-mediated vesicle transport; Retrograde transport at the Trans-Golgi-Network","Synaptic vesicle pathway; VEGFA-VEGFR2 signaling",8,0,59.5,95.2,57,128.6,138.2,117.8,107.5,118.2,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S195(100)]",0,"ENSG00000105402"
"952","CCDC88A",0.0926850166696296,6.67831116300618,1.37935030355218,0.199101997207561,0.341317709498675,-6.05783826853389,"NONE",FALSE,"High","Master Protein","Q3V6T2","Girdin [OS=Homo sapiens]",0,78.539,4,6,12,22,6,1871,215.9,6.21,55.13,6,"cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf19047","55704","A1IGE7; B7ZM78; C9JG83; hsa:55704; Q3V6T2; Q53SF1; Q581G3; Q5HYD0; Q7Z339; Q7Z3C5","ENSG00000115355","RND3 GTPase cycle; RND1 GTPase cycle","Mesodermal commitment pathway",3,0,94,95.2,99.4,102.5,92,107.1,106.4,112.2,108.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1417(100); S1653(99.7); T1673(99.5); S1675(99.5); S1701(99.5); S1702(99.7); S1717(100); S1820(99.5)]",0,"ENSG00000115355"
"953","PHIP",-0.126686576170424,6.28549399427586,-1.37001422331338,0.201902209249725,0.345754885095017,-6.06956405967561,"NONE",FALSE,"High","Master Protein","Q8WWQ0","PH-interacting protein [OS=Homo sapiens]",0,34.67,2,3,3,12,3,1821,206.6,8.85,12.41,3,"cell organization and biogenesis;signal transduction;other biological processes","nucleus","signal transduction activity or receptor binding;other molecular function","Pf00400, Pf00439","55023","A7J992; B2RPK4; hsa:55023; Q05CQ9; Q5VVH4; Q66I29; Q69YV1; Q8NBZ5; Q8WWQ0; Q96H52; Q96ME2; Q9H261","ENSG00000146247","RHOBTB2 GTPase cycle",NA,1,0,171.7,161.1,162.7,53.8,39.5,56.2,63.2,53.7,64.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1783(100)]",0,"ENSG00000146247"
"954","PRKAR2B",-0.154383451582271,6.63003380273042,-1.36080271098734,0.204697668023417,0.349858785152269,-6.0810810888646,"NONE",FALSE,"High","Master Protein","P31323","cAMP-dependent protein kinase type II-beta regulatory subunit [OS=Homo sapiens]",0,16.205,9,2,2,3,2,418,46.3,4.92,12.03,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5577","A4D0R9; hsa:5577; P31323","ENSG00000005249","FCGR3A-mediated IL10 synthesis; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase","Myometrial relaxation and contraction pathways; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways",27,0,79.6,85.1,83,102.4,101.6,135.3,96.3,106.5,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100)]",0,"ENSG00000005249"
"955","NUP98",-0.113056939626873,6.61657974999642,-1.36070526582699,0.204727414105648,0.349858785152269,-6.08120264404294,"NONE",FALSE,"High","Master Protein","P52948","Nuclear pore complex protein Nup98-Nup96 [OS=Homo sapiens]",0,66.832,3,4,4,7,4,1817,197.5,6.4,24.07,4,"cell organization and biogenesis;protein metabolism;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04096, Pf12110, Pf21240","4928","hsa:4928; P52948; Q8IUT2; Q8WYB0; Q96E54; Q9H3Q4; Q9NT02; Q9UF57; Q9UHX0; Q9Y6J4; Q9Y6J5","ENSG00000110713",NA,"SARS-CoV-2 innate immunity evasion and cell-specific immune response",1,0,93.4,91.7,105.4,99.6,96.1,110.1,92.3,95.9,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S612(100); S623(100); S888(100)]",0,"ENSG00000110713"
"956","ZHX3",-0.102910097722185,6.65944710986425,-1.34882419990377,0.208381665555134,0.355731044127593,-6.09597927782358,"NONE",FALSE,"High","Master Protein","Q9H4I2","Zinc fingers and homeoboxes protein 3 [OS=Homo sapiens]",0,23.074,2,1,2,6,1,956,104.6,6.07,14.36,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf11569, Pf18387","23051","E1P5W5; F5H820; hsa:23051; O43145; Q6NUJ7; Q9H4I2","ENSG00000174306",NA,NA,0,0,79.8,73.8,82.4,112.9,122.6,120.9,103.2,112.1,116.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S946(99.4)]",0,"ENSG00000174306"
"957","RBMXL1",-0.206817927734166,6.63104093927568,-1.34642178108314,0.209127216203732,0.356630738604483,-6.09895653020217,"NONE",FALSE,"High","Master Protein","Q96E39","RNA binding motif protein, X-linked-like-1 [OS=Homo sapiens]",0,51.529,15,7,7,21,2,390,42.1,9.89,50.39,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf08081","494115","hsa:494115; Q96E39","ENSG00000213516",NA,NA,0,5,90.9,89.2,92.2,101.8,150.4,95.7,97.8,87.3,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S189(99.1); S208(100); S326(100); S351(100)]",0,"ENSG00000213516"
"958","ZC3H4",-0.0981062580559655,6.64786249334918,-1.34140663130744,0.210690817706338,0.358590252366405,-6.1051600435041,"NONE",FALSE,"High","Master Protein","Q9UPT8","Zinc finger CCCH domain-containing protein 4 [OS=Homo sapiens]",0,37.902,4,3,3,4,3,1303,140.2,6.27,14.54,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00642, Pf14608, Pf18044","23211","hsa:23211; Q9UPT8; Q9Y420","ENSG00000130749",NA,NA,0,0,94.5,99.2,105.5,103.1,99.5,105.6,103,98.6,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1114(98.9); S1269(100); S1275(100)]",0,"ENSG00000130749"
"959","KANK2",-0.162496187164194,6.47068952094581,-1.34132701819588,0.210715718149132,0.358590252366405,-6.10525839429869,"NONE",FALSE,"High","Master Protein","Q63ZY3","KN motif and ankyrin repeat domain-containing protein 2 [OS=Homo sapiens]",0,10.197,2,1,1,2,1,851,91.1,5.63,7.13,1,"cell organization and biogenesis;developmental processes;other biological processes","mitochondrion;other cell component",NA,"Pf12075, Pf12796","25959","B0I1P4; hsa:25959; Q3KQZ3; Q63ZY3; Q6GUF5; Q9H8S4; Q9NUP0; Q9P210","ENSG00000197256",NA,NA,0,0,132.8,151.1,118.8,69,72.3,77.4,73,66.8,84.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S375(100)]",0,"ENSG00000197256"
"960","SEMA6D",0.0949552137420735,6.63735462179626,1.33493508912485,0.212722990712515,0.361629084211275,-6.11314172787333,"NONE",FALSE,"High","Master Protein","Q8NFY4","Semaphorin-6D [OS=Homo sapiens]",0,33.642,4,3,3,4,3,1073,119.8,8.51,10.54,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding","Pf01403, Pf01437","80031","A6NF10; A6NM95; A6NNK1; A7E2A0; hsa:80031; Q8NFY3; Q8NFY4; Q8NFY5; Q8NFY6; Q8NFY7; Q9P249","ENSG00000137872","Other semaphorin interactions","VEGFA-VEGFR2 signaling; IL-18 signaling pathway",3,0,103.3,97.5,102.5,90.2,92.8,100,99.8,107.7,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S713(99.6); S931(99.1)]",0,"ENSG00000137872"
"961","CDS2",-0.191097736867383,6.6209440275458,-1.33013998290206,0.214239317466703,0.3638278523472,-6.11903875355856,"NONE",FALSE,"High","Master Protein","O95674","Phosphatidate cytidylyltransferase 2 [OS=Homo sapiens]",0,58.372,11,3,4,11,3,445,51.4,7.09,41.36,3,"cell organization and biogenesis;other metabolic processes","other membranes;mitochondrion;ER/Golgi","other molecular function","Pf01148","8760","B2RDC6; D3DW04; hsa:8760; O95674; Q5TDY2; Q5TDY3; Q5TDY4; Q5TDY5; Q9BYK5; Q9NTT2","ENSG00000101290","Synthesis of PG",NA,1,0,111.3,111.4,106.4,109.3,69.5,114.3,93.3,101.3,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S33(100)]",0,"ENSG00000101290"
"962","PDPK1",0.104888075552148,6.64187972260444,1.32733432944824,0.215130723486184,0.364961892650158,-6.12248240260029,"NONE",FALSE,"High","Master Protein","O15530","3-phosphoinositide-dependent protein kinase 1 [OS=Homo sapiens]",0,41.965,8,2,3,8,2,556,63.1,7.36,30.71,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf14593","5170","H0Y4Z0; hsa:5170; O15530; Q59EH6; Q6FI20; Q8IV52; Q9BRD5","ENSG00000140992","Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated NF-kB activation; Downstream TCR signaling; CLEC7A (Dectin-1) signaling; Constitutive Signaling by AKT1 E17K in Cancer; PIP3 activates AKT signaling; Regulation of TP53 Degradation; GPVI-mediated activation cascade; CD28 dependent PI3K/Akt signaling; G beta:gamma signalling through PI3Kgamma; RHO GTPases activate PKNs; Activation of AKT2; Integrin signaling; RSK activation; VEGFR2 mediated vascular permeability; VEGFR2 mediated cell proliferation; Estrogen-stimulated signaling through PRKCZ; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac hypertrophic response; Focal adhesion; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; PPAR signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Modulators of TCR signaling and T cell activation; GDNF signaling; Primary ovarian insufficiency; Macrophage-stimulating protein (MSP) signaling network map; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway",46,0,100.2,103.5,97.8,89.9,98.4,98.5,100.1,101.5,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(97.9); S241(100)]",0,"ENSG00000140992"
"963","SIPA1L2",0.0951023350387032,6.66945721717169,1.32141850364619,0.21702046087042,0.367785453936163,-6.12972708436697,"NONE",FALSE,"High","Master Protein","Q9P2F8","Signal-induced proliferation-associated 1-like protein 2 [OS=Homo sapiens]",0,51.808,4,5,5,8,5,1722,190.3,6.77,25.61,5,"other biological processes","other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","57568","hsa:57568; Q2TV88; Q5VXR7; Q5VXR8; Q641Q4; Q8NA38; Q96DZ3; Q9H9F6; Q9P2F8","ENSG00000116991",NA,NA,0,0,101.2,103.9,99.4,96,94.9,101.9,110.1,102.1,105.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.2); S194(99.4); S1461(100); S1488(100); S1652(100)]",0,"ENSG00000116991"
"964","RB1CC1",0.179341468952935,6.63036430231062,1.32001533636942,0.217470715353329,0.36816619030771,-6.13144217159266,"NONE",FALSE,"High","Master Protein","Q8TDY2","RB1-inducible coiled-coil protein 1 [OS=Homo sapiens]",0,25.017,2,3,3,4,3,1594,183,5.41,6.83,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10377","9821","hsa:9821; Q86YR4; Q8TDY2; Q8WVU9; Q92601","ENSG00000023287","Macroautophagy","Alzheimer's disease and miRNA effects; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; Alzheimer's disease; Clock-controlled autophagy in bone metabolism; 8q11.23 (RB1CC1) copy number variation; ADHD and autism (ASD) linked metabolic pathways and SNP",11,0,90.4,96.4,96.5,80.4,123.8,89.3,108.9,101.9,113.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S237(100)]",0,"ENSG00000023287"
"965","APPL1",-0.146934026555753,6.62427398544335,-1.31833573401259,0.218010699239052,0.3686978872105,-6.13349349203614,"NONE",FALSE,"High","Master Protein","Q9UKG1","DCC-interacting protein 13-alpha [OS=Homo sapiens]",0,30.401,3,1,1,3,1,709,79.6,5.41,15.28,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00640, Pf16746","26060","hsa:26060; Q9P2B9; Q9UKG1","ENSG00000157500","Caspase activation via Dependence Receptors in the absence of ligand","Follicle stimulating hormone (FSH) signaling pathway; Chromosomal and microsatellite instability in colorectal cancer",3,0,64,77.6,65.7,118.5,133.3,123.7,99.8,127.3,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S401(100)]",0,"ENSG00000157500"
"966","DNPH1",0.117777513444893,6.66127829611651,1.3173735735127,0.218320533098705,0.368839658402781,-6.13466777917054,"NONE",FALSE,"High","Master Protein","O43598","5-hydroxymethyl-dUMP N-hydrolase [OS=Homo sapiens]",0,16.154,10,1,1,6,1,174,19.1,5.05,14.94,1,"other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf05014","10591","B2LUJ9; hsa:10591; O43598","ENSG00000112667","Purine catabolism",NA,1,0,83.6,80.3,91.7,105.3,104.2,105.1,105.4,110.2,131,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000112667"
"967","EPB41L5",-0.112139030037073,6.63250003887354,-1.31600827757516,0.218760814860138,0.368958835485989,-6.13633306423472,"NONE",FALSE,"High","Master Protein","Q9HCM4","Band 4.1-like protein 5 [OS=Homo sapiens]",0,91.572,8,3,6,12,3,733,81.8,6.58,45.11,3,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00373, Pf08736, Pf09379, Pf09380","57669","hsa:57669; Q7Z5S1; Q8IZ12; Q9H975; Q9HCM4","ENSG00000115109","Neurexins and neuroligins","Endoderm differentiation; Mesodermal commitment pathway; Mesodermal commitment pathway",4,0,100.5,109.7,102.5,100.3,87.7,109.4,101.3,90.1,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S436(98.4); S517(100); S550(100)]",0,"ENSG00000115109"
"968","SEPTIN2",-0.114152873929195,6.64545859643875,-1.31500565587275,0.219084612697997,0.368958835485989,-6.1375552265374,"NONE",FALSE,"High","Master Protein","Q15019","Septin-2 [OS=Homo sapiens]",0,112.891,23,7,7,19,7,361,41.5,6.6,80.09,7,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","other molecular function","Pf00735","4735","B4DGE8; hsa:4735; Q14132; Q15019; Q53QU3; Q8IUK9; Q96CB0","ENSG00000168385","Anchoring of the basal body to the plasma membrane","2q37 copy number variation syndrome",2,0,102.9,100,100.9,108.8,83.7,111.4,100.4,98.3,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S218(100)]",0,"ENSG00000168385"
"969","SRF",-0.10363808284515,6.61668507889965,-1.3145557098391,0.219230053192946,0.368958835485989,-6.13810348629498,"NONE",FALSE,"High","Master Protein","P11831","Serum response factor [OS=Homo sapiens]",0,29.94,5,2,2,3,2,508,51.6,8.1,11.12,2,"cell adhesion;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00319","6722","hsa:6722; P11831; Q5T648","ENSG00000112658","RHO GTPases Activate Formins; NGF-stimulated transcription; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Cardiogenesis; Regulation of NPAS4 gene transcription","Heart development; SRF and miRs in smooth muscle differentiation and proliferation; Genes targeted by miRNAs in adipocytes; Cell differentiation - expanded index; Cell differentiation - index; Mesodermal commitment pathway; Mesodermal commitment pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; PDGFR-beta pathway; Envelope proteins and their potential roles in EDMD physiopathology; 22q11.2 copy number variation syndrome; Insulin signaling; Orexin receptor pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling",22,0,109.5,104.5,114.2,100.8,87.9,95.5,87.1,93.4,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S224(100)]",0,"ENSG00000112658"
"970","UBQLN4",0.190577305477261,6.6797503598446,1.31435367132154,0.219295386287628,0.368958835485989,-6.13834962823747,"NONE",FALSE,"High","Master Protein","Q9NRR5","Ubiquilin-4 [OS=Homo sapiens]",0,24.981,11,2,2,2,2,601,63.8,5.22,8.46,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00240, Pf00627","56893","A6ND44; B2RAY7; hsa:56893; Q5VYA0; Q5VYA1; Q9BR98; Q9NRR5; Q9UHX4","ENSG00000160803",NA,NA,0,0,80.4,78.9,80.6,99.1,97.4,125.7,104.8,156.3,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000160803"
"971","KIAA1671",0.0961464983532307,6.65618432633242,1.31080427312562,0.220445803557915,0.370512411335239,-6.14266955937994,"NONE",FALSE,"High","Master Protein","Q9BY89","Uncharacterized protein KIAA1671 [OS=Homo sapiens]",0,72.202,5,5,5,6,5,1806,196.6,8.47,28.02,5,NA,NA,NA,"Pf15327","85379","B0QYF2; B7ZW08; hsa:85379; Q5THZ5; Q9BY89","ENSG00000197077",NA,NA,0,0,94.1,87.1,95.7,103.2,102.2,97.9,109.6,106.7,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S448(99.3); S749(100); S774(100); S1224(100); S1701(100)]",0,"ENSG00000197077"
"972","ARL6IP4",0.136492794370486,6.58341963955094,1.30856352436278,0.221174652280195,0.371354971729711,-6.1453925784226,"NONE",FALSE,"High","Master Protein","Q66PJ3","ADP-ribosylation factor-like protein 6-interacting protein 4 [OS=Homo sapiens]",0,15.2,7,1,1,2,1,237,26.4,10.86,9.78,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf10500","51329","A4UCR8; B3V0L0; B3V0L1; hsa:51329; Q4F966; Q504R8; Q66PJ3; Q96BI2; Q9NR05; Q9P2R9","ENSG00000182196",NA,NA,0,0,113.5,119.1,121.4,73.9,89.4,78.2,96.5,87.6,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000182196"
"973","ARHGEF3",0.475393158619569,6.48271823255048,1.30777584011829,0.221431338628414,0.371403848552489,-6.14634902573076,"NONE",FALSE,"High","Master Protein","Q9NR81","Rho guanine nucleotide exchange factor 3 [OS=Homo sapiens]",0,7.575,2,1,1,1,1,526,59.7,6.43,2.95,1,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00621","50650","A8K5U7; hsa:50650; Q4FZB6; Q4QQI5; Q4QQQ0; Q59F00; Q6NUN3; Q7Z4U2; Q7Z5T2; Q9H7T4; Q9NR81","ENSG00000163947","RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle",NA,4,0,40.8,119.9,81.1,80.9,72.1,85,84,191.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(99.6)]",0,"ENSG00000163947"
"974","PHRF1",-0.085936980950553,6.59195654181552,-1.30686080573009,0.221729836451072,0.371522682842042,-6.14745960602784,"NONE",FALSE,"High","Master Protein","Q9P1Y6","PHD and RING finger domain-containing protein 1 [OS=Homo sapiens]",0,113.516,8,9,9,16,9,1649,178.6,8.95,57.02,9,"protein metabolism;other metabolic processes",NA,"other molecular function","Pf00628, Pf13639","57661","A6H8W1; B7ZM64; B9EGP0; C9JS82; hsa:57661; Q6PJP2; Q8IVY2; Q8N2Y7; Q9BSM2; Q9P1Y6","ENSG00000070047; ENSG00000274780",NA,NA,0,0,119,116.8,115.8,87.7,83.2,94.4,88.6,87.1,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S867(100); S915(100); S973(100); S991(100); S1034(100); S1124(99.6); S1202(100); S1229(100)]",0,"ENSG00000070047"
"975","BRD4",-0.127897296055461,6.63763201964952,-1.30377635888127,0.222738496284578,0.372829975319417,-6.15119922808556,"NONE",FALSE,"High","Master Protein","O60885","Bromodomain-containing protein 4 [OS=Homo sapiens]",0,13.09,2,2,2,3,2,1362,152.1,9.19,8.65,2,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00439, Pf17035, Pf17105","23476","hsa:23476; O60433; O60885; Q4G0X8; Q86YS8; Q96PD3","ENSG00000141867","Potential therapeutics for SARS","VEGFA-VEGFR2 signaling; 7q11.23 copy number variation syndrome",3,0,109.9,101.2,103,109,81.5,106.7,101.8,96,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S601(100); S1117(100)]",0,"ENSG00000141867"
"976","ARFGAP2",0.0991389033896173,6.63706185071407,1.29929016338665,0.224212355083985,0.374244163849623,-6.15662736145044,"NONE",FALSE,"High","Master Protein","Q8N6H7","ADP-ribosylation factor GTPase-activating protein 2 [OS=Homo sapiens]",0,16.171,4,2,3,6,2,521,56.7,7.99,16.6,2,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01412","84364","B4DX29; B7Z9M7; D3DQQ9; hsa:84364; Q3LIF2; Q8N3I1; Q8N6H7; Q96SX7","ENSG00000149182","COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; CDC42 GTPase cycle","IL-18 signaling pathway; 5q35 copy number variation",5,0,61.3,63.1,63.5,113.2,137.2,121.1,119.9,133.8,133,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S368(100); S432(100)]",0,"ENSG00000149182"
"977","MLF1",-0.135108828403207,6.66677316212632,-1.2983071442525,0.224536387874005,0.374244163849623,-6.15781503574685,"NONE",FALSE,"High","Master Protein","P58340","Myeloid leukemia factor 1 [OS=Homo sapiens]",0.006,1.842,3,1,1,2,1,268,30.6,9.45,2.02,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;other cell component","nucleic acid binding activity;other molecular function","Pf10248","4291","E9PEU9; hsa:4291; P58340; Q2TLE3; Q2TLE5; Q8N8F8; Q96MH1","ENSG00000178053",NA,NA,0,0,102.1,93.3,98.1,96.5,101.2,125.7,95.2,100.6,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S34(100)]",0,"ENSG00000178053"
"978","ACOX1",0.180922285755369,6.54579348928442,1.29658656281238,0.225104479048758,0.374244163849623,-6.15989231467778,"NONE",FALSE,"High","Master Protein","Q15067","Peroxisomal acyl-coenzyme A oxidase 1 [OS=Homo sapiens]",0,3.501,4,2,2,2,2,660,74.4,8.16,1.87,2,"cell organization and biogenesis;other metabolic processes;other biological processes","other membranes;cytosol;other cytoplasmic organelle","other molecular function","Pf01756, Pf02770, Pf14749","51","A8K6X8; A8KAA0; B4DK61; F5GYQ8; hsa:51; Q12863; Q15067; Q15068; Q15101; Q16131; Q7Z3W5; Q9UD31","ENSG00000161533","TYSND1 cleaves peroxisomal proteins","Estrogen receptor pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-3 / omega-6 fatty acid synthesis",8,0,120.6,116.7,134.8,73.4,58.2,88.5,104.8,78.3,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000161533"
"979","CFL1",0.109542862639666,6.68089166610609,1.29647811828144,0.225140324525874,0.374244163849623,-6.16002317660152,"NONE",FALSE,"High","Master Protein","P23528","Cofilin-1 [OS=Homo sapiens]",0,66.252,38,7,9,16,7,166,18.5,8.09,37.98,7,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00241","1072","B3KUQ1; hsa:1072; P23528; Q53Y87; Q9UCA2","ENSG00000172757","Platelet degranulation ; Regulation of actin dynamics for phagocytic cup formation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; EPHB-mediated forward signaling; Sema3A PAK dependent Axon repulsion; RHO GTPases Activate ROCKs","Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; 7q11.23 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway",15,0,86.9,83.7,80.9,114.9,107.4,102.7,120,114.3,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S3(100); T25(100); S156(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000172757"
"980","ZCCHC8",-0.160901640542476,6.65392608272012,-1.29642563854307,0.225157672986302,0.374244163849623,-6.1600865020785,"NONE",FALSE,"High","Master Protein","Q6NZY4","Zinc finger CCHC domain-containing protein 8 [OS=Homo sapiens]",0,10.754,2,1,1,1,1,707,78.5,4.87,3.28,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00098, Pf04046","55596","hsa:55596; Q6NZY4; Q7L2P6; Q8N2K5; Q96SK7; Q9NSS2; Q9NSS3","ENSG00000033030",NA,NA,0,0,94,92.2,88.2,110.2,90.9,125.7,104.2,111.5,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T479(100)]",0,"ENSG00000033030"
"981","DCTN1",0.11776733179946,6.67850282974585,1.29603398752651,0.225287177829738,0.374244163849623,-6.16055903717008,"NONE",FALSE,"High","Master Protein","Q14203","Dynactin subunit 1 [OS=Homo sapiens]",0,15.2,2,1,2,2,1,1278,141.6,5.81,10.34,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf12455","1639","A8MY36; B4DM45; E9PFS5; E9PGE1; G5E9H4; hsa:1639; O95296; Q14203; Q6IQ37; Q9BRM9; Q9UIU1; Q9UIU2","ENSG00000204843","Signaling by ALK fusions and activated point mutants; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; XBP1(S) activates chaperone genes","Vasopressin-regulated water reabsorption; HDAC6 interactions in the central nervous system",8,0,85.3,89.9,108.1,103.7,90.2,107.6,110.8,110.2,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T108(100)]",0,"ENSG00000204843"
"982","AIDA",-0.293121851062177,6.61583749363889,-1.29583956591327,0.225351488981575,0.374244163849623,-6.16079357381544,"NONE",FALSE,"High","Master Protein","Q96BJ3","Axin interactor, dorsalization-associated protein [OS=Homo sapiens]",0,8.352,4,1,1,3,1,306,35,6.55,2.71,1,"developmental processes;other biological processes","other membranes;other cell component","other molecular function","Pf08910, Pf14186","64853","A8K1F0; hsa:64853; Q49A81; Q5JRA4; Q658P1; Q96BJ3; Q9H9E8","ENSG00000186063",NA,NA,0,0,81.2,117.2,70.6,92.7,128.8,128.6,76.3,114.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100)]",0,"ENSG00000186063"
"983","COL4A1",-0.171222290927763,6.4829738415467,-1.29563884391753,0.225417900161875,0.374244163849623,-6.16103568499179,"NONE",FALSE,"High","Master Protein","P02462","Collagen alpha-1(IV) chain [OS=Homo sapiens]",0,13.768,2,2,2,2,2,1669,160.5,8.28,2.88,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;ER/Golgi","extracellular structural activity;other molecular function","Pf01391, Pf01413","1282","A7E2W4; B1AM70; F5H5K0; P02462; Q1P9S9; Q5VWF6; Q86X41; Q8NF88; Q9NYC5","ENSG00000187498","Collagen degradation; Signaling by PDGF; Integrin cell surface interactions; ECM proteoglycans; NCAM1 interactions; Collagen chain trimerization; Non-integrin membrane-ECM interactions; Laminin interactions; Anchoring fibril formation; Crosslinking of collagen fibrils; Scavenging by Class A Receptors","Spinal cord injury; miRNA targets in ECM and membrane receptors; Focal adhesion; Overview of nanoparticle effects; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; Small cell lung cancer; Pleural mesothelioma; Macrophage-stimulating protein (MSP) signaling network map",24,0,118.1,125.5,142.3,78.8,61,89.1,66.6,83,82,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S656(100)]",0,"ENSG00000187498"
"984","ARHGAP35",0.0862874118127692,6.60893797338871,1.29410145999728,0.22592709978242,0.374376926566443,-6.16288920980853,"NONE",FALSE,"High","Master Protein","Q9NRY4","Rho GTPase-activating protein 35 [OS=Homo sapiens]",0,60.376,6,5,5,11,5,1499,170.4,6.64,31.61,5,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00071, Pf00620, Pf16512, Pf19518","2909","A7E2A4; hsa:2909; Q14452; Q9C0E1; Q9NRY4","ENSG00000160007","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Sema4D mediated inhibition of cell attachment and migration; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","Focal adhesion; Regulation of actin cytoskeleton",18,0,110.8,116.6,111.4,87.6,81,89.7,95.2,99.7,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S970(98.6); S975(100); S1179(100)]",0,"ENSG00000160007"
"985","PDE3A",0.211495607302212,6.65141783112012,1.29401229301292,0.225956662173987,0.374376926566443,-6.16299666545715,"NONE",FALSE,"High","Master Protein","Q14432","cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A [OS=Homo sapiens]",0,28.926,5,3,3,4,3,1141,124.9,6,15.25,3,"other metabolic processes;signal transduction;other biological processes","other membranes;cytosol","other molecular function","Pf00233","5139","hsa:5139; O60865; Q13348; Q14432; Q17RD1","ENSG00000172572","G alpha (s) signalling events","NO/cGMP/PKG mediated neuroprotection; Phosphodiesterases in neuronal function",3,0,75.8,67.8,79.2,96.7,82,140.2,110.9,131.2,132.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S312(99.7); S408(100); S520(100)]",0,"ENSG00000172572"
"986","TRAPPC14",-0.221856982331357,6.61209850195979,-1.2927527839431,0.226374582049658,0.374688963392538,-6.16451395336983,"NONE",FALSE,"High","Master Protein","Q8WVR3","Trafficking protein particle complex subunit 14 [OS=Homo sapiens]",0,3.65,2,1,1,1,1,580,62.6,8.87,2.17,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity","Pf15806","55262","A4D2A9; D6W5U4; hsa:55262; Q8WVR3; Q9BQJ1; Q9BUB6; Q9NV47","ENSG00000146826",NA,NA,0,0,88.3,104.2,107.7,102.7,75.7,126.6,77,97.9,107,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S517(99.5)]",0,"ENSG00000146826"
"987","NIPBL",-0.0911465500674522,6.55730805008352,-1.29034785618795,0.227174344534462,0.375631742938442,-6.16740821263735,"NONE",FALSE,"High","Master Protein","Q6KC79","Nipped-B-like protein [OS=Homo sapiens]",0,81.097,4,8,8,13,8,2804,315.9,7.91,45.11,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf12765, Pf12830","25836","hsa:25836; Q6KC79; Q6KCD6; Q6N080; Q6ZT92; Q7Z2E6; Q8N4M5; Q9Y6Y3; Q9Y6Y4","ENSG00000164190","Cohesin Loading onto Chromatin","Cohesin complex - Cornelia de Lange syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome",3,0,126.4,120.3,115.7,86.2,80.6,84.9,87.8,87,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100); S318(100); T713(100); T746(100); S2658(100)]",0,"ENSG00000164190"
"988","ANKZF1",-0.23004898156359,6.60097552870167,-1.28743893510332,0.228144836210417,0.376854628234211,-6.17090396007179,"NONE",FALSE,"High","Master Protein","Q9H8Y5","tRNA endonuclease ANKZF1 [OS=Homo sapiens]",0,15.969,5,2,2,2,2,726,80.9,8.41,5.54,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response","other cell component","other molecular function","Pf00023, Pf18716, Pf18826","55139","hsa:55139; Q9H8Y5; Q9NVZ4","ENSG00000163516",NA,NA,0,0,123.6,108.3,102.2,108.5,76.8,102.7,110.2,85.8,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S56(100)]",0,"ENSG00000163516"
"989","PTPRZ1",0.148468172420722,6.6549234693037,1.28459505039308,0.229096944011872,0.377691000500735,-6.17431619160825,"NONE",FALSE,"High","Master Protein","P23471","Receptor-type tyrosine-protein phosphatase zeta [OS=Homo sapiens]",0,77.513,4,7,11,28,7,2315,254.4,4.88,75.82,7,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00041, Pf00102, Pf00194","5803","A4D0W5; C9JFM0; hsa:5803; O76043; P23471; Q9UDR6","ENSG00000106278","Other interleukin signaling; MDK and PTN in ALK signaling","Spinal cord injury; VEGFA-VEGFR2 signaling; IL-18 signaling pathway",5,0,75.5,79.9,72.8,113.7,83.8,125,117.5,129.4,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1451(100); S1683(98.8); T1687(98.8); S2055(99.6); S2196(100)]",0,"ENSG00000106278"
"990","INPP5E",-0.173845680111881,6.60789219159628,-1.28454411680052,0.229114026039049,0.377691000500735,-6.1743772558405,"NONE",FALSE,"High","Master Protein","Q9NRR6","Phosphatidylinositol polyphosphate 5-phosphatase type IV [OS=Homo sapiens]",0,7.587,2,1,1,1,1,644,70.2,8.95,3.57,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","other molecular function",NA,"56623","hsa:56623; Q15734; Q6PIV5; Q9NRR6","ENSG00000148384","Synthesis of PIPs at the Golgi membrane; ARL13B-mediated ciliary trafficking of INPP5E","Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome",6,0,102.5,99.4,99.7,98.2,119.2,92.8,80.9,93.3,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000148384"
"991","SZRD1",-0.188566893998876,6.65687110237803,-1.28192536943691,0.229993717044306,0.378758573376698,-6.17751457226477,"NONE",FALSE,"High","Master Protein","Q7Z422","SUZ domain-containing protein 1 [OS=Homo sapiens]",0,30.722,16,2,2,3,1,152,17,8.95,7.48,2,NA,NA,NA,"Pf12752, Pf12901","26099","A8MXJ2; C9K0U0; hsa:26099; Q7Z422; Q7Z424; Q8IVM2; Q8TBV3; Q9Y403","ENSG00000055070; ENSG00000291379",NA,NA,0,0,73.8,85.4,108.9,124.2,100.3,114.6,107.7,107.1,91.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000055070"
"992","ARFIP1",-0.225785168063666,6.68356852664943,-1.27810912943109,0.231280664307521,0.380493996118824,-6.1820784282775,"NONE",FALSE,"High","Master Protein","P53367","Arfaptin-1 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,373,41.7,6.7,4.28,1,"transport;other biological processes","other membranes;cytosol;ER/Golgi","other molecular function","Pf06456","27236","B4DS69; hsa:27236; P53367; Q2M2X4; Q3SYL4; Q9Y2X6","ENSG00000164144",NA,NA,0,0,115.5,92.2,88.1,121.1,91.1,122.5,120,83.6,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(98.7)]",0,"ENSG00000164144"
"993","GRIPAP1",-0.157477168501831,6.62800368265714,-1.2765123343154,0.231820910907668,0.380733936702376,-6.18398519077519,"NONE",FALSE,"High","Master Protein","Q4V328","GRIP1-associated protein 1 [OS=Homo sapiens]",0,20.182,5,2,2,2,2,841,95.9,5.11,7.76,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function",NA,"56850","A6NL78; hsa:56850; Q3MJ75; Q4V327; Q4V328; Q4V330; Q5HYG1; Q6N046; Q96DH8; Q9NQ43; Q9ULQ3","ENSG00000068400; ENSG00000292219",NA,NA,0,0,108.3,136.8,120.4,97.7,93.3,91.2,102.5,84.5,81.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S655(99.4); S692(99)]",0,"ENSG00000068400"
"994","IQSEC2",0.11879553857207,6.6440217853227,1.2759467327135,0.23201252140251,0.380733936702376,-6.18466018204646,"NONE",FALSE,"High","Master Protein","Q5JU85","IQ motif and SEC7 domain-containing protein 2 [OS=Homo sapiens]",0,25.179,3,3,3,5,1,1488,162.7,8.56,16.5,3,"cell organization and biogenesis;other biological processes","other cell component","enzyme regulator activity","Pf01369, Pf16453","23096","A0A1W2PQN3; B3KT97; C7SDG1; hsa:23096; O60275; Q5JU85; Q5JUX1","ENSG00000124313",NA,NA,0,2,85.9,93,94.8,94.3,102.2,102.9,100.8,122.1,106.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S246(100); S326(99.1)]",0,"ENSG00000124313"
"995","HARS2",0.122102453678776,6.60479940076054,1.27561079706815,0.232126389104696,0.380733936702376,-6.18506098890927,"NONE",FALSE,"High","Master Protein","P49590","Histidine--tRNA ligase, mitochondrial [OS=Homo sapiens]",0,3.664,2,1,1,2,1,506,56.9,8.24,2.9,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;mitochondrion","other molecular function","Pf03129, Pf13393","23438","B4DDY8; hsa:23438; P49590","ENSG00000112855","Mitochondrial tRNA aminoacylation","Primary ovarian insufficiency",2,0,111.5,102.9,116.8,83.2,74.1,98.8,104.9,96.1,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100)]",0,"ENSG00000112855"
"996","FGFR1",0.357652978636059,6.59625764414897,1.27345778621945,0.232857261337444,0.38154924749268,-6.18762798643624,"NONE",FALSE,"High","Master Protein","P11362","Fibroblast growth factor receptor 1 [OS=Homo sapiens]",0,5.402,3,1,1,1,1,822,91.8,6.21,2.6,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00047, Pf07679, Pf07714","2260","A8K6T9; A8K8V5; C1KBH8; hsa:2260; P11362; P17049; Q02063; Q02065; Q14306; Q14307; Q53H63; Q59H40; Q5BJG2; Q8N685; Q9UD50; Q9UDF0; Q9UDF1; Q9UDF2","ENSG00000077782","Formation of paraxial mesoderm; Signaling by FGFR1 in disease; Epithelial-Mesenchymal Transition (EMT) during gastrulation; Signaling by activated point mutants of FGFR1; Signaling by plasma membrane FGFR1 fusions","Neural crest differentiation; Glioblastoma signaling pathways; Mesodermal commitment pathway; Mesodermal commitment pathway; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; Endometrial cancer; PI3K-Akt signaling pathway; Ras signaling; Breast cancer pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Head and neck squamous cell carcinoma; Endochondral ossification; Thyroid hormones production and peripheral downstream signaling effects; Osteoblast differentiation and related diseases; Endochondral ossification with skeletal dysplasias; Kallmann syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; Macrophage-stimulating protein (MSP) signaling network map",30,0,103.3,49.3,129.1,98.2,63.6,99.5,117.4,115.1,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S451(98.2)]",0,"ENSG00000077782"
"997","UBA1",-0.115776873608273,6.60903927097941,-1.27144788619001,0.233541262812645,0.382286199508763,-6.19002158410253,"NONE",FALSE,"High","Master Protein","P22314","Ubiquitin-like modifier-activating enzyme 1 [OS=Homo sapiens]",0,54.924,6,4,4,4,4,1058,117.8,5.76,17.65,4,"protein metabolism;other metabolic processes;stress response","cytosol;mitochondrion;nucleus;other cell component","other molecular function","Pf00899, Pf09358, Pf10585, Pf16190, Pf16191","7317","hsa:7317; P22314; Q5JRR8; Q96E13","ENSG00000130985","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation","Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway",5,0,104.9,114,116.3,94.8,76.6,107.6,88.3,96.6,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S810(100)]",0,"ENSG00000130985"
"998","UBA6",0.33459391034105,6.46997769988461,1.27050323705201,0.23386331334947,0.382429786960256,-6.19114564472269,"NONE",FALSE,"High","Master Protein","A0AVT1","Ubiquitin-like modifier-activating enzyme 6 [OS=Homo sapiens]",0,23.225,2,1,2,3,1,1052,117.9,6.14,6.77,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;other cell component","other molecular function","Pf00899, Pf09358, Pf10585, Pf16190, Pf16191","55236","A0AVT1; A6N8M7; B2RAV3; hsa:55236; Q4W5K0; Q6UV21; Q86T78; Q86TC7; Q8N5T3; Q8N9E4; Q9H3T7; Q9NVC9","ENSG00000033178","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,40.3,44.1,38.5,110.7,166.4,90.8,95.5,188.7,181.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000033178"
"999","SFSWAP",0.118166766250034,6.67250795621468,1.26892765137121,0.234401276670345,0.382925809335338,-6.19301915330859,"NONE",FALSE,"High","Master Protein","Q12872","Splicing factor, suppressor of white-apricot homolog [OS=Homo sapiens]",0,30.828,2,2,2,3,2,951,104.8,8.05,12.39,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf01805, Pf09750","6433","B2RN45; B7ZM97; F5H6B8; hsa:6433; Q12872; Q6PJF7","ENSG00000061936",NA,"mRNA processing",1,0,83.6,73,83.4,117.2,96,112.6,116.3,121.7,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S909(100)]",0,"ENSG00000061936"
"1000","TCEAL5",-0.244966864037476,6.60729520424627,-1.26220041946388,0.236709666803835,0.386177879633368,-6.20099982639915,"NONE",FALSE,"High","Master Protein","Q5H9L2","Transcription elongation factor A protein-like 5 [OS=Homo sapiens]",0,10.342,8,1,1,2,1,206,23.3,4.81,6.58,1,NA,"nucleus",NA,"Pf04538","340543","A2RUJ4; hsa:340543; Q5H9L2","ENSG00000204065",NA,NA,0,0,65.1,69.1,67.9,133.4,185.3,90.3,117.7,101.3,106.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(100)]",0,"ENSG00000204065"
"1001","GNB2",-0.126920939796666,6.61233768490345,-1.26117146256318,0.237064385510415,0.386177879633368,-6.20221783924319,"NONE",FALSE,"High","Master Protein","P62879","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [OS=Homo sapiens]",0,45.508,14,4,4,7,2,340,37.3,6,21.23,4,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00400","2783","B3KPU1; hsa:2783; P11016; P54312; P62879","ENSG00000172354","G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells",36,2,113.7,109,109.2,100.7,72.6,109.7,95.3,87.1,92.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T31(99.4)]",0,"ENSG00000172354"
"1002","C1orf198",-0.142105221738614,6.68302674642102,-1.26050534857873,0.237294251735972,0.386177879633368,-6.20300596447153,"NONE",FALSE,"High","Master Protein","Q9H425","Uncharacterized protein C1orf198 [OS=Homo sapiens]",0,23.878,10,4,4,6,4,327,36.3,5.72,16.81,4,NA,"cytosol",NA,"Pf15797","84886","A8K8R8; B3KTW1; G5EA08; hsa:84886; Q9H425","ENSG00000119280",NA,NA,0,0,80.4,85.6,92.4,106,125.2,124.3,112.8,93.6,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(99.6); S289(100)]",0,"ENSG00000119280"
"1003","CTIF",-0.19850257854263,6.61611883818398,-1.25988898249394,0.237507113614442,0.386177879633368,-6.20373496505538,"NONE",FALSE,"High","Master Protein","O43310","CBP80/20-dependent translation initiation factor [OS=Homo sapiens]",0,15.2,5,1,1,1,1,598,67.5,6.54,4.36,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity","Pf02854","9811","B3KTR8; hsa:9811; O43310; Q8IVD5","ENSG00000134030; ENSG00000282825",NA,NA,0,0,86.9,100.4,69.5,95.6,131.4,119.9,89.8,102.8,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S292(99)]",0,"ENSG00000134030"
"1004","TUBB",-0.0855025673139282,6.56203301866643,-1.25969216604005,0.23757511712739,0.386177879633368,-6.20396769410077,"NONE",FALSE,"High","Master Protein","P07437","Tubulin beta chain [OS=Homo sapiens]",0,312.663,42,14,24,66,2,444,49.6,4.89,176.1,14,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00091, Pf03953","203068","hsa:203068; P05218; P07437; Q8WUC1; Q9CY33","ENSG00000183311; ENSG00000196230; ENSG00000224156; ENSG00000227739; ENSG00000229684; ENSG00000232421; ENSG00000232575; ENSG00000235067","Potential therapeutics for SARS; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Opioid receptor pathways; Alzheimer's disease; HDAC6 interactions in the central nervous system",15,4,117.3,113.8,115.6,87,75.7,94.4,89.5,85.8,86.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T55(100); S75(100); S172(100); T285(100); T312(100)]",0,"ENSG00000196230"
"1005","KRT78",-0.418696728955425,6.50279156731857,-1.2583447860267,0.238041089559408,0.386550306627815,-6.20556023026502,"NONE",FALSE,"High","Master Protein","Q8N1N4","Keratin, type II cytoskeletal 78 [OS=Homo sapiens]",0,4.474,3,2,2,6,1,520,56.8,6.02,9.35,2,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton","bone, tooth or skin structural activity","Pf00038, Pf16208","196374","A8K4D6; hsa:196374; Q5HYM7; Q7RTT2; Q8N1N4","ENSG00000170423","Formation of the cornified envelope",NA,2,0,71.5,66.2,64.2,107.5,62.2,274.8,83.4,109.7,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S4(98.7)]",0,"ENSG00000170423"
"1006","ADAM22",0.103543925574788,6.65088277570627,1.25512346663423,0.239158176304335,0.38797827408417,-6.2093627346236,"NONE",FALSE,"High","Master Protein","Q9P0K1","Disintegrin and metalloproteinase domain-containing protein 22 [OS=Homo sapiens]",0,21.785,3,2,2,6,2,906,100.4,7.2,19.49,2,"cell adhesion;protein metabolism;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00200, Pf01421, Pf01562, Pf07974, Pf08516","53616","hsa:53616; O75075; O75076; Q9P0K1; Q9P0K2; Q9UIA1; Q9UKK2","ENSG00000008277","LGI-ADAM interactions",NA,1,0,67.2,68.1,64.4,120.7,122.1,115.5,128.7,126.7,122,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S834(100); S857(100)]",0,"ENSG00000008277"
"1007","MEX3D",-0.13543587623425,6.53629670005386,-1.25186535680483,0.240292387078866,0.389431157609443,-6.21320157399498,"NONE",FALSE,"High","Master Protein","Q86XN8","RNA-binding protein MEX3D [OS=Homo sapiens]",0,7.336,2,1,1,2,1,651,64.8,5.35,2.98,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","399664","A0PJL8; A1L023; E9PAL6; hsa:399664; Q71M49; Q86XN8","ENSG00000181588",NA,NA,0,0,120.7,113.9,121.1,85,66.3,100.6,76.1,85,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(99.4)]",0,"ENSG00000181588"
"1008","PGBD5",-0.148554478236026,6.62858014374796,-1.25117526426134,0.240533185889638,0.389434681916557,-6.21401375233857,"NONE",FALSE,"High","Master Protein","Q8N414","PiggyBac transposable element-derived protein 5 [OS=Homo sapiens]",0,10.214,2,1,1,2,1,524,58.4,8.85,6.47,1,"DNA metabolism;other metabolic processes","nucleus","other molecular function","Pf13843","79605","A0A0A0MS21; A0PJF3; B4DM72; B7Z9K3; B9EK58; hsa:79605; Q5SR37; Q6PJN2; Q8N414; U3REJ1","ENSG00000177614",NA,"Clear cell renal cell carcinoma pathways",1,0,98.9,115.4,100.9,99.3,84.4,115.3,82.4,99.6,103.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100)]",0,"ENSG00000177614"
"1009","EIF4G2",0.136339271142659,6.66423514695705,1.24817956563698,0.241580786030794,0.390743154412542,-6.21753570325504,"NONE",FALSE,"High","Master Protein","P78344","Eukaryotic translation initiation factor 4 gamma 2 [OS=Homo sapiens]",0,35.629,2,2,4,6,2,907,102.3,7.14,21.61,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity","Pf02020, Pf02847, Pf02854","1982","hsa:1982; O60877; P78344; P78404; Q0VH00; Q0VH01; Q2NKW9; Q49A79; Q53EU1; Q58EZ2; Q8NI71; Q96C16","ENSG00000110321","ISG15 antiviral mechanism","VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation; Acute viral myocarditis",4,0,105.1,110.1,98.8,99,75.2,104.5,108.1,114.5,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S395(99.5); T508(100)]",0,"ENSG00000110321"
"1010","SATB2",0.132115790910368,6.57038510989516,1.24702428526513,0.241985784861708,0.391010693954759,-6.21889231177849,"NONE",FALSE,"High","Master Protein","Q9UPW6","DNA-binding protein SATB2 [OS=Homo sapiens]",0,23.75,3,1,2,2,1,733,82.5,6.9,6.84,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf02376, Pf16534, Pf16557","23314","A8K5Z8; hsa:23314; Q3ZB87; Q4V763; Q9UPW6","ENSG00000119042","SUMOylation of chromatin organization proteins; RUNX2 regulates osteoblast differentiation","Rett syndrome; Transcription co-factors SKI and SKIL protein partners",4,0,130.7,113.4,122.4,75,88.1,72,89.5,89.8,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S594(99.3)]",0,"ENSG00000119042"
"1011","WDTC1",0.149310029173844,6.50468097207433,1.24079193742628,0.244180195947784,0.394166251025502,-6.22619517018823,"NONE",FALSE,"High","Master Protein","Q8N5D0","WD and tetratricopeptide repeats protein 1 [OS=Homo sapiens]",0.003,2.216,2,1,1,1,1,677,75.9,7.27,2.58,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00400","23038","D3DPL5; hsa:23038; Q5SSC5; Q8N5D0; Q9NV87; Q9UPW4","ENSG00000142784","Neddylation",NA,1,0,139.7,139.7,125.2,61.5,72.4,66.2,88.9,73.7,90.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S511(100)]",0,"ENSG00000142784"
"1012","PCBP2",-0.238010179187145,6.52579939271976,-1.23666130092692,0.245643520248987,0.396007297464031,-6.2310207791256,"NONE",FALSE,"High","Master Protein","Q15366","Poly(rC)-binding protein 2 [OS=Homo sapiens]",0,45.655,10,3,3,6,1,365,38.6,6.79,18.46,3,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013","5094","A8K7X6; B4DXP5; F8VYL7; G3V0E8; hsa:5094; I6L8F9; Q15366; Q32Q82; Q59HD4; Q68Y55; Q6IPF4; Q6PKG5","ENSG00000197111","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses","mRNA processing; Ferroptosis; Modulators of TCR signaling and T cell activation",7,0,123,125.5,116.4,91.3,53.2,114.9,83.4,92,65.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100)]",0,"ENSG00000197111"
"1013","PPP6R2",-0.245187103366756,6.61877871253096,-1.23620389440131,0.245806000202857,0.396007297464031,-6.23155442900316,"NONE",FALSE,"High","Master Protein","O75170","Serine/threonine-protein phosphatase 6 regulatory subunit 2 [OS=Homo sapiens]",0,10.553,2,1,1,1,1,966,104.9,4.87,3.08,1,NA,"cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf04499","9701","A6PVG3; B7Z7T3; hsa:9701; O75170; Q5U5P3; Q7Z2L2; Q7Z5G5; Q7Z731; Q9UGB9","ENSG00000100239",NA,NA,0,0,93,90,65.9,86.8,145,132,91.6,105.9,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S771(98.8)]",0,"ENSG00000100239"
"1014","GRK5",-0.210734978640838,6.67597008739273,-1.22751232371298,0.248910081296977,0.400279649462,-6.24166759961018,"NONE",FALSE,"High","Master Protein","P34947","G protein-coupled receptor kinase 5 [OS=Homo sapiens]",0,7.73,2,1,2,3,1,590,67.7,8.1,7.98,1,"cell-cell signaling;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00615","2869","D3DRD0; hsa:2869; P34947; Q5T059","ENSG00000198873","G alpha (q) signalling events; G alpha (s) signalling events","Myometrial relaxation and contraction pathways; Chemokine signaling pathway; Comprehensive IL-17A signaling; Calcium regulation in cardiac cells",6,0,79,65.5,70.9,134.5,93.3,151.2,112.7,124.4,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S484(99.6)]",0,"ENSG00000198873"
"1015","AHDC1",-0.181776346357387,6.66147806704415,-1.22740548698431,0.248948433948486,0.400279649462,-6.24179158876717,"NONE",FALSE,"High","Master Protein","Q5TGY3","Transcription factor Gibbin [OS=Homo sapiens]",0,34.041,4,3,3,3,3,1603,168.2,9.04,11.69,3,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15735","27245","hsa:27245; Q5TGY3; Q5TGY4; Q6PJK1; Q6ZUQ6; Q99769; Q9NUF5","ENSG00000126705",NA,"Mesodermal commitment pathway",1,0,94.7,88.4,110.3,114,79.7,126.2,106.3,101.1,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S896(100)]",0,"ENSG00000126705"
"1016","UBA52",-0.114963656090529,6.61423128718426,-1.22572494124961,0.249552354371975,0.400817036302886,-6.24374091157842,"NONE",FALSE,"High","Master Protein","P62987","Ubiquitin-ribosomal protein eL40 fusion protein [OS=Homo sapiens]",0,58.125,43,6,7,12,6,128,14.7,9.83,32.28,6,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00240, Pf01020","7311","hsa:7311; P02248; P02249; P02250; P14793; P62987; P62988; Q29120; Q6LBL4; Q6LDU5; Q8WYN8; Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8; Q9UPK7","ENSG00000221983","Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Circadian Clock; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Peroxisomal protein import; Downregulation of ERBB2:ERBB3 signaling; Regulation of signaling by CBL; Signaling by CSF1 (M-CSF) in myeloid cells; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Amyloid fiber formation; Fanconi Anemia Pathway; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; KEAP1-NFE2L2 pathway; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 HD Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; IKK complex recruitment mediated by RIP1; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; ER Quality Control Compartment (ERQC); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Oxidative Stress Induced Senescence; Regulation of TP53 Activity through Phosphorylation; Signaling by ALK fusions and activated point mutants; Metalloprotease DUBs; Regulation of necroptotic cell death; Oncogene Induced Senescence; Cyclin D associated events in G1; APC/C:Cdc20 mediated degradation of Cyclin B; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Negative regulation of FLT3; Cargo recognition for clathrin-mediated endocytosis; Interferon alpha/beta signaling; Inactivation of CSF3 (G-CSF) signaling; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Regulation of TP53 Activity through Methylation; Processing of DNA double-strand break ends; Regulation of BACH1 activity; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Prevention of phagosomal-lysosomal fusion; Downregulation of TGF-beta receptor signaling; HDR through Homologous Recombination (HRR); TICAM1-dependent activation of IRF3/IRF7; TICAM1,TRAF6-dependent induction of TAK1 complex; Glycogen synthesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Modulation by Mtb of host immune system; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; SARS-CoV-1 activates/modulates innate immune responses; Alpha-protein kinase 1 signaling pathway; Ovarian tumor domain proteases; Spry regulation of FGF signaling; RAS processing; PINK1-PRKN Mediated Mitophagy; Josephin domain DUBs; Regulation of FZD by ubiquitination; Chaperone Mediated Autophagy; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; InlA-mediated entry of Listeria monocytogenes into host cells; Formation of Incision Complex in GG-NER; Iron uptake and transport; Recognition of DNA damage by PCNA-containing replication complex; VLDLR internalisation and degradation; Myoclonic epilepsy of Lafora; Evasion by RSV of host interferon responses; DNA Damage Recognition in GG-NER; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Negative regulation of MAPK pathway; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); NRIF signals cell death from the nucleus; Assembly Of The HIV Virion; Dual Incision in GG-NER; Translesion Synthesis by POLH; Downregulation of ERBB4 signaling; Regulation of innate immune responses to cytosolic DNA; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; Gap-filling DNA repair synthesis and ligation in GG-NER; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; Regulation of PTEN localization; Pexophagy; Maturation of protein E; Maturation of protein E; FLT3 signaling by CBL mutants; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","DNA replication; Cytoplasmic ribosomal proteins",199,0,114.2,113.7,112.9,98,73.3,106.6,93.6,94.5,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S65(99.5)]",0,"ENSG00000221983"
"1017","FMNL2",0.219704796035665,6.58404861565138,1.22510940231034,0.249773851666688,0.400817036302886,-6.24445441084945,"NONE",FALSE,"High","Master Protein","Q96PY5","Formin-like protein 2 [OS=Homo sapiens]",0,10.222,2,2,2,5,2,1086,123.2,7.4,12.65,2,"cell organization and biogenesis;other biological processes","cytosol","cytoskeletal activity;other molecular function","Pf02181, Pf06367, Pf06371","114793","B2RZH5; hsa:114793; Q14CC9; Q4ZG52; Q8N3E0; Q96PY5","ENSG00000157827","CDC42 GTPase cycle; RHOC GTPase cycle; RHO GTPases Activate Formins","Epithelial to mesenchymal transition in colorectal cancer",4,0,108.3,127.8,101.9,78.5,89.7,72.8,102.2,78,122.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); S190(100)]",0,"ENSG00000157827"
"1018","PJA2",0.1838011737929,6.61165266092132,1.22362476816014,0.250308743253265,0.401280814331364,-6.24617424589591,"NONE",FALSE,"High","Master Protein","O43164","E3 ubiquitin-protein ligase Praja-2 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,708,78.2,4.39,10.36,1,"protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf13639","9867","A8K6U4; D3DSZ5; O43164; Q68D49; Q8N1G5","ENSG00000198961","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,65.2,65.9,67.3,102,134.5,107.7,99.7,133.3,158,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100)]",0,"ENSG00000198961"
"1019","RPL13",0.0941946369355318,6.40583791220975,1.22241733139037,0.250744449669653,0.401584830089179,-6.24757185035502,"NONE",FALSE,"High","Master Protein","P26373","Large ribosomal subunit protein eL13 [OS=Homo sapiens]",0,21.574,15,4,5,6,4,211,24.2,11.65,10.69,4,"protein metabolism;other metabolic processes;developmental processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01294","6137","B4DLX3; F5H1S2; hsa:6137; P26373; Q3KQT8; Q567Q8; Q9BPX0","ENSG00000167526","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,159.9,147.5,137.7,60.2,46.4,63.5,70.1,75,75.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000167526"
"1020","FNBP1L",-0.107256600063217,6.68592960537726,-1.2170135981573,0.252701938866438,0.404323102186301,-6.25381433598409,"NONE",FALSE,"High","Master Protein","Q5T0N5","Formin-binding protein 1-like [OS=Homo sapiens]",0,12.619,2,1,1,5,1,605,70,6.64,16.12,1,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00018, Pf00611","54874","hsa:54874; J3QSS4; Q5T0N5; Q5T0N6; Q6B097; Q6P653; Q6R4Q4; Q9NXG1","ENSG00000137942","CDC42 GTPase cycle; RHOJ GTPase cycle; Clathrin-mediated endocytosis",NA,3,0,78,80.5,88.4,127.1,111.1,115.7,109.2,113.8,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000137942"
"1021","POGZ",-0.103349922353765,6.46250767957553,-1.21548833290759,0.253256696263723,0.404813837710476,-6.25557269674035,"NONE",FALSE,"High","Master Protein","Q7Z3K3","Pogo transposable element with ZNF domain [OS=Homo sapiens]",0,55.568,4,3,6,10,3,1410,155.2,7.4,28.94,3,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03184, Pf03221","23126","B4DTP8; B4DYL9; B7ZBY5; E9PM80; hsa:23126; O75049; Q3LIC4; Q5SZS1; Q5SZS2; Q5SZS3; Q5SZS4; Q7Z3K3; Q8TDZ7; Q9Y4X7","ENSG00000143442",NA,NA,0,0,142.1,142.2,140.6,69.5,66.5,68,80.2,70.8,70,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S425(100); S1364(100); T1368(99.4)]",0,"ENSG00000143442"
"1022","H1-2",0.168626336801159,6.64903213319215,1.20836484431092,0.255860651134675,0.408575912575137,-6.26376345419432,"NONE",FALSE,"High","Master Protein","P16403","Histone H1.2 [OS=Homo sapiens]",0,105.113,42,10,11,19,2,213,21.4,10.93,46.51,10,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3006","A8K4I2; hsa:3006; P16403","ENSG00000187837","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)",NA,2,0,85.5,81.2,112.2,89.1,102.6,103.8,99,128.1,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2(100); T4(100); S104(100); S113(100); T146(100)]; Met-loss [N-Term]",0,"ENSG00000187837"
"1023","GYS1",-0.177941823348099,6.65007451401959,-1.20764300937222,0.256125716379244,0.408599383314688,-6.26459146897396,"NONE",FALSE,"High","Master Protein","P13807","Glycogen [starch] synthase, muscle [OS=Homo sapiens]",0,27.12,7,3,3,5,3,737,83.7,6.18,13.82,3,"other metabolic processes;developmental processes","cytosol;other cell component","other molecular function","Pf05693","2997","hsa:2997; P13807; Q9BTT9","ENSG00000104812","Glycogen synthesis; Myoclonic epilepsy of Lafora; Glycogen storage disease type XV (GYG1); Glycogen storage disease type 0 (muscle GYS1)","AMP-activated protein kinase signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Insulin signaling; Glycogen synthesis and degradation; Disorders of galactose metabolism ; 2q37 copy number variation syndrome",12,0,84.2,87,101.9,104.9,91.7,132.1,85.5,107.7,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S641(100); S698(100); S727(100)]",0,"ENSG00000104812"
"1024","PGM1",-0.121543885053408,6.61187954478252,-1.2063669995421,0.256594822443193,0.408947998268839,-6.26605428812426,"NONE",FALSE,"High","Master Protein","P36871","Phosphoglucomutase-1 [OS=Homo sapiens]",0,23.694,8,3,3,3,3,562,61.4,6.76,9.73,3,"other metabolic processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf02878, Pf02879, Pf02880","5236","B2R5N9; B4DPV0; hsa:5236; P36871; Q16105; Q16106; Q5BKZ9; Q6NW22; Q86U74; Q96J40; Q9NTY4","ENSG00000079739","Neutrophil degranulation; Glycogen synthesis; Glycogen breakdown (glycogenolysis); Galactose catabolism; Defective PGM1 causes PGM1-CDG","Ectoderm differentiation; Clear cell renal cell carcinoma pathways; Glycogen synthesis and degradation; Opioid receptor pathways; Disorders of galactose metabolism ; Disorders of fructose metabolism; UDP-derived sugars synthesis in fibroblasts; Glucuronidation",13,0,114.1,123.8,104.7,90.1,85.6,104,82.2,94,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(99.3); S505(100)]",0,"ENSG00000079739"
"1025","PLIN3",0.123775543163344,6.66900612059656,1.205552360144,0.256894674857383,0.40902644816317,-6.26698759796966,"NONE",FALSE,"High","Master Protein","O60664","Perilipin-3 [OS=Homo sapiens]",0,39.009,7,2,3,5,2,434,47,5.44,19.2,2,"cell organization and biogenesis;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf03036","10226","A8K4Y9; hsa:10226; K7EQF4; O60664; Q53G77; Q9BS03; Q9UBD7; Q9UP92","ENSG00000105355","Late endosomal microautophagy; Triglyceride catabolism; Retrograde transport at the Trans-Golgi-Network; RHOBTB3 ATPase cycle; Lipophagy; Chaperone Mediated Autophagy",NA,6,0,80.4,78.6,77.7,110.6,99.8,118.4,105.3,135.3,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100); S217(99.5)]",0,"ENSG00000105355"
"1026","ZMYM4",0.195171183019065,6.60467889338525,1.20339984068355,0.257688333919964,0.409890215358071,-6.26945145124093,"NONE",FALSE,"High","Master Protein","Q5VZL5","Zinc finger MYM-type protein 4 [OS=Homo sapiens]",0,37.97,4,4,4,8,4,1548,172.7,6.84,13.11,4,"cell organization and biogenesis;other biological processes",NA,"nucleic acid binding activity;other molecular function","Pf06467, Pf12012","9202","A0JP19; A0JP20; hsa:9202; O43308; Q5T5E1; Q5T5E2; Q5VZL5; Q7L3Q4","ENSG00000146463",NA,NA,0,0,108.5,107.2,115.3,87.8,74.3,85.4,79.2,128.4,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100); S1071(99.5); S1256(100)]",0,"ENSG00000146463"
"1027","SNRNP200",-0.173226790340306,6.4945286517797,-1.20240948215424,0.258054153857804,0.410072423657191,-6.27058396494858,"NONE",FALSE,"High","Master Protein","O75643","U5 small nuclear ribonucleoprotein 200 kDa helicase [OS=Homo sapiens]",0,22.926,2,2,2,2,2,2136,244.4,6.06,5.98,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271, Pf02889, Pf18149, Pf21188","23020","hsa:23020; O75643; O94884; Q6NZY0; Q6PX59; Q8NBE6; Q96IF2; Q9H7S0","ENSG00000144028","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","2q11.2 copy number variation syndrome",3,0,135,121.6,129.2,84.9,52.4,98,79.4,85.1,68.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100)]",0,"ENSG00000144028"
"1028","DACT3",0.0928927329331559,6.64384361305198,1.19820057397427,0.259613514642001,0.411838568342027,-6.27538935822428,"NONE",FALSE,"High","Master Protein","Q96B18","Dapper homolog 3 [OS=Homo sapiens]",0,19.15,5,3,3,4,3,629,64.9,10.36,11.59,3,"cell-cell signaling;signal transduction;other biological processes","other cell component","other molecular function","Pf15268","147906","hsa:147906; Q96B18","ENSG00000197380",NA,NA,0,0,84,87.6,90.7,98,111.3,101.5,110.6,105.7,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S426(100); S505(100)]",0,"ENSG00000197380"
"1029","PACS2",-0.149968205414678,6.64771932277289,-1.19804775819206,0.259670273789182,0.411838568342027,-6.27556359745238,"NONE",FALSE,"High","Master Protein","Q86VP3","Phosphofurin acidic cluster sorting protein 2 [OS=Homo sapiens]",0,66.136,7,4,4,7,4,889,97.6,6.6,28.59,4,"cell organization and biogenesis;other metabolic processes;other biological processes","mitochondrion;ER/Golgi","other molecular function","Pf10254","23241","A2VDJ9; G8JLK3; hsa:23241; O60342; Q6P191; Q86VP3; Q96FL7","ENSG00000179364",NA,NA,0,0,79.7,76.8,80.9,121.5,142.7,99.1,99.7,105.3,120.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S366(100); S390(100)]",0,"ENSG00000179364"
"1030","LSM12",-0.274834756735917,6.64488947218556,-1.19670105933773,0.260170899088924,0.412231948847693,-6.27709838319968,"NONE",FALSE,"High","Master Protein","Q3MHD2","Protein LSM12 [OS=Homo sapiens]",0,22.576,7,1,1,3,1,195,21.7,7.74,11.27,1,NA,"other cell component","nucleic acid binding activity","Pf09793, Pf21166","124801","hsa:124801; Q3MHD2; Q86YB1; Q96NL5","ENSG00000161654",NA,NA,0,0,88.2,97.1,97.5,129.7,80.6,118.7,111.9,112.8,68.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T75(100)]",0,"ENSG00000161654"
"1031","KLF12",-0.356214494419213,6.57707730136008,-1.19253454469921,0.261724685370935,0.413406243514147,-6.28183874313971,"NONE",FALSE,"High","Master Protein","Q9Y4X4","Krueppel-like factor 12 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,402,44.2,9.7,8.51,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","11278","A8K5T2; hsa:11278; L0R3J4; Q5VZM7; Q9UHZ0; Q9Y4X4","ENSG00000118922",NA,NA,0,0,103.2,96.6,94.4,113.9,107.6,96.9,56.9,115.6,111.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000118922"
"1032","RETREG3",-0.128559440438385,6.62742514132492,-1.19228158619445,0.261819258707088,0.413406243514147,-6.2821261477055,"NONE",FALSE,"High","Master Protein","Q86VR2","Reticulophagy regulator 3 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,466,51.4,4.97,11.03,1,"cell organization and biogenesis;other metabolic processes;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function",NA,"162427","B3KR75; hsa:162427; Q86VR2","ENSG00000141699",NA,NA,0,0,69.5,72.3,75.9,112.5,136.4,119.1,105.8,99.5,131.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000141699"
"1033","CLTC",-0.228171761401445,6.66958718492031,-1.19212422441653,0.261878105235066,0.413406243514147,-6.28230491512715,"NONE",FALSE,"High","Master Protein","Q00610","Clathrin heavy chain 1 [OS=Homo sapiens]",0,41.93,3,4,4,7,4,1675,191.5,5.69,16.52,4,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00637, Pf01394, Pf09268, Pf13838","1213","D3DU00; hsa:1213; Q00610; Q6N0A0; Q86TF2","ENSG00000141367","ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Recycling pathway of L1; MHC class II antigen presentation; RHOV GTPase cycle; Lysosome Vesicle Biogenesis; RHOU GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Retrograde neurotrophin signalling; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation; Entry of Influenza Virion into Host Cell via Endocytosis; Formation of annular gap junctions","Synaptic vesicle pathway; VEGFA-VEGFR2 signaling; Dengue-2 interactions with complement and coagulation cascades; Ebola virus infection in host; Fragile X syndrome; 7q11.23 copy number variation syndrome; Complement and coagulation cascades",25,0,88.1,89.6,93.3,111.6,79.3,152.9,85.3,110.2,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T394(100)]",0,"ENSG00000141367"
"1034","RBM12B",-0.121468818728709,6.51492143555478,-1.19066665915557,0.262423676641076,0.413406243514147,-6.28395992082221,"NONE",FALSE,"High","Master Protein","Q8IXT5","RNA-binding protein 12B [OS=Homo sapiens]",0,30.173,4,4,4,9,4,1001,118,6.81,24.31,4,"other biological processes","nucleus;other cell component",NA,"Pf00076","389677","A8MYB5; hsa:389677; Q8IXT5","ENSG00000183808",NA,NA,0,0,134.7,125.4,120,73.1,68.2,95,74.5,85,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100); S254(100); S280(100); S591(100); S638(99.7)]",0,"ENSG00000183808"
"1035","NCKAP5L",-0.20925559212763,6.69523032136144,-1.19023602570334,0.262585038570117,0.413406243514147,-6.28444860076479,"NONE",FALSE,"High","Master Protein","Q9HCH0","Nck-associated protein 5-like [OS=Homo sapiens]",0,14.887,2,1,1,1,1,1334,139.4,8.06,3.79,1,"cell organization and biogenesis","cytoskeleton;other cell component",NA,"Pf15246","57701","hsa:57701; Q2TB26; Q71RH1; Q8N4W1; Q96HX2; Q9HCH0","ENSG00000167566",NA,NA,0,0,95.2,96.8,125.6,111.1,80,131.1,99.4,84.2,112.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S440(100)]",0,"ENSG00000167566"
"1036","OSBPL1A",0.102948656371479,6.60114668434074,1.19007356492184,0.262645934650803,0.413406243514147,-6.28463292617315,"NONE",FALSE,"High","Master Protein","Q9BXW6","Oxysterol-binding protein-related protein 1 [OS=Homo sapiens]",0,24.41,4,2,2,3,2,950,108.4,6.38,9.31,2,"other metabolic processes;transport","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf01237, Pf12796","114876","B7Z7D3; hsa:114876; Q9BXW6; Q9BZF5; Q9NW87","ENSG00000141447","MHC class II antigen presentation; Synthesis of bile acids and bile salts",NA,2,0,115,105,125.6,88.3,81.2,81.8,98.2,93.6,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S465(100); S499(100)]",0,"ENSG00000141447"
"1037","RNPC3",-0.15787570332585,6.58479753223425,-1.18996878145255,0.262685217232947,0.413406243514147,-6.28475180194339,"NONE",FALSE,"High","Master Protein","Q96LT9","RNA-binding region-containing protein 3 [OS=Homo sapiens]",0,6.435,6,2,2,3,2,517,58.5,7.72,2.51,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00076","55599","A8K1C9; D3DT74; hsa:55599; Q5TZ87; Q96FK7; Q96JI8; Q96LT9; Q9NSU7; Q9NXX2","ENSG00000185946","mRNA Splicing - Minor Pathway",NA,1,0,101.1,105.8,110.3,88.6,113.9,91.1,84.4,82.6,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(99.3); S108(100)]",0,"ENSG00000185946"
"1038","NSUN2",-0.105448732401863,6.40945430348914,-1.18501694971794,0.264547002854253,0.41593517211767,-6.29036075778834,"NONE",FALSE,"High","Master Protein","Q08J23","RNA cytosine C(5)-methyltransferase NSUN2 [OS=Homo sapiens]",0,52.822,7,2,3,11,2,767,86.4,6.77,48.26,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;cytoskeleton;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01189","54888","A8K529; B2RNR4; B3KP09; B4DQW2; G3V1R4; hsa:54888; Q08J23; Q9BVN4; Q9H858; Q9NXD9","ENSG00000037474","tRNA modification in the nucleus and cytosol",NA,1,0,143.8,141.3,146.9,65.5,53.8,68.6,66,77.2,68.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S456(100); S743(100)]",0,"ENSG00000037474"
"1039","SLC20A2",-0.114142896027099,6.52485676769562,-1.18334597490392,0.265177634620232,0.416525408758632,-6.29224956016376,"NONE",FALSE,"High","Master Protein","Q08357","Sodium-dependent phosphate transporter 2 [OS=Homo sapiens]",0,28.112,4,3,3,4,3,652,70.3,6.54,13.41,3,"transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf01384","6575","hsa:6575; Q08357","ENSG00000168575","Sodium-coupled phosphate cotransporters; Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)","Proximal tubule transport",3,0,131,126.5,129.4,77.2,86,74.3,85.3,77.7,78.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S256(100)]",0,"ENSG00000168575"
"1040","SRRT",-0.14386282584149,6.59755310215283,-1.1824240488942,0.265526087505496,0.416671706547087,-6.29329082056716,"NONE",FALSE,"High","Master Protein","Q9BXP5","Serrate RNA effector molecule homolog [OS=Homo sapiens]",0,57.325,5,4,5,19,4,876,100.6,5.96,48.72,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04959, Pf12066","51593","A4D2E5; A4D2E6; A6NK22; B4DJL4; B4DZA6; hsa:51593; O95808; Q32MI4; Q6NT74; Q8TDQ5; Q9BWP6; Q9BXP4; Q9BXP5; Q9Y4S4","ENSG00000087087","mRNA Splicing - Major Pathway; RNA polymerase II transcribes snRNA genes",NA,2,0,114.4,111.8,113.4,95.9,69.8,111.7,92.3,96.9,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); S74(100); T544(100)]",0,"ENSG00000087087"
"1041","SNX2",-0.265532189063335,6.63595486655665,-1.18137353225238,0.265923589233111,0.416894618278998,-6.29447658115254,"NONE",FALSE,"High","Master Protein","O60749","Sorting nexin-2 [OS=Homo sapiens]",0,13.322,5,1,1,2,1,519,58.4,5.12,7.3,1,"cell organization and biogenesis;transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00787, Pf03700, Pf09325","6643","B3KN44; B4DEK4; B7Z408; hsa:6643; O43650; O60749; P82862; Q53XK8; Q597H6; Q9BTS8","ENSG00000205302","Golgi Associated Vesicle Biogenesis",NA,1,0,97.8,105,64.7,119.6,77.4,141.1,89.9,106.7,102.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T104(100)]",0,"ENSG00000205302"
"1042","SET",-0.119751401277987,6.65341421079581,-1.17174659395314,0.269588488894097,0.422234562260237,-6.30530631817719,"NONE",FALSE,"High","Master Protein","Q01105","Protein SET [OS=Homo sapiens]",0,10.169,3,1,1,5,1,290,33.5,4.32,16.57,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00956","6418","A5A5H4; A6NGV1; B4DUE2; hsa:6418; Q01105; Q15541; Q5VXV1; Q5VXV2; Q6FHZ5","ENSG00000119335","HuR (ELAVL1) binds and stabilizes mRNA; Condensation of Prophase Chromosomes","Histone modifications; VEGFA-VEGFR2 signaling",4,0,67.6,74.9,77.7,130,128,110.9,113.7,107.7,117.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100)]",0,"ENSG00000119335"
"1043","WTAP",0.20481051552394,6.62672645174332,1.16989471705904,0.270298082856831,0.422940049110593,-6.30738198316892,"NONE",FALSE,"High","Master Protein","Q15007","Pre-mRNA-splicing regulator WTAP [OS=Homo sapiens]",0,15.2,5,1,1,1,1,396,44.2,5.19,4.52,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","other membranes;nucleus;other cell component","other molecular function","Pf17098","9589","hsa:9589; Q15007; Q5TCL8; Q5TCL9; Q96T28; Q9BYJ7; Q9H4E2","ENSG00000146457","Processing of Capped Intron-Containing Pre-mRNA",NA,1,0,73.5,100.1,92.9,97.6,116,81.6,106,97.4,143,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S306(100)]",0,"ENSG00000146457"
"1044","SEC62",0.158539580050304,6.56987138427057,1.16842700268217,0.270861531478045,0.423070810954334,-6.30902531752355,"NONE",FALSE,"High","Master Protein","Q99442","Translocation protein SEC62 [OS=Homo sapiens]",0,33.302,9,5,5,12,5,399,45.8,7.12,26.08,5,"transport;other biological processes","other membranes;ER/Golgi","other molecular function","Pf03839","7095","D3DNQ0; hsa:7095; O00682; O00729; Q99442","ENSG00000008952",NA,NA,0,0,118.9,124.6,122,90.5,57.5,83.2,102.4,97.3,79.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(100); T158(100); S309(100)]",0,"ENSG00000008952"
"1045","PRRC2A",0.100984769200898,6.66079838616145,1.16832657075725,0.270900120984852,0.423070810954334,-6.30913771023898,"NONE",FALSE,"High","Master Protein","P48634","Protein PRRC2A [OS=Homo sapiens]",0,71.096,5,6,7,12,6,2157,228.7,9.45,38.17,6,"other biological processes","plasma membrane;other membranes;cytosol;nucleus",NA,"Pf07001","7916","B0UX77; B0UZE9; B0UZL3; hsa:7916; O95875; P48634; Q05BK4; Q4LE37; Q5SQ29; Q5SQ30; Q5ST84; Q5STX6; Q5STX7; Q68DW9; Q6P9P7; Q6PIN1; Q8MGQ9; Q96QC6","ENSG00000204469; ENSG00000206427; ENSG00000225164; ENSG00000225748; ENSG00000226618; ENSG00000231370; ENSG00000231825",NA,NA,0,0,85,90.1,96.3,102.1,110.2,96.7,106.3,106.4,120.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(99.4); T610(100); T782(100); S1147(100); S1219(100); S1690(99.4)]",0,"ENSG00000204469"
"1046","ARPP19",-0.193287746414409,6.62351834455505,-1.16721938436618,0.271325831432027,0.423330551526834,-6.31037627593363,"NONE",FALSE,"High","Master Protein","P56211","cAMP-regulated phosphoprotein 19 [OS=Homo sapiens]",0,2.786,7,1,1,1,1,112,12.3,9.09,2.68,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf04667","10776","B2R497; hsa:10776; P56211; Q6IAM2; Q86TA6; Q9UD70","ENSG00000128989","MASTL Facilitates Mitotic Progression",NA,1,0,62,54,64.2,138.4,126.1,130.6,98,159,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S104(100)]",0,"ENSG00000128989"
"1047","YWHAE",-0.107090142970008,6.67841882186831,-1.16496515127519,0.272194223930701,0.424279821828943,-6.31289527829037,"NONE",FALSE,"High","Master Protein","P62258","14-3-3 protein epsilon [OS=Homo sapiens]",0,132.739,43,11,13,19,8,255,29.2,4.74,54.85,11,"stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cell component","other molecular function","Pf00244","7531","B3KY71; D3DTH5; hsa:7531; P29360; P42655; P62258; Q4VJB6; Q53XZ5; Q63631; Q7M4R4","ENSG00000108953; ENSG00000274474","Regulation of HSF1-mediated heat shock response; RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; HSF1 activation; NADE modulates death signalling; Activation of BAD and translocation to mitochondria","Cell cycle; Myometrial relaxation and contraction pathways; VEGFA-VEGFR2 signaling; Calcium regulation in cardiac cells; 17p13.3 (YWHAE) copy number variation; Sudden infant death syndrome (SIDS) susceptibility pathways",26,4,86,82.8,87.6,123.3,111.6,110.3,110.2,112.5,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S210(99.4)]",0,"ENSG00000108953"
"1048","BCLAF1",-0.155440667879597,6.5552509611783,-1.16208738118082,0.273306030210452,0.42560633712162,-6.31610574699449,"NONE",FALSE,"High","Master Protein","Q9NYF8","Bcl-2-associated transcription factor 1 [OS=Homo sapiens]",0,368.127,19,28,32,107,28,920,106.1,9.98,298.68,28,"stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15440","9774","A2RU75; B7ZM58; E1P586; hsa:9774; Q14673; Q86WU6; Q86WY0; Q9NYF8","ENSG00000029363",NA,"Interactome of polycomb repressive complex 2 (PRC2)",1,0,118.8,118.8,116.9,86.2,108.2,74,91.3,77.3,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100); S177(100); S183(99.6); S222(100); S285(100); S290(100); S397(100); S496(100); S512(100); S531(100); S648(100); S658(100); S690(100); S884(99.5)]",0,"ENSG00000029363"
"1049","ZC3H7A",0.112566761955377,6.6712570787594,1.1599998773568,0.274114778255228,0.426458835188305,-6.31843085533793,"NONE",FALSE,"High","Master Protein","Q8IWR0","Zinc finger CCCH domain-containing protein 7A [OS=Homo sapiens]",0,15.2,2,1,1,1,1,971,110.5,7.3,4.99,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00642","29066","D3DUG5; hsa:29066; Q8IWR0; Q9NPE9","ENSG00000122299",NA,NA,0,0,108.9,96,88.3,103.1,89.5,102.5,106.6,117,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T210(100)]",0,"ENSG00000122299"
"1050","CMIP",-0.206813495258054,6.60018323909214,-1.158902988841,0.27454049949281,0.426714376354538,-6.31965133493874,"NONE",FALSE,"High","Master Protein","Q8IY22","C-Maf-inducing protein [OS=Homo sapiens]",0,14.896,2,1,1,1,1,773,86.3,6.7,3.99,1,"developmental processes","cytosol;nucleus",NA,NA,"80790","hsa:80790; Q8IY22; Q9C0G9","ENSG00000153815",NA,NA,0,0,92.8,164.6,124.4,86.9,76.5,105.8,79.6,92.3,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S377(100)]",0,"ENSG00000153815"
"1051","GLYR1",0.225528923504049,6.58145655586573,1.15806563363514,0.274865844427298,0.426813566227736,-6.32058245401749,"NONE",FALSE,"High","Master Protein","Q49A26","Cytokine-like nuclear factor N-PAC [OS=Homo sapiens]",0,11.694,5,2,2,3,2,553,60.5,9.17,6.63,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00855, Pf03446, Pf14833","84656","B4DL47; C9JJ40; C9JJ60; hsa:84656; Q49A26; Q5U632; Q6P1Q2; Q6V3W7; Q9BTI1; Q9BXK2","ENSG00000140632",NA,NA,0,0,56.5,47.8,46.7,104.9,101.7,168,120.8,154,161.3,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S5(100)]",0,"ENSG00000140632"
"1052","NRBP1",0.101687709247122,6.58750754757056,1.15629416504058,0.275555136490088,0.427477169916182,-6.32255061573337,"NONE",FALSE,"High","Master Protein","Q9UHY1","Nuclear receptor-binding protein [OS=Homo sapiens]",0,10.526,2,1,1,1,1,535,59.8,5.08,3.68,1,"transport","other membranes;nucleus;other cell component","kinase activity;other molecular function","Pf07714","29959","B3KV40; D6W558; hsa:29959; Q53FZ5; Q96SU3; Q9UHY1","ENSG00000115216","Nuclear Receptor transcription pathway",NA,1,0,135.9,105.8,117.1,81.6,72.6,89.4,88,95.6,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T433(100)]",0,"ENSG00000115216"
"1053","YWHAZ",-0.0835562671223835,6.67314529593922,-1.1551280721922,0.276009619692436,0.42748808719256,-6.32384494608518,"NONE",FALSE,"High","Master Protein","P63104","14-3-3 protein zeta/delta [OS=Homo sapiens]",0,135.574,50,10,11,18,6,245,27.7,4.79,56.6,10,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00244","7534","A8K1N0; B7Z465; hsa:7534; P29213; P29312; P63104; Q32P43; Q5XJ08; Q6GPI2; Q6IN74; Q6NUR9; Q6P3U9; Q86V33","ENSG00000164924","Deactivation of the beta-catenin transactivating complex; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Negative regulation of NOTCH4 signaling; Interleukin-3, Interleukin-5 and GM-CSF signaling; TP53 Regulates Metabolic Genes; NOTCH4 Activation and Transmission of Signal to the Nucleus; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; KSRP (KHSRP) binds and destabilizes mRNA; GP1b-IX-V activation signalling; Activation of BAD and translocation to mitochondria","Cell cycle; Prolactin signaling pathway; Pathogenic Escherichia coli infection; Myometrial relaxation and contraction pathways; Hepatitis B infection; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",23,1,76.7,78.5,79.1,123.9,116,116.8,109.1,114.2,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000164924"
"1054","SSB",0.142070292330549,6.65094633934927,1.15493210402396,0.276086056311862,0.42748808719256,-6.32406236868644,"NONE",FALSE,"High","Master Protein","P05455","Lupus La protein [OS=Homo sapiens]",0,26.345,5,1,1,5,1,408,46.8,7.12,20.99,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf05383, Pf08777","6741","hsa:6741; P05455; Q15367; Q53XJ4","ENSG00000138385","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,91.1,97.2,98.3,102.2,77,106.1,102,128.7,98.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S366(100)]",0,"ENSG00000138385"
"1055","ATP2B4",-0.208040399980495,6.6435722933876,-1.15399273933939,0.276452684767079,0.427650029895614,-6.32510418818657,"NONE",FALSE,"High","Master Protein","P23634","Plasma membrane calcium-transporting ATPase 4 [OS=Homo sapiens]",0,45.601,3,2,2,4,1,1241,137.8,6.6,18.29,2,"stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;enzyme regulator activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","493","B1APW5; B1APW6; hsa:493; P23634; Q13450; Q13452; Q13455; Q16817; Q7Z3S1","ENSG00000058668","Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D-sensitive calcium signaling in depression",4,0,98.2,96.8,100.7,114.9,66.6,135.3,103.2,98.1,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(100)]",0,"ENSG00000058668"
"1056","ZNF609",0.0890217648195151,6.65031122372044,1.15216939705694,0.277165425105104,0.428346566071525,-6.32712457440529,"NONE",FALSE,"High","Master Protein","O15014","Zinc finger protein 609 [OS=Homo sapiens]",0,26.051,4,5,5,6,5,1411,151.1,8.03,15.46,5,"other biological processes","nucleus","other molecular function",NA,"23060","hsa:23060; O15014; Q0D2I2","ENSG00000180357",NA,NA,0,0,101.7,107.2,104.8,92.4,94.3,96.3,108.8,100,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); T746(100); S758(100); S1055(100); S1313(100)]",0,"ENSG00000180357"
"1057","VAPB",0.311784321940132,6.40722385373961,1.15067210187544,0.277751801479702,0.428444321099728,-6.32878187559041,"NONE",FALSE,"High","Master Protein","O95292","Vesicle-associated membrane protein-associated protein B/C [OS=Homo sapiens]",0,4.312,5,1,2,2,1,243,27.2,7.3,2.12,1,"cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00635","9217","A2A2F2; hsa:9217; O95292; O95293; Q9P0H0","ENSG00000124164","Sphingolipid de novo biosynthesis; RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RHOD GTPase cycle","Ciliary landscape",7,0,36,34.9,36.7,108.3,94.2,144.6,92.5,181.1,220.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100)]",0,"ENSG00000124164"
"1058","HNRNPH2",0.17738131607887,6.10764403431705,1.15066717476163,0.277753732673721,0.428444321099728,-6.32878732654623,"NONE",FALSE,"High","Master Protein","P55795","Heterogeneous nuclear ribonucleoprotein H2 [OS=Homo sapiens]",0,99.979,12,4,7,20,1,449,49.2,6.3,70.04,4,"other biological processes","cytosol;nucleus;other cell component",NA,"Pf00076, Pf08080","3188","A1L400; P55795; Q9HHA7","ENSG00000126945","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,169.2,177.8,161.7,40.2,25,37.1,59.7,48.4,63.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S104(100); S161(100)]",0,"ENSG00000126945"
"1059","SRRM1",-0.0880774296638407,6.5382138178302,-1.1492373173949,0.278314617672949,0.428904113354346,-6.33036845881649,"NONE",FALSE,"High","Master Protein","Q8IYB3","Serine/arginine repetitive matrix protein 1 [OS=Homo sapiens]",0,614.082,36,52,80,270,51,904,102.3,11.84,696.14,52,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf01480","10250","hsa:10250; O60585; Q5VVN4; Q8IYB3","ENSG00000133226","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",7,1,129.8,126.1,123,81.6,80.3,77.7,84.3,78.8,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100); S211(100); T220(100); S234(100); S260(100); S380(100); S389(100); S391(99.7); S393(100); S402(100); T406(100); S431(100); S450(100); S452(100); S463(100); S465(100); S551(100); S562(100); S583(100); S597(100); S605(100); S607(100); T614(100); S616(100); S626(100); S628(100); S636(100); S638(100); S646(100); S653(100); S675(100); S695(98.4); S696(99.5); S713(100); S715(100); S725(100); T727(100); S738(100); S740(100); S756(100); T846(100); S874(100); S901(100)]",0,"ENSG00000133226"
"1060","MGRN1",-0.253408553634317,6.57784463031325,-1.14774891643968,0.278899418387304,0.429090705837015,-6.33201275002018,"NONE",FALSE,"High","Master Protein","O60291","E3 ubiquitin-protein ligase MGRN1 [OS=Homo sapiens]",0,5.948,4,1,1,1,1,552,60.7,5.15,2.79,1,"protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13920","23295","A4URL3; A4URL4; O60291; Q86W76","ENSG00000102858","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,108.7,49.4,85.2,116.9,124.6,106.8,105.9,92.1,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(99.4)]",0,"ENSG00000102858"
"1061","STMN1",0.147503426103323,6.69092895780421,1.14759094435261,0.278961543439383,0.429090705837015,-6.33218717300736,"NONE",FALSE,"High","Master Protein","P16949","Stathmin [OS=Homo sapiens]",0,43.401,17,2,2,7,2,149,17.3,5.97,23.99,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf00836","3925","A2A2D1; B2R4E7; B7Z8N4; D3DPJ5; hsa:3925; P16949","ENSG00000117632","Nuclear signaling by ERBB4","Microtubule cytoskeleton regulation; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; IL-18 signaling pathway",7,0,84.3,83.4,75.1,117,113.2,100.9,104.5,143.1,121.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100); S38(100)]",0,"ENSG00000117632"
"1062","APRT",-0.0807656749512384,6.48540074811929,-1.14596743958707,0.279600646551501,0.429668790180838,-6.33397869375624,"NONE",FALSE,"High","Master Protein","P07741","Adenine phosphoribosyltransferase [OS=Homo sapiens]",0,10.816,9,2,2,3,2,180,19.6,6.02,7.88,2,"other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","other molecular function","Pf00156","353","G5E9J2; hsa:353; P07741; Q3KP55; Q68DF9","ENSG00000198931","Neutrophil degranulation; Purine salvage; Defective APRT disrupts adenine salvage",NA,3,0,142.1,129.2,128.3,74.7,69.9,72.2,78.3,76.1,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100)]",0,"ENSG00000198931"
"1063","SIN3A",0.189728967230859,6.56394226249983,1.14498578973615,0.279987640052604,0.429858728660254,-6.33506100291847,"NONE",FALSE,"High","Master Protein","Q96ST3","Paired amphipathic helix protein Sin3a [OS=Homo sapiens]",0,8.084,2,1,1,1,1,1273,145.1,7.25,3.45,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02671, Pf08295, Pf16879","25942","B2RNS5; Q8N8N4; Q8NC83; Q8WV18; Q96L98; Q96ST3; Q9UFQ1","ENSG00000169375","Cytoprotection by HMOX1; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; SUMOylation of transcription cofactors; NoRC negatively regulates rRNA expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of lipid metabolism by PPARalpha; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; MECP2 regulates neuronal receptors and channels; Loss of MECP2 binding ability to 5mC-DNA","Androgen receptor signaling pathway; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Transcription co-factors SKI and SKIL protein partners; Hedgehog signaling pathway; 15q11q13 copy number variation",19,0,97.8,136.9,127.2,88.5,81.8,61.1,85.2,93.4,103.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S832(100)]",0,"ENSG00000169375"
"1064","LAS1L",0.0786263607977471,6.52618128652136,1.14411890493761,0.280329741530359,0.429979453174385,-6.33601619486074,"NONE",FALSE,"High","Master Protein","Q9Y4W2","Ribosomal biogenesis protein LAS1L [OS=Homo sapiens]",0,43.736,6,2,2,3,2,734,83,4.73,14.31,2,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf04031","81887","A9X410; hsa:81887; Q5JXQ0; Q8TEN5; Q9H9V5; Q9Y4W2","ENSG00000001497","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,126.4,124.2,125.3,74,66,81.2,86.4,83.2,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S523(100); S617(100)]",0,"ENSG00000001497"
"1065","ZBTB44",0.107070222650351,6.65065730399082,1.14212080220905,0.281119515611848,0.430785961951677,-6.33821575045314,"NONE",FALSE,"High","Master Protein","Q8NCP5","Zinc finger and BTB domain-containing protein 44 [OS=Homo sapiens]",0,6.841,3,1,1,1,1,570,63.8,6.61,2.34,1,NA,"nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","29068","hsa:29068; Q6IPT8; Q86VJ7; Q86XX5; Q8NCP5","ENSG00000196323",NA,NA,0,0,116.5,109.3,99,91.5,92.6,93.8,94.3,101.4,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S161(100)]",0,"ENSG00000196323"
"1066","CCDC92",-0.11419935949923,6.61624479889211,-1.1403611017772,0.281816510758907,0.431448917034274,-6.34015045264455,"NONE",FALSE,"High","Master Protein","Q53HC0","Coiled-coil domain-containing protein 92 [OS=Homo sapiens]",0,4.671,5,1,1,1,1,331,36.9,8.9,2.76,1,"stress response;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf14916","80212","B3KNQ0; hsa:80212; Q53HC0; Q9H697","ENSG00000119242; ENSG00000275035",NA,NA,0,0,76.1,84.4,74.4,116.2,101.2,120.5,111.5,97.4,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(100)]",0,"ENSG00000119242"
"1067","G3BP2",-0.103823832514193,6.64764768510264,-1.13963764133274,0.282103459165364,0.43148345394365,-6.34094520429554,"NONE",FALSE,"High","Master Protein","Q9UN86-2","Isoform B of Ras GTPase-activating protein-binding protein 2 [OS=Homo sapiens]",0,45.601,4,1,3,8,1,449,50.8,5.38,40.38,1,NA,NA,NA,NA,NA,"Q9UN86-2",NA,NA,NA,0,0,93.9,95.3,101.6,111.4,92.5,107.2,97.3,109.5,93.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T227(99.2)]",0,"ENSG00000138757"
"1068","SCAF1",0.0739465604417155,6.61502619245347,1.13758520283433,0.28291877741237,0.432093808428956,-6.34319780905099,"NONE",FALSE,"High","Master Protein","Q9H7N4","Splicing factor, arginine/serine-rich 19 [OS=Homo sapiens]",0,52.513,6,6,9,17,6,1312,139.2,9.25,43.44,6,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function",NA,"58506","hsa:58506; Q7Z5V7; Q8WVA1; Q9H7N4; Q9NR59","ENSG00000126461",NA,NA,0,0,107.4,106.6,107.1,88.8,89,92.1,98,97.5,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100); S500(100); S719(100); S725(100); S734(99.6); S874(100); S965(99.7); T976(100)]",0,"ENSG00000126461"
"1069","ZNF326",0.145324199666375,6.48977438092955,1.13730046272776,0.283032035055486,0.432093808428956,-6.34351007501964,"NONE",FALSE,"High","Master Protein","Q5BKZ1","DBIRD complex subunit ZNF326 [OS=Homo sapiens]",0,3.826,2,2,2,4,2,582,65.6,5.15,4.42,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04988","284695","A8MYX1; B4DLN0; B4E179; hsa:284695; Q5BKZ1; Q5VW93; Q5VW94; Q5VW96; Q5VW97; Q6NSA2; Q7Z638; Q7Z6C2","ENSG00000162664",NA,NA,0,0,136.4,144.2,132.1,76.8,41.6,77.2,80.5,89.8,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000162664"
"1070","MPST",-0.0789016123324346,6.65514432395558,-1.13410399940824,0.284305904213056,0.433632930538044,-6.34701146035953,"NONE",FALSE,"High","Master Protein","P25325-2","Isoform 2 of 3-mercaptopyruvate sulfurtransferase [OS=Homo sapiens]",0,32.178,5,2,3,4,2,317,35.2,6.61,18.77,2,NA,NA,NA,NA,NA,"P25325-2",NA,NA,NA,0,0,77.7,77.9,82,115.8,110.7,119.9,109.6,106.5,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100)]",0,"ENSG00000128309"
"1071","SKP1",0.147924343878587,6.63895339577683,1.13189507518792,0.285188846312281,0.434366591075199,-6.34942671745984,"NONE",FALSE,"High","Master Protein","P63208","S-phase kinase-associated protein 1 [OS=Homo sapiens]",0.003,2.269,6,2,2,2,1,163,18.6,4.54,2.27,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf01466, Pf03931","6500","D3DQ97; D3DQ98; hsa:6500; P34991; P63208; Q8TAY2","ENSG00000113558","Regulation of PLK1 Activity at G2/M Transition; Circadian Clock; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; SCF-beta-TrCP mediated degradation of Emi1; Vpu mediated degradation of CD4; Degradation of beta-catenin by the destruction complex; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; NIK-->noncanonical NF-kB signaling; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SCF(Skp2)-mediated degradation of p27/p21; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cyclin D associated events in G1; Regulation of BACH1 activity; MAP3K8 (TPL2)-dependent MAPK1/3 activation; NOTCH1 Intracellular Domain Regulates Transcription; Prolactin receptor signaling; Iron uptake and transport; Nuclear events stimulated by ALK signaling in cancer; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling","Cell cycle; TNF-alpha signaling pathway; TGF-beta signaling pathway; Breast cancer pathway; Small cell lung cancer; Notch signaling pathway",39,0,60.7,80.7,77.2,116.3,121.5,96.9,121.8,111.5,133.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T131(100)]",0,"ENSG00000113558"
"1072","FUBP1",-0.12177694644646,6.5738008816195,-1.13156933640873,0.285319231392533,0.434366591075199,-6.3497825795259,"NONE",FALSE,"High","Master Protein","Q96AE4","Far upstream element-binding protein 1 [OS=Homo sapiens]",0,15.2,4,1,2,2,1,644,67.5,7.61,8.11,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00013, Pf09005","8880","hsa:8880; Q12828; Q96AE4","ENSG00000162613",NA,NA,0,0,105.8,117.7,112.3,91.8,98.5,83.6,79.4,89.7,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T629(99.3)]",0,"ENSG00000162613"
"1073","DENND4C",0.0926488710347408,6.64813482925962,1.13048278978954,0.285754487460161,0.43462378707827,-6.35096904183911,"NONE",FALSE,"High","Master Protein","Q5VZ89","DENN domain-containing protein 4C [OS=Homo sapiens]",0,22.322,2,2,3,4,2,1909,212.6,6.83,10.45,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity","Pf02141, Pf03455, Pf03456","55667","A2A3R1; A2A3R2; A2A3R3; A2A3R9; hsa:55667; Q5VZ89; Q6AI48; Q6ZUB3; Q8NCY7; Q9H6N4; Q9NUT1; Q9NWA5; Q9NWT3; R4GN35; R4GNB2","ENSG00000137145","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,69.6,63.7,68.3,115,133.9,113.1,117.5,127.1,134.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1126(99.3); S1325(100)]",0,"ENSG00000137145"
"1074","REPS1",0.167332600342903,6.69626979391406,1.12843737919827,0.286575266094607,0.435466326132588,-6.35320018321209,"NONE",FALSE,"High","Master Protein","Q96D71","RalBP1-associated Eps domain-containing protein 1 [OS=Homo sapiens]",0,47.936,9,3,7,10,3,796,86.6,5.69,21.8,3,"transport","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf12763","85021","B7ZBZ8; B7ZBZ9; B7ZC00; hsa:85021; J3KP76; Q5JWJ5; Q5JWJ6; Q5JWJ7; Q8NDR7; Q8WU62; Q96D71; Q9BXY9","ENSG00000135597","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,75,101.7,78.4,116.8,81.3,119.1,126.5,120.6,111.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S392(99.3); S540(98.6); S558(98.6); S736(100)]",0,"ENSG00000135597"
"1075","RNF20",-0.10680411041161,6.51643187000466,-1.12696294731393,0.287168070069448,0.435827699955537,-6.35480658556671,"NONE",FALSE,"High","Master Protein","Q5VTR2","E3 ubiquitin-protein ligase BRE1A [OS=Homo sapiens]",0,31.15,3,2,3,6,2,975,113.6,5.94,16.15,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00097","56254","A7MCT5; hsa:56254; Q2TB34; Q5VTR2; Q69YL5; Q6P527; Q8N3J4; Q96JD3; Q9H9Y7; Q9HA51; Q9NUR4; Q9NWQ3; Q9NX83","ENSG00000155827","E3 ubiquitin ligases ubiquitinate target proteins; RHOBTB1 GTPase cycle","ATM signaling in development and disease",3,0,130,137.3,125.7,73.3,76.7,80.8,73.5,80.3,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000155827"
"1076","IP6K1",-0.255556928914894,6.56851778049233,-1.12552098531213,0.287748749116368,0.435827699955537,-6.35637605959707,"NONE",FALSE,"High","Master Protein","Q92551","Inositol hexakisphosphate kinase 1 [OS=Homo sapiens]",0,4.179,2,1,1,2,1,441,50.2,7.24,2.76,1,"other metabolic processes;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf03770","9807","A8K157; A8MUX4; hsa:9807; Q7L3I7; Q92551; Q96E38","ENSG00000176095","Synthesis of pyrophosphates in the cytosol; Synthesis of IPs in the nucleus",NA,2,0,36.7,54.3,75.6,111.8,191.9,128.6,93,120.5,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(99.1)]",0,"ENSG00000176095"
"1077","FKBP3",-0.130672839429026,6.65574426586694,-1.12478028294823,0.288047388073784,0.435827699955537,-6.35718166469326,"NONE",FALSE,"High","Master Protein","Q00688","Peptidyl-prolyl cis-trans isomerase FKBP3 [OS=Homo sapiens]",0,6.959,6,1,1,1,1,224,25.2,9.28,3,1,NA,"nucleus","other molecular function","Pf00254, Pf18410","2287","B2R4Q9; hsa:2287; Q00688; Q14317","ENSG00000100442",NA,NA,0,0,72.2,64.1,68.8,133.1,136.2,113.4,113.3,128.3,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(99.7)]",0,"ENSG00000100442"
"1078","DOK1",0.180422038808411,6.66161304656327,1.12442363013567,0.288191271202031,0.435827699955537,-6.35756942391252,"NONE",FALSE,"High","Master Protein","Q99704","Docking protein 1 [OS=Homo sapiens]",0,10.95,2,1,1,1,1,481,52.4,6.47,4.04,1,"signal transduction;other biological processes","cytosol;nucleus;other cell component",NA,"Pf00169, Pf02174","1796","hsa:1796; O43204; Q53TY2; Q99704; Q9UHG6","ENSG00000115325","RET signaling; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1","Kit receptor signaling pathway; VEGFA-VEGFR2 signaling; GDNF signaling",5,0,76.3,72.8,78.5,119,81.9,119.4,115.9,156.6,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S269(100)]",0,"ENSG00000115325"
"1079","GSS",0.102597964066509,6.66651536864908,1.12437346514088,0.288211513597517,0.435827699955537,-6.35762395663296,"NONE",FALSE,"High","Master Protein","P48637","Glutathione synthetase [OS=Homo sapiens]",0,5.067,4,1,1,1,1,474,52.4,5.92,2.5,1,"other metabolic processes;stress response;developmental processes;other biological processes","cytosol","other molecular function","Pf03199, Pf03917","2937","B2R697; B6F210; E1P5P9; hsa:2937; P48637; Q4TTD9","ENSG00000100983","Glutathione synthesis and recycling; Defective GSS causes GSS deficiency","Glutathione metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Amino acid metabolism; One-carbon metabolism and related pathways; Ferroptosis; Metapathway biotransformation Phase I and II",8,0,100.9,90.8,98.8,93.2,94.1,111.7,103.4,117.3,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000100983"
"1080","PACSIN3",-0.0804403626355095,6.64401166390787,-1.12386837036404,0.288415389676458,0.435827699955537,-6.35817292488231,"NONE",FALSE,"High","Master Protein","Q9UKS6","Protein kinase C and casein kinase substrate in neurons protein 3 [OS=Homo sapiens]",0,60.801,15,4,4,6,4,424,48.5,6.18,28.46,4,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00611, Pf14604","29763","A6NH84; hsa:29763; Q9H331; Q9NWV9; Q9UKS6","ENSG00000165912","Clathrin-mediated endocytosis",NA,1,0,82.7,88.1,87.5,102.8,114.8,114.8,105.4,108.1,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S319(100); S354(100)]",0,"ENSG00000165912"
"1081","CHMP2A",0.15618973882319,6.63599770501456,1.12148746653226,0.289377937491711,0.436877700265007,-6.36075809568562,"NONE",FALSE,"High","Master Protein","O43633","Charged multivesicular body protein 2a [OS=Homo sapiens]",0,14.039,8,1,1,1,1,222,25.1,5.97,4.22,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf03357","27243","B2R4W6; hsa:27243; O43633; Q3ZTT0","ENSG00000130724","Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Lysosome Vesicle Biogenesis; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex",NA,10,0,79.8,103.7,115.7,90.3,74.2,112.6,99,109.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000130724"
"1082","SOX5",-0.112471877717385,6.55967084165977,-1.1205411173407,0.289761223579155,0.43705204887355,-6.36178446959946,"NONE",FALSE,"High","Master Protein","P35711","Transcription factor SOX-5 [OS=Homo sapiens]",0,32.038,3,3,3,3,3,763,84,6.6,10.85,3,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","6660","B7Z8V0; F5H5B0; hsa:6660; P35711; Q86UK8; Q8J017; Q8J018; Q8J019; Q8J020; Q8N1D9; Q8N7E0; Q8TEA4","ENSG00000134532",NA,"Neural crest differentiation; Male infertility; Endochondral ossification; Endochondral ossification with skeletal dysplasias",4,0,118.5,110.6,110.6,80.2,101.9,87.5,90.9,83.8,87.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T131(100); S382(100)]",0,"ENSG00000134532"
"1083","SYNRG",0.116161315122516,6.650932776911,1.11675305825019,0.29129942348385,0.438966444252671,-6.36588619927488,"NONE",FALSE,"High","Master Protein","Q9UMZ2","Synergin gamma [OS=Homo sapiens]",0,26.683,3,3,3,3,3,1314,140.6,5.03,11.11,3,"transport","other membranes;ER/Golgi;other cell component",NA,NA,"11276","A8MWU4; B7ZKZ2; B7ZKZ3; hsa:11276; Q17RI2; Q5BKU5; Q6ZT17; Q9UMZ2","ENSG00000274047; ENSG00000275066",NA,"17q12 copy number variation syndrome",1,0,94.6,110.6,91.3,89.9,110.6,94,106.5,104.3,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S752(100); S935(99.6); S1075(100)]",0,"ENSG00000275066"
"1084","GAPVD1",-0.0942378042422352,6.65315450987146,-1.11209660407097,0.293198979980736,0.441138616037781,-6.37091361217163,"NONE",FALSE,"High","Master Protein","Q14C86","GTPase-activating protein and VPS9 domain-containing protein 1 [OS=Homo sapiens]",0,62.249,4,4,4,8,4,1478,164.9,5.22,29.8,4,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00616, Pf02204, Pf18151","26130","A8MYK3; B0QZ62; B0QZ63; B0QZ64; hsa:26130; Q14C76; Q14C86; Q2Q1W1; Q8ND92; Q8WU86; Q96CZ4; Q9NXQ1; Q9P207; Q9Y4N0","ENSG00000165219","RAB GEFs exchange GTP for GDP on RABs; Clathrin-mediated endocytosis",NA,2,0,89.1,81.6,91.3,116.4,103.8,111.4,98,107.9,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S569(99.5); S902(100)]",0,"ENSG00000165219"
"1085","AKAP8L",0.112161912282582,6.64927184088494,1.11189486815435,0.293281494118255,0.441138616037781,-6.37113105437492,"NONE",FALSE,"High","Master Protein","Q9ULX6","A-kinase anchor protein 8-like [OS=Homo sapiens]",0,9.1,2,2,2,3,2,646,71.6,5.05,5.4,2,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04988","26993","B4DJ74; B5BU90; hsa:26993; O94792; Q96J58; Q9NRQ0; Q9UGM0; Q9ULX6","ENSG00000011243","Formation of WDR5-containing histone-modifying complexes",NA,1,0,95,88.9,108.6,91.6,110.3,93.6,106.9,103,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(100)]",0,"ENSG00000011243"
"1086","ZC3H13",-0.0714956645921934,6.63560934849363,-1.11052674399718,0.293841562879643,0.441574061343994,-6.37260489352445,"NONE",FALSE,"High","Master Protein","Q5T200","Zinc finger CCCH domain-containing protein 13 [OS=Homo sapiens]",0,113.728,9,18,20,37,18,1668,196.5,9.42,79.31,18,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf00642","23091","A2A323; hsa:23091; O94936; Q5T1Z9; Q5T200; Q7Z7J3; Q8NDT6; Q9H0L6","ENSG00000123200",NA,NA,0,0,101.9,103.6,102.6,98.6,100.5,100.2,95.1,97.7,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S77(100); S198(100); S207(100); S209(100); S242(100); S265(99.6); S325(100); T364(100); S643(99.4); S877(99.6); S986(100); T1033(100)]",0,"ENSG00000123200"
"1087","TP53BP1",-0.0894269516385355,6.63751167602167,-1.10962117004664,0.294212735791707,0.44172510102306,-6.37357967263694,"NONE",FALSE,"High","Master Protein","Q12888","TP53-binding protein 1 [OS=Homo sapiens]",0,597.567,24,27,43,175,27,1972,213.4,4.7,490.27,27,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09038, Pf18428","7158","F8VY86; hsa:7158; Q12888; Q2M1Z7; Q4LE46; Q5FWZ3; Q7Z3U4","ENSG00000067369","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ); SUMOylation of transcription factors","ATM signaling pathway; ATM signaling in development and disease",7,0,101.8,100.4,103.3,102.5,103.7,96.4,103.7,95.4,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100); S265(100); S294(100); S366(100); S380(100); S500(100); S525(100); S552(100); S598(100); S630(100); S639(99.5); S727(100); S831(99.4); T1056(99.6); S1094(100); S1101(100); S1114(99.5); S1362(100); S1462(100); S1656(100)]",0,"ENSG00000067369"
"1088","HSPA8",-0.0872685158008837,6.58485563667407,-1.09989401737512,0.298222715230742,0.447334072846113,-6.38401147575177,"NONE",FALSE,"High","Master Protein","P11142","Heat shock cognate 71 kDa protein [OS=Homo sapiens]",0,120.609,20,12,12,18,10,646,70.9,5.52,54.26,12,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00012","3312","hsa:3312; P11142; Q9H3R6","ENSG00000109971","AUF1 (hnRNP D0) binds and destabilizes mRNA; Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Late endosomal microautophagy; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; PKR-mediated signaling; Regulation of HSF1-mediated heat shock response; Lysosome Vesicle Biogenesis; Clathrin-mediated endocytosis; mRNA Splicing - Major Pathway; CHL1 interactions; Interleukin-4 and Interleukin-13 signaling; GABA synthesis, release, reuptake and degradation; Lipophagy; Chaperone Mediated Autophagy; Protein methylation; Attenuation phase; Respiratory syncytial virus genome transcription","Parkin-ubiquitin proteasomal system pathway; MAPK signaling pathway; Exercise-induced circadian regulation; Measles virus infection; Opioid receptor pathways; Extrafollicular and follicular B cell activation by SARS-CoV-2; 1p36 copy number variation syndrome; HDAC6 interactions in the central nervous system",27,1,123.1,115.5,117.2,92.5,69.9,97.9,87.6,88.6,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S254(100)]",0,"ENSG00000109971"
"1089","GAS2L1",-0.120247577439838,6.64946520411259,-1.09728731346215,0.299304497023497,0.44854448038783,-6.38679494354206,"NONE",FALSE,"High","Master Protein","Q99501","GAS2-like protein 1 [OS=Homo sapiens]",0,57.349,13,5,7,10,5,681,72.7,10.05,28.42,5,"cell organization and biogenesis;stress response;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf02187","10634","B5MCR7; hsa:10634; Q53EN7; Q92640; Q99501; Q9BUY9","ENSG00000185340",NA,"Ectoderm differentiation",1,0,80.5,73.6,85.8,112.1,138.8,107.2,109.2,99.3,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S297(99.9); S306(95.4); T334(100); S492(99.5); S620(100)]",0,"ENSG00000185340"
"1090","NDE1",0.115711798539849,6.64676594723572,1.09599212729094,0.299843129426818,0.448939437820704,-6.3881760548351,"NONE",FALSE,"High","Master Protein","Q9NXR1-1","Isoform 2 of Nuclear distribution protein nudE homolog 1 [OS=Homo sapiens]",0.006,1.785,3,1,1,1,1,346,38.8,5.27,2.4,1,NA,NA,NA,NA,NA,"Q9NXR1-1",NA,NA,NA,0,0,95.5,84.9,77.6,110.9,97.3,99.8,103.1,116.7,118.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S309(98)]",0,"ENSG00000072864"
"1091","CPNE3",0.116623704118582,6.57706992857449,1.09321751053831,0.300999544100983,0.449844362476734,-6.39113048622461,"NONE",FALSE,"High","Master Protein","O75131","Copine-3 [OS=Homo sapiens]",0,35.047,9,3,3,5,3,537,60.1,5.85,15.6,3,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00168, Pf07002","8895","A8KA47; hsa:8895; O75131; Q8IYA1","ENSG00000085719","Neutrophil degranulation; Glycerophospholipid biosynthesis",NA,2,0,114.1,110.3,121.8,80.8,62.6,100.3,96.5,93,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); S243(99.7)]",0,"ENSG00000085719"
"1092","BRD3",-0.0913622139217827,6.59363662953732,-1.09270275788557,0.301214463774125,0.449844362476734,-6.39167795922308,"NONE",FALSE,"High","Master Protein","Q15059","Bromodomain-containing protein 3 [OS=Homo sapiens]",0,17.193,2,1,1,6,1,726,79.5,9.36,18.3,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf00439, Pf17035","8019","B1APD9; hsa:8019; Q15059; Q4G5Y3; Q5T1R7; Q8N5M3; Q92645","ENSG00000169925",NA,NA,0,0,113.9,111.8,102.5,93.8,99.7,87.3,93.2,90.7,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000169925"
"1093","CDK14",-0.167503709039382,6.6483267787416,-1.09255915687579,0.301274441291097,0.449844362476734,-6.39183065253775,"NONE",FALSE,"High","Master Protein","O94921","Cyclin-dependent kinase 14 [OS=Homo sapiens]",0,4.787,4,2,2,3,2,469,53,8.92,6.87,2,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5218","A4D1E6; A6NK51; A8WFP6; B4DHG5; B4DNM2; hsa:5218; O94921; Q75N06; Q75N22; Q8N764; Q9H3D7; Q9UDR0","ENSG00000058091",NA,NA,0,0,88.3,77.1,70,118.8,132.4,113.4,89.3,129.8,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(100); S134(100)]",0,"ENSG00000058091"
"1094","RANBP3",-0.0880929417275711,6.64418839899501,-1.09087934512874,0.301976731046333,0.450480827301293,-6.39361566611599,"NONE",FALSE,"High","Master Protein","Q9H6Z4","Ran-binding protein 3 [OS=Homo sapiens]",0,28.721,5,3,4,16,3,567,60.2,4.78,42.82,3,"transport","nucleus;other cell component","other molecular function","Pf00638","8498","B2RAT8; hsa:8498; O60405; O75759; O75760; Q9BT47; Q9H6Z4; Q9UG74","ENSG00000031823",NA,NA,0,0,91.5,96.9,92.2,110.6,101.8,103.6,97.1,109.7,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S126(98.8); S333(100)]",0,"ENSG00000031823"
"1095","PRPF38A",-0.0782624852518126,6.4343378341843,-1.08830562503963,0.303055197698397,0.451212614606615,-6.39634642855884,"NONE",FALSE,"High","Master Protein","Q8NAV1","Pre-mRNA-splicing factor 38A [OS=Homo sapiens]",0,6.04,3,2,2,9,2,312,37.5,9.96,18,2,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf03371, Pf12871","84950","hsa:84950; Q8NAV1; Q96JW1; Q9BVZ8","ENSG00000134748","mRNA Splicing - Major Pathway","MECP2 and associated Rett syndrome",2,0,142.1,139.4,129.7,64.1,63.4,72.3,73,73.3,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100)]",0,"ENSG00000134748"
"1096","RAB29",0.347967709250404,6.64566883120884,1.08801249258431,0.303178217620139,0.451212614606615,-6.39665712895536,"NONE",FALSE,"High","Master Protein","O14966","Ras-related protein Rab-7L1 [OS=Homo sapiens]",0,6.757,10,1,1,1,1,203,23.1,7.18,2.7,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00071","8934","B4E1K3; C9JE77; hsa:8934; O14966","ENSG00000117280","RAB geranylgeranylation",NA,1,0,103,80.2,104.9,83.4,47.7,143.9,146.3,113.6,87.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S177(100)]",0,"ENSG00000117280"
"1097","SMAP2",-0.186779833194217,6.65384608440713,-1.08719976886343,0.303519497957883,0.451212614606615,-6.39751821992271,"NONE",FALSE,"High","Master Protein","Q8WU79","Stromal membrane-associated protein 2 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,429,46.8,8.87,7.06,1,NA,"cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01412","64744","B2R7T1; B7Z5B5; B7Z8V2; D3DPV2; hsa:64744; Q5QPL2; Q8WU79; Q96C93; Q9NST2; Q9UJL8","ENSG00000084070",NA,NA,0,0,78.3,55.8,100.1,125,119.3,120.8,100.2,118.1,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100)]",0,"ENSG00000084070"
"1098","NR2C2",-0.155835230454576,6.66347080489762,-1.08707196415359,0.30357319291548,0.451212614606615,-6.3976535850338,"NONE",FALSE,"High","Master Protein","P49116","Nuclear receptor subfamily 2 group C member 2 [OS=Homo sapiens]",0,34.624,9,3,3,3,3,596,65.4,6.28,10.91,3,"developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00104, Pf00105","7182","A8K3H5; B6ZGT8; hsa:7182; P49116; P55092","ENSG00000177463","Nuclear Receptor transcription pathway","Androgen receptor signaling pathway; Nuclear receptors; Hypothesized pathways in pathogenesis of cardiovascular disease; Epithelial to mesenchymal transition in colorectal cancer",5,0,99.5,84.3,99.7,97.5,96.1,136.4,98,111.8,94.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); S46(100); T352(99.4)]",0,"ENSG00000177463"
"1099","CCNYL1",0.164241305323439,6.61166257549083,1.08579398947873,0.304110515479443,0.451599964752002,-6.39900647785796,"NONE",FALSE,"High","Master Protein","Q8N7R7","Cyclin-Y-like protein 1 [OS=Homo sapiens]",0,44.126,13,4,4,8,2,359,40.7,6.07,27.08,4,"other biological processes","plasma membrane;other membranes","enzyme regulator activity;other molecular function","Pf00134","151195","hsa:151195; Q6NX60; Q8N7R7","ENSG00000163249",NA,NA,0,2,94.1,97.7,92.5,83.7,94.4,100.8,127.1,89.5,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S122(99.5); S344(100)]",0,"ENSG00000163249"
"1100","FAM117A",-0.12323710192076,6.62629691483385,-1.08354421321007,0.305058213520211,0.45241096312728,-6.40138512829569,"NONE",FALSE,"High","Master Protein","Q9C073","Protein FAM117A [OS=Homo sapiens]",0,18.49,6,2,2,4,2,453,48.3,8.31,6.18,2,NA,NA,NA,"Pf15388","81558","B7Z7Q3; hsa:81558; Q9C073","ENSG00000121104",NA,NA,0,0,105.8,97.4,100.7,104,103,96.6,93.6,111.5,84.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); T299(99.4)]",0,"ENSG00000121104"
"1101","BUD13",-0.069419271601558,6.55755468828439,-1.08277324740064,0.305383499375179,0.45241096312728,-6.4021993723132,"NONE",FALSE,"High","Master Protein","Q9BRD0","BUD13 homolog [OS=Homo sapiens]",0,19.361,4,2,2,4,2,619,70.5,9.86,14.22,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf09736","84811","A8K0S0; hsa:84811; Q96LS7; Q9BRD0","ENSG00000137656","mRNA Splicing - Major Pathway",NA,1,0,124.3,119.7,116,84,76.8,90.2,85.1,87.7,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100); S325(100)]",0,"ENSG00000137656"
"1102","HNRNPUL2",0.0907651142386383,6.56531901217433,1.08180354991067,0.305793013635707,0.45241096312728,-6.40322286175305,"NONE",FALSE,"High","Master Protein","Q1KMD3","Heterogeneous nuclear ribonucleoprotein U-like protein 2 [OS=Homo sapiens]",0,84.395,6,6,7,20,6,747,85.1,4.91,51.31,6,NA,"nucleus;other cell component",NA,"Pf00622, Pf02037, Pf13671","221092","hsa:221092; Q1KMD3; Q8N3B3","ENSG00000214753",NA,NA,0,0,116.5,116.3,121.2,86,65.7,87,96.3,92.9,85.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S161(100); S185(100); S193(100)]",0,"ENSG00000214753"
"1103","MAST3",-0.113835745165654,6.63638470980183,-1.08084209463466,0.306199464745837,0.45241096312728,-6.40423694505235,"NONE",FALSE,"High","Master Protein","O60307","Microtubule-associated serine/threonine-protein kinase 3 [OS=Homo sapiens]",0,42.939,7,5,6,8,5,1309,143,8.06,17.74,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction","other cell component","kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","23031","hsa:23031; O60307; Q7LDZ8; Q9UPI0","ENSG00000099308",NA,NA,0,0,102.4,93.8,91.5,113.3,97.4,101.5,88.5,109.5,101.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100); S348(100)]",0,"ENSG00000099308"
"1104","TGFB1I1",0.117056353433669,6.66965051297602,1.08070679641526,0.306256694874863,0.45241096312728,-6.40437959270347,"NONE",FALSE,"High","Master Protein","O43294","Transforming growth factor beta-1-induced transcript 1 protein [OS=Homo sapiens]",0,13.198,6,1,1,1,1,461,49.8,7.03,4.19,1,"cell adhesion;cell-cell signaling;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00412, Pf03535","7041","B2R8D5; hsa:7041; O43294; Q9BPW3; Q9Y2V5","ENSG00000140682",NA,"Androgen receptor signaling pathway; Serotonin transporter activity; TGF-beta signaling pathway; Monoamine transport",4,0,94.7,80,83.1,102.9,94.1,118.6,123.6,110.9,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(100)]",0,"ENSG00000140682"
"1105","TXLNA",0.122057439840749,6.66580885620533,1.07905229709513,0.306957202070052,0.45241096312728,-6.40612283651247,"NONE",FALSE,"High","Master Protein","P40222","Alpha-taxilin [OS=Homo sapiens]",0,15.2,3,1,2,3,1,546,61.9,6.52,12.94,1,"transport;other biological processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf09728","200081","D3DPP6; hsa:200081; P40222; Q5TFJ6; Q66K62; Q86T54; Q86T85; Q86T86; Q86Y86; Q86YW3; Q8N2Y3","ENSG00000084652","Other interleukin signaling",NA,1,0,66.2,89.1,86.7,107.4,115.4,105.8,110,119.8,125.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(99.5)]",0,"ENSG00000084652"
"1106","PRPF40A",-0.122340054631448,6.21614699366874,-1.07902818775923,0.306967418958722,0.45241096312728,-6.40614822360504,"NONE",FALSE,"High","Master Protein","O75400","Pre-mRNA-processing factor 40 homolog A [OS=Homo sapiens]",0,25.484,3,3,3,5,3,957,108.7,7.56,11.39,3,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus",NA,"Pf00397, Pf01846","55660","hsa:55660; O43856; O75400; O75404; Q8TBQ1; Q9H782; Q9NWU9; Q9P0Q2; Q9Y5A8","ENSG00000196504","mRNA Splicing - Major Pathway","mRNA processing",2,0,171.2,163.8,167.2,52.7,34.5,48.9,63.4,55.9,51.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S888(100); S938(100)]",0,"ENSG00000196504"
"1107","ZBTB7A",-0.190889976233442,6.61976490481294,-1.07889469066535,0.30702399617668,0.45241096312728,-6.40628878781042,"NONE",FALSE,"High","Master Protein","O95365","Zinc finger and BTB domain-containing protein 7A [OS=Homo sapiens]",0,9.071,4,1,1,1,1,584,61.4,5.19,3.38,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","51341","D6W619; hsa:51341; O00456; O95365; Q14D41; Q5XG86","ENSG00000178951",NA,"IL-18 signaling pathway",1,0,112.1,66.5,68.5,126.9,106.6,114.1,103.8,103.5,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S526(99)]",0,"ENSG00000178951"
"1108","ACTN4",-0.142880022781274,6.60890703519434,-1.07859376440734,0.307151560750629,0.45241096312728,-6.40660559474127,"NONE",FALSE,"High","Master Protein","O43707","Alpha-actinin-4 [OS=Homo sapiens]",0,50.357,3,2,3,4,1,911,104.8,5.44,13.79,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00307, Pf00435, Pf08726","81","A4K467; D6PXK4; hsa:81; O43707; O76048","ENSG00000130402; ENSG00000282844","Platelet degranulation ; Nephrin family interactions","Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Striated muscle contraction pathway; Ebola virus infection in host; Nephrotic syndrome; Alstrom syndrome",9,0,108.8,93.8,107.9,114.7,80.1,96.5,104.3,93.4,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100)]",0,"ENSG00000130402"
"1109","CASC3",0.154287376590159,6.64973198005119,1.07542767983906,0.308496156830247,0.453981720421067,-6.40993457231672,"NONE",FALSE,"High","Master Protein","O15234","Protein CASC3 [OS=Homo sapiens]",0,26.745,3,1,1,2,1,703,76.2,6.48,7.32,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09405","22794","A8K8R0; O15234","ENSG00000108349","Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",NA,6,0,90.9,102.5,90.6,99.9,118.5,79.8,118.6,99.1,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000108349"
"1110","CRIP2",0.143838409993479,6.61333661004029,1.0722635880465,0.30984442142278,0.455555041227006,-6.41325379862454,"NONE",FALSE,"High","Master Protein","P52943","Cysteine-rich protein 2 [OS=Homo sapiens]",0,25.337,8,1,1,4,1,208,22.5,8.72,12.72,1,"other biological processes","other cell component","other molecular function","Pf00412","1397","A1A4U1; B7Z6C0; E9PD13; hsa:1397; P52943","ENSG00000182809",NA,"VEGFA-VEGFR2 signaling",1,0,64.2,64.1,63.5,115.1,123.2,112.1,103.1,157.8,132,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000182809"
"1111","PPP1R18",0.0797266058362993,6.67695225019513,1.06989378592837,0.310857186773355,0.456632699202625,-6.41573476905739,"NONE",FALSE,"High","Master Protein","Q6NYC8","Phostensin [OS=Homo sapiens]",0,17.773,3,2,2,6,2,613,67.9,5.4,13.44,2,NA,"cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf13914, Pf13916","170954","A2AB01; A2AIB8; A4UBI6; A6NCB7; A8MSS7; B7ZCV7; hsa:170954; Q68CK8; Q6NYC8; Q6ZTV1; Q6ZUJ6; Q8NDQ4; Q8TF52; Q9BRL9","ENSG00000146112; ENSG00000206485; ENSG00000225060; ENSG00000229998; ENSG00000230341; ENSG00000234000",NA,"TYROBP causal network in microglia",1,0,93.9,100.5,95.1,106.2,87.8,106.2,107.3,109.5,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S145(100); S224(100)]",0,"ENSG00000146112"
"1112","FYN",-0.073965169158086,6.63928303311963,-1.06907243566622,0.311208793131173,0.456738084883161,-6.41659364397142,"NONE",FALSE,"High","Master Protein","P06241","Tyrosine-protein kinase Fyn [OS=Homo sapiens]",0,25.705,4,3,4,5,3,537,60.7,6.67,14.15,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00017, Pf00018, Pf07714","2534","B5BU57; E1P557; H0UI48; hsa:2534; P06241; Q16248; Q5R3A6; Q5R3A7; Q8N5D7","ENSG00000010810","FCGR activation; Role of LAT2/NTAL/LAB on calcium mobilization; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Regulation of signaling by CBL; Nephrin family interactions; EPHB-mediated forward signaling; RAF/MAP kinase cascade; GPVI-mediated activation cascade; DAP12 signaling; CD28 dependent PI3K/Akt signaling; VEGFA-VEGFR2 Pathway; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Ephrin signaling; Regulation of KIT signaling; Signaling by ERBB2; CRMPs in Sema3A signaling; EPH-ephrin mediated repulsion of cells; Sema3A PAK dependent Axon repulsion; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; EPHA-mediated growth cone collapse; NCAM signaling for neurite out-growth; Signaling by CSF1 (M-CSF) in myeloid cells; Reelin signalling pathway; Platelet Adhesion to exposed collagen; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Dectin-2 family; Nef and signal transduction; PECAM1 interactions; CTLA4 inhibitory signaling; FLT3 signaling through SRC family kinases","Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Pathogenic Escherichia coli infection; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); T cell receptor and co-stimulatory signaling; Ectoderm differentiation; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Ectoderm differentiation; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Prion disease pathway; Acute viral myocarditis; NRF2-ARE regulation; Fragile X syndrome; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; IL-2 signaling pathway; 15q13.3 copy number variation syndrome; Congenital generalized lipodystrophy; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; Interferon type I signaling pathways; T-cell receptor signaling pathway",72,0,96.5,96.9,97.2,104.9,99,103.4,102.2,102.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S186(100)]",0,"ENSG00000010810"
"1113","CCDC6",-0.0914152356331606,6.66173653703712,-1.06602752522021,0.3125149282842,0.458242913710525,-6.41977314481254,"NONE",FALSE,"High","Master Protein","Q16204","Coiled-coil domain-containing protein 6 [OS=Homo sapiens]",0,58.945,6,2,4,12,2,474,53.3,7.34,40.23,2,"cell organization and biogenesis","cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf09755","8030","hsa:8030; Q15250; Q16204; Q6GSG7","ENSG00000108091",NA,"Retinoblastoma gene in cancer; Mesodermal commitment pathway; 16p11.2 proximal deletion syndrome",3,0,90.1,94.2,85.4,105.7,110.5,115.5,95.1,110.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100); S244(100); S323(100)]",0,"ENSG00000108091"
"1114","WIPF2",-0.092312004956697,6.6532052399882,-1.06372352296762,0.313506031946713,0.459283522564664,-6.42217424878623,"NONE",FALSE,"High","Master Protein","Q8TF74","WAS/WASL-interacting protein family member 2 [OS=Homo sapiens]",0,23.088,10,2,2,4,2,440,46.3,10.93,11.28,2,NA,"cytosol;cytoskeleton","cytoskeletal activity","Pf02205","147179","A8K0L3; hsa:147179; Q658J8; Q71RE1; Q8TE44; Q8TF74","ENSG00000171475","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RHOJ GTPase cycle",NA,6,0,90.3,103.4,93.2,99.8,106.9,113.9,95,101.1,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S235(100)]",0,"ENSG00000171475"
"1115","DDX51",0.0959221331535494,6.65256216461699,1.06155221076081,0.314442255419063,0.460241937976602,-6.4244333275173,"NONE",FALSE,"High","Master Protein","Q8N8A6","ATP-dependent RNA helicase DDX51 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,666,72.4,8.16,4.39,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271","317781","A8MPT9; hsa:317781; Q5CZ71; Q8IXK5; Q8N8A6; Q96ED1","ENSG00000185163; ENSG00000288503",NA,NA,0,0,80.2,79.3,71.4,115.2,103.5,112.3,116,126.6,111.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100)]",0,"ENSG00000185163"
"1116","HNRNPF",-0.0986699513213143,6.43560004678047,-1.06084040970169,0.314749633405088,0.460279033796688,-6.42517310887602,"NONE",FALSE,"High","Master Protein","P52597","Heterogeneous nuclear ribonucleoprotein F [OS=Homo sapiens]",0,42.156,15,5,6,9,4,415,45.6,5.58,19.09,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf08080","3185","B3KM84; hsa:3185; P52597; Q5T0N2; Q96AU2","ENSG00000169813","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","MECP2 and associated Rett syndrome",5,1,163.7,130.4,143.5,62.2,55.5,76.3,72.8,68.5,73.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100); S161(100)]",0,"ENSG00000169813"
"1117","EEF1D",-0.0908965226505565,6.63982284833341,-1.05781180750787,0.316060044606149,0.461781551295645,-6.42831638878932,"NONE",FALSE,"High","Master Protein","P29692","Elongation factor 1-delta [OS=Homo sapiens]",0,38.292,5,1,3,42,1,281,31.1,5.01,100.3,1,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00736, Pf10587","1936","B4DDU4; D3DWK3; E9PBQ9; hsa:1936; P29692; Q4VBZ6; Q969J1; Q96I38","ENSG00000104529; ENSG00000273594","Eukaryotic Translation Elongation","Translation factors",2,0,98.3,94,92.8,100.7,107.5,108.2,104.3,92.3,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000104529"
"1118","RALY",-0.0955972540411985,6.53675603390418,-1.05364280947327,0.317870682801885,0.464011587059638,-6.43263163924387,"NONE",FALSE,"High","Master Protein","Q9UKM9-2","Isoform 1 of RNA-binding protein Raly [OS=Homo sapiens]",0,25.904,17,3,3,7,3,290,30.3,9.63,25.09,3,NA,NA,NA,NA,NA,"Q9UKM9-2",NA,NA,NA,0,0,126.2,130.3,119.5,77.3,67.6,96.3,79.8,82.2,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); S119(100); T270(99.1)]",0,"ENSG00000125970"
"1119","FOXK1",-0.0909990664729463,6.64253998509182,-1.05240030643694,0.318411839965144,0.46438616874273,-6.43391512501071,"NONE",FALSE,"High","Master Protein","P85037","Forkhead box protein K1 [OS=Homo sapiens]",0,69.833,11,5,6,10,5,733,75.4,9.32,31.62,5,"other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf00498","221937","hsa:221937; P85037","ENSG00000164916","UCH proteinases",NA,1,0,94.4,94.5,95.7,110,94.4,107.4,95,110.8,97.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); S223(100); S257(99.1); S420(100); S441(100); S445(100)]",0,"ENSG00000164916"
"1120","PTPN13",-0.115031854870681,6.62339926158491,-1.04796621599712,0.320348770429306,0.466793922625561,-6.43848569520168,"NONE",FALSE,"High","Master Protein","Q12923","Tyrosine-protein phosphatase non-receptor type 13 [OS=Homo sapiens]",0,29.742,2,5,5,7,5,2485,276.7,6.42,13.33,5,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00102, Pf00373, Pf00595, Pf09379, Pf09380, Pf16599","5783","B2RTR0; hsa:5783; Q12923; Q15159; Q15263; Q15264; Q15265; Q15674; Q16826; Q8IWH7; Q9NYN9; Q9UDA8","ENSG00000163629","Synthesis of PIPs at the plasma membrane; RND2 GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Interleukin-37 signaling","Apoptosis modulation and signaling; Ectoderm differentiation; Ectoderm differentiation",8,0,98.8,99.7,112.4,92.4,87.8,116,87.4,93.3,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100); S938(100); S1033(100)]",0,"ENSG00000163629"
"1121","PLCB1",0.126281807353978,6.7023162575519,1.03985712847737,0.323914167111726,0.471568171923583,-6.4468047621275,"NONE",FALSE,"High","Master Protein","Q9NQ66","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [OS=Homo sapiens]",0,8.396,2,1,1,2,1,1216,138.5,6.23,6.69,1,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00387, Pf00388, Pf06631, Pf08703, Pf09279, Pf17787","23236","D3DW12; D3DW13; hsa:23236; O60325; Q17RQ6; Q5TFF7; Q5TGC9; Q8IV93; Q9BQW2; Q9H4H2; Q9H8H5; Q9NQ65; Q9NQ66; Q9NQH9; Q9NTH4; Q9UJP6; Q9UM26","ENSG00000182621","Ca2+ pathway; G alpha (q) signalling events; G beta:gamma signalling through PLC beta; Presynaptic function of Kainate receptors; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion; Synthesis of IP3 and IP4 in the cytosol; PLC beta mediated events; Acetylcholine regulates insulin secretion","AMP-activated protein kinase signaling; Thyroid stimulating hormone (TSH) signaling pathway; Alzheimer's disease and miRNA effects; Endothelin pathways; S1P receptor signal transduction; Cell-type dependent selectivity of CCK2R signaling; Chemokine signaling pathway; GPR40 pathway; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; Hippo signaling regulation pathways; Fragile X syndrome; PKC-gamma calcium signaling pathway in ataxia; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Airway smooth muscle cell contraction; Neuroinflammation and glutamatergic signaling; Alzheimer's disease",27,0,83.8,91.8,100,115.7,77.4,116.1,108.5,121.9,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1199(98.9)]",0,"ENSG00000182621"
"1122","FAM53C",-0.0787574264423885,6.67226540936578,-1.03694230387396,0.325203071535433,0.473022649506084,-6.44978250749799,"NONE",FALSE,"High","Master Protein","Q9NYF3","Protein FAM53C [OS=Homo sapiens]",0,32.294,11,5,5,7,5,392,43.1,8.65,20.76,5,"transport","nucleus",NA,"Pf15242","51307","B2RDJ5; D3DQB9; hsa:51307; Q9NYF3","ENSG00000120709",NA,NA,0,0,86.9,90.5,96.5,104.7,116.9,111.5,104.8,100.3,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S234(100); S273(100); S299(100)]",0,"ENSG00000120709"
"1123","TTC7B",0.124110086260271,6.65022226746576,1.03048335638035,0.328072956950542,0.476772097723317,-6.45635713302582,"NONE",FALSE,"High","Master Protein","Q86TV6","Tetratricopeptide repeat protein 7B [OS=Homo sapiens]",0,47.349,5,3,3,7,3,843,94.1,6.89,18.36,3,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol",NA,"Pf12895, Pf13181, Pf13424, Pf19440","145567","hsa:145567; Q86TV6; Q86U24; Q86VT3","ENSG00000165914",NA,NA,0,0,94.7,94.4,93.5,88.2,85,120,110.4,97.8,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S630(100)]",0,"ENSG00000165914"
"1124","PARVA",-0.153018153017791,6.6337531985578,-1.02539404032732,0.330347697794014,0.479650749821914,-6.46151447362372,"NONE",FALSE,"High","Master Protein","Q9NVD7","Alpha-parvin [OS=Homo sapiens]",0,5.836,5,2,3,8,2,372,42.2,5.95,10.87,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity","Pf00307","55742","hsa:55742; Q96C85; Q9HA48; Q9NVD7","ENSG00000197702","Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion",5,0,83.7,93.1,90.8,112.5,142.1,87.2,91.6,108.2,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); T36(100)]",0,"ENSG00000197702"
"1125","RPRD1B",0.0970860887949527,6.62121967088721,1.02384918120938,0.331040536803445,0.480229472056198,-6.4630759380212,"NONE",FALSE,"High","Master Protein","Q9NQG5","Regulation of nuclear pre-mRNA domain-containing protein 1B [OS=Homo sapiens]",0,20.543,4,1,3,4,1,326,36.9,5.97,8.8,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf04818, Pf16566","58490","hsa:58490; Q1WDE7; Q6PKF4; Q9NQG5","ENSG00000101413","RNA polymerase II transcribes snRNA genes","Modulators of TCR signaling and T cell activation",2,0,101.9,111.2,121.7,92.2,84.4,84.9,105.2,93.7,95.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S134(99.6)]",0,"ENSG00000101413"
"1126","MEX3A",0.157666487834042,6.65317304593172,1.02104067251894,0.332302894649188,0.481632614624755,-6.46590980124466,"NONE",FALSE,"High","Master Protein","A1L020","RNA-binding protein MEX3A [OS=Homo sapiens]",0,15.2,4,1,1,1,1,520,54.1,7.27,5.76,1,NA,"cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","92312","A1L020; hsa:92312","ENSG00000254726",NA,NA,0,0,79.4,78.4,108,108.8,114.6,84,106.9,107.9,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S338(100)]",0,"ENSG00000254726"
"1127","APOOL",-0.262105955701101,6.4566298586804,-1.01908749238594,0.333182931158162,0.481633288837512,-6.46787693267754,"NONE",FALSE,"High","Master Protein","Q6UXV4","MICOS complex subunit MIC27 [OS=Homo sapiens]",0,6.062,4,1,1,1,1,268,29.1,9.52,3.16,1,"cell organization and biogenesis","non-structural extracellular;other membranes;mitochondrion;other cell component",NA,"Pf09769","139322","hsa:139322; Q3KNU7; Q5H9D1; Q6UXV4","ENSG00000155008","Platelet degranulation ; Cristae formation",NA,2,0,111.7,101.9,105.7,72.7,152.5,61.8,74.2,92.9,70.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(99.6)]",0,"ENSG00000155008"
"1128","H1-5",0.0909326864225566,6.47595410346502,1.01876538447049,0.333328229819101,0.481633288837512,-6.46820105094579,"NONE",FALSE,"High","Master Protein","P16401","Histone H1.5 [OS=Homo sapiens]",0,64.807,31,7,8,13,3,226,22.6,10.92,32.35,7,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3009","hsa:3009; P16401; Q14529; Q3MJ42","ENSG00000184357","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)",NA,2,0,105.8,110,104.5,72.4,73,79.6,79.4,92.4,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); S107(100); S116(100); T138(100)]; Met-loss [N-Term]",0,"ENSG00000184357"
"1129","SCAMP3",0.0903351130459811,6.67046081631151,1.01835097346406,0.333515235089629,0.481633288837512,-6.46861792737301,"NONE",FALSE,"High","Master Protein","O14828","Secretory carrier-associated membrane protein 3 [OS=Homo sapiens]",0,7.615,2,1,1,3,1,347,38.3,7.64,8.36,1,"transport","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04144","10067","A9Z1W6; B1AVS6; hsa:10067; O14828; O15128; Q96FR8; Q9BPY0","ENSG00000116521; ENSG00000263290",NA,NA,0,0,107,106.4,99,106.5,82.4,97,106.9,108.4,99.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100)]",0,"ENSG00000116521"
"1130","ZNF740",-0.131339641931917,6.5733904828115,-1.01744365749991,0.333924941113636,0.481633288837512,-6.46953016551033,"NONE",FALSE,"High","Master Protein","Q8NDX6","Zinc finger protein 740 [OS=Homo sapiens]",0,4.012,4,1,1,2,1,193,21.8,9.19,5.62,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","283337","A8K9M9; hsa:283337; Q8NDX6","ENSG00000139651","Generic Transcription Pathway",NA,1,0,122.5,109.2,117.5,82.8,110.7,81.7,83.6,82.2,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S44(100)]",0,"ENSG00000139651"
"1131","PRKD3",-0.0939236282635258,6.59457955117971,-1.01649102190526,0.334355517457684,0.481633288837512,-6.47048726603384,"NONE",FALSE,"High","Master Protein","O94806","Serine/threonine-protein kinase D3 [OS=Homo sapiens]",0,51.577,7,4,4,7,2,890,100.4,6.87,26.17,4,"protein metabolism;other metabolic processes;signal transduction","plasma membrane;other membranes;cytosol;nucleus","kinase activity;other molecular function","Pf00069, Pf00130, Pf00169","23683","D6W587; hsa:23683; O94806; Q53TR7; Q8NEL8","ENSG00000115825","Sphingolipid de novo biosynthesis","G protein signaling pathways; Hippo signaling regulation pathways; Chronic hyperglycemia impairment of neuron function",4,0,105.7,106,96.1,103.8,84.7,95.3,86.3,94.5,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S364(100); S391(100); S735(100)]",0,"ENSG00000115825"
"1132","MIGA2",0.116567930546962,6.58001763309267,1.0151615673113,0.334957105203342,0.481633288837512,-6.47182174695763,"NONE",FALSE,"High","Master Protein","Q7L4E1","Mitoguardin 2 [OS=Homo sapiens]",0,14.817,2,1,1,3,1,593,65.5,5.83,8.34,1,"cell organization and biogenesis;developmental processes","plasma membrane;other membranes;mitochondrion","other molecular function","Pf10265","84895","hsa:84895; Q7L4E1; Q8NBM3; Q8TEJ6; Q969E6","ENSG00000148343","Synthesis of PA",NA,1,0,124.3,136.7,137.9,66.6,79.6,80.4,93.8,80.2,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100)]",0,"ENSG00000148343"
"1133","TSC22D4",-0.0893100904022956,6.62981241498385,-1.01473073983368,0.33515223152077,0.481633288837512,-6.47225390197564,"NONE",FALSE,"High","Master Protein","Q9Y3Q8","TSC22 domain family protein 4 [OS=Homo sapiens]",0,38.16,11,3,3,6,3,395,41,7.21,23.6,3,"cell organization and biogenesis;stress response;developmental processes;other biological processes","nucleus;other cell component",NA,"Pf01166","81628","A4D2C3; A8MWR6; D6W5V9; hsa:81628; Q9Y3Q8","ENSG00000166925",NA,NA,0,0,105.7,107.8,105.9,98.9,105,92.3,97.5,89,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S190(99.2); T229(100)]",0,"ENSG00000166925"
"1134","MLC1",-0.134731111450304,6.62971699222887,-1.01466608188884,0.335181523129931,0.481633288837512,-6.47231874642235,"NONE",FALSE,"High","Master Protein","Q15049","Membrane protein MLC1 [OS=Homo sapiens]",0,78.138,8,3,8,26,3,377,41.1,7.49,68.28,3,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function",NA,"23209","B3KW61; B7Z659; hsa:23209; Q15049; Q5JZ83; Q8TAG4; Q96RP5; Q9UGY8","ENSG00000100427",NA,NA,0,0,100.8,106.9,101.8,104.5,70.6,122.7,95.2,100.2,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S357(100)]",0,"ENSG00000100427"
"1135","SMG6",0.119655740738597,6.64758105636071,1.01421952832055,0.335383874995847,0.481633288837512,-6.47276649729609,"NONE",FALSE,"High","Master Protein","Q86US8","Telomerase-binding protein EST1A [OS=Homo sapiens]",0,4.612,2,2,2,2,2,1419,160.4,7.05,2.04,2,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf10373, Pf10374, Pf13638","23293","B7Z874; hsa:23293; O94837; Q86US8; Q86VH6; Q9UF60","ENSG00000070366","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",NA,1,0,92.4,105,100.3,90.6,115.1,87.7,101.1,100.7,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S332(100)]",0,"ENSG00000070366"
"1136","BAIAP2",0.0904698169855811,6.64424625781022,1.01388540949058,0.335535337827678,0.481633288837512,-6.47310140825932,"NONE",FALSE,"High","Master Protein","Q9UQB8","Brain-specific angiogenesis inhibitor 1-associated protein 2 [OS=Homo sapiens]",0,22.038,6,3,3,3,3,552,60.8,8.9,9.29,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf07653, Pf08397","10458","hsa:10458; O43858; Q53HB1; Q86WC1; Q8N5C0; Q96CR7; Q9UBR3; Q9UQ43; Q9UQB8","ENSG00000175866","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC3 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; VEGFA-VEGFR2 Pathway","Regulation of actin cytoskeleton",8,0,90.9,100.1,99.3,100.5,105.1,90,108.7,104.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); T340(100); S366(100)]",0,"ENSG00000175866"
"1137","WWC3",-0.0746901841798913,6.60118040855066,-1.01385381559809,0.335549662627605,0.481633288837512,-6.47313307246018,"NONE",FALSE,"High","Master Protein","Q9ULE0","Protein WWC3 [OS=Homo sapiens]",0,9.072,3,2,2,2,2,1216,136.6,6.42,2.5,2,"other biological processes","cytosol;other cell component","other molecular function","Pf00397","55841","A8KA96; hsa:55841; Q659C1; Q9BTQ1; Q9ULE0; T2C6S4","ENSG00000047644",NA,NA,0,0,104.5,114.4,109.1,91.6,83.5,100.8,90.7,90.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1051(100)]",0,"ENSG00000047644"
"1138","TSG101",0.11377826690082,6.4537310031456,1.00606981485184,0.339092914340844,0.486291420214637,-6.48091016132783,"NONE",FALSE,"High","Master Protein","Q99816","Tumor susceptibility gene 101 protein [OS=Homo sapiens]",0,7.665,3,1,1,1,1,390,43.9,6.46,3.36,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf05743, Pf09454","7251","hsa:7251; Q99816; Q9BUM5","ENSG00000074319","HCMV Late Events; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy","Ebola virus infection in host; 7q11.23 copy number variation syndrome",7,0,151.2,140.2,118.8,63.2,66.1,61.7,87.1,74.3,77.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T220(100)]",0,"ENSG00000074319"
"1139","MCRIP1",0.127034409510975,6.63659977407465,1.0027230531335,0.340624900339843,0.487778068038657,-6.48423907750602,"NONE",FALSE,"High","Master Protein","C9JLW8","Mapk-regulated corepressor-interacting protein 1 [OS=Homo sapiens]",0,15.2,19,1,1,1,1,97,10.9,9.41,4.26,1,"other biological processes","nucleus;other cell component",NA,"Pf14799","348262","C9JLW8; hsa:348262; Q6ZUL0","ENSG00000225663; ENSG00000288213",NA,NA,0,0,96.2,97.4,89.8,86.2,117.3,93.8,100.7,100.4,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000225663"
"1140","PI4K2A",-0.124851848074524,6.60807511448288,-1.00203654218885,0.34093978800504,0.487778068038657,-6.48492081959977,"NONE",FALSE,"High","Master Protein","Q9BTU6","Phosphatidylinositol 4-kinase type 2-alpha [OS=Homo sapiens]",0,25.184,7,2,2,4,2,479,54,8.29,12.44,2,"cell organization and biogenesis;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00454","55361","D3DR59; hsa:55361; Q9BTU6; Q9NSG8","ENSG00000155252","Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane","Thymic stromal lymphopoietin (TSLP) signaling pathway; Wnt signaling pathway",5,0,105.3,108.9,106.4,94.6,117.6,84.2,99.2,84.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100); S51(100); S462(100)]",0,"ENSG00000155252"
"1141","ZNF652",0.126909998725909,6.5998077179229,1.00139532010032,0.341234098297104,0.487778068038657,-6.48555724634513,"NONE",FALSE,"High","Master Protein","Q9Y2D9","Zinc finger protein 652 [OS=Homo sapiens]",0,7.306,2,1,1,1,1,606,69.7,8.65,2.72,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096","22834","A4QPD9; hsa:22834; Q5H9Q0; Q9Y2D9","ENSG00000198740",NA,NA,0,0,109.2,111.4,102.6,92.3,95.9,73.6,106.5,101.4,87.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100)]",0,"ENSG00000198740"
"1142","RCOR2",-0.152583605671987,6.33790601770693,-1.0011971481107,0.341325094179011,0.487778068038657,-6.48575386965196,"NONE",FALSE,"High","Master Protein","Q8IZ40","REST corepressor 2 [OS=Homo sapiens]",0,13.744,4,1,1,1,1,523,58,9.01,3.47,1,"other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf01448, Pf20878","283248","hsa:283248; Q8IZ40; Q96FP3","ENSG00000167771",NA,NA,0,0,155.4,161.1,164,49.8,66.6,52.6,68,63.8,58.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100)]",0,"ENSG00000167771"
"1143","DENND1A",-0.0720453940093275,6.65506623479359,-0.993843507918341,0.344714480654299,0.491828127198475,-6.49302774903352,"NONE",FALSE,"High","Master Protein","Q8TEH3","DENN domain-containing protein 1A [OS=Homo sapiens]",0,11.441,2,2,2,3,2,1009,110.5,6.96,7.67,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf02141, Pf03455, Pf03456","57706","A8MZA3; B1AM80; B7Z3C8; B7Z669; D3PFD3; hsa:57706; Q05C88; Q5VWF0; Q6PJZ5; Q8IVD6; Q8TEH3; Q9H796","ENSG00000119522","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,89.1,86.2,84.5,109.8,111.9,111.5,100.6,106.3,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S473(100); S523(100)]",0,"ENSG00000119522"
"1144","NAF1",0.161417376398843,6.55165072600646,0.99355316859499,0.344848812303265,0.491828127198475,-6.49331404683958,"NONE",FALSE,"High","Master Protein","Q96HR8","H/ACA ribonucleoprotein complex non-core subunit NAF1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,494,53.7,4.87,4.17,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04410","92345","D3DP28; E9PAZ2; hsa:92345; Q96HR8","ENSG00000145414",NA,NA,0,0,119.2,141.5,120,89.4,52.6,77.4,94.7,103,74.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100)]",0,"ENSG00000145414"
"1145","PKN1",0.101459461093905,6.62788468907999,0.993089889095501,0.345063238751381,0.491828127198475,-6.49377073688204,"NONE",FALSE,"High","Master Protein","Q16512","Serine/threonine-protein kinase N1 [OS=Homo sapiens]",0,64.003,10,4,4,9,4,942,103.9,6.37,34.37,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf00433, Pf02185","5585","A8K7W5; B2R9R4; B3KVN3; hsa:5585; Q15143; Q16512; Q504U4; Q8IUV5; Q9UD44","ENSG00000123143","RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOB GTPase cycle; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3","Apoptosis-related network due to altered Notch3 in ovarian cancer; PI3K-Akt signaling pathway; IL-18 signaling pathway; G13 signaling pathway",10,0,102.9,91.7,99.7,101.2,75,103.2,95.2,113.1,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S562(99.5); S573(97.2); T774(99.5); S916(100)]",0,"ENSG00000123143"
"1146","EEPD1",-0.135280750203573,6.64941202251659,-0.990318504489571,0.346348023034889,0.493228598248637,-6.4964990896005,"NONE",FALSE,"High","Master Protein","Q7L9B9","Endonuclease/exonuclease/phosphatase family domain-containing protein 1 [OS=Homo sapiens]",0,26.145,8,4,4,10,4,569,62.4,8.41,15.27,4,"DNA metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes","nucleic acid binding activity","Pf03372, Pf12836","80820","hsa:80820; Q7L9B9; Q96K64; Q9C0F7","ENSG00000122547","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",NA,1,0,96.8,102.4,98.2,101.1,82.9,126.4,110.4,95.2,89.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S25(100); S110(100); S173(100)]",0,"ENSG00000122547"
"1147","SPAST",-0.148810768647976,6.68131620316621,-0.989341432197811,0.346801826644135,0.49344427295835,-6.49745951325443,"NONE",FALSE,"High","Master Protein","Q9UBP0","Spastin [OS=Homo sapiens]",0,14.715,2,1,2,3,1,616,67.2,9.64,10.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00004, Pf09336, Pf17862","6683","A7E2A7; hsa:6683; Q9UBP0; Q9UPR9","ENSG00000021574","Sealing of the nuclear envelope (NE) by ESCRT-III",NA,1,0,74.5,87.6,78,127,103.3,128.1,107.1,132.8,94.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100)]",0,"ENSG00000021574"
"1148","CRK",-0.090311620130084,6.62636132524742,-0.985000289240558,0.348823399576478,0.495888317167954,-6.50171735763172,"NONE",FALSE,"High","Master Protein","P46108-2","Isoform Crk-I of Adapter molecule crk [OS=Homo sapiens]",0,28.309,16,2,2,4,2,204,22.9,5.48,13.03,2,NA,NA,NA,NA,NA,"P46108-2",NA,NA,NA,0,0,91.9,111.3,109.1,99.8,104.6,93.6,93.1,95.5,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S194(100)]",0,"ENSG00000167193"
"1149","RIDA",-0.148574310667744,6.67735426673279,-0.983979512877494,0.349300013543476,0.496133700698828,-6.50271633278754,"NONE",FALSE,"High","Master Protein","P52758","2-iminobutanoate/2-iminopropanoate deaminase [OS=Homo sapiens]",0,14.315,18,3,5,10,3,137,14.5,8.68,10.13,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf01042","10247","hsa:10247; P52758; Q6FHU9; Q6IBG0","ENSG00000132541","Threonine catabolism",NA,1,0,85.3,82.5,87.4,112.6,98,137.3,104.8,128.6,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S3(99.2); S136(100)]; Met-loss [N-Term]",0,"ENSG00000132541"
"1150","PRRC2B",0.0994592822753866,6.64933758257748,0.979712653890875,0.351297468228569,0.498536928825238,-6.50688291670677,"NONE",FALSE,"High","Master Protein","Q5JSZ5","Protein PRRC2B [OS=Homo sapiens]",0,57.522,4,6,6,10,6,2229,242.8,8.34,34.43,6,"other biological processes",NA,NA,"Pf07001","84726","hsa:84726; O60270; Q5JSZ5; Q5JSZ7; Q66VZ2; Q68CR0; Q96EI9; Q9H683","ENSG00000288701",NA,NA,0,0,105.1,96,93.9,100.8,107.3,86.9,106.5,110.4,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100); S388(100); S480(100); S556(100); S613(100); S853(100)]",0,"ENSG00000288701"
"1151","AKAP13",0.073823827904862,6.66620113750594,0.978823283095014,0.351714869108834,0.498550122814611,-6.5077495252256,"NONE",FALSE,"High","Master Protein","Q12802","A-kinase anchor protein 13 [OS=Homo sapiens]",0,74.173,4,7,9,13,7,2813,307.4,5.24,36.91,7,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf00621, Pf10522","11214","hsa:11214; Q12802; Q14572; Q59FP6; Q86W90; Q8WXQ6; Q96JP6; Q96P79; Q9Y5T0; Q9Y5T6","ENSG00000170776","RHOC GTPase cycle; RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle","Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; G protein signaling pathways",8,0,93.9,89.3,94.2,106.5,89.5,109.4,109.1,105.8,112.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S790(100); S983(100); S1559(100); S1876(100); S1929(100); S2498(99.5); S2728(100)]",0,"ENSG00000170776"
"1152","PPHLN1",-0.0678667873465528,6.5980031292837,-0.97839131280942,0.35191773375149,0.498550122814611,-6.50817020787351,"NONE",FALSE,"High","Master Protein","Q8NEY8","Periphilin-1 [OS=Homo sapiens]",0,42.589,11,6,6,13,6,458,52.7,9.11,25.67,6,"cell organization and biogenesis;other biological processes","cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf11488","51535","E9PAX8; hsa:51535; Q86YT2; Q8IXN3; Q8NEY8; Q8TB09; Q96NB9; Q9NXL4; Q9P0P6; Q9P0R9","ENSG00000134283",NA,NA,0,0,113.6,110.3,115.7,91.5,86.3,92.9,95.2,90.7,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S121(100); S133(100); S155(100); T200(99.4); S205(99.6)]",0,"ENSG00000134283"
"1153","EYA4",-0.0755349733232986,6.56643509433768,-0.975998723703232,0.353042916069913,0.499710354749435,-6.51049752917381,"NONE",FALSE,"High","Master Protein","O95677","Eyes absent homolog 4 [OS=Homo sapiens]",0,33.064,2,2,2,7,2,639,69.5,5.2,21.49,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00702","2070","B7Z7F7; hsa:2070; O95464; O95677; O95679; Q8IW39; Q9NTR7","ENSG00000112319","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",NA,1,0,127.9,120.4,128.5,81.3,81.4,84.9,85.5,80.9,89.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100)]",0,"ENSG00000112319"
"1154","TRIP10",-0.0837966504253806,6.64612291461816,-0.974937174711954,0.353542985562972,0.49998453417571,-6.51152862781675,"NONE",FALSE,"High","Master Protein","Q15642","Cdc42-interacting protein 4 [OS=Homo sapiens]",0,12.69,3,1,1,1,1,601,68.3,5.73,4.3,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf00611","9322","B2R8A6; B7WP22; D6W645; hsa:9322; O15184; Q15642; Q53G22; Q5TZN1; Q6FI24; Q8NFL1; Q8TCY1; Q8TDX3; Q96RJ1","ENSG00000125733","RHOQ GTPase cycle; Clathrin-mediated endocytosis","Angiopoietin-like protein 8 regulatory pathway",3,0,70.3,73.6,74.3,109.8,121.5,130.3,104.4,115.1,123.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S296(100)]",0,"ENSG00000125733"
"1155","UBXN1",0.0790549307377777,6.66710597313061,0.972314055110103,0.354780903609467,0.501300809255974,-6.51407256555017,"NONE",FALSE,"High","Master Protein","Q04323","UBX domain-containing protein 1 [OS=Homo sapiens]",0,30.222,10,2,2,3,2,297,33.3,5.25,13.36,2,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00627, Pf00789","51035","hsa:51035; Q04323; Q9BV93; Q9BVV5","ENSG00000162191","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; N-glycan trimming in the ER and Calnexin/Calreticulin cycle",NA,2,0,86.4,81.2,76.1,114.5,103.2,111.5,112.6,118,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S200(100)]",0,"ENSG00000162191"
"1156","SCAF4",0.156226139014803,6.55056568116488,0.970583007112762,0.355599570372985,0.502022922879509,-6.51574828548379,"NONE",FALSE,"High","Master Protein","O95104","SR-related and CTD-associated factor 4 [OS=Homo sapiens]",0,80.572,3,1,3,29,1,1147,125.8,9.55,34.25,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf04818","57466","C9JLZ0; hsa:57466; O95104; Q0P5W8; Q6P1M5; Q8N3I8; Q9UFM1; Q9ULP8","ENSG00000156304",NA,NA,0,0,132,116.9,134.6,75.9,49.8,97.2,98.2,92.9,78.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(100)]",0,"ENSG00000156304"
"1157","SMPD4",-0.22331311914881,6.44331705609787,-0.967612747034266,0.357007524735833,0.503575004640346,-6.5186179053759,"NONE",FALSE,"High","Master Protein","Q9NXE4","Sphingomyelin phosphodiesterase 4 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,866,97.7,8.27,4.73,1,"cell organization and biogenesis;other metabolic processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus","other molecular function","Pf14724","55627","B1PBA3; B4DM23; B4DQ31; B4DRB8; B4DWK7; B4E0L6; E7ESA2; E9PCE6; hsa:55627; Q6FI76; Q6P1P7; Q6ZT43; Q9H0M2; Q9NW20; Q9NWL2; Q9NXE4; Q9P2C9","ENSG00000136699; ENSG00000292130","Glycosphingolipid catabolism",NA,1,0,152.3,107.8,112.3,60.1,90.8,84.4,58.1,83.8,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000136699"
"1158","SLMAP",0.075514505639747,6.5784377254164,0.962653124660128,0.359367558972871,0.505642333731534,-6.52339338616769,"NONE",FALSE,"High","Master Protein","Q14BN4","Sarcolemmal membrane-associated protein [OS=Homo sapiens]",0,10.739,2,1,1,1,1,828,95.1,5.47,3.15,1,"other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi",NA,"Pf00498","7871","hsa:7871; Q14BN4; Q14C95; Q6AI54; Q6UXC9; Q6ZVQ8; Q8NCW9; Q9H297; Q9HCH1; Q9Y681","ENSG00000163681",NA,NA,0,0,115.2,116.1,120.4,80.3,80.9,83.9,85.7,97,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000163681"
"1159","ARHGEF40",-0.0854642555657996,6.65806327330327,-0.962581911531054,0.359401528521831,0.505642333731534,-6.52346180842321,"NONE",FALSE,"High","Master Protein","Q8TER5","Rho guanine nucleotide exchange factor 40 [OS=Homo sapiens]",0,20.71,2,3,3,6,3,1519,164.6,6.15,15.61,3,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity","Pf00621","55701","A5PL07; hsa:55701; Q8TER5; Q9BWP5; Q9H7L6; Q9NTF9; Q9NW24","ENSG00000165801","RHOA GTPase cycle; RHOC GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events",NA,4,0,82.4,89.6,90.1,102.2,111.2,121,96.5,110.7,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100); S1504(100); S1513(100)]",0,"ENSG00000165801"
"1160","EIF3J",-0.113638780373242,6.6296478956029,-0.962579583267894,0.359402639171924,0.505642333731534,-6.52346404537046,"NONE",FALSE,"High","Master Protein","O75822","Eukaryotic translation initiation factor 3 subunit J [OS=Homo sapiens]",0,6.224,5,2,2,2,2,258,29,4.83,2.92,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf08597","8669","B4DUI3; F5H425; hsa:8669; O75822; Q9BUD2; Q9H8Q2; Q9UI65","ENSG00000104131","L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell",8,0,79.2,79.8,85.1,107.1,144,99.4,101,112.5,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T109(100)]",0,"ENSG00000104131"
"1161","PGK1",0.176475301475908,6.56795987684293,0.951558209182019,0.364688259418569,0.512636726417833,-6.53400319014267,"NONE",FALSE,"High","Master Protein","P00558","Phosphoglycerate kinase 1 [OS=Homo sapiens]",0,27.961,7,2,2,4,2,417,44.6,8.1,10.88,2,"protein metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;other membranes;cytosol","kinase activity;other molecular function","Pf00162","5230","A8K4W6; B7Z7A9; hsa:5230; P00558; Q5J7W1; Q6IBT6; Q8NI87","ENSG00000102144","Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism","Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Warburg effect modulated by deubiquitinating enzymes and their substrates; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",13,0,129.8,112.4,138.7,78,49.9,98.8,76.3,93,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000102144"
"1162","AJUBA",0.0789643315451585,6.62973114340561,0.950351795566861,0.365270243397183,0.513012940812567,-6.53515073715438,"NONE",FALSE,"High","Master Protein","Q96IF1","LIM domain-containing protein ajuba [OS=Homo sapiens]",0,21.562,9,3,3,3,3,538,56.9,7.14,6.37,3,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00412","84962","A8MX18; D3DS37; hsa:84962; Q96IF1","ENSG00000129474","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Regulation of PLK1 Activity at G2/M Transition; Activation of anterior HOX genes in hindbrain development during early embryogenesis","Interleukin-1 induced activation of NF-kB; Hippo-Merlin signaling dysregulation; Head and neck squamous cell carcinoma; Pleural mesothelioma",7,0,96.6,102.7,111.1,90.8,100.8,90.7,99.7,102.3,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(100); S137(99.4); S230(100)]",0,"ENSG00000129474"
"1163","METTL3",-0.282399467689404,6.02957719773515,-0.946815428598205,0.366980098944762,0.514737102526739,-6.53850761263966,"NONE",FALSE,"High","Master Protein","Q86U44","N6-adenosine-methyltransferase catalytic subunit [OS=Homo sapiens]",0,7.156,3,1,1,1,1,580,64.4,6.42,3.07,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05063","56339","hsa:56339; O14736; Q86U44; Q86V05; Q9HB32","ENSG00000165819","Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",2,0,177.3,177.1,123.6,23.3,26.9,75.8,60.6,46.3,41.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S243(100)]",0,"ENSG00000165819"
"1164","KSR1",0.065010075113924,6.60285778983719,0.946508717229658,0.367128668713924,0.514737102526739,-6.53879826870489,"NONE",FALSE,"High","Master Protein","Q8IVT5","Kinase suppressor of Ras 1 [OS=Homo sapiens]",0,63.385,5,5,5,7,5,923,102.1,8.66,25.96,5,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","kinase activity;other molecular function","Pf07714, Pf20406","8844","F8WEA9; H7BYU0; hsa:8844; Q13476; Q8IVT5","ENSG00000141068","Signaling by BRAF and RAF1 fusions; RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Clear cell renal cell carcinoma pathways; Ras signaling; MAPK pathway in congenital thyroid cancer",14,0,117.1,111.6,114.1,89,83.8,84.2,92.2,96.7,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T288(100); S334(100); S406(100); T425(100)]",0,"ENSG00000141068"
"1165","MAF1",-0.130926211208013,6.60622749388305,-0.944103853424356,0.368295085225431,0.515929252435969,-6.54107454357876,"NONE",FALSE,"High","Master Protein","Q9H063","Repressor of RNA polymerase III transcription MAF1 homolog [OS=Homo sapiens]",0,21.848,10,1,2,3,1,256,28.8,4.55,9.05,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09174","84232","D3DWL4; hsa:84232; Q9H063","ENSG00000179632","Regulation of PTEN gene transcription",NA,1,0,110.2,99.2,95.8,97.3,98.4,102.2,80.5,91.2,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(97.7)]",0,"ENSG00000179632"
"1166","RABL6",0.0746349600095462,6.67752076702025,0.942587614603742,0.369031874230784,0.516518026367615,-6.54250724265429,"NONE",FALSE,"High","Master Protein","Q3YEC7","Rab-like protein 6 [OS=Homo sapiens]",0,6.118,2,1,1,1,1,729,79.5,5.22,3,1,NA,"cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf08477","55684","A8QVZ7; A8QVZ8; C6K8I4; C6K8I5; hsa:55684; Q3YEC7; Q4F968; Q5T5R7; Q8IWK1; Q8TCL4; Q8WU94; Q96SR8; Q9BU21; Q9H935","ENSG00000196642",NA,NA,0,0,109,105.6,110.4,101.6,92.8,93,104.4,97.2,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S492(100)]",0,"ENSG00000196642"
"1167","UBE4B",0.115657209669627,6.6591129584287,0.940786639478132,0.369908409494229,0.51730122047522,-6.54420650935443,"NONE",FALSE,"High","Master Protein","O95155","Ubiquitin conjugation factor E4 B [OS=Homo sapiens]",0,13.048,3,2,2,2,2,1302,146.1,6.55,5.1,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf04564, Pf10408","10277","A8K8S9; G0ZJH6; O75169; O95155; O95338; Q5SZ12; Q5SZ16; Q96QD4; Q9BYI7","ENSG00000130939",NA,NA,0,0,87.4,90.1,88.1,97.3,128.6,92.8,113.3,100.8,123.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100); S238(100)]",0,"ENSG00000130939"
"1168","GATAD2A",0.0950316806140714,6.61631705313251,0.939720612240078,0.37042795333041,0.517584263557559,-6.54521106354159,"NONE",FALSE,"High","Master Protein","Q86YP4","Transcriptional repressor p66-alpha [OS=Homo sapiens]",0,30.401,8,2,2,2,2,633,68,9.94,10.14,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00320, Pf16563","54815","B5MC40; hsa:54815; Q7L3J2; Q86YP4; Q96F28; Q9NPU2; Q9NXS1","ENSG00000167491","Regulation of PTEN gene transcription; Potential therapeutics for SARS; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation",NA,6,0,117.7,104.4,118.8,86.1,71.9,100,98.8,103.5,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T49(100); S100(100)]",0,"ENSG00000167491"
"1169","DIP2B",-0.14018343313441,6.57310588640655,-0.938498777825889,0.371024079655747,0.517973736525388,-6.5463612775716,"NONE",FALSE,"High","Master Protein","Q9P265","Disco-interacting protein 2 homolog B [OS=Homo sapiens]",0,19.455,2,3,3,3,3,1576,171.4,8.09,9.26,3,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity","Pf00501, Pf06464","57609","hsa:57609; Q6B011; Q8N1L5; Q8NB38; Q9P265","ENSG00000066084",NA,NA,0,0,132.6,113.7,113.9,71.4,74.2,119.2,86.2,83.5,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(100); S203(100); T283(100)]",0,"ENSG00000066084"
"1170","FABP7",0.0876839294223686,6.59824742925401,0.936919245499125,0.371795750016069,0.518607405150619,-6.54784638059076,"NONE",FALSE,"High","Master Protein","O15540","Fatty acid-binding protein, brain [OS=Homo sapiens]",0,46.762,31,3,3,8,3,132,14.9,5.59,29.73,3,"cell cycle OR cell proliferation;transport;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf00061","2173","B2R4L1; hsa:2173; O14951; O15540; Q6IAU7; Q9H047","ENSG00000164434","Triglyceride catabolism; NOTCH3 Intracellular Domain Regulates Transcription","PPAR signaling pathway; Fatty acid transporters; Cell lineage map for neuronal differentiation",5,0,113.9,117.2,121.3,93.6,71.8,82.5,88,103.2,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000164434"
"1171","IBTK",-0.171928436956326,6.63922999349304,-0.924466038478432,0.377920183517654,0.526574512635017,-6.55948214682014,"NONE",FALSE,"High","Master Protein","Q9P2D0","Inhibitor of Bruton tyrosine kinase [OS=Homo sapiens]",0,17.447,3,2,2,2,2,1353,150.4,7.71,5.81,2,"transport;other biological processes","other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00415, Pf00651, Pf12796","25998","hsa:25998; Q2QKU2; Q2QKU3; Q2QKU4; Q5TFD7; Q5TFD9; Q8IUQ9; Q8IUY7; Q8TAI4; Q9HBI8; Q9P2D0; Q9Y3T8","ENSG00000005700; ENSG00000283068",NA,"Genetic causes of porto-sinusoidal vascular disease",1,0,89.3,92.1,108.8,112.2,75.6,125.3,77.5,112.5,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1045(100)]",0,"ENSG00000005700"
"1172","CYBRD1",-0.260054811142479,6.55175367710822,-0.923995958553004,0.378152775005049,0.526574512635017,-6.55991882719669,"NONE",FALSE,"High","Master Protein","Q53TN4","Plasma membrane ascorbate-dependent reductase CYBRD1 [OS=Homo sapiens]",0,30.989,13,2,4,4,2,286,31.6,8.76,11.36,2,"transport;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle","transporter activity;other molecular function","Pf03188","79901","B2RE79; B4DWD7; hsa:79901; Q53TN4; Q6KC16; Q6KC17; Q6P147; Q6ZR51; Q9H0Q8; Q9H5G5","ENSG00000071967","Iron uptake and transport","Iron metabolism disorders",2,0,74.9,81.4,70.6,101.8,209.8,79.9,103.9,76.4,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S260(99.3); S284(99.7)]",0,"ENSG00000071967"
"1173","BRAP",-0.101662217727461,6.65739964087474,-0.920711806674417,0.379780603591957,0.528381985265559,-6.56296446028296,"NONE",FALSE,"High","Master Protein","Q7Z569","BRCA1-associated protein [OS=Homo sapiens]",0,21.034,4,2,2,2,2,592,67.3,5.92,6.49,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02148, Pf07576, Pf13639","8315","B4DRM1; B9EGS8; hsa:8315; O43238; O75341; Q7Z569","ENSG00000089234","RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Negative regulation of MAPK pathway","Ras signaling",6,0,93.7,94.2,93.5,117.1,116.6,91.8,101.5,107.2,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T99(99.5); S117(100)]",0,"ENSG00000089234"
"1174","NFATC2IP",0.194099038698785,6.63666117022979,0.920071996040869,0.380098315380984,0.528381985265559,-6.56355674816081,"NONE",FALSE,"High","Master Protein","Q8NCF5","NFATC2-interacting protein [OS=Homo sapiens]",0,15.2,4,1,1,1,1,419,45.8,6.6,3.83,1,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf11976","84901","B7Z4G5; hsa:84901; Q66K34; Q6NVK1; Q8NCF5; Q8NFR2; Q96ST9","ENSG00000176953",NA,"16p11.2 distal deletion syndrome",1,0,114.4,75.1,74.6,114.2,108.7,78.8,104.6,101.4,150.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S204(100)]",0,"ENSG00000176953"
"1175","VIPAS39",0.105364693110542,6.64729691371548,0.919287661057815,0.380488052857386,0.52847361894745,-6.56428235580709,"NONE",FALSE,"High","Master Protein","Q9H9C1","Spermatogenesis-defective protein 39 homolog [OS=Homo sapiens]",0,31.7,7,2,2,3,2,493,57,7.4,8.91,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04840","63894","B4DPI6; hsa:63894; O95434; Q9H7E1; Q9H9C1; Q9H9I9","ENSG00000151445",NA,NA,0,0,77,77.9,72.7,104.9,111.1,117.1,102.3,139.6,117.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T21(100); S121(100)]",0,"ENSG00000151445"
"1176","TOMM22",0.145430154249673,6.54651038084931,0.915281362871235,0.382483240066993,0.530793067848072,-6.56798059972862,"NONE",FALSE,"High","Master Protein","Q9NS69","Mitochondrial import receptor subunit TOM22 homolog [OS=Homo sapiens]",0,30.401,33,2,2,2,2,142,15.5,4.34,9.71,2,"cell organization and biogenesis;transport;other biological processes","other membranes;mitochondrion","transporter activity","Pf04281","56993","hsa:56993; Q9NS69","ENSG00000100216","Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy",NA,2,0,116.6,135.1,119.1,72.5,87.1,66.1,105.9,89.2,77.4,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S15(100)]",0,"ENSG00000100216"
"1177","RNPS1",0.0831790696492565,6.30033940168392,0.914486398951019,0.382880027229834,0.530892272250713,-6.5687128280552,"NONE",FALSE,"High","Master Protein","Q15287-2","Isoform 2 of RNA-binding protein with serine-rich domain 1 [OS=Homo sapiens]",0,37.872,13,8,12,61,8,282,31.7,11.9,91.82,8,NA,NA,NA,NA,NA,"Q15287-2",NA,NA,NA,0,0,169.7,167.4,155.7,48.8,40.1,49.1,69.1,57,64.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S4(100); S29(100); S132(100); S134(100); S228(100)]; Met-loss [N-Term]",0,"ENSG00000205937"
"1178","CBR1",-0.120606697939721,6.60412437592046,-0.913336752148884,0.383454364261836,0.531237285632697,-6.5697708056164,"NONE",FALSE,"High","Master Protein","P16152","Carbonyl reductase [NADPH] 1 [OS=Homo sapiens]",0.006,1.778,3,1,1,1,1,277,30.4,8.32,1.79,1,"other metabolic processes;other biological processes","cytosol","other molecular function","Pf00106","873","B2RBZ7; B4DFK7; hsa:873; P16152; Q3LHW8","ENSG00000159228","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Nuclear receptors meta-pathway; NRF2 pathway; Omega-6-fatty acids in senescence; Prostaglandin synthesis and regulation",5,0,98.8,100.5,78.8,99.7,105.1,107.4,83.9,103.7,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S151(100)]",0,"ENSG00000159228"
"1179","VCL",-0.127906667362949,6.63283578739283,-0.909663317563865,0.385293636020961,0.533289428119137,-6.57314384769127,"NONE",FALSE,"High","Master Protein","P18206","Vinculin [OS=Homo sapiens]",0,22.574,3,2,2,3,2,1134,123.7,5.66,6.24,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf01044","7414","hsa:7414; P18206; Q16450; Q5SWX2; Q7Z3B8; Q8IXU7","ENSG00000035403","Platelet degranulation ; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants","Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; VEGFA-VEGFR2 signaling; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Melanoma; Regulation of actin cytoskeleton",18,0,98.5,85.8,79.2,108,83,131.5,98.3,110,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S290(100)]",0,"ENSG00000035403"
"1180","NEK1",0.0584962752497029,6.6750952717807,0.909074233785919,0.385589169841043,0.533289428119137,-6.57368369776543,"NONE",FALSE,"High","Master Protein","Q96PY6","Serine/threonine-protein kinase Nek1 [OS=Homo sapiens]",0,57.076,5,5,6,10,5,1258,142.7,5.94,33.39,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069","4750","G5E9Z3; hsa:4750; Q05DG5; Q14CB7; Q5H9T1; Q6PIB8; Q96PY6; Q96SS2; Q9H6P7; Q9Y594","ENSG00000137601",NA,"Ciliopathies; Bardet-Biedl syndrome",2,0,90,91,93.5,103.1,101.4,110.4,107.6,113.3,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S414(100); S436(99.5); S675(100); S1052(100); S1126(100)]",0,"ENSG00000137601"
"1181","IRF2BPL",0.0769075891254474,6.62756717373425,0.906302252929835,0.386981988418694,0.534762578407544,-6.57622006057475,"NONE",FALSE,"High","Master Protein","Q9H1B7","Probable E3 ubiquitin-protein ligase IRF2BPL [OS=Homo sapiens]",0,58.917,10,5,7,13,5,796,82.6,8.24,30.92,5,"protein metabolism;other metabolic processes;developmental processes;other biological processes","nucleus","other molecular function","Pf11261","64207","hsa:64207; Q8NDQ2; Q96JG2; Q9H1B7; Q9H3I7","ENSG00000119669",NA,NA,0,0,93.5,91.1,97.3,101.6,101.3,91.7,108.4,98.8,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100); S334(100); S519(100); S547(100); S659(100)]",0,"ENSG00000119669"
"1182","FIP1L1",-0.0806132477794996,6.64605076236562,-0.902206688896782,0.389046381272021,0.537160485817206,-6.57995557624188,"NONE",FALSE,"High","Master Protein","Q6UN15","Pre-mRNA 3'-end-processing factor FIP1 [OS=Homo sapiens]",0,31.07,4,3,3,5,3,594,66.5,5.59,20.46,3,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf05182","81608","B4DIR3; G3XAD6; hsa:81608; Q0VGE0; Q499Y4; Q49AU3; Q6UN15; Q7Z608; Q8WVN3; Q96F80; Q9H077","ENSG00000145216","Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins",NA,6,0,90.9,96.9,104.9,98.7,95.7,116.4,104.4,95.3,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100); S492(100)]",0,"ENSG00000145216"
"1183","NOTCH2",-0.0747664064586893,6.63212750981062,-0.901067615623,0.389621920429676,0.537396208593814,-6.58099197954881,"NONE",FALSE,"High","Master Protein","Q04721","Neurogenic locus notch homolog protein 2 [OS=Homo sapiens]",0,77.483,3,4,7,20,4,2471,265.2,5.14,38.16,4,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00008, Pf00066, Pf06816, Pf07645, Pf07684, Pf12661, Pf12796","4853","hsa:4853; Q04721; Q5T3X7; Q99734; Q9H240","ENSG00000134250","NOTCH2 Activation and Transmission of Signal to the Nucleus; Pre-NOTCH Processing in Golgi; Pre-NOTCH Transcription and Translation; Notch-HLH transcription pathway; NOTCH2 intracellular domain regulates transcription; NOTCH4 Intracellular Domain Regulates Transcription; Pre-NOTCH Processing in the Endoplasmic Reticulum; Defective LFNG causes SCDO3","Neural crest differentiation; Notch signaling; Canonical and non-canonical Notch signaling; OSX and miRNAs in tooth development; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; Head and neck squamous cell carcinoma; Osteoblast differentiation and related diseases; Genes controlling nephrogenesis; Nephrogenesis; Primary ovarian insufficiency; Notch signaling pathway",20,0,93.9,97.7,95.1,97,93.2,117.9,100.6,101.2,98.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1778(100); T1802(100); S1804(99.5); S2081(100)]",0,"ENSG00000134250"
"1184","TGOLN2",0.114695988687298,6.64601420432861,0.9005657660431,0.389875680744532,0.537396208593814,-6.58144824502804,"NONE",FALSE,"High","Master Protein","O43493","Trans-Golgi network integral membrane protein 2 [OS=Homo sapiens]",0,38.733,8,2,4,6,2,437,45.9,5.63,25.53,2,NA,"plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle",NA,"Pf17818","10618","B2R686; B8ZZ88; D6W5K3; F8W8W7; F8WBK2; hsa:10618; J3KQ45; O15282; O43492; O43493; O43499; O43500; O43501; Q53G68; Q53GV2; Q6MZV1; Q6ZTM7; Q8N6T8; Q92760; Q96QL2","ENSG00000152291; ENSG00000292253","Golgi Associated Vesicle Biogenesis; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network",NA,6,0,92.1,93.2,98.8,105,102,87.5,122.5,102.8,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.6); S298(99.6)]",0,"ENSG00000152291"
"1185","SPECC1L",0.0814265938698142,6.65130803287834,0.897937050200159,0.391206799466556,0.538616433186228,-6.58383468777393,"NONE",FALSE,"High","Master Protein","Q69YQ0","Cytospin-A [OS=Homo sapiens]",0,10.581,2,1,1,2,1,1117,124.5,5.76,4.45,1,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component",NA,"Pf00307","23384","B7Z758; F5H1H6; hsa:23384; O15081; Q69YQ0","ENSG00000100014",NA,NA,0,0,84.3,90.3,87.4,106.2,115.2,93.4,109.2,112.4,109.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S384(99.4)]",0,"ENSG00000100014"
"1186","UBXN2B",-0.106164126526493,6.65999615706753,-0.897514612051733,0.391421010881659,0.538616433186228,-6.5842176435976,"NONE",FALSE,"High","Master Protein","Q14CS0","UBX domain-containing protein 2B [OS=Homo sapiens]",0,13.098,6,1,1,2,1,331,37.1,5.64,7.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus","other molecular function","Pf00789, Pf08059","137886","B3KWZ3; hsa:137886; Q14CS0","ENSG00000215114",NA,NA,0,0,92.9,105.7,109.1,116.5,86.9,101.4,98.7,108.6,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S235(100)]",0,"ENSG00000215114"
"1187","CTPS2",-0.0873433223726989,6.60649758152243,-0.893110722138863,0.393659078682414,0.540925268251597,-6.58820087196564,"NONE",FALSE,"High","Master Protein","Q9NRF8","CTP synthase 2 [OS=Homo sapiens]",0,6.603,3,1,1,2,1,586,65.6,6.9,3,1,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00117, Pf06418, Pf07722","56474","B3KWM2; hsa:56474; Q9BRI0; Q9H809; Q9H8K9; Q9NRF8","ENSG00000047230","Interconversion of nucleotide di- and triphosphates","Pyrimidine metabolism",2,0,108.1,109.7,119.2,88.5,80.9,105.5,85.3,89.6,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S568(100)]",0,"ENSG00000047230"
"1188","IL17RA",-0.123537247449003,6.64673643169839,-0.892460982217843,0.393990039371043,0.540925268251597,-6.58878714723599,"NONE",FALSE,"High","Master Protein","Q96F46","Interleukin-17 receptor A [OS=Homo sapiens]",0,32.903,5,2,2,3,2,866,96.1,5.21,11.96,2,"protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes","signal transduction activity or receptor binding;other molecular function","Pf08357, Pf16556, Pf16578","23765","hsa:23765; O43844; Q20WK1; Q96F46","ENSG00000177663","SARS-CoV-2 activates/modulates innate and adaptive immune responses; Interleukin-17 signaling","IL-17 signaling pathway; Comprehensive IL-17A signaling; COVID-19 and endothelial cell senescence",5,0,78.2,94.8,70,98.4,119,133.3,106.7,109.4,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S629(100); S708(100)]",0,"ENSG00000177663"
"1189","EIF2A",-0.0872639450089023,6.64633704057239,-0.892258486483595,0.394093225460263,0.540925268251597,-6.58896979007837,"NONE",FALSE,"High","Master Protein","Q9BY44","Eukaryotic translation initiation factor 2A [OS=Homo sapiens]",0,21.711,3,1,1,3,1,585,64.9,8.87,12.48,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;translational apparatus;other cell component","translation activity;nucleic acid binding activity","Pf08662","83939","A8MPS6; B4DF96; B4DQ14; D3DNI9; hsa:83939; Q5QTR2; Q7Z4E9; Q8NFM1; Q96EW9; Q96K81; Q9BY44","ENSG00000144895",NA,"Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling; 7q11.23 copy number variation syndrome",3,0,77.3,81.7,83.2,120.6,126.1,99.6,107,107.9,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(100)]",0,"ENSG00000144895"
"1190","GLI3",0.0990520799289953,6.5645957102871,0.890577893088476,0.394950341865673,0.541646183130065,-6.59048426392483,"NONE",FALSE,"High","Master Protein","P10071","Transcriptional activator GLI3 [OS=Homo sapiens]",0,19.696,2,2,2,3,2,1580,169.8,7.4,10.12,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","2737","A4D1W1; hsa:2737; O75219; P10071; Q17RW4; Q75MT0; Q75MU9; Q9UDT5; Q9UJ39","ENSG00000106571","GLI3 is processed to GLI3R by the proteasome; RUNX2 regulates osteoblast differentiation; GLI proteins bind promoters of Hh responsive genes to promote transcription","Ectoderm differentiation; Ectoderm differentiation; Tgif disruption of Shh signaling; Tumor suppressor activity of SMARCB1; Hedgehog signaling pathway; Hedgehog signaling pathway; Endochondral ossification; Osteoblast differentiation and related diseases; Ciliopathies; Endochondral ossification with skeletal dysplasias; Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system; Bardet-Biedl syndrome; 11p11.2 copy number variation syndrome",20,0,128.9,120.2,126,80.8,85.8,65.5,90.4,85.6,93.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S445(100); S664(100)]",0,"ENSG00000106571"
"1191","SCML2",0.0884231462091769,6.34570110792082,0.889912678550562,0.395289968457613,0.541656782974664,-6.5910830576463,"NONE",FALSE,"High","Master Protein","Q9UQR0","Sex comb on midleg-like protein 2 [OS=Homo sapiens]",0,3.311,2,1,1,1,1,700,77.2,8.54,2.37,1,"other biological processes","nucleus","other molecular function","Pf00536, Pf02820, Pf12140, Pf17208","10389","hsa:10389; Q5JXE6; Q86U98; Q8IWD0; Q8NDP2; Q9UGC5; Q9UQR0","ENSG00000102098",NA,NA,0,0,169.8,144.1,137.2,53.1,41.8,62.2,73.1,71.1,63.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S499(100)]",0,"ENSG00000102098"
"1192","HMGN1",-0.246401250285929,6.56316143625539,-0.887663709181634,0.396439703331029,0.542776506574026,-6.59310466584194,"NONE",FALSE,"High","Master Protein","P05114","Non-histone chromosomal protein HMG-14 [OS=Homo sapiens]",0,36.638,18,3,4,5,3,100,10.7,9.6,16.19,3,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01101","3150","hsa:3150; P05114; Q3KQR8","ENSG00000205581","Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER","ATM signaling in development and disease ; p38 MAPK signaling pathway; Pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum",8,0,66.8,91.3,78,105.3,207.2,74.8,115.1,87.3,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100); S99(100)]",0,"ENSG00000205581"
"1193","HOMER3",0.0975874778800288,6.68973014941722,0.886879261666798,0.396841285959566,0.54287089579716,-6.59380879014914,"NONE",FALSE,"High","Master Protein","Q9NSC5","Homer protein homolog 3 [OS=Homo sapiens]",0,64.286,14,4,5,9,4,361,39.8,5.45,26.42,4,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00568","9454","B2RA10; E9PCW9; hsa:9454; O14580; O95350; Q9NSB9; Q9NSC0; Q9NSC1; Q9NSC5","ENSG00000051128","Neurexins and neuroligins","PKC-gamma calcium signaling pathway in ataxia; Cell lineage map for neuronal differentiation",3,0,85.5,89.5,83.4,115.3,86,118.1,108,128.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100); T243(100); S256(100)]",0,"ENSG00000051128"
"1194","RBM4",0.0907518081254581,6.47828841113076,0.886141756762746,0.397219097374021,0.542932635606702,-6.59447029755402,"NONE",FALSE,"High","Master Protein","Q9BWF3","RNA-binding protein 4 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,364,40.3,7.08,4.3,1,"cell-cell signaling;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf00098","5936","B3KUN0; B4E1U0; E7EQS3; hsa:5936; O02916; Q4VC48; Q6P1P2; Q8WU85; Q9BWF3","ENSG00000173933","Circadian Clock",NA,1,0,142.5,138.5,121.4,70.1,68.3,62.1,75.3,85,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(100)]",0,"ENSG00000173933"
"1195","SEC31A",-0.0593130025381434,6.61186754797272,-0.882618166393368,0.399027653175921,0.544948225927282,-6.59762435380834,"NONE",FALSE,"High","Master Protein","O94979","Protein transport protein Sec31A [OS=Homo sapiens]",0,58.769,5,4,4,6,4,1220,132.9,6.89,24.58,4,"cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf12931","22872","B4DIW6; B7ZKZ7; B7ZL00; H7C2W3; hsa:22872; O94979; Q17RR5; Q5H9P6; Q5XG74; Q659G7; Q6ZU90; Q7LCX9; Q86TJ0; Q8IZH4; Q9P048; Q9P0A6; Q9UM05; Q9UM06","ENSG00000138674","MHC class II antigen presentation; Signaling by ALK fusions and activated point mutants; COPII-mediated vesicle transport; XBP1(S) activates chaperone genes; Antigen Presentation: Folding, assembly and peptide loading of class I MHC","Sterol regulatory element-binding proteins (SREBP) signaling",6,0,107.7,106.9,104.4,94.6,86.3,101.2,92,98.5,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S527(100); S799(100); S1163(99.6)]",0,"ENSG00000138674"
"1196","PDZRN3",-0.0710030901830647,6.58845374848059,-0.880492057624718,0.400121705883223,0.545858026325265,-6.59952233060559,"NONE",FALSE,"High","Master Protein","Q9UPQ7","E3 ubiquitin-protein ligase PDZRN3 [OS=Homo sapiens]",0,21.09,3,2,2,3,2,1066,119.5,6.02,6.25,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","other cell component","other molecular function","Pf00595, Pf13923","23024","A7MCZ6; Q8N2N7; Q96CC2; Q9NSQ2; Q9UPQ7","ENSG00000121440",NA,NA,0,0,109.9,110.5,110.9,96,83.3,91.6,83.6,97.5,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S774(99.7); S848(99.4)]",0,"ENSG00000121440"
"1197","CLUH",0.0801719842083433,6.58069249035046,0.880024116201186,0.400362780337832,0.545858026325265,-6.5999395400027,"NONE",FALSE,"High","Master Protein","O75153","Clustered mitochondria protein homolog [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1309,146.6,6.13,5.04,1,"cell organization and biogenesis","other cell component","nucleic acid binding activity","Pf12807, Pf13236, Pf13374, Pf13424, Pf15044","23277","hsa:23277; O75153; Q6AHY2; Q6P3X7; Q6ZUG8; Q8N4U7; Q9BTA3; Q9H979","ENSG00000132361",NA,"Translation factors",1,0,117.8,106.2,124.1,88.9,76.2,80.8,91.2,100.4,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S664(100)]",0,"ENSG00000132361"
"1198","KPNA3",0.0731251772598434,6.66128263866496,0.876438135345585,0.402213576542129,0.547784655467818,-6.60313048940403,"NONE",FALSE,"High","Master Protein","O00505","Importin subunit alpha-4 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,521,57.8,4.94,8.39,1,"cell organization and biogenesis;transport;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00514, Pf01749, Pf16186","3839","hsa:3839; O00191; O00505; O43195; Q5JVM9; Q8IYQ9; Q96AA7","ENSG00000102753","ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways",NA,2,0,105.3,102.2,93.5,101.7,92.3,99.4,108.9,108.2,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(100)]",0,"ENSG00000102753"
"1199","NME2",-0.0656024588701376,6.66692204400838,-0.875986334450897,0.402447182540388,0.547784655467818,-6.60353173421762,"NONE",FALSE,"High","Master Protein","P22392","Nucleoside diphosphate kinase B [OS=Homo sapiens]",0,25.186,22,3,3,3,3,152,17.3,8.41,8.49,3,"cell adhesion;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00334","4831; 654364","A8MWA3; hsa:4831; hsa:654364; P22392; Q1WM23; Q6LCT6","ENSG00000243678","Neutrophil degranulation; Interconversion of nucleotide di- and triphosphates; Azathioprine ADME; Ribavirin ADME","Pyrimidine metabolism",5,0,85.3,89.4,92.3,113.7,111.1,106.2,102.8,112.5,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T94(100)]",0,"ENSG00000243678"
"1200","ANKIB1",-0.111631444419928,6.5798836285061,-0.873764083867563,0.403597584945655,0.54889271552609,-6.60550275480743,"NONE",FALSE,"High","Master Protein","Q9P2G1","Ankyrin repeat and IBR domain-containing protein 1 [OS=Homo sapiens]",0,67.568,4,4,5,11,4,1089,121.9,5.11,29.19,4,"protein metabolism;other metabolic processes;other biological processes","other cell component","other molecular function","Pf00023, Pf01485, Pf12796, Pf19422","54467","hsa:54467; Q6GMS4; Q6P3S9; Q9NTD7; Q9NW49; Q9P2G1","ENSG00000001629",NA,NA,0,0,98.7,97,108.7,86.4,106.3,98,94.2,79.6,106.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S737(100); S891(99.4); S911(99.6)]",0,"ENSG00000001629"
"1201","DPF2",0.0877964578608772,6.63536107283545,0.86658024398842,0.407332120173479,0.55351042474864,-6.61184525865478,"NONE",FALSE,"High","Master Protein","Q92785","Zinc finger protein ubi-d4 [OS=Homo sapiens]",0,14.314,4,1,1,1,1,391,44.1,6.33,4.12,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00628, Pf14051","5977","A8K7C9; B4DT58; hsa:5977; Q92785","ENSG00000133884",NA,"Tumor suppressor activity of SMARCB1",1,0,86.1,87.5,78,92.5,104.4,118.2,104.7,110.1,120.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100)]",0,"ENSG00000133884"
"1202","DENR",-0.15050055622274,6.6739865537265,-0.864660184413612,0.408334313152492,0.554410648140488,-6.61353288427541,"NONE",FALSE,"High","Master Protein","O43583","Density-regulated protein [OS=Homo sapiens]",0,32.385,13,2,2,3,2,198,22.1,5.3,12.46,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes",NA,"nucleic acid binding activity","Pf01253, Pf21023","8562","hsa:8562; O43583; Q9H3U6; Q9UKZ0","ENSG00000139726",NA,NA,0,0,73.2,69.7,76,145.4,126.1,103.2,124.4,121.1,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100)]",0,"ENSG00000139726"
"1203","CRMP1",-0.0756769366305479,6.68221519052853,-0.863452832745,0.408965375228705,0.554805895572108,-6.61459244190657,"NONE",FALSE,"High","Master Protein","Q14194","Dihydropyrimidinase-related protein 1 [OS=Homo sapiens]",0,104.816,16,8,11,25,5,572,62.1,7.03,77.76,8,"other metabolic processes;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf01979","1400","A0EJG6; hsa:1400; Q13024; Q14194; Q4W5F1; Q96TC8","ENSG00000072832","CRMPs in Sema3A signaling",NA,1,0,80.6,81.6,81.6,123.5,115.6,112.4,109.3,120.4,106.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T509(100); T514(100); S518(98.4); S542(99.5)]",0,"ENSG00000072832"
"1204","CASKIN1",-0.0689019769732475,6.62752990758214,-0.862753453241801,0.409331237436147,0.554841012870259,-6.61520563047473,"NONE",FALSE,"High","Master Protein","Q8WXD9","Caskin-1 [OS=Homo sapiens]",0,74.271,5,5,5,8,5,1431,149.7,9.14,31.69,5,"signal transduction","other cell component","other molecular function","Pf00536, Pf07653, Pf12796, Pf16600, Pf16632, Pf16907","57524","hsa:57524; Q8WXD9; Q9P2P0","ENSG00000167971",NA,NA,0,0,112.9,109.5,102.7,99.9,96.3,92.7,100.3,93.8,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T737(100); S787(100); T1065(100); S1242(100); S1257(100)]",0,"ENSG00000167971"
"1205","HMGN3",-0.105872890416644,6.65669934394655,-0.858446330234269,0.411589384267919,0.556611598633832,-6.61897257977914,"NONE",FALSE,"High","Master Protein","Q15651","High mobility group nucleosome-binding domain-containing protein 3 [OS=Homo sapiens]",0,11.271,10,3,3,13,3,99,10.7,9.66,12.37,3,"cell organization and biogenesis","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01101","9324","B2RD37; hsa:9324; Q15651; Q5HYD3; Q7RTT0; Q969M5; Q9BZT7","ENSG00000118418",NA,NA,0,0,63.9,74.8,73.9,124.5,145.8,110.5,126.3,106.3,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100)]",0,"ENSG00000118418"
"1206","ZNF219",-0.0947644701560977,6.64253091481429,-0.857376835414518,0.412151430750468,0.556611598633832,-6.61990544424062,"NONE",FALSE,"High","Master Protein","Q9P2Y4","Zinc finger protein 219 [OS=Homo sapiens]",0,43.614,7,2,2,3,2,722,76.8,9.39,15.55,2,"developmental processes;signal transduction;other biological processes","other membranes;nucleus","nucleic acid binding activity;other molecular function","Pf00096","51222","D3DS16; hsa:51222; Q53Y57; Q8IYC1; Q9BW28; Q9P2Y4","ENSG00000165804",NA,"Ectoderm differentiation; IL-18 signaling pathway",2,0,89.6,89.8,87.9,101.7,103.4,121.1,112.9,91.3,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S698(100)]",0,"ENSG00000165804"
"1207","POLDIP3",0.124126482729888,6.63474366216819,0.856915335196122,0.412394124088761,0.556611598633832,-6.62030767918604,"NONE",FALSE,"High","Master Protein","Q9BY77","Polymerase delta-interacting protein 3 [OS=Homo sapiens]",0,30.401,5,2,2,4,2,421,46.1,9.99,13.29,2,"other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","84271","A8K6F8; A8K6V9; hsa:84271; Q009A7; Q5H972; Q6PGN6; Q7Z6Z0; Q9BY77; Q9NSP5; Q9NSP6","ENSG00000100227","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,3,0,82.5,113,103.5,97,82.3,99.7,122.5,96.3,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(99.7)]",0,"ENSG00000100227"
"1208","ULK1",0.0590143657964921,6.650796076559,0.856830348897898,0.412438827346499,0.556611598633832,-6.62038173142725,"NONE",FALSE,"High","Master Protein","O75385","Serine/threonine-protein kinase ULK1 [OS=Homo sapiens]",0,43.129,5,3,3,6,3,1050,112.6,8.79,13.4,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf12063, Pf21127","8408","hsa:8408; O75385; Q9UQ28","ENSG00000177169","RAB GEFs exchange GTP for GDP on RABs; Regulation of TNFR1 signaling; Macroautophagy; TBC/RABGAPs; Receptor Mediated Mitophagy","Target of rapamycin signaling; Alzheimer's disease and miRNA effects; Nanoparticle triggered autophagic cell death; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; 7q11.23 copy number variation syndrome; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; Clock-controlled autophagy in bone metabolism; 8q11.23 (RB1CC1) copy number variation; ADHD and autism (ASD) linked metabolic pathways and SNP",20,0,100.8,111.9,105.1,94.7,87.6,100.4,101.9,99.6,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S623(100); S638(99.2); S758(100)]",0,"ENSG00000177169"
"1209","HSD17B4",0.126830373417075,6.64287893799253,0.856575411502134,0.412572945843214,0.556611598633832,-6.62060383167616,"NONE",FALSE,"High","Master Protein","P51659","Peroxisomal multifunctional enzyme type 2 [OS=Homo sapiens]",0,27.507,2,1,2,4,1,736,79.6,8.84,16.88,1,"other metabolic processes;developmental processes","cytosol;other cytoplasmic organelle","other molecular function","Pf00106, Pf01575, Pf02036","3295","B4DNV1; B4DVS5; E9PB82; F5HE57; hsa:3295; P51659","ENSG00000133835","TYSND1 cleaves peroxisomal proteins; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of pristanoyl-CoA; Beta-oxidation of very long chain fatty acids","Androgen receptor network in prostate cancer; Steroid biosynthesis; Disorders of bile acid synthesis and biliary transport; Primary ovarian insufficiency",10,0,104.9,97.2,101.5,98,62.4,120.5,105.5,101.3,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S318(99.3)]",0,"ENSG00000133835"
"1210","MARK3",-0.0824527733673257,6.604263074833,-0.856364654218177,0.412683844575329,0.556611598633832,-6.62078739967164,"NONE",FALSE,"High","Master Protein","P27448","MAP/microtubule affinity-regulating kinase 3 [OS=Homo sapiens]",0,61.142,8,4,5,9,3,753,84.4,9.57,22.88,4,"protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","4140","A0A0A0MQR8; A0A0A0MST9; A0A0A0MT23; hsa:4140; O60219; P27448; Q86TT8; Q8TB41; Q8WX83; Q96RG1; Q9UMY9; Q9UN34","ENSG00000075413","Signaling by BRAF and RAF1 fusions; RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","Complement system in neuronal development and plasticity",10,1,106.6,104.4,103.4,91.2,80.1,113.4,88,99.5,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T211(100); S469(100); T507(100)]",0,"ENSG00000075413"
"1211","COIL",0.0715030281630797,6.65535745242814,0.85311149318826,0.414398235279084,0.558462361664299,-6.62361596681351,"NONE",FALSE,"High","Master Protein","P38432","Coilin [OS=Homo sapiens]",0,20.086,5,2,2,5,2,576,62.6,9.07,16.74,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf15862","8161","B2R931; hsa:8161; P38432","ENSG00000121058",NA,NA,0,0,101,98.7,105.4,96.1,82.6,109.3,108,103,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T122(100); S566(100)]",0,"ENSG00000121058"
"1212","STARD3NL",-0.0826479942789238,6.35549827270068,-0.849822041163798,0.416136723637446,0.560321784264053,-6.62646669700979,"NONE",FALSE,"High","Master Protein","O95772","STARD3 N-terminal-like protein [OS=Homo sapiens]",0.008,1.654,3,1,1,2,1,234,26.6,4.81,4.2,1,"cell organization and biogenesis;transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf10457","83930","A4D1X0; hsa:83930; O95772","ENSG00000010270","Pregnenolone biosynthesis",NA,1,0,157.4,148.5,150.4,55.8,50.1,64.6,70.5,59.1,69.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000010270"
"1213","ARHGAP21",-0.0567966211628335,6.63900551371694,-0.8492026009438,0.416464659505083,0.560321784264053,-6.62700246313376,"NONE",FALSE,"High","Master Protein","Q5T5U3","Rho GTPase-activating protein 21 [OS=Homo sapiens]",0,118.085,10,16,17,30,16,1958,217.3,7.8,64.27,16,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity","Pf00169, Pf00620, Pf17820","57584","hsa:57584; Q0VF98; Q5T5U3; Q7Z3P7; Q8N3A2; Q8NI19; Q8TBV5; Q9P2C3","ENSG00000107863","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; RND3 GTPase cycle",NA,13,0,98.7,101.7,97.3,100.2,101.8,101.8,95.9,100.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100); S253(100); S319(98.3); S459(100); S612(100); S954(100); S1099(100); S1433(99.5); S1514(100); S1568(99.8); S1669(100); S1742(100); S1861(99.6)]",0,"ENSG00000107863"
"1214","TANK",0.10870140544999,6.65173790676109,0.846130071367428,0.418093896848293,0.561826144364812,-6.62965499252774,"NONE",FALSE,"High","Master Protein","Q92844","TRAF family member-associated NF-kappa-B activator [OS=Homo sapiens]",0,8.28,2,1,1,2,1,425,47.8,5.68,6.18,1,"stress response;signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity;other molecular function","Pf12845","10010","D3DPB5; hsa:10010; Q7Z4J6; Q92844; Q92885","ENSG00000136560","Activation of IRF3, IRF7 mediated by TBK1, IKBKE; TICAM1-dependent activation of IRF3/IRF7; TRAF6 mediated IRF7 activation","TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Novel intracellular components of RIG-I-like receptor pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response",7,0,79.8,80.6,90.1,99.5,134.6,94.1,122,109.7,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100)]",0,"ENSG00000136560"
"1215","REEP3",0.0940609777691765,6.6697567042138,0.845458119841335,0.418450786237768,0.561826144364812,-6.630233989953,"NONE",FALSE,"High","Master Protein","Q6NUK4","Receptor expression-enhancing protein 3 [OS=Homo sapiens]",0,7.707,11,1,1,1,1,255,29.2,9.57,3.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;ER/Golgi","cytoskeletal activity","Pf03134","221035","hsa:221035; Q5JQR5; Q5QGT2; Q6NUK4; Q6PEW8; Q6PJY4","ENSG00000165476",NA,NA,0,0,78.5,79.8,72.3,98.4,125.3,121.7,105.7,128,130.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S150(99.1)]",0,"ENSG00000165476"
"1216","PCDH9",-0.120041790325577,6.61132192768812,-0.845148018794232,0.41861555854633,0.561826144364812,-6.63050105989992,"NONE",FALSE,"High","Master Protein","Q9HC56","Protocadherin-9 [OS=Homo sapiens]",0,7.909,2,1,1,1,1,1237,136,5.47,4.09,1,"cell adhesion;developmental processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00028, Pf08266, Pf08374","5101","A2A6U1; hsa:5101; Q5VT83; Q7Z3U0; Q8N3K7; Q9HC56","ENSG00000184226",NA,NA,0,0,136.1,120.4,93.4,103.3,85.8,89.2,97,96.4,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S943(100); T954(100)]",0,"ENSG00000184226"
"1217","ARHGAP31",0.108544605709371,6.63972846937981,0.83514284848139,0.423955616683668,0.568525527056489,-6.6390725640351,"NONE",FALSE,"High","Master Protein","Q2M1Z3","Rho GTPase-activating protein 31 [OS=Homo sapiens]",0,20.201,2,2,2,2,2,1444,156.9,5.76,7.32,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00620","57514","hsa:57514; Q2M1Z3; Q9ULL6","ENSG00000031081","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOU GTPase cycle","Genetic causes of porto-sinusoidal vascular disease",5,0,100.5,93.5,108.2,86.5,108.5,93.4,90.2,105.4,122.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S954(100); S1080(100)]",0,"ENSG00000031081"
"1218","MIEF1",0.0944495704961925,6.57345663351898,0.83117503948863,0.426086133902672,0.570913440500132,-6.64244741964656,"NONE",FALSE,"High","Master Protein","Q9NQG6","Mitochondrial dynamics protein MIEF1 [OS=Homo sapiens]",0,5.38,2,1,1,1,1,463,51.3,7.64,2.68,1,"cell organization and biogenesis;stress response;other biological processes","other membranes;mitochondrion","other molecular function","Pf20266, Pf21297","54471","hsa:54471; Q7L890; Q9BUI3; Q9NQG6","ENSG00000100335",NA,NA,0,0,122.4,120.8,113.8,73.8,67.4,98.8,85,89.5,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(99.6)]",0,"ENSG00000100335"
"1219","C9orf78",-0.0863205040723019,6.61995029966193,-0.827930709767781,0.427833566313146,0.57278456129865,-6.64519658686258,"NONE",FALSE,"High","Master Protein","Q9NZ63","Splicing factor C9orf78 [OS=Homo sapiens]",0,12.319,6,1,1,3,1,289,33.7,6.74,8.78,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf07052","51759","B3KPX8; Q8WVU6; Q9NT39; Q9NZ63","ENSG00000136819","mRNA Splicing - Major Pathway",NA,1,0,98.6,97.2,110.9,99.9,110.5,89.4,97.3,90.2,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S261(100)]",0,"ENSG00000136819"
"1220","GTPBP1",-0.0786157110550825,6.64818544473798,-0.824866152668982,0.429488620154383,0.574529039419634,-6.64778487127781,"NONE",FALSE,"High","Master Protein","O00178","GTP-binding protein 1 [OS=Homo sapiens]",0,30.401,3,1,5,13,1,669,72.4,8.34,34.29,1,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;other cytoplasmic organelle","nucleic acid binding activity;other molecular function","Pf00009, Pf03144","9567","hsa:9567; O00178; Q6IC67","ENSG00000100226",NA,NA,0,0,84.1,88.1,88.3,105.7,119,108.2,96.9,101.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100)]",0,"ENSG00000100226"
"1221","REEP1",0.0721327914157674,6.67032208295001,0.822122476016357,0.430974043220884,0.576043930005309,-6.65009508792844,"NONE",FALSE,"High","Master Protein","Q9H902","Receptor expression-enhancing protein 1 [OS=Homo sapiens]",0,22.138,20,3,4,7,3,201,22.2,9.5,19.13,3,"cell organization and biogenesis","other membranes;cytoskeleton;mitochondrion;ER/Golgi;other cell component","signal transduction activity or receptor binding;cytoskeletal activity","Pf03134","65055","B7Z4D7; B7Z4F2; B7Z5R9; D6W5M2; hsa:65055; Q53TI0; Q9H902","ENSG00000068615","Expression and translocation of olfactory receptors",NA,1,0,94.2,93.4,100.7,93.6,98,113.7,113.2,105.8,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100); S192(99.1)]",0,"ENSG00000068615"
"1222","PRKCA",0.0818507124798424,6.65968337610006,0.820754032788573,0.431716210142704,0.576563711090748,-6.65124484277264,"NONE",FALSE,"High","Master Protein","P17252","Protein kinase C alpha type [OS=Homo sapiens]",0,39.133,9,4,4,5,3,672,76.7,7.05,15.33,4,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5578","B5BU22; hsa:5578; P17252; Q15137; Q32M72; Q96RE4","ENSG00000154229","G alpha (z) signalling events; Disinhibition of SNARE formation; RET signaling; Regulation of KIT signaling; SHC1 events in ERBB2 signaling; Ca2+ pathway; WNT5A-dependent internalization of FZD4; Inactivation, recovery and regulation of the phototransduction cascade; Syndecan interactions; HuR (ELAVL1) binds and stabilizes mRNA; VEGFR2 mediated cell proliferation; Trafficking of GluR2-containing AMPA receptors; Depolymerization of the Nuclear Lamina; Acetylcholine regulates insulin secretion; EGFR Transactivation by Gastrin; RHO GTPases Activate NADPH Oxidases; Calmodulin induced events; ROBO receptors bind AKAP5","Target of rapamycin signaling; Thyroxine (thyroid hormone) production; Follicle stimulating hormone (FSH) signaling pathway; Microtubule cytoskeleton regulation; Endothelin pathways; Glioblastoma signaling pathways; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; T cell receptor and co-stimulatory signaling; Common pathways underlying drug addiction; Cardiac hypertrophic response; Complement system; Myometrial relaxation and contraction pathways; Transcriptional activation by NRF2 in response to phytochemicals; Kit receptor signaling pathway; Focal adhesion; Melatonin metabolism and effects; G protein signaling pathways; Wnt signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; NRF2-ARE regulation; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Fragile X syndrome; Overview of interferons-mediated signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Hippocampal synaptogenesis and neurogenesis; Chronic hyperglycemia impairment of neuron function; TROP2 regulatory signaling; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; Osteoarthritic chondrocyte hypertrophy; ErbB signaling pathway",75,1,74.7,70,79.8,111.1,95.8,128.8,116.2,121.4,121.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S319(100); T497(100)]",0,"ENSG00000154229"
"1223","CACNB2",-0.0629411791288623,6.65576283053862,-0.814201407009623,0.435281908978119,0.580850429642102,-6.6567272528954,"NONE",FALSE,"High","Master Protein","Q08289","Voltage-dependent L-type calcium channel subunit beta-2 [OS=Homo sapiens]",0,10.508,2,1,1,1,1,660,73.5,8.1,3.91,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;cytoskeletal activity","Pf00625, Pf12052","783","A6PVM5; A6PVM7; A6PVM8; hsa:783; O00304; Q08289; Q5QJ99; Q5QJA0; Q5VVG9; Q5VVH0; Q5VWV6; Q6TME1; Q6TME2; Q6TME3; Q8WX81; Q96NZ3; Q96NZ4; Q96NZ5; Q9BWU2; Q9HD32; Q9Y340; Q9Y341","ENSG00000165995","Sensory processing of sound by inner hair cells of the cochlea; Adrenaline,noradrenaline inhibits insulin secretion; NCAM1 interactions; Presynaptic depolarization and calcium channel opening; Phase 0 - rapid depolarisation; Phase 2 - plateau phase","Arrhythmogenic right ventricular cardiomyopathy; MAPK signaling pathway; Opioid receptor pathways; Affected pathways in Duchenne muscular dystrophy",11,0,81,85.1,91.2,107.2,114.2,113.6,111.6,107.4,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(100)]",0,"ENSG00000165995"
"1224","HSP90B1",0.0698447373008406,6.52377586292368,0.813426712282313,0.435704772454762,0.58093969660635,-6.65737289480445,"NONE",FALSE,"High","Master Protein","P14625","Endoplasmin [OS=Homo sapiens]",0,130.019,17,12,12,15,11,803,92.4,4.84,47.27,12,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","7184","hsa:7184; P14625; Q96A97","ENSG00000166598","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Interleukin-4 and Interleukin-13 signaling; Trafficking and processing of endosomal TLR; Scavenging by Class A Receptors; ATF6 (ATF6-alpha) activates chaperone genes","Photodynamic therapy-induced unfolded protein response; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",11,0,131.4,126.6,125.4,73,68.4,76.2,90.7,77.5,87.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T675(100); S680(100)]",0,"ENSG00000166598"
"1225","CAMK2G",0.0527560561112814,6.64921325069364,0.807773792561642,0.438798724312786,0.584587361696707,-6.66206792385166,"NONE",FALSE,"High","Master Protein","Q13555-6","Isoform 6 of Calcium/calmodulin-dependent protein kinase type II subunit gamma [OS=Homo sapiens]",0,134.031,15,8,17,71,1,588,65.2,7.94,216.58,8,NA,NA,NA,NA,NA,"Q13555-6",NA,NA,NA,0,0,86.3,91.9,92.4,102,103.7,103.4,108.6,107.1,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T287(100); S311(100); S315(100); S321(99.4); S402(99.7); S449(100)]",0,"ENSG00000148660"
"1226","SCAP",-0.0789139053451251,6.60156276488774,-0.805872579037845,0.43984258637698,0.585026561758606,-6.66364056452598,"NONE",FALSE,"High","Master Protein","Q12770","Sterol regulatory element-binding protein cleavage-activating protein [OS=Homo sapiens]",0,27.266,4,2,2,2,2,1279,139.6,6.86,9.19,2,"cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;ER/Golgi","other molecular function","Pf00400, Pf12349","22937","hsa:22937; Q12770; Q8N2E0; Q8WUA1","ENSG00000114650","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Sterol regulatory element-binding proteins (SREBP) signaling",2,0,120.1,116.8,102.4,99.9,86.6,86.7,98,86.6,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S851(100)]",0,"ENSG00000114650"
"1227","SDCCAG8",-0.126418257575682,6.6466962042289,-0.80550804942574,0.440042920662656,0.585026561758606,-6.66394172597185,"NONE",FALSE,"High","Master Protein","Q86SQ7","Serologically defined colon cancer antigen 8 [OS=Homo sapiens]",0,7.774,2,1,1,1,1,713,82.6,5.81,2.55,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component",NA,"Pf15964","10806","O60527; Q3ZCR6; Q86SQ7; Q8N5F2; Q9P0F1","ENSG00000054282; ENSG00000276111","Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2","Ciliopathies; 16p11.2 distal deletion syndrome; Bardet-Biedl syndrome",10,0,93.9,67.5,74.1,112.8,153.1,102.7,114.6,99.9,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100)]",0,"ENSG00000054282"
"1228","ALDOA",0.078786141085927,6.67748673279178,0.805215374334729,0.440203809950716,0.585026561758606,-6.6641834377467,"NONE",FALSE,"High","Master Protein","P04075","Fructose-bisphosphate aldolase A [OS=Homo sapiens]",0,91.973,21,6,7,12,5,364,39.4,8.09,40.64,6,"cell organization and biogenesis;other metabolic processes;other biological processes","non-structural extracellular;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00274","226","B4DXI7; hsa:226; P04075; Q6FH76; Q6FI10; Q96B15; Q9BWD9; Q9UCN2","ENSG00000149925","Glycolysis; Gluconeogenesis; Neutrophil degranulation; Platelet degranulation","VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; 16p11.2 proximal deletion syndrome; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways",11,1,88.1,85.1,91.3,109.1,84.8,120.3,107.1,118.4,112.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000149925"
"1229","PWP1",-0.153066589536388,6.63086319535489,-0.802435755255709,0.44173377633843,0.586154432587398,-6.66647522268365,"NONE",FALSE,"High","Master Protein","Q13610","Periodic tryptophan protein 1 homolog [OS=Homo sapiens]",0,23.976,5,1,2,3,1,501,55.8,4.77,9.1,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf00400","11137","A8K3R6; hsa:11137; Q13610; Q7Z3X9","ENSG00000136045",NA,NA,0,0,112.8,99.6,108.9,101.1,125.6,83.4,97.4,73.6,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000136045"
"1230","DYNC1LI1",-0.0644903894487028,6.6667040605435,-0.802336830152523,0.441788292159441,0.586154432587398,-6.66655665856312,"NONE",FALSE,"High","Master Protein","Q9Y6G9","Cytoplasmic dynein 1 light intermediate chain 1 [OS=Homo sapiens]",0,30.401,7,2,4,4,2,523,56.5,6.42,15.67,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf05783","51143","A2RRG7; hsa:51143; Q53HC8; Q53HK7; Q9Y6G9","ENSG00000144635","MHC class II antigen presentation; RHO GTPases Activate Formins; HCMV Early Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Neutrophil degranulation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Ciliary landscape; Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption",16,0,95,101.3,98.6,107.3,104.6,102.2,94.4,103.5,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000144635"
"1231","RTN4",-0.137416026101288,6.67144386044705,-0.801717007162614,0.442129967227382,0.586154432587398,-6.66706670190214,"NONE",FALSE,"High","Master Protein","Q9NQC3","Reticulon-4 [OS=Homo sapiens]",0,201.37,14,10,16,53,10,1192,129.9,4.5,206.21,10,"cell adhesion;cell organization and biogenesis;stress response;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf02453","57142","O94962; Q7L7Q5; Q7L7Q6; Q7L7Q8; Q8IUA4; Q96B16; Q9BXG5; Q9H212; Q9H3I3; Q9NQC3; Q9UQ42; Q9Y293; Q9Y2Y7; Q9Y5U6","ENSG00000115310","Axonal growth inhibition (RHOA activation)","Alzheimer's disease and miRNA effects; Spinal cord injury; 22q11.2 copy number variation syndrome; Alzheimer's disease; Neurogenesis regulation in the olfactory epithelium; 13q12.12 copy number variation",7,0,74.6,75.7,85.3,124.1,85.3,144.1,111.7,125.2,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S107(100); S111(100); S181(100); S863(99.5); T890(100); S983(100)]",0,"ENSG00000115310"
"1232","AP2M1",-0.0788756759227489,6.64378267840966,-0.800634542513063,0.442727093237134,0.586469655976463,-6.66795662072495,"NONE",FALSE,"High","Master Protein","Q96CW1","AP-2 complex subunit mu [OS=Homo sapiens]",0,15.2,4,1,1,3,1,435,49.6,9.54,14.55,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00928, Pf01217","1173","A6NE12; D3DNT1; hsa:1173; P20172; P53679; Q96CW1","ENSG00000161203","Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation; Nef mediated downregulation of CD28 cell surface expression; Formation of annular gap junctions","Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; GDNF signaling",21,0,93.4,88.4,103.3,110.9,84.4,113.5,97.4,106.7,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T156(100)]",0,"ENSG00000161203"
"1233","PFKFB3",0.130591120993815,6.62912948748443,0.797530128869588,0.444442570057401,0.588250519570105,-6.67050300142829,"NONE",FALSE,"High","Master Protein","Q16875","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 [OS=Homo sapiens]",0,14.773,3,1,1,1,1,520,59.6,8.21,4.89,1,"other metabolic processes","cytosol;nucleus","kinase activity;other molecular function","Pf00300, Pf01591","5209","B7Z955; hsa:5209; O43622; O75902; Q16875; Q5VX15; Q5VX18; Q5VX19","ENSG00000170525","Regulation of glycolysis by fructose 2,6-bisphosphate metabolism","AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway",3,0,85.6,76.7,60.5,112.6,103.4,113.3,100.8,138,126,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S461(100)]",0,"ENSG00000170525"
"1234","ATN1",-0.0833844229679634,6.6448903285134,-0.796898097306064,0.444792365900435,0.588250519570105,-6.6710203625507,"NONE",FALSE,"High","Master Protein","P54259","Atrophin-1 [OS=Homo sapiens]",0,46.212,6,5,6,7,5,1190,125.3,8.98,22.49,5,"developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf03154","1822","hsa:1822; P54259; Q99495; Q99621; Q9UEK7","ENSG00000111676","Regulation of PTEN gene transcription",NA,1,0,93.9,93.8,105.2,104.5,119.2,91.8,103.8,97.1,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S34(100); S77(100); S632(100); S645(100); T653(100); S661(100)]",0,"ENSG00000111676"
"1235","LARP4B",-0.093564358473766,6.6483465674521,-0.795946585292856,0.445319321385666,0.588470552632718,-6.67179856358732,"NONE",FALSE,"High","Master Protein","Q92615","La-related protein 4B [OS=Homo sapiens]",0,5.447,2,1,1,2,1,738,80.5,6.92,6.23,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf05383","23185","A7MD20; hsa:23185; Q5T3R3; Q5T3R4; Q5T3R5; Q68CY4; Q92615","ENSG00000107929",NA,NA,0,0,65.1,82.1,89.5,114.1,114.3,122.3,100,113.2,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S601(99.8)]",0,"ENSG00000107929"
"1236","ARHGEF26",0.0765329630699991,6.67422291584668,0.794385720861049,0.446184637030257,0.589136996467136,-6.67307336581829,"NONE",FALSE,"High","Master Protein","Q96DR7","Rho guanine nucleotide exchange factor 26 [OS=Homo sapiens]",0,75.663,9,5,6,13,5,871,97.3,8.95,54.25,5,"cell organization and biogenesis;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00169, Pf00621","26084","B3KVP8; E9PBD0; hsa:26084; Q68CL1; Q6AZ96; Q6Q8Q8; Q96AW8; Q96DR6; Q96DR7; Q9H9D7; Q9H9R2; Q9UFW5","ENSG00000114790; ENSG00000277101","NRAGE signals death through JNK; G alpha (12/13) signalling events; CDC42 GTPase cycle; RHOG GTPase cycle","MECP2 and associated Rett syndrome",5,0,76.1,82.5,86.9,111.9,102.6,115.8,105.5,130.8,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S222(100); S333(100); S392(100); S422(99.7)]",0,"ENSG00000114790"
"1237","GAP43",-0.105520204946703,6.59085274695731,-0.7930147682225,0.446945586544455,0.58955669826322,-6.67419125443339,"NONE",FALSE,"High","Master Protein","P17677","Neuromodulin [OS=Homo sapiens]",0,109.862,46,7,9,12,7,238,24.8,4.72,47.26,7,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00612, Pf06614, Pf10580","2596","A8K0Y4; hsa:2596; P17677","ENSG00000172020","L1CAM interactions","Glial cell differentiation; Spinal cord injury",3,0,53.8,58.1,53.7,129.4,178.3,109.2,124.3,120.1,118,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T107(100); S151(99.2); T181(99.3)]",0,"ENSG00000172020"
"1238","ERBB2",-0.0867691218885716,6.64271630765634,-0.7925117633078,0.447224995373693,0.58955669826322,-6.67460098564323,"NONE",FALSE,"High","Master Protein","P04626","Receptor tyrosine-protein kinase erbB-2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1255,137.8,5.91,5.9,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","2064","B2RZG3; B4DHN3; hsa:2064; P04626; Q14256; Q6LDV1; Q9UMK4; X5D2V5","ENSG00000141736","PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; SHC1 events in ERBB2 signaling; GRB7 events in ERBB2 signaling; Downregulation of ERBB2:ERBB3 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema4D induced cell migration and growth-cone collapse; PLCG1 events in ERBB2 signaling; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants","Leptin signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; Mammary gland development pathway - Puberty (Stage 2 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Pathways affected in adenoid cystic carcinoma; Physico-chemical features and toxicity-associated pathways; Endometrial cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; 2q11.2 copy number variation syndrome; 17q12 copy number variation syndrome; ErbB signaling pathway; DNA damage response (only ATM dependent)",52,0,93.1,85,89.8,103.3,119.6,105.1,116.8,98.8,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1054(100)]",0,"ENSG00000141736"
"1239","TPMT",0.09884576015238,6.66327729071368,0.782482255962614,0.452820260073551,0.596150031552491,-6.68272307399145,"NONE",FALSE,"High","Master Protein","P51580","Thiopurine S-methyltransferase [OS=Homo sapiens]",0,11.055,6,1,2,4,1,245,28.2,6.23,8.85,1,"other metabolic processes","cytosol","other molecular function","Pf05724","7172","hsa:7172; O14806; O15423; O15424; O15425; O15426; O15515; O15548; O43213; P51580; Q5VUK6; Q9UBE6; Q9UBT8; Q9UE62","ENSG00000137364","Azathioprine ADME; Methylation; Defective TPMT causes TPMT deficiency","Metapathway biotransformation Phase I and II; Methylation pathways",5,0,97.8,100.8,103.5,110,71.9,103.5,113.5,109.3,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000137364"
"1240","YY1AP1",0.138450266872547,6.61287461282692,0.782237938040039,0.452957131816843,0.596150031552491,-6.68291979389718,"NONE",FALSE,"High","Master Protein","Q9H869","YY1-associated protein 1 [OS=Homo sapiens]",0,9.997,2,1,1,2,1,796,87.9,7.84,5.55,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","other molecular function",NA,"55249","B0QZ54; B4DMP2; B4E0I0; D3DV96; D3DV98; H7BY62; hsa:55249; Q5VYZ1; Q5VYZ4; Q5VYZ7; Q7L4C3; Q7L5E2; Q8IXA6; Q8TEW5; Q8TF04; Q96HB6; Q9BQ64; Q9H869; Q9NV84","ENSG00000163374",NA,"Envelope proteins and their potential roles in EDMD physiopathology",1,0,113.8,102.4,111.1,76.3,81.4,102.1,122.9,80.3,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S711(100)]",0,"ENSG00000163374"
"1241","HS1BP3",-0.10281793046469,6.63910986203479,-0.779334629585332,0.454585700937467,0.59756794677325,-6.6852533443644,"NONE",FALSE,"High","Master Protein","Q53T59","HCLS1-binding protein 3 [OS=Homo sapiens]",0,11.707,5,1,2,5,1,392,42.8,5.01,8.36,1,"other biological processes","mitochondrion;ER/Golgi","other molecular function","Pf00787","64342","B2RAW2; D6W529; hsa:64342; Q53T59; Q86VC2; Q8N367","ENSG00000118960",NA,NA,0,0,88.2,102.5,120.8,104.7,76.7,115.8,91.6,95.5,104.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(100)]",0,"ENSG00000118960"
"1242","DISP2",0.0965101697776003,6.61713494257211,0.778374221490773,0.455125271530302,0.59756794677325,-6.68602359742926,"NONE",FALSE,"High","Master Protein","A7MBM2","Protein dispatched homolog 2 [OS=Homo sapiens]",0,18.351,3,2,2,3,2,1401,151.9,7.85,9.52,2,"transport;signal transduction","plasma membrane;other membranes","transporter activity",NA,"85455","A7MBM2; Q6AHW3; Q9C0C1","ENSG00000140323","Release of Hh-Np from the secreting cell",NA,1,0,98.2,107.7,96.1,84.8,113.8,86.6,106.8,104.1,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1373(100)]",0,"ENSG00000140323"
"1243","PIP5K1C",-0.116366760815938,6.66552485590812,-0.778360577643903,0.45513293985242,0.59756794677325,-6.68603453385468,"NONE",FALSE,"High","Master Protein","O60331","Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [OS=Homo sapiens]",0,25.948,6,1,2,5,1,668,73.2,5.29,13.19,1,"cell adhesion;cell-cell signaling;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf01504","23396","B7Z9E7; C6GIJ7; C6GIJ8; hsa:23396; O60331; Q7LE07","ENSG00000186111","Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion","B cell receptor signaling pathway; Focal adhesion; Regulation of actin cytoskeleton",7,0,81.4,100.8,80.5,111.9,87.6,133.7,104.2,117.2,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S555(98.8)]",0,"ENSG00000186111"
"1244","DCAF10",0.087646116307142,6.63319736712655,0.777139399888782,0.455819627272951,0.597988449927216,-6.68701270327605,"NONE",FALSE,"High","Master Protein","Q5QP82","DDB1- and CUL4-associated factor 10 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,559,60.5,7.5,7.97,1,"protein metabolism;other metabolic processes","nucleus;other cell component",NA,"Pf00400","79269","A4VCJ5; hsa:79269; Q32NE2; Q5QP82; Q8N2Q5; Q96ET5; Q9BTQ5; Q9H5P6","ENSG00000122741","Neddylation",NA,1,0,126.3,86.6,97.6,97.8,85.5,96.7,103.6,98.7,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100)]",0,"ENSG00000122741"
"1245","ZC3H18",0.0558607367765678,6.60547003461527,0.775554324089323,0.456711950406474,0.598677833785836,-6.6882803397034,"NONE",FALSE,"High","Master Protein","Q86VM9","Zinc finger CCCH domain-containing protein 18 [OS=Homo sapiens]",0,75.081,11,9,9,17,9,953,106.3,8.32,45.02,9,"other biological processes","nucleus;other cell component","other molecular function","Pf18044","124245","hsa:124245; Q86VM9; Q96DG4; Q96MP7","ENSG00000158545",NA,NA,0,0,113.6,116.3,111.4,87.7,86.2,86.4,97.4,91.9,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); T162(100); S534(99.7); T796(99); S842(100); S868(100); S893(100)]",0,"ENSG00000158545"
"1246","DTNB",-0.100107028609919,6.63325155406038,-0.773935718902149,0.457624326017406,0.599392375650406,-6.68957243748658,"NONE",FALSE,"High","Master Protein","O60941-6","Isoform 6 of Dystrobrevin beta [OS=Homo sapiens]",0,13.621,5,2,2,4,1,545,61.5,8.09,5.43,2,NA,NA,NA,NA,NA,"O60941-6",NA,NA,NA,0,0,117.7,117,110.1,99.3,70.8,111.5,81.3,103.1,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S530(98.8)]",0,"ENSG00000138101"
"1247","PARD3B",-0.0606867098560411,6.64558030069578,-0.767355321068565,0.461345798429814,0.603782151593791,-6.69480090568575,"NONE",FALSE,"High","Master Protein","Q8TEW8","Partitioning defective 3 homolog B [OS=Homo sapiens]",0,74.058,5,5,5,8,5,1205,132.4,8.37,29.73,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00595, Pf12053","117583","E9PE87; hsa:117583; Q8IUC7; Q8IUC9; Q8TEW8; Q96DK9; Q96N09; Q96NX6; Q96NX7; Q96Q29","ENSG00000116117",NA,NA,0,0,101.3,99,100.2,99.2,108.2,99.8,103,94,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T133(100); S352(100); S730(100); S746(100)]",0,"ENSG00000116117"
"1248","IGF2BP3",0.107822795913709,6.37134395637764,0.766390540982443,0.461893068056433,0.604014012073797,-6.69556416018856,"NONE",FALSE,"High","Master Protein","O00425","Insulin-like growth factor 2 mRNA-binding protein 3 [OS=Homo sapiens]",0,4.329,2,1,1,2,1,579,63.7,8.87,4.82,1,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf00076","10643","A0A4Z5; hsa:10643; O00425; Q63HM0; Q6MZZ2; Q86VB1","ENSG00000136231","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA",NA,1,0,155,156.8,148.1,48.5,63.3,52,68.2,63.9,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S184(100)]",0,"ENSG00000136231"
"1249","LMNB2",0.0925353628804162,6.6482333073603,0.763197847526604,0.463707119777997,0.60590073617109,-6.69808390402723,"NONE",FALSE,"High","Master Protein","Q03252","Lamin-B2 [OS=Homo sapiens]",0,35.01,9,5,6,6,3,620,69.9,5.59,15.79,5,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus","cytoskeletal activity;other molecular function","Pf00038, Pf00932","84823","hsa:84823; O75292; Q03252; Q14734; Q96DF6","ENSG00000176619",NA,"Gastric cancer network 2; Fas ligand pathway and stress induction of heat shock proteins; IL-18 signaling pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome",6,0,99,106.8,95,96.8,73.7,115.1,106.3,113.1,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S316(100); S407(100); S420(99.5)]",0,"ENSG00000176619"
"1250","ADCY2",0.0644398320881718,6.65069481877981,0.751863832844227,0.470184149959034,0.613872426186515,-6.7069537025328,"NONE",FALSE,"High","Master Protein","Q08462","Adenylate cyclase type 2 [OS=Homo sapiens]",0,17.025,2,2,2,5,2,1091,123.5,8.09,12.97,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00211, Pf06327, Pf16214","108","B7Z2C1; hsa:108; Q08462; Q2NKL8; Q9UDB2; Q9UPU2","ENSG00000078295","FCGR3A-mediated IL10 synthesis; G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Adenylate cyclase activating pathway; Hedgehog 'off' state","Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Phosphodiesterases in neuronal function; Thermogenesis; Envelope proteins and their potential roles in EDMD physiopathology; GPR143 in melanocytes and retinal pigment epithelium cells; Calcium regulation in cardiac cells",23,0,82.5,95.9,86.4,109.8,92.8,105.3,103.6,114.1,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S1085(100)]",0,"ENSG00000078295"
"1251","HDGFL2",-0.0933936836338871,6.55066487506418,-0.749501391535429,0.471541500129724,0.615152460600887,-6.70878767837934,"NONE",FALSE,"High","Master Protein","Q7Z4V5","Hepatoma-derived growth factor-related protein 2 [OS=Homo sapiens]",0,15.959,10,4,4,6,4,671,74.3,7.49,5.82,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00855, Pf11467","84717","I3L080; K7EQZ6; Q7Z4V5; Q96GI5; Q9BW08","ENSG00000167674",NA,NA,0,0,113.6,122.6,111.1,84,95.3,81.7,82.1,78.2,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S369(99.3); S625(100); S652(100); S664(100)]",0,"ENSG00000167674"
"1252","SLC47A2",-0.0884019740348387,6.62399025600668,-0.74844499908996,0.472149266766041,0.615453357318034,-6.70960610252836,"NONE",FALSE,"High","Master Protein","Q86VL8","Multidrug and toxin extrusion protein 2 [OS=Homo sapiens]",0,5.163,2,1,1,2,1,602,65,8.28,4.98,1,"transport","plasma membrane;other membranes","transporter activity","Pf01554","146802","A0JBX9; A0P8Z7; Q63HJ9; Q86VL8; Q8IV44; Q96NA1","ENSG00000180638","Transport of bile salts and organic acids, metal ions and amine compounds","Proximal tubule transport",2,0,63.3,56,60.5,128.8,146.4,119.8,120.8,137.8,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(99.6)]",0,"ENSG00000180638"
"1253","TBC1D10A",0.139503600976679,6.56944878307569,0.746472598826562,0.473285375880565,0.616441926126961,-6.71113144355804,"NONE",FALSE,"High","Master Protein","Q9BXI6","TBC1 domain family member 10A [OS=Homo sapiens]",0,16.618,6,2,2,2,2,508,57.1,8.44,6.45,2,"protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00566","83874","B3KXT8; hsa:83874; O76053; Q20WK7; Q543A2; Q9BXI6","ENSG00000099992","TBC/RABGAPs","Deregulation of Rab and Rab effector genes in bladder cancer",2,0,62.8,53.1,53.1,99.6,107.6,144.8,121.1,107,167.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S407(99.2)]",0,"ENSG00000099992"
"1254","TRIM9",-0.0727278972010019,6.56707896169394,-0.745329546524951,0.47394457751371,0.616808253989134,-6.71201377633356,"NONE",FALSE,"High","Master Protein","Q9C026-5","Isoform 5 of E3 ubiquitin-protein ligase TRIM9 [OS=Homo sapiens]",0,28.266,6,3,5,9,3,550,61.3,7.37,31.63,3,NA,NA,NA,NA,NA,"Q9C026-5",NA,NA,NA,0,0,115.4,108.1,105.2,83.4,86.1,98.2,84.4,86.3,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T41(100); S46(100); S134(100); S543(100)]",0,"ENSG00000100505"
"1255","EIF5B",0.0769721748148191,6.68159889475729,0.742956671839577,0.475314893432156,0.618098729945242,-6.71384157937372,"NONE",FALSE,"High","Master Protein","O60841","Eukaryotic translation initiation factor 5B [OS=Homo sapiens]",0,54.351,3,3,3,12,3,1220,138.7,5.49,49.19,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf00009, Pf11987, Pf14578","9669","hsa:9669; O60841; O95805; Q53RV7; Q53SI8; Q9UF81; Q9UMN7","ENSG00000158417","GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; Ciliary landscape",3,0,82.5,85.4,91.1,114.4,119.5,94,118,111.9,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); S214(100)]",0,"ENSG00000158417"
"1256","MPRIP",-0.0654708349716788,6.65787192266408,-0.741850319781301,0.47595466597917,0.618437909934718,-6.7146920184488,"NONE",FALSE,"High","Master Protein","Q6WCQ1","Myosin phosphatase Rho-interacting protein [OS=Homo sapiens]",0,25.628,4,2,2,3,2,1025,116.5,6.21,7.5,2,NA,"cytosol;cytoskeleton","cytoskeletal activity","Pf00169","23164","hsa:23164; Q3KQZ5; Q5FB94; Q6DHW2; Q6WCQ1; Q7Z5Y2; Q8N390; Q96G40","ENSG00000133030","Signaling by BRAF and RAF1 fusions","Smith-Magenis and Potocki-Lupski syndrome copy number variation",2,0,80.5,82.1,85.7,110.7,128.4,106.1,107.4,116.2,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100); S977(100)]",0,"ENSG00000133030"
"1257","SRSF2",-0.0978958411629227,6.48920022626935,-0.740829093661006,0.476545699494582,0.618713270942846,-6.71547602051202,"NONE",FALSE,"High","Master Protein","Q01130","Serine/arginine-rich splicing factor 2 [OS=Homo sapiens]",0,48.076,18,6,9,21,5,221,25.5,11.85,47.58,6,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00076","6427","B3KWD5; B4DN89; H0YG49; hsa:6427; Q01130","ENSG00000161547","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Minor Pathway","mRNA processing",7,1,142,135.9,127.9,67.4,87.3,66.6,82.3,67,82.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.7); S191(100); S208(100)]",0,"ENSG00000161547"
"1258","CHAMP1",-0.0517488683411766,6.61820378650517,-0.738573062360119,0.477853031089935,0.619917445738294,-6.71720457951698,"NONE",FALSE,"High","Master Protein","Q96JM3","Chromosome alignment-maintaining phosphoprotein 1 [OS=Homo sapiens]",0,86.022,15,9,11,13,9,812,89,8.44,48.54,9,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function",NA,"283489","B3KU06; hsa:283489; Q6P181; Q8NC88; Q96JM3; Q9BST0","ENSG00000198824",NA,NA,0,0,106.5,105,108.3,93.7,99.5,93.8,95.3,94.1,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S204(100); S214(100); S416(100); S427(100); S445(100); S459(99.5); S476(100); S542(100); S603(100); S653(99.5)]",0,"ENSG00000198824"
"1259","PCNP",0.118767991839761,6.63126538453153,0.737249969752495,0.478620800540462,0.620320753996458,-6.71821613956733,"NONE",FALSE,"High","Master Protein","Q8WW12","PEST proteolytic signal-containing nuclear protein [OS=Homo sapiens]",0,60.58,17,2,3,9,2,178,18.9,7.49,38.34,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes","nucleus",NA,"Pf15473","57092","B2RBE7; D3DN52; hsa:57092; Q53GF3; Q6AI44; Q8WW12; Q96CU3; Q9NS81","ENSG00000081154",NA,NA,0,0,66.3,73.2,68.5,110.7,142.8,97.8,106.7,157.1,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S119(100)]",0,"ENSG00000081154"
"1260","HRH1",0.101391085862958,6.65346595336533,0.736727647234522,0.478924111541383,0.620320753996458,-6.7186150318334,"NONE",FALSE,"High","Master Protein","P35367","Histamine H1 receptor [OS=Homo sapiens]",0,10.777,4,2,2,3,2,487,55.7,9.22,8.08,2,"cell-cell signaling;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00001","3269","A8K047; hsa:3269; P35367; Q6P9E5","ENSG00000196639","G alpha (q) signalling events; Histamine receptors","IL-4 signaling pathway; GPCRs, class A rhodopsin-like; Monoamine GPCRs",5,0,62.2,60.6,59.5,129.3,96.9,139.2,125.9,152.6,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100); S380(100)]",0,"ENSG00000196639"
"1261","BRAT1",0.0786253719835885,6.49704532489978,0.731716186903672,0.481840447359575,0.623603180087887,-6.72242940655078,"NONE",FALSE,"High","Master Protein","Q6PJG6","BRCA1-associated ATM activator 1 [OS=Homo sapiens]",0,22.932,2,1,1,2,1,821,88.1,5.27,7.14,1,"cell cycle OR cell proliferation;other metabolic processes;stress response;other biological processes","nucleus;other cell component",NA,"Pf02985","221927","A4D200; C9JY24; hsa:221927; Q6PJG6; Q8IW85; Q8IZ43; Q8WVR8; Q96IV9; Q9H7J8; Q9UFA3","ENSG00000106009",NA,NA,0,0,136.1,138,113.1,86.1,54.7,71.2,84.8,84.7,80.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S742(100)]",0,"ENSG00000106009"
"1262","MPP2",-0.112713561362555,6.62378108199851,-0.727341215860138,0.484395551478179,0.626413264669087,-6.72574030986589,"NONE",FALSE,"High","Master Protein","Q14168","MAGUK p55 subfamily member 2 [OS=Homo sapiens]",0,8.801,5,1,1,1,1,576,64.5,6.77,2.85,1,"cell-cell signaling;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component",NA,"Pf00595, Pf00625, Pf02828, Pf07653","4355","B4DGE9; B4DRJ0; B7Z3G8; E7EV80; E7EV91; E7EX01; hsa:4355; Q14168; Q53ES9; Q5CZB9; Q9BQJ2","ENSG00000108852",NA,NA,0,0,112.2,85.5,84.6,97.1,113.9,109,111.1,106.6,82.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T141(100)]",0,"ENSG00000108852"
"1263","STX1B",0.0855136491737989,6.62704641611491,0.719264300005589,0.489135073167786,0.631093974587672,-6.73180607679498,"NONE",FALSE,"High","Master Protein","P61266","Syntaxin-1B [OS=Homo sapiens]",0,11.716,6,1,1,1,1,288,33.2,5.38,4.13,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00804, Pf05739","112755","hsa:112755; P61266; Q15531; Q2VPS2","ENSG00000099365","LGI-ADAM interactions; Toxicity of botulinum toxin type C (botC)","Synaptic vesicle pathway; 15q11q13 copy number variation",4,0,105.8,100.1,88.6,96.3,78.1,108.6,108.7,110.6,91.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000099365"
"1264","CCAR2",-0.0657842736959333,6.66144277599083,-0.718679973940744,0.489479078620191,0.631093974587672,-6.73224255102211,"NONE",FALSE,"High","Master Protein","Q8N163","Cell cycle and apoptosis regulator protein 2 [OS=Homo sapiens]",0,31.863,2,1,4,7,1,923,102.8,5.22,25.71,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf14443, Pf14444, Pf19256, Pf19257","57805","A6NL03; B2RB79; D3DSR6; hsa:57805; Q6P0Q9; Q8N163; Q8N3G7; Q8N8M1; Q8TF34; Q9H9Q9; Q9HD12; Q9NT55","ENSG00000158941","Regulation of HSF1-mediated heat shock response","TAR syndrome",2,0,84.3,84.1,94.9,109,96.5,122.9,105.5,111.8,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S678(100)]",0,"ENSG00000158941"
"1265","TAOK2",-0.0575522301566274,6.6366989969825,-0.718428579243628,0.489627126726748,0.631093974587672,-6.73243023751161,"NONE",FALSE,"High","Master Protein","Q9UL54-2","Isoform 2 of Serine/threonine-protein kinase TAO2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1049,119.2,7.47,5.95,1,NA,NA,NA,NA,NA,"Q9UL54-2",NA,NA,NA,0,0,70.8,71.7,81.3,118.5,114.7,116,105.2,114.7,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1011(100)]",0,"ENSG00000149930"
"1266","STX7",-0.0868495917915455,6.6816516052592,-0.717989334063559,0.489885868555853,0.631093974587672,-6.73275802822322,"NONE",FALSE,"High","Master Protein","O15400","Syntaxin-7 [OS=Homo sapiens]",0,22.334,5,1,1,3,1,261,29.8,5.55,10.54,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf05739, Pf14523","8417","E1P579; hsa:8417; O15400; Q5SZW2; Q96ES9","ENSG00000079950",NA,NA,0,0,78.8,76.5,70.3,117,106.9,139.5,110.1,129,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T79(99.6)]",0,"ENSG00000079950"
"1267","HSPA4",0.0775065398807255,6.6547590006765,0.717882913174236,0.489948569731974,0.631093974587672,-6.73283741871562,"NONE",FALSE,"High","Master Protein","P34932","Heat shock 70 kDa protein 4 [OS=Homo sapiens]",0,7.914,2,1,1,1,1,840,94.3,5.19,2.96,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport","non-structural extracellular;cytosol;mitochondrion;nucleus","other molecular function","Pf00012","3308","hsa:3308; O95756; P34932; Q2TAL4; Q9BUK9","ENSG00000170606","Regulation of HSF1-mediated heat shock response","Parkin-ubiquitin proteasomal system pathway; HDAC6 interactions in the central nervous system",3,0,90.1,84.2,96.5,103.6,90.2,111.6,118.2,113.5,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S647(100)]",0,"ENSG00000170606"
"1268","NAB2",0.0714637123306874,6.56543463753139,0.713014374070972,0.492822384793221,0.634236018666213,-6.73645807466892,"NONE",FALSE,"High","Master Protein","Q15742","NGFI-A-binding protein 2 [OS=Homo sapiens]",0,66.635,17,3,4,5,3,525,56.6,6.96,21.54,3,"developmental processes;other biological processes","nucleus","other molecular function","Pf04904, Pf04905","4665","B2RAK3; hsa:4665; O76006; Q14797; Q15742","ENSG00000166886","NGF-stimulated transcription; EGR2 and SOX10-mediated initiation of Schwann cell myelination",NA,2,0,131.6,101.5,115.4,80.2,84.3,80.8,86.3,92.4,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S171(100); S205(99.4)]",0,"ENSG00000166886"
"1269","MAPKAP1",0.0829506359221392,6.65949912004459,0.712434895531357,0.493165139514353,0.634236018666213,-6.73688754998037,"NONE",FALSE,"High","Master Protein","Q9BPZ7","Target of rapamycin complex 2 subunit MAPKAP1 [OS=Homo sapiens]",0.006,1.827,2,1,1,2,1,522,59.1,7.55,5.25,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf05422, Pf16978, Pf16979","79109","A8K1Z5; B1AMA4; B7Z309; hsa:79109; Q00426; Q5JSV5; Q5JSV6; Q5JSV9; Q658R0; Q699U1; Q699U2; Q699U3; Q699U4; Q6GVJ0; Q6GVJ1; Q6GVJ2; Q9BPZ7","ENSG00000119487","PIP3 activates AKT signaling; CD28 dependent PI3K/Akt signaling; Constitutive Signaling by AKT1 E17K in Cancer; Regulation of TP53 Degradation; VEGFR2 mediated vascular permeability","Target of rapamycin signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Head and neck squamous cell carcinoma; ADHD and autism (ASD) linked metabolic pathways and SNP; Interferon type I signaling pathways",13,0,71.2,69.2,66.7,109.2,107.1,137.3,110.1,135.3,130.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(100)]",0,"ENSG00000119487"
"1270","RIOK2",-0.0778999018680686,6.66536797672559,-0.711514504083549,0.493709845295664,0.634436588600412,-6.73756904478842,"NONE",FALSE,"High","Master Protein","Q9BVS4","Serine/threonine-protein kinase RIO2 [OS=Homo sapiens]",0,22.192,5,2,2,2,2,552,63.2,5.94,6.51,2,"cell cycle OR cell proliferation;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf01163, Pf09202","55781","D6RDI3; hsa:55781; Q9BVS4; Q9NUT0","ENSG00000058729","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,90.7,95.3,106.5,106.5,89.6,117.3,94.8,114.9,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.6); S350(100)]",0,"ENSG00000058729"
"1271","DMAP1",0.0881202580818856,6.65263731779795,0.710598612825666,0.494252259322429,0.63463390024721,-6.73824642133542,"NONE",FALSE,"High","Master Protein","Q9NPF5","DNA methyltransferase 1-associated protein 1 [OS=Homo sapiens]",0,30.401,3,1,1,3,1,467,53,9.5,14.19,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf05499, Pf16282","55929","A8K001; D3DPY8; hsa:55929; Q0JSM4; Q5TG41; Q7Z3H7; Q9H0S8; Q9NPF5; Q9P2C2","ENSG00000178028","HATs acetylate histones",NA,1,0,93.1,91.5,105.6,101.8,71.3,118.5,108.9,107.8,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T445(99.6)]",0,"ENSG00000178028"
"1272","RFFL",0.104193632521919,6.66007601047248,0.707802420496217,0.495910526532572,0.636262562343677,-6.74030957932671,"NONE",FALSE,"High","Master Protein","Q8WZ73","E3 ubiquitin-protein ligase rififylin [OS=Homo sapiens]",0,16.876,5,1,1,3,1,363,40.5,5.48,9.27,1,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13920, Pf21272","117584","E1P633; Q8NHW0; Q8TBY7; Q8WZ73; Q96BE6","ENSG00000092871","Regulation of TP53 Degradation","TNF-alpha signaling pathway; 17q12 copy number variation syndrome",3,0,77.5,96.8,95,88.3,129.7,101.3,100.5,107.9,130.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100)]",0,"ENSG00000092871"
"1273","SMARCC1",0.121734950111677,6.51990814991781,0.706020882648509,0.496968856705135,0.637119539782231,-6.74162026128949,"NONE",FALSE,"High","Master Protein","Q92922","SWI/SNF complex subunit SMARCC1 [OS=Homo sapiens]",0,28.028,2,3,3,6,3,1105,122.8,5.76,15.41,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf04433, Pf16495, Pf16496, Pf16498","6599","hsa:6599; Q17RS0; Q6P172; Q8IWH2; Q92922","ENSG00000173473","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",6,0,127.3,129.5,115.7,77.9,83.4,61.2,83.3,74.2,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S310(100); S328(100); S330(100)]",0,"ENSG00000173473"
"1274","HACD3",-0.126365507069294,6.54713772902184,-0.702332896352095,0.499164162565221,0.638948710962627,-6.74432406797994,"NONE",FALSE,"High","Master Protein","Q9P035","Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 [OS=Homo sapiens]",0,42.508,8,3,4,36,3,362,43.1,8.94,69.2,3,"other metabolic processes;signal transduction;other biological processes","other membranes;ER/Golgi;nucleus","enzyme regulator activity;other molecular function","Pf04387","51495","A0PJA1; B4DRF4; hsa:51495; Q280Z3; Q6PD63; Q8IUI5; Q8NC86; Q8NCB1; Q96T12; Q9NQA7; Q9P035","ENSG00000074696","Synthesis of very long-chain fatty acyl-CoAs",NA,1,0,124.5,119.9,114.3,91.3,50.4,117.1,86.6,88.4,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100); S135(100)]",0,"ENSG00000074696"
"1275","CCM2",0.080514608028607,6.66231882777478,0.701786106527461,0.499490153291277,0.638948710962627,-6.74472385470893,"NONE",FALSE,"High","Master Protein","Q9BSQ5","Cerebral cavernous malformations 2 protein [OS=Homo sapiens]",0,6.068,2,1,1,2,1,444,48.8,5.54,5.89,1,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","mitochondrion;other cell component",NA,"Pf16545","83605","A4D2L4; B3KUV0; D3DVL4; E9PDJ3; F5H0E1; F5H551; hsa:83605; Q71RE5; Q8TAT4; Q9BSQ5","ENSG00000136280",NA,NA,0,0,76.3,81.4,81,94.1,113.2,126.3,121.6,107.1,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S384(100)]",0,"ENSG00000136280"
"1276","PHB2",0.0679234362315064,6.40130430162399,0.701199473848009,0.499840044063423,0.638948710962627,-6.74515246050986,"NONE",FALSE,"High","Master Protein","Q99623","Prohibitin-2 [OS=Homo sapiens]",0,33.259,9,3,3,4,3,299,33.3,9.83,11.28,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;mitochondrion;nucleus;other cell component","other molecular function","Pf01145","11331","B4DP75; hsa:11331; Q2YDA4; Q7KYU3; Q92978; Q99623","ENSG00000215021","Processing of SMDT1; Cellular response to mitochondrial stress",NA,2,0,158.9,145.9,140.4,56.3,59,59.3,79.1,65.8,70.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S293(100)]",0,"ENSG00000215021"
"1277","DLGAP4",0.0505450482176633,6.66075858822269,0.70055330580731,0.500225619076199,0.638948710962627,-6.74562419001169,"NONE",FALSE,"High","Master Protein","Q9Y2H0","Disks large-associated protein 4 [OS=Homo sapiens]",0,71.846,6,4,5,12,4,992,107.9,7.08,42.68,4,"other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf03359","22839","E1P5T5; hsa:22839; Q5QPG4; Q5T2Y4; Q5T2Y5; Q9H137; Q9H138; Q9H1L7; Q9Y2H0","ENSG00000080845","Neurexins and neuroligins",NA,1,0,83.2,81.3,86.7,101.2,112.1,115.2,108.5,111.8,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S665(99.5); S744(100); S973(100)]",0,"ENSG00000080845"
"1278","SMAD2",0.118542858972092,6.59243146067803,0.700339535246439,0.500353218511175,0.638948710962627,-6.74578016506112,"NONE",FALSE,"High","Master Protein","Q15796","Mothers against decapentaplegic homolog 2 [OS=Homo sapiens]",0,2.797,3,1,1,1,1,467,52.3,6.58,1.78,1,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf03165, Pf03166","4087","hsa:4087; Q15796","ENSG00000175387","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Ub-specific processing proteases; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Formation of axial mesoderm; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Signaling by NODAL; FOXO-mediated transcription of cell cycle genes; Germ layer formation at gastrulation; Formation of definitive endoderm; Transcriptional regulation of pluripotent stem cells; Signaling by Activin; SMAD2/3 Phosphorylation Motif Mutants in Cancer; TGFBR1 KD Mutants in Cancer; SMAD4 MH2 Domain Mutants in Cancer; SMAD2/3 MH2 Domain Mutants in Cancer","Cell cycle; AGE/RAGE pathway; Endoderm differentiation; Mesodermal commitment pathway; Extracellular vesicle-mediated signaling in recipient cells; Mesodermal commitment pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; Tgif disruption of Shh signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Canonical and non-canonical TGF-B signaling; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Neovascularization processes; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Hepatitis B infection; TGF-beta receptor signaling in skeletal dysplasias; Regucalcin in proximal tubule epithelial kidney cells; Overlap between signal transduction pathways contributing to LMNA laminopathies; LDLRAD4 and what we know about it; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Progeria-associated lipodystrophy; Th17 cell differentiation pathway; GDNF signaling; Inflammatory bowel disease signaling; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; TGF-beta receptor signaling",49,0,60.6,101.4,69.8,100.2,95.9,116.4,102.2,119.3,120.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T172(100)]",0,"ENSG00000175387"
"1279","TAOK1",-0.055067190641636,6.64140113080691,-0.689701950863581,0.506728081418911,0.645815611351821,-6.75348744321131,"NONE",FALSE,"High","Master Protein","Q7L7X3","Serine/threonine-protein kinase TAO1 [OS=Homo sapiens]",0,22.393,2,2,2,7,2,1001,116,7.65,18.74,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069","57551","A2RUT8; B7ZLV6; hsa:57551; Q7L7X3; Q96L75; Q9H2K7; Q9H7S5; Q9P2I6","ENSG00000160551","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Microtubule cytoskeleton regulation; MAPK signaling pathway",8,0,90.2,90.7,88.6,102.8,116.9,102.8,101.4,100.4,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S421(100); S445(100)]",0,"ENSG00000160551"
"1280","NUP107",0.0786336024613021,6.65151158511359,0.688629617309352,0.50737345246093,0.645815611351821,-6.75425846653048,"NONE",FALSE,"High","Master Protein","P57740","Nuclear pore complex protein Nup107 [OS=Homo sapiens]",0,25.285,4,2,2,4,2,925,106.3,5.43,16.47,2,"cell organization and biogenesis;other metabolic processes;transport;developmental processes","other membranes;cytosol;nucleus;other cell component","other molecular function","Pf04121","57122","B4DZ67; hsa:57122; P57740; Q6PJE1","ENSG00000111581","HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation","Gastric cancer network 1; Primary ovarian insufficiency",37,0,102.7,99.1,88.7,95.7,83.7,114.8,94.6,115.4,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S86(99.4)]",0,"ENSG00000111581"
"1281","MIA2",0.0713563773153902,6.63105359861008,0.688398150593113,0.507512823758451,0.645815611351821,-6.75442475198329,"NONE",FALSE,"High","Master Protein","Q96PC5","Melanoma inhibitory activity protein 2 [OS=Homo sapiens]",0,36.19,3,3,4,9,3,1412,159.7,4.69,19.88,3,"transport;other biological processes","other membranes;ER/Golgi","enzyme regulator activity;other molecular function","Pf07653","4253","A0A193H6U5; A1L4H0; B3KRA6; B4DQS6; D3DSA6; G3XAC5; hsa:4253; O00169; O15320; Q6MZN2; Q6P2R8; Q86TF6; Q8IX92; Q8IX93; Q96PC5; Q9H6C1","ENSG00000150527","Cargo concentration in the ER",NA,1,0,82.3,84.9,94.3,99.2,101.5,106.5,98.5,102.8,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S747(99.7); S1144(100)]",0,"ENSG00000150527"
"1282","PHC3",0.0523867641420344,6.60821186213645,0.688290346688705,0.507577742882674,0.645815611351821,-6.7545021809294,"NONE",FALSE,"High","Master Protein","Q8NDX5","Polyhomeotic-like protein 3 [OS=Homo sapiens]",0,44.226,3,3,5,6,3,983,106.1,6.62,20.7,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00536, Pf21319","80012","A2RRP9; hsa:80012; Q5HYF0; Q6NSG2; Q8NDX5; Q8NFT7; Q8NFZ1; Q8TBM2; Q9H971; Q9H9I4","ENSG00000173889","SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6",NA,9,0,113.9,107.3,111.3,87.5,87.5,90.6,96.3,91.2,102.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100); T609(100); S616(100)]",0,"ENSG00000173889"
"1283","MTMR2",-0.0689609106592384,6.68060431747528,-0.688072061157453,0.507709209169355,0.645815611351821,-6.75465892845493,"NONE",FALSE,"High","Master Protein","Q13614","Myotubularin-related protein 2 [OS=Homo sapiens]",0,21.85,3,1,1,2,1,643,73.3,7.4,6.98,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02893, Pf06602","8898","A6NN98; hsa:8898; Q13614; Q9UPS9","ENSG00000087053","Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane; Synthesis of PIPs at the ER membrane","Intracellular trafficking proteins involved in CMT neuropathy",5,0,86,116.4,109.9,104.9,100.3,105.5,100.1,102.9,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(100)]",0,"ENSG00000087053"
"1284","SNRNP70",0.0598011017862534,6.65354326640842,0.684596786828693,0.509805051293409,0.647976513793492,-6.75714840579448,"NONE",FALSE,"High","Master Protein","P08621","U1 small nuclear ribonucleoprotein 70 kDa [OS=Homo sapiens]",0,33.505,11,2,2,3,2,437,51.5,9.94,11.32,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf12220","6625","B3KUA3; hsa:6625; P08621; P78493; P78494; Q15364; Q15686; Q15687; Q15689; Q99377; Q9UE45; Q9UE46; Q9UE47; Q9UE48; Q9UFQ6","ENSG00000104852","mRNA Splicing - Major Pathway","mRNA processing",2,0,78.8,87.4,85.6,98.5,117.1,110.5,117.3,109.9,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S320(100)]",0,"ENSG00000104852"
"1285","TMX2",-0.102551876982192,6.53410464263473,-0.682827327724585,0.51087418345904,0.648830091365878,-6.75841155190935,"NONE",FALSE,"High","Master Protein","Q9Y320","Thioredoxin-related transmembrane protein 2 [OS=Homo sapiens]",0,2.755,9,1,1,1,1,296,34,8.69,3.24,1,"developmental processes","other membranes;mitochondrion;ER/Golgi;other cell component","other molecular function","Pf00085","51075","B7Z4R4; hsa:51075; Q53G73; Q561W0; Q5J7Q7; Q8NBP9; Q9H3L1; Q9Y320","ENSG00000213593",NA,NA,0,0,126.7,123,98.6,73.3,104.9,83.1,85.8,76.8,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S288(97.8)]",0,"ENSG00000213593"
"1286","TTC28",-0.0683271939428156,6.63971861362981,-0.679871632308873,0.512663091494079,0.650595773964492,-6.7605148936343,"NONE",FALSE,"High","Master Protein","Q96AY4","Tetratricopeptide repeat protein 28 [OS=Homo sapiens]",0,45.548,2,5,5,8,5,2481,270.7,6.89,24.24,5,"cell cycle OR cell proliferation;other biological processes","cytoskeleton;other cell component","other molecular function","Pf12770, Pf13176, Pf13424","23331","hsa:23331; K7ZRV2; O95928; O95929; Q5W189; Q96AY4; Q9NTE4; Q9UG31; Q9UGG5; Q9UPV8; Q9Y3S5","ENSG00000100154",NA,NA,0,0,98.6,98.1,100.6,101,81.6,118.5,92.9,100.1,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S28(100); S2104(99.1); S2108(100); S2117(99.4); S2398(100)]",0,"ENSG00000100154"
"1287","PNPLA6",0.0664191134720404,6.64358831838635,0.677327384737141,0.514206010933514,0.652046783095179,-6.7623188087774,"NONE",FALSE,"High","Master Protein","Q8IY17","Patatin-like phospholipase domain-containing protein 6 [OS=Homo sapiens]",0,45.029,4,3,3,5,3,1375,150.9,7.74,20.33,3,"other metabolic processes","other membranes;cytosol;ER/Golgi","other molecular function","Pf00027, Pf01734","10908","A6NGQ0; B4DFB9; B7Z7T2; F5H5K9; hsa:10908; J3KQS3; O60859; Q86W58; Q8IY17; Q9UG58","ENSG00000032444","Glycerophospholipid catabolism",NA,1,0,92.8,82.8,82.7,102.8,96.8,113.5,101.2,123.2,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S354(100); S420(100); T464(100)]",0,"ENSG00000032444"
"1288","GSK3B",0.0857102218418424,6.59079529135094,0.676198052882865,0.514891775726048,0.652109961514604,-6.76311755671979,"NONE",FALSE,"High","Master Protein","P49841","Glycogen synthase kinase-3 beta [OS=Homo sapiens]",0,61.632,13,3,3,11,3,420,46.7,8.78,43.33,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069","2932","D3DN89; hsa:2932; P49841; Q9BWH3; Q9UL47","ENSG00000082701","Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Ubiquitin-dependent degradation of Cyclin D; Regulation of RUNX2 expression and activity; Regulation of HSF1-mediated heat shock response; Constitutive Signaling by AKT1 E17K in Cancer; B-WICH complex positively regulates rRNA expression; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; CRMPs in Sema3A signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; AKT phosphorylates targets in the cytosol; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Maturation of nucleoprotein; Maturation of nucleoprotein","IL-5 signaling pathway; Androgen receptor signaling pathway; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; IL-17 signaling pathway; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac progenitor differentiation; T cell receptor and co-stimulatory signaling; Cardiac hypertrophic response; Focal adhesion; Copper homeostasis; Melatonin metabolism and effects; Wnt signaling pathway; IL6 signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Regulation of apoptosis by parathyroid hormone-related protein; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Wnt signaling pathway and pluripotency; PI3K/AKT/mTOR - vitamin D3 signaling; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; Acute viral myocarditis; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; NRF2-ARE regulation; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Influence of laminopathies on Wnt signaling; MAP3K1 role in promoting and blocking gonadal determination; Overlap between signal transduction pathways contributing to LMNA laminopathies; Glycogen synthesis and degradation; Pleural mesothelioma; CCL18 signaling pathway; Alzheimer's disease; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; Sildenafil treatment; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; Notch signaling pathway; ErbB signaling pathway; DNA damage response (only ATM dependent)",95,0,111.8,112.4,115.6,76.5,101.8,81.4,87.7,91,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(99.4); S215(100); T390(98.7)]",0,"ENSG00000082701"
"1289","HYOU1",-0.158790121872728,6.64659813990336,-0.675929405423886,0.515054987985493,0.652109961514604,-6.7633073860665,"NONE",FALSE,"High","Master Protein","Q9Y4L1","Hypoxia up-regulated protein 1 [OS=Homo sapiens]",0,60.801,4,2,3,9,2,999,111.3,5.22,32.51,2,"protein metabolism;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;ER/Golgi;other cell component","other molecular function","Pf00012","10525","A8C1Z0; B7Z909; hsa:10525; Q2I204; Q53H25; Q9Y4L1","ENSG00000149428; ENSG00000280682","XBP1(S) activates chaperone genes; Scavenging by Class F Receptors","VEGFA-VEGFR2 signaling",3,0,104.7,102.6,99.2,125.6,54.6,128.9,104.7,101.9,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S567(100)]",0,"ENSG00000149428"
"1290","PWWP2A",0.0792838015427435,6.51770612458674,0.673150807197386,0.516744910439851,0.652799000430289,-6.76526675467299,"NONE",FALSE,"High","Master Protein","Q96N64","PWWP domain-containing protein 2A [OS=Homo sapiens]",0,9.303,2,1,1,1,1,755,81.9,9,3.64,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf00855","114825","G5EA07; hsa:114825; Q2HJJ2; Q8IYR3; Q96N64; Q96PV3","ENSG00000170234",NA,NA,0,0,136.1,127.3,138.4,64.8,80.6,66.1,82.2,91.4,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(100)]",0,"ENSG00000170234"
"1291","TPD52",0.180034693214036,6.50902112220951,0.673104727901432,0.516772963658569,0.652799000430289,-6.76529918632198,"NONE",FALSE,"High","Master Protein","P55327","Tumor protein D52 [OS=Homo sapiens]",0.006,1.773,5,1,1,1,1,224,24.3,4.83,2.65,1,"transport;other biological processes","ER/Golgi;other cell component","other molecular function","Pf04201","7163","B7Z414; C9J502; D0UFD1; D0UFD2; D0UFD3; D0UFD4; D0UFD5; E5RKB4; hsa:7163; P55327; Q13056; Q53EK8; Q6FGP3; Q6FGS3; Q86YZ2; Q9UCX8","ENSG00000076554","Golgi Associated Vesicle Biogenesis",NA,1,0,30.8,43.5,48.1,143.6,178,93.3,161.4,167,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(100)]",0,"ENSG00000076554"
"1292","SUZ12",0.0497510600102595,6.61799552373881,0.672484214710043,0.517150823376121,0.652799000430289,-6.76573572093169,"NONE",FALSE,"High","Master Protein","Q15022","Polycomb protein SUZ12 [OS=Homo sapiens]",0,16.681,6,2,2,2,2,739,83,8.81,4.72,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf09733","23512","hsa:23512; Q15022; Q96BD9","ENSG00000178691","HCMV Early Events; SUMOylation of chromatin organization proteins; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; PRC2 methylates histones and DNA; Defective pyroptosis","Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Pleural mesothelioma; NF1 copy number variation syndrome",15,0,111.9,104.5,102.3,91.2,88.6,94.5,93.2,98.6,105.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T348(77.1); S350(77.1); S546(100)]",0,"ENSG00000178691"
"1293","PRKACG",0.259028287539524,6.11432170081025,0.672404778130891,0.517199208061498,0.652799000430289,-6.76579157859481,"NONE",FALSE,"High","Master Protein","P22612","cAMP-dependent protein kinase catalytic subunit gamma [OS=Homo sapiens]",0,6.233,5,1,1,3,1,351,40.4,8.59,5.8,1,"cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5568","hsa:5568; O60850; P22612; Q5VZ02; Q86YI1","ENSG00000165059","FCGR3A-mediated IL10 synthesis; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; MAPK6/MAPK4 signaling; Triglyceride catabolism; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; RET signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; CD209 (DC-SIGN) signaling; Rap1 signalling; HDL assembly; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5; PKA-mediated phosphorylation of key metabolic factors","AMP-activated protein kinase signaling; Dopamine metabolism; Polycystic kidney disease pathway; Common pathways underlying drug addiction; G protein signaling pathways; MAPK signaling pathway; Cannabinoid receptor signaling; Chemokine signaling pathway; Lipid metabolism pathway; Ras signaling; Hedgehog signaling pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GPR143 in melanocytes and retinal pigment epithelium cells; Vasopressin-regulated water reabsorption; Cardiomyocyte signaling pathways converging on titin; ADHD and autism (ASD) linked metabolic pathways and SNP",44,0,188,179.3,181.7,53.2,14.3,44,75.7,54,38.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T198(100)]",0,"ENSG00000165059"
"1294","HSF1",-0.0725420890598736,6.6352108764335,-0.670170118844484,0.518561451489958,0.654012587968787,-6.76736047183261,"NONE",FALSE,"High","Master Protein","Q00613","Heat shock factor protein 1 [OS=Homo sapiens]",0,12.943,4,1,1,1,1,529,57.2,5.19,3.47,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00447, Pf06546","3297","A8K4L0; A8MW26; hsa:3297; Q00613; Q53XT4","ENSG00000185122; ENSG00000284774","Regulation of HSF1-mediated heat shock response; Attenuation phase; Aggrephagy; HSF1 activation","10q11.21q11.23 copy number variation syndrome; HDAC6 interactions in the central nervous system",7,0,105.9,84.9,79.9,104.3,112.9,105.4,99.9,100.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(100)]",0,"ENSG00000185122"
"1295","ATP1A2",-0.057012971822652,6.56176948112241,-0.665854323869514,0.521198444347647,0.656423481095441,-6.77037701816997,"NONE",FALSE,"High","Master Protein","P50993","Sodium/potassium-transporting ATPase subunit alpha-2 [OS=Homo sapiens]",0,75.252,8,6,7,10,6,1020,112.2,5.66,36.51,6,"other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf13246","477","D3DVE4; hsa:477; P50993; Q07059; Q5JW74; Q86UZ5; Q9UQ25","ENSG00000018625","Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases","Synaptic vesicle pathway",4,0,134.8,127.2,119.8,80.8,67.2,94.7,85.1,81.9,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S439(100)]",0,"ENSG00000018625"
"1296","QKI",0.0662761052300374,6.50821708200894,0.665725189449033,0.521277470281674,0.656423481095441,-6.77046700386686,"NONE",FALSE,"High","Master Protein","Q96PU8","KH domain-containing RNA-binding protein QKI [OS=Homo sapiens]",0,34.523,9,2,3,3,2,341,37.6,8.56,11.14,2,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf16544, Pf16551","9444","hsa:9444; Q2I375; Q5MJQ1; Q969L9; Q96EJ3; Q96KA3; Q96PU6; Q96PU7; Q96PU8; Q9P0X6; Q9P0X7; Q9P0X8; Q9P0X9; Q9P0Y0; Q9P0Y1","ENSG00000112531","Signaling by BRAF and RAF1 fusions","VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation",3,0,149.2,126.8,134,69.1,69.7,67.7,90.1,75.7,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S69(100); S188(100)]",0,"ENSG00000112531"
"1297","CTPS1",-0.0972397782762178,6.59369486492895,-0.662792340992724,0.523074204873693,0.658178182231201,-6.77250643987196,"NONE",FALSE,"High","Master Protein","P17812","CTP synthase 1 [OS=Homo sapiens]",0,13.518,2,1,1,2,1,591,66.6,6.46,5.02,1,"cell cycle OR cell proliferation;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00117, Pf06418, Pf07722","1503","B4DR64; D3DPW1; hsa:1503; P17812; Q5VW67; Q96GK6","ENSG00000171793","Interconversion of nucleotide di- and triphosphates","Pyrimidine metabolism",2,0,118,115.1,105.1,99.5,66.9,104.6,89.3,106.7,78.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S575(99.6)]",0,"ENSG00000171793"
"1298","JCAD",0.0473744688227296,6.646795898337,0.661282403418421,0.524000669527172,0.658835972779926,-6.77355321496582,"NONE",FALSE,"High","Master Protein","Q9P266","Junctional cadherin 5-associated protein [OS=Homo sapiens]",0,42.994,8,6,6,7,6,1359,148.3,7.09,20.86,6,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf15351","57608","hsa:57608; Q5HYA7; Q5T992; Q86WZ9; Q9BYJ2; Q9P266","ENSG00000165757",NA,NA,0,0,75.7,79.5,73,107.8,113.5,118,116.4,111.9,120,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S375(98.6); S694(99.3); S770(100); S1044(100); S1281(100); S1304(100)]",0,"ENSG00000165757"
"1299","PAGR1",-0.0959194122691365,6.61377878954949,-0.658474318000094,0.525726247870334,0.660483891456026,-6.77549414860654,"NONE",FALSE,"High","Master Protein","Q9BTK6","PAXIP1-associated glutamate-rich protein 1 [OS=Homo sapiens]",0,20.387,7,1,1,3,1,254,27.7,4.46,10.33,1,"DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf15364","79447","A2ICR6; hsa:79447; Q9BTK6","ENSG00000280789","Formation of WDR5-containing histone-modifying complexes; Activation of anterior HOX genes in hindbrain development during early embryogenesis","16p11.2 proximal deletion syndrome; Kleefstra syndrome",4,0,81.8,78.7,80.9,118.9,109.9,102.5,126.3,92.7,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S237(100)]",0,"ENSG00000280789"
"1300","MYPOP",-0.0619201075873015,6.57721724206118,-0.657833108406448,0.526120746870609,0.660483891456026,-6.77593629208606,"NONE",FALSE,"High","Master Protein","Q86VE0","Myb-related transcription factor, partner of profilin [OS=Homo sapiens]",0,13.922,4,1,1,1,1,399,42.5,10.07,3.97,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf13873","339344","hsa:339344; Q86VE0","ENSG00000176182",NA,NA,0,0,113.3,96.3,113.8,85.5,98.4,92,93.3,94.8,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000176182"
"1301","KIF13B",-0.0603080905627023,6.64245017156547,-0.655003441772582,0.52786377569939,0.662162707103308,-6.7778827787477,"NONE",FALSE,"High","Master Protein","Q9NQT8","Kinesin-like protein KIF13B [OS=Homo sapiens]",0,55.16,3,4,4,5,4,1826,202.7,5.88,17.72,4,"transport;signal transduction;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225, Pf00498, Pf01302, Pf12423, Pf12473, Pf16183","23303","B4DGY5; B5MC45; F8VPJ2; hsa:23303; O75134; Q9BYJ6; Q9NQT8","ENSG00000197892","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,90.1,90.4,88.8,106,95.3,117.6,93.9,110.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); S1381(100); S1644(100); S1797(100)]",0,"ENSG00000197892"
"1302","HADHB",0.049820839970601,6.58362153100597,0.653600184244033,0.528729427860366,0.662739190682117,-6.77884521576784,"NONE",FALSE,"High","Master Protein","P55084","Trifunctional enzyme subunit beta, mitochondrial [OS=Homo sapiens]",0,8.788,4,3,3,4,2,474,51.3,9.41,8.88,3,"other metabolic processes;other biological processes","other membranes;mitochondrion;ER/Golgi","nucleic acid binding activity;other molecular function","Pf00108, Pf02803","3032","B2RB16; B4E2W0; hsa:3032; O14969; P55084; Q53TA6; Q96C77; Q9H3F5; Q9T2V8","ENSG00000138029","Acyl chain remodeling of CL; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of myristoyl-CoA to lauroyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA; Beta oxidation of palmitoyl-CoA to myristoyl-CoA","Fatty acid beta-oxidation; Valproic acid pathway; Female steroid hormones in cardiomyocyte energy metabolism; Sudden infant death syndrome (SIDS) susceptibility pathways",12,0,120.2,110.9,106.5,85,76.6,93.4,89.3,98.8,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S197(100)]",0,"ENSG00000138029"
"1303","CANX",0.0541016422920126,6.58423219977183,0.652040856784769,0.529692342638998,0.663164339840107,-6.77991248155822,"NONE",FALSE,"High","Master Protein","P27824","Calnexin [OS=Homo sapiens]",0,263.04,13,10,21,113,10,592,67.5,4.6,452.09,10,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf00262","821","B2R5V8; B4DGP8; B4E2T8; D3DWQ3; D6R9K3; hsa:821; P27824","ENSG00000127022; ENSG00000283777","MHC class II antigen presentation; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Interleukin-35 Signalling; Interleukin-27 signaling; Assembly of Viral Components at the Budding Site; Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein","15q11q13 copy number variation",9,0,116.7,116.6,112.3,86.2,83.3,82.4,97.1,86.4,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S564(100); S583(100)]",0,"ENSG00000127022"
"1304","TBC1D9B",-0.0554657712566753,6.64059702521738,-0.651735041899013,0.529881310754595,0.663164339840107,-6.78012152005245,"NONE",FALSE,"High","Master Protein","Q66K14","TBC1 domain family member 9B [OS=Homo sapiens]",0,103.574,6,5,9,16,5,1250,140.4,5.25,54.97,5,NA,"other membranes","enzyme regulator activity;other molecular function","Pf00566, Pf02893","23061","D3DWQ5; D3DWQ6; hsa:23061; O75163; Q53EY0; Q66K14; Q6MZI2; Q96H49","ENSG00000197226; ENSG00000284400",NA,NA,0,0,88.4,87.3,96.9,102,109.4,107.6,95.1,103.2,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S411(100); S435(100); S442(100); S995(99.7); S1238(100)]",0,"ENSG00000197226"
"1305","TMEM245",-0.0729591641544438,6.63754612724668,-0.650169463830314,0.530849331250365,0.663866749885513,-6.78119025951811,"NONE",FALSE,"High","Master Protein","Q9H330","Transmembrane protein 245 [OS=Homo sapiens]",0,60.801,3,1,4,12,1,879,97.3,8.91,47.6,1,NA,"other membranes",NA,"Pf01594","23731","B4DSW7; hsa:23731; Q5JTQ5; Q5SS43; Q6ZME3; Q8NDJ5; Q96CG6; Q9H330","ENSG00000106771",NA,NA,0,0,93.9,96.3,98.6,97.2,84.5,123.9,92.3,102.8,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S327(98.8); S332(99.4)]",0,"ENSG00000106771"
"1306","ANKRD13D",-0.0843440692444961,6.63908045206709,-0.648230069709924,0.532049933602952,0.664446250951475,-6.78251092267885,"NONE",FALSE,"High","Master Protein","Q6ZTN6","Ankyrin repeat domain-containing protein 13D [OS=Homo sapiens]",0,3.763,4,1,1,2,1,605,68.1,5.59,2.35,1,"other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf11904, Pf12796","338692","D6RCN6; hsa:338692; Q0VAK0; Q0VGC3; Q6ZTN6; Q6ZVD0; Q86SU1","ENSG00000172932",NA,NA,0,0,99.4,105.9,96.5,90.1,114.8,104.3,85.9,96.7,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S552(100); T556(100)]",0,"ENSG00000172932"
"1307","UBE2J1",-0.0671397471220105,6.61068408056777,-0.648105682417477,0.532126991417633,0.664446250951475,-6.78259550308348,"NONE",FALSE,"High","Master Protein","Q9Y385","Ubiquitin-conjugating enzyme E2 J1 [OS=Homo sapiens]",0,25.48,5,1,1,3,1,318,35.2,6.74,15.06,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf00179","51465","A8K3F9; hsa:51465; Q53F25; Q5W0N4; Q9BZ32; Q9NQL3; Q9NY66; Q9P011; Q9P0S0; Q9UF10; Q9Y385","ENSG00000198833","Antigen processing: Ubiquitination & Proteasome degradation","Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway",3,0,102.1,104.8,93.8,91,108.7,98.4,94,90.7,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000198833"
"1308","OPTN",0.0810588580265046,6.68750752796462,0.645876298637547,0.533509206588268,0.665662863266096,-6.78410891083269,"NONE",FALSE,"High","Master Protein","Q96CV9","Optineurin [OS=Homo sapiens]",0,6.539,2,1,1,2,1,577,65.9,5.17,3.1,1,"cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf11577, Pf16516, Pf18414","10133","B3KP00; D3DRS4; D3DRS8; hsa:10133; Q5T672; Q5T673; Q5T674; Q5T675; Q7LDL9; Q8N562; Q96CV9; Q9UET9; Q9UEV4; Q9Y218","ENSG00000123240","Regulation of PLK1 Activity at G2/M Transition; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TBC/RABGAPs; TNFR1-induced proapoptotic signaling","HDAC6 interactions in the central nervous system",6,0,72.4,68.8,73.9,129.9,134.7,97.3,124.3,123.3,126.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(100)]",0,"ENSG00000123240"
"1309","RING1",-0.125834063449687,6.60017780241817,-0.643005144786363,0.535292423189725,0.667377566574203,-6.78605094305234,"NONE",FALSE,"High","Master Protein","Q06587","E3 ubiquitin-protein ligase RING1 [OS=Homo sapiens]",0,20.1,4,1,1,3,1,406,42.4,5.62,9.95,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00097, Pf16207","6015","A8JZZ0; Q06587; Q5JP96; Q5SQW2; Q86V19","ENSG00000204227; ENSG00000206287; ENSG00000226788; ENSG00000228520; ENSG00000231115; ENSG00000235107","Oxidative Stress Induced Senescence; SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6","Pleural mesothelioma; Notch signaling pathway",11,0,86.1,83.4,124.9,102.1,104.4,96.3,78.2,92.6,125,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S38(100)]",0,"ENSG00000204227"
"1310","CMTM4",0.140282857526964,6.68987717117599,0.640094465159895,0.53710374936058,0.669124670959135,-6.78801161319053,"NONE",FALSE,"High","Master Protein","Q8IZR5","CKLF-like MARVEL transmembrane domain-containing protein 4 [OS=Homo sapiens]",0,9.827,6,1,2,2,1,234,25.8,7.75,5.66,1,NA,"other membranes",NA,"Pf01284","146223","hsa:146223; Q52M40; Q8IZR4; Q8IZR5; Q8IZV1","ENSG00000183723",NA,NA,0,0,100.5,95.6,71.6,116,100.9,98.8,130.3,138.8,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(99.4)]",0,"ENSG00000183723"
"1311","HTT",0.0509141337631576,6.64979077870834,0.636691540088912,0.539225937150719,0.671256086521719,-6.7902935162374,"NONE",FALSE,"High","Master Protein","P42858","Huntingtin [OS=Homo sapiens]",0,83.958,2,4,7,14,4,3142,347.4,6.2,54.65,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf20925, Pf20926, Pf20927","3064","hsa:3064; P42858; Q9UQB7","ENSG00000197386","Regulation of MECP2 expression and activity","Mesodermal commitment pathway; Mesodermal commitment pathway; ERK pathway in Huntington's disease; Rett syndrome; 15q25 copy number variation; HDAC6 interactions in the central nervous system",7,0,108.2,101.1,108.7,96.8,81.4,103.4,94.8,102.7,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S419(100); S432(100); S1199(100); S1864(100); S1874(100)]",0,"ENSG00000197386"
"1312","GAPDH",-0.0625752402793402,6.59355253730389,-0.634015619514288,0.540898164623695,0.67282454623923,-6.79208006574611,"NONE",FALSE,"High","Master Protein","P04406","Glyceraldehyde-3-phosphate dehydrogenase [OS=Homo sapiens]",0,127.293,30,10,14,28,10,335,36,8.46,81.62,10,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00044, Pf02800","2597","E7EUT4; hsa:2597; P00354; P04406; Q53X65","ENSG00000111640","Glycolysis; Gluconeogenesis","Cori cycle; Alzheimer's disease and miRNA effects; HIF1A and PPARG regulation of glycolysis; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; 7q11.23 copy number variation syndrome; Glycolysis in senescence; Alzheimer's disease; Sildenafil treatment; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways",16,0,117.5,112.2,116.9,92.2,66.9,104.7,87.4,92.6,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T153(99.5); T211(99.7)]",0,"ENSG00000111640"
"1313","HSP90AA1",0.0806216353780176,6.67802400424377,0.632679112760418,0.541734497370403,0.673351637249426,-6.79296978111873,"NONE",FALSE,"High","Master Protein","P07900","Heat shock protein HSP 90-alpha [OS=Homo sapiens]",0,223.28,23,16,16,28,9,732,84.6,5.02,101.91,16,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","3320","A8K500; B3KPJ9; hsa:3320; P07900; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5","ENSG00000080824","Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Aggrephagy; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Extra-nuclear estrogen signaling; Neutrophil degranulation; vRNP Assembly; Estrogen-dependent gene expression; Regulation of necroptotic cell death; Interleukin-4 and Interleukin-13 signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; PIWI-interacting RNA (piRNA) biogenesis; VEGFR2 mediated vascular permeability; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; eNOS activation; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Uptake and function of diphtheria toxin; Constitutive Signaling by Overexpressed ERBB2; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication; Scavenging by Class F Receptors; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants","Nucleotide-binding oligomerization domain (NOD) pathway; TNF-alpha signaling pathway; Corticotropin-releasing hormone signaling pathway; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Aryl hydrocarbon receptor pathway; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced AP-1 survival signaling; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Th17 cell differentiation pathway; HDAC6 interactions in the central nervous system",71,7,82.8,85.3,100.2,114.1,80.9,116.9,115,120.5,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100); S263(100)]",0,"ENSG00000080824"
"1314","CLASRP",0.061199261929417,6.47623790233043,0.627510114165311,0.544976103242466,0.676865297177857,-6.79639454055125,"NONE",FALSE,"High","Master Protein","Q8N2M8","CLK4-associating serine/arginine rich protein [OS=Homo sapiens]",0,20.907,5,3,3,8,3,674,77.1,10.4,19.51,3,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf09750","11129","A0A0A0MQS2; B4DDT8; F8WAG9; hsa:11129; O96026; Q6UW71; Q8N2M8; Q96DX2","ENSG00000104859",NA,"mRNA processing",1,0,139.9,138.3,131.5,70.4,66,63.2,82.6,71.3,84.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S285(100); S501(99.7); S547(100)]",0,"ENSG00000104859"
"1315","PSEN1",-0.118019831649501,6.63894558640726,-0.626803528845388,0.545420089252175,0.67690158605289,-6.79686068543444,"NONE",FALSE,"High","Master Protein","P49768","Presenilin-1 [OS=Homo sapiens]",0,26.739,4,1,2,4,1,467,52.6,5.31,11.64,1,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;other molecular function","Pf01080","5663","B2R6D3; hsa:5663; O95465; P49768; Q14762; Q15719; Q15720; Q96P33; Q9UIF0","ENSG00000080815","Degradation of the extracellular matrix; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Neutrophil degranulation; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3","Alzheimer's disease and miRNA effects; Notch signaling; Canonical and non-canonical Notch signaling; Inclusion body myositis; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; TROP2 regulatory signaling; Notch signaling pathway",22,0,71.8,72.5,76.4,101.8,105.8,154.5,90.9,113,142.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S366(99.6)]",0,"ENSG00000080815"
"1316","KDM3B",0.0882471944172645,6.60410904388542,0.625335947017876,0.546342917367901,0.677531642207002,-6.7978273258502,"NONE",FALSE,"High","Master Protein","Q7LBC6","Lysine-specific demethylase 3B [OS=Homo sapiens]",0,19.377,2,1,3,4,1,1761,191.5,7.18,10.13,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02373","51780","A6H8X7; hsa:51780; Q7LBC6; Q9BVH6; Q9BW93; Q9BZ52; Q9NYF4; Q9UPS0","ENSG00000120733","HDMs demethylate histones","Thermogenesis",2,0,97.2,101.1,89.4,106.5,93.1,81.1,110.9,88,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(99.2); T729(99.2)]",0,"ENSG00000120733"
"1317","PAXX",0.0739422005001282,6.65503892868304,0.624057517359382,0.547147537684591,0.677891648839351,-6.79866767804861,"NONE",FALSE,"High","Master Protein","Q9BUH6","Protein PAXX [OS=Homo sapiens]",0,22.659,15,2,2,2,2,204,21.6,5.48,7.39,2,"DNA metabolism;other metabolic processes;stress response","nucleus;other cell component","other molecular function","Pf15384","286257","hsa:286257; Q8IY19; Q9BUH6","ENSG00000148362",NA,NA,0,0,92.8,108,98.8,89.3,116.9,94.1,102.5,97.4,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100); S152(100)]",0,"ENSG00000148362"
"1318","WBP4",0.152160724508947,6.58156501877094,0.623555052667033,0.547463966403348,0.677891648839351,-6.79899753023434,"NONE",FALSE,"High","Master Protein","O75554","WW domain-binding protein 4 [OS=Homo sapiens]",0,9.48,4,1,1,1,1,376,42.5,5.57,2.7,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00397, Pf06220","11193","B7Z4M2; hsa:11193; O75554; Q32P29","ENSG00000120688","mRNA Splicing - Major Pathway",NA,1,0,70.2,79.6,77.5,85.1,182.4,77.8,121.7,94.7,128.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100)]",0,"ENSG00000120688"
"1319","CARD19",-0.125873337344037,6.70258363544186,-0.612134313975698,0.554684505917631,0.686311685866242,-6.80642876872871,"NONE",FALSE,"High","Master Protein","Q96LW7-2","Isoform 2 of Caspase recruitment domain-containing protein 19 [OS=Homo sapiens]",0,15.2,13,1,1,1,1,183,20.6,8.1,4.18,1,NA,NA,NA,NA,NA,"Q96LW7-2",NA,NA,NA,0,0,136.2,89.6,115.6,110.8,101,101.9,75.5,102.9,130.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(100)]",0,"ENSG00000165233"
"1320","ILF3",0.0582467351620757,6.6523243514149,0.608079348989101,0.557261158961396,0.688400437252017,-6.80903671941296,"NONE",FALSE,"High","Master Protein","Q12906-7","Isoform 7 of Interleukin enhancer-binding factor 3 [OS=Homo sapiens]",0,46.975,9,3,3,5,3,898,95.7,8.81,20.91,3,NA,NA,NA,NA,NA,"Q12906-7",NA,NA,NA,0,0,89.9,92.8,99.3,102.5,88.8,108.7,114.8,108.4,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S190(99.4); S482(100)]",0,"ENSG00000129351"
"1321","PHF3",0.0836796600084995,6.65523407755777,0.607840488376062,0.557413149749612,0.688400437252017,-6.80918984261946,"NONE",FALSE,"High","Master Protein","Q92576","PHD finger protein 3 [OS=Homo sapiens]",0,18.361,2,2,2,2,2,2039,229.3,6.96,6.55,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00628, Pf07500, Pf07744","23469","A3KFI8; hsa:23469; Q14CR5; Q5CZI1; Q5T1T6; Q92576; Q9NQ16; Q9UI45","ENSG00000118482",NA,NA,0,0,99.9,114.7,97.1,92.6,108.8,90.2,120.1,96.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(100); S1614(99.4)]",0,"ENSG00000118482"
"1322","SIRT2",0.0477873688888897,6.66290475003142,0.607274349878344,0.557773486349111,0.688400437252017,-6.80955254720943,"NONE",FALSE,"High","Master Protein","Q8IXJ6","NAD-dependent protein deacetylase sirtuin-2 [OS=Homo sapiens]",0,43.703,9,2,2,5,2,389,43.2,5.36,26.43,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","other molecular function","Pf02146","22933","A8K3V1; B2RB45; hsa:22933; O95889; Q8IXJ6; Q924Y7; Q9P0G8; Q9UNT0; Q9Y6E9; U5TP13","ENSG00000068903; ENSG00000283100","Initiation of Nuclear Envelope (NE) Reformation","NAD+ metabolism; NAD+ biosynthetic pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; HDAC6 interactions in the central nervous system",5,0,88.2,96.7,90.3,102.2,97.6,111.4,110.7,101.8,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S368(100); S372(100)]",0,"ENSG00000068903"
"1323","HECTD4",0.0606931238565922,6.59717981557177,0.606824481265513,0.558059913287021,0.688400437252017,-6.80984053886791,"NONE",FALSE,"High","Master Protein","Q9Y4D8","Probable E3 ubiquitin-protein ligase HECTD4 [OS=Homo sapiens]",0,63.639,2,4,6,13,4,3996,439.1,6.19,32.72,4,"protein metabolism;other metabolic processes;other biological processes","other membranes","other molecular function","Pf00632",NA,"L8B0P6; Q3MJD5; Q6P0A0; Q7L530; Q8NB70; Q8WU73; Q96NT9; Q9NZS4; Q9UFT6; Q9Y4D8",NA,NA,NA,0,0,114.5,111.5,107.7,89.8,66,103.1,95.3,92.7,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1107(99.4); S1139(99.4); T2080(100)]",0,"ENSG00000173064"
"1324","RBM39",-0.0418433275730132,6.50635776396954,-0.605443670277533,0.558939581352619,0.688964801183892,-6.81072325674857,"NONE",FALSE,"High","Master Protein","Q14498","RNA-binding protein 39 [OS=Homo sapiens]",0,41.304,8,4,4,16,4,530,59.3,10.1,58.35,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf00076, Pf15519","9584","A2RRD3; A5D8W2; B0BLV3; E1P5S0; E1P5S1; hsa:9584; Q14498; Q14499","ENSG00000131051","mRNA Splicing - Major Pathway","VEGFA-VEGFR2 signaling; mRNA processing",3,0,135.8,128.3,125.8,77.7,63.5,82.3,78.6,84.2,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S97(100); S117(100); S129(100); S136(100)]",0,"ENSG00000131051"
"1325","TBC1D5",-0.0460137097869326,6.66644843028352,-0.601099602648531,0.561712139254442,0.691859782085471,-6.81348816408074,"NONE",FALSE,"High","Master Protein","Q92609","TBC1 domain family member 5 [OS=Homo sapiens]",0,33.613,5,3,4,9,3,795,88.9,6.54,28.51,3,"other metabolic processes;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00566","9779","A6NP25; C9JP52; hsa:9779; Q92609","ENSG00000131374",NA,NA,0,0,92.6,90.6,100.5,109.8,95.6,111.2,104.5,107.3,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S522(100); S541(100); S554(99.7)]",0,"ENSG00000131374"
"1326","SOX6",-0.0567995403665158,6.68112091431496,-0.5974772205458,0.564029988850183,0.694113271863356,-6.81577962308463,"NONE",FALSE,"High","Master Protein","P35712","Transcription factor SOX-6 [OS=Homo sapiens]",0,3.757,2,1,1,1,1,828,91.9,7.78,2.47,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","55553","hsa:55553; P35712; Q86VX7; Q9BXQ3; Q9BXQ4; Q9BXQ5; Q9H0I8","ENSG00000110693","Deactivation of the beta-catenin transactivating complex","NOTCH1 regulation of endothelial cell calcification; Endochondral ossification; Endochondral ossification with skeletal dysplasias",4,0,67.8,66.5,72.1,132.2,113.4,127.5,125.1,116.5,121.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(98.7)]",0,"ENSG00000110693"
"1327","RPL11",-0.0454109878574265,6.39167943400946,-0.596490838826404,0.564662070796286,0.694113271863356,-6.81640136645977,"NONE",FALSE,"High","Master Protein","P62913","Large ribosomal subunit protein uL5 [OS=Homo sapiens]",0,26.719,17,3,4,4,3,178,20.2,9.6,10.1,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00281, Pf00673","6135","hsa:6135; P25121; P39026; P62913; Q8TDH2; Q9Y674","ENSG00000142676","L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","MET in type 1 papillary renal cell carcinoma; Cytoplasmic ribosomal proteins",15,0,155.1,146.6,149.7,58.2,50.3,66.8,71.5,70.8,65.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T47(100)]",0,"ENSG00000142676"
"1328","DKC1",-0.0422388464646701,6.64722314663793,-0.596248128523883,0.564817662398613,0.694113271863356,-6.81655420728125,"NONE",FALSE,"High","Master Protein","O60832","H/ACA ribonucleoprotein complex subunit DKC1 [OS=Homo sapiens]",0,66.096,9,5,6,15,5,514,57.6,9.42,44.66,5,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01472, Pf01509, Pf08068, Pf16198","1736","F5BSB3; hsa:1736; O43845; O60832; Q96G67; Q9Y505","ENSG00000130826","rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase",NA,2,0,102.1,100.2,101.5,98.3,96.4,105.9,98.1,96.1,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S455(100); S494(100); S513(100)]",0,"ENSG00000130826"
"1329","PSMA3",-0.054522881467701,6.67005660411555,-0.592808634886042,0.567025155420974,0.696207812662253,-6.81871393634998,"NONE",FALSE,"High","Master Protein","P25788","Proteasome subunit alpha type-3 [OS=Homo sapiens]",0,23.949,5,1,2,65,1,255,28.4,5.33,107.36,1,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00227, Pf10584","5684","B2RCK6; hsa:5684; P25788; Q86U83; Q8N1D8; Q9BS70","ENSG00000100567","FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cross-presentation of soluble exogenous antigens (endosomes); Regulation of ornithine decarboxylase (ODC); Somitogenesis","Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease",62,0,83.8,86,87.3,117.6,121.6,99.4,108.5,110.2,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100)]",0,"ENSG00000100567"
"1330","SDE2",-0.0869066040663649,6.63817069226727,-0.592022747112344,0.567530218347001,0.696207812662253,-6.8192057831285,"NONE",FALSE,"High","Master Protein","Q6IQ49","Splicing regulator SDE2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,451,49.7,6.05,5.1,1,"cell cycle OR cell proliferation;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity","Pf13019, Pf13297","163859","A8K4P3; hsa:163859; Q5TD36; Q6IQ49; Q6ZS26; Q8NAG7","ENSG00000143751","mRNA Splicing - Major Pathway",NA,1,0,81.1,110.4,109.2,106.9,117.4,86,100.5,91.5,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100)]",0,"ENSG00000143751"
"1331","CAMSAP2",-0.0411656157189277,6.67772205611046,-0.591600263598683,0.567801837410207,0.696207812662253,-6.81946994336336,"NONE",FALSE,"High","Master Protein","Q08AD1","Calmodulin-regulated spectrin-associated protein 2 [OS=Homo sapiens]",0,65.509,8,8,11,16,8,1489,168,6.8,47.31,8,"cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;ER/Golgi","cytoskeletal activity;other molecular function","Pf08683, Pf11971, Pf17095","23271","B1APG6; hsa:23271; Q08AD1; Q08AD2; Q6PGN8; Q96FB3; Q9UG20; Q9UPS4","ENSG00000118200",NA,NA,0,0,89.8,91,91.3,107.2,108.8,113.8,102.1,114.1,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S464(100); S611(100); S673(100); S844(100); S862(100); S1276(100); S1313(100)]",0,"ENSG00000118200"
"1332","NAA10",-0.0480355882824615,6.61611889894465,-0.590444218466441,0.568545440595784,0.696596215504744,-6.82019187156088,"NONE",FALSE,"High","Master Protein","P41227","N-alpha-acetyltransferase 10 [OS=Homo sapiens]",0,12.517,5,1,1,1,1,235,26.4,5.64,4.05,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00583","8260","A6NM98; hsa:8260; P41227","ENSG00000102030",NA,NA,0,0,105.5,104.1,100.3,95.9,94.9,98.3,88.8,104.9,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S205(100)]",0,"ENSG00000102030"
"1333","CTTNBP2NL",-0.0495867936127432,6.69209412700372,-0.589521329347587,0.569139459172308,0.696800898251468,-6.82076725631013,"NONE",FALSE,"High","Master Protein","Q9P2B4","CTTNBP2 N-terminal-like protein [OS=Homo sapiens]",0,44.668,5,2,3,5,2,639,70.1,8.06,17.88,2,"protein metabolism;other metabolic processes;other biological processes","cytoskeleton;other cell component","other molecular function","Pf09727","55917","B3KMS5; hsa:55917; Q96B40; Q9P2B4","ENSG00000143079",NA,NA,0,0,73.8,84.8,86.6,122.7,113.4,115.4,113.3,111.5,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S488(100); S557(98.8); S560(98.8); S568(100)]",0,"ENSG00000143079"
"1334","TFG",0.105564471305907,6.66747086535203,0.58721229102706,0.570627182751577,0.698098622376741,-6.82220318431863,"NONE",FALSE,"High","Master Protein","Q92734","Protein TFG [OS=Homo sapiens]",0,15.2,6,1,1,1,1,400,43.4,5.1,4.74,1,"cell organization and biogenesis;transport","cytosol;ER/Golgi;other cell component","other molecular function","Pf00564","10342","D3DN49; G5E9V1; hsa:10342; K0J5S8; K0J6K2; Q15656; Q92734; Q969I2","ENSG00000114354","Signaling by ALK fusions and activated point mutants; COPII-mediated vesicle transport",NA,2,0,109.7,85.5,74.6,105,88.9,116.1,134.4,94.8,110.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S197(100)]",0,"ENSG00000114354"
"1335","INO80B",0.0509547987637839,6.63262642046707,0.586505354748759,0.571083095380427,0.698133042442589,-6.82264176089728,"NONE",FALSE,"High","Master Protein","Q9C086","INO80 complex subunit B [OS=Homo sapiens]",0,8.414,4,1,2,3,1,356,38.6,9.61,6.46,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf04438, Pf04795","83444","hsa:83444; Q9C086","ENSG00000115274","UCH proteinases; DNA Damage Recognition in GG-NER",NA,2,0,91.9,92.2,91.2,97.7,84.8,116.1,103.6,102.8,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000115274"
"1336","POLR2A",-0.0451164758051643,6.59701896085346,-0.584422207130666,0.572427716590521,0.698786700827214,-6.82393126778749,"NONE",FALSE,"High","Master Protein","P24928","DNA-directed RNA polymerase II subunit RPB1 [OS=Homo sapiens]",0,16.757,2,2,4,8,2,1970,217,7.37,15.53,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00623, Pf04983, Pf04990, Pf04992, Pf04997, Pf04998, Pf05000, Pf05001","5430","A6NN93; B9EH88; hsa:5430; P24928; Q6NX41",NA,"Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere","Pyrimidine metabolism; Eukaryotic transcription initiation; mRNA processing",44,0,117.2,116.1,103.3,91.8,77.4,98.9,89.6,94.7,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1877(98.7); S1920(99.6); S1934(99.6); S3842(99.4)]",0,"ENSG00000181222"
"1337","AKT1S1",-0.0896632505698634,6.66446910838536,-0.584350312852592,0.572474153802687,0.698786700827214,-6.82397569545741,"NONE",FALSE,"High","Master Protein","Q96B36","Proline-rich AKT1 substrate 1 [OS=Homo sapiens]",0,45.224,14,3,5,13,3,256,27.4,4.75,29.08,3,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity","Pf15798","84335","A8MTQ1; B2RE93; hsa:84335; J3KPM3; Q96B36; Q96BI4; Q96IK7; Q96NG2; Q9BWR5","ENSG00000204673","HSF1-dependent transactivation; Constitutive Signaling by AKT1 E17K in Cancer; mTORC1-mediated signalling; AKT phosphorylates targets in the cytosol","Target of rapamycin signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Thermogenesis; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Thyroid hormones production and peripheral downstream signaling effects; Autophagy; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; DYRK1A involvement regarding cell proliferation in brain development; JAK-STAT signaling in the regulation of beta cells; ADHD and autism (ASD) linked metabolic pathways and SNP",22,0,79.5,87.8,92,110.3,154.1,91.2,113.5,101.2,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S212(100)]",0,"ENSG00000204673"
"1338","ZRSR2",-0.0781922269328517,6.51265406654468,-0.583515786149674,0.573013334886904,0.698922094570573,-6.82449102595912,"NONE",FALSE,"High","Master Protein","Q15696","U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 [OS=Homo sapiens]",0,4.322,2,1,1,1,1,482,58,9.72,2.81,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf00642","8233","hsa:8233; Q14D69; Q15696","ENSG00000169249","mRNA Splicing - Minor Pathway",NA,1,0,127.5,109.5,125.4,84.9,57.6,96.9,75.5,81.3,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100)]",0,"ENSG00000169249"
"1339","SP1",0.152584806447318,6.62582491276695,0.578340241597537,0.576363458821545,0.70248331948974,-6.82767166978833,"NONE",FALSE,"High","Master Protein","P08047","Transcription factor Sp1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,785,80.6,7.34,3.97,1,"stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6667","E4Z9M7; G5E9M8; hsa:6667; P08047; Q86TN8; Q9H3Q5; Q9NR51; Q9NY21; Q9NYE7","ENSG00000185591","PPARA activates gene expression; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Oncogene Induced Senescence; Activation of gene expression by SREBF (SREBP); SARS-CoV-1 targets host intracellular signalling and regulatory pathways; Regulation of CDH11 gene transcription; NFE2L2 regulating tumorigenic genes","Androgen receptor signaling pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Leptin signaling pathway; IL-17 signaling pathway; Androgen receptor network in prostate cancer; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Constitutive androstane receptor pathway; Estrogen receptor pathway; Nuclear receptors meta-pathway; Myometrial relaxation and contraction pathways; Copper homeostasis; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Mitochondrial gene expression; Oxidative stress response; Breast cancer pathway; Ethanol metabolism production of ROS by CYP2E1; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Gastrin signaling pathway; IL-18 signaling pathway; Angiotensin II receptor type 1 pathway; Pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; Genetic causes of porto-sinusoidal vascular disease; HDAC6 interactions in the central nervous system; Pathways in cancer; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway",42,0,70.8,98.6,96.2,91,144.6,77.2,115.4,82.3,152.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100)]",0,"ENSG00000185591"
"1340","DCTN2",0.0740958178598321,6.66108770154422,0.573741836021693,0.579348994305942,0.705595193065147,-6.83047546902647,"NONE",FALSE,"High","Master Protein","Q13561","Dynactin subunit 2 [OS=Homo sapiens]",0,15.2,6,1,1,1,1,401,44.2,5.21,4.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf04912","10540","B2RBK5; hsa:10540; Q13561; Q86YN2; Q9BW17","ENSG00000175203","MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2","Vasopressin-regulated water reabsorption",12,0,72,82.6,102.9,111.9,107.6,100.9,118.5,115.3,103.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T198(100)]",0,"ENSG00000175203"
"1341","ZNF318",-0.0510430802281743,6.45617057414301,-0.572395453587527,0.580224734725238,0.706134800202527,-6.83129245064674,"NONE",FALSE,"High","Master Protein","Q5VUA4","Zinc finger protein 318 [OS=Homo sapiens]",0,23.783,2,4,4,8,4,2279,251,7.2,18.05,4,"cell cycle OR cell proliferation;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function",NA,"24149","hsa:24149; O94796; Q4G0E4; Q5VUA4; Q8NEM6; Q9UNU8; Q9Y2W9","ENSG00000171467",NA,"Androgen receptor signaling pathway",1,0,145.3,144.6,150,64.8,65.6,64.5,78.4,69.6,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S709(100); S1761(100); S2101(100)]",0,"ENSG00000171467"
"1342","NELFB",0.0933094789939659,6.60039927968278,0.564598354017052,0.585310422620669,0.711793300832289,-6.83598845245103,"NONE",FALSE,"High","Master Protein","Q8WX92","Negative elongation factor B [OS=Homo sapiens]",0,30.401,4,1,1,6,1,580,65.7,6.13,15.33,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf06209","25920","A0A0X1KG71; A2BFA3; hsa:25920; Q8WX92; Q96EW5; Q9H9R4; Q9ULN8; Q9Y3W0","ENSG00000188986","Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; NTRK3 as a dependence receptor","Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation; 5q35 copy number variation",18,0,97.4,111.5,114.3,93.8,65.9,100.5,97.1,119.4,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(100)]",0,"ENSG00000188986"
"1343","ATF2",-0.145030713885221,6.59661781483182,-0.563252245718613,0.58619086012846,0.712333197118129,-6.83679308580759,"NONE",FALSE,"High","Master Protein","P15336","Cyclic AMP-dependent transcription factor ATF-2 [OS=Homo sapiens]",0,24.578,10,3,3,5,3,505,54.5,7.88,8.65,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170","1386","A1L3Z2; A4D7U4; A4D7U5; A4D7V1; D3DPE9; G8JLM5; hsa:1386; P15336; Q13000; Q3B7B7; Q4ZFU9; Q53RY2; Q8TAR1; Q96JT8","ENSG00000115966","NGF-stimulated transcription; Heme signaling; Regulation of PTEN gene transcription; TP53 Regulates Transcription of DNA Repair Genes; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Estrogen-dependent gene expression; HATs acetylate histones; Activation of the AP-1 family of transcription factors; Response of EIF2AK4 (GCN2) to amino acid deficiency","Energy metabolism; IL-1 signaling pathway; B cell receptor signaling pathway; AGE/RAGE pathway; ATM signaling pathway; Interleukin-1 (IL-1) structural pathway; Myometrial relaxation and contraction pathways; Photodynamic therapy-induced AP-1 survival signaling; TGF-beta signaling pathway; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; DNA IR-double strand breaks and cellular response via ATM; Ethanol effects on histone modifications; p38 MAPK signaling pathway; PI3K-Akt signaling pathway; Thermogenesis; Gastrin signaling pathway; Hepatitis B infection; Thyroid hormones production and peripheral downstream signaling effects; Host-pathogen interaction of human coronaviruses - MAPK signaling; Pleural mesothelioma; 10q11.21q11.23 copy number variation syndrome; T-cell receptor signaling pathway",36,0,100.2,78.7,105.2,105.3,129.4,82.8,134.3,75.3,85.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(100); S307(100)]",0,"ENSG00000115966"
"1344","PTDSS2",0.0956006747898712,6.61906405382523,0.561561967006092,0.587297417048213,0.712661007242405,-6.83780090157454,"NONE",FALSE,"High","Master Protein","Q9BVG9","Phosphatidylserine synthase 2 [OS=Homo sapiens]",0,14.996,3,2,2,4,2,487,56.2,6.25,5.2,2,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf03034","81490","hsa:81490; Q9BVG9","ENSG00000174915","Synthesis of PS","Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",3,0,70.6,76.5,78.9,103.5,128.3,100,89.9,144,124,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000174915"
"1345","ADGRL3",0.0653917885705972,6.69636856898496,0.561506146537202,0.587333979620732,0.712661007242405,-6.83783413575842,"NONE",FALSE,"High","Master Protein","Q9HAR2","Adhesion G protein-coupled receptor L3 [OS=Homo sapiens]",0,27.046,4,3,3,5,3,1447,161.7,6.44,12.87,3,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction","plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf01825, Pf02140, Pf02191, Pf02354, Pf02793, Pf16489","23284","E9PE04; hsa:23284; O94867; Q9HAR2; Q9NWK5","ENSG00000150471",NA,"GPCRs, other; GPCRs, class B secretin-like",2,0,83.1,91.6,74.8,109.3,97.2,126.3,111.1,128.8,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1132(100); S1419(99.7)]",0,"ENSG00000150471"
"1346","UBR4",-0.0481311360615955,6.59234446712975,-0.559015114547091,0.588966859223878,0.7141113776028,-6.83931408882376,"NONE",FALSE,"High","Master Protein","Q5T4S7","E3 ubiquitin-protein ligase UBR4 [OS=Homo sapiens]",0,54.089,2,6,7,14,6,5183,573.5,6.04,37.56,6,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","other molecular function","Pf02207, Pf13764, Pf19423","23352","A8MPT2; A8MQ33; A8MQB1; O60646; O75050; Q4QRK5; Q5T4S7; Q5T4S8; Q5T4S9; Q5TBN8; Q5TBP2; Q6DKH8; Q6P4A4; Q7L8P7; Q8IXJ4; Q8TDN5; Q8WV67; Q9HA46; Q9P2N9; Q9UG82","ENSG00000127481","Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation",NA,2,0,115.7,107.3,117.1,82.9,88.2,97.2,90.2,87.3,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S2885(99.2)]",0,"ENSG00000127481"
"1347","GNAO1",0.0601700512727774,6.66205875066071,0.557771964479893,0.589782658816647,0.714569635626405,-6.84005035506318,"NONE",FALSE,"High","Master Protein","P09471-2","Isoform Alpha-2 of Guanine nucleotide-binding protein G(o) subunit alpha [OS=Homo sapiens]",0,13.764,8,3,3,3,1,354,40.1,5.9,5.15,3,NA,NA,NA,NA,NA,"P09471-2",NA,NA,NA,0,0,97.3,100.1,110.7,105.2,74,108,102.8,97.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000087258"
"1348","GTF2F2",0.078445707628596,6.62456964078857,0.556244211437928,0.590786053952783,0.715254332382005,-6.84095307689154,"NONE",FALSE,"High","Master Protein","P13984","General transcription factor IIF subunit 2 [OS=Homo sapiens]",0,7.68,4,1,1,6,1,249,28.4,9.23,7.6,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf02270, Pf17683","2963","A6NNS5; hsa:2963; P13984; Q5W0H3","ENSG00000188342","TP53 Regulates Transcription of DNA Repair Genes; Estrogen-dependent gene expression; Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM","Eukaryotic transcription initiation",33,0,97.4,99.1,102.5,89.6,124.8,79.1,104.8,95,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S248(100)]",0,"ENSG00000188342"
"1349","STAG2",0.076328378230845,6.60338757531502,0.55032779804808,0.594680422668763,0.718921525983514,-6.84442707815176,"NONE",FALSE,"High","Master Protein","Q8N3U4","Cohesin subunit SA-2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1231,141.2,5.43,3.91,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf08514, Pf21581","10735","B1AMT5; D3DTF5; hsa:10735; O00540; Q5JTI6; Q68DE9; Q8N3U4; Q9H1N8","ENSG00000101972","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Meiotic synapsis; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cell cycle; Cohesin complex - Cornelia de Lange syndrome",9,0,83.8,105.2,120.9,103.1,74,90.6,91.6,110.3,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1061(100)]",0,"ENSG00000101972"
"1350","VIM",0.0531027886871271,6.64403460000874,0.550122077132907,0.594816079757142,0.718921525983514,-6.84454724657624,"NONE",FALSE,"High","Master Protein","P08670","Vimentin [OS=Homo sapiens]",0,898.126,77,42,81,267,40,466,53.6,5.12,819.87,42,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00038, Pf04732","7431","B0YJC2; D3DRU4; hsa:7431; P08670; Q15867; Q15868; Q15869; Q548L2; Q6LER9; Q8N850; Q96ML2; Q9NTM3","ENSG00000026025","Aggrephagy; Interleukin-4 and Interleukin-13 signaling; Chaperone Mediated Autophagy; Late endosomal microautophagy; Striated Muscle Contraction; RHOBTB1 GTPase cycle; Caspase-mediated cleavage of cytoskeletal proteins","Allograft rejection; Spinal cord injury; Primary focal segmental glomerulosclerosis (FSGS); Mammary gland development pathway - Puberty (Stage 2 of 4); Apoptosis-related network due to altered Notch3 in ovarian cancer; Striated muscle contraction pathway; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Ciliary landscape; Burn wound healing; CCL18 signaling pathway; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; T-cell receptor signaling pathway",21,0,75.8,73.8,75.2,107.4,108.4,122.4,103,129.7,121.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S10(99.6); S26(99.5); T33(99); S39(100); S42(99.5); S51(100); S73(100); S83(100); S205(99.2); S214(100); S339(100); S419(100); S420(99.6); S430(100); S438(99.6); T446(100); S459(99.4)]",0,"ENSG00000026025"
"1351","SLC30A1",-0.0865078167145521,6.62344637171146,-0.549636067564045,0.595136630884637,0.718921525983514,-6.8448309734692,"NONE",FALSE,"High","Master Protein","Q9Y6M5","Proton-coupled zinc antiporter SLC30A1 [OS=Homo sapiens]",0,13.931,3,1,1,1,1,507,55.3,6.48,4.75,1,"stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf01545","7779","hsa:7779; Q0VAK9; Q9BZF6; Q9Y6M5","ENSG00000170385","Zinc efflux and compartmentalization by the SLC30 family","Zinc homeostasis",2,0,131.6,113.5,86.4,104.6,97.6,87.4,94.1,107.5,83.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(99.5)]",0,"ENSG00000170385"
"1352","SRGAP3",0.0503788374936978,6.6650561138703,0.5489209411631,0.595608464365438,0.718959329766564,-6.84524802827142,"NONE",FALSE,"High","Master Protein","O43295","SLIT-ROBO Rho GTPase-activating protein 3 [OS=Homo sapiens]",0,71.264,9,9,9,16,9,1099,124.4,6.68,36.64,9,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00611, Pf00620","9901","hsa:9901; O43295; Q8IX13; Q8IZV8","ENSG00000196220","CDC42 GTPase cycle; RAC1 GTPase cycle; Inactivation of CDC42 and RAC1",NA,3,0,92,93.7,87.7,105.5,114.7,95.5,102.3,109,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S858(100); S874(99.3); S895(99.4); S908(100); S919(100); S1069(99.4)]",0,"ENSG00000196220"
"1353","RAPGEF1",0.0354341264674618,6.65393940161221,0.547212936695806,0.596736191467045,0.719526593606403,-6.84624205750182,"NONE",FALSE,"High","Master Protein","Q13905","Rap guanine nucleotide exchange factor 1 [OS=Homo sapiens]",0,33.577,5,3,3,6,3,1077,120.5,5.92,20.71,3,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00617, Pf00618","2889","hsa:2889; Q13905; Q5JUE4; Q68DL3; Q8IV73","ENSG00000107263","RAC3 GTPase cycle; Regulation of signaling by CBL; Downstream signal transduction; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1","Integrin-mediated cell adhesion; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; IL-3 signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; MET in type 1 papillary renal cell carcinoma; Insulin signaling; Interferon type I signaling pathways",17,0,92.3,89.4,97.4,103.1,99,104.5,104.7,108.1,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S281(100); S311(100)]",0,"ENSG00000107263"
"1354","AHSG",-0.0700540569857546,6.36409509529343,-0.54687390292349,0.596960176313156,0.719526593606403,-6.84643902336781,"NONE",FALSE,"High","Master Protein","P02765","Alpha-2-HS-glycoprotein [OS=Homo sapiens]",0,6.885,4,1,1,2,1,367,39.3,5.72,5,1,"stress response;transport;developmental processes;other biological processes","extracellular matrix;ER/Golgi;other cell component","enzyme regulator activity","Pf00031","197","A8K9N6; B2R7G1; hsa:197; O14961; O14962; P02765; Q9P152","ENSG00000145192","Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,4,0,151.8,164.7,139.2,55.7,65.6,52.6,69.8,62.7,68.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000145192"
"1355","MVB12B",0.0704815428594792,6.62005370715815,0.541012692167298,0.600839439205016,0.723667870688255,-6.8498260343815,"NONE",FALSE,"High","Master Protein","Q9H7P6","Multivesicular body subunit 12B [OS=Homo sapiens]",0,8.569,3,1,2,2,1,319,35.6,8.15,6.05,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10240","89853","hsa:89853; Q8N6S7; Q9H7P6","ENSG00000196814","HCMV Late Events; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy",NA,5,0,105.9,106.2,136.7,91.3,63.6,103.8,94,96,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T226(100)]",0,"ENSG00000196814"
"1356","ANKLE2",-0.0729168491537227,6.52440504098442,-0.533554240508781,0.605794921233341,0.728653555818484,-6.85408639791279,"NONE",FALSE,"High","Master Protein","Q86XL3","Ankyrin repeat and LEM domain-containing protein 2 [OS=Homo sapiens]",0,11.916,4,2,2,2,2,938,104.1,7.09,5.74,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","other membranes;ER/Golgi","enzyme regulator activity;other molecular function","Pf00023, Pf01693, Pf03020","23141","A8KAG3; B3KN97; B3KSF8; hsa:23141; O75176; Q6P6A5; Q86XL3; Q8TAZ9; Q96DH4","ENSG00000176915","RHOG GTPase cycle; RAC2 GTPase cycle; Initiation of Nuclear Envelope (NE) Reformation",NA,3,0,121.6,127.7,117.6,71.4,85.3,83.4,74.1,79.1,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T47(99.3); S662(100)]",0,"ENSG00000176915"
"1357","OTUB1",-0.0457508791790611,6.6419029214297,-0.533217332134924,0.606019268795995,0.728653555818484,-6.85427752989668,"NONE",FALSE,"High","Master Protein","Q96FW1","Ubiquitin thioesterase OTUB1 [OS=Homo sapiens]",0,29.117,10,1,2,3,1,271,31.3,4.94,14.05,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus","enzyme regulator activity;other molecular function","Pf10275","55611","hsa:55611; Q32Q78; Q96FW1; Q96II3; Q9NXQ4; Q9P0B8","ENSG00000167770","Ub-specific processing proteases; Ovarian tumor domain proteases",NA,2,0,97.8,84.7,86.5,105.8,109.4,104.6,102,100,113.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000167770"
"1358","HMG20A",0.0559792825253789,6.63944058797689,0.532295656246243,0.606633234365579,0.728653555818484,-6.85479982607627,"NONE",FALSE,"High","Master Protein","Q9NP66","High mobility group protein 20A [OS=Homo sapiens]",0,5.827,4,1,1,2,1,347,40.1,6.49,5.36,1,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00505","10363","A6NHY3; D3DW78; hsa:10363; Q53G31; Q9NP66; Q9NSF6","ENSG00000140382",NA,NA,0,0,96.6,112.3,106.2,94.8,106.6,85.4,104.4,94.6,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100)]",0,"ENSG00000140382"
"1359","SEPTIN5",-0.0927208678132914,6.67662653549755,-0.532098188561979,0.606764817620907,0.728653555818484,-6.85491161652544,"NONE",FALSE,"High","Master Protein","Q99719","Septin-5 [OS=Homo sapiens]",0,18,5,1,2,5,1,369,42.8,6.67,9.77,1,"cell-cell signaling;cell cycle OR cell proliferation;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf00735","5413","hsa:5413; O15251; Q96MY5; Q99719","ENSG00000184702",NA,"Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway; 22q11.2 copy number variation syndrome",3,0,111.2,97.9,103.5,122.5,71.9,112,102.5,116.1,83.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S327(100)]",0,"ENSG00000184702"
"1360","SNX27",0.070768238746739,6.61268720316295,0.529461150585188,0.608523436789516,0.730228124147419,-6.85640075033146,"NONE",FALSE,"High","Master Protein","Q96L92","Sorting nexin-27 [OS=Homo sapiens]",0,7.444,2,1,1,1,1,541,61.2,6.49,3.49,1,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00595, Pf00787, Pf00788","81609","hsa:81609; Q32Q36; Q4AEJ5; Q5VWB0; Q5VWB1; Q5VWB2; Q6IPP6; Q86UB1; Q96D79; Q96L92; Q9H3K8","ENSG00000143376",NA,NA,0,0,117.2,121,126.7,71.1,96,89.1,91,84.3,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000143376"
"1361","ATXN2L",0.0342198503246154,6.66162085145471,0.527845835899033,0.609601979626624,0.730952260257644,-6.85730947284406,"NONE",FALSE,"High","Master Protein","Q8WWM7","Ataxin-2-like protein [OS=Homo sapiens]",0,101.926,10,7,9,21,7,1075,113.3,8.59,53.76,7,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf06741, Pf07145, Pf14438","11273","A8K1R6; B9EGM2; E9PAR9; hsa:11273; O95135; Q63ZY4; Q6NVJ8; Q6PJW6; Q8IU61; Q8IU95; Q8WWM3; Q8WWM4; Q8WWM5; Q8WWM6; Q8WWM7; Q99703","ENSG00000168488",NA,"16p11.2 distal deletion syndrome",1,0,83.4,85.5,87.2,103.6,107.4,114.2,107.8,109.9,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S111(100); S339(100); S449(100); S559(98.9); S594(100)]",0,"ENSG00000168488"
"1362","TUBB2B",-0.0417933363523142,6.63709843833442,-0.527216193391042,0.610022658376784,0.730952260257644,-6.85766297959081,"NONE",FALSE,"High","Master Protein","Q9BVA1","Tubulin beta-2B chain [OS=Homo sapiens]",0,281.564,42,14,22,61,5,445,49.9,4.89,162.78,14,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00091, Pf03953","347733","A8K068; hsa:347733; Q9BVA1","ENSG00000137285","MHC class II antigen presentation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Assembly and cell surface presentation of NMDA receptors; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",35,13,105.8,98.9,103.7,99,82.6,111.1,97.8,99.6,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T55(100); S75(100); S172(100); T312(100)]",0,"ENSG00000137285"
"1363","PARD3",-0.0712494209492851,6.65144914122474,-0.522675215815302,0.613061022311218,0.734053990030746,-6.8602006777077,"NONE",FALSE,"High","Master Protein","Q8TEW0","Partitioning defective 3 homolog [OS=Homo sapiens]",0,45.03,5,5,5,7,5,1356,151.3,7.68,25.59,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00595, Pf12053","56288","F5H5T0; hsa:56288; Q5T2U1; Q5VUA2; Q5VUA3; Q5VWV0; Q5VWV1; Q5VWV3; Q5VWV4; Q5VWV5; Q6IQ47; Q8TCZ9; Q8TEW0; Q8TEW1; Q8TEW2; Q8TEW3; Q96K28; Q96RM6; Q96RM7; Q9BY57; Q9BY58; Q9HC48; Q9NWL4; Q9NYE6","ENSG00000148498","Tight junction interactions; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","Chemokine signaling pathway; Complement system in neuronal development and plasticity",4,0,92.1,91.8,90.5,101.2,131.1,99,106.2,89.1,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S695(99.2); S873(100)]",0,"ENSG00000148498"
"1364","RFTN2",-0.0539169008902496,6.59468185676157,-0.518484267824209,0.615872062125527,0.736879182836408,-6.8625243690741,"NONE",FALSE,"High","Master Protein","Q52LD8","Raftlin-2 [OS=Homo sapiens]",0,7.514,2,1,1,2,1,501,55.9,5.83,3.27,1,"transport;other biological processes","plasma membrane;other membranes",NA,"Pf15250","130132","hsa:130132; Q14DH4; Q2TA69; Q52LD8; Q53QE0; Q53SE1; Q96NM3","ENSG00000162944",NA,NA,0,0,113.4,117.5,107.2,92.5,67.4,107.8,93.1,91,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S453(99.5)]",0,"ENSG00000162944"
"1365","ACTB",-0.0355095479702747,6.58926624591069,-0.51362007269213,0.619142910466985,0.740249985261626,-6.86519917277666,"NONE",FALSE,"High","Master Protein","P60709","Actin, cytoplasmic 1 [OS=Homo sapiens]",0,328.803,46,14,22,125,6,375,41.7,5.48,365.96,14,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00022","60","hsa:60; P02570; P60709; P70514; P99021; Q11211; Q64316; Q75MN2; Q96B34; Q96HG5","ENSG00000075624","UCH proteinases; Clathrin-mediated endocytosis; DNA Damage Recognition in GG-NER; RHOF GTPase cycle; Adherens junctions interactions; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHO GTPases Activate WASPs and WAVEs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; B-WICH complex positively regulates rRNA expression; Signaling by BRAF and RAF1 fusions; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; EPH-ephrin mediated repulsion of cells; HATs acetylate histones; Interaction between L1 and Ankyrins; Prefoldin mediated transfer of substrate  to CCT/TriC; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Formation of annular gap junctions; Folding of actin by CCT/TriC; Cell-extracellular matrix interactions","Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway",47,11,116.9,112.2,116.8,90.4,79.1,91.9,95,89.2,88.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T66(100); S233(98.7)]",0,"ENSG00000075624"
"1366","ACIN1",-0.0750115492695658,6.55831590254003,-0.511224958873345,0.620756700121475,0.741186305300426,-6.86650747402307,"NONE",FALSE,"High","Master Protein","Q9UKV3","Apoptotic chromatin condensation inducer in the nucleus [OS=Homo sapiens]",0,99.137,10,11,12,39,11,1341,151.8,6.43,95.06,11,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02037, Pf16294","22985","B2RTT4; D3DS45; hsa:22985; O75158; Q9UG91; Q9UKV1; Q9UKV2; Q9UKV3","ENSG00000100813","mRNA Splicing - Major Pathway; Apoptotic cleavage of cellular proteins",NA,2,0,123.4,121.2,120.5,76.5,109.4,72.9,89.3,77.4,91.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S365(100); S386(99.6); S388(100); T414(100); S490(100); S710(100); S729(100); S825(100); S990(100); S1004(100)]",0,"ENSG00000100813"
"1367","TAB2",-0.0553394484283247,6.62377418124025,-0.511109775687,0.620834362344168,0.741186305300426,-6.86657024556116,"NONE",FALSE,"High","Master Protein","Q9NYJ8","TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [OS=Homo sapiens]",0,27.67,5,2,2,2,2,693,76.4,8.54,8.32,2,"stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02845","23118","B2RCC4; E1P5A0; hsa:23118; O94838; Q6I9W8; Q76N06; Q9NYJ8; Q9UFP7","ENSG00000055208","SARS-CoV-2 activates/modulates innate and adaptive immune responses; FCERI mediated NF-kB activation; Downstream TCR signaling; CLEC7A (Dectin-1) signaling; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Nuclear signaling by ERBB4; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NF-kappa-B signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway","IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; MAPK signaling pathway; TLR4 signaling and tolerance; Exercise-induced circadian regulation; miRNA role in immune response in sepsis; Measles virus infection; Hepatitis B infection; Toll-like receptor signaling pathway",27,0,84.9,67.6,76.2,113.2,110,118.4,97.9,117.9,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S372(100); S582(100)]",0,"ENSG00000055208"
"1368","SRSF1",-0.0605508844890839,6.52079168565471,-0.507625034251658,0.623186268369475,0.742834802990801,-6.86846299794617,"NONE",FALSE,"High","Master Protein","Q07955","Serine/arginine-rich splicing factor 1 [OS=Homo sapiens]",0,53.241,13,5,6,29,5,248,27.7,10.36,59.74,5,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","6426","B2R6Z7; D3DTZ3; hsa:6426; Q07955; Q13809","ENSG00000136450","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,133.5,133.7,128.3,72.7,83.3,72.2,87.1,70.1,85.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100); S205(99); S234(100); S238(100)]",0,"ENSG00000136450"
"1369","SMARCA5",0.0379374317840577,6.4097807051545,0.506721526946717,0.623796791364349,0.742834802990801,-6.86895173967628,"NONE",FALSE,"High","Master Protein","O60264","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 [OS=Homo sapiens]",0,15.12,4,2,2,2,2,1052,121.8,8.09,6.34,2,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf09110, Pf09111","8467","hsa:8467; O60264","ENSG00000153147","Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; NoRC negatively regulates rRNA expression","10q11.21q11.23 copy number variation syndrome",5,0,154.9,153.7,143,60.6,53.7,60.3,72.5,76.2,68.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S116(100)]",0,"ENSG00000153147"
"1370","ZNF521",0.0382961336183794,6.66849336081526,0.506400343073596,0.624013895984753,0.742834802990801,-6.86912528160787,"NONE",FALSE,"High","Master Protein","Q96K83","Zinc finger protein 521 [OS=Homo sapiens]",0,15,2,2,2,2,2,1311,147.8,7.01,4.78,2,"developmental processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf12874, Pf13912","25925","A3QVP7; B0YJB7; hsa:25925; Q8IXI0; Q8TES6; Q96K83; Q9C065; Q9HAL5; Q9UFK4","ENSG00000198795","Formation of the anterior neural plate; Formation of the posterior neural plate; RUNX2 regulates osteoblast differentiation",NA,3,0,96.5,104.4,92.7,101.1,96.6,106.7,100.2,109.1,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S273(100); S605(100)]",0,"ENSG00000198795"
"1371","CCDC9",0.0710519935071545,6.53581319563717,0.506367860523215,0.624035854718375,0.742834802990801,-6.86914282676054,"NONE",FALSE,"High","Master Protein","Q9Y3X0","Coiled-coil domain-containing protein 9 [OS=Homo sapiens]",0,18.171,6,2,2,3,2,531,59.7,5.4,8.69,2,NA,"nucleus","nucleic acid binding activity","Pf15266","26093","hsa:26093; Q9Y3X0","ENSG00000105321",NA,"IL-18 signaling pathway",1,0,125.6,138.2,116.7,67.4,86.6,72,91,74.5,95.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S386(100)]",0,"ENSG00000105321"
"1372","QSOX2",0.0453701637657078,6.58476653085196,0.505689481012688,0.624494539073606,0.742838985253736,-6.86950900355062,"NONE",FALSE,"High","Master Protein","Q6ZRP7","Sulfhydryl oxidase 2 [OS=Homo sapiens]",0,16.9,6,2,2,3,2,698,77.5,7.72,7.32,2,"protein metabolism;other metabolic processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus","other molecular function","Pf00085, Pf04777, Pf18108, Pf18371","169714","A2CEE0; A6NLB0; hsa:169714; Q5TB37; Q6ZRP7; Q7Z7B6; Q86VV7; Q8N3G2","ENSG00000165661",NA,NA,0,0,114,115.5,103.6,81.4,82.2,94.5,101.1,91.8,89.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100); S578(99.6)]; Met-loss [N-Term]",0,"ENSG00000165661"
"1373","NCKIPSD",0.0463978602295558,6.66709221353813,0.502510172914672,0.626646472314365,0.743994732448221,-6.87121893496168,"NONE",FALSE,"High","Master Protein","Q9NZQ3","NCK-interacting protein with SH3 domain [OS=Homo sapiens]",0,13.271,2,1,2,4,1,722,78.9,6.38,10.69,1,"cell organization and biogenesis;transport;other biological processes","cytosol;cytoskeleton;nucleus","cytoskeletal activity;other molecular function","Pf00018, Pf09431","51517","B4DFL5; hsa:51517; Q6GU34; Q6SPF3; Q8TC10; Q9NZQ3; Q9UGM8","ENSG00000213672","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs",NA,3,0,87.7,86.2,91.3,112.1,89.3,113.9,107.8,118.9,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T180(99.7)]",0,"ENSG00000213672"
"1374","CADM4",-0.0673192129680489,6.57063614277976,-0.501913578369365,0.627050693841905,0.743994732448221,-6.87153866276768,"NONE",FALSE,"High","Master Protein","Q8NFZ8","Cell adhesion molecule 4 [OS=Homo sapiens]",0,45.601,9,2,2,5,2,388,42.8,6.3,24.31,2,"cell adhesion;other biological processes","other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf07686, Pf08205, Pf13927","199731","B2R7L5; hsa:199731; Q8NFZ8; Q9Y4A4","ENSG00000105767",NA,NA,0,0,111,119.1,104.9,77.6,76.9,110.5,83.4,85,103.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100)]",0,"ENSG00000105767"
"1375","SCAF8",0.0368683306237383,6.51861783527168,0.501798802540825,0.627128474935662,0.743994732448221,-6.87160013227987,"NONE",FALSE,"High","Master Protein","Q9UPN6","SR-related and CTD-associated factor 8 [OS=Homo sapiens]",0,42.761,2,2,2,4,2,1271,140.4,8.29,16.58,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf04818","22828","B7Z888; hsa:22828; Q5TBU6; Q6NSK3; Q9BQN8; Q9BX43; Q9UPN6","ENSG00000213079",NA,NA,0,0,134.4,129.7,129.1,78,66.5,72.5,77.7,86.5,86,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S617(99.5)]",0,"ENSG00000213079"
"1376","STIM1",-0.0677060535801939,6.62406548896733,-0.501322088746249,0.627451585133464,0.743994732448221,-6.87185529912554,"NONE",FALSE,"High","Master Protein","Q13586","Stromal interaction molecule 1 [OS=Homo sapiens]",0,26.397,3,2,2,6,2,685,77.4,6.67,18.12,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi","cytoskeletal activity;other molecular function","Pf07647, Pf16533","6786","E9PQJ4; hsa:6786; Q13586; Q8N382","ENSG00000167323","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Elevation of cytosolic Ca2+ levels","CAMKK2 pathway; Affected pathways in Duchenne muscular dystrophy",5,0,103.8,101.9,97.7,111,77.7,101.6,112.9,93.7,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S257(100); S575(100)]",0,"ENSG00000167323"
"1377","NCAM1",-0.0402124477075816,6.66758254554557,-0.500888474071519,0.627745555503187,0.743994732448221,-6.87208719685962,"NONE",FALSE,"High","Master Protein","P13591-1","Isoform 2 of Neural cell adhesion molecule 1 [OS=Homo sapiens]",0,89.613,8,6,7,29,6,848,93.3,4.87,81.94,6,NA,NA,NA,NA,NA,"P13591-1",NA,NA,NA,0,0,89.6,92.5,89.2,115.6,100.2,107.5,109.8,105.3,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S774(100); T788(100); T802(99.5)]",0,"ENSG00000149294"
"1378","GLCCI1",-0.0417169575880401,6.66461553880586,-0.498631754847909,0.629276613609015,0.745268093911403,-6.87329101957324,"NONE",FALSE,"High","Master Protein","Q86VQ1","Glucocorticoid-induced transcript 1 protein [OS=Homo sapiens]",0,32.827,8,3,3,4,3,547,58,9.44,16.47,3,NA,"other cell component",NA,"Pf15388","113263","A4D103; hsa:113263; Q86VQ1; Q96FD0","ENSG00000106415",NA,NA,0,0,71,82.9,78.6,108.2,120.2,124.7,107.8,113.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S223(100); S303(100)]",0,"ENSG00000106415"
"1379","PHF2",-0.0539250590261497,6.65093588376016,-0.496778992821265,0.630534996611022,0.74621690679419,-6.87427549894594,"NONE",FALSE,"High","Master Protein","O75151","Lysine-specific demethylase PHF2 [OS=Homo sapiens]",0,23.572,5,3,3,5,3,1096,120.7,9.17,13.9,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00628, Pf02373, Pf17811","5253","hsa:5253; O75151; Q4VXG0; Q8N3K2; Q9Y6N4","ENSG00000197724","HDMs demethylate histones",NA,1,0,102.7,95.9,100.5,109.4,76.8,114.5,100.4,106.6,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S539(99.5); S681(100)]",0,"ENSG00000197724"
"1380","HNRNPC",-0.0382538415732796,6.51144871273399,-0.494545709539071,0.632053484881892,0.747471947338585,-6.8754575458948,"NONE",FALSE,"High","Master Protein","P07910","Heterogeneous nuclear ribonucleoproteins C1/C2 [OS=Homo sapiens]",0,65.048,15,4,8,18,4,306,33.7,5.08,53.46,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","3183","D3DS19; D3DS22; hsa:3183; P07910; P22628; Q53EX2; Q59FD3; Q5FWE8; Q86SF8; Q86U45; Q96HK7; Q96HM4; Q96IY5; Q9BTS3","ENSG00000092199","SUMOylation of RNA binding proteins; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",6,0,130.1,131.7,126.1,78.4,68.3,76,86.8,81.1,76.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000092199"
"1381","EML4",0.0435862574889336,6.65284421659319,0.487675005888272,0.636736426043242,0.752464769951174,-6.87906237648437,"NONE",FALSE,"High","Master Protein","Q9HC35","Echinoderm microtubule-associated protein-like 4 [OS=Homo sapiens]",0,26.14,5,2,3,5,2,981,108.8,6.4,22.35,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","27436","A6H8Y6; A6P4T4; A6P4V4; B2RBK3; B2RTW7; B5MCW9; hsa:27436; Q3SWW0; Q53R29; Q53TW8; Q6PJ45; Q9HC35; Q9NV40","ENSG00000143924","EML4 and NUDC in mitotic spindle formation; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants","Non-small cell lung cancer",4,0,107.6,97.8,94.8,101.5,88.8,102.8,96,102.2,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S144(100); S146(99.5)]",0,"ENSG00000143924"
"1382","GTF2F1",-0.0515053147110596,6.63227552316833,-0.486431461597132,0.637585817362997,0.752923338593641,-6.87970969723605,"NONE",FALSE,"High","Master Protein","P35269","General transcription factor IIF subunit 1 [OS=Homo sapiens]",0,20.528,5,2,2,4,2,517,58.2,7.49,12.3,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf05793","2962","B2RCS0; hsa:2962; P35269; Q9BWN0","ENSG00000125651","Estrogen-dependent gene expression; Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM",NA,32,0,92.6,106.4,92.9,103,106.7,95.4,94.6,112.7,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T331(100); S385(100)]",0,"ENSG00000125651"
"1383","TRAPPC10",-0.0478328952629692,6.5915318006386,-0.483015048102232,0.639922214934676,0.755135975974976,-6.88147999743935,"NONE",FALSE,"High","Master Protein","P48553","Trafficking protein particle complex subunit 10 [OS=Homo sapiens]",0,3.997,2,1,1,1,1,1259,142.1,6.04,2.38,1,"cell organization and biogenesis;transport","cytosol;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf12584","7109","hsa:7109; P48553; Q3MIR2; Q86SI7; Q9UMD4; Q9Y4L3","ENSG00000160218","RAB GEFs exchange GTP for GDP on RABs; COPII-mediated vesicle transport",NA,2,0,90.9,112.8,104.2,93.9,90.8,95.9,85.1,99.9,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S708(100)]",0,"ENSG00000160218"
"1384","TXLNB",-0.0948587061955832,6.66182198413891,-0.480440358294985,0.641685729321685,0.756669877350426,-6.88280628676791,"NONE",FALSE,"High","Master Protein","Q8N3L3","Beta-taxilin [OS=Homo sapiens]",0,11.28,4,1,1,1,1,684,76.5,4.93,3.69,1,NA,"other cell component","other molecular function","Pf09728","167838","hsa:167838; Q5HYH7; Q5VTF3; Q76L25; Q86T52; Q8N3L3; Q8N3S2","ENSG00000164440",NA,NA,0,0,91.6,92.5,83.8,132.8,84.6,104.3,125.1,107.9,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S554(100)]",0,"ENSG00000164440"
"1385","TCEA1",0.0443548738159132,6.68221930713658,0.476182507737969,0.644607272790132,0.759566114941152,-6.88498479414522,"NONE",FALSE,"High","Master Protein","P23193","Transcription elongation factor A protein 1 [OS=Homo sapiens]",0,57.018,5,2,4,17,2,301,33.9,8.38,45.02,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf01096, Pf07500, Pf08711","6917","A6NF25; A8K339; hsa:6917; P23193; Q15563; Q6FG87","ENSG00000187735","Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER",NA,15,0,80.9,92.7,88.6,114.7,100.2,110,101.9,114.8,123.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(100)]",0,"ENSG00000187735"
"1386","MORC2",-0.0515252556827166,6.57235201539297,-0.474295509531472,0.64590409332634,0.760545079587725,-6.8859443544224,"NONE",FALSE,"High","Master Protein","Q9Y6X9","ATPase MORC2 [OS=Homo sapiens]",0,30.824,2,2,2,5,2,1032,117.8,8.38,17.3,2,"cell organization and biogenesis;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf07496, Pf13589, Pf17942","22880","B2RNB1; hsa:22880; Q9UF28; Q9Y6V2; Q9Y6X9","ENSG00000133422","Fatty acyl-CoA biosynthesis",NA,1,0,120.6,111.9,107.5,80.1,72.9,108.2,84.6,94.6,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S615(100); S743(100)]",0,"ENSG00000133422"
"1387","PAK4",-0.057349850258384,6.61636432415252,-0.473323280319959,0.646572737358222,0.760783494858413,-6.88643732566429,"NONE",FALSE,"High","Master Protein","O96013","Serine/threonine-protein kinase PAK 4 [OS=Homo sapiens]",0,10.771,4,1,1,1,1,591,64,9.73,3.98,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;other cell component","kinase activity;other molecular function","Pf00069, Pf00786","10298","B4DGG6; hsa:10298; O96013; Q8N4E1; Q8NCH5; Q8NDE3; Q9BU33; Q9ULS8","ENSG00000130669","RHOG GTPase cycle; RAC2 GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Activation of RAC1; RHOH GTPase cycle","Integrin-mediated cell adhesion; Focal adhesion; MET in type 1 papillary renal cell carcinoma; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 22q11.2 copy number variation syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; TROP2 regulatory signaling; ErbB signaling pathway",25,0,95.4,104.1,108,93.7,115.1,87.9,103.3,87.4,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100)]",0,"ENSG00000130669"
"1388","CCDC167",-0.0431725243052599,6.55864260151311,-0.472532656375387,0.647116728473582,0.760875000625999,-6.88683750204263,"NONE",FALSE,"High","Master Protein","Q9P0B6","Coiled-coil domain-containing protein 167 [OS=Homo sapiens]",0.004,2.104,7,1,1,2,1,97,11.5,9.5,4.77,1,NA,"other membranes",NA,"Pf15188","154467","hsa:154467; Q5T7F7; Q9BTQ9; Q9P0B6","ENSG00000198937",NA,NA,0,0,113.6,117,124.8,78.2,83.2,89.4,91.9,80.9,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000198937"
"1389","RPTOR",-0.0506906674023817,6.67235657573299,-0.471384460732058,0.647907138385004,0.761255903415642,-6.88741752757925,"NONE",FALSE,"High","Master Protein","Q8N122","Regulatory-associated protein of mTOR [OS=Homo sapiens]",0,44.756,3,2,3,6,2,1335,148.9,6.89,26.99,2,"cell organization and biogenesis;stress response;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00400, Pf02985, Pf14538","57521","B2RN36; C6KEF2; F5H7J5; hsa:57521; Q8N122; Q8N4V9; Q8TB32; Q9P2P3","ENSG00000141564","Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; HSF1-dependent transactivation","AMP-activated protein kinase signaling; Target of rapamycin signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; CAMKK2 pathway; Autophagy; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; JAK-STAT signaling in the regulation of beta cells; ADHD and autism (ASD) linked metabolic pathways and SNP; Interferon type I signaling pathways",34,0,89.1,86.8,91.7,113.5,85.2,125.3,102.2,109.3,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S859(100); S863(100); S877(100)]",0,"ENSG00000141564"
"1390","NOP58",-0.0519997671778922,6.57729443037894,-0.466694548232098,0.651140428963713,0.763599302655118,-6.88977270638892,"NONE",FALSE,"High","Master Protein","Q9Y2X3","Nucleolar protein 58 [OS=Homo sapiens]",0,71.014,7,4,4,9,4,529,59.5,8.92,37.44,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01798, Pf08156","51602","hsa:51602; Q53SA4; Q6PK08; Q9P036; Q9UFN3; Q9Y2X3","ENSG00000055044","SUMOylation of RNA binding proteins; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol",NA,3,0,119.1,111.8,118.2,89.6,63.7,104.6,89.8,93.4,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S502(100); S514(100)]",0,"ENSG00000055044"
"1391","RGL1",-0.048904917142977,6.65310110065412,-0.466471274090668,0.651294548460657,0.763599302655118,-6.88988426929642,"NONE",FALSE,"High","Master Protein","Q9NZL6","Ral guanine nucleotide dissociation stimulator-like 1 [OS=Homo sapiens]",0,30.925,8,3,4,8,3,768,86.6,6.09,6.65,3,"signal transduction","plasma membrane;other membranes;cytosol","enzyme regulator activity","Pf00617, Pf00618, Pf00788","23179","hsa:23179; Q5SXQ2; Q5SXQ6; Q9HBY3; Q9HBY4; Q9NZL5; Q9NZL6; Q9UG43; Q9Y2G6","ENSG00000143344","PPARA activates gene expression; RAF/MAP kinase cascade","Ras signaling",3,0,95.3,93.6,85.1,115.2,103.7,100.3,113.4,101.1,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S508(99.3); T749(100)]",0,"ENSG00000143344"
"1392","SP3",0.0766275871556719,6.54433179492625,0.466455717209647,0.651305287558777,0.763599302655118,-6.88989204066909,"NONE",FALSE,"High","Master Protein","Q02447","Transcription factor Sp3 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,781,81.9,5.26,5.52,1,"developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6670","A0AVL9; B4E2B7; hsa:6670; Q02447; Q69B26; Q69B27; Q8TD56; Q8WWU4; Q9BQR1","ENSG00000172845","SUMOylation of transcription factors","Selenium metabolism and selenoproteins; MECP2 and associated Rett syndrome; Non-genomic actions of 1,25 dihydroxyvitamin D3; Sudden infant death syndrome (SIDS) susceptibility pathways",5,0,125.3,103.9,120.4,86.8,64.7,84.6,110.7,73.4,88.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100)]",0,"ENSG00000172845"
"1393","OSBPL3",0.0436393877486747,6.66175338688699,0.46442176922441,0.652710069734703,0.764199957448697,-6.89090595791675,"NONE",FALSE,"High","Master Protein","Q9H4L5","Oxysterol-binding protein-related protein 3 [OS=Homo sapiens]",0,14.724,2,1,1,2,1,887,101.2,6.87,8.3,1,"other metabolic processes;transport","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf01237, Pf15409","26031","A4D167; A4D168; A4D169; A4D170; A4D171; A4D172; B8ZZ79; B8ZZP0; hsa:26031; O14591; O43357; O43358; Q8N702; Q8N703; Q8N704; Q8NFH0; Q8NFH1; Q8NI12; Q8NI13; Q9BZF4; Q9H4L5; Q9UED6","ENSG00000070882","Synthesis of bile acids and bile salts","Orexin receptor pathway",2,0,91.2,95.6,101.6,107.2,89.7,103,96.3,106,118.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100)]",0,"ENSG00000070882"
"1394","DTD1",0.0400976479931927,6.65967183471602,0.464358008629253,0.652754130320762,0.764199957448697,-6.89093767394887,"NONE",FALSE,"High","Master Protein","Q8TEA8","D-aminoacyl-tRNA deacylase 1 [OS=Homo sapiens]",0,26.912,8,1,4,11,1,209,23.4,8.24,29.7,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02580","92675","A8K5X5; D3DW37; hsa:92675; Q496D1; Q5W184; Q8TEA8; Q8WXU8; Q9BW67; Q9H464; Q9H474","ENSG00000125821",NA,NA,0,0,85,85.7,85.6,105.3,123.2,99.1,111.1,111.2,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(99.6); S197(100)]",0,"ENSG00000125821"
"1395","REEP2",0.115231234895222,6.67896838532256,0.462765661467457,0.653854949122619,0.76441581414932,-6.89172839527223,"NONE",FALSE,"High","Master Protein","Q9BRK0","Receptor expression-enhancing protein 2 [OS=Homo sapiens]",0,4.15,4,1,1,1,1,252,28.2,9.54,2.11,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi","signal transduction activity or receptor binding;cytoskeletal activity","Pf03134","51308","hsa:51308; Q53EM8; Q9BRK0; Q9NYF2","ENSG00000132563",NA,NA,0,0,94.5,81.7,72.7,98.4,93.3,132.4,138,143.6,81.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S150(100)]",0,"ENSG00000132563"
"1396","PALS2",-0.194050370524647,6.47670261975112,-0.462736247188839,0.653875292005178,0.76441581414932,-6.89174297727304,"NONE",FALSE,"High","Master Protein","Q9NZW5","Protein PALS2 [OS=Homo sapiens]",0,10.297,5,1,1,2,1,540,61.1,6.18,6.68,1,"cell organization and biogenesis","plasma membrane;other membranes;other cell component",NA,"Pf00595, Pf00625, Pf02828, Pf07653","51678","A4D157; hsa:51678; Q9H0E1; Q9NZW5","ENSG00000105926",NA,NA,0,0,104.4,36.3,27.6,139.6,71.5,167.7,107.1,108.3,123.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100)]",0,"ENSG00000105926"
"1397","ZC3H11A",-0.0424148361832115,6.35829015587755,-0.461731912315257,0.654570068251687,0.764680280162314,-6.8922403402359,"NONE",FALSE,"High","Master Protein","O75152","Zinc finger CCCH domain-containing protein 11A [OS=Homo sapiens]",0,24.641,2,1,1,3,1,810,89.1,8.37,11.12,1,"other metabolic processes;transport","nucleus","other molecular function","Pf15663","9877","hsa:9877; O75152; Q6AHY4; Q6AHY9; Q6AW79; Q6AWA1; Q6PJK4; Q86XZ7","ENSG00000058673","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,3,0,169.8,146.3,157.7,56.3,45.6,61.2,73,63.4,62.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S108(100)]",0,"ENSG00000058673"
"1398","VPS52",-0.0846489691080592,6.60740202216617,-0.459113081534707,0.65638335244167,0.766250093837487,-6.89353236699625,"NONE",FALSE,"High","Master Protein","Q8N1B4","Vacuolar protein sorting-associated protein 52 homolog [OS=Homo sapiens]",0,14.37,3,1,1,1,1,723,82.2,5.99,4.28,1,"transport;developmental processes;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04129, Pf20655","6293","A2BF38; B0UZZ4; B4DNI9; hsa:6293; Q53GR4; Q5JPA0; Q5SQW1; Q8IUN6; Q8N1B4; Q9NPT5","ENSG00000206286; ENSG00000223501; ENSG00000224455; ENSG00000225590; ENSG00000228425; ENSG00000236014","Retrograde transport at the Trans-Golgi-Network",NA,1,0,86.3,87.7,73.1,88.5,120.9,123.4,83,125,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S355(100)]",0,"ENSG00000223501"
"1399","RPS17",0.113776423405444,6.50056925837285,0.458134664798818,0.65706141573522,0.766298240809361,-6.89401327497482,"NONE",FALSE,"High","Master Protein","P08708","Small ribosomal subunit protein eS17 [OS=Homo sapiens]",0,16.006,33,2,2,2,2,135,15.5,9.85,3.81,2,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","other molecular function","Pf00833","6218","B2R4U4; hsa:6218; P08708; P0CW22","ENSG00000182774; ENSG00000278229","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,137.8,155.9,81.2,60.8,72.4,84.1,93.6,101.2,68.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(99.1)]",0,"ENSG00000182774"
"1400","STAT5B",-0.0848115864335846,6.5758223301074,-0.457698652895734,0.657363686968815,0.766298240809361,-6.89422726582866,"NONE",FALSE,"High","Master Protein","P51692","Signal transducer and activator of transcription 5B [OS=Homo sapiens]",0,6.041,2,1,1,1,1,787,89.8,6.05,2.38,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf21354","6777","hsa:6777; P51692; Q8WWS8","ENSG00000173757","Interleukin-3, Interleukin-5 and GM-CSF signaling; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Growth hormone receptor signaling; Signaling by Leptin; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Prolactin receptor signaling; Interleukin-20 family signaling; Erythropoietin activates STAT5; Signaling by FLT3 fusion proteins; Interleukin-2 signaling; STAT5 activation downstream of FLT3 ITD mutants; Interleukin-15 signaling; Interleukin-9 signaling; Interleukin-21 signaling; STAT5 Activation","IL-5 signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; AGE/RAGE pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; RAC1/PAK1/p38/MMP2 pathway; Chemokine signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; White fat cell differentiation; Non-small cell lung cancer; EGF/EGFR signaling pathway; Measles virus infection; Hepatitis B infection; Endochondral ossification; Endochondral ossification with skeletal dysplasias; IL-2 signaling pathway; 3q29 copy number variation syndrome; FOXP3 in COVID-19; Familial partial lipodystrophy; Acute myeloid leukemia; JAK-STAT signaling in the regulation of beta cells; EPO receptor signaling; ErbB signaling pathway",51,0,115.1,107.7,99.3,93.8,78.9,99.3,92.5,117.4,69.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000173757"
"1401","SPICE1",-0.166557834190996,6.6149080723371,-0.456779478573133,0.658001130716191,0.766493822504513,-6.89467774979406,"NONE",FALSE,"High","Master Protein","Q8N0Z3","Spindle and centriole-associated protein 1 [OS=Homo sapiens]",0,9.003,2,1,1,1,1,855,96.2,7.44,3.48,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component",NA,"Pf15678","152185","D3DN72; hsa:152185; Q8N0Z3; Q8WUX6","ENSG00000163611",NA,NA,0,0,108.6,40.3,129.8,128.7,78.7,120.7,112.7,97.1,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S640(100)]",0,"ENSG00000163611"
"1402","EPN1",0.0418123488681692,6.66374909275634,0.454145361108376,0.659829481831513,0.768075402531405,-6.89596391931177,"NONE",FALSE,"High","Master Protein","Q9Y6I3","Epsin-1 [OS=Homo sapiens]",0,47.334,11,3,5,6,3,576,60.3,4.83,24.64,3,"transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle","other molecular function","Pf01417","29924","hsa:29924; Q86ST3; Q9HA18; Q9Y6I3","ENSG00000063245","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation","VEGFA-VEGFR2 signaling; EGF/EGFR signaling pathway",5,0,82,75.8,81.2,117,96.1,119.1,112.3,121.7,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); T470(100)]",0,"ENSG00000063245"
"1403","XPR1",-0.0400587892039637,6.65601220685841,-0.45126694509433,0.661830106441694,0.76917850589553,-6.89736122800096,"NONE",FALSE,"High","Master Protein","Q9UBH6","Solute carrier family 53 member 1 [OS=Homo sapiens]",0,9.139,4,3,4,6,3,696,81.5,8.44,14.31,3,"stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity;other molecular function","Pf03105, Pf03124","9213","hsa:9213; O95719; Q7L8K9; Q8IW20; Q9NT19; Q9UBH6; Q9UFB9","ENSG00000143324",NA,NA,0,0,81.1,79.4,75.2,115.2,111.8,118.4,110.4,122.5,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S666(100); S676(100); T690(100)]",0,"ENSG00000143324"
"1404","MPDZ",-0.0476367454029676,6.6661643400435,-0.451171901120366,0.661896214177656,0.76917850589553,-6.8974072213406,"NONE",FALSE,"High","Master Protein","O75970","Multiple PDZ domain protein [OS=Homo sapiens]",0,77.568,6,5,6,13,5,2070,221.5,5.06,39.95,5,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf00595, Pf09045, Pf16667","8777","A6NLC2; B2RTS3; B7ZMI4; hsa:8777; O43798; O75970; Q4LE30; Q5CZ80; Q5JTX3; Q5JTX6; Q5JTX7; Q5JUC3; Q5JUC4; Q5VZ62; Q8N790","ENSG00000107186",NA,NA,0,0,78.4,86.9,82.8,110.3,93.4,131.3,107.7,111.9,110.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(100); S354(99.1); S1595(100); S1818(100)]",0,"ENSG00000107186"
"1405","MAP2",0.0334403365111493,6.67670847317402,0.450748059035654,0.662191054401482,0.76917850589553,-6.8976122124926,"NONE",FALSE,"High","Master Protein","P11137-3","Isoform 3 of Microtubule-associated protein 2 [OS=Homo sapiens]",0,717.957,28,33,51,148,1,1823,199,4.91,546.24,33,NA,NA,NA,NA,NA,"P11137-3",NA,NA,NA,0,34,97,98.9,101.3,109.2,95.3,99,105.2,107.6,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S136(97.5); T146(96.6); T423(100); S494(100); S650(99.5); S784(100); S817(100); S829(100); S858(100); S909(100); S1001(100); S1151(99.5); S1176(100); T1250(99.6); S1320(100); S1343(100); S1349(100); S1476(99.8); S1536(100); S1551(100); T1588(98.7); T1601(100); T1612(100); T1627(100); T1645(100); S1649(100); S1675(100); S1778(100); S1786(100)]",0,"ENSG00000078018"
"1406","HSPA5",-0.0410083670540784,6.56399850204767,-0.445623280937975,0.665760848417594,0.772067252716098,-6.90007619337185,"NONE",FALSE,"High","Master Protein","P11021","Endoplasmic reticulum chaperone BiP [OS=Homo sapiens]",0,100.841,21,11,12,14,9,654,72.3,5.16,41.53,11,"protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","translation activity;other molecular function","Pf00012","3309","B0QZ61; hsa:3309; P11021; Q2EF78; Q9NPF1; Q9UK02","ENSG00000044574","Regulation of HSF1-mediated heat shock response; Platelet degranulation ; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; ATF6B (ATF6-beta) activates chaperones; IRE1alpha activates chaperones; PERK regulates gene expression; ATF6 (ATF6-alpha) activates chaperone genes","Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Photodynamic therapy-induced unfolded protein response; Prion disease pathway; Unfolded protein response; Orexin receptor pathway",14,0,120.2,115.9,123.3,85.5,72.8,91,97.1,83.4,82.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T648(100)]",0,"ENSG00000044574"
"1407","CAMKK2",0.118147262055154,6.70032240628078,0.445615504863228,0.665766271768441,0.772067252716098,-6.90007991156283,"NONE",FALSE,"High","Master Protein","Q96RR4-3","Isoform 3 of Calcium/calmodulin-dependent protein kinase kinase 2 [OS=Homo sapiens]",0,10.383,4,1,1,3,1,541,59.6,5.76,7.51,1,NA,NA,NA,NA,NA,"Q96RR4-3",NA,NA,NA,0,0,98.5,41.4,81.9,123.4,95.4,135.6,117.9,122.7,155.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S522(100)]",0,"ENSG00000110931"
"1408","DNAJB1",0.0457673127733829,6.61638969871417,0.445141016611195,0.666097237637418,0.772067252716098,-6.90030667408101,"NONE",FALSE,"High","Master Protein","P25685","DnaJ homolog subfamily B member 1 [OS=Homo sapiens]",0,6.382,5,2,2,2,2,340,38,8.63,1.9,2,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00226, Pf01556","3337","B4DX52; hsa:3337; P25685","ENSG00000132002","MAPK6/MAPK4 signaling; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Regulation of HSF1-mediated heat shock response; Attenuation phase","Nuclear receptors meta-pathway; NRF2 pathway",7,0,105.5,85.3,108.6,95,93.8,95.6,95.6,97.1,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000132002"
"1409","EPS15",0.052173003702606,6.6953974066903,0.444165536606403,0.666777893678326,0.772307680967373,-6.9007721374615,"NONE",FALSE,"High","Master Protein","P42566","Epidermal growth factor receptor substrate 15 [OS=Homo sapiens]",0,77.124,9,5,5,14,5,896,98.6,4.64,39.64,5,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function",NA,"2060","B2R8J7; D3DPJ2; hsa:2060; P42566; Q5SRH4","ENSG00000085832","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell","VEGFA-VEGFR2 signaling; Ebola virus infection in host; EGF/EGFR signaling pathway",8,0,94,94.9,96.1,118.9,89.1,102.1,120.5,107.7,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(99.6); S563(99.5); T777(100); S796(100); S814(100)]",0,"ENSG00000085832"
"1410","ESYT2",0.0664603392748759,6.64404463178478,0.442748225740146,0.66776741255966,0.772905260494585,-6.90144668054251,"NONE",FALSE,"High","Master Protein","A0FGR8","Extended synaptotagmin-2 [OS=Homo sapiens]",0,22.548,3,2,4,6,2,921,102.3,9.26,18.41,2,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00168, Pf17047","57488","A0FGR8; A4D229; hsa:57488; Q69YJ2; Q6UKI4; Q6ZTU0; Q6ZVU1; Q9BQS0; Q9NW47; Q9ULJ2","ENSG00000117868","Glycosphingolipid transport",NA,1,0,58.2,65.5,77.9,126.6,87.4,134.4,115.3,122.5,136.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S676(100); S761(100)]",0,"ENSG00000117868"
"1411","STK32C",0.0595749369778034,6.55968464870369,0.440866446419099,0.669082246150962,0.773354923552879,-6.9023390816826,"NONE",FALSE,"High","Master Protein","Q86UX6","Serine/threonine-protein kinase 32C [OS=Homo sapiens]",0,11.955,3,1,1,4,1,486,55,6.61,3.59,1,"other metabolic processes;signal transduction",NA,"kinase activity;other molecular function","Pf00069","282974","hsa:282974; Q5T0Q5; Q86UE1; Q86UX6","ENSG00000165752",NA,NA,0,0,129.9,120.6,92.7,78,72,96.4,96.6,82.7,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100)]",0,"ENSG00000165752"
"1412","NKAP",0.0705741860255031,6.38089935338242,0.44083583155074,0.669103647093545,0.773354923552879,-6.9023535700908,"NONE",FALSE,"High","Master Protein","Q8N5F7","NF-kappa-B-activating protein [OS=Homo sapiens]",0,27.521,8,2,2,7,2,415,47.1,10.11,18.83,2,"cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf06047, Pf15692","79576","hsa:79576; Q6IPW6; Q8N5F7; Q96BQ2; Q9H638","ENSG00000101882","mRNA Splicing - Major Pathway",NA,1,0,146.6,146.2,143.8,70.1,34.6,66.1,73.1,82.6,63,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100)]; Met-loss [N-Term]",0,"ENSG00000101882"
"1413","HTATSF1",-0.0533263682391008,6.5843308466213,-0.439746530427615,0.669865312806823,0.773512721757477,-6.90286845043999,"NONE",FALSE,"High","Master Protein","O43719","17S U2 SnRNP complex component HTATSF1 [OS=Homo sapiens]",0,22.782,4,3,3,4,3,755,85.8,4.4,8.98,3,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00076","27336","D3DWG9; hsa:27336; O43719; Q59G06; Q99730","ENSG00000102241","mRNA Splicing - Major Pathway",NA,1,0,122.5,126.6,114.8,94.8,88.9,73.9,93.7,94.3,78.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100); S642(100)]",0,"ENSG00000102241"
"1414","SCRIB",0.0331777801231157,6.66124498110678,0.439285056468334,0.670188105738402,0.773512721757477,-6.90308620667888,"NONE",FALSE,"High","Master Protein","Q14160","Protein scribble homolog [OS=Homo sapiens]",0,380.315,16,20,30,67,20,1630,174.8,5.07,234.91,20,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00560, Pf00595, Pf13855","23513","hsa:23513; Q14160; Q6P496; Q7Z5D1; Q8WWV8; Q96C69; Q96GG1","ENSG00000180900; ENSG00000274287","RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; Asymmetric localization of PCP proteins; RHOJ GTPase cycle; RND3 GTPase cycle","Thyroid stimulating hormone (TSH) signaling pathway; Complement system in neuronal development and plasticity",8,0,87.5,91.2,85.3,106.4,103.2,110,112.4,112,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S504(99.6); S708(100); S835(100); S853(100); S1220(100); S1226(99.6); S1309(100); T1342(100); S1348(100); S1378(100); S1448(100); S1475(100); S1486(100); S1508(100); S1541(100); S1566(100)]",0,"ENSG00000180900"
"1415","TDRD3",0.0834481286833197,6.66030265284578,0.437879611664406,0.671171625888505,0.774100419399322,-6.90374804288255,"NONE",FALSE,"High","Master Protein","Q9H7E2","Tudor domain-containing protein 3 [OS=Homo sapiens]",0,4.769,3,1,1,1,1,651,73.1,9.23,2.4,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00567, Pf00627, Pf08585","81550","B2MWP9; hsa:81550; Q53XA6; Q6P992; Q9H7E2","ENSG00000083544",NA,NA,0,0,117.3,85.1,73.4,108.2,80.8,117.7,123.3,117.1,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S489(100)]",0,"ENSG00000083544"
"1416","TOM1L1",-0.0344406971970992,6.66298619599128,-0.435468858299174,0.672860179374676,0.775087416715669,-6.90487854313,"NONE",FALSE,"High","Master Protein","O75674","TOM1-like protein 1 [OS=Homo sapiens]",0,23.297,5,1,2,4,1,476,53,5.24,20.48,1,"protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00790, Pf03127","10040","B7Z9E2; hsa:10040; O75674; Q53G06; Q8N749","ENSG00000141198",NA,NA,0,0,91.2,91.7,95.6,110.7,102.8,104,107.6,109.4,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S323(100)]",0,"ENSG00000141198"
"1417","SEPTIN9",-0.109154930783721,6.5498577851834,-0.435301820094569,0.672977248459622,0.775087416715669,-6.90495665199245,"NONE",FALSE,"High","Master Protein","Q9UHD8","Septin-9 [OS=Homo sapiens]",0,60.623,10,5,6,14,5,586,65.4,8.97,41.46,5,"cell cycle OR cell proliferation;other biological processes","cytoskeleton;other cell component","other molecular function","Pf00735","10801","A8K2V3; B3KPM0; B4DTL9; B4E0N2; B4E274; B7Z654; hsa:10801; Q96QF3; Q96QF4; Q96QF5; Q9HA04; Q9UG40; Q9UHD8; Q9Y5W4","ENSG00000184640",NA,NA,0,0,64.7,68.5,74.2,101.9,205.2,81.1,100.1,92.9,134.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); T49(100); S111(100)]",0,"ENSG00000184640"
"1418","RPS6KB1",0.0344840790354706,6.68199995785902,0.430247933649747,0.676523622000547,0.778622391470305,-6.9073062817077,"NONE",FALSE,"High","Master Protein","P23443","Ribosomal protein S6 kinase beta-1 [OS=Homo sapiens]",0,2.966,2,2,2,3,2,525,59.1,6.65,6.12,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00433","6198","B2R779; B4DLT4; B4DTG1; E7ESB8; F6UYM1; hsa:6198; P23443; Q7Z721","ENSG00000108443","mTORC1-mediated signalling","IL-5 signaling pathway; AMP-activated protein kinase signaling; Target of rapamycin signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Kit receptor signaling pathway; IL6 signaling pathway; BDNF-TrkB signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; PI3K-Akt signaling pathway; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Thermogenesis; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; GDNF signaling; G13 signaling pathway; Acute myeloid leukemia; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways; ErbB signaling pathway",42,0,91.9,91.1,98.3,105,97.8,112.1,99.4,113.1,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S441(100); S447(100)]",0,"ENSG00000108443"
"1419","DENND2B",0.0430285067794651,6.67174660484474,0.426265469680761,0.679324061324337,0.781294480677462,-6.90913919657792,"NONE",FALSE,"High","Master Protein","P78524","DENN domain-containing protein 2B [OS=Homo sapiens]",0,23.668,4,3,4,6,3,1137,126.4,9.25,10.56,3,"other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","enzyme regulator activity","Pf02141, Pf03455, Pf03456","6764","B2R6X7; B3KXQ6; hsa:6764; P78523; P78524; Q16492; Q7KYY2; Q7KZ12; Q8NE12; Q9BQQ6","ENSG00000166444","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,80.6,86.1,82.6,110.3,100.8,118.5,98.9,123.9,122.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100); T364(100); S368(99.3); S622(100)]",0,"ENSG00000166444"
"1420","MPHOSPH8",0.0403926085025335,6.65053198503307,0.425278532906294,0.680018866766016,0.781542810255026,-6.90959089434783,"NONE",FALSE,"High","Master Protein","Q99549","M-phase phosphoprotein 8 [OS=Homo sapiens]",0,8.815,2,1,1,1,1,860,97.1,6.06,3.26,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00385, Pf12796","54737","B7Z6F9; hsa:54737; Q5JPE5; Q5JTQ0; Q86TK3; Q96MK4; Q99549; Q9BTP1","ENSG00000196199",NA,NA,0,0,105.1,94.6,94.9,99.1,83.6,112.9,104.1,110.9,97.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000196199"
"1421","OTUD5",-0.0554521564486894,6.59806784138585,-0.422691755970022,0.681841461639825,0.78254489431465,-6.91077001737726,"NONE",FALSE,"High","Master Protein","Q96G74","OTU domain-containing protein 5 [OS=Homo sapiens]",0,23.423,6,2,2,2,2,571,60.6,6.54,9.27,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf02338","55593","B4DGG7; G5E9D7; hsa:55593; Q4KMN9; Q8N6T5; Q96G74; Q9H650; Q9H9U0; Q9NT65","ENSG00000068308; ENSG00000292211","Ovarian tumor domain proteases; Negative regulators of DDX58/IFIH1 signaling","Gastric cancer network 2; Novel intracellular components of RIG-I-like receptor pathway",4,0,104.9,110.2,122.3,93.8,107.1,75.4,87.3,88,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S508(99.4)]",0,"ENSG00000068308"
"1422","C7orf50",0.0367102911118407,6.57426002616689,0.422679957989065,0.681849779237397,0.78254489431465,-6.91077537934614,"NONE",FALSE,"High","Master Protein","Q9BRJ6","Uncharacterized protein C7orf50 [OS=Homo sapiens]",0,39.305,18,2,2,5,2,194,22.1,9.64,16.34,2,NA,NA,NA,"Pf10180","84310","Q9BRJ6","ENSG00000146540",NA,NA,0,0,111,118.7,120.9,78.4,81.2,89.3,84.3,92.9,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S175(100)]",0,"ENSG00000146540"
"1423","SRP72",0.0449771576099653,6.66548855484188,0.414981266509178,0.687286913684233,0.788129300188588,-6.91424353843479,"NONE",FALSE,"High","Master Protein","O76094","Signal recognition particle subunit SRP72 [OS=Homo sapiens]",0,30.401,4,1,3,12,1,671,74.6,9.26,59.03,1,"other biological processes","cytosol;ER/Golgi;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf08492, Pf13181, Pf17004","6731","G5E9Z8; hsa:6731; O76094; Q7Z3C0","ENSG00000174780","SRP-dependent cotranslational protein targeting to membrane",NA,1,0,94.2,92.7,107.1,104.4,81.7,111.6,110.2,95.3,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S620(99.3); S621(98.9); T624(97.9)]",0,"ENSG00000174780"
"1424","SOX13",0.0313153260422672,6.63986241673761,0.413440470155358,0.688377363508464,0.788129300188588,-6.91493026465049,"NONE",FALSE,"High","Master Protein","Q9UN79","Transcription factor SOX-13 [OS=Homo sapiens]",0,22.441,6,2,3,5,2,622,69.2,6.71,11.97,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","9580","B4E2B0; hsa:9580; O95275; O95826; Q3KQV7; Q5SXX1; Q9UHW7; Q9UN79","ENSG00000143842","Deactivation of the beta-catenin transactivating complex",NA,1,0,94.3,90.5,88.7,100.6,96,110.3,109.7,101.4,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S310(100); S335(99.3)]",0,"ENSG00000143842"
"1425","EIF3B",0.0569198614951292,6.64018436725786,0.413242871228235,0.688517262479752,0.788129300188588,-6.91501815535788,"NONE",FALSE,"High","Master Protein","P55884","Eukaryotic translation initiation factor 3 subunit B [OS=Homo sapiens]",0,44.395,8,2,2,7,2,814,92.4,5,38.62,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08662","8662","A4D208; hsa:8662; P55884; Q2NL77; Q9UMF9","ENSG00000106263","L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell",8,0,76.9,74,94.7,98.9,133.2,101.1,102.2,108.5,131.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100)]",0,"ENSG00000106263"
"1426","ANP32B",-0.0687877856446724,6.61805264662156,-0.413059226686615,0.688647292934391,0.788129300188588,-6.91509980290444,"NONE",FALSE,"High","Master Protein","Q92688","Acidic leucine-rich nuclear phosphoprotein 32 family member B [OS=Homo sapiens]",0,4.088,4,1,1,9,1,251,28.8,4.06,17.23,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf12799","10541","B2R9C7; hsa:10541; O00655; P78458; P78459; Q92688","ENSG00000136938",NA,NA,0,0,54.9,64.7,66.8,130.7,172.6,97.7,107.2,121.7,136.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T244(100)]",0,"ENSG00000136938"
"1427","USF1",0.0525764810785478,6.64881223442454,0.410956587503836,0.690136839164618,0.789280533648673,-6.91603213112231,"NONE",FALSE,"High","Master Protein","P22415","Upstream stimulatory factor 1 [OS=Homo sapiens]",0.004,2.132,2,1,1,1,1,310,33.5,5.54,2.44,1,"stress response;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","7391","B2RBZ4; hsa:7391; P22415; Q5SY46; Q7Z5Y1","ENSG00000158773","Estrogen-dependent gene expression","7q11.23 copy number variation syndrome; Familial hyperlipidemia type 2",3,0,100.5,109.1,98.3,96.8,107.7,89.7,114,106.2,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S186(100)]",0,"ENSG00000158773"
"1428","CDC23",-0.0559464480521932,6.64487772489992,-0.406045072949517,0.693621676287592,0.792177694276841,-6.91819204188681,"NONE",FALSE,"High","Master Protein","Q9UJX2","Cell division cycle protein 23 homolog [OS=Homo sapiens]",0,9.11,2,2,2,2,2,597,68.8,7.02,5.22,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf04049","8697","A8K6E5; B4E3A2; B7WP05; D3DQB7; hsa:8697; O75433; Q53FN2; Q9BS73; Q9UJX2","ENSG00000094880","Separation of Sister Chromatids; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects","Cell cycle",19,0,87.7,70.3,104.7,104,96.7,124,109.9,104.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S588(100); T596(100)]",0,"ENSG00000094880"
"1429","NUMA1",0.02968294968493,6.63549567369256,0.406018029141536,0.69364088549118,0.792177694276841,-6.91820386537422,"NONE",FALSE,"High","Master Protein","Q14980","Nuclear mitotic apparatus protein 1 [OS=Homo sapiens]",0,67.958,2,2,2,8,2,2115,238.1,5.78,33.95,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf21670","4926","H0YH75; hsa:4926; Q14980; Q14981; Q9BTE9","ENSG00000137497","Recruitment of NuMA to mitotic centrosomes; Mitotic Prophase","Ectoderm differentiation; Ectoderm differentiation; 8p23.1 copy number variation syndrome",5,0,107.3,105.4,111.4,90.5,86.5,101.3,93.5,100.4,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S1757(99.6)]",0,"ENSG00000137497"
"1430","SPEG",-0.0387830221642886,6.62858419827925,-0.403531653697336,0.695407933489384,0.79332393260024,-6.9192876521781,"NONE",FALSE,"High","Master Protein","Q15772","Striated muscle preferentially expressed protein kinase [OS=Homo sapiens]",0,31.091,2,6,7,7,6,3267,354.1,8.51,13.59,6,"other metabolic processes;other biological processes","nucleus","kinase activity;other molecular function","Pf00069, Pf07679, Pf16650","10290","A8K0G6; A8MRU0; hsa:10290; Q15772; Q27J74; Q695L1; Q6FGA6; Q6ZQW1; Q6ZTL8; Q9P2P9","ENSG00000072195",NA,NA,0,0,104.9,100.8,98.1,96.4,109.2,93.5,105.7,93.1,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100); S390(100); S2015(99.6); S2109(99.4); S2130(100); T2495(99.1)]",0,"ENSG00000072195"
"1431","ZKSCAN1",0.0284619975292522,6.58646410370716,0.402621239895892,0.696055439876011,0.79332393260024,-6.91968288367813,"NONE",FALSE,"High","Master Protein","P17029","Zinc finger protein with KRAB and SCAN domains 1 [OS=Homo sapiens]",0,40.618,9,3,3,7,3,563,63.6,7.05,24.15,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352, Pf02023","7586","A4D294; hsa:7586; P17029; P52745; Q2M1U1; Q8TBW5; Q8TEK7","ENSG00000106261","Generic Transcription Pathway",NA,1,0,122.2,117.3,117.8,86.7,78.6,83.9,89.6,96.6,87.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100); S208(100); S359(99.2)]",0,"ENSG00000106261"
"1432","CSTF3",-0.0707526833153862,6.6407607562281,-0.40255457658496,0.696102862428642,0.79332393260024,-6.91971178985023,"NONE",FALSE,"High","Master Protein","Q12996","Cleavage stimulation factor subunit 3 [OS=Homo sapiens]",0,8.169,2,1,1,4,1,717,82.9,8.12,6.61,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf05843","1479","A8K471; D3DR04; E9PB40; hsa:1479; Q12996; Q32P22; Q96FQ8; Q96QD6; Q96QK4","ENSG00000176102","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",5,0,93.5,98.5,102.5,111.8,71.4,118.2,101.4,119.7,81.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S691(100)]",0,"ENSG00000176102"
"1433","ZNF608",-0.0258310766186867,6.62430090384782,-0.399982739464619,0.697933454125988,0.794692253969606,-6.92082344279622,"NONE",FALSE,"High","Master Protein","Q9ULD9","Zinc finger protein 608 [OS=Homo sapiens]",0,30.7,3,5,5,7,5,1512,162.1,8.79,21.12,5,"other biological processes","nucleus","other molecular function",NA,"57507","A7E2W9; hsa:57507; Q3SYM6; Q68D12; Q8IY05; Q9ULD9; Q9Y5A1","ENSG00000168916",NA,NA,0,0,109.5,106.1,107.9,94,89.6,97.8,96.1,93.9,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T481(100); S627(100); S964(100); S1430(100)]",0,"ENSG00000168916"
"1434","CCNY",-0.0354201221548012,6.6410156588944,-0.399499864826109,0.698277384921823,0.794692253969606,-6.92103139280995,"NONE",FALSE,"High","Master Protein","Q8ND76","Cyclin-Y [OS=Homo sapiens]",0,51.916,13,4,5,9,2,341,39.3,7.2,33.91,4,"cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00134","219771","B7ZKX9; D3DRY9; hsa:219771; Q2M3V4; Q2TU96; Q6NT86; Q7Z4U7; Q8ND76; Q8TEX2; Q8TEX3; Q96M99; Q96P45","ENSG00000108100",NA,NA,0,0,77.2,84.1,81.6,108.6,104.9,119.7,117.5,101,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S100(99.5); S326(100)]",0,"ENSG00000108100"
"1435","ARHGEF17",0.0287692355621187,6.66131708624216,0.39880824807878,0.698770119252687,0.794698839456714,-6.92132881450895,"NONE",FALSE,"High","Master Protein","Q96PE2","Rho guanine nucleotide exchange factor 17 [OS=Homo sapiens]",0,33.827,3,6,6,8,6,2063,221.5,6.29,21.14,6,"cell organization and biogenesis;other biological processes","cytosol","enzyme regulator activity","Pf00621, Pf19056, Pf19057","9828","B2RP20; hsa:9828; Q86XU2; Q8N2S0; Q96PE2; Q9Y4G3","ENSG00000110237","RHOC GTPase cycle; RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle",NA,5,0,84.2,90.5,87.2,102.8,103.5,115.4,104.3,114.5,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(100); S420(100); S764(100)]",0,"ENSG00000110237"
"1436","PTOV1",-0.0302749176500381,6.59207961582235,-0.39041821708095,0.704759199276683,0.800951959066537,-6.92489712760099,"NONE",FALSE,"High","Master Protein","Q86YD1","Prostate tumor-overexpressed gene 1 protein [OS=Homo sapiens]",0,6.909,2,1,1,1,1,416,46.8,10.54,3.28,1,"other biological processes","plasma membrane;other membranes;nucleus;other cell component",NA,"Pf11232","53635","hsa:53635; Q6UXX7; Q86YD1; Q96BU3; Q9HBN4; Q9NYL1","ENSG00000104960",NA,NA,0,0,126.6,111.4,118.1,92,81.5,84.4,86.9,89.3,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000104960"
"1437","UBAP2L",-0.0269457303279248,6.66627806216882,-0.388885987650594,0.705855272797606,0.801639391235694,-6.92554085821188,"NONE",FALSE,"High","Master Protein","Q14157-1","Isoform 2 of Ubiquitin-associated protein 2-like [OS=Homo sapiens]",0,66.258,7,5,7,11,5,983,103.9,6.98,37.07,5,NA,NA,NA,NA,NA,"Q14157-1",NA,NA,NA,0,0,87.6,91.2,89.6,111.1,104.6,109.2,102.7,111.9,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(99.4); S467(100); S493(100); S609(100)]",0,"ENSG00000143569"
"1438","MOCS3",0.0422116539744533,6.64463237507331,0.383820631432849,0.709483795618634,0.80519996832379,-6.92765149150019,"NONE",FALSE,"High","Master Protein","O95396","Adenylyltransferase and sulfurtransferase MOCS3 [OS=Homo sapiens]",0,8.145,2,1,1,2,1,460,49.6,6.21,5.59,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;other cell component","other molecular function","Pf00581, Pf00899","27304","hsa:27304; O95396","ENSG00000124217","Molybdenum cofactor biosynthesis","Metabolic Epileptic Disorders",2,0,97.1,93.8,102.8,97.2,83.6,112.3,90.7,107.9,115.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000124217"
"1439","ACTN1",0.0496693516423905,6.67036549948578,0.376849608153625,0.714489967389335,0.810318017219871,-6.93051229714793,"NONE",FALSE,"High","Master Protein","P12814","Alpha-actinin-1 [OS=Homo sapiens]",0,50.357,3,2,3,4,1,892,103,5.41,13.67,2,"cell adhesion;cell organization and biogenesis;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00307, Pf00435, Pf08726","87","B3V8S3; B4DHH3; B7TY16; hsa:87; P12814; Q1HE25; Q9BTN1","ENSG00000072110","Platelet degranulation ; RHOD GTPase cycle; RHOF GTPase cycle; Nephrin family interactions; Syndecan interactions; RHOBTB2 GTPase cycle; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Ebola virus infection in host; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Regulation of actin cytoskeleton",12,2,96.6,96.6,83,113.7,76.3,118.6,116,107.7,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000072110"
"1440","DDX41",0.113952997408189,6.01989116634216,0.3750885237665,0.715756948914811,0.811191208770119,-6.93122696907694,"NONE",FALSE,"High","Master Protein","Q9UJV9","Probable ATP-dependent RNA helicase DDX41 [OS=Homo sapiens]",0,8.22,3,2,2,2,2,622,69.8,6.84,2.67,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf00270, Pf00271","51428","B2RDC8; Q96BK6; Q96K05; Q9NT96; Q9NW04; Q9UJV9","ENSG00000183258","mRNA Splicing - Major Pathway; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN","5q35 copy number variation",5,0,181.9,190.8,163.6,19.2,30.8,56.5,51.4,50.6,52.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S405(100)]",0,"ENSG00000183258"
"1441","EHBP1",0.0268384691121772,6.672223121363,0.374345048729545,0.716292102826858,0.811234359343117,-6.9315277056953,"NONE",FALSE,"High","Master Protein","Q8NDI1","EH domain-binding protein 1 [OS=Homo sapiens]",0,49.152,6,5,6,8,5,1231,139.9,5.35,23.57,5,"transport","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle",NA,"Pf00307, Pf10358, Pf12130","23301","hsa:23301; O94977; Q53TG7; Q53TV6; Q580X2; Q6NX72; Q6PIT3; Q6QNV2; Q8NDI1; Q9NWI9","ENSG00000115504",NA,"Ciliary landscape",1,0,87.9,89.2,88.6,112.6,105,104.3,105.3,113.9,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); T378(99.4); S436(100); T694(100); S751(100)]",0,"ENSG00000115504"
"1442","TERF2IP",0.0258630249496274,6.67046246902537,0.373576149974958,0.716845727288203,0.811298354323403,-6.93183811680246,"NONE",FALSE,"High","Master Protein","Q9NYB0","Telomeric repeat-binding factor 2-interacting protein 1 [OS=Homo sapiens]",0,37.681,4,1,1,5,1,399,44.2,4.73,19.32,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf08914, Pf11626, Pf16589","54386","B4DQN4; hsa:54386; Q4W4Y2; Q8WYZ3; Q9NWR2; Q9NYB0","ENSG00000166848","Meiotic synapsis; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Telomere Extension By Telomerase; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand","Splicing factor NOVA regulated synaptic proteins; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",16,0,89.3,90.2,88.7,111.2,102.3,105.9,110.5,108.6,109.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000166848"
"1443","SNX16",0.0468068978803178,6.63441959771224,0.371897646758827,0.718054888540862,0.812103657726047,-6.93251358967148,"NONE",FALSE,"High","Master Protein","P57768","Sorting nexin-16 [OS=Homo sapiens]",0,14.379,6,1,1,1,1,344,39.1,4.65,4.01,1,"transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00787","64089","A8K4D8; P57768; Q658L0; Q8N4U3","ENSG00000104497",NA,NA,0,0,111.7,98,81.5,107.4,91.8,94.1,109.9,95.2,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(99.5)]",0,"ENSG00000104497"
"1444","BANP",-0.0684595959365328,6.5450999559735,-0.370507476200782,0.719056962930926,0.812673797439939,-6.93307079310112,"NONE",FALSE,"High","Master Protein","Q8N9N5","Protein BANP [OS=Homo sapiens]",0,7.48,3,1,1,1,1,519,56.5,5.49,3.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf10523","54971","A8MU25; A8MX25; B2RCF7; B4DNJ9; F5GZM0; hsa:54971; Q8N9N5; Q96GJ7; Q9NWY1","ENSG00000172530","Regulation of TP53 Activity through Association with Co-factors",NA,1,0,115.9,95.9,90.5,107.6,64.6,98,112,85.6,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S145(100)]",0,"ENSG00000172530"
"1445","STK39",-0.0294608558906839,6.63959257717352,-0.369388999754439,0.719863600608677,0.812811057694951,-6.93351762522671,"NONE",FALSE,"High","Master Protein","Q9UEW8","STE20/SPS1-related proline-alanine-rich protein kinase [OS=Homo sapiens]",0,6.753,2,1,1,2,1,545,59.4,6.29,5.53,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf12202","27347","O14774; Q53S90; Q53SL7; Q53SS1; Q9UER4; Q9UEW8; X5D9C8","ENSG00000198648",NA,NA,0,0,97.5,96.6,108,102.1,97.1,98,95,98.1,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T354(100)]",0,"ENSG00000198648"
"1446","NFIC",0.0470259743311132,6.64275781075983,0.368958039261611,0.720174503325306,0.812811057694951,-6.93368944390489,"NONE",FALSE,"High","Master Protein","P08651","Nuclear factor 1 C-type [OS=Homo sapiens]",0,15.618,3,1,1,3,1,508,55.6,8.38,8.57,1,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4782","A8K1H0; B7Z4U5; B7Z9C3; hsa:4782; K7EMU1; P08651; P08652; Q14932; Q9UPJ3; Q9UPJ9; Q9UPK0; Q9UPK1","ENSG00000141905","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,89.8,87.5,100.6,101.3,75,122.9,98.3,106.5,114.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S339(99.7)]",0,"ENSG00000141905"
"1447","SBF1",-0.026349953894834,6.64846325686014,-0.366629426232414,0.721855336942514,0.814145065577182,-6.93461446096309,"NONE",FALSE,"High","Master Protein","O95248","Myotubularin-related protein 5 [OS=Homo sapiens]",0,34.703,3,3,3,3,3,1868,208.3,6.9,10.64,3,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf02141, Pf02893, Pf03456, Pf06602, Pf12335","6305","A0A024R4Z9; A6PVG9; G5E933; hsa:6305; O60228; O95248; Q5JXD8; Q5PPM2; Q96GR9; Q9UGB8","ENSG00000100241","RAB GEFs exchange GTP for GDP on RABs; Synthesis of PIPs at the ER membrane",NA,2,0,96.3,102.3,98.9,97.3,104.1,103.1,99.3,98.3,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1142(99.6); S1229(100); T1820(100)]",0,"ENSG00000100241"
"1448","SFT2D1",0.0598873492097258,6.71260766887125,0.358840562606426,0.7274887889827,0.819932115759507,-6.93766711405816,"NONE",FALSE,"High","Master Protein","Q8WV19","Vesicle transport protein SFT2A [OS=Homo sapiens]",0,15.2,17,1,1,2,1,159,17.8,8.65,9.07,1,"transport","other membranes",NA,"Pf04178","113402","hsa:113402; Q5TI64; Q8WV19; Q9UIC7","ENSG00000198818",NA,NA,0,0,85.6,53.7,84.3,125.9,117.6,119.1,137.4,117.1,118.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100)]",0,"ENSG00000198818"
"1449","CC2D1A",-0.0454307781150174,6.63333129379472,-0.356962781043181,0.728849514598954,0.820898832177704,-6.93839352141126,"NONE",FALSE,"High","Master Protein","Q6P1N0","Coiled-coil and C2 domain-containing protein 1A [OS=Homo sapiens]",0,17.221,3,2,2,2,2,951,104,8.09,7.38,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf00168, Pf21528","54862","hsa:54862; Q6P1N0; Q7Z435; Q86XV0; Q8NF89; Q9H603; Q9NXI1","ENSG00000132024; ENSG00000288293",NA,"Sudden infant death syndrome (SIDS) susceptibility pathways",1,0,85.4,93.3,72.1,104.3,95.8,125.2,97.6,113.7,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T204(97.4); S455(100)]",0,"ENSG00000132024"
"1450","MTMR10",-0.0690000453130279,6.61430606636306,-0.353844469773508,0.731111378847324,0.822781750492514,-6.93959162115109,"NONE",FALSE,"High","Master Protein","Q9NXD2","Myotubularin-related protein 10 [OS=Homo sapiens]",0,4.489,2,1,1,3,1,777,88.2,8.53,6.59,1,NA,"cytosol;other cell component",NA,"Pf06602, Pf12578","54893","hsa:54893; Q6P4Q6; Q9NXD2","ENSG00000166912; ENSG00000277086","Synthesis of PIPs at the early endosome membrane","15q13.3 copy number variation syndrome; 15q11q13 copy number variation",3,0,60.3,68.2,103.8,100.9,108,132.3,95.5,118.5,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S769(99.5)]",0,"ENSG00000166912"
"1451","ZNF462",0.0336983477221064,6.59879128809816,0.353268291450861,0.73152960782147,0.822781750492514,-6.93981187645472,"NONE",FALSE,"High","Master Protein","Q96JM2","Zinc finger protein 462 [OS=Homo sapiens]",0,37.844,2,3,3,3,3,2506,284.5,7.58,12.2,3,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function",NA,"58499","hsa:58499; Q5T0T4; Q8N408; Q96JM2","ENSG00000148143",NA,"Mesodermal commitment pathway",1,0,101.7,109,111,94.3,68.5,102.1,91.3,99.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1090(100); S2172(100)]",0,"ENSG00000148143"
"1452","SQSTM1",0.0260263809104861,6.60526377100956,0.351881916402923,0.732536312138042,0.823346598766725,-6.94034041220607,"NONE",FALSE,"High","Master Protein","Q13501","Sequestosome-1 [OS=Homo sapiens]",0,32.737,11,2,2,4,2,440,47.7,5.22,10.51,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00564, Pf00569, Pf16577","8878","A6NFN7; B2R661; B3KUW5; hsa:8878; Q13446; Q13501; Q9BUV7; Q9BVS6; Q9UEU1","ENSG00000161011; ENSG00000284099","Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Signaling by ALK fusions and activated point mutants; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; Nuclear events mediated by NFE2L2; PINK1-PRKN Mediated Mitophagy; NRIF signals cell death from the nucleus; Pexophagy","IL-1 signaling pathway; RANKL/RANK signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Nuclear receptors meta-pathway; NRF2 pathway; Interleukin-1 induced activation of NF-kB; Clear cell renal cell carcinoma pathways; CAMKK2 pathway; 7q11.23 copy number variation syndrome; Opioid receptor pathways; Clock-controlled autophagy in bone metabolism; Autophagy in pancreatic ductal adenocarcinoma; HDAC6 interactions in the central nervous system",24,0,108.9,111.7,122.6,87.9,84,89.6,90.9,94.4,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S272(100)]",0,"ENSG00000161011"
"1453","REST",0.0361179399265916,6.62121996593456,0.350219920037587,0.733743862194413,0.823846670241846,-6.94097135576133,"NONE",FALSE,"High","Master Protein","Q13127","RE1-silencing transcription factor [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1097,121.8,6.74,4.01,1,"cell organization and biogenesis;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","5978","A2RUE0; B9EGJ0; hsa:5978; Q12956; Q12957; Q13127; Q13134; Q59ER1; Q8IWI3","ENSG00000084093","HDACs deacetylate histones; Potential therapeutics for SARS; NGF-stimulated transcription; Regulation of PTEN gene transcription; Regulation of NPAS4 gene transcription","MECP2 and associated Rett syndrome; DYRK1A involvement regarding cell proliferation in brain development; 11p11.2 copy number variation syndrome ; Sudden infant death syndrome (SIDS) susceptibility pathways",9,0,96.7,102,83.3,108.5,91.6,93.5,104.6,99.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S864(100)]",0,"ENSG00000084093"
"1454","NSFL1C",0.0336090531880506,6.68470178311489,0.349880118832403,0.733990844688508,0.823846670241846,-6.9410999960511,"NONE",FALSE,"High","Master Protein","Q9UNZ2-4","Isoform 2 of NSFL1 cofactor p47 [OS=Homo sapiens]",0,49.044,19,5,5,7,5,339,37.3,5.11,17.41,5,NA,NA,NA,NA,NA,"Q9UNZ2-4",NA,NA,NA,0,0,78.2,84.2,95.4,115,118.8,100.5,111.5,110.8,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100); S140(100)]",0,"ENSG00000088833"
"1455","MEPCE",-0.0353556063333116,6.65808363231301,-0.349185179856607,0.734496056642974,0.823847123327377,-6.94136270370165,"NONE",FALSE,"High","Master Protein","Q7L2J0","7SK snRNA methylphosphate capping enzyme [OS=Homo sapiens]",0,56.956,12,5,6,6,5,689,74.3,9.57,20.89,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf06859","56257","B3KP86; D6W5V7; hsa:56257; Q7L2J0; Q9NPD4","ENSG00000146834",NA,"IL-18 signaling pathway; 1p36 copy number variation syndrome",2,0,94.2,90,85.4,102.6,128.2,100,103.8,101.4,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(98.8); S69(100); S216(100); S217(100); S330(100)]",0,"ENSG00000146834"
"1456","NEIL2",-0.0776341593585181,6.54039675846453,-0.348263579985471,0.735166254419765,0.824032504954023,-6.94171031065752,"NONE",FALSE,"High","Master Protein","Q969S2","Endonuclease 8-like 2 [OS=Homo sapiens]",0,13.625,6,1,1,3,1,332,36.8,6.79,3.39,1,"DNA metabolism;other metabolic processes;stress response","cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf06831","252969","B4DFR7; hsa:252969; Q7Z3Q7; Q8N842; Q8NG52; Q969S2","ENSG00000154328; ENSG00000292286","Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway","Base excision repair; DNA repair pathways, full network; 8p23.1 copy number variation syndrome",6,0,138.2,95.7,87.5,89.3,67.4,109.2,68.3,96.9,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(98.5)]",0,"ENSG00000154328"
"1457","NFRKB",-0.0351405992042437,6.63718374475256,-0.344762894940081,0.737714125585916,0.82632083250255,-6.94302252807906,"NONE",FALSE,"High","Master Protein","Q6P4R8","Nuclear factor related to kappa-B-binding protein [OS=Homo sapiens]",0,26.52,4,2,2,3,2,1299,138.9,9.25,5.46,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf14465","4798","hsa:4798; Q12869; Q15312; Q6P4R8; Q9H048","ENSG00000170322","UCH proteinases; DNA Damage Recognition in GG-NER","Overview of nanoparticle effects",3,0,84,96.4,97.7,114.7,91.8,100.2,97.6,111.7,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(98); S1291(99.6)]",0,"ENSG00000170322"
"1458","NOLC1",-0.0297877643848974,6.60342065418421,-0.343713114716475,0.738478832873158,0.826610051611107,-6.94341351401032,"NONE",FALSE,"High","Master Protein","Q14978","Nucleolar and coiled-body phosphoprotein 1 [OS=Homo sapiens]",0,49.288,7,6,6,16,6,699,73.6,9.47,30.14,6,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf05022","9221","hsa:9221; Q14978; Q15030; Q5VV70; Q9BUV3","ENSG00000166197",NA,NA,0,0,110.3,110.8,110.6,87.7,100.7,88.7,96.3,89.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S538(100); S563(100); S623(100); S698(100)]",0,"ENSG00000166197"
"1459","LSM14A",-0.0310839816841311,6.62419979916866,-0.341903733820327,0.739797573736296,0.827518602013458,-6.94408467960992,"NONE",FALSE,"High","Master Protein","Q8ND56","Protein LSM14 homolog A [OS=Homo sapiens]",0,65.774,13,9,10,20,8,463,50.5,9.52,62.45,9,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","nucleic acid binding activity","Pf09532, Pf12701","26065","B4DTG6; hsa:26065; Q76LX7; Q8ND56; Q96AR3; Q96K73; Q96SN5; Q9UFR3","ENSG00000257103; ENSG00000262860",NA,NA,0,1,98.8,104.2,103.9,92,83.7,112.6,101.9,98.8,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100); S178(99.6); S183(99); S192(100); S216(100)]",0,"ENSG00000257103"
"1460","BORCS6",0.0249894670807969,6.62682823276099,0.340349912105406,0.740930764764117,0.828218498695232,-6.9446582901801,"NONE",FALSE,"High","Master Protein","Q96GS4","BLOC-1-related complex subunit 6 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,357,37.2,5.76,5.13,1,"cell organization and biogenesis;transport;other biological processes","other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf10157","54785","hsa:54785; Q53HS4; Q96GS4; Q9NXW8","ENSG00000196544",NA,NA,0,0,104.2,98,97.4,98.1,85.3,102.6,98.8,105.9,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T196(100)]",0,"ENSG00000196544"
"1461","PIP4P2",0.0513053556441454,6.63851006704678,0.335273641929439,0.744637397610918,0.8310733733754,-6.94651447358546,"NONE",FALSE,"High","Master Protein","Q8N4L2","Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase [OS=Homo sapiens]",0,7.514,10,1,1,1,1,257,28.1,8.68,2.88,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle","other molecular function","Pf09788","55529","B2R9H4; hsa:55529; Q68CU2; Q8N4L2","ENSG00000155099",NA,NA,0,0,91.3,79.4,77.5,114,77.7,122.9,126.1,102.9,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); T22(100)]",0,"ENSG00000155099"
"1462","SLC39A7",-0.0549474563572261,6.41881672099698,-0.334545792841261,0.745169431491485,0.8310733733754,-6.94677838540307,"NONE",FALSE,"High","Master Protein","Q92504","Zinc transporter SLC39A7 [OS=Homo sapiens]",0,19.346,3,3,6,14,3,469,50.1,6.87,13.18,3,"transport;other biological processes","other membranes;ER/Golgi;nucleus","transporter activity","Pf02535","7922","B0UXF6; hsa:7922; Q5STP8; Q92504; Q9UIQ0","ENSG00000112473; ENSG00000206288; ENSG00000224399; ENSG00000226614; ENSG00000227402; ENSG00000229802","Zinc influx into cells by the SLC39 gene family","Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis",4,0,152.3,136.8,135.9,66.1,77.4,52.2,83.3,64.3,68.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S276(99.5)]",0,"ENSG00000112473"
"1463","PJA1",-0.0481702255807779,6.63021522542198,-0.334131913387068,0.745472026929439,0.8310733733754,-6.94692820468412,"NONE",FALSE,"High","Master Protein","Q8NG27","E3 ubiquitin-protein ligase Praja-1 [OS=Homo sapiens]",0,11.771,3,2,2,4,2,643,71,5.17,7.34,2,"protein metabolism;other metabolic processes","other cell component","other molecular function","Pf13639","64219","A2A322; Q5JUT8; Q5JUT9; Q8NG27; Q8NG28; Q9HAC1","ENSG00000181191","Antigen processing: Ubiquitination & Proteasome degradation","TGF-beta signaling pathway",2,0,77.7,79.3,83.8,109.8,143,92.6,110.7,96.4,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100); S265(100)]",0,"ENSG00000181191"
"1464","SUDS3",-0.0585661429281901,6.48239186848969,-0.334063974732572,0.745521702586756,0.8310733733754,-6.94695278033375,"NONE",FALSE,"High","Master Protein","Q9H7L9","Sin3 histone deacetylase corepressor complex component SDS3 [OS=Homo sapiens]",0,8.632,7,1,1,1,1,328,38.1,5.66,3.53,1,"cell organization and biogenesis;other biological processes","cytosol;nucleus","other molecular function","Pf08598","64426","hsa:64426; Q4KMQ5; Q8N6H0; Q9H7L9; Q9H8D2","ENSG00000111707","Ub-specific processing proteases; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Potential therapeutics for SARS",NA,4,0,130.7,114.7,107.4,68.9,63.7,99.2,66.3,91.6,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S234(100); S236(99)]",0,"ENSG00000111707"
"1465","LEO1",0.0369930641585956,6.67595858191519,0.332813445526688,0.7464362891262,0.831524930958334,-6.94740426599512,"NONE",FALSE,"High","Master Protein","Q8WVC0","RNA polymerase-associated protein LEO1 [OS=Homo sapiens]",0,14.066,5,3,4,4,2,666,75.4,4.51,10.74,3,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus","other molecular function","Pf04004","123169","hsa:123169; Q8WVC0; Q96N99","ENSG00000166477","E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events","Endoderm differentiation",6,0,89,85.6,90.4,115.6,89.8,113.4,101.5,128,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S546(100); S630(100); S658(100)]",0,"ENSG00000166477"
"1466","CTNNB1",-0.0266219687972065,6.65795377091611,-0.331069202523171,0.747712651863397,0.832378613807002,-6.9480312368766,"NONE",FALSE,"High","Master Protein","P35222","Catenin beta-1 [OS=Homo sapiens]",0,88.231,7,6,8,22,6,781,85.4,5.86,76.03,6,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00514","1499","A8K1L7; hsa:1499; P35222; Q8NEW9; Q8NI94; Q9H391","ENSG00000168036","Deactivation of the beta-catenin transactivating complex; InlA-mediated entry of Listeria monocytogenes into host cells; RHO GTPases activate IQGAPs; Formation of paraxial mesoderm; Somitogenesis; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Formation of axial mesoderm; Myogenesis; Transcriptional Regulation by VENTX; Ca2+ pathway; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; Cardiogenesis; Germ layer formation at gastrulation; Formation of definitive endoderm; VEGFR2 mediated vascular permeability; Adherens junctions interactions; Regulation of CDH11 function; Regulation of CDH19 Expression and Function; CDH11 homotypic and heterotypic interactions; Binding of TCF/LEF:CTNNB1 to target gene promoters; RUNX3 regulates WNT signaling; Specification of the neural plate border; Formation of the nephric duct; Apoptotic cleavage of cell adhesion  proteins; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production","Androgen receptor signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Heart development; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Gastric cancer network 2; Brain-derived neurotrophic factor (BDNF) signaling pathway; Polycystic kidney disease pathway; Primary focal segmental glomerulosclerosis (FSGS); Endoderm differentiation; Ectoderm differentiation; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; Ectoderm differentiation; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Embryonic stem cell pluripotency pathways; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; OSX and miRNAs in tooth development; miRNA regulation of prostate cancer signaling pathways; Wnt signaling pathway and pluripotency; PTF1A related regulatory pathway; Wnt signaling in kidney disease; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Ciliary landscape; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Genes controlling nephrogenesis; GDNF/RET signaling axis; Mammalian disorder of sexual development; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; 1q21.1 copy number variation syndrome; 7q11.23 copy number variation syndrome; Development of ureteric collection system; Pleural mesothelioma; Alzheimer's disease; Urotensin-II-mediated signaling pathway; Markers of kidney cell lineage; TROP2 regulatory signaling; 8p23.1 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; ADHD and autism (ASD) linked metabolic pathways and SNP; HDAC6 interactions in the central nervous system; Wnt/Beta-catenin signaling inhibitors in current and past clinical trials; TGF-beta receptor signaling; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response (only ATM dependent)",103,0,84.2,79.9,83.2,103.9,108.2,124.2,107.8,114.1,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S191(100); S552(100); S675(100)]",0,"ENSG00000168036"
"1467","TAF12",0.0230844444880987,6.58740831493162,0.329567833695517,0.748811934404153,0.833034135615254,-6.94856832790513,"NONE",FALSE,"High","Master Protein","Q16514","Transcription initiation factor TFIID subunit 12 [OS=Homo sapiens]",0,28.857,13,2,2,3,2,161,17.9,7.99,11.61,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03847","6883","D3DPM5; hsa:6883; Q15775; Q16514; Q5T077","ENSG00000120656","Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; HATs acetylate histones","Eukaryotic transcription initiation",11,0,113.6,125.2,118.4,86.3,79.9,84.8,92.6,89.5,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000120656"
"1468","SYN1",-0.0271010966970824,6.59263420181218,-0.327601218899762,0.750252762320099,0.83400037387731,-6.94926824331374,"NONE",FALSE,"High","Master Protein","P17600","Synapsin-1 [OS=Homo sapiens]",0,10.897,3,1,1,1,1,705,74.1,9.83,3.79,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf02078, Pf02750, Pf10581","6853","B1AJQ1; hsa:6853; O75825; P17600; Q5H9A9","ENSG00000008056","Sensory processing of sound by inner hair cells of the cochlea; Serotonin Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle","Synaptic vesicle pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; GDNF signaling; Monoamine transport",7,0,105,105.9,105.5,84.7,91.1,100.6,88.7,95.6,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(99.2)]",0,"ENSG00000008056"
"1469","STAT3",0.0409382549821036,6.64608512315725,0.326987588721445,0.75070254241775,0.83400037387731,-6.94948579511212,"NONE",FALSE,"High","Master Protein","P40763","Signal transducer and activator of transcription 3 [OS=Homo sapiens]",0,29.718,3,1,2,10,1,770,88,6.3,27.69,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf21354","6774","A8K7B8; hsa:6774; K7ENL3; O14916; P40763; Q9BW54","ENSG00000168610","Signaling by ALK fusions and activated point mutants; Senescence-Associated Secretory Phenotype (SASP); Interleukin-4 and Interleukin-13 signaling; Transcriptional regulation of granulopoiesis; PKR-mediated signaling; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; Signaling by ALK; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Cytoprotection by HMOX1; Association of TriC/CCT with target proteins during biosynthesis; Interleukin-10 signaling; Growth hormone receptor signaling; Interleukin-6 signaling; Signaling by Leptin; PTK6 Activates STAT3; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; STAT3 nuclear events downstream of ALK signaling; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation; Interleukin-20 family signaling; Interleukin-35 Signalling; Interleukin-23 signaling; Interleukin-27 signaling; Interleukin-37 signaling; Signalling to STAT3; Nuclear events stimulated by ALK signaling in cancer; MET activates STAT3; Interleukin-15 signaling; Interleukin-9 signaling; Interleukin-21 signaling","IL-5 signaling pathway; Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Cell differentiation - expanded index; Cell differentiation - index; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; IL-17 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Androgen receptor network in prostate cancer; AGE/RAGE pathway; Interleukin-11 signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Mammary gland development pathway - Involution (Stage 4 of 4); Dopaminergic neurogenesis; IL-3 signaling pathway; TCA cycle nutrient use and invasiveness of ovarian cancer; Estrogen receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; VEGFA-VEGFR2 signaling; Development of pulmonary dendritic cells and macrophage subsets; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Leptin-insulin signaling overlap; IL-4 signaling pathway; PDGFR-beta pathway; Prion disease pathway; Clear cell renal cell carcinoma pathways; MET in type 1 papillary renal cell carcinoma; Non-small cell lung cancer; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Extracellular vesicles in the crosstalk of cardiac cells; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; EGF/EGFR signaling pathway; IL-10 anti-inflammatory signaling pathway ; Regulatory circuits of the STAT3 signaling pathway; Interactions between immune cells and microRNAs in tumor microenvironment; Neural crest cell migration during development; Neural crest cell migration in cancer; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; EGFR tyrosine kinase inhibitor resistance; TGF-beta receptor signaling in skeletal dysplasias; mBDNF and proBDNF regulation of GABA neurotransmission; IL-2 signaling pathway; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Th17 cell differentiation pathway; Urotensin-II-mediated signaling pathway; Inflammatory bowel disease signaling; 2q11.2 copy number variation syndrome; 2q21.1 copy number variation syndrome; Neurogenesis regulation in the olfactory epithelium; Acute myeloid leukemia; Autophagy in pancreatic ductal adenocarcinoma; IL-26 signaling pathways; JAK-STAT signaling in the regulation of beta cells; TAR syndrome; Osteoarthritic chondrocyte hypertrophy; IL-19 signaling pathway; TGF-beta receptor signaling; EPO receptor signaling; Interferon type I signaling pathways; Notch signaling pathway; Serotonin HTR1 group and FOS pathway",119,0,93,71.2,100.3,99.6,101,115.5,101.3,116.1,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100)]",0,"ENSG00000168610"
"1470","USP16",0.0338122347863985,6.63568594351989,0.325116043725077,0.752074960002876,0.834627037303677,-6.95014685515581,"NONE",FALSE,"High","Master Protein","Q9Y5T5","Ubiquitin carboxyl-terminal hydrolase 16 [OS=Homo sapiens]",0,14.464,2,1,1,1,1,823,93.5,6.93,4.31,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","translation activity;other molecular function","Pf00443, Pf02148","10600","A8MU43; B3KN13; B4DFV8; B4DY37; D3DSD9; hsa:10600; Q53GP7; Q53HA0; Q5VKN8; Q8NEL3; Q9H3E6; Q9Y5T5","ENSG00000156256; ENSG00000291527","Ub-specific processing proteases",NA,1,0,80.8,72.4,90.2,102.9,106.5,116.8,104.1,123.9,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S552(99.1)]",0,"ENSG00000156256"
"1471","AP3B1",0.0602767469270313,6.60835131292259,0.324350809225429,0.752636375095967,0.834627037303677,-6.95041607949848,"NONE",FALSE,"High","Master Protein","O00203","AP-3 complex subunit beta-1 [OS=Homo sapiens]",0,9.333,2,2,2,2,2,1094,121.2,6.04,3.4,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01602, Pf14796, Pf14797","8546","E5RJ68; hsa:8546; O00203; O00580; Q7Z393; Q9HD66","ENSG00000132842","Golgi Associated Vesicle Biogenesis; Signaling by BRAF and RAF1 fusions",NA,2,0,109.7,109.1,108.8,107.9,56,101.3,95.1,115.9,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S750(100)]",0,"ENSG00000132842"
"1472","GPS1",0.0248153415378303,6.63691436032664,0.324126651923947,0.752800857175866,0.834627037303677,-6.95049482487674,"NONE",FALSE,"High","Master Protein","Q13098","COP9 signalosome complex subunit 1 [OS=Homo sapiens]",0,28.986,4,2,2,4,2,491,55.5,6.74,9.94,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity","Pf01399, Pf10602, Pf21151","2873","hsa:2873; Q13098; Q8NA10; Q9BWL1","ENSG00000169727","Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER",NA,5,0,108.6,99.5,99.2,99,91.3,97.7,94.6,101.2,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S474(100)]",0,"ENSG00000169727"
"1473","ALS2",0.0298056520590357,6.62564788646016,0.322651944564866,0.75388329260101,0.83525969689399,-6.95101155479293,"NONE",FALSE,"High","Master Protein","Q96Q42","Alsin [OS=Homo sapiens]",0,71.104,4,5,6,16,5,1657,183.5,6.27,52.04,5,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00415, Pf00621, Pf02204, Pf02493","57679","hsa:57679; Q53TT1; Q53TV2; Q8N1E0; Q96PC4; Q96Q41; Q96Q42; Q9H973; Q9HCK9","ENSG00000003393","RAC1 GTPase cycle; RAB GEFs exchange GTP for GDP on RABs","Amyotrophic lateral sclerosis (ALS); IL-18 signaling pathway",4,0,102.5,93.4,89.8,92.9,110,96.8,104.1,98.7,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S466(99.3); S483(100); S492(100); T510(100); S1464(99.7)]",0,"ENSG00000003393"
"1474","PHF12",-0.0215406459382255,6.59929225526817,-0.32043684187421,0.755510235163838,0.836494371633231,-6.95178338297338,"NONE",FALSE,"High","Master Protein","Q96QT6","PHD finger protein 12 [OS=Homo sapiens]",0,27.978,4,3,3,5,3,1004,109.6,7.74,21.22,3,"other biological processes","nucleus;other cell component","other molecular function","Pf00628, Pf16737","57649","hsa:57649; Q0VAI5; Q2TAK2; Q6ZML2; Q96QT6; Q9BV34; Q9H7U9; Q9P205","ENSG00000109118",NA,NA,0,0,118,121.1,121.4,85,82.9,90.5,87.2,92.3,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(100); T671(100); T880(99.6)]",0,"ENSG00000109118"
"1475","MCRS1",-0.0464877274381568,6.48220958647091,-0.319622885558447,0.756108385091038,0.836589074215982,-6.95206568979288,"NONE",FALSE,"High","Master Protein","Q96EZ8","Microspherule protein 1 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,462,51.8,9.38,6.99,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity","Pf00498, Pf13325","10445","hsa:10445; O14742; O75497; Q6VN53; Q7Z372; Q96EZ8","ENSG00000187778","UCH proteinases; Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones; DNA Damage Recognition in GG-NER","3q29 copy number variation syndrome; 8p23.1 copy number variation syndrome",6,0,165.9,102.6,125.2,79.7,58.3,81.1,84.6,81.3,72,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S282(100)]",0,"ENSG00000187778"
"1476","KLC2",-0.0305106267796296,6.67015759415014,-0.316721394338238,0.758241977193791,0.838381373157362,-6.95306630396651,"NONE",FALSE,"High","Master Protein","Q9H0B6","Kinesin light chain 2 [OS=Homo sapiens]",0,21.275,3,2,4,10,2,622,68.9,7.15,24.28,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity","Pf13424","64837","A8MXL7; B2RDY4; hsa:64837; Q9H0B6; Q9H9C8; Q9HA20","ENSG00000174996","MHC class II antigen presentation; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; RHO GTPases activate KTN1","Alzheimer's disease and miRNA effects; Alzheimer's disease",6,0,72.6,76.4,72.4,111.8,145.6,113.7,109.7,115.7,128.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S582(99.7); S610(99.6)]",0,"ENSG00000174996"
"1477","NAP1L4",-0.0297253374327999,6.67116740641538,-0.306373741082326,0.765868391241522,0.845872471028754,-6.95656202594719,"NONE",FALSE,"High","Master Protein","Q99733","Nucleosome assembly protein 1-like 4 [OS=Homo sapiens]",0,54.118,11,2,4,10,2,375,42.8,4.69,21.11,2,"cell organization and biogenesis","nucleus;other cell component","other molecular function","Pf00956","4676","B2R6J4; F5HFY4; hsa:4676; Q99733","ENSG00000205531; ENSG00000273562",NA,NA,0,0,71.8,90.3,87.1,119,104.8,114.3,110,113.8,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(99.5); S125(100)]",0,"ENSG00000205531"
"1478","PUM2",-0.0231755962258697,6.64349907763565,-0.305791463999341,0.766298334814021,0.845872471028754,-6.95675535306362,"NONE",FALSE,"High","Master Protein","Q8TB72","Pumilio homolog 2 [OS=Homo sapiens]",0,37.164,5,4,4,7,4,1066,114.1,7.08,23.72,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00806","23369","B3KSL0; B4E2B6; D6W527; hsa:23369; O00234; Q53TV7; Q8TB72; Q8WY43; Q9HAN2","ENSG00000055917","Neddylation","Male infertility",2,0,93.7,96.3,96.7,97.1,109.2,102.8,100.6,99,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S136(100); S182(100); S587(100)]",0,"ENSG00000055917"
"1479","RBM10",-0.0207497221951103,6.61862883777053,-0.305191509510044,0.766741418663771,0.845872471028754,-6.95695417220563,"NONE",FALSE,"High","Master Protein","P98175","RNA-binding protein 10 [OS=Homo sapiens]",0,39.989,4,3,3,7,3,930,103.5,5.97,24.63,3,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf00641, Pf01585, Pf17780","8241","A0A0A0MR66; C4AM81; hsa:8241; P98175; Q14136; Q5JRR2; Q9BTE4; Q9BTX0; Q9NTB1","ENSG00000182872","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,112.8,108,100.7,95.2,86.5,98.2,94.5,97.2,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(99.3); S723(100); S797(100)]",0,"ENSG00000182872"
"1480","MTCL1",0.030308333641158,6.55751669957911,0.304719287090126,0.767090231079997,0.845872471028754,-6.95711039287804,"NONE",FALSE,"High","Master Protein","Q9Y4B5","Microtubule cross-linking factor 1 [OS=Homo sapiens]",0,38.439,3,3,3,5,3,1905,209.4,6.43,15.88,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf11365, Pf14818","23255","E9PAY7; hsa:23255; Q6ZMQ9; Q8IWA9; Q9Y4B5","ENSG00000168502",NA,NA,0,0,124.3,125.5,123.1,73.3,77.7,84.5,79.2,87.1,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100); S306(100); S1514(100)]",0,"ENSG00000168502"
"1481","ZNF777",0.037524240441007,6.64248742709991,0.303187688973549,0.768221940705136,0.846548418116665,-6.95761544371257,"NONE",FALSE,"High","Master Protein","Q9ULD5","Zinc finger protein 777 [OS=Homo sapiens]",0,7.27,2,1,1,3,1,831,93.7,6.61,4.19,1,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","27153","hsa:27153; Q8N2R2; Q8N659; Q9ULD5","ENSG00000196453","Generic Transcription Pathway",NA,1,0,104,108.7,87.1,100.1,74.5,115.6,102.1,108.6,98.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(99.3)]",0,"ENSG00000196453"
"1482","SUPV3L1",-0.0335058546497864,6.60998838434383,-0.301081815158547,0.769778925289083,0.847134890321975,-6.95830578840555,"NONE",FALSE,"High","Master Protein","Q8IYB8","ATP-dependent RNA helicase SUPV3L1, mitochondrial [OS=Homo sapiens]",0,27.036,2,1,1,3,1,786,87.9,7.99,10.7,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","mitochondrion;nucleus;other cytoplasmic organelle","nucleic acid binding activity;other molecular function","Pf00271, Pf12513, Pf18114, Pf18147","6832","A8K301; hsa:6832; O43630; Q8IYB8","ENSG00000156502","Mitochondrial RNA degradation",NA,1,0,102.8,108.5,112,85.9,75.8,115.5,93.5,91.8,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S725(100)]",0,"ENSG00000156502"
"1483","DDX54",-0.033180999343875,6.53695470685603,-0.301063724507228,0.769792305359981,0.847134890321975,-6.95831169840809,"NONE",FALSE,"High","Master Protein","Q8TDD1","ATP-dependent RNA helicase DDX54 [OS=Homo sapiens]",0,19.797,2,2,2,7,2,881,98.5,10.02,12,2,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","ER/Golgi;nucleus","signal transduction activity or receptor binding;other molecular function","Pf00270, Pf00271, Pf08147","79039","hsa:79039; Q86YT8; Q8TDD1; Q9BRZ1","ENSG00000123064",NA,NA,0,0,128.9,128.6,128.6,74.2,82.3,75.6,81.9,75.7,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S782(100)]",0,"ENSG00000123064"
"1484","IFT43",-0.0447671816964093,6.60981752521373,-0.299796144710981,0.770730021400655,0.847595279599643,-6.95872493423666,"NONE",FALSE,"High","Master Protein","Q96FT9","Intraflagellar transport protein 43 homolog [OS=Homo sapiens]",0,7.618,5,1,1,3,1,208,23.5,4.75,7.68,1,"cell organization and biogenesis;transport","cytoskeleton;other cell component",NA,"Pf15305","112752","B3KPT6; B4DZI9; G3V385; hsa:112752; O95418; Q96FT9; Q9ULA9","ENSG00000119650","Intraflagellar transport","Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); Ciliopathies; Bardet-Biedl syndrome",6,0,57.4,74.4,68.8,114.5,167.4,100.8,116,109.9,123.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S78(100)]",0,"ENSG00000119650"
"1485","ARGLU1",-0.126555950085582,6.46996382231978,-0.297406101108127,0.77249916078053,0.848273355119247,-6.95949944280258,"NONE",FALSE,"High","Master Protein","Q9NWB6","Arginine and glutamate-rich protein 1 [OS=Homo sapiens]",0,6.491,5,1,1,1,1,273,33.2,10.35,2.56,1,NA,"cytosol;mitochondrion;nucleus",NA,"Pf15346","55082","B4E0Y3; hsa:55082; Q5T257; Q6IQ34; Q9NWB6","ENSG00000134884",NA,NA,0,0,73.7,77.3,67.7,91.1,243.8,54.9,108.4,64.9,126.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S77(99.4)]",0,"ENSG00000134884"
"1486","SIRT6",-0.0287956377881597,6.57982067808315,-0.297113178543804,0.772716080516978,0.848273355119247,-6.95959394762318,"NONE",FALSE,"High","Master Protein","Q8N6T7","NAD-dependent protein deacylase sirtuin-6 [OS=Homo sapiens]",0,6.249,3,1,1,1,1,355,39.1,9.19,2.91,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02146","51548","B2RCD0; hsa:51548; O75291; Q6IAF5; Q6PK99; Q8N6T7; Q8NCD2; Q9BSI5; Q9BWP3; Q9NRC7; Q9UQD1","ENSG00000077463","Pre-NOTCH Transcription and Translation; Processing of DNA double-strand break ends","SREBF and miR33 in cholesterol and lipid homeostasis; NAD+ metabolism; NAD+ biosynthetic pathways; Thermogenesis; Thyroid hormones production and peripheral downstream signaling effects; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction; 10q11.21q11.23 copy number variation syndrome",9,0,116.2,111.5,107,89.9,85.2,88.8,80.7,99,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T294(100)]",0,"ENSG00000077463"
"1487","RPS3A",-0.0272181550044452,6.46027757241,-0.296856832732033,0.77290593079799,0.848273355119247,-6.95967657677976,"NONE",FALSE,"High","Master Protein","P61247","Small ribosomal subunit protein eS1 [OS=Homo sapiens]",0,41.777,20,5,5,5,5,264,29.9,9.73,14.89,5,"protein metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01015","6189","B2R4D4; D3DP05; hsa:6189; P33443; P49241; P61247","ENSG00000145425; ENSG00000292158","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,150.2,136,137,67.1,52.7,79.5,72.9,81.5,75.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000145425"
"1488","UBTD1",0.0364253852374583,6.63805217856789,0.295393758348428,0.773989789197428,0.848892026861695,-6.96014683622772,"NONE",FALSE,"High","Master Protein","Q9HAC8","Ubiquitin domain-containing protein 1 [OS=Homo sapiens]",0,4.816,7,1,1,1,1,227,25.9,7.83,2.77,1,NA,NA,NA,"Pf00240, Pf16455","80019","D3DR57; hsa:80019; Q53HI3; Q9HAC8","ENSG00000165886",NA,NA,0,0,102.2,95.6,92.7,91.8,95.5,110.4,87.2,115.9,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000165886"
"1489","ZNF768",-0.0271542177861583,6.65300619249266,-0.294662330283452,0.774531829931393,0.848916015075913,-6.96038107560334,"NONE",FALSE,"High","Master Protein","Q9H5H4","Zinc finger protein 768 [OS=Homo sapiens]",0,19.277,6,3,3,5,3,540,60.2,7.97,14.09,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf05001","79724","hsa:79724; Q569L7; Q96CX4; Q9H5H4","ENSG00000169957",NA,NA,0,0,95.6,100.3,95.6,102.9,86.8,114.5,99.9,111.6,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100); S125(100); S160(100)]",0,"ENSG00000169957"
"1490","RALGAPB",-0.0265450796111235,6.63518194454221,-0.291573210195023,0.776822496832733,0.850855244853034,-6.96136407365541,"NONE",FALSE,"High","Master Protein","Q86X10","Ral GTPase-activating protein subunit beta [OS=Homo sapiens]",0,56.882,6,4,4,5,4,1494,166.7,6.79,19.84,4,"other biological processes",NA,"enzyme regulator activity;other molecular function","Pf20412","57148","A2A2E8; A2A2E9; hsa:57148; Q5TG31; Q86X10; Q8N3D1; Q8WWC0; Q9H3X8; Q9UJR1; Q9ULK1; Q9Y3G9","ENSG00000170471","Translocation of SLC2A4 (GLUT4) to the plasma membrane",NA,1,0,94.9,91.8,106.8,97.5,99.1,104,106.1,103.4,92.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T379(98.9); S479(100); T734(99.1); S1300(100)]",0,"ENSG00000170471"
"1491","RPL18",-0.0305598470785169,6.38447890971921,-0.290077611415794,0.777932337254134,0.851446485724737,-6.96183633655357,"NONE",FALSE,"High","Master Protein","Q07020","Large ribosomal subunit protein eL18 [OS=Homo sapiens]",0,50.565,17,3,4,5,3,188,21.6,11.72,15.93,3,"protein metabolism;other metabolic processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf17135","6141","F8VWC5; hsa:6141; Q07020; Q8WTZ6","ENSG00000063177","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,156.1,138.9,139.4,61.1,41.9,73.6,72.4,64,74.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]; Met-loss [N-Term]",0,"ENSG00000063177"
"1492","TBC1D17",0.0567599449540284,6.61741909817575,0.288815216236553,0.77886953445958,0.851446485724737,-6.96223310406088,"NONE",FALSE,"High","Master Protein","Q9HA65","TBC1 domain family member 17 [OS=Homo sapiens]",0,15.172,11,2,2,7,2,648,72.6,5.21,17.9,2,"other metabolic processes;transport","cytosol;other cytoplasmic organelle","enzyme regulator activity","Pf00566, Pf12068","79735","B4DT12; B9A6L8; F5H1W7; hsa:79735; Q9HA65","ENSG00000104946","TBC/RABGAPs",NA,1,0,65.3,63.1,84.9,99.8,100.7,138.5,94.1,147.7,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S602(99.2); T620(100)]",0,"ENSG00000104946"
"1493","NPAS3",-0.0220171634297444,6.63158654257723,-0.288000707588761,0.779474421144384,0.851446485724737,-6.96248819951212,"NONE",FALSE,"High","Master Protein","Q8IXF0","Neuronal PAS domain-containing protein 3 [OS=Homo sapiens]",0,59.225,6,3,4,9,3,933,100.7,6.62,26.37,3,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00989, Pf08447","64067","hsa:64067; Q86US6; Q86US7; Q8IXF0; Q8IXF2; Q9BY81; Q9H323; Q9Y4L8","ENSG00000151322",NA,NA,0,0,97.1,95.8,95.4,101.4,98.2,101.8,93.5,108.1,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S622(99.3); S639(99.7)]",0,"ENSG00000151322"
"1494","SIPA1",-0.0418239197628916,6.64573512101577,-0.287314083126151,0.779984456627851,0.851446485724737,-6.96270269302327,"NONE",FALSE,"High","Master Protein","Q96FS4","Signal-induced proliferation-associated protein 1 [OS=Homo sapiens]",0,8.915,2,1,2,2,1,1042,112.1,6.6,2.87,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf21022","6494","hsa:6494; O14518; O60484; O60618; Q2YD83; Q96FS4","ENSG00000213445","Rap1 signalling","MAPK cascade",2,0,92.6,71.9,87.9,119.1,111.4,100.2,92,121.3,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(99.4)]",0,"ENSG00000213445"
"1495","MEX3C",0.0372576292724673,6.69792272967213,0.286917800286682,0.780278871930951,0.851446485724737,-6.96282625817488,"NONE",FALSE,"High","Master Protein","Q5U5Q3","RNA-binding E3 ubiquitin-protein ligase MEX3C [OS=Homo sapiens]",0,13.666,2,1,1,1,1,659,69.3,5,4.18,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","51320","A1L022; Q5U5Q3; Q9NZE3","ENSG00000176624","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,73.6,98.4,91,108.7,93.3,126.1,109.1,125.2,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S545(100)]",0,"ENSG00000176624"
"1496","TTYH3",0.0386749551633701,6.57035796683074,0.286267753700105,0.780761898423386,0.851446485724737,-6.96302858652497,"NONE",FALSE,"High","Master Protein","Q9C0H2","Protein tweety homolog 3 [OS=Homo sapiens]",0,29.907,6,2,3,6,2,523,57.5,5.39,17.93,2,"transport","plasma membrane;other membranes","transporter activity","Pf04906","80727","A4D201; B7WP98; hsa:80727; Q6L749; Q6ZVG3; Q8TEG6; Q9C0H2","ENSG00000136295","Stimuli-sensing channels",NA,1,0,106.8,107.9,114.4,84.6,100.9,75.7,98.4,80.6,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S437(100); S496(100)]",0,"ENSG00000136295"
"1497","RABGAP1",0.025542698912675,6.60315319130608,0.285928087342736,0.781014331574713,0.851446485724737,-6.96313412895392,"NONE",FALSE,"High","Master Protein","Q9Y3P9","Rab GTPase-activating protein 1 [OS=Homo sapiens]",0,15.489,2,2,2,3,2,1069,121.7,5.25,10.62,2,"cell cycle OR cell proliferation;other biological processes","cytosol;cytoskeleton","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00566, Pf00640, Pf12473","23637","B9A6L2; hsa:23637; Q05CW2; Q6ZMY1; Q9HA28; Q9P0E2; Q9UG67; Q9Y3P9","ENSG00000011454","TBC/RABGAPs",NA,1,0,128.5,110.4,111.6,99.2,72,86,93,93.9,93.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); T996(100)]",0,"ENSG00000011454"
"1498","LUC7L",-0.0313933386445742,6.61383209004944,-0.284773344670824,0.781872713516535,0.851813263323755,-6.96349201383144,"NONE",FALSE,"High","Master Protein","Q9NQ29","Putative RNA-binding protein Luc7-like 1 [OS=Homo sapiens]",0,8.218,3,1,1,2,1,371,43.7,9.92,7.05,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf03194","55692","B8ZZ13; hsa:55692; Q96S32; Q9NPH4; Q9NQ29","ENSG00000007392",NA,"VEGFA-VEGFR2 signaling",1,0,122.6,128.6,130.2,92.4,92.6,73.4,95,87.8,85.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(100)]",0,"ENSG00000007392"
"1499","TRIM2",-0.0337421988347995,6.66933385893588,-0.283981778722025,0.782461305451456,0.851885824213993,-6.96373651824586,"NONE",FALSE,"High","Master Protein","Q9C040","Tripartite motif-containing protein 2 [OS=Homo sapiens]",0,47.445,8,5,5,6,5,744,81.5,6.96,18.85,5,"protein metabolism;other metabolic processes;other biological processes","other cell component","other molecular function","Pf00630, Pf00643, Pf01436, Pf13445","23321","D3DP09; hsa:23321; O60272; Q9BSI9; Q9C040; Q9UFZ1","ENSG00000109654","Interferon gamma signaling",NA,1,0,98.7,88.6,95.4,108.2,83.1,122.4,97.3,116.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100); S440(99.6); S459(99.2)]",0,"ENSG00000109654"
"1500","INVS",-0.0307363045330469,6.53910075989426,-0.281822496433833,0.784067638463735,0.852840417087569,-6.96440008982333,"NONE",FALSE,"High","Master Protein","Q9Y283","Inversin [OS=Homo sapiens]",0.01,1.564,2,1,1,1,1,1065,117.8,9.35,2.16,1,"cell-cell signaling;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00612, Pf12796","27130","A2A2Y2; hsa:27130; Q2NKL0; Q5W0T6; Q8IVX8; Q9BRB9; Q9Y283; Q9Y488; Q9Y498","ENSG00000119509",NA,"Wnt signaling in kidney disease; Wnt signaling; Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome; NPHP1 deletion syndrome",6,0,123.3,127.5,121.3,71.4,73,92.2,77.4,82.6,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S614(100)]",0,"ENSG00000119509"
"1501","IRX5",0.0234641515433891,6.61737623568254,0.28139840944771,0.784383251255172,0.852840417087569,-6.96452983132127,"NONE",FALSE,"High","Master Protein","P78411","Iroquois-class homeodomain protein IRX-5 [OS=Homo sapiens]",0,4.015,2,1,1,1,1,483,50.3,6.47,2.19,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920","10265","H0YMS7; hsa:10265; P78411; P78416; Q7Z2E1","ENSG00000176842",NA,"FTO obesity variant mechanism; Pre-implantation embryo",2,0,100.5,104.6,104.9,96.8,99,87.4,102.5,95.8,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T237(100)]",0,"ENSG00000176842"
"1502","RNF13",-0.0467937730201777,6.57933625782072,-0.279713386268573,0.785637681389761,0.85363561653002,-6.96504343401017,"NONE",FALSE,"High","Master Protein","O43567","E3 ubiquitin-protein ligase RNF13 [OS=Homo sapiens]",0,3.625,2,1,1,1,1,381,42.8,4.98,2.42,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02225, Pf13639","11342","A6NC87; B3KR12; hsa:11342; O43567; Q05D66; Q6IBJ9","ENSG00000082996",NA,NA,0,0,115.3,97.7,97.1,105.7,64.6,103.7,108.8,94.5,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T380(100)]",0,"ENSG00000082996"
"1503","SH2B1",-0.0243477898112223,6.59910162316844,-0.27832132950352,0.786674498920003,0.854193467889184,-6.96546545025771,"NONE",FALSE,"High","Master Protein","Q9NRF2","SH2B adapter protein 1 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,756,79.3,5.38,5.63,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus","signal transduction activity or receptor binding","Pf00017, Pf00169, Pf08916","25970","A8K2R7; hsa:25970; Q96FK3; Q96SX3; Q9NRF1; Q9NRF2; Q9NRF3; Q9P2P7; Q9Y3Y3","ENSG00000178188","Factors involved in megakaryocyte development and platelet production","Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; 16p11.2 distal deletion syndrome",4,0,101.5,107.8,96.4,87.9,86.7,107,92.5,100.5,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(99.6)]",0,"ENSG00000178188"
"1504","CXorf38",-0.0309802370825123,6.64433708453249,-0.276608622173063,0.787950743808737,0.855010381579693,-6.96598183267338,"NONE",FALSE,"High","Master Protein","Q8TB03","Uncharacterized protein CXorf38 [OS=Homo sapiens]",0,9.078,4,1,1,1,1,319,36.6,6.3,3.6,1,NA,NA,NA,"Pf15112","159013","B3KW28; D3DWB5; hsa:159013; Q5JPF5; Q8N941; Q8TB03","ENSG00000185753",NA,NA,0,0,67.1,90.8,81.1,112.8,113.8,114.5,102.2,112.7,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T314(100)]",0,"ENSG00000185753"
"1505","HDGF",0.0398401526083285,6.641278430619,0.27154602660884,0.791727058664454,0.858537248996936,-6.96748986564472,"NONE",FALSE,"High","Master Protein","P51858","Hepatoma-derived growth factor [OS=Homo sapiens]",0,106.436,20,7,9,24,7,240,26.8,4.73,82.51,7,"cell organization and biogenesis;signal transduction;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00855","3068","B3KU21; D3DVC9; P51858; Q5SZ07; Q5SZ08; Q5SZ09","ENSG00000143321","XBP1(S) activates chaperone genes","IL-18 signaling pathway",2,0,57.6,64.3,63.4,135.1,149.1,98.4,123.8,133.9,123.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S103(100); S133(99.6); S165(100)]",0,"ENSG00000143321"
"1506","FTH1",-0.0204064432639228,6.54023873723229,-0.269363775436405,0.793356615222966,0.859733065102178,-6.96813144988534,"NONE",FALSE,"High","Master Protein","P02794","Ferritin heavy chain [OS=Homo sapiens]",0,7.866,14,2,2,10,2,183,21.2,5.55,10.32,2,"transport;other biological processes","non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00210","2495","B3KNR5; hsa:2495; P02794; Q3KRA8; Q3SWW1","ENSG00000167996","Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Iron uptake and transport; Scavenging by Class A Receptors","Iron metabolism in placenta; Nuclear receptors meta-pathway; NRF2 pathway; Ferroptosis; Iron metabolism disorders",9,0,127.8,132.3,125,86.9,67.5,76,85.7,85.5,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S179(100)]",0,"ENSG00000167996"
"1507","TMPO",0.0212463517403325,6.652012095688,0.266903815074746,0.795194804836217,0.860754843446944,-6.9688485675043,"NONE",FALSE,"High","Master Protein","P42167","Lamina-associated polypeptide 2, isoforms beta/gamma [OS=Homo sapiens]",0,55.967,11,3,5,11,3,454,50.6,9.38,47.81,3,NA,"other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03020, Pf08198","7112","A2T926; hsa:7112; P42167; Q14861","ENSG00000120802","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOG GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle","Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies",12,0,87.5,86.9,92.7,95,109.4,115,106.7,108.1,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T74(100); T160(100); T208(100)]",0,"ENSG00000120802"
"1508","VAC14",-0.0394283075070767,6.6989382554035,-0.266690383329446,0.795354352890926,0.860754843446944,-6.96891048071388,"NONE",FALSE,"High","Master Protein","Q08AM6","Protein VAC14 homolog [OS=Homo sapiens]",0,4.016,2,1,1,2,1,782,87.9,6.13,2.73,1,"other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf11916, Pf12755","55697","B3KPJ5; B3KSM8; hsa:55697; Q08AM6; Q13174; Q6IA12; Q7L4Y1; Q9BW96; Q9H6V6","ENSG00000103043","Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane",NA,3,0,82.8,105.9,105.8,107.6,85.4,124.8,107,119.9,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S517(98.6)]",0,"ENSG00000103043"
"1509","HNRNPL",-0.0237358176408451,6.47929122284595,-0.265124806684799,0.796524982696334,0.861450478303788,-6.96936313821638,"NONE",FALSE,"High","Master Protein","P14866","Heterogeneous nuclear ribonucleoprotein L [OS=Homo sapiens]",0,20.902,2,1,2,8,1,589,64.1,8.22,15.24,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf11835, Pf13893","3191","A6ND69; A6NIT8; hsa:3191; P14866; Q9H3P3","ENSG00000104824; ENSG00000282947","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing; Hippocampal synaptogenesis and neurogenesis",4,0,144,139.1,132.9,64.5,60.8,81.1,78.3,71.4,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S185(100)]",0,"ENSG00000104824"
"1510","ZMYND8",0.0269110379293043,6.64587994129567,0.263663464790859,0.797618153786704,0.862061474821126,-6.96978328851782,"NONE",FALSE,"High","Master Protein","Q9ULU4","MYND-type zinc finger-containing chromatin reader ZMYND8 [OS=Homo sapiens]",0,39.29,5,5,5,8,5,1186,131.6,7.2,25.26,5,"cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00439, Pf00628, Pf00855, Pf12064","23613","B3KVL2; B7Z2A8; B7Z3E0; B7Z680; B7ZM62; E1P5U5; F5H0X3; H7C0U2; hsa:23613; J3KPU3; Q13517; Q2HXV1; Q2HXV2; Q2HXV3; Q2HXV4; Q2HXV7; Q2HXV8; Q2HXV9; Q2HXW0; Q2HXW1; Q2HXW2; Q4JJ94; Q4JJ95; Q5TH09; Q5TH11; Q6MZM1; Q8WXC5; Q9H1F3; Q9H1F4; Q9H1F5; Q9H1L8; Q9H1L9; Q9H2G5; Q9NYN3; Q9UIX6; Q9ULU4","ENSG00000101040",NA,NA,0,0,92,96.4,96.1,95.5,101.1,107.9,108.7,92.3,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S425(100); S475(100); S547(100); S652(100); S756(100)]",0,"ENSG00000101040"
"1511","CBX3",-0.0484073778212171,6.55985529589235,-0.259547305391084,0.800699762172176,0.864819332802774,-6.97095442150963,"NONE",FALSE,"High","Master Protein","Q13185","Chromobox protein homolog 3 [OS=Homo sapiens]",0,33.847,15,5,7,13,5,183,20.8,5.33,35.02,5,"cell organization and biogenesis;stress response;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00385, Pf01393","11335","hsa:11335; Q13185; Q96CD7; Q99409; Q9BVS3; Q9P0Z6","ENSG00000122565","Transcriptional Regulation by E2F6; RNA Polymerase I Promoter Escape; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression","Exercise-induced circadian regulation; Effect of progerin on genes involved in progeria; NIPBL role in DNA damage - Cornelia de Lange syndrome",6,0,118.5,115.8,115.4,74.3,128.3,67.2,92.7,80.6,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S99(99.5); S176(100)]",0,"ENSG00000122565"
"1512","FBXL2",0.0242967505690634,6.66788243240089,0.256379906121827,0.803073532799261,0.866809527465869,-6.97184324282858,"NONE",FALSE,"High","Master Protein","Q9UKC9","F-box/LRR-repeat protein 2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,423,47,7.4,3.52,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;other cell component","other molecular function","Pf00646, Pf13516","25827","B4DQV0; E9PD06; hsa:25827; Q6IAN3; Q9NVQ8; Q9UK27; Q9UKA5; Q9UKC9; Q9Y3Y9","ENSG00000153558",NA,NA,0,0,96,86.5,91.2,113.5,86.9,112.3,102,109,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T404(100)]",0,"ENSG00000153558"
"1513","STK11",0.0398321933414607,6.67691811944719,0.250963443082726,0.807137726160209,0.870620468667192,-6.97333823985716,"NONE",FALSE,"High","Master Protein","Q15831","Serine/threonine-protein kinase STK11 [OS=Homo sapiens]",0,7.934,3,1,1,2,1,433,48.6,7.43,7.19,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069","6794","B2RBX7; E7EW76; hsa:6794; Q15831","ENSG00000118046","Regulation of TP53 Activity through Phosphorylation; Energy dependent regulation of mTOR by LKB1-AMPK; FOXO-mediated transcription of cell death genes; AMPK inhibits chREBP transcriptional activation activity","AMP-activated protein kinase signaling; Polycystic kidney disease pathway; mir-124 predicted interactions with cell cycle and differentiation ; ATM signaling in development and disease ; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Female steroid hormones in cardiomyocyte energy metabolism; ADHD and autism (ASD) linked metabolic pathways and SNP",14,0,94.7,91.2,83.7,121.6,70.5,121.7,117.9,109.6,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100)]",0,"ENSG00000118046"
"1514","FAM169A",0.0242855504538912,6.61867684950646,0.249436373834023,0.808284649831231,0.871281736145686,-6.97375403373603,"NONE",FALSE,"High","Master Protein","Q9Y6X4","Soluble lamin-associated protein of 75 kDa [OS=Homo sapiens]",0,124.057,21,7,11,27,7,670,74.9,4.6,80.52,7,NA,"other membranes;nucleus",NA,NA,"26049","A8K1T9; hsa:26049; Q6MZT0; Q9H989; Q9Y6X4","ENSG00000198780","RHOF GTPase cycle",NA,1,0,95.7,106,102.6,103.6,80.6,94.8,106.4,99.8,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S447(99.6); S526(100); S635(99.6)]",0,"ENSG00000198780"
"1515","RALGAPA1",-0.0251596153223383,6.65642439692618,-0.238667065599968,0.816386525349345,0.879434197604047,-6.97661516953002,"NONE",FALSE,"High","Master Protein","Q6GYQ0","Ral GTPase-activating protein subunit alpha-1 [OS=Homo sapiens]",0,74.666,4,5,6,15,5,2036,229.7,6.19,50.38,5,"other biological processes","nucleus;other cell component","enzyme regulator activity;other molecular function","Pf02145, Pf20412","253959","A6NMA4; B9EK38; C5NU19; hsa:253959; O94960; Q6GYP9; Q6GYQ0; Q6ZT23; Q86YF3; Q86YF5; Q8ND69","ENSG00000174373","RHOH GTPase cycle",NA,1,0,84.7,82.9,80.8,108.4,132.2,101.5,102.2,107.9,123.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S740(100); T754(100); S773(100); S797(100); S860(100)]",0,"ENSG00000174373"
"1516","EYA1",0.0236838601663054,6.62631127643737,0.237024615859551,0.817624194958898,0.880186468451795,-6.97704056555658,"NONE",FALSE,"High","Master Protein","Q99502","Eyes absent homolog 1 [OS=Homo sapiens]",0,4.64,2,1,1,1,1,592,64.6,6.21,2.28,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00702","2138","A6NHQ0; G5E9R4; hsa:2138; Q0P516; Q8WX80; Q99502","ENSG00000104313","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the ureteric bud","Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system; Markers of kidney cell lineage",6,0,107.7,108,115.9,92.6,98.9,85,90.5,94.1,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S314(100)]",0,"ENSG00000104313"
"1517","MLLT1",0.0236607812837395,6.55345385960917,0.23587476760578,0.81849097929582,0.880538746348569,-6.9773366496882,"NONE",FALSE,"High","Master Protein","Q03111","Protein ENL [OS=Homo sapiens]",0,18.037,6,4,6,7,4,559,62,8.59,12.24,4,"other biological processes","cytosol;nucleus","other molecular function","Pf03366, Pf17793","4298","hsa:4298; Q03111; Q14768","ENSG00000130382","Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events",NA,3,0,128.4,129.2,127.9,79.1,78.3,73.5,95.6,82.4,80.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S292(100); S475(100)]",0,"ENSG00000130382"
"1518","SLC9A1",0.0657744982382447,6.56487518525374,0.235113466712398,0.819065009037106,0.880575819992462,-6.97753190044728,"NONE",FALSE,"High","Master Protein","P19634","Sodium/hydrogen exchanger 1 [OS=Homo sapiens]",0,22.935,3,2,2,2,2,815,90.7,7.21,7.33,2,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;mitochondrion;nucleus;other cell component","transporter activity;other molecular function","Pf00999, Pf16644","6548","B1ALD6; D3DPL4; hsa:6548; P19634; Q96EM2","ENSG00000090020","Hyaluronan uptake and degradation; Sodium/Proton exchangers","Osteoclast signaling; G protein signaling pathways; Gastrin signaling pathway; Opioid receptor pathways; Regulation of actin cytoskeleton",7,0,119.7,89.4,89.8,97.2,103.9,72.1,128.3,64,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S785(99.4)]",0,"ENSG00000090020"
"1519","HNRNPDL",0.0483436461218583,6.58548128848182,0.227332505851529,0.824938353622069,0.885852982522805,-6.97949169427114,"NONE",FALSE,"High","Master Protein","O14979","Heterogeneous nuclear ribonucleoprotein D-like [OS=Homo sapiens]",0,27.746,4,1,1,2,1,420,46.4,9.57,8.13,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf00076","9987","hsa:9987; O14979; Q6SPF2; Q7KZ74; Q7KZ75; Q96IM0; Q96S43","ENSG00000152795","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",NA,1,0,101.3,118.9,119.5,102.5,48.4,106.5,91.6,111.1,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(100)]",0,"ENSG00000152795"
"1520","DCAF8",0.0312352021445177,6.65052056839771,0.227172635541214,0.825059150388887,0.885852982522805,-6.97953127703417,"NONE",FALSE,"High","Master Protein","Q5TAQ9","DDB1- and CUL4-associated factor 8 [OS=Homo sapiens]",0,30.401,4,1,1,6,1,597,66.8,5.39,26.12,1,"protein metabolism;other metabolic processes","cytosol;mitochondrion;nucleus;other cell component",NA,"Pf00400","50717","D3DVE6; hsa:50717; Q12839; Q4QQI6; Q53F14; Q5TAQ9; Q66K50; Q68CS7; Q96E00","ENSG00000132716","Neddylation",NA,1,0,72,80.3,73.5,121.8,85.6,125.8,101.2,122.2,130.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000132716"
"1521","LMNA",-0.0204819114918271,6.64646900503591,-0.225463616790491,0.826350772160119,0.88665644981283,-6.97995269676405,"NONE",FALSE,"High","Master Protein","P02545","Prelamin-A/C [OS=Homo sapiens]",0,60.533,11,6,9,13,6,664,74.1,7.02,38.78,6,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00038, Pf00932","4000","B4DI32; D3DVB0; D6RAQ3; E7EUI9; hsa:4000; P02545; P02546; Q5I6Y4; Q5I6Y6; Q5TCJ2; Q5TCJ3; Q6UYC3; Q969I8; Q96JA2","ENSG00000160789","Signaling by BRAF and RAF1 fusions; XBP1(S) activates chaperone genes","Arrhythmogenic right ventricular cardiomyopathy; Adipogenesis; Fas ligand pathway and stress induction of heat shock proteins; Lamin A processing pathway; Nephrotic syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome; Primary ovarian insufficiency; 7q11.23 distal copy number variation",14,0,85.4,83.6,91.4,101.6,100.8,120.3,97.8,110.3,114.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(99.5); S392(100); S404(99.3); S406(99.3); S636(100)]",0,"ENSG00000160789"
"1522","PUS1",-0.0309240451441495,6.6739313275751,-0.215729624327513,0.833717723511108,0.89397327514463,-6.98229290044376,"NONE",FALSE,"High","Master Protein","Q9Y606","Pseudouridylate synthase 1 homolog [OS=Homo sapiens]",0,3.699,4,1,1,1,1,427,47.4,8.41,2.15,1,"RNA metabolism OR transcription;other metabolic processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01416","80324","A8K877; B3KQC1; hsa:80324; Q8WYT2; Q9BU44; Q9Y606","ENSG00000177192",NA,NA,0,0,94.8,91.4,101,105.5,113.5,100.5,126.8,97.4,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T426(100)]",0,"ENSG00000177192"
"1523","PSIP1",0.0219783637376807,6.64551901673481,0.214154942767789,0.834911103856062,0.894615080687255,-6.98266187066567,"NONE",FALSE,"High","Master Protein","O75475","PC4 and SFRS1-interacting protein [OS=Homo sapiens]",0,107.799,16,8,8,16,8,530,60.1,9.13,66.04,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00855, Pf11467","11168","D3DRI9; hsa:11168; O00256; O75475; O95368; Q6P391; Q86YB9; Q9NZI3; Q9UER6","ENSG00000164985","Vpr-mediated nuclear import of PICs; Formation of WDR5-containing histone-modifying complexes; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection","MECP2 and associated Rett syndrome",8,0,96.4,106.4,106,98.8,85.2,103.7,106.2,108.6,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); T122(100); S129(100); S177(100); S273(98.9)]",0,"ENSG00000164985"
"1524","AKAP17A",-0.0281112566486161,6.57171184238078,-0.213493370185276,0.835412612112363,0.894615080687255,-6.98281608785696,"NONE",FALSE,"High","Master Protein","Q02040","A-kinase anchor protein 17A [OS=Homo sapiens]",0,9.244,3,2,2,3,2,695,80.7,9.73,7.92,2,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus","other molecular function",NA,"8227","hsa:8227; Q02040; Q02832; Q2TB98; Q5JQ74; Q5JQ76; Q8N6U9","ENSG00000197976; ENSG00000292343",NA,NA,0,0,111.3,113.8,110.3,89.9,102.6,73.7,91,81.5,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S537(100); S633(100)]",0,"ENSG00000197976"
"1525","TNIP1",0.0196042776420562,6.5893207769069,0.205779634146364,0.841265733086931,0.899711247194721,-6.98457932252801,"NONE",FALSE,"High","Master Protein","Q15025","TNFAIP3-interacting protein 1 [OS=Homo sapiens]",0,8.509,2,1,1,1,1,636,71.8,6.62,2.75,1,"cell adhesion;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus","other molecular function",NA,"10318","A4F1W8; A4F1W9; A4F1X2; A4F1X4; A4F1X5; A4F1X6; A4F1X7; A4F1X9; B7Z699; E7EPY1; E7ET96; hsa:10318; O76008; Q05KP3; Q05KP4; Q15025; Q6N077; Q96EL9; Q99833; Q9H1J3","ENSG00000145901","Ovarian tumor domain proteases","RAC1/PAK1/p38/MMP2 pathway",2,0,120,109.6,116.1,82.1,76,98.3,84.2,93.5,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000145901"
"1526","UBE2V1",-0.0231953923723811,6.65145581311731,-0.205768591438531,0.841274119619574,0.899711247194721,-6.9845818006253,"NONE",FALSE,"High","Master Protein","Q13404","Ubiquitin-conjugating enzyme E2 variant 1 [OS=Homo sapiens]",0.004,2.083,8,1,1,2,1,147,16.5,7.93,5.24,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component",NA,"Pf00179","387522; 7335","E1P629; hsa:387522; hsa:7335; Q13403; Q13404; Q13532; Q5TGE0; Q5TGE3; Q96H34; Q9GZT0; Q9GZW1; Q9H4J3; Q9H4J4; Q9UKL1; Q9UM48; Q9UM49; Q9UM50","ENSG00000244687","SARS-CoV-2 activates/modulates innate and adaptive immune responses; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; CLEC7A (Dectin-1) signaling; Aggrephagy; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; activated TAK1 mediates p38 MAPK activation; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","IL-1 signaling pathway; Interleukin-1 induced activation of NF-kB; MYD88 distinct input-output pathway",19,0,81.8,88.4,100.2,97.6,123.8,104.1,101,99.8,119.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100)]",0,"ENSG00000244687"
"1527","DBF4",0.0273889023362379,6.49795083512089,0.202253179849342,0.843945005378873,0.901976587281153,-6.98536399422677,"NONE",FALSE,"High","Master Protein","Q9UBU7","Protein DBF4 homolog A [OS=Homo sapiens]",0,6.049,2,1,1,1,1,674,76.8,7.9,2.43,1,"cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;other biological processes","nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf07535","10926","A4D1D8; A8K954; hsa:10926; O75226; Q75MS6; Q75N01; Q9UBU7; Q9Y2M6","ENSG00000006634","Activation of ATR in response to replication stress; Activation of the pre-replicative complex","Cell cycle; DNA replication",4,0,128.6,146.3,116.8,65.4,57.8,92.2,87.3,73.1,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S359(100)]",0,"ENSG00000006634"
"1528","EIF4ENIF1",0.0161980579248082,6.62095622456913,0.201307691696897,0.844663711835558,0.90215391211756,-6.98557208899371,"NONE",FALSE,"High","Master Protein","Q9NRA8","Eukaryotic translation initiation factor 4E transporter [OS=Homo sapiens]",0,34.031,6,4,4,10,4,985,108.1,8.32,21.87,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf10477","56478","B1AKL2; B1AKL3; B2RBF1; hsa:56478; Q8NCF2; Q9H708; Q9NRA8","ENSG00000184708",NA,"Primary ovarian insufficiency; 10q11.21q11.23 copy number variation syndrome",2,0,110.9,107.3,111.2,84.8,98.3,94.6,93.7,96.7,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S78(99.7); S564(100); S951(100)]",0,"ENSG00000184708"
"1529","POU3F3",-0.030239598097654,6.56805890456027,-0.199439344303106,0.846084365254406,0.903080238126351,-6.98598045507173,"NONE",FALSE,"High","Master Protein","P20264","POU domain, class 3, transcription factor 3 [OS=Homo sapiens]",0,25.764,3,1,2,4,1,500,50.3,7.87,11.47,1,"cell cycle OR cell proliferation;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf00157","5455","hsa:5455; P20264; P78379; Q4ZG25","ENSG00000198914","Nephron development",NA,1,0,116.2,116.2,117.3,79.5,59.7,117.2,89.4,84.6,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S393(100)]",0,"ENSG00000198914"
"1530","MARCKS",-0.0341112885625261,6.65023062707458,-0.197931358867922,0.847231431644067,0.903358919747902,-6.98630730270477,"NONE",FALSE,"High","Master Protein","P29966","Myristoylated alanine-rich C-kinase substrate [OS=Homo sapiens]",0,358.753,38,11,30,112,11,332,31.5,4.45,400.08,11,"cell organization and biogenesis;stress response;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf02063","4082","E1P560; hsa:4082; P29966; Q2LA83; Q5TDB7","ENSG00000277443","Acetylcholine regulates insulin secretion","Brain-derived neurotrophic factor (BDNF) signaling pathway",2,0,75,86.8,83.7,106.2,163.2,90.2,120.8,104.5,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S46(100); S101(100); S118(99.3); S131(99.4); S145(100); T150(100); S159(100); S170(100)]",0,"ENSG00000277443"
"1531","CSTF2T",-0.0253978374477155,6.64703980738777,-0.197640768347124,0.847452516013504,0.903358919747902,-6.98637000388483,"NONE",FALSE,"High","Master Protein","Q9H0L4","Cleavage stimulation factor subunit 2 tau variant [OS=Homo sapiens]",0,12.541,4,1,1,1,1,616,64.4,7.25,4.08,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf14304, Pf14327","23283","B2RAR9; hsa:23283; O75174; Q53HK6; Q7LGE8; Q8N6T1; Q9H0L4","ENSG00000177613","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",5,0,71.5,99.1,90.9,106.2,120.2,101.5,115.1,107,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S563(98.2)]",0,"ENSG00000177613"
"1532","RCN1",-0.036848981394666,6.58041691532078,-0.195086476272486,0.849396447383673,0.904525758556979,-6.98691721586262,"NONE",FALSE,"High","Master Protein","Q15293","Reticulocalbin-1 [OS=Homo sapiens]",0,20.009,11,3,3,3,3,331,38.9,5,5.98,3,"developmental processes","ER/Golgi","other molecular function","Pf13202","5954","B7Z1M1; D3DR00; hsa:5954; Q15293","ENSG00000049449","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation","VEGFA-VEGFR2 signaling",3,0,89.8,117,108.6,96.7,108,74.8,116,81.9,85,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100)]",0,"ENSG00000049449"
"1533","DBNL",-0.0135840519096559,6.66321912375776,-0.194746021195349,0.849655629820985,0.904525758556979,-6.98698961905056,"NONE",FALSE,"High","Master Protein","Q9UJU6","Drebrin-like protein [OS=Homo sapiens]",0,82.414,10,5,7,35,1,430,48.2,5.05,98.05,5,"cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00241, Pf14604","28988","A4D2I9; B4DDP6; B4DEM2; C9J7P1; hsa:28988; P84070; Q6IAI8; Q96F30; Q96K74; Q9HBN8; Q9NR72; Q9UJU6","ENSG00000136279","Neutrophil degranulation; Caspase-mediated cleavage of cytoskeletal proteins; Neurexins and neuroligins","T-cell receptor signaling pathway",4,5,80.9,81.5,83.4,112.6,114,112,105.4,117.4,111.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(100); S269(100); S283(100); T291(100)]",0,"ENSG00000136279"
"1534","MYL9",0.0386558431595603,6.63464129727928,0.192464389661519,0.851393081888645,0.905312123943637,-6.98747160621791,"NONE",FALSE,"High","Master Protein","P24844","Myosin regulatory light polypeptide 9 [OS=Homo sapiens]",0,13.066,10,1,2,2,1,172,19.8,4.92,5.89,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf13499","10398","E1P5T6; hsa:10398; P24844; Q9BQL9; Q9BUF9; Q9H136","ENSG00000101335","RHO GTPases activate CIT; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; Smooth Muscle Contraction; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs","Focal adhesion; Striated muscle contraction pathway",10,0,75.3,91.8,96.1,104.1,87.2,116,91.2,156,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.5)]",0,"ENSG00000101335"
"1535","SOWAHC",0.0352077537663655,6.65867632829491,0.192319105002086,0.85150374402787,0.905312123943637,-6.98750210626386,"NONE",FALSE,"High","Master Protein","Q53LP3","Ankyrin repeat domain-containing protein SOWAHC [OS=Homo sapiens]",0,5.561,2,1,1,1,1,525,55.6,7.03,2.86,1,NA,NA,NA,"Pf12796","65124","hsa:65124; Q53LP3; Q8NE15; Q9H6U1","ENSG00000198142","RHOA GTPase cycle; RHOB GTPase cycle; RHOF GTPase cycle",NA,3,0,77.6,64,67.3,132.5,81.3,133.2,127.3,131.8,105.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(99.5)]",0,"ENSG00000198142"
"1536","MYEF2",0.0156755539913593,6.63143720676701,0.191060958765361,0.852462205754263,0.905741093613904,-6.98776527675274,"NONE",FALSE,"High","Master Protein","Q9P2K5","Myelin expression factor 2 [OS=Homo sapiens]",0,42.614,4,1,2,10,1,600,64.1,8.75,39.87,1,"developmental processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","50804","A7MCZ9; C9J921; C9K0J4; hsa:50804; Q6NUM5; Q7L388; Q7Z4B7; Q9H922; Q9NUQ1; Q9P2K5","ENSG00000104177",NA,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Mitochondrial gene expression",4,0,107.3,111.8,106.1,93.3,76.7,106.2,97.5,96.9,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S17(100)]",0,"ENSG00000104177"
"1537","ADCY6",0.0152207699679847,6.64795798535417,0.189711385221609,0.853490598983916,0.905749628666106,-6.98804566586605,"NONE",FALSE,"High","Master Protein","O43306","Adenylate cyclase type 6 [OS=Homo sapiens]",0,29.409,2,2,2,3,2,1168,130.5,8.22,10.17,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00211, Pf06327, Pf16214","112","hsa:112; O43306; Q9NR75; Q9UDB0","ENSG00000174233","FCGR3A-mediated IL10 synthesis; G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Adrenaline,noradrenaline inhibits insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Adenylate cyclase activating pathway; Hedgehog 'off' state","Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Phosphodiesterases in neuronal function; Thermogenesis; Envelope proteins and their potential roles in EDMD physiopathology; Ciliopathies; Vasopressin-regulated water reabsorption; Calcium regulation in cardiac cells",24,0,100.6,91.1,101.3,98.4,103.6,100.5,96.3,104.6,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S576(100)]",0,"ENSG00000174233"
"1538","AMOT",-0.0170398921636021,6.64694973249453,-0.189528205361451,0.853630206879915,0.905749628666106,-6.98808357150765,"NONE",FALSE,"High","Master Protein","Q4VCS5","Angiomotin [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1084,118,7.64,10.71,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf12240","154796","hsa:154796; Q4VCS5; Q504X5; Q9HD27; Q9UPT1","ENSG00000126016",NA,"VEGFA-VEGFR2 signaling; Hippo-Merlin signaling dysregulation; Pleural mesothelioma; GNAQ pathways in port-wine stain",4,0,88.4,94.7,95.1,102.2,99.9,109.7,93.2,112.8,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S714(100)]",0,"ENSG00000126016"
"1539","PRR12",-0.0201735212592338,6.58789968625762,-0.188760307346874,0.854215507282278,0.905749628666106,-6.9882420781054,"NONE",FALSE,"High","Master Protein","Q9ULL5","Proline-rich protein 12 [OS=Homo sapiens]",0,55.766,4,4,4,8,4,2036,210.9,7.87,29.99,4,NA,"nucleus;other cell component",NA,"Pf13926","57479","E9PB06; hsa:57479; Q8N4J6; Q9ULL5","ENSG00000126464",NA,NA,0,0,113.4,100.1,108,102.1,72.1,93.5,84.4,101.2,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S651(100); S709(99.4); S917(100); S1925(100)]",0,"ENSG00000126464"
"1540","SERINC1",-0.0240593075193933,6.59016113248129,-0.188137596034152,0.854690213324634,0.905749628666106,-6.98837014682486,"NONE",FALSE,"High","Master Protein","Q9NRX5","Serine incorporator 1 [OS=Homo sapiens]",0,20.328,7,2,2,7,2,453,50.5,5.85,12.99,2,"other metabolic processes;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf03348","57515","B3KY69; E1P565; hsa:57515; O75655; Q7Z2F5; Q8TAG1; Q9NRX5; Q9NTH8; Q9ULG7","ENSG00000111897","Serine biosynthesis","Sphingolipid pathway",2,0,113.2,119.8,113.6,73.8,105.8,89.7,86.2,87.1,101.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S364(100)]",0,"ENSG00000111897"
"1541","FLNA",0.0139231033239957,6.66501694345565,0.186632331469002,0.855837960792967,0.906377386122078,-6.98867798915022,"NONE",FALSE,"High","Master Protein","P21333","Filamin-A [OS=Homo sapiens]",0,167.252,7,11,15,26,11,2647,280.6,6.06,77.22,11,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00307, Pf00630","2316","E9KL45; hsa:2316; P21333; Q5HY53; Q5HY55; Q8NF52","ENSG00000196924","OAS antiviral response; Platelet degranulation ; RHO GTPases activate PAKs; GP1b-IX-V activation signalling; Cell-extracellular matrix interactions","Androgen receptor signaling pathway; Prolactin signaling pathway; Focal adhesion; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; IL-4 signaling pathway; Ebola virus infection in host; Joubert syndrome; NPHP1 deletion syndrome",14,0,76.5,77.8,77.1,116.1,106.5,121.3,110.4,121.9,115.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S968(100); S1084(100); S1459(100); S2152(100); S2180(100)]",0,"ENSG00000196924"
"1542","RBM17",0.0385558605253244,6.64672052799157,0.185137340104932,0.856978226270349,0.90670374942038,-6.98898130064658,"NONE",FALSE,"High","Master Protein","Q96I25","Splicing factor 45 [OS=Homo sapiens]",0,27.901,8,2,2,3,2,401,44.9,5.97,16.12,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00076, Pf01585","84991","hsa:84991; Q96GY6; Q96I25","ENSG00000134453","mRNA Splicing - Major Pathway","mRNA processing",2,0,77.5,81.9,99.2,96.4,69.5,150.8,115,104.7,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T71(100); S222(100)]",0,"ENSG00000134453"
"1543","NLGN2",0.0247516088787867,6.64329392792656,0.184043535465933,0.857812717262289,0.90670374942038,-6.98920168309973,"NONE",FALSE,"High","Master Protein","Q8NFZ4","Neuroligin-2 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,835,90.8,6.18,9.55,1,"cell adhesion;cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00135","57555","hsa:57555; Q8NFZ4; Q9P2I1","ENSG00000169992; ENSG00000283859","Neurexins and neuroligins","Disruption of postsynaptic signaling by CNV; NRXN1 deletion syndrome",3,0,89.6,89.4,79.5,126.4,86.3,99.3,107.1,101.6,118.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S718(100)]",0,"ENSG00000169992"
"1544","ABHD2",-0.0224305721137075,6.53214236145304,-0.184043347121091,0.857812860971242,0.90670374942038,-6.98920172093626,"NONE",FALSE,"High","Master Protein","P08910","Monoacylglycerol lipase ABHD2 [OS=Homo sapiens]",0,8.801,3,1,1,3,1,425,48.3,6.7,10.22,1,"other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","other molecular function","Pf00561","11057","P08910; Q53G48; Q53GU0; Q5FVD9; Q8TC79","ENSG00000140526",NA,"Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",2,0,122.6,97.2,121.7,86.1,65.1,94.2,90.3,94.6,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000140526"
"1545","KIAA1191",-0.0381619065733876,6.58905170082456,-0.181989564548486,0.859380241895323,0.907772527361273,-6.98961201850754,"NONE",FALSE,"High","Master Protein","Q96A73","Putative monooxygenase p33MONOX [OS=Homo sapiens]",0,7.451,6,1,1,2,1,305,33.2,9.39,2.7,1,NA,"other cell component","other molecular function","Pf15302","57179","B2RD69; B8K1S6; hsa:57179; Q6IA24; Q8NDU3; Q96A73; Q9BRE5; Q9H7D5; Q9ULM9","ENSG00000122203",NA,"5q35 copy number variation",1,0,70.6,82.7,64.2,102.1,137.3,108.8,118.7,82.6,145,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(99.2)]",0,"ENSG00000122203"
"1546","CIC",0.0125539744809,6.64989719637899,0.180512767946267,0.860507684596435,0.908375511812019,-6.98990422180612,"NONE",FALSE,"High","Master Protein","Q96RK0","Protein capicua homolog [OS=Homo sapiens]",0,67.123,7,7,7,15,7,1608,163.7,8.56,28.08,7,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","23152","hsa:23152; Q7LGI1; Q96RK0; Q9UEG5; Q9Y6T1","ENSG00000079432",NA,NA,0,0,89.7,83.5,85.5,107.1,109.8,104.9,106.8,107,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S496(100); S904(100); S1246(99.4)]",0,"ENSG00000079432"
"1547","ZRANB2",-0.0241243588593409,6.63928884242077,-0.17830567360213,0.862193280242383,0.909566537398558,-6.99033651607062,"NONE",FALSE,"High","Master Protein","O95218-2","Isoform 2 of Zinc finger Ran-binding domain-containing protein 2 [OS=Homo sapiens]",0,101.461,19,6,8,21,6,320,36.3,9.76,68.58,6,NA,NA,NA,NA,NA,"O95218-2",NA,NA,NA,0,0,99.4,112.1,104.1,110.6,93.1,85.2,107,103.4,84.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100); S188(100); S280(100); S307(99.7)]",0,"ENSG00000132485"
"1548","SPIRE1",-0.0223580419685252,6.66173784785784,-0.176442349426112,0.863616901591308,0.909951731277467,-6.99069736488239,"NONE",FALSE,"High","Master Protein","Q08AE8-2","Isoform 2 of Protein spire homolog 1 [OS=Homo sapiens]",0,42.265,8,5,6,9,5,742,83.9,8.62,25.06,5,NA,NA,NA,NA,NA,"Q08AE8-2",NA,NA,NA,0,0,101.7,105.5,102.5,101.8,78.3,116.6,108.4,108.3,86.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S468(98.4); T495(99.5); S509(100)]",0,"ENSG00000134278"
"1549","DAXX",0.016962501466133,6.66209032192722,0.17636821994406,0.863673548865684,0.909951731277467,-6.99071164280633,"NONE",FALSE,"High","Master Protein","Q9UER7","Death domain-associated protein 6 [OS=Homo sapiens]",0,33.812,8,3,3,5,3,740,81.3,4.87,17.34,3,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf03344, Pf20920","1616","B4E1I3; F5ANJ6; F5ANJ7; F5H082; hsa:1616; O14747; O15141; O15208; Q5STK9; Q9BWI3; Q9UER7","ENSG00000204209; ENSG00000206206; ENSG00000206279; ENSG00000227046; ENSG00000231617","SUMOylation of transcription cofactors; HCMV Early Events; Inhibition of DNA recombination at telomere; Regulation of TP53 Degradation; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations","Androgen receptor signaling pathway; Amyotrophic lateral sclerosis (ALS); Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; p38 MAPK signaling pathway",11,0,83.6,98.7,85.3,109.5,90.1,115.6,105.1,114.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(100); S671(100); S688(99)]",0,"ENSG00000204209"
"1550","FAM117B",-0.0169271690370278,6.6877506034879,-0.174736193791437,0.864920894699315,0.910678000096311,-6.99102447363683,"NONE",FALSE,"High","Master Protein","Q6P1L5","Protein FAM117B [OS=Homo sapiens]",0,23.675,5,2,2,5,2,589,61.9,9.82,12.71,2,NA,NA,NA,"Pf15388","150864","hsa:150864; Q53QZ5; Q585T9; Q6P1L5; Q8N8W1; Q96Q34","ENSG00000138439",NA,NA,0,0,83.9,92,100.4,99.1,105.3,123.4,102.1,111.7,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(99.2); S273(100)]",0,"ENSG00000138439"
"1551","RBMX",0.0146947421605654,6.65140109928161,0.171660136862952,0.867272964715895,0.912239832020878,-6.99160624331406,"NONE",FALSE,"High","Master Protein","P38159","RNA-binding motif protein, X chromosome [OS=Homo sapiens]",0,56.289,15,7,9,37,2,391,42.3,10.05,64.51,7,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08081","27316","B4E3U4; D3DWH0; E9PG86; hsa:27316; P38159; Q5JQ67; Q8N8Y7; Q969R3","ENSG00000147274","RND2 GTPase cycle; mRNA Splicing - Major Pathway; RND3 GTPase cycle; RND1 GTPase cycle; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",8,0,93,96.2,97.4,95.3,107,104.9,98.7,100.2,115.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S189(99.1); S208(100); S326(100); S352(100)]",0,"ENSG00000147274"
"1552","PKM",0.0175978383808175,6.56784038641242,0.171334299069877,0.867522193196325,0.912239832020878,-6.9916672670442,"NONE",FALSE,"High","Master Protein","P14618","Pyruvate kinase PKM [OS=Homo sapiens]",0,197.92,35,15,16,25,15,531,57.9,7.84,83.51,15,"cell organization and biogenesis;other metabolic processes;other biological processes","non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00224, Pf02887","5315","A6NFK3; B2R5N8; B3KRY0; B4DFX8; B4DUU6; hsa:5315; P14618; P14786; Q53GK4; Q96E76; Q9BWB5; Q9UCV6; Q9UPF2","ENSG00000067225","Neutrophil degranulation","Photodynamic therapy-induced HIF-1 survival signaling; Amino acid metabolism; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",10,0,121.6,118.7,114.5,86.9,63.6,96.1,82.8,97.7,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S127(100)]",0,"ENSG00000067225"
"1553","SHROOM3",-0.0147143506284353,6.66395340417426,-0.170175152516227,0.868408931132696,0.912584272767907,-6.99188342083108,"NONE",FALSE,"High","Master Protein","Q8TF72","Protein Shroom3 [OS=Homo sapiens]",0,15.123,3,3,3,4,3,1996,216.7,7.8,9.92,3,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity","Pf00595, Pf08687, Pf08688","57619","hsa:57619; Q5QTQ3; Q6ZRW3; Q8TF72; Q96IR9; Q9P247","ENSG00000138771",NA,NA,0,0,83.8,105.2,96.4,107.3,96.6,108,103.8,107.8,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S910(100); S1441(100); S1462(100)]",0,"ENSG00000138771"
"1554","FHIP1B",0.0306807200101833,6.6486049197063,0.167303458795502,0.870606581025448,0.914304980845258,-6.99241264200275,"NONE",FALSE,"High","Master Protein","Q8N612","FHF complex subunit HOOK-interacting protein 1B [OS=Homo sapiens]",0,11.395,3,1,1,1,1,972,105.5,6.77,3.57,1,"cell organization and biogenesis;transport;other biological processes","cytosol;other cell component",NA,"Pf10257, Pf19311, Pf19314","84067","hsa:84067; Q8N612; Q9C0A4; Q9H0N3; Q9H624","ENSG00000051009",NA,NA,0,0,69,108.2,102,104,97,107.6,92.7,100.2,138.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(100)]",0,"ENSG00000051009"
"1555","ARHGAP1",0.0144211922730051,6.63662752226999,0.165136665862399,0.872265555190759,0.915090791556379,-6.99280603093535,"NONE",FALSE,"High","Master Protein","Q07960","Rho GTPase-activating protein 1 [OS=Homo sapiens]",0,17.786,5,3,3,4,3,439,50.4,6.29,12.87,3,"transport;signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf13716","392","D3DQQ6; hsa:392; Q07960","ENSG00000175220","RHOA GTPase cycle; RHOB GTPase cycle; RHOC GTPase cycle; RND2 GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle",NA,13,0,106.7,109.5,116.4,93.9,75.6,104.9,93.7,96.7,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S47(98.9); S51(99.8)]",0,"ENSG00000175220"
"1556","SPPL2B",0.0253301551868228,6.62809523105256,0.164861512499491,0.872476269400567,0.915090791556379,-6.99285562116514,"NONE",FALSE,"High","Master Protein","Q8TCT7","Signal peptide peptidase-like 2B [OS=Homo sapiens]",0,12.226,5,1,1,1,1,592,64.6,8.32,4.16,1,"protein metabolism;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle","other molecular function","Pf02225, Pf04258","56928","D6W609; hsa:56928; O60365; Q567S3; Q8IUH9; Q8TCT7; Q9BUY6; Q9H3M4; Q9NPN2; Q9P1Z6","ENSG00000005206","Regulation of TNFR1 signaling",NA,1,0,86.2,77.7,96.5,99.8,81.4,125.6,119.3,108.7,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S550(100)]",0,"ENSG00000005206"
"1557","POP5",-0.0145724681349542,6.6318184579606,-0.161846730030763,0.874785694930115,0.916923734184937,-6.99339358157191,"NONE",FALSE,"High","Master Protein","Q969H6","Ribonuclease P/MRP protein subunit POP5 [OS=Homo sapiens]",0,30.986,12,1,2,6,1,163,18.8,7.27,15.28,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01900","51367","A6NL80; hsa:51367; Q53FS5; Q969H6; Q9Y2Q6","ENSG00000167272","tRNA processing in the nucleus",NA,1,0,82.5,96,89.9,105.1,89.6,114.1,109,103.5,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(100)]",0,"ENSG00000167272"
"1558","KLHL13",0.0182923737071103,6.66158196728552,0.160785357190624,0.875599039067529,0.917187183413483,-6.99358062393696,"NONE",FALSE,"High","Master Protein","Q9P2N7","Kelch-like protein 13 [OS=Homo sapiens]",0,9.627,3,1,1,1,1,655,73.8,6.62,3.7,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00651, Pf01344, Pf07707","90293","B3KV78; B3KWM7; B7Z3S9; B7Z5P2; B7Z802; D3DWH6; hsa:90293; Q6P2E3; Q96QI7; Q9P2N7; Q9UDN9","ENSG00000003096","Antigen processing: Ubiquitination & Proteasome degradation; Neddylation",NA,2,0,87.9,83.1,104.9,106.6,99.6,107.5,103.7,122,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S645(98.3)]",0,"ENSG00000003096"
"1559","MFGE8",-0.0145871089795673,6.66252744831435,-0.153048091751716,0.881532766048503,0.922810438865398,-6.99490714534722,"NONE",FALSE,"High","Master Protein","Q08431","Lactadherin [OS=Homo sapiens]",0,16.197,6,2,2,2,2,387,43.1,8.15,4.97,2,"cell adhesion;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi","signal transduction activity or receptor binding;other molecular function","Pf00008, Pf00754","4240","B2R6M7; F5GZN3; hsa:4240; Q08431; Q53FU9; Q7Z3D2; Q9BTL9","ENSG00000140545","Amyloid fiber formation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation","Extracellular vesicle-mediated signaling in recipient cells; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Ebola virus infection in host; Complement system in neuronal development and plasticity; Extrafollicular and follicular B cell activation by SARS-CoV-2",9,0,79.2,94.2,90.2,101.7,107.9,118.4,98.6,115.1,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000140545"
"1560","BCL9",0.0353405592150002,6.52477914051327,0.152189834104454,0.88219145000973,0.922907978471717,-6.99505028005858,"NONE",FALSE,"High","Master Protein","O00512","B-cell CLL/lymphoma 9 protein [OS=Homo sapiens]",0,9.741,2,1,1,1,1,1426,149.2,8.91,3.65,1,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus","other molecular function","Pf11502","607","hsa:607; O00512; Q5T489","ENSG00000116128","Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex","Wnt signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; 1q21.1 copy number variation syndrome",5,0,118.1,85.8,154.5,92.1,57.8,83.8,96,99.4,68.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S291(100)]",0,"ENSG00000116128"
"1561","RELCH",0.0197178960167257,6.63615998635048,0.150904365333793,0.883178181320394,0.923348361252327,-6.99526316394213,"NONE",FALSE,"High","Master Protein","Q9P260","RAB11-binding protein RELCH [OS=Homo sapiens]",0,13.825,2,2,3,5,2,1216,134.5,5.45,6.59,2,"transport","ER/Golgi;other cytoplasmic organelle",NA,NA,"57614","hsa:57614; Q9P260","ENSG00000134444",NA,NA,0,0,78.7,79.4,79,109.7,133.6,95.5,96.3,119.4,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100); S180(100)]",0,"ENSG00000134444"
"1562","CPSF7",-0.0118245938010162,6.62984384984499,-0.145657833139931,0.887207610105381,0.926967234117786,-6.99611339324967,"NONE",FALSE,"High","Master Protein","Q8N684","Cleavage and polyadenylation specificity factor subunit 7 [OS=Homo sapiens]",0,17.564,7,2,2,3,2,471,52,8,10.3,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076","79869","B3KU04; C9K0Q4; hsa:79869; Q7Z3H9; Q8N684; Q9H025; Q9H9V1","ENSG00000149532","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB1 GTPase cycle; Processing of Intronless Pre-mRNAs",NA,5,0,113,97.8,105.4,102.1,92.1,91.7,98,95.2,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(100); T203(99.3)]",0,"ENSG00000149532"
"1563","SLC7A11",-0.0192903972014191,6.61729521838667,-0.143527815020852,0.888844476868216,0.9280832925457,-6.99645002682975,"NONE",FALSE,"High","Master Protein","Q9UPY5","Cystine/glutamate transporter [OS=Homo sapiens]",0,3.566,3,1,1,1,1,501,55.4,9.19,2.25,1,"cell adhesion;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf13520","23657","A8K2U4; hsa:23657; Q9UPY5","ENSG00000151012","NFE2L2 regulating anti-oxidant/detoxification enzymes; Basigin interactions; Amino acid transport across the plasma membrane","Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; NRF2-ARE regulation; p53 transcriptional gene network; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Amino acid metabolism in triple-negative breast cancer cells",12,0,116.1,100.5,112.3,107.5,63,104.1,93.1,94.9,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000151012"
"1564","HNRNPH1",0.0107242553744245,6.44586047609557,0.139008300247142,0.892319430010644,0.931115926967629,-6.99714794788314,"NONE",FALSE,"High","Master Protein","P31943","Heterogeneous nuclear ribonucleoprotein H [OS=Homo sapiens]",0,119.899,17,5,8,21,2,449,49.2,6.3,74.66,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08080","3187","B3KW86; D3DWQ2; P31943; Q6IBM4","ENSG00000169045; ENSG00000284254","mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","MECP2 and associated Rett syndrome; mRNA processing; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells",6,4,149.2,137.1,141.6,70.1,50.5,70.8,76.3,74.8,74.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(100); S63(100); S104(100); S161(100)]",0,"ENSG00000169045"
"1565","PSAT1",-0.0270349121785198,6.63650977358213,-0.136667913394659,0.894119851444682,0.932398464893113,-6.99750062010225,"NONE",FALSE,"High","Master Protein","Q9Y617","Phosphoserine aminotransferase [OS=Homo sapiens]",0,25.097,5,2,3,4,1,370,40.4,7.66,12.54,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00266","29968","hsa:29968; Q5T7G5; Q5T7G6; Q96AW2; Q9BQ12; Q9Y617","ENSG00000135069","Serine biosynthesis","Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Male infertility; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",7,0,104.7,111.4,108.2,108.1,67.5,105.3,93.8,128.6,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100)]",0,"ENSG00000135069"
"1566","XRCC1",-0.0148758497247474,6.43264443741711,-0.132618143912777,0.897236766555503,0.935051342923742,-6.9980967872243,"NONE",FALSE,"High","Master Protein","P18887","DNA repair protein XRCC1 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,633,69.5,6.28,10.08,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00533, Pf01834","7515","hsa:7515; P18887; Q6IBS4; Q9HCB1","ENSG00000073050","Gap-filling DNA repair synthesis and ligation in TC-NER; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; HDR through MMEJ (alt-NHEJ); Resolution of AP sites via the single-nucleotide replacement pathway; Gap-filling DNA repair synthesis and ligation in GG-NER","Base excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",8,0,161.5,142.5,140.1,64.2,63.6,59.7,81.2,71.6,65.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T453(100)]",0,"ENSG00000073050"
"1567","GPR161",-0.0228151158609009,6.56226204998735,-0.130339037268414,0.898991701812167,0.936282359513374,-6.99842443863005,"NONE",FALSE,"High","Master Protein","Q8N6U8","G-protein coupled receptor 161 [OS=Homo sapiens]",0,16.351,5,2,2,2,2,529,58.5,8.24,5.74,2,"signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf00001","23432","B3KV34; B7Z5D7; B7Z5E8; B7Z5Z6; F5GXD6; F5H6J7; hsa:23432; O75963; Q5TGK0; Q5TGK1; Q5TGK2; Q8N6U8","ENSG00000143147","Hedgehog 'off' state; Hedgehog 'on' state","Hedgehog signaling pathway; GPCRs, class A rhodopsin-like; Ciliopathies; Alstrom syndrome; Bardet-Biedl syndrome",7,0,95.1,89.3,67.6,77.9,115.3,117.8,97.1,107.8,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S360(100); S517(100)]",0,"ENSG00000143147"
"1568","SLC4A2",-0.0192110762486708,6.57625600738656,-0.126722643867443,0.901777537061681,0.938357435604755,-6.99893272703619,"NONE",FALSE,"High","Master Protein","P04920","Anion exchange protein 2 [OS=Homo sapiens]",0,21.796,3,2,2,3,2,1241,136.9,6.29,6.74,2,"transport;developmental processes;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf00955, Pf07565","6522","B2R6T0; B4DIT0; D3DX05; F8W682; hsa:6522; P04920; Q45EY5; Q969L3","ENSG00000164889","Bicarbonate transporters","Proximal tubule transport",2,0,89.5,116.5,97.8,90.8,97.4,91,94.1,80.2,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S144(99.5)]",0,"ENSG00000164889"
"1569","PAG1",-0.0103765956598538,6.6292483008718,-0.126245259721809,0.902145388924695,0.938357435604755,-6.99899875904989,"NONE",FALSE,"High","Master Protein","Q9NWQ8","Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 [OS=Homo sapiens]",0,63.653,17,5,9,21,5,432,47,4.65,42.89,5,"signal transduction;other biological processes","plasma membrane;other membranes","other molecular function","Pf15347","55824","A8K1A3; hsa:55824; Q2M1Z9; Q5BKU4; Q9NWQ8; Q9NYK0","ENSG00000076641","Phosphorylation of CD3 and TCR zeta chains; GAB1 signalosome",NA,2,0,113,117.7,110.8,91.2,98.3,88.7,97.5,97,90.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(99.5); S239(100); S249(99.3); S288(99.4); S298(100)]",0,"ENSG00000076641"
"1570","HNRNPK",-0.00855095949447815,6.63864763169947,-0.125513819906414,0.902709052634477,0.938357435604755,-6.99909945031937,"NONE",FALSE,"High","Master Protein","P61978-2","Isoform 2 of Heterogeneous nuclear ribonucleoprotein K [OS=Homo sapiens]",0,62.639,16,6,7,29,6,464,51,5.33,62.37,6,NA,NA,NA,NA,NA,"P61978-2",NA,NA,NA,0,0,98.8,102,102,94.9,102.4,99.6,99.5,99,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S284(100); S379(100)]",0,"ENSG00000165119"
"1571","KLC4",-0.009633060756018,6.65246755442572,-0.124145804400052,0.903763428547085,0.938855452188952,-6.99928620839474,"NONE",FALSE,"High","Master Protein","Q9NSK0","Kinesin light chain 4 [OS=Homo sapiens]",0,50.824,9,4,5,11,4,619,68.6,6.18,39.62,4,"other biological processes","cytoskeleton;other cell component","cytoskeletal activity","Pf13374, Pf13424","89953","B3KNY4; B3KPI3; B3KSQ3; B4DME9; hsa:89953; Q66K28; Q96EG6; Q9NSK0","ENSG00000137171","MHC class II antigen presentation; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; RHO GTPases activate KTN1","Alzheimer's disease and miRNA effects; Alzheimer's disease",6,0,91.1,88.1,84.5,104.1,109.9,109.3,101.1,106.7,116.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S460(99.5); S519(99.6); S590(100); S611(99.6)]",0,"ENSG00000137171"
"1572","TBCK",-0.0183563384593572,6.72646758561156,-0.12148522422695,0.905814591335083,0.940387667340239,-6.9996435818671,"NONE",FALSE,"High","Master Protein","Q8TEA7","TBC domain-containing protein kinase-like protein [OS=Homo sapiens]",0,14.077,2,1,1,4,1,893,100.6,6.58,7.12,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00566, Pf00581","93627","B9A6J1; hsa:93627; Q4W5B3; Q4W5E1; Q6NUP4; Q8N7M8; Q8TEA7; Q8WW57; Q96GV6; Q9P080","ENSG00000145348",NA,NA,0,0,79.1,87.8,70.3,132.7,92.6,131,119,130.4,110.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S890(100)]",0,"ENSG00000145348"
"1573","CDK7",0.0119488679496085,6.43817727762386,0.119091293889716,0.907660806913383,0.941705299988964,-6.99995854193753,"NONE",FALSE,"High","Master Protein","P50613","Cyclin-dependent kinase 7 [OS=Homo sapiens]",0,7.42,5,2,2,5,2,346,39,8.47,9.45,2,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","1022","hsa:1022; P50613; Q9BS60; Q9UE19","ENSG00000134058; ENSG00000277273","RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Cyclin E associated events during G1/S transition ; Cyclin A:Cdk2-associated events at S phase entry","MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Cardiac hypertrophic response; Eukaryotic transcription initiation; G1 to S cell cycle control; Nucleotide excision repair; DNA repair pathways, full network; Pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum",43,0,159.6,147.9,164,57.2,46.1,72.2,74.8,69.6,69.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); T170(100)]",0,"ENSG00000134058"
"1574","USP47",0.0136788381484791,6.65018071728076,0.116645121049094,0.909547911794345,0.943063654414467,-7.00027391953509,"NONE",FALSE,"High","Master Protein","Q96K76","Ubiquitin carboxyl-terminal hydrolase 47 [OS=Homo sapiens]",0,23.665,2,2,2,3,2,1375,157.2,5.08,10.02,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00443, Pf19718","55031","B3KXF5; E9PM46; hsa:55031; Q658U0; Q86Y73; Q8TEP6; Q96K76; Q9BWI0; Q9NWN1","ENSG00000170242","Ub-specific processing proteases",NA,1,0,89.2,87.6,102.2,102.7,80.7,121,107.8,110.8,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S832(100); S933(99.6)]",0,"ENSG00000170242"
"1575","EFNB3",0.0124446752466119,6.64030315475169,0.111158910078468,0.913782401175995,0.946852621409031,-7.00095750460468,"NONE",FALSE,"High","Master Protein","Q15768","Ephrin-B3 [OS=Homo sapiens]",0,35.513,7,2,3,11,2,340,35.8,8.6,26.52,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00812","1949","B2RBW2; D3DTQ6; hsa:1949; O00680; Q15768; Q8TBH7; Q92875","ENSG00000108947","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells",NA,4,0,71.8,74.3,74.8,95.3,136.9,123.2,118.3,111.3,116.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100); S274(100)]",0,"ENSG00000108947"
"1576","LARP7",-0.00836260522397048,6.61301569348947,-0.108021684205338,0.916205133872564,0.948434045426502,-7.00133364563845,"NONE",FALSE,"High","Master Protein","Q4G0J3","La-related protein 7 [OS=Homo sapiens]",0,36.28,5,2,4,7,2,582,66.9,9.55,24.37,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf05383, Pf08777","51574","B2ZHN6; hsa:51574; Q3B7A9; Q4G0J3; Q9P1S7; Q9Y3Z8","ENSG00000174720",NA,"VEGFA-VEGFR2 signaling",1,0,101.2,105.7,101,91.1,96.9,97.7,98.8,92.4,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T257(99.5); S261(100); S300(100)]",0,"ENSG00000174720"
"1577","USP5",0.0209610496622226,6.67513302235544,0.107677627607039,0.91647088825833,0.948434045426502,-7.00137424309678,"NONE",FALSE,"High","Master Protein","P45974","Ubiquitin carboxyl-terminal hydrolase 5 [OS=Homo sapiens]",0,29.464,3,1,1,5,1,858,95.7,5.03,21.01,1,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cytoplasmic organelle","other molecular function","Pf00443, Pf00627, Pf02148, Pf17807","8078","D3DUS7; D3DUS8; hsa:8078; P45974; Q96J22","ENSG00000111667","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Ub-specific processing proteases","IL-18 signaling pathway",3,0,71.6,89.8,90.8,115.4,72.5,138.3,97.3,132.1,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T623(100)]",0,"ENSG00000111667"
"1578","TUBA1A",0.0110399809166397,6.5923621138063,0.102568885477141,0.920418215123823,0.951915416401825,-7.00196185307093,"NONE",FALSE,"High","Master Protein","Q71U36","Tubulin alpha-1A chain [OS=Homo sapiens]",0,322.324,44,15,21,54,15,451,50.1,5.06,194.19,15,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00091, Pf03953","7846","A8K0B8; G3V1U9; hsa:7846; P04687; P05209; Q71U36","ENSG00000167552","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Recycling pathway of L1; MHC class II antigen presentation; Recruitment of mitotic centrosome proteins and complexes; Formation of tubulin folding intermediates by CCT/TriC; Prefoldin mediated transfer of substrate  to CCT/TriC; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; Intraflagellar transport; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; Sealing of the nuclear envelope (NE) by ESCRT-III; PKR-mediated signaling; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease; PAFAH1B1 copy number variation",42,0,114.2,113.2,108.7,95.1,66.1,99.8,97.9,96.9,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100); T73(100); S158(100); S287(100); T334(100)]",0,"ENSG00000167552"
"1579","PRKCE",-0.0203307157718911,6.64688612545186,-0.100054615735579,0.92236173878382,0.953321315829762,-7.00224058336055,"NONE",FALSE,"High","Master Protein","Q02156","Protein kinase C epsilon type [OS=Homo sapiens]",0,35.993,5,2,2,6,2,737,83.6,7.12,18.99,2,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5581","B0LPH7; hsa:5581; Q02156; Q32MQ3; Q53SL4; Q53SM5; Q9UE81","ENSG00000171132","Role of phospholipids in phagocytosis; G alpha (z) signalling events; SHC1 events in ERBB2 signaling; DAG and IP3 signaling; Effects of PIP2 hydrolysis","Physiological and pathological hypertrophy of the heart; Oncostatin M signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; VEGFA-VEGFR2 signaling; Wnt signaling pathway and pluripotency; Non-genomic actions of 1,25 dihydroxyvitamin D3; Hippo signaling regulation pathways; Gastrin signaling pathway; Osteoblast differentiation and related diseases; Kisspeptin/kisspeptin receptor system in the ovary; Opioid receptor pathways; Orexin receptor pathway; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; HDAC6 interactions in the central nervous system",21,0,90.3,108.2,114.5,111.7,61.5,119.1,117.3,99.5,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T710(100)]",0,"ENSG00000171132"
"1580","PRR36",-0.0113939197271691,6.65912845840659,-0.0985327709429634,0.923538383580436,0.953933317723589,-7.00240594052381,"NONE",FALSE,"High","Master Protein","Q9H6K5","Proline-rich protein 36 [OS=Homo sapiens]",0,15.116,2,2,2,2,2,1346,132.7,10.48,5.14,2,NA,NA,NA,"Pf15363","80164","A0A087WZ52; hsa:80164; Q9H3X1; Q9H6K5","ENSG00000183248",NA,NA,0,0,81.9,80.3,99.1,97.3,100.3,127.4,107.9,110.8,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S110(100); S1310(100)]",0,"ENSG00000183248"
"1581","PEG10",0.00718664531399504,6.46405434130766,0.097391459942495,0.924420938945641,0.95424096923421,-7.00252829085081,"NONE",FALSE,"High","Master Protein","Q86TG7-5","Isoform 5 of Retrotransposon-derived protein PEG10 [OS=Homo sapiens]",0,6.053,4,2,2,6,2,401,45,7.93,5.52,2,NA,NA,NA,NA,NA,"Q86TG7-5",NA,NA,NA,0,0,151.8,143.9,139.5,70.1,58.3,65.3,74.2,73.3,80.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(100); S392(99.5)]",0,"ENSG00000242265"
"1582","MAD1L1",-0.0137147072606112,6.52494343732522,-0.0904476740736442,0.929792730796794,0.959179353135505,-7.00324201472142,"NONE",FALSE,"High","Master Protein","Q9Y6D9","Mitotic spindle assembly checkpoint protein MAD1 [OS=Homo sapiens]",0,7.955,3,1,1,2,1,718,83,5.92,2.6,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf05557","8379","B3KR41; hsa:8379; Q13312; Q75MI0; Q86UM4; Q9UNH0; Q9Y6D9","ENSG00000002822","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition; Pleural mesothelioma; CCL18 signaling pathway",10,0,88.4,78.7,115.9,90,106.5,80.1,95.3,87.8,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000002822"
"1583","PACS1",0.00900208378667422,6.63915507194579,0.0874944613550516,0.932078514838036,0.9609299660238,-7.00352959763841,"NONE",FALSE,"High","Master Protein","Q6VY07","Phosphofurin acidic cluster sorting protein 1 [OS=Homo sapiens]",0,29.706,5,2,3,8,2,963,104.8,7.74,13.4,2,"other biological processes","cytosol;ER/Golgi","other molecular function","Pf10254","55690","hsa:55690; Q6PJY6; Q6PKB6; Q6VY07; Q7Z590; Q7Z5W4; Q8N8K6; Q96MW0; Q9NW92; Q9ULP5","ENSG00000175115","Nef mediated downregulation of MHC class I complex cell surface expression",NA,1,0,62.2,68,58.3,127.6,136.9,115.2,118.8,132.4,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S519(100); S781(97)]",0,"ENSG00000175115"
"1584","LENG1",0.0130962484840813,6.60625355524917,0.0861085369559884,0.933151445143165,0.961428761662655,-7.0036612727793,"NONE",FALSE,"High","Master Protein","Q96BZ8","Leukocyte receptor cluster member 1 [OS=Homo sapiens]",0,14.706,9,1,1,1,1,264,30.5,9.8,4.14,1,NA,"nucleus",NA,"Pf10197","79165","hsa:79165; Q96BZ8; Q9HCU7","ENSG00000105617; ENSG00000275935; ENSG00000276628; ENSG00000276774; ENSG00000276959; ENSG00000277457; ENSG00000277808; ENSG00000278257; ENSG00000278426; ENSG00000278516","mRNA Splicing - Major Pathway",NA,1,0,132.8,104.2,80.8,94.9,81.4,101.2,90.6,96.5,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100)]",0,"ENSG00000105617"
"1585","ENO1",-0.00962343602873528,6.64843510406973,-0.0850390664650277,0.933979485491805,0.961674776228786,-7.00376144708019,"NONE",FALSE,"High","Master Protein","P06733","Alpha-enolase [OS=Homo sapiens]",0,218.577,39,16,20,40,16,434,47.1,7.39,108,16,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00113, Pf03952","2023","B2RD59; hsa:2023; P06733; P22712; Q16704; Q4TUS4; Q53FT9; Q53HR3; Q658M5; Q6GMP2; Q71V37; Q7Z3V6; Q8WU71; Q96GV1; Q9BT62; Q9UCH6; Q9UM55","ENSG00000074800","Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism","Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; IL-18 signaling pathway; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",9,0,109.1,100.2,105.9,105.5,71.9,110.9,93.3,106.7,100.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S40(99.5); S272(100); S419(100)]",0,"ENSG00000074800"
"1586","DNAJC19",0.0132402907727824,6.3674067127832,0.0824995058394601,0.935946078066189,0.963092055109723,-7.00399431194561,"NONE",FALSE,"High","Master Protein","Q96DA6","Mitochondrial import inner membrane translocase subunit TIM14 [OS=Homo sapiens]",0,10.119,12,1,1,1,1,116,12.5,10.1,3.54,1,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","other membranes;mitochondrion;other cell component","other molecular function","Pf00226","131118","B2R4B1; C9JBV1; hsa:131118; Q96DA6","ENSG00000205981","Mitochondrial protein import",NA,1,0,183.5,149.3,177.5,57.7,50.3,45.2,76,55.7,63.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100)]",0,"ENSG00000205981"
"1587","UBAC1",0.00872537440417176,6.65560712827949,0.0813812628394183,0.936812171452152,0.96337584361053,-7.00409461372506,"NONE",FALSE,"High","Master Protein","Q9BSL1","Ubiquitin-associated domain-containing protein 1 [OS=Homo sapiens]",0,6.715,2,2,2,3,2,405,45.3,4.92,7.78,2,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00627","10422","hsa:10422; O75500; Q9BSL1; Q9UMW7","ENSG00000130560","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,88.5,93.2,101.1,100.7,120.4,94.1,102.7,99,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S98(100)]",0,"ENSG00000130560"
"1588","LRRFIP2",-0.00892773317233519,6.68775178508951,-0.070504294377887,0.945240879270938,0.968681475784489,-7.00499890985621,"NONE",FALSE,"High","Master Protein","Q9Y608","Leucine-rich repeat flightless-interacting protein 2 [OS=Homo sapiens]",0,23.239,5,2,3,6,2,721,82.1,6.95,13.16,2,"cell-cell signaling;signal transduction;other biological processes",NA,"other molecular function","Pf09738","9209","A8K649; A8MXR0; B4DY63; Q68CV3; Q9NXH5; Q9Y608","ENSG00000093167",NA,"VEGFA-VEGFR2 signaling",1,0,81.2,77.2,101.8,115.8,106.7,113.5,124.6,102.2,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(99.5); S328(100)]",0,"ENSG00000093167"
"1589","CLASP1",-0.0116526777704689,6.63111311222953,-0.0685954468126453,0.946720837858509,0.968681475784489,-7.00514426407492,"NONE",FALSE,"High","Master Protein","Q7Z460","CLIP-associating protein 1 [OS=Homo sapiens]",0,74.03,7,6,8,17,2,1538,169.3,9.03,35.04,6,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf02985, Pf12348, Pf21040","23332","A2RU21; B7ZLX3; F5GWS0; hsa:23332; O75118; Q2KHQ9; Q5H9P0; Q7Z460; Q8N5B8; Q9BQT5","ENSG00000074054","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Role of ABL in ROBO-SLIT signaling","Microtubule cytoskeleton regulation; Splicing factor NOVA regulated synaptic proteins; 7q11.23 copy number variation syndrome",17,4,68.3,83.6,78.3,107.6,162.6,91.4,110.5,101.8,126.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S600(99.7); S646(97.6); S688(100); S797(98.9); S1091(99.6)]",0,"ENSG00000074054"
"1590","RUFY3",0.0130179013616765,6.59148064196923,0.0675093957221944,0.947562965659636,0.968681475784489,-7.00522518546501,"NONE",FALSE,"High","Master Protein","Q7L099","Protein RUFY3 [OS=Homo sapiens]",0,12,6,1,1,1,1,469,52.9,5.49,3.51,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;other cell component",NA,"Pf02759","22902","B3KM25; B4DYW7; D9N163; hsa:22902; O94948; Q7L099; Q9UI00","ENSG00000018189",NA,NA,0,0,84.4,85.8,98.9,104.8,128.3,72.9,103.2,118.6,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(99.3)]",0,"ENSG00000018189"
"1591","KCTD12",-0.00652053431283228,6.60944109317769,-0.0669171253342172,0.948022242970137,0.968681475784489,-7.00526877173142,"NONE",FALSE,"High","Master Protein","Q96CX2","BTB/POZ domain-containing protein KCTD12 [OS=Homo sapiens]",0,60.801,18,2,5,12,2,325,35.7,5.64,56.64,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf02214","115207","hsa:115207; Q96CX2","ENSG00000178695",NA,NA,0,0,107.7,106.8,108.4,92.1,72.5,108.4,89.4,100.2,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S151(100); S176(99.3); S185(100)]",0,"ENSG00000178695"
"1592","USP24",-0.00745974991125475,6.64665618288831,-0.0668421540905072,0.948080381014077,0.968681475784489,-7.00527426164327,"NONE",FALSE,"High","Master Protein","Q9UPU5","Ubiquitin carboxyl-terminal hydrolase 24 [OS=Homo sapiens]",0,69.002,2,4,5,17,3,2620,294.2,6.14,53.33,4,"protein metabolism","cytosol;nucleus","other molecular function","Pf00443","23358","hsa:23358; Q6ZSY2; Q8N2Y4; Q9NXD1; Q9UPU5","ENSG00000162402","Ub-specific processing proteases",NA,1,0,108.9,102.5,103.6,105.8,71.4,110.3,97.4,106.5,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2047(100); S2561(100)]",0,"ENSG00000162402"
"1593","PDCD4",-0.0142335306542822,6.59049091586148,-0.0661862429848606,0.948589034892179,0.968681475784489,-7.00532202977958,"NONE",FALSE,"High","Master Protein","Q53EL6","Programmed cell death protein 4 [OS=Homo sapiens]",0,25.333,5,4,5,11,4,469,51.7,5.21,29.82,4,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf02847","27250","B2RCV4; B5ME91; hsa:27250; O15501; Q53EL6; Q5VZS6; Q6PJI5; Q8TAR5; Q99834","ENSG00000150593","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Translation inhibitors in chronically activated PDGFRA cells; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways",4,0,63.3,65.6,66.8,114.6,200.2,82.7,119.3,104.9,125.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S94(100); S457(100)]",0,"ENSG00000150593"
"1594","PBDC1",0.010422299584933,6.67624243436747,0.0655196560531515,0.949105992760008,0.968681475784489,-7.00537009323291,"NONE",FALSE,"High","Master Protein","Q9BVG4","Protein PBDC1 [OS=Homo sapiens]",0,16.612,12,3,3,4,3,233,26,4.79,8.12,3,NA,NA,NA,"Pf04669","51260","hsa:51260; Q9BVG4","ENSG00000102390",NA,NA,0,0,99.5,111.9,107.8,118.4,79,94,100.8,121.7,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(99.7); S197(100)]",0,"ENSG00000102390"
"1595","IGF2BP2",0.00624378761246014,6.65073467643852,0.0650129532749715,0.949498972426839,0.968681475784489,-7.00540630325304,"NONE",FALSE,"High","Master Protein","Q9Y6M1","Insulin-like growth factor 2 mRNA-binding protein 2 [OS=Homo sapiens]",0,35.423,6,2,3,10,2,599,66.1,8.46,26.8,2,"other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf00076","10644","A0A4Z0; B3FTN2; B3FTN3; B3FTN4; hsa:10644; Q9Y6M1","ENSG00000073792","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA",NA,1,0,97.7,97.7,106.6,97.9,80.8,115.8,104.2,97.5,104.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.3); S164(100)]",0,"ENSG00000073792"
"1596","RPL18A",-0.00534192440868875,6.29356334024462,-0.0649495020735677,0.949548183807416,0.968681475784489,-7.00541081781809,"NONE",FALSE,"High","Master Protein","Q02543","Large ribosomal subunit protein eL20 [OS=Homo sapiens]",0,50.071,10,2,2,7,2,176,20.7,10.71,26.67,2,"protein metabolism;other metabolic processes","cytosol;translational apparatus;other cell component","other molecular function","Pf01775","6142","hsa:6142; Q02543","ENSG00000105640","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins",15,0,175.7,156.8,154.1,50.4,36.4,58.5,65.1,63.8,60.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100)]",0,"ENSG00000105640"
"1597","EIF4B",-0.00855736679326036,6.62152222527793,-0.0649449977560161,0.949551677267279,0.968681475784489,-7.00541113813372,"NONE",FALSE,"High","Master Protein","P23588","Eukaryotic translation initiation factor 4B [OS=Homo sapiens]",0,50.064,8,3,7,13,3,611,69.1,5.73,48.16,3,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus","nucleic acid binding activity","Pf00076","1975","B4DS13; hsa:1975; P23588; Q4G0E3; Q53HQ2; Q6GPH5; Q6IB46; Q8WYK5","ENSG00000063046","Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; Interferon type I signaling pathways",16,0,67.8,69.4,67.3,113.7,162.5,100.2,108,123.2,122.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100); S497(99.2); S597(100)]",0,"ENSG00000063046"
"1598","HNRNPD",0.0170420070931501,6.59695570716331,0.0648325844145425,0.949638863203187,0.968681475784489,-7.00541912499685,"NONE",FALSE,"High","Master Protein","Q14103","Heterogeneous nuclear ribonucleoprotein D0 [OS=Homo sapiens]",0,43.267,13,4,5,9,4,355,38.4,7.81,27.08,4,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08143","3184","A8K9J2; hsa:3184; P07029; Q01858; Q14100; Q14101; Q14102; Q14103; Q4W5A1; Q9UCE8; Q9UCE9","ENSG00000138668","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,87.4,92.2,101.7,80.4,156.4,78.9,100,76.9,139.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(99.5); S190(100)]",0,"ENSG00000138668"
"1599","PHLDB1",0.00498935426096025,6.64982751723048,0.0644681206952079,0.949921540077325,0.968681475784489,-7.00544492473572,"NONE",FALSE,"High","Master Protein","Q86UU1","Pleckstrin homology-like domain family B member 1 [OS=Homo sapiens]",0,56.966,10,10,11,18,10,1377,151.1,8.63,50.32,10,"other biological processes","plasma membrane;other membranes;cytosol;other cell component",NA,"Pf00169, Pf00498","23187","B0YJ63; B0YJ64; hsa:23187; O75133; Q4KMF8; Q86UU1; Q8TEQ2","ENSG00000019144",NA,NA,0,0,87.2,83.3,80.1,104,117.9,109.4,105.4,113.9,111.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S381(100); S430(100); S443(100); S461(100); S470(100); S520(99.5); S539(100); S563(100)]",0,"ENSG00000019144"
"1600","GPALPP1",-0.0100035238775522,6.63156233467976,-0.0644186565806652,0.949959904849459,0.968681475784489,-7.00544841501307,"NONE",FALSE,"High","Master Protein","Q8IXQ4","GPALPP motifs-containing protein 1 [OS=Homo sapiens]",0,24.478,6,1,1,4,1,340,38.1,5.41,12.12,1,NA,NA,NA,"Pf12572","55425","A8K8X8; hsa:55425; Q05BX8; Q05D87; Q5T3Z3; Q5T3Z5; Q8IXQ4; Q9C0F9; Q9H2R0; Q9P0W6","ENSG00000133114",NA,NA,0,0,71.4,83,80.2,102.7,157.2,94.6,116.6,99.9,117.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100)]",0,"ENSG00000133114"
"1601","TJP1",-0.00424792788890382,6.67093348082183,-0.064004315873026,0.950281276183191,0.968681475784489,-7.00547754652436,"NONE",FALSE,"High","Master Protein","Q07157","Tight junction protein ZO-1 [OS=Homo sapiens]",0,147.687,9,11,13,24,3,1748,195.3,6.7,74.71,11,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00595, Pf00625, Pf00791, Pf07653","7082","B4E3K1; hsa:7082; Q07157; Q2NKP3; Q4ZGJ6","ENSG00000104067; ENSG00000277401","RUNX1 regulates expression of components of tight junctions; Signaling by Hippo; Regulation of gap junction activity; SARS-CoV-2 targets PDZ proteins in cell-cell junction; Apoptotic cleavage of cell adhesion  proteins","Epithelial to mesenchymal transition in colorectal cancer; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Disruption of postsynaptic signaling by CNV; 1q21.1 copy number variation syndrome; 15q11q13 copy number variation",11,8,84.8,82.3,86.2,106.9,111.9,116.4,106.5,111.5,115.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S212(100); T589(100); S617(100); S912(100); S968(100); S1051(100); S1278(100); S1617(100)]",0,"ENSG00000104067"
"1602","SF3A1",0.00851252640434819,6.63644682988698,0.0625919410528299,0.951376814007846,0.969192859213986,-7.00557543663508,"NONE",FALSE,"High","Master Protein","Q15459","Splicing factor 3A subunit 1 [OS=Homo sapiens]",0,30.401,3,1,1,4,1,793,88.8,5.22,19.16,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00240, Pf01805, Pf12230","10291","E9PAW1; hsa:10291; Q15459","ENSG00000099995","mRNA Splicing - Major Pathway","mRNA processing",2,0,97.8,106.3,103.9,105.4,97.2,86.9,111.5,105.1,84,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000099995"
"1603","N4BP1",0.00570097857426521,6.64943475769975,0.0600341125133748,0.953361117245386,0.970608448748889,-7.00574716158773,"NONE",FALSE,"High","Master Protein","O75113","NEDD4-binding protein 1 [OS=Homo sapiens]",0,8.323,2,2,2,2,2,896,100.3,5.36,2.93,2,"stress response;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf11977","9683","A7MD49; hsa:9683; O75113; Q2YDX1","ENSG00000102921","Regulation of NF-kappa B signaling",NA,1,0,88.4,102.2,89,112.5,99.7,96.4,108.3,102.4,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T242(100)]",0,"ENSG00000102921"
"1604","SSR1",-0.0162175654091676,6.62892327014756,-0.0584733636006457,0.954572075712699,0.971235428655314,-7.00584842892531,"NONE",FALSE,"High","Master Protein","P43307","Translocon-associated protein subunit alpha [OS=Homo sapiens]",0,10.694,10,1,1,1,1,286,32.2,4.49,3.63,1,"other biological processes","other membranes;ER/Golgi",NA,"Pf03896","6745","A8K685; hsa:6745; P43307; Q53GX2; Q53H19; Q5TAM3; Q6IB43; Q8NBH9; Q96IA2; Q9TNQ8; Q9UN49","ENSG00000124783","SRP-dependent cotranslational protein targeting to membrane; XBP1(S) activates chaperone genes",NA,2,0,91.5,81.4,168.4,93.7,67.4,114.7,87.8,86.3,117,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100)]",0,"ENSG00000124783"
"1605","PELP1",-0.00488438188787921,6.45841477241468,-0.0560116214539785,0.956482346173874,0.971430227055408,-7.00600273831246,"NONE",FALSE,"High","Master Protein","Q8IZL8","Proline-, glutamic acid- and leucine-rich protein 1 [OS=Homo sapiens]",0,80.12,9,4,5,29,4,1130,119.6,4.34,127.13,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf08166, Pf08167","27043","hsa:27043; O15450; Q5EGN3; Q6NTE6; Q8IZL8; Q96FT1; Q9BU60","ENSG00000141456","Major pathway of rRNA processing in the nucleolus and cytosol; PTK6 Expression",NA,2,0,142.5,136.5,143.2,67,52.1,76.8,78.1,77.5,72.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S481(100); T745(99.6); S1033(100); S1043(100)]",0,"ENSG00000141456"
"1606","CALD1",0.0136487695503051,6.59092404047014,0.0559611568205591,0.95652150896496,0.971430227055408,-7.00600583222043,"NONE",FALSE,"High","Master Protein","Q05682-4","Isoform 4 of Caldesmon [OS=Homo sapiens]",0,22.235,10,4,4,4,4,538,62.6,6.37,11.18,4,NA,NA,NA,NA,NA,"Q05682-4",NA,NA,NA,0,0,74.8,83.5,85.9,94.5,180.7,74.1,118.3,88.7,113.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100); T533(99.7)]",0,"ENSG00000122786"
"1607","ARHGEF12",-0.00365931065496827,6.63600592297703,-0.0559254110857973,0.956549249312525,0.971430227055408,-7.00600802204949,"NONE",FALSE,"High","Master Protein","Q9NZN5-2","Isoform 2 of Rho guanine nucleotide exchange factor 12 [OS=Homo sapiens]",0,44.009,4,4,4,7,4,1525,171,5.74,15.79,4,NA,NA,NA,NA,NA,"Q9NZN5-2",NA,NA,NA,0,0,87,93.9,90.8,101.6,101.4,108,104.7,105.7,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S290(100); T717(100); S1370(100)]",0,"ENSG00000196914"
"1608","FRMD5",0.00586191154514193,6.50442022565004,0.0543683599959968,0.957757652027356,0.972052542356123,-7.00610205193183,"NONE",FALSE,"High","Master Protein","Q7Z6J6","FERM domain-containing protein 5 [OS=Homo sapiens]",0,7.949,2,1,1,3,1,570,65,8.35,5.71,1,"cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00373, Pf08736, Pf09379, Pf09380","84978","hsa:84978; Q7Z6J6; Q8NBG4","ENSG00000171877",NA,NA,0,0,127.9,125.3,130.3,72.7,59.2,89.3,75.2,82.6,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000171877"
"1609","CDK11B",0.00694889708296742,6.37227495860533,0.0531501990553834,0.958703126361805,0.972407397279345,-7.00617376644537,"NONE",FALSE,"High","Master Protein","P21127","Cyclin-dependent kinase 11B [OS=Homo sapiens]",0,48.701,7,4,5,14,4,795,92.6,5.54,39.49,4,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","984","B7ZVY7; hsa:984; J3KTL7; J3QR29; J3QR44; O95265; P21127; Q12817; Q12818; Q12819; Q12820; Q12822; Q8N530; Q9NZS5; Q9UBJ0; Q9UBQ1; Q9UBR0; Q9UNY2; Q9UP57; Q9UP58; Q9UP59","ENSG00000248333","Recruitment of mitotic centrosome proteins and complexes","1p36 copy number variation syndrome",2,0,159.6,153.7,151.2,60.9,35.3,68.8,73.9,70.3,62.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100); S283(100); S589(100); S752(99.5)]",0,"ENSG00000248333"
"1610","MICAL3",-0.00416869269178033,6.66303957972714,-0.0515282848933312,0.95996207796302,0.972516729287952,-7.00626672965392,"NONE",FALSE,"High","Master Protein","Q7RTP6","[F-actin]-monooxygenase MICAL3 [OS=Homo sapiens]",0,56.657,5,7,7,13,7,2002,224.2,5.55,30.22,7,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00412, Pf01494, Pf12130","57553","B2RXJ5; E9PEF0; O94909; Q5U4P4; Q6ICK4; Q7RTP6; Q96DF2; Q9P2I3","ENSG00000243156",NA,NA,0,0,88.7,84,86.6,109,118.6,102.4,112.2,105.8,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S685(99.5); S977(100); S1221(100); S1310(100); S1649(100); S1792(100)]",0,"ENSG00000243156"
"1611","RETREG2",-0.00696946146499045,6.63669609437269,-0.0514759187074072,0.960002727256673,0.972516729287952,-7.00626968314527,"NONE",FALSE,"High","Master Protein","Q8NC44","Reticulophagy regulator 2 [OS=Homo sapiens]",0,86.922,13,4,4,9,4,543,57.8,4.45,39.19,4,"cell organization and biogenesis;other metabolic processes","other membranes;ER/Golgi","other molecular function",NA,"79137","hsa:79137; Q6P1P5; Q8NC44; Q9H0K7","ENSG00000144567",NA,NA,0,0,91.9,99.2,89.6,103.4,119.9,88.7,103.9,91.5,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T330(99.4); S379(100); S385(100)]",0,"ENSG00000144567"
"1612","PRRC2C",0.00372192312777386,6.65731351161888,0.0488734980922407,0.962023008215713,0.973958777548414,-7.00641268057717,"NONE",FALSE,"High","Master Protein","Q9Y520","Protein PRRC2C [OS=Homo sapiens]",0,38.485,2,5,6,10,5,2896,316.7,9.13,24.56,5,"cell organization and biogenesis;other biological processes","cytosol;other cell component",NA,"Pf07001","23215","hsa:23215; Q05DM8; Q49A39; Q6PD54; Q9H2N2; Q9HA05; Q9NSM8; Q9NXL3; Q9UF29; Q9UPQ6; Q9Y520","ENSG00000117523",NA,"VEGFA-VEGFR2 signaling",1,0,93,95.2,92.8,104.3,109.1,99.3,108.7,101.9,105.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2105(100); T2673(100); T2682(98.1); S2694(99.6)]",0,"ENSG00000117523"
"1613","USP14",0.0127975375366001,6.58378750562176,0.0460803510735432,0.964191666926267,0.975549163312876,-7.00655790988815,"NONE",FALSE,"High","Master Protein","P54578","Ubiquitin carboxyl-terminal hydrolase 14 [OS=Homo sapiens]",0,28.436,3,1,1,4,1,494,56,5.3,17.8,1,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00443","9097","B7Z4N8; hsa:9097; J3QRZ5; P54578; Q53XY5","ENSG00000101557","Ub-specific processing proteases; Regulation of NF-kappa B signaling",NA,2,0,107.8,110.3,108.6,94.4,44.6,129.6,89.6,123,75.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S143(100)]",0,"ENSG00000101557"
"1614","THRAP3",0.00513800013126176,6.58946679549546,0.0444988041247521,0.965419751441345,0.97583040529836,-7.00663635530645,"NONE",FALSE,"High","Master Protein","Q9Y2W1","Thyroid hormone receptor-associated protein 3 [OS=Homo sapiens]",0,242.262,19,21,27,73,21,955,108.6,10.15,178.65,21,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf15440","9967","D3DPS5; hsa:9967; Q5VTK6; Q9Y2W1","ENSG00000054118","PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation","Interactome of polycomb repressive complex 2 (PRC2)",3,0,108.5,107.5,107.2,88.3,106.3,79.1,97.2,86.8,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S211(99.6); S243(100); S248(100); S253(100); S320(100); S379(100); S535(99.6); S560(100); S575(100); S672(100); S682(100); S939(99.5)]",0,"ENSG00000054118"
"1615","SDC3",-0.0086222706777388,6.62919421844477,-0.0441823333296683,0.965665505243169,0.97583040529836,-7.00665172361359,"NONE",FALSE,"High","Master Protein","O75056","Syndecan-3 [OS=Homo sapiens]",0,5.549,4,2,2,2,2,442,45.5,4.69,5.04,2,"other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01034","9672","hsa:9672; O75056; Q5T1Z6; Q5T1Z7; Q96CT3; Q96PR8","ENSG00000162512","Cell surface interactions at the vascular wall; RSV-host interactions; Respiratory syncytial virus (RSV) attachment and entry; A tetrasaccharide linker sequence is required for GAG synthesis; HS-GAG biosynthesis; HS-GAG degradation; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS; Defective B3GALT6 causes EDSP2 and SEMDJL1; Attachment and Entry; Retinoid metabolism and transport; Syndecan interactions",NA,14,0,45.7,52.3,64.4,142.6,93,149.3,120.1,161.2,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000162512"
"1616","BCKDK",-0.0169338709715365,6.50873886956886,-0.042250123896719,0.96716603403779,0.976697845045198,-7.0067431763381,"NONE",FALSE,"High","Master Protein","O14874","Branched-chain alpha-ketoacid dehydrogenase kinase [OS=Homo sapiens]",0,5.258,3,1,2,15,1,412,46.3,8.82,4.32,1,"other metabolic processes;other biological processes","mitochondrion","kinase activity;other molecular function","Pf02518, Pf10436","10295","A8MY43; hsa:10295; O14874; Q6FGL4; Q96G95; Q96IN5","ENSG00000103507","Branched-chain amino acid catabolism","Thiamine metabolic pathways",2,0,116.2,39.9,119.6,76.8,157.4,81.5,105.6,81.7,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100)]",0,"ENSG00000103507"
"1617","YEATS2",-0.00351105669067575,6.61179604540046,-0.0408806399875107,0.968229639752289,0.976697845045198,-7.0068055197699,"NONE",FALSE,"High","Master Protein","Q9ULM3","YEATS domain-containing protein 2 [OS=Homo sapiens]",0,20.325,2,2,2,3,2,1422,150.7,8.98,8.16,2,"cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf03366","55689","A7E2B9; D3DNS9; hsa:55689; Q641P6; Q9NW96; Q9ULM3","ENSG00000163872","Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones",NA,2,0,107.2,102,102.3,95.2,81,102.1,88.3,102.7,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S447(100); S465(100)]",0,"ENSG00000163872"
"1618","PRPF3",0.00556684698918009,6.48411211335384,0.0407651862362005,0.968319309609761,0.976697845045198,-7.00681068175623,"NONE",FALSE,"High","Master Protein","O43395","U4/U6 small nuclear ribonucleoprotein Prp3 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,683,77.5,9.5,8.37,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","other molecular function","Pf01480, Pf06544, Pf08572","9129","B4DSY9; hsa:9129; O43395; O43446; Q5VT54","ENSG00000117360","mRNA Splicing - Major Pathway","mRNA processing",2,0,128.5,132.4,133.7,78.3,48.2,87.1,81.9,88.5,70.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S619(100)]",0,"ENSG00000117360"
"1619","CNN3",0.00771407455633533,6.54799209369881,0.0395136327827493,0.969291387511082,0.977074456095174,-7.00686570265741,"NONE",FALSE,"High","Master Protein","Q15417","Calponin-3 [OS=Homo sapiens]",0,11.054,3,1,2,2,1,329,36.4,6.05,5.86,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf00307, Pf00402","1266","B4DFK6; B4DP09; F8WA86; hsa:1266; Q15417; Q6FHA7","ENSG00000117519",NA,NA,0,0,54.7,61.3,53.2,124.7,166.1,93.2,97.7,130.8,146.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000117519"
"1620","ZBTB21",0.00310065372145285,6.6488972951857,0.0382245582530227,0.970292663394171,0.977214063955211,-7.0069205801626,"NONE",FALSE,"High","Master Protein","Q9ULJ3","Zinc finger and BTB domain-containing protein 21 [OS=Homo sapiens]",0,13.089,3,2,2,2,2,1066,118.8,8.29,5.24,2,"other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651, Pf18450","49854","hsa:49854; Q5R2W1; Q5R2W2; Q6P4R0; Q9ULJ3","ENSG00000173276",NA,NA,0,0,91.6,79.7,82.6,104.2,105.3,116.9,104.4,110.6,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S345(100); S411(100)]",0,"ENSG00000173276"
"1621","PNKP",-0.00491290072213335,6.52741358279094,-0.0377935596273419,0.970627449553552,0.977214063955211,-7.0069385224552,"NONE",FALSE,"High","Master Protein","Q96T60","Bifunctional polynucleotide phosphatase/kinase [OS=Homo sapiens]",0,15.2,4,1,1,2,1,521,57,8.46,8.69,1,"DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf08645, Pf13671, Pf17913","11284","hsa:11284; Q96T60; Q9BUL2; Q9P1V2; Q9UKU8; Q9UNF8; Q9UNI0","ENSG00000039650","APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway","Base excision repair; DNA repair pathways, full network",3,0,121,122.6,130.3,85.8,52.4,93.4,83.2,92.6,78.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T118(100)]",0,"ENSG00000039650"
"1622","LRRC47",0.00540482144960208,6.6780444703462,0.0312883438260836,0.975681188490925,0.981679641149936,-7.00718462830943,"NONE",FALSE,"High","Master Protein","Q8N1G4","Leucine-rich repeat-containing protein 47 [OS=Homo sapiens]",0,99.962,6,3,4,12,3,583,63.4,8.28,54.07,3,"protein metabolism;RNA metabolism OR transcription;other metabolic processes",NA,"other molecular function","Pf00560, Pf13855","57470","hsa:57470; Q8N1G4; Q9ULN5","ENSG00000130764",NA,NA,0,0,92.3,86.6,97.3,122.9,68.7,122.2,111.5,118.3,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S520(100)]",0,"ENSG00000130764"
"1623","DDX23",-0.00238170563602758,6.59611781908342,-0.0305357125327806,0.976265966658301,0.981679641149936,-7.00721011110251,"NONE",FALSE,"High","Master Protein","Q9BUQ8","Probable ATP-dependent RNA helicase DDX23 [OS=Homo sapiens]",0,25.973,3,4,5,20,4,820,95.5,9.55,23.65,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf00270, Pf00271","9416","B2R600; B4DH15; hsa:9416; O43188; Q9BUQ8","ENSG00000174243","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway",NA,2,0,115.2,111.1,109.5,91.1,92.1,83.8,93.4,91.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); S39(100); S109(100)]",0,"ENSG00000174243"
"1624","SNTB2",-0.00284455681037077,6.63703608580753,-0.0255883881213331,0.980110282751064,0.984516956834366,-7.00736217791525,"NONE",FALSE,"High","Master Protein","Q13425","Beta-2-syntrophin [OS=Homo sapiens]",0,70.256,7,4,4,14,4,540,57.9,8.82,43.17,4,NA,"plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6645","hsa:6645; Q13425; Q9BY09","ENSG00000168807",NA,NA,0,0,101,98.6,97.3,96.4,76.1,121.2,100.2,100.2,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S110(100); S393(100)]",0,"ENSG00000168807"
"1625","UVRAG",0.00506981293084507,6.62496445291978,0.0253517825883343,0.980294151259709,0.984516956834366,-7.0073687788671,"NONE",FALSE,"High","Master Protein","Q9P2Y5","UV radiation resistance-associated gene protein [OS=Homo sapiens]",0,14.416,3,1,1,1,1,699,78.1,8.29,3.2,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;other biological processes","other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf10186","7405","B3KTC1; hsa:7405; O00392; Q9P2Y5","ENSG00000198382","Macroautophagy; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex; SARS-CoV-2 modulates autophagy","Nanoparticle triggered autophagic cell death; Autophagy",6,0,93.6,76.5,86.5,124.7,74.7,109.2,124,114.7,84.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100)]",0,"ENSG00000198382"
"1626","RPS6KC1",-0.00148289963054893,6.66046481115387,-0.0169590629806166,0.986816920321806,0.990458311171702,-7.00756326295344,"NONE",FALSE,"High","Master Protein","Q96S38","Ribosomal protein S6 kinase delta-1 [OS=Homo sapiens]",0,34.507,5,3,4,4,3,1066,118.6,4.87,14.18,3,"other metabolic processes;signal transduction","other membranes;other cytoplasmic organelle","kinase activity;other molecular function","Pf00069, Pf00787, Pf04212","26750","B1APS8; B3KVM4; D3DTA4; hsa:26750; Q8TDD3; Q96S38; Q9NSF4; Q9UL66","ENSG00000136643",NA,NA,0,0,94.1,103,105.2,96.4,88.5,115.4,97.6,103,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S282(99.5); S528(100); S664(99.5)]",0,"ENSG00000136643"
"1627","KLHL22",0.00450643819690821,6.57985874541396,0.0151000603919431,0.988261881984376,0.99102203295536,-7.00759590450209,"NONE",FALSE,"High","Master Protein","Q53GT1","Kelch-like protein 22 [OS=Homo sapiens]",0,5.917,2,1,1,2,1,634,71.6,5.49,5.83,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00651, Pf01344, Pf07707, Pf13415, Pf13964","84861","A8K3Q4; A8MTV3; B7Z2G1; D3DX30; hsa:84861; Q53GT1; Q96B68; Q96KC6","ENSG00000099910","Antigen processing: Ubiquitination & Proteasome degradation; Neddylation","22q11.2 copy number variation syndrome",3,0,105.7,109.1,111.7,72.7,154.4,65.2,106.4,65.4,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T605(100)]",0,"ENSG00000099910"
"1628","ASPSCR1",-0.00197906415486315,6.63813801249039,-0.0146739979972126,0.988593057384391,0.99102203295536,-7.00760285237727,"NONE",FALSE,"High","Master Protein","Q9BZE9","Tether containing UBX domain for GLUT4 [OS=Homo sapiens]",0,12.088,3,1,1,1,1,553,60.1,6.64,3.67,1,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf00789, Pf11470","79058","A8K3K9; hsa:79058; Q7Z6N7; Q8WV59; Q96LS5; Q96M40; Q9BZE9","ENSG00000169696","Translocation of SLC2A4 (GLUT4) to the plasma membrane",NA,1,0,90.9,85.8,96.1,101.1,125.4,92.4,118.1,93.1,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S500(100)]",0,"ENSG00000169696"
"1629","SLC12A2",-0.00169899865187872,6.53475269112416,-0.0128816522770309,0.989986259778824,0.991809438894439,-7.00762990283586,"NONE",FALSE,"High","Master Protein","P55011","Solute carrier family 12 member 2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1212,131.4,6.4,4.39,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522, Pf08403","6558","hsa:6558; P55011; Q8N713; Q8WWH7","ENSG00000064651","Cation-coupled Chloride cotransporters","Polycystic kidney disease pathway",2,0,107.4,119.5,106.2,90.8,58.8,98.8,83.9,99.5,83.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S940(99.4)]",0,"ENSG00000064651"
"1630","KIDINS220",-0.000824232234726274,6.65444208715491,-0.0120710836529947,0.990616332187717,0.99183181234991,-7.00764098059028,"NONE",FALSE,"High","Master Protein","Q9ULH0","Kinase D-interacting substrate of 220 kDa [OS=Homo sapiens]",0,45.176,4,5,6,7,5,1771,196.4,6.62,25.08,5,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf07693, Pf12796","57498","A1L4N4; Q4VC08; Q6MZU2; Q9H889; Q9H9E4; Q9NT37; Q9UF42; Q9ULH0","ENSG00000134313","RND2 GTPase cycle; RND1 GTPase cycle; ARMS-mediated activation","Brain-derived neurotrophic factor (BDNF) signaling pathway; Neural crest cell migration in cancer",5,0,95.1,96.7,101.4,102.1,95.1,104.8,105.8,99.9,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S918(100); S1526(100); S1555(100); S1633(100); S1681(98.8)]",0,"ENSG00000134313"
"1631","KDM5A",0.000870898247900875,6.61574964572885,0.010548785743056,0.991799665101076,0.992407758090102,-7.00765984028966,"NONE",FALSE,"High","Master Protein","P29375","Lysine-specific demethylase 5A [OS=Homo sapiens]",0,7.947,2,2,2,3,2,1690,192,6.49,4.41,2,"cell organization and biogenesis;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00628, Pf01388, Pf02373, Pf02375, Pf02928, Pf08429, Pf21323","5927","A8MV76; hsa:5927; P29375; Q4LE72; Q86XZ1","ENSG00000073614","HDMs demethylate histones; Chromatin modifications during the maternal to zygotic transition (MZT)",NA,2,0,97.4,101.4,95.9,88.9,97.7,105.2,103.3,99.7,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(96.6); S1331(99.5)]",0,"ENSG00000073614"
"1632","EPB41L4B",0.00110638825112463,6.6844135464195,0.00859648691122931,0.993317282360539,0.993317282360539,-7.00768031201804,"NONE",FALSE,"High","Master Protein","Q9H329","Band 4.1-like protein 4B [OS=Homo sapiens]",0,12.021,2,1,1,1,1,900,99.7,9.04,3.46,1,"cell organization and biogenesis;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf00373, Pf08736, Pf09379, Pf09380","54566","hsa:54566; Q5T4G5; Q5T4G6; Q9H328; Q9H329; Q9P2V3","ENSG00000095203",NA,"Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",2,0,85.6,92.4,78,128.4,88.4,113,116,111.4,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S602(100)]",0,"ENSG00000095203"
